Citrus Sinensis ID: 003704
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 801 | 2.2.26 [Sep-21-2011] | |||||||
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | yes | no | 0.927 | 0.957 | 0.678 | 0.0 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.932 | 0.963 | 0.608 | 0.0 | |
| Q8RWZ1 | 768 | Protein STRUBBELIG OS=Ara | no | no | 0.905 | 0.944 | 0.452 | 0.0 | |
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | no | no | 0.863 | 0.962 | 0.393 | 1e-141 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.369 | 0.421 | 0.644 | 1e-112 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.389 | 0.435 | 0.531 | 2e-92 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.368 | 0.422 | 0.539 | 2e-84 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.385 | 0.449 | 0.474 | 5e-75 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.411 | 0.448 | 0.428 | 7e-71 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.362 | 0.792 | 0.429 | 8e-63 |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/772 (67%), Positives = 606/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T+ S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/787 (60%), Positives = 581/787 (73%), Gaps = 40/787 (5%)
Query: 20 FVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNAS 79
F+ F LI S A+TNP+DVAAINSL+ AL SP+LPGWVAS GDPCGESWQGV CNAS
Sbjct: 17 FLSFALISLPSLSLALTNPDDVAAINSLFLALESPLLPGWVASGGDPCGESWQGVLCNAS 76
Query: 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSG 139
+ IIL ANLGGELG L F+S++ +D SNNHIGGSIPS LPV++QN FLS N F+G
Sbjct: 77 QVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSGNNFTG 136
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+IP SL++L L+ MSLNNNLLSG+IPD FQ L +IN+DLSSNNLSG LPPS++NLS L
Sbjct: 137 TIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNLSTL 196
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPS 259
T+L LQNN LSG LDVLQDLPL+DLN+ENNLF+GPIPEK+L IPNF K GN FN T+APS
Sbjct: 197 TSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTIAPS 256
Query: 260 RPPTSSVTPPPAP-PFFGPRPVSGSSPVS----RTPPSQHTPGKQADGPTALEDSNSGKK 314
P + +P PFFGP + S+ R+PPS H P + PT GK+
Sbjct: 257 PSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSR----PTP-----QGKE 307
Query: 315 KSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEA 374
S T+K+I+WISI G FV+LALV LL +C+++R + +++ K H + G RE +
Sbjct: 308 DSFTSKRIIWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEY-GRAREGS 366
Query: 375 RDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEI 434
R N ++ P+N KD +PKE R+G ER+ + + +++ HEI
Sbjct: 367 RSNASMLPPSNTFNKDKEARPKE-------RVGGASKLHGGAERS---VGSESKQESHEI 416
Query: 435 DMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFT 494
DM+ M +M P PP +++VI K PAE + +T++K+ P T
Sbjct: 417 DMNGNAMDLMHPSSIPP---------------IKRVIAKATEPAEASLKRTTSKSHGPLT 461
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
+ FT+ASLQQ+TNSFS ENLIG GMLGSVYRA+LP GKL AV+KLDK++ + +++ +F
Sbjct: 462 AVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEGKF 521
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LELVNNIDRIRHANIV+L G+C+EH QRLLI+EYC NGTL D+LH DD LK LSWN R+
Sbjct: 522 LELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNVRV 581
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
R+AL AA+ALEYLHEIC PP +HRNFKSANILLDDD+ V VSDCGLAPLISSG+VSQLSG
Sbjct: 582 RIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQLSG 641
Query: 675 HLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
LL AYGYGAPEFE GIYT + DVYSFGVVMLELLTGRKSYD+ R+RGEQFLVRWAIPQL
Sbjct: 642 QLLAAYGYGAPEFEYGIYTMKCDVYSFGVVMLELLTGRKSYDKKRDRGEQFLVRWAIPQL 701
Query: 735 HDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794
HDIDAL++MVDPSL G YPAKSLSHFAD+ISRCVQSEPE+RP MSEVVQDL DMI+RE
Sbjct: 702 HDIDALAKMVDPSLKGDYPAKSLSHFADVISRCVQSEPEYRPLMSEVVQDLSDMIQREHR 761
Query: 795 SNESLGD 801
N+S GD
Sbjct: 762 RNDSNGD 768
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8RWZ1|SUB_ARATH Protein STRUBBELIG OS=Arabidopsis thaliana GN=SUB PE=1 SV=1 | Back alignment and function description |
|---|
Score = 636 bits (1640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/815 (45%), Positives = 501/815 (61%), Gaps = 90/815 (11%)
Query: 13 WKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQ 72
W++ FF VL FS VTN DV+AIN+LY LG+P L W+A GDPCGE WQ
Sbjct: 6 WEV---FFGLSVLALTMPFSAGVTNLRDVSAINNLYITLGAPSLHHWLAFGGDPCGEKWQ 62
Query: 73 GVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFL 132
GV C++S+I I + G +GG L + L FSSI+V+D S+NHI G+IP LP +++N L
Sbjct: 63 GVVCDSSNITEIRIPGMKVGGGLSDTLADFSSIQVMDFSSNHISGTIPQALPSSIRNLSL 122
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
S N+F+G+IP +L+ L+ L+++SL +NLLSGEIPD FQ L+ L LDLSSN L G LP S
Sbjct: 123 SSNRFTGNIPFTLSFLSDLSELSLGSNLLSGEIPDYFQQLSKLTKLDLSSNILEGHLPSS 182
Query: 193 LENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPF 252
+ +L+ L L+LQ+N+L+GTLDV++DL L DLN+ENNLFSGPIP +L+IPNF+KDG PF
Sbjct: 183 MGDLASLKILYLQDNKLTGTLDVIEDLFLTDLNVENNLFSGPIPPNLLKIPNFKKDGTPF 242
Query: 253 NSTVAPSRPPTSSVTPPP---APPFFGPRPVSG--------------------SSPVSRT 289
N+++ PP PP APP PVSG S P+ +
Sbjct: 243 NTSIITPPPPPVVDPPPATHRAPPVPRIPPVSGVPPAPFAPFAPLQPQQHPPPSPPLVWS 302
Query: 290 PPSQHT----PGKQADGPTALE---DSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLL 342
PPS P G L+ S SG K +T++I+ + + ++ ++ L L
Sbjct: 303 PPSSDNGGGDPWNSVSGQPTLQISPPSGSGSGKFWSTQRIILVVSSVAIIVLVSGLCVTL 362
Query: 343 FMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLALPT-NQMEKDASVKPKEDHRS 401
+ RC + +I+ R+ GA + R + PT ++ ++ VKP + + +
Sbjct: 363 W--RCCR-----SKIYNRYYSGARKDLQRPYFNKPPSQPTPTMGKVSREPMVKPFDGYGA 415
Query: 402 EMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPP 461
R+ G P Q +E + +P + D+++
Sbjct: 416 GDRKYG-YPMPQRAEESRR----AMPPTSYYNKDVNT----------------------- 447
Query: 462 PPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPF-------TTARSFTIASLQQYTNSFSQE 514
P P+ + P + + T++K A F ++A FTIASLQQYTN+FS+E
Sbjct: 448 PQKPLQQP-------PRQFQSNDTASKRAAHFPPGLNSSSSATVFTIASLQQYTNNFSEE 500
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
N+IG G +G+VYRA+L GK LAVKKL + Q D EFL LV+N+ +++ +I+EL G
Sbjct: 501 NIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQSDGEFLNLVSNVLKLKRGHILELLG 560
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
YC E GQRLL+YEYC NG+LQD LH D +L L+WN RI +ALGA++AL++LHE+CQPP
Sbjct: 561 YCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLTWNVRINIALGASKALQFLHEVCQPP 620
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTC 694
+VH+NFKS+ +LLD L+V V+D GLA ++ SQ++ GY APE E G YTC
Sbjct: 621 VVHQNFKSSKVLLDGKLSVRVADSGLAYMLPPRPTSQMA-------GYAAPEVEYGSYTC 673
Query: 695 QSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA 754
QSDV+S GVVMLELLTGR+ +DRTR RG Q L +WAIP+LHDIDAL+RMVDPSL G YP
Sbjct: 674 QSDVFSLGVVMLELLTGRRPFDRTRPRGHQTLAQWAIPRLHDIDALTRMVDPSLHGAYPM 733
Query: 755 KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
KSLS FADIISR +Q EP FRPP+SE+VQDL MI
Sbjct: 734 KSLSRFADIISRSLQMEPGFRPPISEIVQDLQHMI 768
|
Regulates the expression of transcription factors that define the cell fates. Seems to be required for the regulation of cell shape and the orientation of the mitotic division plane. Involved in root hair specification, in the formation of the outer integument and the shape of organs such as carpels and petals and is necessary for the shape and height of the stem. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1293), Expect = e-141, Method: Compositional matrix adjust.
Identities = 314/798 (39%), Positives = 432/798 (54%), Gaps = 106/798 (13%)
Query: 11 KNWKIYANF---FVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPV-LPGWVASAGDP 66
+NW + A F VGF L + G T+ +D +A+N+L++ + SP L W A+AGDP
Sbjct: 3 ENWAVVALFTLCIVGFELRFIHG----ATDASDTSALNTLFSGMHSPAQLTQWTAAAGDP 58
Query: 67 CGESWQGVQCNASDIIAIILNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSILPV 125
CG++W+GV C+ S + I L+G L G LG L +S+ +DLS+N++GG +P P
Sbjct: 59 CGQNWRGVTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPP 118
Query: 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
+Q L++NQF+G+ SL+ +T L ++L +N G+I F L L LD S N+
Sbjct: 119 NLQRLNLANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSF 178
Query: 186 SGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNF 245
+ LP + +L+ L +L+LQNNQ SGT+DVL LPL LNI NN F+G IP + I
Sbjct: 179 TNSLPATFSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TL 237
Query: 246 RKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTA 305
KDGN FN+ AP PP + R PS+ + G+++
Sbjct: 238 IKDGNSFNTGPAPPPPPGTPPI--------------------RGSPSRKSGGRESRSSDE 277
Query: 306 LEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGA 365
N KKS + I +L+ L + F LF + KR +D
Sbjct: 278 -STRNGDSKKSGIGAGAIAGIIISLLVVTALLVAFFLFRRKKSKRSSPMDI--------- 327
Query: 366 FRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMST 425
E DN L +N ++ S+ Q+ +++ T
Sbjct: 328 -------EKTDNQPFTLASNDFHENNSI-------------------QSSSSVETKKLDT 361
Query: 426 IPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKT 485
SL + + PPP P V + +V P
Sbjct: 362 ------------SLSINLRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVP----------- 398
Query: 486 STKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRA 545
+ R +++A LQ T SFS +NL+G G G VYRA+ DGK+LAVKK+D A
Sbjct: 399 --------SNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKIDSSA 450
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
D+F+E+V+ I + H N+ +L GYCAEHGQ L++YE+ NG+L D LH +E
Sbjct: 451 LPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLSEEES 510
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
L WN+R+++ALG ARALEYLHE+C P IV +N KSANILLD +L +SD GLA +
Sbjct: 511 KALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLASFLP 570
Query: 666 SGSVSQLSGHLL--TAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRG 722
+ + LL T GY APE SG Y+ +SD+YSFGVVMLELLTGRK +D TR+R
Sbjct: 571 TAN------ELLNQTDEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFDSTRSRS 624
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
EQ LVRWA PQLHDIDAL++MVDP+L G YP KSLS FAD+I+ CVQ EPEFRPPMSEVV
Sbjct: 625 EQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVV 684
Query: 783 QDLVDMIRRERCSNESLG 800
Q LV +++R S ++G
Sbjct: 685 QALVVLVQRANMSKRTVG 702
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1045), Expect = e-112, Method: Compositional matrix adjust.
Identities = 192/298 (64%), Positives = 237/298 (79%), Gaps = 2/298 (0%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
TA +T++SLQ TNSFSQEN+IG G LG VYRA+ P+GK++A+KK+D A S Q++D F
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LE V+N+ R+RH NIV L GYC EHGQRLL+YEY NG L D LH++D+ NL+WN R+
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
++ALG A+ALEYLHE+C P IVHRNFKSANILLD++L +SD GLA L + + Q+S
Sbjct: 499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAAL-TPNTERQVST 557
Query: 675 HLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
++ ++GY APEF SGIYT +SDVY+FGVVMLELLTGRK D +R R EQ LVRWA PQ
Sbjct: 558 QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQ 617
Query: 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
LHDIDALS+MVDPSL+G YPAKSLS FADII+ C+Q EPEFRPPMSEVVQ LV +++R
Sbjct: 618 LHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLVQR 675
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 175/329 (53%), Positives = 216/329 (65%), Gaps = 17/329 (5%)
Query: 455 PPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQE 514
PPP + + KPIV + V S ++T++ LQ TNSFS +
Sbjct: 371 PPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSN--------VNTYTVSDLQVATNSFSVD 422
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
NL+G G G VYRAQ DGK+LAVKK+D A D+F E+V+ I + H N+ +L G
Sbjct: 423 NLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHENVTKLDG 482
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
YC+EHGQ L++YE+ NG+L D LH +E L WN R+++ALG ARALEYLHE+C P
Sbjct: 483 YCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYLHEVCSPS 542
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA--YGYGAPEFE-SGI 691
IVH+N KSANILLD +L +SD GLA + + + LL GY APE SG
Sbjct: 543 IVHKNIKSANILLDSELNPHLSDSGLASFLPTAN------ELLNQNDEGYSAPETSMSGQ 596
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
Y+ +SDVYSFGVVMLELLTGRK +D TR+R EQ LVRWA PQLHDIDAL +MVDP+L G
Sbjct: 597 YSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSLVRWATPQLHDIDALGKMVDPALKGL 656
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSE 780
YP KSLS FAD+I+ CVQ EPEFRPPMSE
Sbjct: 657 YPVKSLSRFADVIALCVQPEPEFRPPMSE 685
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 165/306 (53%), Positives = 204/306 (66%), Gaps = 11/306 (3%)
Query: 490 AKPFTTARS---FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRAS 546
AK T+ RS F ++ LQ T +FS NL+G G +G VYRA+ DG+ LAVKK+D
Sbjct: 380 AKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLF 439
Query: 547 SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN 606
K + +V ++ +IRH NI EL GYC+E G +L+YEY NG+L + LH D
Sbjct: 440 DSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSK 499
Query: 607 NLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
L+WNTR+R+ALG ARA+EYLHE C P ++H+N KS+NILLD DL +SD GL+
Sbjct: 500 PLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYL- 558
Query: 667 GSVSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
SQ G GY APE YT +SDVYSFGVVMLELLTGR +D + R E+
Sbjct: 559 -RTSQNLGE-----GYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFDGEKPRPERS 612
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
LVRWA PQLHDIDALS + DP+L G YP KSLS FADII+ CVQ EPEFRPPMSEVV+ L
Sbjct: 613 LVRWATPQLHDIDALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEAL 672
Query: 786 VDMIRR 791
V M++R
Sbjct: 673 VRMVQR 678
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (723), Expect = 5e-75, Method: Compositional matrix adjust.
Identities = 151/318 (47%), Positives = 203/318 (63%), Gaps = 9/318 (2%)
Query: 474 PIVPAEGTAVKTSTKTAKPFTTA-RSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPD 532
P T ++ST P T ++F++A LQ + FS L+G G +G VY+A+ D
Sbjct: 377 PSTQVAATPDRSSTSQDSPDTRGVKAFSLADLQNTASCFSPNRLLGEGTIGRVYKAKFQD 436
Query: 533 GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592
G+ AVK++D + +EF +V++I I H N+ EL GYC+E G+ +L+YEY ++G
Sbjct: 437 GRKFAVKEIDSSLLGKGNPEEFSHIVSSISSIHHKNMAELVGYCSEQGRNMLVYEYFTSG 496
Query: 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652
+L LH D+ L+WNTRIR+ALG A+A+EYLHE C PP+VH+N KS+NILLD++L
Sbjct: 497 SLHRFLHLSDDFSKPLTWNTRIRIALGTAKAIEYLHETCSPPLVHKNIKSSNILLDNELN 556
Query: 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTG 711
+SD GLA S + GY APE + YT +SDVYSFGVVMLELLTG
Sbjct: 557 PRLSDYGLANFHHRTSQN-------LGVGYNAPECTDPSAYTQKSDVYSFGVVMLELLTG 609
Query: 712 RKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSE 771
RK YD R + EQ LVRWA PQL D+D L MVDP+L G Y +S+S FADI+S CV +E
Sbjct: 610 RKPYDSGRPKAEQSLVRWAKPQLKDMDTLDEMVDPALCGLYAPESVSSFADIVSICVMTE 669
Query: 772 PEFRPPMSEVVQDLVDMI 789
P RPP+S VV+ L ++
Sbjct: 670 PGLRPPVSNVVEALKRLV 687
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 144/336 (42%), Positives = 220/336 (65%), Gaps = 6/336 (1%)
Query: 461 PPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAG 520
PPP P + + P+ + K+ + T + + A+ F+ A LQ TN FS+ENL+G G
Sbjct: 365 PPPAPQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEG 424
Query: 521 MLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580
LGSVYRA+LPDG+ V+ + + S ++++F E++ ++RH NIV L G+C E+G
Sbjct: 425 PLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENG 484
Query: 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF 640
+ LL+YEY + +L + +H DE+ LSW R+R+A+G ARAL+YLH PPI H +
Sbjct: 485 EHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDL 542
Query: 641 KSANILLDDDLAVSVSDCGLAPL--ISSGSVSQLSGHL-LTAYGYGAPEF-ESGIYTCQS 696
K+ NILLD++L ++DCGLA L ++S SV + + + GY APE + G +S
Sbjct: 543 KATNILLDEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKS 602
Query: 697 DVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKS 756
D Y+ GV++LELLTGRK++D +R RGEQ LV+WA +LHD +L +M+D ++G + ++
Sbjct: 603 DTYALGVLLLELLTGRKAFDSSRPRGEQLLVKWASTRLHDRRSLEQMIDGGIAGTFSSRV 662
Query: 757 LSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
S +ADIIS C Q+E EFRPP+SE+V+ L +I+++
Sbjct: 663 ASQYADIISLCTQAEKEFRPPVSEIVEALTALIQKQ 698
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 128/298 (42%), Positives = 190/298 (63%), Gaps = 8/298 (2%)
Query: 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
++ +++ T++F ++LIG G G VY A L DGK +A+KKLD A + + EFL V
Sbjct: 59 LSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDV-APEAETNTEFLNQV 117
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN-----NLSWNTR 613
+ + R++H N+++L GYC + R+L YE+ + G+L D+LH ++ L W TR
Sbjct: 118 SMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTR 177
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+++A+ AAR LEYLHE QPP++HR+ +S+N+LL +D V+D L+ + S
Sbjct: 178 VKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHS 237
Query: 674 GHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732
+L +GY APE+ +G T +SDVYSFGVV+LELLTGRK D T RG+Q LV WA P
Sbjct: 238 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 297
Query: 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+L + D + + VDP L G+YP KS++ A + + CVQ E EFRP MS VV+ L +++
Sbjct: 298 RLSE-DKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLK 354
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 801 | ||||||
| 356547026 | 784 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.965 | 0.985 | 0.692 | 0.0 | |
| 356542131 | 784 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.965 | 0.985 | 0.677 | 0.0 | |
| 255553857 | 709 | lrr receptor-linked protein kinase, puta | 0.883 | 0.998 | 0.672 | 0.0 | |
| 297739262 | 781 | unnamed protein product [Vitis vinifera] | 0.973 | 0.998 | 0.698 | 0.0 | |
| 304281946 | 776 | strubbelig receptor family 3 [Arabidopsi | 0.927 | 0.957 | 0.678 | 0.0 | |
| 304281933 | 776 | SRF3 [Arabidopsis thaliana] | 0.927 | 0.957 | 0.678 | 0.0 | |
| 42566272 | 776 | STRUBBELIG-receptor family 3 [Arabidopsi | 0.927 | 0.957 | 0.678 | 0.0 | |
| 304281935 | 776 | SRF3 [Arabidopsis thaliana] | 0.927 | 0.957 | 0.677 | 0.0 | |
| 297809795 | 776 | hypothetical protein ARALYDRAFT_490225 [ | 0.927 | 0.957 | 0.676 | 0.0 | |
| 449479018 | 791 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.968 | 0.981 | 0.686 | 0.0 |
| >gi|356547026|ref|XP_003541919.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1064 bits (2751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/807 (69%), Positives = 642/807 (79%), Gaps = 34/807 (4%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFV--LIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPG 58
MG +RS + K KIY +GF+ LI FS A T+P DVAAIN LY ALG+PVLPG
Sbjct: 1 MGEERSGSQNKRVKIYGEVLLGFIIMLICTVQFSLADTDPIDVAAINRLYTALGNPVLPG 60
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGS 118
WV+SAGDPCGE WQGVQCN S I IILNGANLGGELG++LG+F SIR I L+NNHIGG+
Sbjct: 61 WVSSAGDPCGEGWQGVQCNGSVIQEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGN 120
Query: 119 IPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINL 178
IPS LPVT+Q+FFLSDNQF+GSIP+SL+TLT LTDMSLN NLL+GEIPDAFQSLT LINL
Sbjct: 121 IPSSLPVTLQHFFLSDNQFTGSIPASLSTLTELTDMSLNGNLLTGEIPDAFQSLTQLINL 180
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238
DLS+NNLSGELPPS+ENLS LT++HLQNN LSGTLDVLQ LPL+DLN+ENN F+GPIP K
Sbjct: 181 DLSNNNLSGELPPSMENLSALTSVHLQNNNLSGTLDVLQGLPLQDLNVENNQFAGPIPPK 240
Query: 239 MLQIPNFRKDGNPFN----STVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQH 294
+L IP+FRKDGNPFN ST+AP+ PP S P PA P SG+ S TP S
Sbjct: 241 LLSIPSFRKDGNPFNLNGNSTIAPAHPPRS---PVPATP-------SGTV-ASVTPSSGR 289
Query: 295 TPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEV 354
P K +GPTA ++SNS K K +T KK+VWIS++G+L+F+IL L LLF+PRC KR V
Sbjct: 290 IPTKPTEGPTAAKESNSEKSKKNT-KKVVWISVSGILVFIILVLGLLLFVPRCSKREW-V 347
Query: 355 DRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEK---DASVKPKEDHRSEMRRMGAIPH 411
+R K+HQVGA+ G R+ R+ G P NQ EK A V+PK DH+ E RR+ AIP+
Sbjct: 348 NRSSKQHQVGAY-GVERQNPREYGAFVQPPNQTEKVPKGAIVRPKGDHQEEARRVRAIPN 406
Query: 412 AQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVI 471
Q EQE+++QRM TIP+ +HEIDMSSLD+ MP PPPPPPP VE+VI
Sbjct: 407 PQGEQEKDEQRMETIPKLLEHEIDMSSLDVFSMPSPPPPPPPL-----------PVERVI 455
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLP 531
V+P + + + K+ P T A++FTIASLQQYTNSFSQ+NLIG GMLGSVYRA+LP
Sbjct: 456 VEPTLFHKEANINPPKKSPVPPTFAKTFTIASLQQYTNSFSQDNLIGLGMLGSVYRAELP 515
Query: 532 DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
DGK+LAVKKLDKR S QQ DDEFLEL+N+IDRIRH NIVEL GYCAEHGQRLLIYEYCSN
Sbjct: 516 DGKILAVKKLDKRVSDQQTDDEFLELINSIDRIRHPNIVELIGYCAEHGQRLLIYEYCSN 575
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+LQD LHSDDE K LSWN RIR+ALGAARALEYLHE QP +VHRNFKSANILLDDD+
Sbjct: 576 GSLQDALHSDDEFKTRLSWNARIRIALGAARALEYLHEQFQPSVVHRNFKSANILLDDDV 635
Query: 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTG 711
+V VSDCGLAPLI+ GSVSQLSG LLTAYGYGAPEFESGIYT QSD+YSFGVVMLELLTG
Sbjct: 636 SVRVSDCGLAPLITKGSVSQLSGQLLTAYGYGAPEFESGIYTYQSDIYSFGVVMLELLTG 695
Query: 712 RKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSE 771
R+SYDRTR RGEQFLVRWAIPQLHDIDALS+MVDPSL G YPAKSLS+FADIISRCVQSE
Sbjct: 696 RQSYDRTRPRGEQFLVRWAIPQLHDIDALSKMVDPSLKGNYPAKSLSNFADIISRCVQSE 755
Query: 772 PEFRPPMSEVVQDLVDMIRRERCSNES 798
PEFRP MSEVV L++MIR+E +ES
Sbjct: 756 PEFRPAMSEVVLYLINMIRKESQQSES 782
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542131|ref|XP_003539524.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1051 bits (2717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/807 (67%), Positives = 634/807 (78%), Gaps = 34/807 (4%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFV--LIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPG 58
MG +RS ++ K KI+ +GF+ LI FS A T+P DVAAIN LY ALG+PVLPG
Sbjct: 1 MGEERSGLQNKRVKIHGEVLLGFIIMLICTIQFSVADTDPVDVAAINRLYTALGNPVLPG 60
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGS 118
WV+SAGDPCG+ WQGVQCN S I IILNGANLGGELG++LG+F SIR I L+NNHIGGS
Sbjct: 61 WVSSAGDPCGQGWQGVQCNGSVIQEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGS 120
Query: 119 IPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINL 178
IPS LPVT+Q+FFLSDNQF+GSIP+SL+TLT LTDMSLN+NLL+GE+PDAFQSL LINL
Sbjct: 121 IPSSLPVTLQHFFLSDNQFTGSIPASLSTLTELTDMSLNDNLLTGEVPDAFQSLMQLINL 180
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238
DLS+NNLSGELPPS+ENLS LT++HLQNN+LSGTLDVLQDLPL+DLN+ENN F+GPIP K
Sbjct: 181 DLSNNNLSGELPPSMENLSALTSVHLQNNKLSGTLDVLQDLPLQDLNVENNQFAGPIPPK 240
Query: 239 MLQIPNFRKDGNPFN----STVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQH 294
+L IP+FRKDGNPFN ST+AP+ PP S VT P + VS TP S
Sbjct: 241 LLSIPSFRKDGNPFNLNDNSTIAPAHPPHSPVTASPT-----------GTVVSVTPSSGR 289
Query: 295 TPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEV 354
P K GPTA ++SNSGK K +T KK+VWISI+G+L+F+IL L LLF+PRC RR V
Sbjct: 290 VPTKPTKGPTAAKESNSGKSKKNT-KKVVWISISGILVFIILVLGLLLFVPRC-SRRERV 347
Query: 355 DRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEK---DASVKPKEDHRSEMRRMGAIPH 411
+R K+HQVGA+ G R+ RD G P +Q EK A V+ K DH+ E RR+ IP
Sbjct: 348 NRSSKQHQVGAY-GGERQNPRDYGAFVQPPSQTEKVPKGAVVRLKGDHQEEARRLRTIPK 406
Query: 412 AQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVI 471
Q EQE+++QRM TIP+ +HEIDMSSLD+ MP PPPPPPP E+VI
Sbjct: 407 PQGEQEKDEQRMETIPKLLEHEIDMSSLDVFSMPSPPPPPPPL-----------PAERVI 455
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLP 531
V+ + + K+ P T ++FTIASLQQYTNSFSQ+NLIG GMLGSVYRA+LP
Sbjct: 456 VESASFHKEANINPPKKSPVPPTFVKTFTIASLQQYTNSFSQDNLIGLGMLGSVYRAELP 515
Query: 532 DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
DGK+LAVKKLDKR S Q DDEFLEL+N+IDRIRH NIVEL GYCAEHGQRLLIYEYCSN
Sbjct: 516 DGKILAVKKLDKRVSDHQTDDEFLELINSIDRIRHPNIVELIGYCAEHGQRLLIYEYCSN 575
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+LQD LHS DE K LSWN RIR+ALGAAR+LEYLHE QPP+VHRNFKSA+ILL DD+
Sbjct: 576 GSLQDALHSHDEFKTRLSWNARIRIALGAARSLEYLHEQFQPPVVHRNFKSASILLYDDV 635
Query: 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTG 711
+V VSDCGL+PLI+ GSVSQLSG LLTAYGYGAPEFESGIYT QSDVYSFGVVMLELLTG
Sbjct: 636 SVRVSDCGLSPLITKGSVSQLSGQLLTAYGYGAPEFESGIYTYQSDVYSFGVVMLELLTG 695
Query: 712 RKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSE 771
R+SYDRTR RGEQFLVRWAIPQLHDIDALS+MVDPSL G YPAKSLS+FADIISRCVQSE
Sbjct: 696 RQSYDRTRPRGEQFLVRWAIPQLHDIDALSKMVDPSLKGNYPAKSLSNFADIISRCVQSE 755
Query: 772 PEFRPPMSEVVQDLVDMIRRERCSNES 798
PEFRP MSEVV L++MIR+E ++S
Sbjct: 756 PEFRPAMSEVVLYLINMIRKENQKSQS 782
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553857|ref|XP_002517969.1| lrr receptor-linked protein kinase, putative [Ricinus communis] gi|223542951|gb|EEF44487.1| lrr receptor-linked protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/802 (67%), Positives = 604/802 (75%), Gaps = 94/802 (11%)
Query: 1 MGVKRSNIECKN-WKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGW 59
MG KRS E + +IY FVGFVLI++A S VTNP+DVAAINSLY++LGSP+LPGW
Sbjct: 1 MGTKRSGKEEYSVLEIYLKVFVGFVLIYSATISYGVTNPSDVAAINSLYSSLGSPILPGW 60
Query: 60 VASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSI 119
VAS GDPCGE WQGV C ASDI +I DLS+N IGGSI
Sbjct: 61 VASGGDPCGELWQGVACEASDITSI------------------------DLSSNRIGGSI 96
Query: 120 PSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLD 179
PS LPVTMQNFFL+ N F+GSIP S+++LTLLT MSLNNN LSGEIPD+FQ L GLINLD
Sbjct: 97 PSNLPVTMQNFFLAANNFTGSIPDSISSLTLLTAMSLNNNFLSGEIPDSFQFLAGLINLD 156
Query: 180 LSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKM 239
LSSNN SG+LPPS ENL LTTL LQ NQLSGTL+VL+DLPL+DLNIENNLFSGPIPEK+
Sbjct: 157 LSSNNFSGQLPPSFENLIHLTTLRLQENQLSGTLNVLEDLPLKDLNIENNLFSGPIPEKL 216
Query: 240 LQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQ 299
L IP+FRKDGNPFN++ AP PTS +TPPPAP +SG+ +P S TPGKQ
Sbjct: 217 LAIPDFRKDGNPFNNSTAPLPAPTSPLTPPPAPG------LSGAPSSPSSPSSGKTPGKQ 270
Query: 300 ADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFK 359
DGP++ E+S+SG+KK TTK++VWISIAGVLLFVILA+ +LFMPRC +RR E RIFK
Sbjct: 271 IDGPSSPEESSSGEKKFLTTKRVVWISIAGVLLFVILAIALVLFMPRCSRRREEAGRIFK 330
Query: 360 RHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERN 419
RHQVGA +GN RE RD+G+L PTN E E+
Sbjct: 331 RHQVGADKGN-RENPRDHGSLDQPTN-----------------------------ETEKV 360
Query: 420 KQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
+ +P+ D P + VIV P VP E
Sbjct: 361 SKEALALPKEDH---------------------------------PKPQTVIVTPTVPTE 387
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
+ K K P T+ARSFTIASLQQYTNSFSQENLIG GMLG+VYRA+LP+GKLLAVK
Sbjct: 388 ASTAKPPIKAQNPLTSARSFTIASLQQYTNSFSQENLIGGGMLGNVYRAELPNGKLLAVK 447
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
KLD++ASSQQKDDEF+ELVNNIDRIRHAN+VEL GYCAEHGQRLLIYEYCSNGTLQD LH
Sbjct: 448 KLDQKASSQQKDDEFIELVNNIDRIRHANVVELMGYCAEHGQRLLIYEYCSNGTLQDALH 507
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
SDDELK LSWNTRIRMALGAARALEYLHE+CQPP+VHRNFKS NILLDDDL V VSDCG
Sbjct: 508 SDDELKKKLSWNTRIRMALGAARALEYLHEVCQPPVVHRNFKSVNILLDDDLDVRVSDCG 567
Query: 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTR 719
LAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYT SDV+SFGVVMLELLTGR SYDRTR
Sbjct: 568 LAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTVHSDVFSFGVVMLELLTGRTSYDRTR 627
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779
R EQFLVRWAIPQLHDIDALS+MVDPSL+G+YPAKSLSHFADIISRCVQ++PEFRPPMS
Sbjct: 628 TRNEQFLVRWAIPQLHDIDALSKMVDPSLNGEYPAKSLSHFADIISRCVQNQPEFRPPMS 687
Query: 780 EVVQDLVDMIRRERCSNESLGD 801
EVVQDL DMIRRER S ES+G+
Sbjct: 688 EVVQDLTDMIRRERPSRESIGE 709
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739262|emb|CBI28913.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/802 (69%), Positives = 646/802 (80%), Gaps = 22/802 (2%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWV 60
MG KRS I+C N +IYA FVGFVLI+AA T+P DV AIN+LYAALGSP+LPGWV
Sbjct: 1 MGGKRSAIDCLNLEIYAQTFVGFVLIFAAQVLLGYTSPGDVTAINNLYAALGSPLLPGWV 60
Query: 61 ASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP 120
++ GDPC ++WQGV CN S+I +IILNGANLGGELG++LG F+SI+VIDLSNN IGGSIP
Sbjct: 61 STGGDPCADAWQGVSCNGSEINSIILNGANLGGELGDSLGTFASIKVIDLSNNQIGGSIP 120
Query: 121 SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDL 180
S LP+T+QNFFLS NQF+GSIP+SL++L+LLTDMSLNNNLL+GEIPDAFQ+L GLINLDL
Sbjct: 121 SSLPLTLQNFFLSANQFTGSIPTSLSSLSLLTDMSLNNNLLTGEIPDAFQALVGLINLDL 180
Query: 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKML 240
SSN+LSG+LPPS+ENLS LTTL LQ NQLSGTLDVLQDLPL+DLN+ENNLFSG IP+K+L
Sbjct: 181 SSNHLSGQLPPSMENLSSLTTLRLQINQLSGTLDVLQDLPLKDLNVENNLFSGTIPDKLL 240
Query: 241 QIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQA 300
IPNFRKDGNPF + AP PTS +T P PP P S PV K A
Sbjct: 241 SIPNFRKDGNPFGNVTAPLLAPTSPLTLPSPPPPLSGPPSSNQPPV-----------KPA 289
Query: 301 DGPTALEDSNS-GKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFK 359
DGP+A E+SNS GK K +TK+IVWISI VL+F+IL L +L + C R E D I K
Sbjct: 290 DGPSATEESNSGGKGKGLSTKRIVWISITVVLVFIILVLALVLLVKWCCGERQESDWISK 349
Query: 360 RHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERN 419
R++ GA++G +R RDNG+L Q+ K+A PKE+H+ +RR+G P QNEQ+RN
Sbjct: 350 RNETGAYKG-SRLNLRDNGSL---EQQVPKEAVGTPKEEHQEVVRRIGVAPKPQNEQDRN 405
Query: 420 KQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
+RM TIP++D HEID+S LD+MM PPPPPPPPPPPPPPPPP+VE VIV PIVP E
Sbjct: 406 VERMFTIPKQDSHEIDISGLDVMMP----PPPPPPPPPPPPPPPPPLVETVIVNPIVPVE 461
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
A K S KT P +ARSFTIASLQQYTNSFSQENLIG+GMLG+VYRAQLP GKLLAVK
Sbjct: 462 VNAEKPSMKTLNPPISARSFTIASLQQYTNSFSQENLIGSGMLGTVYRAQLPGGKLLAVK 521
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
KLDK+ +QQKDDEF +LVN+ID IRHAN+VEL GYCAEHG+RLLIYEYCS+GTL D LH
Sbjct: 522 KLDKKICNQQKDDEFFDLVNSIDGIRHANVVELMGYCAEHGERLLIYEYCSDGTLHDALH 581
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
SDDE K LSW+ R+RMALGAARAL+YLHE+C+PPIVHRNFKSAN+LLDD+L V VSDCG
Sbjct: 582 SDDEFKKKLSWSARVRMALGAARALQYLHEVCRPPIVHRNFKSANVLLDDELTVRVSDCG 641
Query: 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTR 719
LAPLIS SVSQLSG L+AYG APE ESGIYT +SDVYSFG VMLELLTGRKSYD R
Sbjct: 642 LAPLISRCSVSQLSGR-LSAYGCEAPEHESGIYTLKSDVYSFGAVMLELLTGRKSYDSKR 700
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779
NRGE+ LVRWAI QLHDIDALSRMVDPSL+G+YPAKSLS FADIISRCVQ EPEFRP MS
Sbjct: 701 NRGEKLLVRWAIHQLHDIDALSRMVDPSLNGEYPAKSLSRFADIISRCVQDEPEFRPQMS 760
Query: 780 EVVQDLVDMIRRERCSNESLGD 801
EVV DL+DMI++E SN S GD
Sbjct: 761 EVVDDLIDMIQKE-ASNRSNGD 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281946|gb|ADM21184.1| strubbelig receptor family 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2523), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/772 (67%), Positives = 606/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R +++G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKVGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVAVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281933|gb|ADM21173.1| SRF3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/772 (67%), Positives = 605/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566272|ref|NP_192248.2| STRUBBELIG-receptor family 3 [Arabidopsis thaliana] gi|75127761|sp|Q6R2K3.1|SRF3_ARATH RecName: Full=Protein STRUBBELIG-RECEPTOR FAMILY 3; AltName: Full=Leucine-rich repeat receptor kinase-like protein SRF3; Flags: Precursor gi|41323405|gb|AAR99871.1| strubbelig receptor family 3 [Arabidopsis thaliana] gi|224589608|gb|ACN59337.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332656913|gb|AEE82313.1| STRUBBELIG-receptor family 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/772 (67%), Positives = 606/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T+ S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281935|gb|ADM21174.1| SRF3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/772 (67%), Positives = 604/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GN FN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNLFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297809795|ref|XP_002872781.1| hypothetical protein ARALYDRAFT_490225 [Arabidopsis lyrata subsp. lyrata] gi|297318618|gb|EFH49040.1| hypothetical protein ARALYDRAFT_490225 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/772 (67%), Positives = 603/772 (78%), Gaps = 29/772 (3%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPADVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNNLSG LPPS+ENLS LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNLSGTLPPSMENLSTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLNEGNPFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TK+
Sbjct: 261 LSPSMSPTKPAPTRPFSGVPP----PPTERNRGKVADGPSDSEGSSSENSKGKNSSHTKR 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NG
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGLPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
P + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 PP-------PPARSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E K S K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLAEKVTVLPIISPERPVKKPSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
DRIRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ +ALGAA
Sbjct: 536 DRIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSIALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQLSG LL AYG
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLAAYG 655
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGEQFLVRWAIPQLHDIDAL
Sbjct: 656 YGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDIDALG 715
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQDL+DMIRRER
Sbjct: 716 KMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMIRRER 767
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449479018|ref|XP_004155482.1| PREDICTED: LOW QUALITY PROTEIN: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/798 (68%), Positives = 638/798 (79%), Gaps = 22/798 (2%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWV 60
MG KRS+ N +I+ VGFV + AA +TNP D +AI+SL+ ALG P LPGW
Sbjct: 1 MGWKRSS-RNGNLRIWVQVLVGFV-VCAAQVLLGITNPGDFSAISSLHTALGLPSLPGW- 57
Query: 61 ASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP 120
DPCG++WQGV CN S II II+N ANLGGELG+NLG FSSI+ IDLSNNHIGGSIP
Sbjct: 58 GIGQDPCGDAWQGVVCNDSSIIRIIINAANLGGELGDNLGLFSSIQTIDLSNNHIGGSIP 117
Query: 121 SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDL 180
S LPVT+QNFFLS NQF+GSIPSSL++LT LT MSLN+N LSGEIPD+FQ ++ L+N DL
Sbjct: 118 SNLPVTLQNFFLSANQFTGSIPSSLSSLTQLTAMSLNDNKLSGEIPDSFQVISQLVNFDL 177
Query: 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKML 240
S+NNLSG LPPS+ NL LTTLHLQNNQLSGTLDVLQDLPL+DLNIENNLFSGPIPEK+L
Sbjct: 178 SNNNLSGPLPPSVSNLLALTTLHLQNNQLSGTLDVLQDLPLKDLNIENNLFSGPIPEKVL 237
Query: 241 QIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFF---GPRPVSGSSPVSRTPPSQHTPG 297
IPNFRKDGNPFNS+V+P+ PP S P P G PVSG+ P SQ P
Sbjct: 238 SIPNFRKDGNPFNSSVSPTSPPVSPSPPSKPAPAPPVSGGPPVSGAP-----PSSQQRPK 292
Query: 298 KQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRI 357
KQADGP+A E+S+SGK K S TK++V I+IA VL F+IL L +LFMPRC +RR D +
Sbjct: 293 KQADGPSASEESSSGKNKKS-TKRVVLITIAVVLSFIILVLACVLFMPRCRRRR-RSDSV 350
Query: 358 FKRHQVGAFRGNNREEARDNGTLALPTNQM---EKDASVKPKEDHRSEMRRMGAIPHAQN 414
KRHQ+GA+RG RE + G + +Q+ K+ V+ K++ ++E+++ +P
Sbjct: 351 SKRHQIGAYRG-ERENVGNQGAMPQTNDQIPKVPKEPVVRMKQETQTEVQK---VPKDNV 406
Query: 415 EQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKP 474
E+E+N RMS IP++D HE+DMS+LD+ +M PPPPPPPPPPPPPPPPPPP VE+V P
Sbjct: 407 EREKNMPRMSAIPKKDHHEVDMSTLDVYLM--PPPPPPPPPPPPPPPPPPPPVEEVTAVP 464
Query: 475 IVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGK 534
VPAE +K TK AR +TIASLQQYTNSFSQENL+G GMLG+VYRA LP GK
Sbjct: 465 TVPAEVPPLKPLTKNKITLPFARPYTIASLQQYTNSFSQENLLGEGMLGNVYRAHLPSGK 524
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
+LAVKKLDKRA S QKDDEFLELVNNIDRIRHAN+VEL GYCAEHG+RLLI+EYCS GTL
Sbjct: 525 VLAVKKLDKRAFSLQKDDEFLELVNNIDRIRHANVVELSGYCAEHGERLLIFEYCSGGTL 584
Query: 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654
QD LHSD+E + LSWN RIRMALGAARALEYLHE+CQPP++HRNFKSANILLDDDL+V
Sbjct: 585 QDALHSDEEFRKKLSWNARIRMALGAARALEYLHEVCQPPVIHRNFKSANILLDDDLSVR 644
Query: 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKS 714
VSDCGLAPLIS G+VSQLSG LLTAYGYGAPEFESG+YT +SDVYSFGVVMLELLTGR S
Sbjct: 645 VSDCGLAPLISKGAVSQLSGQLLTAYGYGAPEFESGVYTLESDVYSFGVVMLELLTGRMS 704
Query: 715 YDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEF 774
YDRTR RGEQFLVRWAIPQLHDI+AL+ MVDPSL+G+YPAKSLS+FADIIS+CVQSEPEF
Sbjct: 705 YDRTRIRGEQFLVRWAIPQLHDIEALTSMVDPSLNGRYPAKSLSYFADIISKCVQSEPEF 764
Query: 775 RPPMSEVVQDLVDMIRRE 792
RPPMS VVQDL++MIRRE
Sbjct: 765 RPPMSSVVQDLLNMIRRE 782
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 801 | ||||||
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.395 | 0.408 | 0.805 | 9.5e-222 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.566 | 0.585 | 0.564 | 3e-203 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.360 | 0.376 | 0.604 | 4.1e-149 | |
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.369 | 0.421 | 0.630 | 2.3e-133 | |
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.390 | 0.434 | 0.542 | 3.6e-120 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.378 | 0.422 | 0.548 | 1.8e-118 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.368 | 0.422 | 0.522 | 1e-109 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.377 | 0.439 | 0.475 | 1.4e-103 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.394 | 0.429 | 0.424 | 1.6e-96 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.345 | 0.274 | 0.393 | 6.8e-62 |
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1323 (470.8 bits), Expect = 9.5e-222, Sum P(2) = 9.5e-222
Identities = 257/319 (80%), Positives = 281/319 (88%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDK 543
KTS K P T+ + ++IASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDK
Sbjct: 459 KTSPKRL-PLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDK 517
Query: 544 RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE 603
RAS QQ+D EF+ELVNNID IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE
Sbjct: 518 RASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDE 577
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPL 663
K LSWNTR+ MALGAARALEYLHE+C+PPI+HRNFKSAN+ +V VSDCGLAPL
Sbjct: 578 FKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPL 637
Query: 664 ISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGE 723
ISSGSVSQLSG LL AYGYGAPEF+SGIYT QSDVYSFGVVMLELLTGR SYDR R+RGE
Sbjct: 638 ISSGSVSQLSGQLLAAYGYGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGE 697
Query: 724 QFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
QFLVRWAIPQLHDIDAL +MVDPSL+GQYPAKSLSHFADIISRCVQSEPEFRP MSEVVQ
Sbjct: 698 QFLVRWAIPQLHDIDALGKMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQ 757
Query: 784 DLVDMIRRERC-SNESLGD 801
DL+DMIRRER S +S D
Sbjct: 758 DLLDMIRRERHGSGDSTAD 776
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1322 (470.4 bits), Expect = 3.0e-203, Sum P(2) = 3.0e-203
Identities = 271/480 (56%), Positives = 331/480 (68%)
Query: 322 IVWISIAGXXXXXXXXXXXXXXMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+WISI G +C+++R + +++ K H + G RE +R N ++
Sbjct: 315 IIWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEY-GRAREGSRSNASML 373
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
P+N KD +PKE R+G ER+ + + +++ HEIDM+ M
Sbjct: 374 PPSNTFNKDKEARPKE-------RVGGASKLHGGAERS---VGSESKQESHEIDMNGNAM 423
Query: 442 MMMXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAEGTAVKTSTKTAKPFTTARSFTI 501
+M AE + +T++K+ P T + FT+
Sbjct: 424 DLMHPSSIPPIKRVIAKATEP---------------AEASLKRTTSKSHGPLTAVKHFTV 468
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQ+TNSFS ENLIG GMLGSVYRA+LP GKL AV+KLDK++ + +++ +FLELVNNI
Sbjct: 469 ASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNI 528
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
DRIRHANIV+L G+C+EH QRLLI+EYC NGTL D+LH DD LK LSWN R+R+AL AA
Sbjct: 529 DRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAA 588
Query: 622 RALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ALEYLHEIC PP +HRNFKSANI V VSDCGLAPLISSG+VSQLSG LL AYG
Sbjct: 589 KALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQLSGQLLAAYG 648
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YGAPEFE GIYT + DVYSFGVVMLELLTGRKSYD+ R+RGEQFLVRWAIPQLHDIDAL+
Sbjct: 649 YGAPEFEYGIYTMKCDVYSFGVVMLELLTGRKSYDKKRDRGEQFLVRWAIPQLHDIDALA 708
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNESLGD 801
+MVDPSL G YPAKSLSHFAD+ISRCVQSEPE+RP MSEVVQDL DMI+RE N+S GD
Sbjct: 709 KMVDPSLKGDYPAKSLSHFADVISRCVQSEPEYRPLMSEVVQDLSDMIQREHRRNDSNGD 768
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 4.1e-149, Sum P(2) = 4.1e-149
Identities = 179/296 (60%), Positives = 224/296 (75%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
++A FTIASLQQYTN+FS+EN+IG G +G+VYRA+L GK LAVKKL + Q D E
Sbjct: 480 SSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQSDGE 539
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
FL LV+N+ +++ +I+EL GYC E GQRLL+YEYC NG+LQD LH D +L L+WN R
Sbjct: 540 FLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLTWNVR 599
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQLS 673
I +ALGA++AL++LHE+CQPP+VH+NFKS+ + +V V+D GLA ++ SQ++
Sbjct: 600 INIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLPPRPTSQMA 659
Query: 674 GHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
G Y APE E G YTCQSDV+S GVVMLELLTGR+ +DRTR RG Q L +WAIP+
Sbjct: 660 G-------YAAPEVEYGSYTCQSDVFSLGVVMLELLTGRRPFDRTRPRGHQTLAQWAIPR 712
Query: 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
LHDIDAL+RMVDPSL G YP KSLS FADIISR +Q EP FRPP+SE+VQDL MI
Sbjct: 713 LHDIDALTRMVDPSLHGAYPMKSLSRFADIISRSLQMEPGFRPPISEIVQDLQHMI 768
|
|
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 2.3e-133, Sum P(2) = 2.3e-133
Identities = 188/298 (63%), Positives = 231/298 (77%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
TA +T++SLQ TNSFSQEN+IG G LG VYRA+ P+GK++A+KK+D A S Q++D F
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LE V+N+ R+RH NIV L GYC EHGQRLL+YEY NG L D LH++D+ NL+WN R+
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQLSG 674
++ALG A+ALEYLHE+C P IVHRNFKSANI +SD GLA L + + Q+S
Sbjct: 499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAAL-TPNTERQVST 557
Query: 675 HLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
++ ++GY APEF SGIYT +SDVY+FGVVMLELLTGRK D +R R EQ LVRWA PQ
Sbjct: 558 QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQ 617
Query: 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
LHDIDALS+MVDPSL+G YPAKSLS FADII+ C+Q EPEFRPPMSEVVQ LV +++R
Sbjct: 618 LHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLVQR 675
|
|
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 3.6e-120, Sum P(2) = 3.6e-120
Identities = 174/321 (54%), Positives = 221/321 (68%)
Query: 482 AVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKL 541
AVK ST P + R +++A LQ T SFS +NL+G G G VYRA+ DGK+LAVKK+
Sbjct: 389 AVKKSTVVV-P-SNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKI 446
Query: 542 DKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD 601
D A D+F+E+V+ I + H N+ +L GYCAEHGQ L++YE+ NG+L D LH
Sbjct: 447 DSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLS 506
Query: 602 DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLA 661
+E L WN+R+++ALG ARALEYLHE+C P IV +N KSANI +SD GLA
Sbjct: 507 EEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLA 566
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDR-TR 719
+ + + +L T GY APE SG Y+ +SD+YSFGVVMLELLTGRK +D TR
Sbjct: 567 SFLPTAN--ELLNQ--TDEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFDSSTR 622
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779
+R EQ LVRWA PQLHDIDAL++MVDP+L G YP KSLS FAD+I+ CVQ EPEFRPPMS
Sbjct: 623 SRSEQSLVRWATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMS 682
Query: 780 EVVQDLVDMIRRERCSNESLG 800
EVVQ LV +++R S ++G
Sbjct: 683 EVVQALVVLVQRANMSKRTVG 703
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
Identities = 169/308 (54%), Positives = 213/308 (69%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
+ ++T++ LQ TNSFS +NL+G G G VYRAQ DGK+LAVKK+D A D+
Sbjct: 402 SNVNTYTVSDLQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADD 461
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F E+V+ I + H N+ +L GYC+EHGQ L++YE+ NG+L D LH +E L WN R
Sbjct: 462 FTEIVSKIAHLDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPR 521
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQLS 673
+++ALG ARALEYLHE+C P IVH+N KSANI +SD GLA + + + +L
Sbjct: 522 VKIALGTARALEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLPTAN--ELL 579
Query: 674 GHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732
GY APE SG Y+ +SDVYSFGVVMLELLTGRK +D TR+R EQ LVRWA P
Sbjct: 580 NQ--NDEGYSAPETSMSGQYSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSLVRWATP 637
Query: 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
QLHDIDAL +MVDP+L G YP KSLS FAD+I+ CVQ EPEFRPPMSEVVQ LV +++R
Sbjct: 638 QLHDIDALGKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVVLVQRA 697
Query: 793 RCSNESLG 800
S ++G
Sbjct: 698 NMSKRTVG 705
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
Identities = 160/306 (52%), Positives = 200/306 (65%)
Query: 490 AKPFTTARS---FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRAS 546
AK T+ RS F ++ LQ T +FS NL+G G +G VYRA+ DG+ LAVKK+D
Sbjct: 380 AKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLF 439
Query: 547 SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN 606
K + +V ++ +IRH NI EL GYC+E G +L+YEY NG+L + LH D
Sbjct: 440 DSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSK 499
Query: 607 NLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISS 666
L+WNTR+R+ALG ARA+EYLHE C P ++H+N KS+NI +SD GL+
Sbjct: 500 PLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLR 559
Query: 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
SQ G GY APE + YT +SDVYSFGVVMLELLTGR +D + R E+
Sbjct: 560 --TSQNLGE-----GYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFDGEKPRPERS 612
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
LVRWA PQLHDIDALS + DP+L G YP KSLS FADII+ CVQ EPEFRPPMSEVV+ L
Sbjct: 613 LVRWATPQLHDIDALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEAL 672
Query: 786 VDMIRR 791
V M++R
Sbjct: 673 VRMVQR 678
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 1.4e-103, Sum P(2) = 1.4e-103
Identities = 148/311 (47%), Positives = 197/311 (63%)
Query: 481 TAVKTSTKTAKPFTTA-RSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
T ++ST P T ++F++A LQ + FS L+G G +G VY+A+ DG+ AVK
Sbjct: 384 TPDRSSTSQDSPDTRGVKAFSLADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVK 443
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
++D + +EF +V++I I H N+ EL GYC+E G+ +L+YEY ++G+L LH
Sbjct: 444 EIDSSLLGKGNPEEFSHIVSSISSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLH 503
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCG 659
D+ L+WNTRIR+ALG A+A+EYLHE C PP+VH+N KS+NI +SD G
Sbjct: 504 LSDDFSKPLTWNTRIRIALGTAKAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYG 563
Query: 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718
LA SQ G GY APE + YT +SDVYSFGVVMLELLTGRK YD
Sbjct: 564 LANF--HHRTSQNLG-----VGYNAPECTDPSAYTQKSDVYSFGVVMLELLTGRKPYDSG 616
Query: 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
R + EQ LVRWA PQL D+D L MVDP+L G Y +S+S FADI+S CV +EP RPP+
Sbjct: 617 RPKAEQSLVRWAKPQLKDMDTLDEMVDPALCGLYAPESVSSFADIVSICVMTEPGLRPPV 676
Query: 779 SEVVQDLVDMI 789
S VV+ L ++
Sbjct: 677 SNVVEALKRLV 687
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.6e-96, Sum P(2) = 1.6e-96
Identities = 137/323 (42%), Positives = 211/323 (65%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDK 543
K+ + T + + A+ F+ A LQ TN FS+ENL+G G LGSVYRA+LPDG+ V+ +
Sbjct: 388 KSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYRAKLPDGQFAVVRNIPM 447
Query: 544 RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE 603
+ S ++++F E++ ++RH NIV L G+C E+G+ LL+YEY + +L + +H DE
Sbjct: 448 SSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYEYVGHLSLYNAMH--DE 505
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPL 663
+ LSW R+R+A+G ARAL+YLH PPI H + K+ NI ++DCGLA L
Sbjct: 506 VYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILLDEELTPRIADCGLASL 565
Query: 664 --ISSGSVSQLSGHL-LTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTR 719
++S SV + + + GY APE + G +SD Y+ GV++LELLTGRK++D +R
Sbjct: 566 RPLTSNSVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYALGVLLLELLTGRKAFDSSR 625
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779
RGEQ LV+WA +LHD +L +M+D ++G + ++ S +ADIIS C Q+E EFRPP+S
Sbjct: 626 PRGEQLLVKWASTRLHDRRSLEQMIDGGIAGTFSSRVASQYADIISLCTQAEKEFRPPVS 685
Query: 780 EVVQDLVDMIRRE-RCSNESLGD 801
E+V+ L +I+++ + ++ S+ D
Sbjct: 686 EIVEALTALIQKQNKEASSSVAD 708
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 6.8e-62, Sum P(3) = 6.8e-62
Identities = 111/282 (39%), Positives = 160/282 (56%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
TNSF Q N+IG G G VY+A LPDGK +A+KKL Q + EF V + R +H
Sbjct: 731 TNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS--GDCGQIEREFEAEVETLSRAQHP 788
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V L+G+C RLLIY Y NG+L LH ++ L W TR+R+A GAA+ L YL
Sbjct: 789 NLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYL 848
Query: 628 HEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
HE C P I+HR+ KS+NI ++D GLA L+S + +S L+ GY PE+
Sbjct: 849 HEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYE-THVSTDLVGTLGYIPPEY 907
Query: 688 -ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
++ + T + DVYSFGVV+LELLT ++ D + +G + L+ W + H+ A S + DP
Sbjct: 908 GQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRA-SEVFDP 966
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ + K + +I C+ P+ RP ++V L D+
Sbjct: 967 LIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6R2K3 | SRF3_ARATH | No assigned EC number | 0.6787 | 0.9275 | 0.9574 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 801 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-06 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 9e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 8e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 1e-04 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 2e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-04 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 3e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 3e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| PRK14952 | 584 | PRK14952, PRK14952, DNA polymerase III subunits ga | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 4e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 5e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 8e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 9e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.001 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 0.001 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.001 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.001 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.001 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.001 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| pfam10146 | 215 | pfam10146, zf-C4H2, Zinc finger-containing protein | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.002 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 0.003 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.003 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.004 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.004 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.004 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.004 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.004 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 0.004 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 0.004 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.004 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 37/279 (13%)
Query: 517 IGAGMLGSVYRAQLPDGKLL-----AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ L AVK L + AS +++++ FLE + + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVR 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C + ++ EY G L D L + L+ ++MAL A+ +EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESG 690
VHR+ + N L+ ++L V +SD GL+ I + G + APE + G
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 691 IYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749
+T +SDV+SFGV++ E+ T G + Y P + + + L + D
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELLED---- 219
Query: 750 GQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
G P +++ +C +PE RP SE+V+DL
Sbjct: 220 GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 82/277 (29%), Positives = 129/277 (46%), Gaps = 34/277 (12%)
Query: 517 IGAGMLGSVYRAQL--PDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ +L GK AVK L + AS QQ + EFL + ++ H N+V+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHPNVVK 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C E ++ EY G L L + + LS + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPE-FES 689
+HR+ + N L+ ++L V +SD GL+ + + G L + APE +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177
Query: 690 GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
G +T +SDV+SFGV++ E+ T G + Y P + + + L + +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEYLKNGYR 221
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
Q P D++ +C +PE RP SE+V+ L
Sbjct: 222 LPQ-PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 517 IGAGMLGSVYRAQL----PDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ L ++ AVK L + AS QQ + EFL + ++ H NIV+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHPNIVK 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C E +++ EY G L D L + LS + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESG 690
+HR+ + N L+ ++L V +SD GL+ + ++ G L APE + G
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEG 179
Query: 691 IYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749
+T +SDV+SFGV++ E+ T G + Y P + + + L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPY----------------PGMSNAEVLEYLKKGYRL 223
Query: 750 GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+ P ++ +C +PE RP SE+V+ L
Sbjct: 224 PK-PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 62/273 (22%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G+VY A+ GK +A+K + K SS + E L + + ++ H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ L+ EYC G+L+D+L E + LS + +R+ L LEYLH I
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 636 VHRNFKSANILLDDDLA-VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIY 692
+HR+ K NILLD D V ++D GL+ L++S S L + T Y APE G Y
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGT-PAYMAPEVLLGKGYY 171
Query: 693 TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752
+ +SD++S GV++ E
Sbjct: 172 SEKSDIWSLGVILYE--------------------------------------------- 186
Query: 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
L D+I + +Q +PE RP E+++ L
Sbjct: 187 ----LPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 32/282 (11%)
Query: 515 NLIGAGMLGSVYRAQL---PDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY+ +L AVK L + AS +++ D FL+ + ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-----DDELKNNLSWNTRIRMALGAARALE 625
L G C E L+ EY G L D L K+ LS + A+ A+ +E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
YL VHR+ + N L+ +DL V +SD GL+ + + + AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E + GI+T +SDV+SFGV++ E+ T G Y N E+ L + R+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEV--------LEYLRKGYRL 226
Query: 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
P P + +++ C Q +PE RP SE+V+ L
Sbjct: 227 PKPEY---CPDE----LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 89/275 (32%), Positives = 130/275 (47%), Gaps = 31/275 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G+VY+A+ GK++AVK L KR+ +KD + + R+ H NIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ L+ EYC G L D L LS + ++AL R LEYLH I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA--PLISSGSVSQLSGHLLTAYGYGAPE--FESGI 691
+HR+ K NILLD++ V ++D GLA L SS S++ G Y APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG----TPWYMAPEVLLGGNG 175
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
Y + DV+S GV++ ELLTG+ + + L+R R++ P L
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------------RILGPPLEFD 222
Query: 752 YPAKSLSH--FADIISRCVQSEPEFRPPMSEVVQD 784
P S D+I +C+ +P RP E++Q
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 76/278 (27%), Positives = 118/278 (42%), Gaps = 31/278 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G G VY A+ GKL+A+K + K+ + ++ E + + +++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNI 59
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V L + + L+ EYC G L D+L L + + ALEYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHS 115
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-LSGHLLTAYGYGAPE-F 687
IVHR+ K NILLD+D V ++D GLA + G G T Y APE
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVG---TPE-YMAPEVL 168
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y D++S GV++ ELLTG+ + ++ ++ P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPG---------------DDQLLELFKKIGKPK 213
Query: 748 LSGQYPAKSLSH-FADIISRCVQSEPEFRPPMSEVVQD 784
P +S D+I + + +PE R E +Q
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 32/282 (11%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+++ L+G G GSVY A D G+L+AVK ++ S+++ + + + ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 569 IVELKGYC--AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARAL 624
IV G E + EY S G+L +L +L + R R L L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGL 114
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-TAYGYG 683
YLH IVHR+ K ANIL+D D V ++D G A + + +G + T Y +
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY-WM 170
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
APE Y +D++S G ++E+ TG+ + N + AL +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---------------PMAALYK 215
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ + P D + +C++ +P+ RP E++Q
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 68/299 (22%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVKKL----DKRASSQQKDDEFLELVNNIDRIRHA 567
+ N IG G G VY A L G+L+AVK++ + + ++ DE + ++ ++H
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHP 59
Query: 568 NIVELKGYCAE-HGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
N+V K Y E H +++ I+ EYCS GTL+++L E L + L L
Sbjct: 60 NLV--KYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLA 113
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VSQLSGHLLTAYGY 682
YLH IVHR+ K ANI LD + + + D G A + + + ++ T Y
Sbjct: 114 YLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP-AY 169
Query: 683 GAPEFESGIYTCQS--------DVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--- 731
APE + T D++S G V+LE+ TG++ + + + I
Sbjct: 170 MAPE----VITGGKGKGHGRAADIWSLGCVVLEMATGKRPW-------SELDNEFQIMFH 218
Query: 732 ------PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
P + D LS D + RC++S+P+ RP SE++Q
Sbjct: 219 VGAGHKPPIPDSLQLSPEG----------------KDFLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 56/282 (19%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F IG G G VY+A GK +A+K + S++K ++ + + + + +H NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML----HSDDE------LKNNLSWNTRIRMALG 619
V+ G + + ++ E+CS G+L+D+L + E K L
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK---------- 109
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
LEYLH I+HR+ K+ANILL D V + D GL+ +S ++
Sbjct: 110 ---GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGT 160
Query: 680 YGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
+ APE +G Y ++D++S G+ +EL G+ P ++
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGK-------------------PPYSELP 201
Query: 739 ALSRMVDPSLSGQYPAKSLS----HFADIISRCVQSEPEFRP 776
+ + + +G ++ F D + +C+Q PE RP
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 74/272 (27%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V G+ +AVK L +++ Q FL + + +RH N+V+L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ ++ EY + G+L D L S L+ ++ AL +EYL E
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEE---KNF 123
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTC 694
VHR+ + N+L+ +DL VSD GLA S Q SG L + APE ++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA---KEASQGQDSGKL--PVKWTAPEALREKKFST 178
Query: 695 QSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753
+SDV+SFG+++ E+ + GR Y R IP + + V+ + P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPR-------------IP----LKDVVPHVEKGYRMEAP 221
Query: 754 AKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
++ C + +P RP ++ + L
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 4e-26
Identities = 72/286 (25%), Positives = 129/286 (45%), Gaps = 46/286 (16%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDRIRHAN 568
+ IG G G VY + DGKL +K++D S ++++D E V + ++ H N
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE-VKILKKLNHPN 60
Query: 569 IVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGAARA 623
I++ E +L I EY G L + + + +++ L A
Sbjct: 61 IIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----A 115
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP-LISSGSVSQLS-GHLLTAYG 681
L+YLH I+HR+ K NI L + V + D G++ L S+ +++ G T Y
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG---TPY- 168
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
Y +PE ++ Y +SD++S G V+ EL T + ++ ++ L
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-----------------NLLEL 211
Query: 741 SRMVDPSLSGQYPAKSLSH---FADIISRCVQSEPEFRPPMSEVVQ 783
+ + L GQYP + +++S +Q +PE RP +++++Q
Sbjct: 212 ALKI---LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-26
Identities = 86/305 (28%), Positives = 137/305 (44%), Gaps = 26/305 (8%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE-FLELVNNIDRIRHA- 567
S+ +G G G VY A+ D KL+A+K L K+ S+ K+ E FL + + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV+L + + G L+ EY G+L+D+L K LS + + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR-KGPLSESEALFILAQILSALEYL 117
Query: 628 HEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQLSGHLLTAY----GY 682
H I+HR+ K NILLD D V + D GLA L+ + L + GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 683 GAPEFESGI----YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI- 737
APE G+ + SD++S G+ + ELLTG ++ +N A Q I
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-------ATSQTLKII 227
Query: 738 -DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSN 796
+ + + LS P +D++ + + +P+ R S + + + + S+
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
Query: 797 ESLGD 801
S
Sbjct: 288 LSDLL 292
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 30/270 (11%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F N IG G G V++ + D ++ A+K++D ++++ +E ++ + ++ + I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARALEYL 627
+ + G+ ++ EY NG L +L L + W I++ LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
H I+HR+ KS N+ LD V + D G+A L+S + + ++ Y +PE
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPEL 172
Query: 688 -ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
E Y +SDV++ GVV+ E TG+ +D N+G L+ + R V P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD-ANNQGA--LIL----------KIIRGVFP 219
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
+S Y + A +I +C+ + RP
Sbjct: 220 PVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 29/290 (10%)
Query: 515 NLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+G G G V + G+ +AVK L+ Q + D F + + + H NI
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENI 68
Query: 570 VELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
V+ KG C + G R LI EY +G+L+D L ++ ++ + + + ++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL--LTAYGYGAP 685
+HR+ + NIL++ + V +SD GLA ++ + Y AP
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E + ++ SDV+SFGV + EL T G S +FL I ++R+
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP----AEFLR--MIGIAQGQMIVTRL 235
Query: 744 VDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
++ G+ P D++ C ++EP+ RP ++ + +VD +R
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD-LILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/278 (25%), Positives = 129/278 (46%), Gaps = 31/278 (11%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ QE IG+G G V+ + + +A+K + + A S++ +F+E + ++ H +
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKL 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L G C E L++E+ +G L D L + + S T + M L + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLES 118
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FE 688
++HR+ + N L+ ++ V VSD G+ + + +G + +PE F
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFS 174
Query: 689 SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y+ +SDV+SFGV+M E+ + G+ Y+ R+ E + I+A R+ P
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSE---------VVETINAGFRLYKPR 224
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
L+ Q +++ C + PE RP S ++ L
Sbjct: 225 LASQ-------SVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-24
Identities = 78/222 (35%), Positives = 121/222 (54%), Gaps = 19/222 (8%)
Query: 31 FSCAVTNPNDVAAINSLYAALGSPV--LPGWVASAGDPCGESWQGVQC-NASDIIAIILN 87
FS + ++ + S +++ P+ L W +SA D C WQG+ C N+S +++I L+
Sbjct: 23 FSM--LHAEELELLLSFKSSINDPLKYLSNWNSSA-DVC--LWQGITCNNSSRVVSIDLS 77
Query: 88 GANLGGELGENLGAFSSIRVIDLSNNHIGGSIP---SILPVTMQNFFLSDNQFSGSIPSS 144
G N+ G++ + I+ I+LSNN + G IP +++ LS+N F+GSIP
Sbjct: 78 GKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR- 136
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
++ L + L+NN+LSGEIP+ S + L LDL N L G++P SL NL+ L L L
Sbjct: 137 -GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 205 QNNQLSG----TLDVLQDLPLRDLNIENNLFSGPIPEKMLQI 242
+NQL G L ++ L L NNL SG IP ++ +
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGY-NNL-SGEIPYEIGGL 235
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 42/271 (15%)
Query: 515 NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+LIG G G VY+ L G +A+K++ ++ ++ ++ + ++H NIV+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G +I EY NG+L+ ++ +L + L + L YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGLAYLHE---Q 118
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF--ESGI 691
++HR+ K+ANIL D V ++D G+A + + + T Y + APE SG
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPY-WMAPEVIEMSGA 176
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID---ALSRMV---D 745
T SD++S G ++ELLTG P +D++ AL R+V
Sbjct: 177 ST-ASDIWSLGCTVIELLTGN-------------------PPYYDLNPMAALFRIVQDDH 216
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P L P D + +C Q +P RP
Sbjct: 217 PPL----PEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ + E +IG G G V R +LP K +A+K L +S +Q+ D FL + + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQF 62
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + ++I EY NG+L L +D + + M G A +
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGM 119
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI--SSGSVSQLSGHLLTAYGY 682
+YL E+ VHR+ + NIL++ +L VSD GL+ + S + + G + +
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRW 174
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSY 715
APE +T SDV+SFG+VM E+++ G + Y
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 57/152 (37%), Positives = 85/152 (55%), Gaps = 7/152 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATL 148
NL G + S++++ L+ N G +P S ++N LS NQFSG++P L +L
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
+ L + L+ N LSGEIPD S L++LDLS N LSG++P S + L+ L L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 209 LSGTLDVLQDL----PLRDLNIENNLFSGPIP 236
LSG ++ ++L L +NI +N G +P
Sbjct: 559 LSG--EIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 511 FSQENLIGAGMLGSVYRAQL--PDGKL----LAVKKLDKRASSQQKDDEFLELVNNIDRI 564
F +E +G G G VY+ +L P+ +L +A+K L + A + + + F + + +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDL 65
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML-----HSD-------DELKNNLSWNT 612
+H NIV L G C + +++EY ++G L + L HSD + +K++L +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 613 RIRMALGAARALEYL--HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
+ +A+ A +EYL H VHR+ + N L+ + L V +SD GL+ I S
Sbjct: 126 FLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 671 QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLEL 708
++ L + PE G +T +SD++SFGVV+ E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKK---LDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
L+G+G GSVY L DG AVK+ D + Q+ + + + + +++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 572 LKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
G L I+ E G+L +L + ++ LG LEYLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHD- 120
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVSQLSGHLLTAYGYGAPEF-- 687
VHR+ K ANIL+D + V ++D G+A + G + Y + APE
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG---SPY-WMAPEVIA 174
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
+ G Y +D++S G +LE+ TG+ + QL + A+ ++
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWS----------------QLEGVAAVFKIGR-- 216
Query: 748 LSGQYPA--KSLSHFA-DIISRCVQSEPEFRPPMSEVVQ 783
S + P LS A D I +C+Q +P RP +E+++
Sbjct: 217 -SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 76/270 (28%), Positives = 119/270 (44%), Gaps = 28/270 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +GAG G V+ +AVK L K + + FL+ + ++RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEA--FLQEAQIMKKLRHDK 62
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L C+E ++ EY S G+L D L S + L + MA A + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
+HR+ + NIL+ ++L ++D GLA LI + G + APE
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI-KWTAPEAA 176
Query: 688 ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G +T +SDV+SFG+++ E++T GR Y NR L ++ RM P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----------EVLEQVERGYRMPRP 226
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P + D++ +C +PE RP
Sbjct: 227 P---NCPEE----LYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 29/277 (10%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDK-RASSQQKDDEFLELVNNI---DRIRHANIV 570
+G G S Y+A+ + G L+AVK++ R +S ++++ L I R+ H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+ G E L E+ + G++ +L K + I R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHE- 121
Query: 631 CQPPIVHRNFKSANILLDDD-LAVSVSDCGLAPLISSG--SVSQLSGHLLTAYGYGAPEF 687
I+HR+ K AN+L+D + ++D G A +++ + G LL + APE
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 688 ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G Y DV+S G V++E+ T + ++ + + I ++ + P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE-KHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
L D+ RC++ +PE RPP E+++
Sbjct: 239 GLR------------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVK--KLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G VY+ L +AVK + ++K FL+ + + H NIV+L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKLI 58
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C + ++ E G+L L KN L+ ++M+L AA +EYL
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIY 692
+HR+ + N L+ ++ + +SD G++ G + G + APE G Y
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 693 TCQSDVYSFGVVMLELLT-GRKSY-----DRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
T +SDV+S+G+++ E + G Y +TR R I++ RM P
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---------------IESGYRMPAP 217
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
L + + ++ +C +PE RP SE+ +L
Sbjct: 218 QLCPEEIYR-------LMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 41/271 (15%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
+GAG G V + P GK++AVK + + +++ +D + IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK----TIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRI--RMALGAARALEYLHE 629
G +G + EY G+L D LK RI ++A+ + L YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL------DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FE 688
+ I+HR+ K +NIL++ + + D G +S V+ L+ + Y APE +
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTFVGTSSYMAPERIQ 172
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD--- 745
Y+ +SD++S G+ ++EL TGR Y P + L +V+
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIVNEPP 221
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P L + F ++ C+ +P RP
Sbjct: 222 PRLPSGKFSPDFQDF---VNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 32/287 (11%)
Query: 517 IGAGMLGSV--YR---AQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G V Y A G+++AVK L KR QQ + + +N + + H NIV+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 572 LKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
KG C+E G + LI EY G+L+D L K+ L+ + A + YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLH- 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS----VSQLSGHLLTAYGYGAP 685
+HR+ + N+LLD+D V + D GLA + G V + + Y A
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AV 179
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL--VRWAIPQLHDIDALSR 742
E + ++ SDV+SFGV + ELLT S + E+ + + + + I+ L R
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 743 -MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
M P P ++ C ++E +FRP ++ L +M
Sbjct: 240 GMRLPC-----PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 51/293 (17%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G+VY A+ + +++A+KK+ S +K + ++ V + ++RH N +E KG
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 575 -YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y EH L+ EYC G+ D+L + K L + GA + L YLH +
Sbjct: 83 CYLREH-TAWLVMEYCL-GSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FES 689
+HR+ K+ NILL + V ++D G A L VS + + T Y + APE +
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPY-WMAPEVILAMDE 188
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV----- 744
G Y + DV+S G+ +E L RK P L +++A+S +
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERK------------------PPLFNMNAMSALYHIAQN 229
Query: 745 -DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSN 796
P+LS +F + + C+Q P+ RP E+++ + RER
Sbjct: 230 DSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH--RFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-20
Identities = 81/296 (27%), Positives = 138/296 (46%), Gaps = 33/296 (11%)
Query: 496 ARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKL-LAVKKLDKRASSQQKDDEF 554
++S TI + +S +EN+I G G+ Y+ + + VK+++ S +
Sbjct: 680 SKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE--- 733
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ ++ +++H NIV+L G C LI+EY L ++L NLSW R
Sbjct: 734 ---IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRR 783
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLAVSVSDCGLAPLISSGSVSQL 672
++A+G A+AL +LH C P +V N I++D D+ + +S GL + +S
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS- 842
Query: 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731
Y APE E+ T +SD+Y FG++++ELLTG+ D +V WA
Sbjct: 843 --------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWAR 893
Query: 732 PQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
D L +DPS+ G + ++ C ++P RP ++V++ L
Sbjct: 894 YCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 76/301 (25%), Positives = 129/301 (42%), Gaps = 54/301 (17%)
Query: 516 LIGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVNNIDRI----R 565
+G G G V +A+ P+ +AVK L A+ + + +LV+ ++ + +
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK 74
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTR 613
H NI+ L G C + G ++ EY ++G L+D L + + L+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV--SQ 671
+ A AR +E+L +HR+ + N+L+ +D + ++D GLA I
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 672 LSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW 729
+G L + APE +YT QSDV+SFGV++ E+ T G Y
Sbjct: 192 TNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----------- 238
Query: 730 AIPQLHD-IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ +L + RM P Q + L H ++ C P RP ++V+DL M
Sbjct: 239 PVEELFKLLKEGYRMEKP----QNCTQELYH---LMRDCWHEVPSQRPTFKQLVEDLDRM 291
Query: 789 I 789
+
Sbjct: 292 L 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 40/238 (16%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEF--- 554
+Q+ T +E +G G G V+ + + L+AVK L K +S +F
Sbjct: 2 VQRDTIVLKRE--LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFERE 58
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN--- 611
EL+ N H NIV+ G C E ++++EY +G L L S L
Sbjct: 59 AELLTNFQ---HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 612 ----TRIRM---ALGAARALEYL---HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
T ++ A+ A + YL H VHR+ + N L+ DL V + D G++
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPEFESGIY---TCQSDVYSFGVVMLELLT-GRKSY 715
+ + ++ GH + + P ES +Y T +SDV+SFGVV+ E+ T G++ +
Sbjct: 170 RDVYTTDYYRVGGHTMLPIRWMPP--ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 80/268 (29%), Positives = 122/268 (45%), Gaps = 28/268 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
F+ E +G+G G V+ + +A+K L ++ K +F + V + R+RH +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L C+ +I E G+L L S + L + I MA A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE- 122
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES- 689
+HR+ + NIL+ +DL V+D GLA LI V S + Y + APE S
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI-PYKWTAPEAASH 178
Query: 690 GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
G ++ +SDV+SFG+++ E+ T G+ Y N E + I A RM P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNNHEVYDQ---------ITAGYRM--PC- 225
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRP 776
PAK I+ C +EPE RP
Sbjct: 226 ----PAKCPQEIYKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-20
Identities = 74/208 (35%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 38 PNDVAAINSL-YAALGSPVLPGWV-ASAGDPCGESWQGVQCNASDIIAIILNGANLGGEL 95
PND+ + +SL LG VL G + S N + + + L L G++
Sbjct: 157 PNDIGSFSSLKVLDLGGNVLVGKIPNSLT------------NLTSLEFLTLASNQLVGQI 204
Query: 96 GENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
LG S++ I L N++ G IP + ++ + L N +G IPSSL L L
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L N LSG IP + SL LI+LDLS N+LSGE+P + L L LHL +N +G +
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 214 DV-LQDLP-LRDLNIENNLFSGPIPEKM 239
V L LP L+ L + +N FSG IP+ +
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 42/283 (14%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F +G G GSVY+ + L D + A+K++D + SQ++ ++ + + + + H NI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 570 VELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGAARAL 624
+ K + G +L I EY G L + + + + W I++ G L
Sbjct: 62 ISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----L 116
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
+ LHE I+HR+ KSANILL + V + D G++ ++ G Y A
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH----YMA 169
Query: 685 PEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
PE G Y+ +SD++S G ++ E+ T + + + L
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-----------------EARSMQDLRYK 212
Query: 744 VDPSLSGQYPAKSLSHFAD---IISRCVQSEPEFRPPMSEVVQ 783
V G+YP + D I +Q +P+ RP +++
Sbjct: 213 V---QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 32/274 (11%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ +A+K L + + S + FL N + +++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ +I EY NG+L D L + + +K L+ N I MA A + ++ + +
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQ 695
HR+ ++ANIL+ + L ++D GLA LI + G + APE G +T +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 183
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ-LHDIDALSRMVDPSLSGQYP 753
SDV+SFG+++ E++T GR Y N P+ + +++ RM P P
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTN-----------PEVIQNLERGYRMPRPDNC---P 229
Query: 754 AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
+ +++ C + +PE RP E ++ +++
Sbjct: 230 EE----LYELMRLCWKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 60/174 (34%), Positives = 93/174 (53%), Gaps = 9/174 (5%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-ILPVTMQNFF-LS 133
C++ ++ +IL +L GE+ ++LGA S+R + L +N G +PS + + F +S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
+N G I S + L +SL N G +PD+F S L NLDLS N SG +P L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQDLP----LRDLNIENNLFSGPIPEKMLQIP 243
+LS+L L L N+LSG ++ +L L L++ +N SG IP ++P
Sbjct: 496 GSLSELMQLKLSENKLSG--EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547
|
Length = 968 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+F +E +G+G G V+ + +A+K + + A S+ D+F+E + ++ H N+
Sbjct: 7 TFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L G C + ++ EY +NG L + L E K L + M A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG------YG 683
+HR+ + N L+ +D V VSD GLA + L ++ G +
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-------LDDQYTSSQGTKFPVKWA 168
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
PE F+ ++ +SDV+SFGV+M E+ + G+ Y+R N E + + A
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SE---------VVESVSAGY 218
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
R+ P L+ + I+ C +PE RP +++ L
Sbjct: 219 RLYRPKLAP-------TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 42/288 (14%)
Query: 516 LIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G G GSV QL DG L AVK + + + +EFL + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 572 LKGYCAEHGQR------LLIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARA 623
L G C E ++I + +G L L L L T ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL--LTAYG 681
+EYL +HR+ + N +L +D+ V V+D GL+ I SG + G + +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKW 181
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
+YT +SDV++FGV M E+ T G+ Y N
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------------------- 221
Query: 741 SRMVDPSLSGQ---YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+ D G P L D++ C +++P+ RP +++ + L
Sbjct: 222 HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G+V + + DGK+L K++D ++++ + + VN + ++H NIV Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY--Y 65
Query: 576 CAEH---GQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH--E 629
Q L I EYC G L ++ + + + R+ AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES 689
++HR+ K ANI LD + V + D GLA ++ S S ++ T Y Y +PE +
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPY-YMSPEQLN 183
Query: 690 GI-YTCQSDVYSFGVVMLELLTGR 712
+ Y +SD++S G ++ EL
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 32/271 (11%)
Query: 517 IGAGMLGS--VYRAQLPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G +YR + D L+ K+++ R S +++ D E + + ++H NI+
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNE-IVILSLLQHPNIIAYY 65
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDML-HSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
+ + L+ EY + GTL D + +L + A+ Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI- 691
I+HR+ K+ NI L + + D G++ ++ S S + T Y Y +PE G+
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPY-YMSPELCQGVK 177
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
Y +SD+++ G V+ ELLT ++++D T + I Q + +S
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKIVQGNYTPVVSV--------- 224
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
Y ++ +S ++ +Q +PE RP EV+
Sbjct: 225 YSSELIS----LVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 38/294 (12%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVN 559
F + NL +GAG G V A D + +AVK L A S +++ EL
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
H NIV L G C G L+I EYC G L + L E + L+ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQ 149
Query: 620 AARALEYL-HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
A+ + +L + C +HR+ + N+LL V + D GLA I + S + G+
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 679 AYGYGAPE--FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735
+ APE F +YT +SDV+S+G+++ E+ + G Y P +
Sbjct: 206 PVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPY----------------PGMP 248
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
+++ P + + DI+ C ++P RP ++VQ + +
Sbjct: 249 VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 42/271 (15%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKL---DKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G G VY+ + P GK+ A+KK+ +Q E L+ + +V+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE-LK---TLRSCESPYVVKC 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARALEYLHEI 630
G + G+ ++ EY G+L D+L K + +A + L+YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YGAPE- 686
I+HR+ K +N+L++ V ++D G+ S + T G Y +PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGI-----SKVLENTLDQCNTFVGTVTYMSPER 171
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
+ Y+ +D++S G+ +LE G+ + +L + A+ P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--------FFEL--MQAICDGPPP 221
Query: 747 SLSGQYPAKSLS-HFADIISRCVQSEPEFRP 776
SL PA+ S F D IS C+Q +P+ RP
Sbjct: 222 SL----PAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 66/299 (22%), Positives = 126/299 (42%), Gaps = 71/299 (23%)
Query: 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RI 564
F +G G GSVY+A G+++A+K + +++ E++ I +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-------PVEEDLQEIIKEISILKQC 55
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDE----LKNNLSWNTRI 614
IV+ G ++ ++ EYC G++ D++ +++E L L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL------ 109
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS--GSVSQL 672
+ LEYLH +HR+ K+ NILL+++ ++D G++ ++ + +
Sbjct: 110 -------KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159
Query: 673 SGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731
G T + + APE I Y ++D++S G+ +E+ G+
Sbjct: 160 IG---TPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK------------------- 196
Query: 732 PQLHDIDALSRMV------DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
P DI + + P+LS P K F D + +C+ +PE RP +++Q
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 70/293 (23%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G VY A LP+ + +A+K+ L+K +S DE + V + + H N+V K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVV--K 63
Query: 574 GYCA--EHGQRLLIYEYCSNGTLQDMLHSD------DE------LKNNLSWNTRIRMALG 619
Y + + L+ Y S G+L D++ S DE LK L
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL----------- 112
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
+ LEYLH Q +HR+ K+ NILL +D +V ++D G++ ++ G T
Sbjct: 113 --KGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT-RKVRKTF 166
Query: 680 YG---YGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
G + APE + Y ++D++SFG+ +EL TG Y
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY------------------- 207
Query: 735 HDIDALSRMV------DPSLSGQYPAKSLSH-FADIISRCVQSEPEFRPPMSE 780
+ ++ PSL K S F +IS C+Q +P RP E
Sbjct: 208 SKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-18
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 3/157 (1%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF--FLSDNQFSGSIPSSLAT 147
GE+ +NLG +++ V+DLS N++ G IP L + F L N G IP SL
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L + L +N SGE+P F L + LD+S+NNL G + ++ L L L N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 208 QLSGTL-DVLQDLPLRDLNIENNLFSGPIPEKMLQIP 243
+ G L D L +L++ N FSG +P K+ +
Sbjct: 463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ +++ +IGAG G V+R ++P K +A+K L + +Q+ D FL + + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQF 63
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + ++I EY NG L L D S + M G A +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGM 120
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS---SGSVSQLSGHLLTAYG 681
+YL ++ VHR+ + NIL++ +L VSD GL+ ++ G+ + G +
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIR 175
Query: 682 YGAPEFES-GIYTCQSDVYSFGVVMLELLT-GRKSY 715
+ APE + +T SDV+SFG+VM E+++ G + Y
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANIVE 571
IG G G VY+A+ G+L+A+KK+ + + + F + + + ++RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 572 LKGYCAEH--GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------- 622
LK G +++EY + L +L + ++ +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD-----------SPEVKFTESQIKCYMKQLL 110
Query: 623 -ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
L+YLH I+HR+ K +NIL+++D + ++D GLA + + + + ++T +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW- 166
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y PE + Y + D++S G ++ EL G+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S +G G G V+ +AVK L S + FLE + ++RH
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDK 62
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 63 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIE 119
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688
+ +HR+ +SANIL+ D L ++D GLA LI + G + APE
Sbjct: 120 RM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 689 -SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G +T +SDV+SFG+++ EL+T GR Y NR L ++ RM
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----------EVLEQVERGYRM--- 222
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P +++ +C + +PE RP
Sbjct: 223 ----PCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 46/288 (15%)
Query: 517 IGAGMLGSVYRAQ-LPDG---KL-LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G+G G+VY+ +P+G K+ +A+K L + +S + + E L+ + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNN--LSWNTRIRMALGAARALEYLH 628
L G C Q LI + G L D + + D + + L+W +I A+ + YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
E +VHR+ + N+L+ V ++D GLA L+ + + A E
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 688 ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLV----RWAIPQLHDIDALSR 742
IYT +SDV+S+GV + EL+T G K Y+ L+ R P + ID
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+V +C + E RP E++ + M R
Sbjct: 244 LV---------------------KCWMIDAESRPTFKELINEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 37/287 (12%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGK---LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
E +IGAG G V R +L GK +A+K L + +Q+ D FL + + + H NI
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ L+G + ++I E+ NG L L +D + + M G A ++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-----VSQLSGHLLTAYGYGA 684
+ VHR+ + NIL++ +L VSD GL+ + + S L G + + A
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI--PIRWTA 179
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE +T SDV+S+G+VM E+++ G + Y W + I+A+ +
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WDMSNQDVINAIEQ 226
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
D L P + ++ C Q + RP ++V L MI
Sbjct: 227 --DYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-17
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 6/175 (3%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP---SILPVTMQNFFLS 133
+ +I++ L+ +L GE+ E + ++ ++ L +N+ G IP + LP +Q L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLW 340
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N+FSG IP +L LT + L+ N L+GEIP+ S L L L SN+L GE+P SL
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
Query: 194 ENLSQLTTLHLQNNQLSGTLDV-LQDLPLRD-LNIENNLFSGPIPEKMLQIPNFR 246
L + LQ+N SG L LPL L+I NN G I + +P+ +
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 37/295 (12%)
Query: 510 SFSQENL-----IGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELV 558
+F + NL +G G G V+ A+ L+ VK L K + EF +
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRREL 59
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML----HSDDELK-NNLSWNTR 613
+ ++ H N+V L G C E +I EY G L+ L D++LK LS +
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ + A +++L VHR+ + N L+ V VS L+ + + +L
Sbjct: 120 VALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 674 GHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732
L+ + APE + ++ +SDV+SFGV+M E+ T +GE
Sbjct: 177 NALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGEL-----PFY 220
Query: 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
L D + L+R+ L P S +++RC P+ RP SE+V L +
Sbjct: 221 GLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/214 (29%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
LIG+G GSVY G+L+AVK+++ + S D +++ + R ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 568 NIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NIV+ G + L I+ EY G++ +L++ + L N +R L + L Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQIL---KGLNY 121
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS-QLSGHLLTAYG---Y 682
LH I+HR+ K ANIL+D+ + +SD G++ + + S+S + +G + G +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSY 715
APE + YT ++D++S G +++E+LTG+ +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 38/279 (13%)
Query: 515 NLIGAGMLGSVYRAQLPD------GKL-LAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N +G+G G VY D G + +AVK L K A+ Q+K EFL+ + + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHP 59
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN---LSWNTRIRMALGAARAL 624
NIV+L G C + + +I E G L L + L+ + + L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 625 EYLHEICQPPIVHRNFKSANILL-----DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
YL ++ +HR+ + N L+ D D V + D GLA I + G L
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 680 YGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ APE G +T QSDV+SFGV+M E+LT G++ Y N L +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----------QEVLQHV 226
Query: 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
A R+ Q P +++ C +P RP
Sbjct: 227 TAGGRL-------QKPENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 52/285 (18%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVK--KLDKRASSQQKDDEFLELVNNID---RIRHANIV 570
IG+G G VY+A+ + G+L+A+K KL+ D+F + I RH NIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP-------GDDFEIIQQEISMLKECRHPNIV 63
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----RMALGAARALEY 626
G + ++ EYC G+LQD+ + LS +I R L + L Y
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLS-ELQIAYVCRETL---KGLAY 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LHE + +HR+ K ANILL +D V ++D G++ +++ ++++ + T Y + APE
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA-TIAKRKSFIGTPY-WMAPE 171
Query: 687 F----ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL-- 740
G Y + D+++ G+ +EL + LH + AL
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMF----------------DLHPMRALFL 215
Query: 741 -SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
S+ P + K F D I +C+ +P+ RP ++++Q
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 50/291 (17%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
L+G+G+ G+V++ +P+G + A+K + R S +Q E + + + + HA IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L G C G L L+ + G+L D + +++L + + A+ + YL E
Sbjct: 73 RLLGICP--GASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FE 688
+VHRN + NILL D V ++D G+A L+ T + A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 689 SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTR--------NRGEQFLVRWAIPQLHDIDA 739
G YT QSDV+S+GV + E+++ G + Y R +GE R A PQ+ ID
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE----RLAQPQICTIDV 240
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
MV +C + RP E+ + M R
Sbjct: 241 YMVMV---------------------KCWMIDENVRPTFKELANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 77/269 (28%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
S E +G G G V+ +A+K L S + FL+ + ++RH +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L +E ++ EY S G+L D L E+ L + MA A + Y+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE- 688
+ VHR+ ++ANIL+ ++L V+D GLA LI + G + APE
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 689 SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
G +T +SDV+SFG+++ EL T GR Y NR L ++ RM P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------EVLDQVERGYRMPCPP 226
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRP 776
+ P D++ +C + EPE RP
Sbjct: 227 ---ECPES----LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 517 IGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLE--LVNNIDRIRHAN 568
IG G G V++A+ P ++AVK L + AS+ + D E L+ D H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD---HPN 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDEL------KNNLSW 610
IV+L G CA L++EY + G L + L HS LS
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
++ +A A + YL E VHR+ + N L+ +++ V ++D GL+ I S
Sbjct: 130 TEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 671 QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT 710
+ S + + PE YT +SDV+++GVV+ E+ +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 69/278 (24%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G VY+AQ + L A K+ + S ++ +D +E ++ + +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-IDILSECKHPNIVGLYEAY 71
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR-MALGAARALEYLHEICQPPI 635
+ ++ E+C G L ++ EL+ L+ +IR + AL +LH +
Sbjct: 72 FYENKLWILIEFCDGGALDSIM---LELERGLT-EPQIRYVCRQMLEALNFLHS---HKV 124
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE------FES 689
+HR+ K+ NILL D V ++D G++ S ++ + + T Y + APE F+
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRDTFIGTPY-WMAPEVVACETFKD 182
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD---P 746
Y ++D++S G+ ++EL + +L+ + L +++ P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHH----------------ELNPMRVLLKILKSEPP 226
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+L P+K S F D + C+ +P+ RP +E+++
Sbjct: 227 TLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 35/271 (12%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG G G+V + + G+ +AVK + ++Q FLE + ++ H N+V L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGVI 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+G +++ E S G L + L + ++ ++ +L A +EYL +V
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQ 695
HR+ + NIL+ +D VSD GLA + S G + + APE + ++ +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS-----KLPVKWTAPEALKHKKFSSK 177
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA 754
SDV+S+GV++ E+ + GR Y P++ + + V+ + P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----------------PKM-SLKEVKECVEKGYRMEPPE 220
Query: 755 KSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+ +++ C ++EP+ RP ++ + L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 39/282 (13%)
Query: 510 SFSQENLIGAGMLGSV----YRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
+F +E +G+G G V +RAQ+ +A+K +++ A S+ ++F+E + ++
Sbjct: 7 TFMKE--LGSGQFGVVHLGKWRAQIK----VAIKAINEGAMSE---EDFIEEAKVMMKLS 57
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H +V+L G C + ++ E+ NG L + L + + LS + + M +E
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGME 114
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
YL + +HR+ + N L+ V VSD G+ + + SG + P
Sbjct: 115 YLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV-KWSPP 170
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E F Y+ +SDV+SFGV+M E+ T G+ +++ N + V I + R+
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGF------RL 220
Query: 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
P L+ +++ C +PE RP +E+++ +
Sbjct: 221 YRPKLASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 43/285 (15%)
Query: 517 IGAGMLGSVYRA--QLPDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G GSV + + GK + AVK L + + K EFL + + ++ H IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK-EFLREASVMAQLDHPCIVRL 61
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G C +L+ E G L L E+ + +A A + YL
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYLESK-- 114
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VSQLSGHL-LTAYGYGAPE-F 687
VHR+ + N+LL + +SD G++ + +GS + +G L Y APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APECI 170
Query: 688 ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G ++ +SDV+S+GV + E + G K Y + + ++ M++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----------------AEVIA-MLES 213
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
P + I+ C + PE RP SE L RR
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSE----LESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 37/278 (13%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V+ +L D +AVK + K +FL+ + + H NIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 61
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
C + ++ E G L ++ L I+M AA +EYL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTC 694
+HR+ + N L+ + + +SD G++ G + G + APE G Y+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 695 QSDVYSFGVVMLELLT-GRKSY-----DRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
+SDV+SFG+++ E + G Y +TR EQ VR P+L M
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLM----- 229
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
RC + +P RP S V Q+L
Sbjct: 230 ----------------ERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 69/290 (23%), Positives = 128/290 (44%), Gaps = 57/290 (19%)
Query: 516 LIGAGMLGSVYRAQLPDG--KLLAVKK-----LDKRASSQQKDDEFLELVNNI----DRI 564
+G+G G VY+ + + LLA+K+ +++D ++V+ + +++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGA 620
RH NIV E+ + ++ + L + +S E K + WN ++M L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQLSGHLLTA 679
AL YLH+ + IVHR+ NI+L +D V+++D GLA S ++ + G +L
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL-- 178
Query: 680 YGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
Y PE Y ++DV++FG ++ ++ T + P + +
Sbjct: 179 --YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ-------------------PPFYSTN 217
Query: 739 ALS---RMV----DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
LS ++V +P G Y D+I+ C+ + E RP + +V
Sbjct: 218 MLSLATKIVEAVYEPLPEGMYSED----VTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 51/290 (17%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G+VY A +++AVKK+ + +K + ++ V + +++H N +E KG
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 575 -YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y EH L+ EYC G+ D+L K L + GA + L YLH
Sbjct: 89 CYLKEH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FES 689
++HR+ K+ NILL + V ++D G S+ S + + T Y + APE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPY-WMAPEVILAMDE 194
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV----- 744
G Y + DV+S G+ +E L RK P L +++A+S +
Sbjct: 195 GQYDGKVDVWSLGITCIE-LAERK------------------PPLFNMNAMSALYHIAQN 235
Query: 745 -DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
P+L S F D C+Q P+ RP +E+++ D +RR+R
Sbjct: 236 DSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLRH--DFVRRDR 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 37/277 (13%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ + +AVK L S Q FLE N + ++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ +I EY + G+L D L SD+ K L I + A + Y+ + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYI 125
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQ 695
HR+ ++AN+L+ + L ++D GLA +I + G + APE G +T +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 184
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY-- 752
SDV+SFG+++ E++T G+ Y P + + D +S +L Y
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY----------------PGMSNSDVMS-----ALQRGYRM 223
Query: 753 --PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
DI+ C + + E RP + +Q ++D
Sbjct: 224 PRMENCPDELYDIMKTCWKEKAEERPTF-DYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 30/279 (10%)
Query: 516 LIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G V R + GK++ AVK L K D+FL+ + + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G H +++ E G+L D L + + +T A+ A + YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHLLTAYGYGAPE-FES 689
+HR+ + NILL D V + D GL L + + HL + + APE +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID-ALSRMVDPSL 748
++ SDV+ FGV + E+ T Y E + L ID R+ P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT----YGE-----EPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
Q +++ +C P RP + + + L +
Sbjct: 226 CPQ-------DIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
L+G G G V++ L D +AVK K Q+ +FL + + H NIV+L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
C + ++ E G D L + K+ L ++ AL AA + YL
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTC 694
+HR+ + N L+ ++ + +SD G++ G S SG + APE G Y+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSS 173
Query: 695 QSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753
+SDV+S+G+++ E + G Y N+ + ++ RM P
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAR----------EQVEKGYRM-------SCP 216
Query: 754 AKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
K ++ RC +PE RP SE+ ++L
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 40/292 (13%)
Query: 511 FSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
F+ ++G G GSV AQL + +AVK L S +EFL + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 567 ANIVELKGYC--AEHGQRL----LIYEYCSNGTLQDMLHSDDELKN--NLSWNTRIRMAL 618
N+++L G + RL +I + +G L L + L T +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQLSGHLL 677
A +EYL +HR+ + N +L++++ V V+D GL+ I SG Q L
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 678 TAYGYGAPEFESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD 736
+YT SDV++FGV M E++T G+ Y N
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---------------- 221
Query: 737 IDALSRMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
S + + + G + P L +++ +C EP+ RP + L
Sbjct: 222 ----SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F + N IG G G VYRA+ G+++A+KK+ ++D + + I +RH
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRH 65
Query: 567 ANIVELKGYCAEHGQRL----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
NIVELK G+ L L+ EYC QD+ D + S + + L R
Sbjct: 66 PNIVELKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
L+YLHE I+HR+ K +N+LL D + ++D GLA ++ ++T + Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLW-Y 174
Query: 683 GAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
APE YT D+++ G ++ ELL +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 42/276 (15%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG-Y 575
+G G GSV + +L + ++ K + + L + + IV+ G +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 576 CAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLSWNTRI------RMALGAARALEYLH 628
E + I EYC G+L D K RI ++A + L YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSL------DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-TAYGYGAPE- 686
I+HR+ K +NILL V + D G +S V+ L+G T++ Y APE
Sbjct: 123 S---RKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSF-YMAPER 174
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSY--DRTRNRGE----QFLVRWAIPQLHDIDAL 740
+ Y+ SDV+S G+ +LE+ R + + G ++V P+L D
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD---- 230
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
+P ++ ++ F I +C++ +P RP
Sbjct: 231 ----EPGNGIKW-SEEFKDF---IKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 67/262 (25%), Positives = 107/262 (40%), Gaps = 28/262 (10%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ + +AVK L K + KD FL + ++RH +++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
++ E G+L + L L I MA A + YL +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQ 695
HR+ + N+L+ ++ V+D GLA +I G + APE ++ +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI-KWTAPEAALYNRFSIK 184
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA 754
SDV+SFG+++ E++T GR Y N L +D RM P P
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNA----------EVLQQVDQGYRM--PC-----PP 227
Query: 755 KSLSHFADIISRCVQSEPEFRP 776
DI+ C + +P+ RP
Sbjct: 228 GCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 49/288 (17%)
Query: 515 NLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+IG G G VY L DG+ + AVK L+ R + ++ ++FL+ + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 571 ELKGYC-AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L G C G L++ Y +G L++ + S+ +N + I L A+ +EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG---SVSQLSGHLLTAYGYGAPE 686
VHR+ + N +LD+ V V+D GLA I SV +G L
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS----- 741
++ +T +SDV+SFGV++ EL+T RG P D+D+
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT----------RG--------APPYPDVDSFDITVYL 215
Query: 742 ----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
R++ P +Y L +++ C +PE RP SE+V +
Sbjct: 216 LQGRRLLQP----EYCPDPLY---EVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 510 SFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
S E ++G G G + R +LP + +A+ L S +Q+ FL + +
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFD 64
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H+NIV L+G +++ EY SNG L L + L + M G A ++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMK 121
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGA 684
YL E+ VH+ + +L++ DL +S S ++ + +SG + A
Sbjct: 122 YLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAA 176
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE + ++ SDV+SFG+VM E+++ G + Y W + I A
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-------------WDMSGQDVIKA--- 220
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
V+ P + ++ C Q E RP S++ L M+
Sbjct: 221 -VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 73/289 (25%), Positives = 128/289 (44%), Gaps = 32/289 (11%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIR 565
+F E IG G VY+A L DG+++A+KK+ K + L+ ++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H N+++ E+ + ++ E G L M+ + K + T + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
++H I+HR+ K AN+ + V + D GL SS + + S + T Y Y +P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY-YMSP 175
Query: 686 EF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E E+G Y +SD++S G ++ E+ + P D L +
Sbjct: 176 ERIHENG-YNFKSDIWSLGCLLYEMAALQS------------------PFYGDKMNLYSL 216
Query: 744 VDPSLSGQYPAKSLSHFA----DIISRCVQSEPEFRPPMSEVVQDLVDM 788
YP H++ D++SRC+ +PE RP +S V+Q +M
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 36 TNPNDVAAINSLYAALGSPVLPGWVASAGDPCG---ESWQGVQCNASDII-AIILNGANL 91
T +V+A+ +L ++LG P+ GW GDPC W G C ++G
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWSGADCQFDSTKGKWFIDG--- 422
Query: 92 GGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT--MQNFFLSDNQFSGSIPSSLATLT 149
+ L N + G IP+ + +Q+ LS N G+IP SL ++T
Sbjct: 423 ----------------LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT 466
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
L + L+ N +G IP++ LT L L+L+ N+LSG +P +L
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V + + G+++A+KK + + L V + ++RH NIV LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
G+ L++EY L+ + + L + +A+ Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG--IY 692
I+HR+ K NIL+ + + + D G A + + S L+ ++ T + Y APE G Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPELLVGDTNY 179
Query: 693 TCQSDVYSFGVVMLELLTGR 712
DV++ G +M ELL G
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 84/304 (27%), Positives = 134/304 (44%), Gaps = 59/304 (19%)
Query: 516 LIGAGMLGSVYRAQ---LPD--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G GSV + L D G+++AVKKL + +D F + + ++H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIV 68
Query: 571 ELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ KG C G+R L+ EY G+L+D L K+ R L + L Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-----KH--------RERLDHRKLLLYAS 115
Query: 629 EICQ-------PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS----VSQLSGHLL 677
+IC+ VHR+ + NIL++ + V + D GL ++ V + +
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 678 TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSY-DRTRNRGEQFL------VRW 729
Y APE ++ SDV+SFGVV+ EL T Y D++ + +F+ +
Sbjct: 176 FWY---APESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQG 228
Query: 730 AIPQLHDIDAL---SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
+ H I+ L R+ P PA+ + I+ C ++P RP SE+ V
Sbjct: 229 QMIVYHLIELLKNNGRLPAPP---GCPAEIYA----IMKECWNNDPSQRPSFSELALQ-V 280
Query: 787 DMIR 790
+ IR
Sbjct: 281 EAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 514 ENLIGAGMLGSVYRAQLP-DG-KLLAVKKLDKRASSQQKDDEF---LELVNNIDRIRHAN 568
E++IG G G V RA + DG K+ A K+ K +S+ +F LE++ + H N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPN 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTRIRM 616
I+ L G C G + EY G L D L L+ + L+ ++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VSQLS 673
A A ++YL E +HR+ + N+L+ ++LA ++D GL S G V +
Sbjct: 125 ASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGL----SRGEEVYVKKTM 177
Query: 674 GHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLT 710
G L + +YT +SDV+SFGV++ E+++
Sbjct: 178 GRLPVRW-MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 49/285 (17%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKL-----DKRASSQQKDDEFLELVNNIDRI 564
+ + LIG G G+VYR +P G+++A+K + D S Q++ L ++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLS------QL 56
Query: 565 RHA---NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMAL 618
R + NI + G G RL +I EY G+++ ++ + E ++ IR L
Sbjct: 57 RQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI----IREVL 111
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
AL+Y+H++ ++HR+ K+ANIL+ + V + D G+A L++ S S+ S + T
Sbjct: 112 ---VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGT 164
Query: 679 AYGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736
Y + APE E Y ++D++S G+ + E+ TG Y +
Sbjct: 165 PY-WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-------------VDAFRA 210
Query: 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
+ + + P L +K L F ++ C+ EP+ R E+
Sbjct: 211 MMLIPKSKPPRLEDNGYSKLLREF---VAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK-G 574
+G G G V + DGK +KKL+ R +S+++ + + +++H NIV +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNL-------SWNTRIRMALGAARALEYL 627
+ E G ++ +C G D+ H E K L W +I MAL +YL
Sbjct: 68 WEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYL 118
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS--VSQLSGHLLTAYGYGAP 685
HE I+HR+ K+ N+ L + V D G+A ++ + S L G T Y Y +P
Sbjct: 119 HE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG---TPY-YMSP 171
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS-RM 743
E F + Y +SDV++ G + E+ T + +++ D+++L R+
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----------------DMNSLVYRI 214
Query: 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
++ L P ++I+ + PE RP + +++
Sbjct: 215 IEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 42/277 (15%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI---DRIRHANIVEL 572
IG G G VY+A GK +A+KK+ R +++ ++N I +H NIV+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKHPNIVDY 80
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDML-HSDDELKNNLSWNTRI-RMALGAARALEYLHE 629
G L ++ EY G+L D++ + + +I + + LEYLH
Sbjct: 81 YD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-----PQIAYVCREVLQGLEYLH- 133
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES 689
++HR+ KS NILL D +V ++D G A ++ S+ + + T Y + APE
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-KSKRNSVVGTPY-WMAPEVIK 189
Query: 690 G-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW-AIPQLHDIDALSRMVDPS 747
Y + D++S G++ +E+ G Y R FL+ IP L + + S
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS------ 243
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
F D +++C+ +PE RP E++Q
Sbjct: 244 ----------PEFKDFLNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G V + +A+K + + + S+ DEF+E + ++ H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ ++ EY SNG L + L E + + M + YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQ 695
HR+ + N L+DD V VSD GL+ + + G + PE ++ +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLLYSKFSSK 181
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRN 720
SDV++FGV+M E+ + G+ Y+R N
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNN 207
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 5e-15
Identities = 79/275 (28%), Positives = 114/275 (41%), Gaps = 56/275 (20%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V + D GKL A+K L K+ ++K+ E NI RI H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 575 YCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------AL 624
+ A + L+ EY G L L R + AR AL
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK------------EGRFSEERARFYAAEIVLAL 106
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGS-VSQLSGHLLTAYGY 682
EYLH + I++R+ K NILLD D + ++D GLA L S GS + G T Y
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG---TP-EY 159
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTGRKS-YDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE Y D +S GV++ E+LTG+ Y R + +++ +
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL--------- 210
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
++P D+IS +Q +P R
Sbjct: 211 ----------RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEF----LELVNNIDR 563
+ + +G G G VY+A+ G+++A+KK LD +++ L ++ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKE 54
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
++H NIV+L + L++EYC L+ L LS N + R
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK---RPGPLSPNLIKSIMYQLLRG 110
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L Y H I+HR+ K NIL++ D + ++D GLA + + ++T + Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLW-YR 165
Query: 684 APE--FESGIYTCQSDVYSFGVVMLELLTGR 712
APE S Y+ D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 515 NLIGAGMLGSVYRAQLP-DG-KLLAVKKLDKRASSQQKDDEF---LELVNNIDRIRHANI 569
++IG G G V +A++ DG ++ A K K +S+ +F LE++ + H NI
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTRIRMA 617
+ L G C G L EY +G L D L L+ + LS + A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VSQLSG 674
AR ++YL + +HR+ + NIL+ ++ ++D GL S G V + G
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMG 171
Query: 675 HLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLT 710
L + +YT SDV+S+GV++ E+++
Sbjct: 172 RLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 517 IGAGMLGSVYR---AQLPDGKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY + G+ +A+K +++ AS +++ EFL + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTR---IRMALGAARAL 624
L G + L++ E + G L+ L S + E L T I+MA A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
YL VHR+ + N ++ +DL V + D G+ I + G L + A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT 710
PE + G++T +SDV+SFGVV+ E+ T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 17/187 (9%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L + ++D FL+ + + R+++ NI+ L G C +I EY NG L
Sbjct: 46 LVAVKMLRADVTKTARND-FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 595 -----QDMLHSDDELKNNL---SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646
Q + S NN+ S + MA+ A ++YL + VHR+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161
Query: 647 LDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGV 703
+ + + ++D G++ + SG ++ G + + A +ES G +T SDV++FGV
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA--WESILLGKFTTASDVWAFGV 219
Query: 704 VMLELLT 710
+ E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 512 SQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+ ++ +G G G VY +AVK L + + +EFL+ + I+H N+V
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLV 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+L G C +I E+ + G L D L + + ++ + MA + A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE-- 121
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FES 689
+ +HR+ + N L+ ++ V V+D GL+ L++ + + +G + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 179
Query: 690 GIYTCQSDVYSFGVVMLELLT 710
++ +SDV++FGV++ E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+A+ G+++A+KK+ R S+ L + + + H NI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G L++E+ + + L +L + ++ + L + H I
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFCH---SHGI 119
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE--FES 689
+HR+ K N+L++ + + ++D GLA S T Y Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS------PVRPYTHYVVTRWYRAPELLLGD 173
Query: 690 GIYTCQSDVYSFGVVMLELLTGR 712
Y+ D++S G + ELL+ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 35/285 (12%)
Query: 515 NLIGAGMLGSVYRAQL----PDGKLLAVK-KLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+G G G VY D L V K + S+Q + +FL + + H NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN---LSWNTRIRMALGAARALEY 626
V L G E R ++ E + G L+ L + L+ + A A+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 627 LHEICQPPIVHRNFKSANILLDD---DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L E +HR+ + N LL ++D G+A I S + G + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGE-QFLVRWAIPQLHDIDAL 740
PE F GI+T ++DV+SFGV++ E+ + G Y N+ +F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG---------- 238
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
R+ P I++ C Q PE RP + +++ +
Sbjct: 239 -RL-------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 72/286 (25%), Positives = 113/286 (39%), Gaps = 46/286 (16%)
Query: 517 IGAGMLGSVYRAQLPDGKLLA---VKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V + G A VK+L + +++ + FL+ V + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRIRMALGAARALEYLHEICQ 632
G C E LL+ E+C G L++ L S+ + ++ + RMA A L +LH Q
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FE 688
+H + N L DL+V + D GLA + APE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 689 SGIY----TCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
+ T +S+++S GV M EL T + Y P L D L ++
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----------------PDLSDEQVLKQV 222
Query: 744 V--------DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
V P L +Y + + +++ C PE RP EV
Sbjct: 223 VREQDIKLPKPQLDLKYSDR----WYEVMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 53/289 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
F+ IG G G VY+A +++A+K +D + +DE ++ I +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIEDIQQEIQFLSQC 56
Query: 568 NIVELKGY--CAEHGQRL-LIYEYCSNGTLQDMLHS--DDELKNNLSWNTRIRMALGAAR 622
+ Y G +L +I EYC G+ D+L DE ++ +R L
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE--TYIA--FILREVL---L 109
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG- 681
LEYLHE + I HR+ K+ANILL ++ V ++D G+ SG ++ T G
Sbjct: 110 GLEYLHE--EGKI-HRDIKAANILLSEEGDVKLADFGV-----SGQLTSTMSKRNTFVGT 161
Query: 682 --YGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ APE +SG Y ++D++S G+ +EL G LH +
Sbjct: 162 PFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLS----------------DLHPM 204
Query: 738 DALSRMVD---PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
L + PSL G +K F D +S C+ +P+ RP E+++
Sbjct: 205 RVLFLIPKNNPPSLEGNKFSKP---FKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 9e-15
Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 51/296 (17%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHAN 568
F+ IG G G+VY A+ + +++A+KK+ S +K + ++ V + RI+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 569 IVELKG-YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+E KG Y EH L+ EYC G+ D+L K L + GA + L YL
Sbjct: 87 SIEYKGCYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYL 141
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
H ++HR+ K+ NILL + V ++D G A + S + + T Y + APE
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----NSFVGTPY-WMAPEV 192
Query: 687 ---FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
+ G Y + DV+S G+ +E L RK P L +++A+S +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIE-LAERK------------------PPLFNMNAMSAL 233
Query: 744 V------DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
P+L + +F + + C+Q P+ RP E+++ + + RER
Sbjct: 234 YHIAQNESPTLQSN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM--FVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G V+ +A+K L + FL+ + ++RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+E ++ E+ G+L D L D L + MA A + Y+ + +
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYI 124
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQ 695
HR+ ++ANIL+ D+L ++D GLA LI + G + APE G +T +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 696 SDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA 754
SDV+SFG+++ EL+T GR Y NR L ++ RM P Q
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNR----------EVLEQVERGYRMPCP----QGCP 229
Query: 755 KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
+SL +++ C + +P+ RP E +Q ++
Sbjct: 230 ESLH---ELMKLCWKKDPDERPTF-EYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 32/281 (11%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
S E +GAG G V+ A +AVK + + S + FL N + ++H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L + +I E+ + G+L D L SD+ K L ++ +A+ E +
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDFSAQIAEGMAF 117
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FE 688
I Q +HR+ ++ANIL+ L ++D GLA +I + G + APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 176
Query: 689 SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
G +T +SDV+SFG++++E++T GR Y N P++ I AL R
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PEV--IRALERGYRMP 223
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPP---MSEVVQDL 785
P + +I+ RC ++ PE RP + V+ D
Sbjct: 224 RPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 45/234 (19%)
Query: 511 FSQENLI-----GAGMLGSVYRA-------QLPDGKL-LAVKKLDKRASSQQKDDEF--L 555
F ++ L+ G G G V RA PD + +AVK L A+ + D +
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------DDEL----- 604
EL+ I + H NI+ L G C + G +I EY + G L++ L + D
Sbjct: 69 ELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 605 -KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
+ LS+ + A AR +EYL +HR+ + N+L+ +D + ++D GLA
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR- 182
Query: 664 ISSGSVSQLSGHLLTAYG-----YGAPE--FESGIYTCQSDVYSFGVVMLELLT 710
V + + T+ G + APE F+ +YT QSDV+SFG++M E+ T
Sbjct: 183 ----GVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V + + +P G ++AVK++ +SQ++ ++L ++ + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDEL-KNNLSWNTRI------RMALGAARALEYLH 628
G + E M S D+ K I ++A+ +ALEYLH
Sbjct: 69 LFREGDVWICMEV--------MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHLLTAYGYGAPE- 686
+ ++HR+ K +N+L++ + V + D G++ L+ S + + +G Y APE
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG----CKPYMAPER 174
Query: 687 ----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
Y +SDV+S G+ M+EL TGR YD + +Q L +
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ---------------LKQ 219
Query: 743 MVDPSLSGQYPAKSLS-HFADIISRCVQSEPEFRPPMSEVVQ 783
+V+ S Q PA+ S F D +++C++ + RP E++Q
Sbjct: 220 VVEEP-SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 517 IGAGMLGSV----YRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
IG G G V YR G +AVK + A++Q FL + + ++RH+N+V+L
Sbjct: 14 IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQL 64
Query: 573 KGYCAE-HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
G E G ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE--- 119
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESG 690
VHR+ + N+L+ +D VSD GL SS +Q +G L + APE
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKL--PVKWTAPEALREK 174
Query: 691 IYTCQSDVYSFGVVMLELLT-GRKSYDR 717
++ +SDV+SFG+++ E+ + GR Y R
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 517 IGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G +Y+ L +L+A+K L K ++ Q+ EF + + + + H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDML-----HSD-----DE---LKNNLSWNTRIRMAL 618
L G + +++EY + G L + L HSD DE +K++L + +A+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
A +EYL VH++ + NIL+ + L V +SD GL+ I S ++ L
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 679 AYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT 710
+ PE G ++ SD++SFGVV+ E+ +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 76/308 (24%), Positives = 131/308 (42%), Gaps = 63/308 (20%)
Query: 517 IGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V +A +AVK L + ASS + D E N + ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQVNHPHVI 66
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLH----------------------SDDELKNNL 608
+L G C++ G LLI EY G+L+ L + DE L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE--RAL 124
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ I A +R ++YL E+ +VHR+ + N+L+ + + +SD GL S
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGL-----SRD 176
Query: 669 VSQLSGHLLTAYG-----YGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNR 721
V + ++ + G + A E IYT QSDV+SFGV++ E++T G Y
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP----- 231
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
I + L ++ + P +++ C + EP+ RP +++
Sbjct: 232 --------GIAP----ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
Query: 782 VQDLVDMI 789
++L M+
Sbjct: 280 SKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 57/307 (18%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL--------PDGKLLAVKKLDKRASSQQKDDEFLEL 557
FS++ L +G G G V A+ + +AVK L A+ + D L
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD----L 67
Query: 558 VNNIDRI----RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
V+ ++ + +H NI+ L G C + G +I EY S G L++ L + S++
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127
Query: 614 ------------IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRT 718
+++ + + + + APE F+ +YT QSDV+SFGV+M E+ T G Y
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYP-- 241
Query: 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
IP ++ L +++ PA + ++ C + P RP
Sbjct: 242 -----------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF 286
Query: 779 SEVVQDL 785
++V+DL
Sbjct: 287 KQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 44/269 (16%)
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNIDRIR----HANIVELKGYCAEHGQRLLIYEYCSN 591
+AVK L A+ D + +LV+ ++ ++ H NI+ L G C + G ++ EY S
Sbjct: 47 VAVKMLKDDAT----DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102
Query: 592 GTLQDML---------HSDDELK---NNLSWNTRIRMALGAARALEYLHEICQPPIVHRN 639
G L++ L +S D K L++ + A AR +EYL +HR+
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 640 FKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSD 697
+ N+L+ +D + ++D GLA + + + + + + APE F+ +YT QSD
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSD 218
Query: 698 VYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKS 756
V+SFGV++ E+ T G Y IP ++ L +++ PA
Sbjct: 219 VWSFGVLLWEIFTLGGSPYP-------------GIP----VEELFKLLKEGHRMDKPANC 261
Query: 757 LSHFADIISRCVQSEPEFRPPMSEVVQDL 785
I+ C + P RP ++V+DL
Sbjct: 262 THELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 43/285 (15%)
Query: 517 IGAGMLGSVYRAQ----LPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V+ A+ LP+ L+AVK L + + S ++D F + ++H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-----------DDELKNNLSWNTRIRMALG 619
G C E L+++EY +G L L S +D L+ + +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
A + YL + VHR+ + N L+ L V + D G++ I S ++ G +
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 680 YGYGAPEFESGIY---TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736
+ PE S +Y T +SD++SFGVV+ E+ T G+Q W QL +
Sbjct: 188 IRWMPPE--SILYRKFTTESDIWSFGVVLWEIFT----------YGKQ---PWY--QLSN 230
Query: 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
+A+ + + P I+ C Q EP+ R + ++
Sbjct: 231 TEAIE-CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 57/271 (21%), Positives = 115/271 (42%), Gaps = 38/271 (14%)
Query: 524 SVYRAQLPDGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582
S+Y+ + K + ++ K + D + N+ RI NI+++ G+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 583 L----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHR 638
L LI EYC+ G L+++L D E +LS+ T++ MA+ + L L++ P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVL--DKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 639 NFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI---YTCQ 695
N S + L+ ++ + + GL ++SS ++ Y + + + I YT +
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN-----FMVYFSYKMLNDIFSEYTIK 202
Query: 696 SDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY-PA 754
D+YS GVV+ E+ TG+ ++ + ++ + P
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENL-----------------TTKEIYDLIINKNNSLKLPL 245
Query: 755 KSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
I+ C + RP + E++ +L
Sbjct: 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 40/267 (14%)
Query: 536 LAVKKLDKRASSQQKDDEF--LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593
+AVK L A+ + D +E++ I + H NI+ L G C + G +I EY S G
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 594 LQDMLHS------------DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641
L++ L + + LS+ + A AR +EYL +HR+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 642 SANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVY 699
+ N+L+ +D + ++D GLA I + + + + APE F+ IYT QSDV+
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVW 226
Query: 700 SFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLS 758
SFGV++ E+ T G Y +P ++ L +++ P+ +
Sbjct: 227 SFGVLLWEIFTLGGSPYP-------------GVP----VEELFKLLKEGHRMDKPSNCTN 269
Query: 759 HFADIISRCVQSEPEFRPPMSEVVQDL 785
++ C + P RP ++V+DL
Sbjct: 270 ELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 517 IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANI 569
+G G G V+ A+ D L+AVK L + + +KD EL+ N+ +H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL---QHEHI 69
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML--HSDDEL-------KNNLSWNTRIRMALGA 620
V+ G C E ++++EY +G L L H D + L+ + + +A
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
A + YL VHR+ + N L+ ++L V + D G++ + S ++ GH +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 681 GYGAPEFESGIY---TCQSDVYSFGVVMLELLT-GRKSYDRTRN 720
+ P ES +Y T +SDV+S GVV+ E+ T G++ + + N
Sbjct: 187 RWMPP--ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 53/238 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNN----IDR 563
+ F +IG G +V A+ K A+K LDKR ++K ++ V + R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTR 57
Query: 564 I-RHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
+ H I++L Y + + L + EY NG ++L ++ S + +
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNG---ELLQY---IRKYGSLDEKC------T 104
Query: 622 R--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
R ALEYLH I+HR+ K NILLD D+ + ++D G A ++ S + +
Sbjct: 105 RFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
Query: 674 GHLLTAYG------------------YGAPEFESGIYTC-QSDVYSFGVVMLELLTGR 712
T Y +PE + SD+++ G ++ ++LTG+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 53/276 (19%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQK-------DDEFLELVNNIDRIRHAN 568
+G G G V Q+ GK+ A KKLDK+ ++K + + LE V++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
IV L Y E L L+ + G L+ +++ E ARA+ Y
Sbjct: 55 IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE------------PGFPEARAIFYA 101
Query: 628 HEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
+I Q IV+R+ K N+LLDD V +SD GLA + G ++ G T
Sbjct: 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGT-P 158
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
GY APE + +Y D ++ G + E++ GR + R R E+ + ++
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKV-------EKEELK- 207
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
R ++ +YP K D+ +Q +PE R
Sbjct: 208 --RRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 517 IGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANI 569
+G G G V+ A+ D L+AVK L + +KD EL+ N+ +H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL---QHEHI 69
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML--HSDDEL----------KNNLSWNTRIRMA 617
V+ G C + ++++EY +G L L H D + K L + + +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
A + YL VHR+ + N L+ +L V + D G++ + S ++ GH +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 678 TAYGYGAPEFESGIY---TCQSDVYSFGVVMLELLT 710
+ P ES +Y T +SDV+SFGV++ E+ T
Sbjct: 187 LPIRWMPP--ESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 49/279 (17%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHAN 568
FS IG G G+VY A+ + + +++A+KK+ S +K + ++ V + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 IVELKG-YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
++ +G Y EH L+ EYC G+ D+L K L + GA + L YL
Sbjct: 77 TIQYRGCYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
H ++HR+ K+ NILL + V + D G A +++ + + T Y + APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPY-WMAPEV 182
Query: 687 ---FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
+ G Y + DV+S G+ +E L RK P L +++A+S +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERK------------------PPLFNMNAMSAL 223
Query: 744 V------DPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P+L + ++ +F D C+Q P+ RP
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V++A+ G+ +A+KK+ R ++ L + + +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 576 CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
HG L+ EY L ++L ++ + +RM L + + Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---G 119
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIY 692
I+HR+ K AN+L+ D + ++D GLA L S S + T + Y APE + + Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW-YRAPELLYGARKY 178
Query: 693 TCQSDVYSFGVVMLELLTGR 712
D+++ G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 93 GELGENLGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTL 150
G + LG+ S + + LS N + G IP L + + LS NQ SG IP+S + + +
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
L+ + L+ N LSGEIP ++ L+ +++S N+L G LP +
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 514 ENLIGAGMLGSVY--RAQLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
E +IGAG G V R +LP + +A+K L + +Q+ D FL + + + H NI
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ L+G + +++ EY NG+L L D + + M G A ++YL +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS---SGSVSQLSGHLLTAYGYGAPE 686
+ VHR+ + NIL++ +L VSD GL+ ++ + + G + + APE
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE 179
Query: 687 -FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNR 721
+T SDV+S+G+VM E+++ G + Y N+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L + A+ ++D FL+ + + R++ NI+ L C +I EY NG L
Sbjct: 48 LVAVKMLREDANKNARND-FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 595 QDML-------HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
L ++ +S++T I MA A ++YL + VHR+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163
Query: 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVV 704
+ + ++D G++ + SG ++ G + + + +ES G +T SDV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMS--WESILLGKFTTASDVWAFGVT 221
Query: 705 MLELLT 710
+ E+LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 78/302 (25%), Positives = 121/302 (40%), Gaps = 61/302 (20%)
Query: 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR- 565
T F +IG G G VY+A G+L+A+K +D DE E+ + +R
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRK 58
Query: 566 ---HANIVE------LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM 616
H NI K Q L+ E C G++ D++ K R++
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKE 112
Query: 617 AL------GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
R L YLHE ++HR+ K NILL + V + D G++ + S ++
Sbjct: 113 EWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLG 168
Query: 671 QLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724
+ + + T Y + APE + Y +SDV+S G+ +EL G+
Sbjct: 169 RRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------- 218
Query: 725 FLVRWAIPQLHDIDAL---SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
+H + AL R P+L P F D IS C+ E RP M E+
Sbjct: 219 -------CDMHPMRALFKIPRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEEL 269
Query: 782 VQ 783
++
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNID---RI 564
++ + L+G G G VY D G+ LAVK++ S + E L I +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTR--IRMALGAA 621
+H IV+ G C + L I+ EY G+++D L + L + TR R L
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRKYTRQIL--- 114
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI-----SSGSVSQLSGHL 676
+EYLH IVHR+ K ANIL D V + D G + + S + ++G
Sbjct: 115 EGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG-- 169
Query: 677 LTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLT 710
T Y + +PE SG Y ++DV+S G ++E+LT
Sbjct: 170 -TPY-WMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 66/279 (23%), Positives = 131/279 (46%), Gaps = 46/279 (16%)
Query: 517 IGAGMLG-SVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G ++ DGK +K+++ S ++ +E + V + ++H NIV+ +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 576 CAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E+G ++ +YC G L + +L +D++ L W +I + AL+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFVQICL------ALKHVH 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF- 687
+ I+HR+ KS NI L D + + D G+A +++S +V + T Y Y +PE
Sbjct: 119 D---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPY-YLSPEIC 173
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
E+ Y +SD+++ G V+ E+ T + +++ + +V
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------------------MKNLVLKI 213
Query: 748 LSGQYPAKSLSHFADI---ISRCVQSEPEFRPPMSEVVQ 783
+ G YP S + D+ +S+ + P RP ++ +++
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 533 GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR--LLIYEYCS 590
G+ +AVK L + D E + + + H NIV+ KG C E G LI E+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKE-IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650
+G+L++ L + KN ++ +++ A+ + ++YL VHR+ + N+L++ +
Sbjct: 92 SGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESE 145
Query: 651 LAVSVSDCGLAPLISSGS-VSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLE 707
V + D GL I + + L + + APE +S Y SDV+SFGV + E
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYE 204
Query: 708 LLT 710
LLT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V +++ + VK+L ASS+++++ FL+ + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE-FLQQGDPYRILQHPNILQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C E LL++EYC G L+ L + + N RMA A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FES 689
+H + N L DL V V D G+ P + + APE F
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 690 GIYTCQ----SDVYSFGVVMLELL 709
G+ T + S+V++ GV + EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
N +++IG G G V +A++ DG + A+K++ + AS D EL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTR 613
H NI+ L G C G L EY +G L D L L+ + LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VS 670
+ A AR ++YL Q +HR+ + NIL+ ++ ++D GL S G V
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVK 179
Query: 671 QLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLT 710
+ G L + +YT SDV+S+GV++ E+++
Sbjct: 180 KTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 516 LIGAGMLGSVYRA--QLPDGKLLAVK-KLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
IG G G VY+ P+ + +AV K K +S ++FL+ + + H +IV+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G E+ ++ E G L+ L + K +L + I + + AL YL
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-- 126
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS-GHLLTAYGYGAPE---FE 688
VHR+ + N+L+ V + D GL+ + S + S G L + APE F
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFR 183
Query: 689 SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
+T SDV+ FGV M E+L G K + +N I ++ + + L
Sbjct: 184 R--FTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENGERLPM----- 229
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
P ++++C +P RP +E+ L D+++ E+
Sbjct: 230 -----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFL--ELVNNIDRIRHANIVELK 573
+G+G G VY+A+ L G+L AVK + + DD L + + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN-NLSWNTRIRMALGAARALEYLHEICQ 632
G + + EYC G+LQD+ H L +++ R + + L YLH +
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK 127
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF----E 688
+HR+ K ANILL D+ V ++D G+A I++ ++++ + T Y + APE +
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA-TIAKRKSFIGTPY-WMAPEVAAVEK 182
Query: 689 SGIYTCQSDVYSFGVVMLEL 708
+G Y D+++ G+ +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 517 IGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G GSV QL D +L AVK + ++ + ++FL + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 574 GYCAEHGQR------LLIYEYCSNGTLQD-MLHSD-DELKNNLSWNTRIRMALGAARALE 625
G C + + ++I + +G L +L+S + L ++ A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
YL +HR+ + N +L++++ V V+D GL+ I +G + + A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E +YT +SDV+SFGV M E+ T G+ Y N S +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------------------SEI 223
Query: 744 VDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
D G + P L ++S C P+ RP + +L
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
T F +E +G G VY+ L + +A+K L +A ++ EF
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAMMR 62
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML-----HSD-------DELKNNLS 609
R++H NIV L G + +I+ YCS+ L + L HSD +K+ L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 610 WNTRIRMALGAARALEYL--HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+ + A +E+L H + H++ + N+L+ D L V +SD GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT 710
+L G+ L + +PE G ++ SD++S+GVV+ E+ +
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 79/305 (25%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYR-AQLPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ SL T+++ IG G G VY+ DG L AVK LD + DE +E
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEY 69
Query: 560 NIDRI--RHANIVELKG--YCAEH---GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
NI + H N+V+ G Y A+ GQ L+ E C+ G++ +++ K L
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV------KGLLICGQ 123
Query: 613 RIRMAL------GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
R+ A+ GA L++LH I+HR+ K NILL + V + D G++ ++S
Sbjct: 124 RLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 667 GSVSQLSGHLLTAYGYGAPE-------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTR 719
+ + + + T + + APE ++ Y + DV+S G+ +EL G
Sbjct: 181 TRLRR-NTSVGTPF-WMAPEVIACEQQYDYS-YDARCDVWSLGITAIELGDGDPP----- 232
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMV-DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
+ +H + L ++ +P + +P K F IS+C+ + E RP +
Sbjct: 233 -----------LFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
Query: 779 SEVVQ 783
+ +++
Sbjct: 282 THLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 64/270 (23%), Positives = 103/270 (38%), Gaps = 43/270 (15%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V ++ + A+K + KR + E + I + H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 575 YCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
Y ++ + + EYC G L +L + R +A A EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHNR-- 112
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY------GYGAPE 686
I++R+ K N+LLD + V + D G A + SG + Y APE
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---------KTWTFCGTPEYVAPE 162
Query: 687 FESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
Y D +S G+++ ELLTGR + + + + I L L
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPF--GEDDEDPMEIYNDI--LKGNGKL----- 213
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
++P D+I + ++ PE R
Sbjct: 214 -----EFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 57/229 (24%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR------ 563
+ + +G G VY+A G+++A+KK+ K E E + I+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI--------KLGERKEAKDGINFTALREI 53
Query: 564 -----IRHANIVELKG-YCAEHGQRL-LIYEYCSNGTLQDMLHSDDE--LKNNL------ 608
++H NI+ L + H + L++E+ + +D E +K+
Sbjct: 54 KLLQELKHPNIIGLLDVFG--HKSNINLVFEF---------METDLEKVIKDKSIVLTPA 102
Query: 609 ---SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
S+ + M L R LEYLH I+HR+ K N+L+ D + ++D GLA S
Sbjct: 103 DIKSY---MLMTL---RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR--S 151
Query: 666 SGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
GS ++ H + Y APE F + Y D++S G + ELL
Sbjct: 152 FGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
F + ++G+G G+VY+ +P+G+ + A+K+L + A+S + + E L+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVD 67
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+ ++ L G C +L I + G L D + E K+N+ + + A+ +
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMN 123
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS-QLSGHLLTAYGYGA 684
YL E +VHR+ + N+L+ V ++D GLA L+ + G +
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 685 PEFESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL--- 740
IYT QSDV+S+GV + EL+T G K YD IP L
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-------------GIPASEISSILEKG 227
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
R+ P P ++ + I+ +C + + RP E++ + M R
Sbjct: 228 ERLPQP------PICTIDVYM-IMVKCWMIDADSRPKFRELIIEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 20/191 (10%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L A+ ++D FL+ V + R++ NI+ L G C + +I EY NG L
Sbjct: 48 LVAVKILRPDANKNARND-FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 595 QDML---HSDDELKNN------------LSWNTRIRMALGAARALEYLHEICQPPIVHRN 639
L H DD+ +N +S+++ + +AL A ++YL + VHR+
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163
Query: 640 FKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDV 698
+ N L+ ++L + ++D G++ + +G ++ G + + A E G +T SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 699 YSFGVVMLELL 709
++FGV + E+L
Sbjct: 224 WAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F Q ++G G G V Q+ GK+ A KKL+K+ ++K + L ++++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ ++ E RA+ Y
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGE------------AGFEEGRAVFY 107
Query: 627 LHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
EIC Q IV+R+ K NILLDD + +SD GLA + G + G + T
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 165
Query: 680 YGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
GY APE ++ YT D ++ G ++ E++ G+ + + + +
Sbjct: 166 -GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 36/278 (12%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F++ IG G G VY+ K ++A+K +D ++ +DE ++ I + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 570 VELKGYCAEH--GQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ Y + G +L +I EY G+ D+L + ++ T +R L + L+Y
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREIL---KGLDY 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH + +HR+ K+AN+LL + V ++D G+A ++ + + + + + APE
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 171
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
+ Y ++D++S G+ +EL G FL+ P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------- 218
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+L GQY F + + C+ +P FRP E+++
Sbjct: 219 PTLEGQYSKP----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 516 LIGAGMLGSVYRA-QLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G+G G+VY+ +PDG K+ K+ + +S + + E L+ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNN--LSWNTRIRMALGAARALEYLH 628
L G C +L + + G L D + + D + + L+W +I A+ + YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP--- 685
E+ +VHR+ + N+L+ V ++D GLA L+ + + H A G P
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYH---ADGGKVPIKW 177
Query: 686 -EFESGI---YTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
ES + +T QSDV+S+GV + EL+T G K YD R IP L ++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDL--LEKG 227
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
R+ P P ++ + I+ +C + E RP E+V + M R
Sbjct: 228 ERLPQP------PICTIDVYM-IMVKCWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDR-------IRH 566
LIG G G VY A + G+++AVK+++ + + D ++V + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 567 ANIVELKGYCAEHGQRLL-IY-EYCSNGTLQDMLHS----DDELKNNLSWNTRIRMALGA 620
NIV+ G+ E + L I+ EY G++ L + +++L +
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV-------- 117
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL----APLISSGSVSQLSGHL 676
L YLH I+HR+ K+ N+L+D D +SD G+ + + + G +
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 677 LTAYGYGAPEF---ESGIYTCQSDVYSFGVVMLELLTGRKSYDR 717
+ APE S Y+ + D++S G V+LE+ GR+ +
Sbjct: 175 F----WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L AS ++D FL+ V + R+ NI L G C +I EY NG L
Sbjct: 48 LVAVKVLRPDASDNARED-FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 595 QDMLHS----DDELKNN---LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
L L N LS++T + MA A + YL + VHR+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVML 706
+ + ++D G++ + S ++ G + A E G +T +SDV++FGV +
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 707 ELLT 710
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 32/276 (11%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIRHANIVE 571
L+G G G VY D G+ LA K++ S + E L + + ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 572 LKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
G + ++ L EY G+++D L + L +++ ++ G + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLH- 123
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG-APEFE 688
IVHR+ K ANIL D V + D G + + + +S +T Y +PE
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 689 SGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
SG Y ++DV+S G ++E+LT + WA + + A+ ++
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP--------------WA--EYEAMAAIFKIATQP 225
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ Q P+ H D + C+ E RP E+++
Sbjct: 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 65/278 (23%), Positives = 123/278 (44%), Gaps = 36/278 (12%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN- 568
F++ IG G G V++ K++A+K +D ++ +DE ++ I + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 61
Query: 569 --IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ + G + + +I EY G+ D+L + ++ T +R L + L+Y
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREIL---KGLDY 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH +HR+ K+AN+LL + V ++D G+A ++ + + + + APE
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE 171
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
+ Y ++D++S G+ +EL G + FL+ P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------- 218
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+L G Y +K L F + C+ EP FRP E+++
Sbjct: 219 PTLEGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 46/276 (16%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN---IVEL 572
+G G GSVY+ P G +A+K++ + + +F +++ +D + A IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G G + EY G+L D L++ + + R+ + L++L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE------ 686
I+HR+ K N+L++ + V + D G +S V+ L+ + Y APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD--IDALSRM 743
++ YT QSDV+S G+ +LE+ GR Y P+ + LS +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYP---------------PETYANIFAQLSAI 222
Query: 744 VD---PSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
VD P+L Y + D +++C+ P RP
Sbjct: 223 VDGDPPTLPSGYSDDA----QDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V Q+ GKL A KKL+K+ ++K E + I H+ + Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 576 CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ L L+ + G L+ +++ DE LE+LH Q
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG-IYT 693
I++R+ K N+LLD+D V +SD GLA + G S+ G+ T G+ APE G Y
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTP-GFMAPELLQGEEYD 175
Query: 694 CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724
D ++ GV + E++ R + R RGE+
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF---RARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 67/280 (23%), Positives = 133/280 (47%), Gaps = 44/280 (15%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL-KGY 575
+G G G VY+AQ + +LA K+ S ++ +D +E ++ + H NIV+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-IDILASCDHPNIVKLLDAF 71
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA-RALEYLHEICQPP 634
E+ +LI E+C+ G + ++ EL+ L+ +IR+ AL YLHE
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVML---ELERPLT-EPQIRVVCKQTLEALNYLHE---NK 123
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF------E 688
I+HR+ K+ NIL D + ++D G++ ++ ++ + + T Y + APE +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDSFIGTPY-WMAPEVVMCETSK 181
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV---- 744
Y ++DV+S G+ ++E+ P H+++ + ++
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIE-------------------PPHHELNPMRVLLKIAK 222
Query: 745 -DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+P Q P++ S F D + +C++ + R ++++Q
Sbjct: 223 SEPPTLAQ-PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 65/281 (23%), Positives = 125/281 (44%), Gaps = 34/281 (12%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK------LDKRASSQQKDDEFLELVNNID 562
+F E IG G VYRA L DG +A+KK +D +A + + ++ ++ +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-----DCIKEIDLLK 57
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
++ H N+++ E + ++ E G L M+ + K + T + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
ALE++H ++HR+ K AN+ + V + D GL SS + + S L+ Y
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 683 GAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
+PE E+G Y +SD++S G ++ E+ + + G++ + ++ D
Sbjct: 173 MSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCDY- 225
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
P L + ++ L ++ C+ +PE RP ++ V
Sbjct: 226 -----PPLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 517 IGAGMLGSVYRA-------QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+G G G VY P+ ++ A+K +++ AS +++ EFL + + ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERI-EFLNEASVMKEFNCHHV 71
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNL-----SWNTRIRMALGAARA 623
V L G ++ L+I E + G L+ L S E++NN S I+MA A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+ YL+ VHR+ + N ++ +D V + D G+ I + G L +
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
+PE + G++T SDV+SFGVV+ E+ T + Y N EQ L
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVL--------------- 231
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
R V P +++ C Q P+ RP E++ + +
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG+G G VY+A+ + LA K+ K + E++ D +H+NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD-CKHSNIVAYFGSY 75
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ + E+C G+LQD+ H L + ++A + L+ L+ + +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPL-------SESQIAYVSRETLQGLYYLHSKGKM 128
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES----GIY 692
HR+ K ANILL D+ V ++D G++ I++ ++++ + T Y + APE + G Y
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITA-TIAKRKSFIGTPY-WMAPEVAAVERKGGY 186
Query: 693 TCQSDVYSFGVVMLEL 708
D+++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 51/288 (17%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ---QKDDEFL-ELVNNIDRIRHANIV 570
++G G G+VY G+L+AVK+++ S+ +K+ E L E V+ + ++H NIV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+ G C + + E+ G++ +L+ L + ++ G A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-----TAYGYGAP 685
C +VHR+ K N++L + + + D G A ++ + ++L T Y + AP
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY-WMAP 177
Query: 686 EF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
E ESG Y +SD++S G + E+ TG+ P L +D L+ M
Sbjct: 178 EVINESG-YGRKSDIWSIGCTVFEMATGK-------------------PPLASMDRLAAM 217
Query: 744 --------VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ P L + A + D ++ C+ + RP ++++
Sbjct: 218 FYIGAHRGLMPRLPDSFSAAA----IDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V+ + D KL+ +K++ ++ + + + H NI+E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSD-----DELKNNLSWNTRIRMALGAARALEYLHE 629
E +++ EY GTL + + DE L + +I +AL H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLAL---------HH 116
Query: 630 ICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YGAP 685
+ I+HR+ K+ NILLD + V + D G++ ++SS S + T G Y +P
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY------TVVGTPCYISP 170
Query: 686 EF-ESGIYTCQSDVYSFGVVMLELLTGRKSYD 716
E E Y +SD+++ G V+ EL + +++++
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 61/293 (20%)
Query: 511 FSQENL-----IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
F+ E+L IG G G+V + P G ++AVK++ R++ +K+ + L+ ++D +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQK--RLLMDLDVV 56
Query: 565 RHA----NIVELKGYCAEHGQRLLIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ IV+ G G + E S ++ + LK+ + ++A+
Sbjct: 57 MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY--EVLKSVIPEEILGKIAV 114
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
+AL YL E + I+HR+ K +NILLD + + + D G+ SG L+
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI------------SGQLVD 160
Query: 679 AYG---------YGAPE----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
+ Y APE Y +SDV+S G+ + E+ TG+ Y + + +Q
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 726 --LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
+V+ P L S ++ S S F + I+ C+ + RP
Sbjct: 221 TQVVKGDPPILS----------NSEEREF---SPS-FVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 84/371 (22%), Positives = 154/371 (41%), Gaps = 74/371 (19%)
Query: 443 MMPPPPPPPPPPPPPPPP--------------PPPPPVVEKVIVKPIVPAEGTAVKTSTK 488
M P PPP P P P P + P+ P S+
Sbjct: 1 MKPIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPP-------PSSS 53
Query: 489 TAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASS 547
++ +++ S + S + + + N IG+G G+VY+ P G+L A+K +
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YG 109
Query: 548 QQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
+D ++ I+ +R H N+V+ +G+ ++ E+ G+L+ +D++
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169
Query: 605 KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+++ R L + YLH + IVHR+ K +N+L++ V ++D G++ ++
Sbjct: 170 LADVA-----RQILSG---IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
Query: 665 S------SGSVSQLSGHLLTAYGYGAPE-----FESGIYT-CQSDVYSFGVVMLELLTGR 712
+ + SV ++ Y +PE G Y D++S GV +LE GR
Sbjct: 219 AQTMDPCNSSVGTIA--------YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
Query: 713 KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEP 772
+ R +G+ WA +L + S + PA + F IS C+Q EP
Sbjct: 271 FPFGVGR-QGD-----WA--------SLMCAICMSQPPEAPATASREFRHFISCCLQREP 316
Query: 773 EFRPPMSEVVQ 783
R +++Q
Sbjct: 317 AKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 35/288 (12%)
Query: 517 IGAGMLGSVYRAQLPD---GKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY D G+ +AVK +++ AS +++ EFL + + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 72
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNL-----SWNTRIRMALGAARAL 624
L G ++ L++ E ++G L+ L S E +NN + I+MA A +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
YL+ VHR+ + N ++ D V + D G+ I + G L + A
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE + G++T SD++SFGVV+ E+ + + Y N EQ L +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVL---------------K 232
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
V P D++ C Q P+ RP E+V L D +
Sbjct: 233 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 54/287 (18%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G VY A+ L +A+K++ +R S + E + ++H NIV+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQP 633
+E+G + E G+L +L S LK+N T I L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIIFYTKQILEGLKYLHDN--- 127
Query: 634 PIVHRNFKSANILLD--------DDLAVSVSDCGLAPLISS--GSVSQLSGHLLT--AYG 681
IVHR+ K N+L++ D S G+ P + G++ ++ ++ G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI-DAL 740
YGAP +D++S G ++E+ TG+ P ++ +
Sbjct: 188 YGAP----------ADIWSLGCTIVEMATGK-------------------PPFIELGEPQ 218
Query: 741 SRMVDPSLSGQYP--AKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ M + +P +SLS A + I RC + +P+ R +++QD
Sbjct: 219 AAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 70/277 (25%), Positives = 132/277 (47%), Gaps = 41/277 (14%)
Query: 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G +Y A+ D + +K++D ++ + + V + +++H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 576 CAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E+G+ ++ EYC G L + +L S+D++ LSW +I +LG L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSWFVQI--SLG----LKHIH 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVS-VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
+ I+HR+ KS NI L + V+ + D G+A ++ S+ + T Y Y +PE
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPY-YLSPEI 173
Query: 688 -ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
++ Y ++D++S G V+ EL T + ++ N Q +++ I P
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE--GNNLHQLVLKICQGYFAPI-------SP 224
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ S +SL IS+ + P RP ++ +++
Sbjct: 225 NFS--RDLRSL------ISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 34/179 (18%)
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP-LISSGSVSQLS 673
+M + +AL YL E ++HR+ K +NILLD V + D G++ L+ S + ++ +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 674 GHLLTAYGYGAPE-----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728
G Y APE + Y ++DV+S G+ ++EL TG+ Y +
Sbjct: 176 G----CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------- 223
Query: 729 WAIPQLHDIDALSRMVD---PSLSGQYPAKSLSH-FADIISRCVQSEPEFRPPMSEVVQ 783
+ + L++++ PSL P + S F + C+ + RP E++Q
Sbjct: 224 -------EFEVLTKILQEEPPSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 47/278 (16%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKG 574
IG G G V A G+ +AVKK+D R Q+++ F E+V I R +H NIVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVV--IMRDYQHPNIVEMYS 83
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM--------ALGAARALEY 626
+ ++ E+ G L D++ T RM L +AL +
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-------------THTRMNEEQIATVCLAVLKALSF 130
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH ++HR+ KS +ILL D V +SD G +S V + + T Y + APE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAPE 185
Query: 687 FESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
S + Y + D++S G++++E++ G Y + P L + + +
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLQAMKRIRDNLP 232
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P L + K + R + +P R +E++
Sbjct: 233 PKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 83/300 (27%), Positives = 136/300 (45%), Gaps = 57/300 (19%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
TI S+ +++ IG G G+VY A + G+ +A+K+++ QQ E + +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL---QQQPKKELI--I 64
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R H NIV L Y G L ++ EY + G+L D++ T
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVV-------------TE 109
Query: 614 IRMALG--AA------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
M G AA +ALE+LH ++HR+ KS NILL D +V ++D G I+
Sbjct: 110 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 666 SGSVSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSY-DRTRNRGE 723
S+ S + T Y + APE + Y + D++S G++ +E++ G Y + R
Sbjct: 167 PEQ-SKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 724 QFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ P+L Q P K + F D ++RC++ + E R E++Q
Sbjct: 225 YLIATNGTPEL----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V A + GKL+AVKK+D R QQ+ + V + +H N+VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ ++ E+ G L D++ + ++ + L +AL LH +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQGV 137
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-YTC 694
+HR+ KS +ILL D V +SD G +S V + + T Y + APE S + Y
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAPELISRLPYGP 195
Query: 695 QSDVYSFGVVMLELLTGRKSY 715
+ D++S G++++E++ G Y
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIR 565
++ L+G G G VY D G+ LAVK++ SQ+ E L + + +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 566 HANIVELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H IV+ G + ++ L EY G+++D L + L N+ TR R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TR-RYTRQILQG 118
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+ YLH IVHR+ K ANIL D V + D G + I + +S +T Y
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 684 -APEFESGI-YTCQSDVYSFGVVMLELLT 710
+PE SG Y ++DV+S ++E+LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/279 (23%), Positives = 127/279 (45%), Gaps = 26/279 (9%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD--KRASSQQKDDEFLELVNNIDRIRH 566
+F E IG G VYRA L D K +A+KK+ + ++ + D E ++ + ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE-IDLLKQLNH 61
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
N+++ E + ++ E G L M+ + K + T + + A+E+
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
+H ++HR+ K AN+ + V + D GL SS + + S L+ Y +PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 687 --FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
E+G Y +SD++S G ++ E+ + + G++ + ++ D
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCDY----- 225
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P L ++ ++ L +++S C+ +P+ RP + V Q
Sbjct: 226 -PPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 517 IGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V ++ G + VK+L AS Q++ +FLE ++H+N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARALEYLHEIC 631
G C E LL+ E+C G L+ L S ++ + RMA A L +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRS-CRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI 691
+ +H + N LL DL V + D GL+ L + APE +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 692 Y--------TCQSDVYSFGVVMLELL 709
+ T +S+V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-LSGHLLTAYG 681
ALEYLH I+HR+ K NILLD+ V ++D +A ++ +++ SG G
Sbjct: 112 ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP----G 164
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYD 716
Y APE Y+ D +S GV E L G++ Y
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
++Y +SF + IG G G V A + GK +AVKK+D R QQ+ + V +
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRD 75
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H N+V++ + ++ E+ G L D++ + ++ + L RA
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRA 130
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L YLH ++HR+ KS +ILL D + +SD G +S V + + T Y +
Sbjct: 131 LSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPY-WM 185
Query: 684 APEFESGI-YTCQSDVYSFGVVMLELLTGRKSY 715
APE S + Y + D++S G++++E++ G Y
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F Q ++G G G V Q+ GK+ A K+L+K+ ++K + L ++++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ +++ N + R AA L
Sbjct: 61 FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYN----MGNPGFEEE-RALFYAAEILCG 114
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
L ++ + V+R+ K NILLDD + +SD GLA I G + G + T GY APE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTV-GYMAPE 171
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724
+ YT D + G ++ E++ G+ + R R E+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL--VNNIDRI-RHANIVEL 572
+G G GSVY A+ G+L+A+KK+ K+ S +E + L V ++ ++ H NIV+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKL 63
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR-MALGAARALEYLHEIC 631
K E+ + ++EY Q M + S + IR + + L ++H+
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKP---FS-ESVIRSIIYQILQGLAHIHKH- 118
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE- 686
HR+ K N+L+ V ++D GLA I S T Y Y APE
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-------YTDYVSTRWYRAPEI 169
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGR 712
S Y+ D+++ G +M EL T R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 23/194 (11%)
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
+D K L+ I + A+ +E+L +HR+ + NILL ++ V + D G
Sbjct: 168 QEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 660 LAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLT-GRKSYD 716
LA I G + APE F+ +YT QSDV+SFGV++ E+ + G Y
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPY- 282
Query: 717 RTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P + + R + + P + + C EP RP
Sbjct: 283 ---------------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 327
Query: 777 PMSEVVQDLVDMIR 790
SE+V+ L ++++
Sbjct: 328 TFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-------HAN 568
IG G V +AQ GK A+K + K S LE VNN+ I+ H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-------LEQVNNLREIQALRRLSPHPN 59
Query: 569 IVELKG--YCAEHGQRLLIYEYCSNGTLQDMLHSDDEL----KNNLSWNTRIRMALGAAR 622
I+ L + + G+ L++E L DM + EL K L +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFE------LMDM--NLYELIKGRKRPLPEKRVKSYMYQLLK 111
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY-- 680
+L+++H + I HR+ K NIL+ DD+ + ++D G S + S T Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFG-----SCRGIY--SKPPYTEYIS 160
Query: 681 --GYGAPE--FESGIYTCQSDVYSFGVVMLELLT 710
Y APE G Y + D+++ G V E+L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 60/207 (28%), Positives = 83/207 (40%), Gaps = 33/207 (15%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V + GK A+K L K + K E + I IRH +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+ L L+ EY G L L AR ALE
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP------------VARFYAAQVVLALE 115
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
YLH IV+R+ K N+LLD D + ++D G A + + + L G T Y AP
Sbjct: 116 YLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-LCG---TP-EYLAP 167
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTG 711
E S Y D ++ G+++ E+L G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N F ++G G G V + + + K ++A+KK +++ + L + + ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIVELK G+ L++EY ++ML +E+ N + +A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
H + IVHR+ K N+L+ + + + D G A +S GS + + ++ T + Y +PE
Sbjct: 117 H---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPEL 172
Query: 688 ESGI-YTCQSDVYSFGVVMLELLTGR 712
G Y D++S G ++ EL G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 67/287 (23%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
TI S+ +++ IG G G+V+ A + G+ +A+K+++ + Q K + + +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEI 67
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ +++ NIV + ++ EY + G+L D++ + ++ R
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR----- 122
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
+ALE+LH ++HR+ KS N+LL D +V ++D G I+ S+ S + T
Sbjct: 123 ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGT 178
Query: 679 AYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSY-DRTRNRGEQFLVRWAIPQLHD 736
Y + APE + Y + D++S G++ +E++ G Y + R + P+L +
Sbjct: 179 PY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
Query: 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ LS + F D ++RC++ + E R E++Q
Sbjct: 238 PEKLSPI----------------FRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 66/284 (23%), Positives = 130/284 (45%), Gaps = 48/284 (16%)
Query: 511 FSQENLIGAGMLGSVY-----RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
F++ IG G G V+ R Q +++A+K +D ++ +DE ++ I +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ----QVVAIKIID----LEEAEDEIEDIQQEITVLS 57
Query: 566 HANIVELKGYCAEH--GQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGA 620
+ + Y + G +L +I EY G+ D+L + DE + T ++ L
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----IATMLKEIL-- 111
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
+ L+YLH +HR+ K+AN+LL + V ++D G+A ++ + + + +
Sbjct: 112 -KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTP 165
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
+ APE + Y ++D++S G+ +EL G + + V + IP+ +
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKG----EPPNSDMHPMRVLFLIPKNN---- 217
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+L+G++ F + I C+ +P FRP E+++
Sbjct: 218 -----PPTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 41/292 (14%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ + QQ E + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELI--I 65
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R + NIV L Y G L ++ EY + G+L D++ + ++ R
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ALE+LH ++HR+ KS NILL D +V ++D G I+ S+ S
Sbjct: 124 -----ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS 174
Query: 674 GHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSY-DRTRNRGEQFLVRWAI 731
+ T Y + APE + Y + D++S G++ +E++ G Y + R +
Sbjct: 175 TMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+L Q P K + F D ++RC+ + E R E++Q
Sbjct: 234 PEL----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 30/281 (10%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVK---KLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G+G G+VY+ +P+G+ + + K+ + + + EF++ + + H ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C +L + + +G L D +H E K+N+ + + A+ + YL E
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE-- 127
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESG 690
+VHR+ + N+L+ V ++D GLA L+ + + A E
Sbjct: 128 -RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 691 IYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749
+T QSDV+S+GV + EL+T G K YD R IP L ++ R+ P
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDL--LEKGERLPQP--- 233
Query: 750 GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
P ++ + ++ +C + + RP E+ + M R
Sbjct: 234 ---PICTIDVYM-VMVKCWMIDADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 70/314 (22%), Positives = 125/314 (39%), Gaps = 48/314 (15%)
Query: 520 GMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIRHANIVELKGYC 576
M+ + + + P L+AVKK++ + S ++ L + +++H NI+
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPI 635
+ ++ + G+ +D+L L I L AL+Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIH---SKGF 122
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLIS--SGSVSQLSGHLLTAYG-----YGAPE-F 687
+HR+ K+++ILL D V +S GL +S Q H + +PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 688 ESGI--YTCQSDVYSFGVVMLELLTGRKSY---DRTRNRGEQFLVRWAIPQLHDI----- 737
+ + Y +SD+YS G+ EL G + T+ E+ VR +P L D
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPL 238
Query: 738 ------DALSRMVDPSLSGQYPA---KSLS-HFADIISRCVQSEPEFRPPMSEVVQDLVD 787
+ S P+ ++ S HF + C+Q +PE RP S+++
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH--S 296
Query: 788 MIRRERCSNESLGD 801
++ + N SL D
Sbjct: 297 FFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVE 571
L+G G G VY D G+ LAVK++ S + E L I ++ H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 572 LKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
G + +R L E+ G+++D L S L N+ TR + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TR-KYTRQILEGVSYLH- 123
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG-APEFE 688
IVHR+ K ANIL D V + D G + + + +S +T Y +PE
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 689 SGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
SG Y ++D++S G ++E+LT + WA + + A+ ++
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP--------------WA--EFEAMAAIFKIATQP 225
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ P H D + R + E + RP E+++
Sbjct: 226 TNPVLPPHVSDHCRDFLKR-IFVEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 41/275 (14%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVK--KLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G+VY+A L ++LAVK LD Q++ LE++ D I+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS---PYIIGFY 65
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G + + E+ G+L D+ E + R+A+ + L YL +
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DVYRKIPE-------HVLGRIAVAVVKGLTYLWSL--- 114
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG-IY 692
I+HR+ K +N+L++ V + D G +S+ V+ ++ + Y APE SG Y
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 693 TCQSDVYSFGVVMLELLTGRKSYDR-TRNRGEQFLVRWAIPQLHDIDALSRMVD---PSL 748
SDV+S G+ +EL GR Y + +N+G L + L +VD P L
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQG----------SLMPLQLLQCIVDEDPPVL 220
Query: 749 S-GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
GQ+ K F I++C++ +P+ RP ++
Sbjct: 221 PVGQFSEK----FVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 2/85 (2%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L+N L G IP+ L L +++LS N++ G +PPSL +++ L L L N +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 214 -DVLQDL-PLRDLNIENNLFSGPIP 236
+ L L LR LN+ N SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F ++G G G V Q+ GK+ A KKL+K+ ++K + L ++++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ +++ + N RA+ Y
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN---MGNP---------GFDEQRAIFY 107
Query: 627 LHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
E+C + IV+R+ K NILLDD + +SD GLA I G + G + T
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTV 165
Query: 680 YGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
GY APE + YT D + G ++ E++ G+ + + + R
Sbjct: 166 -GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL-KG 574
IG G G V A + G+ +AVK +D R Q+++ F E+V D +H N+VE+ K
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRD-YQHQNVVEMYKS 86
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y G+ L ++ E+ G L D++ + L+ + +AL YLH
Sbjct: 87 YLV--GEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLH---SQ 136
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-Y 692
++HR+ KS +ILL D V +SD G IS V + + T Y + APE S Y
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPY-WMAPEVISRTPY 194
Query: 693 TCQSDVYSFGVVMLELLTGRKSY 715
+ D++S G++++E++ G Y
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 74/292 (25%), Positives = 137/292 (46%), Gaps = 41/292 (14%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+K+++ + QQ E + +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKKELI--I 64
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R + NIV L Y G L ++ EY + G+L D++ + ++ R
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 122
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+AL++LH ++HR+ KS NILL D +V ++D G I+ S+ S
Sbjct: 123 -----ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS 173
Query: 674 GHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSY-DRTRNRGEQFLVRWAI 731
+ T Y + APE + Y + D++S G++ +E++ G Y + R +
Sbjct: 174 TMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
Query: 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+L + + LS + F D ++RC++ + + R E++Q
Sbjct: 233 PELQNPERLSAV----------------FRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 50/283 (17%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G VY+A+ + LA K+ + S ++ +D +E + + H IV+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-IEILATCNHPYIVKLLGAF 78
Query: 577 AEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G+ ++ E+C G + ML D L R L AL+YLH + I
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQVICRQML---EALQYLHSM---KI 131
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS---GHLLTAYGYGAPE------ 686
+HR+ K+ N+LL D + ++D G +S+ +V L + T Y + APE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPY-WMAPEVVMCET 186
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD- 745
+ Y ++D++S G+ ++E+ P H+++ + ++
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIE-------------------PPHHELNPMRVLLKI 227
Query: 746 -----PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P+LS P+K F D + + PE RP +++++
Sbjct: 228 AKSEPPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 103 SSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S+++ +DLS+N I + ++N LS N S +P L+ L+ L ++ L+ N +
Sbjct: 140 SNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
S ++P + L+ L LDLS+N++ EL SL NL L+ L L NN+L + + +L
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
Query: 221 LRDLNIENNL 230
L L++ NN
Sbjct: 257 LETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 80/342 (23%), Positives = 125/342 (36%), Gaps = 86/342 (25%)
Query: 516 LIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++G G G V A +AVK L + A++ + EL I H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 570 VELKGYCAE-HGQRLLIYEYCSNGTLQDMLH----------------------------- 599
V L G C + +G ++I E+C G L + L
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 600 -------SDDELKNNLS----------------WNTRIRM------ALGAARALEYLHEI 630
L + W + + M + AR +E+L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--- 190
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FE 688
+HR+ + NILL ++ V + D GLA I G + APE F+
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
+YT QSDV+SFGV++ E+ + S E+F R L D +RM P
Sbjct: 251 K-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-----LKD---GTRMRAPEN 301
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ I+ C Q +P+ RP S +V+ L D+++
Sbjct: 302 AT-------PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHAN 568
F L+G G G VY+ + + G+L A+K +D + +++E + +N + + H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 569 IVELKGYCAEHG------QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
I G + Q L+ E+C G++ D++ + W I + R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LR 122
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
L +LH Q ++HR+ K N+LL ++ V + D G++ + +V + + + T Y +
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPY-W 177
Query: 683 GAPEF------ESGIYTCQSDVYSFGVVMLELLTG 711
APE Y +SD++S G+ +E+ G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 40/214 (18%)
Query: 516 LIGAGMLGSVY---RAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIV 570
++G G G V+ + PD G+L A+K L K+A+ + +D ++ +I + H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+L G+ LI ++ G L ++++ +++++K L+ +AL AL+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELAL----ALD 112
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---- 681
+LH + I++R+ K NILLD++ + ++D GL S S+ AY
Sbjct: 113 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEK----KAYSFCGT 161
Query: 682 --YGAPEF--ESGIYTCQSDVYSFGVVMLELLTG 711
Y APE G +T +D +SFGV+M E+LTG
Sbjct: 162 VEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 8e-09
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI--SSGSVSQLSGHLLTA 679
R L+YLH ++HR+ K +NIL++ + + + D GLA + L+ +++T
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 680 YGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+ Y APE S YT D++S G + ELLT +
Sbjct: 171 W-YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 69/298 (23%), Positives = 124/298 (41%), Gaps = 53/298 (17%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKK-LDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
L+G G G V + + + G+++A+KK L+ K E + + ++RH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHENLVNLI 66
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
+ L++E+ + L D+ N L + + R +E+ H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCH---SH 119
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPEFES 689
I+HR+ K NIL+ V + D G A +++ G + T Y Y APE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------GEVYTDYVATRWYRAPELLV 173
Query: 690 G--IYTCQSDVYSFGVVMLELLTGR----------KSYDRTRNRG-------EQFL---- 726
G Y D+++ G ++ E+LTG + Y + G E F
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 727 -VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+P++ +I+ L + P LSG D+ +C++ +P+ RP S+++
Sbjct: 234 FAGMRLPEVKEIEPLEKRF-PKLSGL--------VLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 51/290 (17%)
Query: 514 ENLIGAGMLGSVYRA----QLPDGKL----LAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
E+L G G +++ G+L + +K LDK S + + F E + + ++
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLS 57
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H ++V G C + +++ EY G+L D ++ N+SW ++ +A A AL
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALH 114
Query: 626 YLHEICQPPIVHRNFKSANILL---DDDLA-----VSVSDCGLAPLISSGSVSQLSGHLL 677
+L + + H N + N+LL +D + +SD G++ + + LL
Sbjct: 115 FLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LL 165
Query: 678 TAYGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
+ PE + +D +SFG + E+ +G G++ L
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG----------GDK--------PLS 207
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+D+ ++ Q PA + A++I++C+ EP+FRP +++DL
Sbjct: 208 ALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQ---QKDDEFLELVNNIDRIRHANIV 570
IG G G+VY+A+ L G+ +A+KK+ S + + L+ ++ H NIV
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 571 ELKGYCAEHGQRL-------LIYEYCSNGTLQDMLHS--DDELKNNLSWNTRIRMALGAA 621
L C HG R L++E+ QD L + K L T +
Sbjct: 65 RLLDVC--HGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R +++LH IVHR+ K NIL+ D V ++D GLA + S L+ ++T +
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLW- 171
Query: 682 YGAPEFESGI-YTCQSDVYSFGVVMLEL 708
Y APE Y D++S G + EL
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V Q+ + GK+ A KKLDK+ ++ ++ L I +++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y E L L+ + G L+ H + + L I + + +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSM--- 114
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE-FESGI 691
IV+R+ K N+LLDD +SD GLA + G +++Q +G GY APE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG----TNGYMAPEILKEEP 170
Query: 692 YTCQSDVYSFGVVMLELLTGRKSY 715
Y+ D ++ G + E++ GR +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G Q + + A+K++ SS +D E V + +++H NIV K
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65
Query: 575 YCAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
G ++ EYC G L + L +D + L W + M LG ++++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI---LQWFVQ--MCLG----VQHI 116
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
HE ++HR+ KS NI L + V + D G A L++S + ++ T Y Y PE
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPY-YVPPEI 171
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSY 715
+E+ Y +SD++S G ++ EL T + +
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 517 IGAGMLGSVYRA---QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G+G G+V + K +AVK L + DE L N + ++ + IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK-NNLSWNTRIRMALGAARALEYLHEICQ 632
G C E +L+ E G L L + + N+ + + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEE--- 113
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE-FESG 690
VHR+ + N+LL +SD GL+ + + + + H + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 691 IYTCQSDVYSFGVVMLELLT-GRKSYDRTR 719
++ +SDV+SFGV+M E + G+K Y +
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 29/165 (17%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTM-------------------------QNFF 131
ENL + +DL+ N + +I +L +T +
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
LSDN+ S+PS L L L ++ L+ N LS ++P +L+ L NLDLS N +S +LPP
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPI 235
+E LS L L L NN + L L +L L L + NN
Sbjct: 204 EIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 65/262 (24%), Positives = 97/262 (37%), Gaps = 68/262 (25%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQK-------DDEFLELVNNI 561
F + L+G G +G V+ +L GKL A+K LDK+ ++ + E L ++
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-- 59
Query: 562 DRIRHANIVELKGYCAEHGQRLLIY--EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
H + L Y + + L +YC G L +L LS
Sbjct: 60 ----HPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEE-------- 103
Query: 620 AAR--------ALEYLHEICQPPIVHRNFKSANILL---------DDDLAVSVSDCG--- 659
AR ALEYLH IV+R+ K NILL D DL+
Sbjct: 104 VARFYAAEVLLALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 660 ---LAPLISSGSVSQLSGHLLTAYG------------YGAPEFESGI-YTCQSDVYSFGV 703
L SV+ + + Y APE SG + D ++ G+
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220
Query: 704 VMLELLTGRKSYDRTRNRGEQF 725
++ E+L G + + NR E F
Sbjct: 221 LLYEMLYGTTPF-KGSNRDETF 241
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY- 680
+AL+Y+H ++HR+ K +NILL+ D V ++D GLA +S + +LT Y
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP-ENPVLTDYV 173
Query: 681 ---GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE S YT D++S G ++ E+L G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLA-----VKKLDKRASSQQKD---DEFLELVNNIDRIRH 566
+L+ G G ++ L D K VK + AS Q E L + H
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG----LSH 67
Query: 567 ANIVELKGYCAE-HGQRLLIYEYCSNGTLQDML----HSDDELKNNLSWNTRIRMALGAA 621
NI+ + C E ++Y Y + G L+ L + LS + MA+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ YLH+ ++H++ + N ++D++L V ++D L+ + L +
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLT 710
+ A E + Y+ SDV+SFGV++ EL+T
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIVELK 573
I G G V+ A+ G + A+K + K+A +K+ D+ L + + + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHS----DDELKNNLSWNTRIRMALGAARALEYLH 628
Y + + L L+ EY G L +L + D+++ I +AL EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI--AEIVLAL------EYLH 110
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---VSQLSGHLLTAYG---Y 682
I+HR+ K NIL+D + + ++D GL+ + ++ G Y
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
APE ++ D +S G ++ E L G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQK-------DDEFLELVNNI 561
+F ++G G G V Q+ GK+ A KKL+K+ ++K + + LE VN+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 562 DRIRHANIVELK-GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ A E K C L+ + G L+ ++ N+
Sbjct: 61 FVVSLAYAYETKDALC-------LVLTLMNGGDLKFHIY-------NMG-----NPGFDE 101
Query: 621 ARALEYLHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
RA+ Y EI + IV+R+ K NILLDD + +SD GLA I G +
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IR 159
Query: 674 GHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW 729
G + T GY APE ++ YT D + G ++ E++ G+ + R R E+ V+
Sbjct: 160 GRVGTV-GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF---RQRKEK--VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 28/156 (17%)
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL--TAYGYGA 684
+H + ++HR+ KSANILL + V + D G + + ++ +VS G T Y Y A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-TVSDDVGRTFCGTPY-YVA 213
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743
PE + Y+ ++D++S GV++ ELLT ++ +D GE + ++
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE---------NMEEV------ 253
Query: 744 VDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRP 776
+ +L+G+Y P +I++ + S+P+ RP
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 601 DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
D+ K L+ I + AR +E+L +HR+ + NILL ++ V + D GL
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL 219
Query: 661 APLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718
A I G + APE F+ +YT QSDV+SFGV++ E+ + S
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPG 278
Query: 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
E+F R + +RM P +Y + I+ C + PE RP
Sbjct: 279 VQIDEEFCRR--------LKEGTRMRAP----EYATPEIYS---IMLDCWHNNPEDRPTF 323
Query: 779 SEVVQDLVDMIRRE 792
SE+V+ L D+++
Sbjct: 324 SELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 70/304 (23%), Positives = 131/304 (43%), Gaps = 40/304 (13%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDE 553
+ ++ S ++++ IG G G V++ +G AVK LD DE
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDE 59
Query: 554 FLELVNNIDRI--RHANIVELKGYC----AEHGQRL-LIYEYCSNGTLQDMLHSDDELKN 606
+E NI + H N+V+ G ++G +L L+ E C+ G++ D++ +
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 607 NLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+ + A L++LH +HR+ K NILL + V + D G++ ++S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 667 GSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRN 720
+ + + + T + + APE + Y + DV+S G+ +EL G
Sbjct: 177 TRLRR-NTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP------ 228
Query: 721 RGEQFLVRWAIPQLHDIDALSRMV-DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779
+ LH + AL ++ +P + P + F D I +C+ + E RP +S
Sbjct: 229 ----------LADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278
Query: 780 EVVQ 783
+++Q
Sbjct: 279 DLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 47/269 (17%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-------LELVNNIDRIRHA 567
+IG G G VY + D GK+ A+K LDK+ ++ + L LV+ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD----C 56
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGAA 621
+ Y +L I + + G L Q + S+ E++ + + LG
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA-----EIILG-- 109
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
LE++H +V+R+ K ANILLD+ V +SD GLA S G +G
Sbjct: 110 --LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THG 160
Query: 682 YGAPE-FESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y APE + G+ Y +D +S G ++ +LL G + + + + + H+ID
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDR 209
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCV 768
++ + L + + S ++ R V
Sbjct: 210 MTLTMAVELPDSFSPELRSLLEGLLQRDV 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+F + IG G G VY+A+ G+++A+KK+ ++ + ++ + + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV+L + L++E+ LH D + + S + I + L + + L
Sbjct: 61 IVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 629 EI--CQP-PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
+ C ++HR+ K N+L++ + A+ ++D GLA + G + H + Y AP
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 169
Query: 686 EFESG--IYTCQSDVYSFGVVMLELLTGR 712
E G Y+ D++S G + E++T R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 24/179 (13%)
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
++A+ L YL+ + + I+HR+ K +NIL++ + + D G +S ++ ++
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFG----VSGELINSIAD 160
Query: 675 HLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
+ Y +PE + G YT +SDV+S G+ ++EL G+ + + + I
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-- 218
Query: 734 LHDIDALSRMVD---PSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+D L ++V P L S +P D + C+ +P RP Q L M
Sbjct: 219 ---LDLLQQIVQEPPPRLPSSDFPE----DLRDFVDACLLKDPTERP----TPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+ + G+++A+KK+ + + + ++ + ++H NIV L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP-- 633
+ + LI+E+ S D+ D L + A YL++I Q
Sbjct: 68 LMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--------MDAELVKSYLYQILQGIL 115
Query: 634 -----PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-- 686
++HR+ K N+L+D+ + ++D GLA G ++ H + Y APE
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGR 712
S Y+ D++S G + E+ T +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIV 570
IG G G VY+A+ DGK A+KK + +Q I +R H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 571 ELKGYCAEHGQRL--LIYEYCSNGTLQDM-LHSDDELKNNLSWNTRIRMAL------GAA 621
L EH + L+++Y + Q + H +S + +L G
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ---AKRVSIPPSMVKSLLWQILNG-- 120
Query: 622 RALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSVSQLSGH-L 676
+ YLH ++HR+ K ANIL+ + V + D GLA L ++ +
Sbjct: 121 --VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 677 LTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLT 710
+ Y APE G YT D+++ G + ELLT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-08
Identities = 23/59 (38%), Positives = 30/59 (50%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L + L+NN L+ AF+ L L LDLS NNL+ P + L L +L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 52/225 (23%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+++L+ F ++G G G VY+ + + G+L A+K +D ++ +++E +N
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEIN 64
Query: 560 NIDRI-RHANIVELKGYCAEHG------QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
+ + H NI G + Q L+ E+C G++ D++ + N L +
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDW 122
Query: 613 RIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672
+ R L +LH ++HR+ K N+LL ++ V + D G++ + +V +
Sbjct: 123 IAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRR 178
Query: 673 SGHLLTAYGYGAPEF------ESGIYTCQSDVYSFGVVMLELLTG 711
+ + T Y + APE Y +SD++S G+ +E+ G
Sbjct: 179 NTFIGTPY-WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 29/206 (14%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
+G G G V+ + A+K + + K ++ + + + H I+ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 574 GYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLS--WNTRIRMALGAARALEYLHE 629
+ EH QR L + EY G L L + N+ + + I ALEYLH
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLHS 119
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YGAPE 686
IV+R+ K NILLD + + ++D G A +L T G Y APE
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYLAPE 168
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTG 711
+S + D ++ G+++ E+L G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H I+HR+ K +NI +++D + + D GLA +++G++ T +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRW- 180
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M ELLTG+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+F Q +G G +VY+ + G+++A+K++ A E ++ + ++H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE-ISLMKELKHEN 59
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV L + +L++EY D +LK + + +R AL + +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-----------DKDLKKYMDTHG-VRGALDPNTVKSFTY 107
Query: 629 EICQ-------PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
++ + ++HR+ K N+L++ + ++D GLA V+ S ++T +
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-PVNTFSNEVVTLW- 165
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI---PQLHD 736
Y AP+ S Y+ D++S G +M E++TGR + N +Q L + I P
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF-PGTNNEDQLLKIFRIMGTPTEST 224
Query: 737 IDALSRMVDPSL---SGQYPAKSLSHF--------ADIISRCVQSEPEFR 775
+S++ P +YP + L D++ R +Q PE R
Sbjct: 225 WPGISQL--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 36/213 (16%)
Query: 516 LIGAGMLGSVYRAQLPDG----KLLAVKKLDKRA-SSQQKDDEFLELVNNI-DRIRHANI 569
++G G G V++ + G K+ A+K L K QKD + NI + ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDE---LKNNLSWN-TRIRMALGAARAL 624
V+L Y + G +L LI EY S G L +H + E +++ + + I +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLAL------ 113
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP-LISSGSVSQLSGHLLTAYG-- 681
E+LH Q I++R+ K NILLD V ++D GL I G+V+ T G
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH------TFCGTI 164
Query: 682 -YGAPEF--ESGIYTCQSDVYSFGVVMLELLTG 711
Y APE SG + D +S G +M ++LTG
Sbjct: 165 EYMAPEILMRSG-HGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 66/281 (23%), Positives = 106/281 (37%), Gaps = 56/281 (19%)
Query: 517 IGAGMLGSVY----RAQLPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNI-DRIRHANIV 570
+G G G V+ GKL A+K L K Q K E + + +R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-ARALEYLH 628
Y + +L LI +Y + G L L+ + + +R+ + AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALDHLH 122
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF- 687
Q I++R+ K NILLD + V ++D GL+ + + T Y APE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE-YMAPEVI 178
Query: 688 --ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
SG + D +S GV+ ELLTG + + Q
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--------------------- 217
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
++I R ++S+P F MS +D +
Sbjct: 218 ---------------SEISRRILKSKPPFPKTMSAEARDFI 243
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 517 IGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G VY+A+ DG + A+K+++ S E L ++H N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALL----RELKHPNVISLQ 64
Query: 574 GYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY----- 626
H R L+++Y + D+ H + + + +++ G ++L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 627 LHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS--GSVSQLSGHLLTAY 680
+H + ++HR+ K ANIL+ + V ++D G A L +S ++ L ++T +
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-F 179
Query: 681 GYGAPEFESGI--YTCQSDVYSFGVVMLELLT 710
Y APE G YT D+++ G + ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 19/225 (8%)
Query: 510 SFSQENLIGAGMLGSVY---RAQLPD-GKLLAVKKLDKRASSQQ-KDDEFLELVNNI-DR 563
+F ++G G G V+ + D GKL A+K L K A Q+ K E N+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 564 IRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA- 621
+R + + Y + +L LI +Y S G + L+ D + +R G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYSGEII 115
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
ALE+LH++ IV+R+ K NILLD + V ++D GL+ S + T
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE- 171
Query: 682 YGAPEFESGI--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724
Y APE G + D +S G+++ ELLTG + R Q
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 56/288 (19%)
Query: 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASSQQ-KDDEFLELVNNI-DR 563
+F ++G G G V+ + GKL A+K L K Q+ K E + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 564 IRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-A 621
IR + + Y + +L LI +Y + G L L + K +++ G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIV 115
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
ALE+LH++ I++R+ K NILLD + V ++D GL+ V + +
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIE 171
Query: 682 YGAPEFESGIYTCQS---DVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
Y AP+ G D +S GV+M ELLTG +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF----------------------- 208
Query: 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
VD + Q A+I R ++SEP + MS + +D++
Sbjct: 209 ----TVDGEKNSQ---------AEISRRILKSEPPYPQEMSALAKDII 243
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 47/269 (17%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-------LELVNNIDRIRHA 567
+IG G G VY + D GK+ A+K LDK+ ++ + L LV+ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD----C 56
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGAA 621
+ Y +L I + + G L Q + S+ E++ + T I + L
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR---FYATEIILGL--- 110
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
E++H +V+R+ K ANILLD+ V +SD GLA S G +G
Sbjct: 111 ---EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THG 160
Query: 682 YGAPE-FESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y APE + G Y +D +S G ++ +LL G + + + + + H+ID
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDR 209
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCV 768
++ V+ L + + S ++ R V
Sbjct: 210 MTLTVNVELPDSFSPELKSLLEGLLQRDV 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANI 569
N I G G VYRA+ G+++A+KKL ++ + F L +N + +++H NI
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNI 66
Query: 570 VELK----GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
V +K G + + ++ EY + L+ ++ + +K + + L +
Sbjct: 67 VTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
+LH I+HR+ K++N+LL++ + + D GLA GS + L+ Y AP
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAP 175
Query: 686 E--FESGIYTCQSDVYSFGVVMLELLTGR 712
E + Y+ D++S G + ELLT +
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V + Q L+ +KL ++ + + + IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
G+ + E+ G+L +L + + ++++ R L YL E Q I+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG----KVSIAVLRGLAYLREKHQ--IM 126
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-YTCQ 695
HR+ K +NIL++ + + D G +S + ++ + Y +PE G Y+ Q
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 696 SDVYSFGVVMLELLTGR 712
SD++S G+ ++EL GR
Sbjct: 183 SDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN--IDRIRHANIVEL 572
L+G G G V + GK A+K L K+ KD+ L + + RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 573 KGYCAEHGQRLLIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGA--ARALE 625
K H + + EY + G L ++ + S+D R R GA AL
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----------RARF-YGAEIVSALG 109
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG--- 681
YLH C +V+R+ K N++LD D + ++D GL IS G+ + T G
Sbjct: 110 YLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK------TFCGTPE 160
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE E Y D + GVVM E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-----RHANI 569
++G G G V A+L +L AVK L K Q D +E R+ +H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD---VECTMTEKRVLALAGKHPFL 58
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+L C + RL + EY + G L + + A L++LH
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA----RFYAAEIVLGLQFLH 113
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPE 686
E I++R+ K N+LLD + + ++D G+ ++ + S G Y APE
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG----TPDYIAPE 166
Query: 687 FESGI-YTCQSDVYSFGVVMLELLTGRKSYD 716
S Y D ++ GV++ E+L G+ ++
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+YLH I+HR+ K N+L++ + + + D GLA + ++ ++T Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 682 YGAPEFESGI--YTCQSDVYSFGVVMLELLTGR 712
Y APE G YT D++S G + ELL R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 19/161 (11%)
Query: 563 RIRHANIVEL--KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
R+ H NIV L G G ++EY TL+++L +D L R+ L
Sbjct: 34 RLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAAD----GALPAGETGRLMLQV 88
Query: 621 ARALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLIS---SGSVSQLS- 673
AL H IVHR+ K NI++ V D G+ L+ V+ L+
Sbjct: 89 LDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 674 -GHLLTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLTGR 712
+L Y APE G T SD+Y++G++ LE LTG+
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-----IV 570
IG G G VY+ + D ++ A+K L K+ +K+ NI +R IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI-LVRTLLDESPFIV 59
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-ARALEYLHE 629
LK L+ +Y S G L L + + R + + ALE+LH+
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYIAELVLALEHLHK 114
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--F 687
IV+R+ K NILLD +++ D GL+ ++ + ++ + Y APE
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 688 ESGIYTCQSDVYSFGVVMLELLTG 711
+ YT D +S GV++ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 41/251 (16%)
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
S + F E + + ++ H ++V+L G C +++ EY G L LH + K
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE---K 95
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL-DDDLA------VSVSDC 658
NN+S + ++ +A A AL YL + +VH N NIL+ L + +SD
Sbjct: 96 NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152
Query: 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIY---TCQSDVYSFGVVMLELLTGRKSY 715
G+ I+ S + + + APE T +D +SFG +LE+ + +
Sbjct: 153 GIP--ITVLSREER----VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206
Query: 716 DRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
T + E+ D + P + A++I++C +P R
Sbjct: 207 LSTLSSSEK---------------ERFYQD---QHRLPMPDCAELANLINQCWTYDPTKR 248
Query: 776 PPMSEVVQDLV 786
P +++DL
Sbjct: 249 PSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
HA+ +E +C +I EYC L L LS N + +
Sbjct: 68 HASFLERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
Y+H Q I+HR+ K+ NI L ++L + + D G++ L+ GS + T Y Y +P
Sbjct: 121 YMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPY-YMSP 174
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
E + Y +SD++S G ++ E+ +++ G+ FL + R+V
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFE-----GQNFL-----------SVVLRIV 218
Query: 745 D---PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ PSL Y I+ + +P RP +E++++
Sbjct: 219 EGPTPSLPETYS----RQLNSIMQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKL------DKRASSQQKDDE------FLELVNNI 561
+G G G V +A GK++A+KK+ + +Q L + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 562 DRIRHANIVELKG-YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ I+H NI+ L Y L++ D++ SD LK + + +IR+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVM----------DIMASD--LKKVV--DRKIRLTESQ 120
Query: 621 ARA-----LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-------------P 662
+ L L+ + + +HR+ ANI ++ ++D GLA
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 663 LISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+ +++ ++T + Y APE + Y D++S G + ELLTG+
Sbjct: 181 DETMQRREEMTSKVVTLW-YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 547 SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS-NGTLQDMLHSDDELK 605
S+ + +++ + + +++A+I E Y + + Q Y + T +D L ++
Sbjct: 182 SKDESADYVPMQDMKGTVKYADI-ESSNYESPYDQ----YLPSAPERTRRDTLINESPA- 235
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
LS+ + + A +E+L VHR+ + N+L+ + V + D GLA I
Sbjct: 236 --LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 666 SGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLT--GRKSYDRTRNR 721
S G + APE F + +YT SDV+SFG+++ E+ T G + N
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
EQF + I RM PA + +I+ +C + + E RP S++
Sbjct: 349 -EQF--------YNAIKRGYRMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
Query: 782 VQDLVDMI 789
V + D++
Sbjct: 393 VHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 20/141 (14%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H I+HR+ K +N+ +++D + + D GLA + +++G++ T +
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRW- 182
Query: 682 YGAPEFESGI--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y APE Y D++S G +M ELLTGR + T + I QL I
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----------IDQLKLILR 232
Query: 740 LSRMVDPSLSGQYPAKSLSHF 760
L L + ++S ++
Sbjct: 233 LVGTPGAELLKKISSESARNY 253
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN---IVEL 572
+G G G V+ A+ D G+++A+K++ K S K +E ++ D + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK--SLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
Y + + L L EY G + +L++ L + + R MA A++ LHE+
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFE-AVDALHEL- 120
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS------GSVSQLSGHLLTAYGYGAP 685
+HR+ K N L+D + ++D GL+ I + GS ++ +L GY
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYD-- 176
Query: 686 EFESGIYTCQSDVYSFGVVMLELLTG 711
+T D +S G ++ E L G
Sbjct: 177 ------FTV--DYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-06
Identities = 21/41 (51%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVK 484
P PP P PP P PPPPP PP V + VKP V AE ++
Sbjct: 9 PPEPPAPLPPAPVPPPPPAPPAPVPEPTVKP-VNAEAPKIR 48
|
Length = 94 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYT 693
+HR+ + NILL + D GLA I + S + G+ + APE F +YT
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYT 294
Query: 694 CQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDA-LSRMVDPSLSGQ 751
+SDV+S+G+++ E+ + G Y +P +D+ +M+
Sbjct: 295 FESDVWSYGILLWEIFSLGSSPYPG-------------MP----VDSKFYKMIKEGYRML 337
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
P + S DI+ C ++P RP ++VQ
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-----LELVNNIDRIRHANIV 570
IG G G V++ + + G+++A+KK + +DD L + + +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS----DDELKNNLSWNTRIRMALGAARALEY 626
L + L++EYC + L ++ + + L + W T +A+ +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNF 115
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GY 682
H + +HR+ K NIL+ + + D G A +++ G T Y Y
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP------GDDYTDYVATRWY 166
Query: 683 GAPEFESG--IYTCQSDVYSFGVVMLELLTG 711
APE G Y DV++ G V ELLTG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANI 645
Y+ ++ ++++L D+ L+ + AR +E+L VHR+ + N+
Sbjct: 214 YKGSNDSEVKNLL--SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 646 LLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGV 703
LL V + D GLA I S G + APE F++ +YT SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGI 327
Query: 704 VMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY--------PAK 755
++ W I L +VD + + P
Sbjct: 328 LL-----------------------WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDH 364
Query: 756 SLSHFADIISRCVQSEPEFRPP---MSEVVQDLVDM 788
+ DI+ +C SEPE RP +S++V+ L+
Sbjct: 365 ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-06
Identities = 21/43 (48%), Positives = 23/43 (53%), Gaps = 5/43 (11%)
Query: 441 MMMMPP--PPPPPPPP---PPPPPPPPPPPVVEKVIVKPIVPA 478
M +PP PPPPPPPP PP PPPPPPP V +
Sbjct: 1 MASLPPGNPPPPPPPPGFEPPSQPPPPPPPGVNVKKRSRKQLS 43
|
Length = 2365 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 19/200 (9%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA--SSQQKDDEFLELVNNIDRIRHANIVELK 573
I G GSVY A+ G A+K L K + Q + E + + + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
Y + L L+ EY + G ++ + L + + + LG +E LH Q
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG----VEDLH---Q 115
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI- 691
I+HR+ K N+L+D + ++D GL+ + + Y APE G+
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVG 169
Query: 692 YTCQSDVYSFGVVMLELLTG 711
SD +S G V+ E L G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 30/93 (32%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ L+Y+H I+HR+ K N+ +++D + + D GLA + S+++G+++T +
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEMTGYVVTRW- 180
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE YT D++S G +M E+LTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 517 IGAGMLGSVY--RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G G +VY R++L D L+A+K++ + + + V+ + ++HANIV L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
L++EY +D+ D+ N+++ + R L Y H +
Sbjct: 72 IIHTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI--Y 692
++HR+ K N+L+++ + ++D GLA S S ++T + Y P+ G Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLW-YRPPDILLGSTDY 182
Query: 693 TCQSDVYSFGVVMLELLTGR 712
+ Q D++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI--RHANIVEL 572
++G G G V+ A+L + A+K L K D E + + + H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 573 KGYCAEHGQRLLIY--EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---ALEYL 627
YC + L + EY + G L M H K +L R AA L++L
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLP-----RATFYAAEIICGLQFL 112
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAP 685
H IV+R+ K NILLD D + ++D G+ ++ G Y AP
Sbjct: 113 H---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG----TPDYIAP 165
Query: 686 EFESG-IYTCQSDVYSFGVVMLELLTGRKSY 715
E G Y D +SFGV++ E+L G+ +
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 44/293 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLEL--VNNIDRIR 565
+S+ + +G G +VY+ + +GKL+A+K + + +++ F + + + ++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ---EEEGTPFTAIREASLLKGLK 61
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
HANIV L L++EY Q M D+ L R L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLS 117
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
Y+H Q I+HR+ K N+L+ D + ++D GLA S S S ++T + Y P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW-YRPP 172
Query: 686 E--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ----FLV-------RWAIP 732
+ S Y+ D++ G + +E++ G ++ ++ +Q FLV W P
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW--P 230
Query: 733 QLHDIDALSRMVDPSLSGQYPAKSL----------SHFADIISRCVQSEPEFR 775
+H + P Y K+L +H D+ S+ +Q P+ R
Sbjct: 231 GVHSLPHFK----PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F E + + ++ H +IV L G C + +++ E+ G L +H ++ L+ +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV---LTTPWK 107
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILL-----DDDLA--VSVSDCGLAPLISS 666
++A A AL YL + +VH N + NILL D + + +SD G+ + S
Sbjct: 108 FKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 667 GSVSQLSGHLLTAYGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKS--YDRTRNRG 722
+ + APE +S + +D +SFG + E+ + D+T
Sbjct: 165 RQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
E+F + +V P S AD+++ C+ +P RP ++
Sbjct: 219 ERFY-----------EGQCMLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIM 258
Query: 783 QDLV 786
+D+
Sbjct: 259 RDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG+G G V A GK +A+KK+ L + + +H NI+ ++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 576 C---AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA-RALEYLHEIC 631
+ + + L ++HSD L IR L R L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH-----IRYFLYQLLRGLKYIHSAN 127
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE- 686
++HR+ K +N+L+++D + + D G+A +SS + +T Y Y APE
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH--KYFMTEYVATRWYRAPEL 182
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRK 713
YT D++S G + E+L GR+
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY- 680
R L+Y+H ++HR+ K +N+LL+ + + + D GLA + LT Y
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD---HTGFLTEYV 170
Query: 681 ---GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE S YT D++S G ++ E+L+ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 16/199 (8%)
Query: 517 IGAGMLGSVYRAQLPDGKL--LAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVELK 573
+G G G V A + +A+K+ +K +QK D ++ I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G + L+ E+ G L + N++ ++ L EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQSL--- 150
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-Y 692
IV+R+ K N+LLD D + ++D G A ++ + + + L Y APE + +
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYIAPEILLNVGH 205
Query: 693 TCQSDVYSFGVVMLELLTG 711
+D ++ G+ + E+L G
Sbjct: 206 GKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN--IDRIRHANIVEL 572
L+G G G V + G+ A+K L K+ KD+ L N + RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKIL-KKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA--ARALEYLHEI 630
K H + + EY + G L L + + R R GA AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF-YGAEIVSALDYLHS- 113
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYGYGAPE-FE 688
+ +V+R+ K N++LD D + ++D GL I G+ + Y APE E
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLE 169
Query: 689 SGIYTCQSDVYSFGVVMLELLTGR 712
Y D + GVVM E++ GR
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLS 673
++++ R L YL E + I+HR+ K +NIL++ + + D G++ LI S ++
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MA 155
Query: 674 GHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
+ Y +PE G YT QSD++S G+ ++E+ GR
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRIRM 616
V+ + ++HANIV L L++EY + D+ D N +S N +I M
Sbjct: 54 VSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFM 109
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL 676
R L Y H+ I+HR+ K N+L+++ + ++D GLA S S +
Sbjct: 110 -FQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEV 164
Query: 677 LTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+T + Y P+ S Y+ D++ G ++ E+ TGR
Sbjct: 165 VTLW-YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE-----FLELVNNIDRIRHANIV 570
IG G G+V++A+ +++A+K++ DDE L + + ++H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 571 ELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
L Y H + L++EYC QD+ D ++ + L + H
Sbjct: 63 RL--YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE- 686
++HR+ K N+L++ + + ++D GLA + G V S ++T + Y P+
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLW-YRPPDV 170
Query: 687 -FESGIYTCQSDVYSFGVVMLEL 708
F + +Y+ D++S G + EL
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 517 IGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G VY+A+ DG K A+K+++ S E L ++H N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALL----RELKHPNVIALQ 64
Query: 574 GYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY----- 626
H R L+++Y + D+ H + + + +++ ++L Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 627 LHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS--GSVSQLSGHLLTAY 680
+H + ++HR+ K ANIL+ + V ++D G A L +S ++ L ++T +
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-F 179
Query: 681 GYGAPEFESGI--YTCQSDVYSFGVVMLELLT 710
Y APE G YT D+++ G + ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 505 QQYTNSFSQE-------NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLE 556
QY F E IG G G V++A+ +++A+KK+ + L
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 557 LVNNIDRIRHANIVELKGYC-----AEHGQR---LLIYEYCSNGTLQDMLHSDDELKNNL 608
+ + ++H N+V L C + + L++E+C + +L L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----------EHDLAGLL 109
Query: 609 SWNTRIRMALGAARA--------LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
S N ++ L + L Y+H + I+HR+ K+ANIL+ D + ++D GL
Sbjct: 110 S-NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165
Query: 661 APLISSGSVSQ---LSGHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLT 710
A S S+ + ++T + Y PE G Y D++ G +M E+ T
Sbjct: 166 ARAFSLSKNSKPNRYTNRVVTLW-YRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 51/228 (22%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANIVE 571
+G G G VY+A Q+ G+++A+KK+ +KD F L + + +++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDG-FPITALREIKILKKLKHPNVVP 71
Query: 572 LKGYCAEHG-----QRLLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIR--------M 616
L E +R +Y M+ + D +L L N ++
Sbjct: 72 LIDMAVERPDKSKRKRGSVY----------MVTPYMDHDLSGLLE-NPSVKLTESQIKCY 120
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI----------SS 666
L + YLHE I+HR+ K+ANIL+D+ + ++D GLA
Sbjct: 121 MLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 667 GSVSQLSGHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTGR 712
G + + ++T + Y PE G YT D++ G V E+ T R
Sbjct: 178 GGTRKYTNLVVTRW-YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 39/213 (18%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-----LELVNNIDRIRHANIV 570
IG G G+VY+A+ P G +A+K + R + + + L+ ++ H NIV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 571 ELKGYCA-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS--------WNTRIRMA 617
L CA + L++E H D +L+ L T +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFE-----------HVDQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
R L++LH C IVHR+ K NIL+ V ++D GLA + S L+ ++
Sbjct: 115 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVV 169
Query: 678 TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELL 709
T + Y APE Y D++S G + E+
Sbjct: 170 TLW-YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 3/122 (2%)
Query: 112 NNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
+ + GS + + + + L+ N+ +I S L LT LT + L+NN ++ P
Sbjct: 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLL 138
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNL 230
+ L LDLS N + LP L NL L L L N LS +L +L L +L++ N
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 231 FS 232
S
Sbjct: 198 IS 199
|
Length = 394 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLE-----LVNNIDRIRHANIV 570
IG G G V A+ DGK AVK L K+A ++K+ + + L+ N+ +H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV---KHPFLV 59
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLH 628
L Y + +L + +Y + G L L + R R A A AL YLH
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLH 113
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPE 686
+ I++R+ K NILLD V ++D GL + S + S G Y APE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG----TPEYLAPE 166
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTG 711
Y D + G V+ E+L G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V A+L G+ AVK L K D E + + + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 575 YCAEHGQRLLIY--EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---ALEYLHE 629
YC + L + E+ + G L M H D+ + +L R AA L++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDL-----YRATFYAAEIVCGLQFLH- 113
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPEF 687
I++R+ K N++LD D + ++D G+ + S G Y APE
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG----TPDYIAPEI 167
Query: 688 ESGI-YTCQSDVYSFGVVMLELLTGRKSY 715
G+ YT D +SFGV++ E+L G+ +
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 47/217 (21%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE-----FLELVNNIDRIRHANIV 570
IG G G VY+A+ G+++A+KK+ R + +DE + ++ + + H NIV
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI--RLET---EDEGVPSTAIREISLLKELNHPNIV 61
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L +L L++E+ L D LK + ++ L YL++
Sbjct: 62 RLLDVVHS-ENKLYLVFEF---------LDLD--LKKYM--DSSPLTGLDPPLIKSYLYQ 107
Query: 630 ICQP-------PIVHRNFKSANILLDDDLAVSVSDCGLA-----PLISSGSVSQLSGHLL 677
+ Q ++HR+ K N+L+D + A+ ++D GLA P+ + H +
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-------RTYTHEV 160
Query: 678 TAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTGR 712
Y APE G Y+ D++S G + E++ R
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 511 FSQENLIGAGMLGSVYRAQLPD-GKLLAVKK--LDKRASSQQKDDEFLELVNNIDRIR-- 565
F IG G G VY+A+ D G+L+A+KK LD +K+ + + I +R
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-----NEKEGFPITAIREIKILRQL 63
Query: 566 -HANIVELK----------GYCAEHGQRLLIYEYCSN---GTLQDMLHSDDELKNNLSWN 611
H NIV LK + + G L++EY + G L+ L E + S+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE-DHIKSFM 122
Query: 612 TRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
++ L Y H + +HR+ K +NILL++ + ++D GLA L +S
Sbjct: 123 KQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 672 LSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGR 712
+ ++T + Y PE G Y DV+S G ++ EL T +
Sbjct: 174 YTNKVITLW-YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 58/210 (27%)
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG-LAPLISSGSVSQLSGHLL 677
GA R L YLH Q +HRN K+++IL+ D VS+S L L+ +G +++
Sbjct: 109 GALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV---- 161
Query: 678 TAYGYGAPEFESGI---------------YTCQSDVYSFGVVMLELLTGRKSYDRTRNRG 722
Y P+F + + Y +SD+YS G+ EL TGR + + R
Sbjct: 162 ----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF-QDMLRT 216
Query: 723 EQFLVRWAIPQLHDIDAL------SRM------VDPSLSGQYPAKSLSH----------- 759
+ L + P +D SRM VD + A ++
Sbjct: 217 QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276
Query: 760 -------FADIISRCVQSEPEFRPPMSEVV 782
F +++ C+Q +PE RP S ++
Sbjct: 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDK-------RASSQQKDDEFLELVNNIDRIRHAN 568
+G G G V A+ G+L A+K L K S + E N RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---AL 624
+V L C + + + EY + G L M+H ++ + R AA L
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV------FSEPRAVFYAACVVLGL 114
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY-G 683
+YLHE IV+R+ K N+LLD + V ++D GL + G + G
Sbjct: 115 QYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLC--------KEGMGFGDRTSTFCG 163
Query: 684 APEF-------ESGIYTCQSDVYSFGVVMLELLTG 711
PEF E+ YT D + GV++ E+L G
Sbjct: 164 TPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ + K AVK L K+A ++K+++ + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEIC 631
+ + +Y + G L L + R R A A AL YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPE-FE 688
IV+R+ K NILLD + ++D GL + +G+ S G Y APE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG----TPEYLAPEVLH 169
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
Y D + G V+ E+L G + +RN E +
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 28/164 (17%)
Query: 95 LGENLGAFSSIRVIDLSNNHIG----GSIPSIL-PVTMQNFFLSDNQFSGSIPSSLATLT 149
L + L ++ +DLS+N +G G + S+L ++Q L++N LA
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132
Query: 150 L-----LTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENL 196
L + L N L G + A ++ L L+L++N + L L+
Sbjct: 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 197 SQLTTLHLQNN--------QLSGTLDVLQDLPLRDLNIENNLFS 232
L L L NN L+ TL L+ L LN+ +N +
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKS--LEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN--IDRIRHANIVEL 572
L+G G G V + GK A+K L K+ KD+ L + + RH + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 573 KGYCAEHGQRL-LIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
K Y + RL + EY + G L ++ + S+D TR A AL+Y
Sbjct: 61 K-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR--------TRFYGA-EIVSALDY 110
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGA 684
LH IV+R+ K N++LD D + ++D GL + + ++ G Y A
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG----TPEYLA 163
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLTGR 712
PE E Y D + GVVM E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 21/56 (37%), Positives = 23/56 (41%), Gaps = 1/56 (1%)
Query: 437 SSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
SLD + PP P P P P PP P P VEK KP + A KP
Sbjct: 83 PSLDPATVAPPNTPVEPEPAPVEPPKPKP-VEKPKPKPKPQQKVEAPPAPKPEPKP 137
|
Length = 226 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
S+ N+IG G G VY A D + +A+KK+ + Q K+ E L + N + H
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKN----LNH 118
Query: 567 ANIVELKGY----CAEHGQRLL----IYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RM 616
NI+ LK Y C + ++ + + E+ + M H +NN + +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA---RNNHALPLFLVKLY 175
Query: 617 ALGAARALEYLHE--ICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQLS 673
+ RAL Y+H IC HR+ K N+L+D + + + D G A + +G Q S
Sbjct: 176 SYQLCRALAYIHSKFIC-----HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRS 227
Query: 674 GHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTG 711
+ + Y APE G YT D++S G ++ E++ G
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 62/286 (21%), Positives = 116/286 (40%), Gaps = 31/286 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ F + + +GAG G V++ L+ +KL ++ + + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV G G+ + E+ G+L +L + + ++++ + L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----KVSIAVIKGLTYLR 120
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688
E + I+HR+ K +NIL++ + + D G +S + ++ + Y +PE
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERL 174
Query: 689 SGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
G Y+ QSD++S G+ ++E+ G R+ IP D L M
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIG----------------RYPIPP-PDAKELELMFGCP 217
Query: 748 LSGQYPAKSLSHFADIISRCVQSE-PEFRPPMSEVVQDLVDMIRRE 792
+ G S R + S P+ RPPM+ + +L+D I E
Sbjct: 218 VEGDPAESETSPRPRPPGRPLSSYGPDSRPPMA--IFELLDYIVNE 261
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V A+L + A+K L K + D E + + + +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 575 YCAEHGQRLLIY--EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---ALEYLHE 629
+C + L + EY + G L M H + + + R AA L++LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEA-----RARFYAAEIICGLQFLH- 113
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPEF 687
+ I++R+ K N+LLD D + ++D G+ + G S G Y APE
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG----TPDYIAPEI 167
Query: 688 ESG-IYTCQSDVYSFGVVMLELLTGRKSY 715
G Y D +SFGV++ E+L G+ +
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 174 GLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNL 230
L +LDLS+N L+ +P + + L L L L N L+ + + LP LR L++ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 231 F 231
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 517 IGAGMLGSVY--RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G G +V+ R++L + L+A+K++ + + + V+ + ++HANIV L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
L++EY Q M D+ N +S + R L Y H +
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYM----DDCGNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIY 692
++HR+ K N+L+++ + ++D GLA S S ++T + Y P+ S Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLW-YRPPDVLLGSSEY 182
Query: 693 TCQSDVYSFGVVMLELLTGR 712
+ Q D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-05
Identities = 14/44 (31%), Positives = 21/44 (47%), Gaps = 5/44 (11%)
Query: 37 NPNDVAAINSLYAALGSP---VLPGWVASAGDPCGESWQGVQCN 77
+D A+ + ++L L W S+ DPC SW GV C+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 64/260 (24%), Positives = 111/260 (42%), Gaps = 26/260 (10%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V+ A D K +AVKK+ + Q L + I R+ H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 576 CAEHGQRL-----LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRM-ALGAARALEYL 627
G L + E S +Q+ + +D + L+ R+ R L+Y+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 628 HEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHL---LTAYGYG 683
H ++HR+ K AN+ ++ +DL + + D GLA ++ G+L L Y
Sbjct: 131 H---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY--SHKGYLSEGLVTKWYR 185
Query: 684 APE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
+P YT D+++ G + E+LTG+ + + L+ ++P + + D
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245
Query: 742 RM-VDPSL---SGQYPAKSL 757
+ V PS G P + L
Sbjct: 246 LLNVIPSFVRNDGGEPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G V +L ++ A+K + K + +D ++++ ++ H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
+ + EY + G L + +L + ++L AL YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL----ALNYLHE--- 114
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPEFESG 690
I++R+ K N+LLD + + ++D G+ L + S G Y APE G
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG----TPNYIAPEILRG 170
Query: 691 -IYTCQSDVYSFGVVMLELLTGRKSYD 716
Y D ++ GV+M E++ GR +D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 40/177 (22%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA--PLISSGSVSQLSGHLLTA 679
L YLH I+HR+ K+ NI ++D V + D G A P+++ + L+G + T
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVET- 222
Query: 680 YGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
APE Y ++D++S G+V+ E+L A P
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEML--------------------AYPS----- 254
Query: 739 ALSRMVDPSLSGQYPAKSL-SHFADIISRCVQSEPEF-RPPMSEVVQDLVDMIRRER 793
+ DP + + KS SH IIS EF R P S +V+ ++ ER
Sbjct: 255 --TIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLER 309
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H +VHR+ K +NIL++++ + + D GLA + Q++G++ T Y
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRY- 170
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y + D++S G + E+L G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 61/205 (29%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN---IDRIRHANIVE 571
L+G G G V + G+ A+K L K + DE V + RH +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTA 59
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA--ARALEYLHE 629
LK H + + EY + G L H E + R R GA ALEYLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL--FFHLSRE---RVFTEERARF-YGAEIVSALEYLH- 112
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYGYGAPE-F 687
+V+R+ K N++LD D + ++D GL IS G+ + Y APE
Sbjct: 113 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVL 167
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGR 712
E Y D + GVVM E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F +G G G V A+ G+ A+K L KR + K + + +I + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 569 IVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV + + E R+ + E+ G L L N+++ + L A EY
Sbjct: 80 IVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFEY 133
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH I++R+ K N+LLD+ V V+D G A V + L Y APE
Sbjct: 134 LHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPE 185
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTG 711
+S + D ++ GV++ E + G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-05
Identities = 15/47 (31%), Positives = 19/47 (40%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PP P PPPPP PP P V + ++ +
Sbjct: 12 PPAPLPPAPVPPPPPAPPAPVPEPTVKPVNAEAPKIREAQSKRGQKQ 58
|
Length = 94 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
F ++L+G G G V + G + A+K + K Q+ F E +I I ++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARALE 625
+ Y + L L+ EY G L +L+ +D+ ++ + L A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-----AQFYL--AELVL 113
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
+H + Q VHR+ K N+L+D + ++D G A +++ + + + G P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA------NKMVNSKLPVGTP 167
Query: 686 EFES------------GIYTCQSDVYSFGVVMLELLTGR 712
++ + G Y + D +S GV+ E++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 36/112 (32%), Positives = 47/112 (41%), Gaps = 11/112 (9%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVN 559
F ++NL +GAG G V A D L +AVK L A + +++ EL
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN 611
+H NIV L G C G L+I EYC G L + L E N
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 28/91 (30%), Positives = 52/91 (57%), Gaps = 10/91 (10%)
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L+Y+H I+HR+ K N+ +++D + + D GLA + ++++G+++T + Y
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTRW-YR 181
Query: 684 APE--FESGIYTCQSDVYSFGVVMLELLTGR 712
APE Y D++S G +M E+LTG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 4e-05
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 173 TGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
T L LDLS+N ++ +LPP L NL L TL L N+++ L L
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT-DLSPLS 42
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 44/130 (33%), Positives = 66/130 (50%), Gaps = 6/130 (4%)
Query: 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKS 642
LLI EY S G L + LK +L + + L + + L E+ ++HR+ KS
Sbjct: 141 LLIMEYGSGGDLNKQIKQ--RLKEHLPFQEY-EVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 643 ANILLDDDLAVSVSDCGLAPLIS-SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYS 700
ANI L + + D G + S S S+ S T Y Y APE +E Y+ ++D++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY-YLAPELWERKRYSKKADMWS 256
Query: 701 FGVVMLELLT 710
GV++ ELLT
Sbjct: 257 LGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 11/170 (6%)
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
++HANIV L ++EY Q M+ L +N R+ M R
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH---PYNVRLFM-FQLLRG 115
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L Y+H I+HR+ K N+L+ + ++D GLA S S S ++T + Y
Sbjct: 116 LAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVVTLW-YR 170
Query: 684 APEFESGI--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731
P+ G Y+ D++ G + +E+L G+ ++ + EQ W +
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN--IVEL 572
+IG G V +L + ++ A+K + K +D ++++ ++ +N +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
C + RL L+ EY + G L M H + K L A AL +LHE
Sbjct: 62 HS-CFQTTSRLFLVIEYVNGGDL--MFHMQRQRK--LPEEHARFYAAEICIALNFLHE-- 114
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPEFES 689
I++R+ K N+LLD D + ++D G+ L + S G Y APE
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG----TPNYIAPEILR 169
Query: 690 G-IYTCQSDVYSFGVVMLELLTGRKSYD 716
G Y D ++ GV+M E++ GR +D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 7e-05
Identities = 25/82 (30%), Positives = 36/82 (43%), Gaps = 22/82 (26%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+++ +DLSNN + + D F G L L + L+ N L+
Sbjct: 1 NLKSLDLSNNRLT--------------VIPDGAFKG--------LPNLKVLDLSGNNLTS 38
Query: 164 EIPDAFQSLTGLINLDLSSNNL 185
P+AF L L +LDLS NNL
Sbjct: 39 ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ DGK AVK L K+ +K+ + + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEI 630
Y + ++L + ++ + G L L + R R A A AL YLH I
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHSI 115
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FES 689
IV+R+ K NILLD V ++D GL + S + Y APE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 690 GIYTCQSDVYSFGVVMLELLTG 711
Y D + G V+ E+L G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 18/50 (36%), Positives = 19/50 (38%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
MM PPPP PP PP P P P P A K+S K
Sbjct: 152 MMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
|
Length = 274 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H I+HR+ K +N+ +++D + + D GLA + +++G++ T +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADDEMTGYVATRW- 180
Query: 682 YGAPEFESGI--YTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQ------KDDEFLELVNNIDR 563
+ Q IG+G G V A G +AVKKL + +Q ++ L+ VN+ +
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
I N+ + E L+ E + L ++H + + + RM+ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE---------RMSYLLYQM 132
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
L + + I+HR+ K +NI++ D + + D GLA + + ++ +++T Y Y
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRY-YR 189
Query: 684 APEFESGI-YTCQSDVYSFGVVMLELLTG 711
APE G+ Y D++S G +M EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
F +IG G G V Q GK+ A+K L K S K D+ + D + +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLK--SEMFKKDQLAHVKAERDVLAES 58
Query: 568 N---IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ +V L Y + Q L LI E+ G L ML D ++ TR MA A
Sbjct: 59 DSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMA-ECVLA 113
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+E +H++ +HR+ K NIL+D + +SD GL+
Sbjct: 114 IEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ DG AVK L K+ ++K+ + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEI 630
Y + ++L + +Y + G L H E R R A A A+ YLH +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL 115
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAYGYGAPE-F 687
I++R+ K NILLD V ++D GL + + S G Y APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG----TPEYLAPEVL 168
Query: 688 ESGIYTCQSDVYSFGVVMLELLTG 711
Y D + G V+ E+L G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 14/22 (63%), Positives = 14/22 (63%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
P PPP P PP P PPP PPV
Sbjct: 3 APVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 13/24 (54%), Positives = 14/24 (58%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPP 465
+P PP PP PPPPPPPP
Sbjct: 256 TRLPAPPQPPEEEPPPPPPPPEDD 279
|
Length = 584 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY- 680
L+Y+H ++HR+ K N+L++ D + + D GLA S + +G +T Y
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG-ENAGF-MTEYV 170
Query: 681 ---GYGAPE----FESGIYTCQSDVYSFGVVMLELLTGRK 713
Y APE F+S YT DV+S G ++ ELL GRK
Sbjct: 171 ATRWYRAPEIMLSFQS--YTKAIDVWSVGCILAELL-GRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 28/91 (30%), Positives = 52/91 (57%), Gaps = 7/91 (7%)
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
+++LH I+HR+ K +NI++ D + + D GLA ++G+ ++ +++T Y Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 183
Query: 683 GAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
APE G+ Y D++S G +M E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 28/152 (18%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S++ +DLSNN I + SSL+ L L+ + L+NN L
Sbjct: 209 SALEELDLSNNSI-----------------------IELLSSLSNLKNLSGLELSNNKLE 245
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
++P++ +L+ L LDLS+N +S SL +L+ L L L N LS L ++ L L
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 223 DLNIENNLFSGPIPEK--MLQIPNFRKDGNPF 252
+ N L + E + N N
Sbjct: 303 LELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 28/83 (33%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--FESGIYT 693
+HR+ + N+LL D + D GLA I + S + G+ + APE F+ +YT
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC-VYT 292
Query: 694 CQSDVYSFGVVMLELLT-GRKSY 715
QSDV+S+G+++ E+ + G+ Y
Sbjct: 293 VQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 14/203 (6%)
Query: 517 IGAGMLGSVYRAQLPDG-KLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G V + + D ++ A+K + K S+ + L + ++ IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR-ALEYLHEICQP 633
+ L+ + + G L H E + +L +R R ALE LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGEL--FHHLQREGRFDL---SRARFYTAELLCALENLHKF--- 112
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-Y 692
+++R+ K NILLD +++ D GL L + + Y APE G Y
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 693 TCQSDVYSFGVVMLELLTGRKSY 715
T D ++ GV++ E+LTG +
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H ++HR+ K +N+LL+ + + + D GLA +S ++ +++T +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRW- 173
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRK 713
Y APE YT DV+S G + ELL GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 16/66 (24%), Positives = 23/66 (34%)
Query: 427 PRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTS 486
+ + + L ++ P P P P PP P PP + +P P K
Sbjct: 32 VGIELVPLAVFLLAAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPE 91
Query: 487 TKTAKP 492
K KP
Sbjct: 92 KKPKKP 97
|
Length = 244 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 517 IGAGMLGSVYRA--QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G+G G V + ++ ++ K+ K + + DE + + ++ + IV + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
C E +L+ E S G L L K+ ++ + + + + ++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG-------APE- 686
VHR+ + N+LL + +SD GL+ + + A G APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD------SYYKARSAGKWPLKWYAPEC 169
Query: 687 --FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTR 719
F ++ +SDV+S+G+ M E + G+K Y + +
Sbjct: 170 INFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 14/22 (63%), Positives = 15/22 (68%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPP 465
+P P P PPPPPPPP PP P
Sbjct: 266 LPEPEPQPPPPPPPPEPPEPEE 287
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 8/105 (7%)
Query: 251 PFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSN 310
+T PS + T PAP P +G++P + P+ TPG P +
Sbjct: 217 SPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAP 276
Query: 311 SGKKKSSTTKKIVWISIAGVLLFVILALVFL----LFMPRCIKRR 351
+ T +I+ I+I I+A VFL + R +RR
Sbjct: 277 EASRYELTVTQIIQIAIPA----SIIACVFLGSCACCLHRRCRRR 317
|
Length = 401 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 16/38 (42%), Positives = 18/38 (47%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTA 482
P P PPPPPPP PP P + P PA+ A
Sbjct: 53 AAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNA 90
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 3e-04
Identities = 16/47 (34%), Positives = 19/47 (40%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PPPPP PP P P P V P + + + A
Sbjct: 16 LPPAPVPPPPPAPPAPVPEPTVKPVNAEAPKIREAQSKRGQKQQKAG 62
|
Length = 94 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
P P PPP P PP P PPP
Sbjct: 1 PAAPVPPPAPAPPAPAPPPAA 21
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 13/38 (34%), Positives = 14/38 (36%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAV 483
PPPPPP P P PPP P + A
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAA 80
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 51/290 (17%)
Query: 531 PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYC 589
P G+ + V++++ A + + FL+ ++ ++ H NIV + + ++ +
Sbjct: 23 PTGEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81
Query: 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD 649
+ G+ +D++ + + +S + G +AL+Y+H + VHR+ K+++IL+
Sbjct: 82 AYGSAKDLICT--HFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISV 136
Query: 650 DLAVSVSDCGLAP---LISSGS----VSQLSGHLLTAYGYGAPE-FESGI--YTCQSDVY 699
D V +S GL +I+ G V + + + +PE + + Y +SD+Y
Sbjct: 137 DGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 700 SFGVVMLELLTGR---KSYDRTRNRGEQFLVRWAIPQLHD---IDALSRMVDPSLSGQ-- 751
S G+ EL G K T+ E+ + +P L D I A + PS SG
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTTTIPAEELTMKPSRSGANS 252
Query: 752 ----------------------YPAKSLSHFADIISRCVQSEPEFRPPMS 779
Y HF + +C+Q P+ RP S
Sbjct: 253 GLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|237866 PRK14952, PRK14952, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 24/93 (25%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 409 IPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVE 468
+P A + + QR+ I R D I + L P P P P P P P V
Sbjct: 362 LPSASDAESALLQRVERIETRLDMSIPANLLHNAPQAAPAPSAAAPEPKHQPAPEPRPVL 421
Query: 469 KVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
P AV++ T + RS T
Sbjct: 422 APTPASGEP-NAAAVRSMWSTVRDKVRQRSRTT 453
|
Length = 584 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 67/260 (25%), Positives = 105/260 (40%), Gaps = 32/260 (12%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQK-DDEFLELVNNIDRIRHANIVELK 573
LIG G +G VY A P + +A+KK+ + S FL + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
C++ Y TL+ +L S + K +LS + ++GA L H+IC
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQ-KESLSKELAEKTSVGAF--LSIFHKICAT 125
Query: 634 -------PIVHRNFKSANILLDDDLAVSVSDCGLAPLI---------SSGSVSQLSGHLL 677
++HR+ K NILL V + D G A + +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 678 TAYG-------YGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW 729
T G Y APE G+ + +D+Y+ GV++ ++LT Y R +G + R
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKKGRKISYRD 243
Query: 730 AIPQLHDIDALSRMVDPSLS 749
I ++ A R + P LS
Sbjct: 244 VILSPIEV-APYREIPPFLS 262
|
Length = 932 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 43/243 (17%)
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F E + + ++ H ++ + G C + +++ E+ +G L D+ ++ + ++W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--K 119
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILL------DDDLA-VSVSDCGLAPLISS 666
I +A A AL YL + +VH N + NILL + + +SD P +S
Sbjct: 120 ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSD----PGVSF 172
Query: 667 GSVSQLSGHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTGRKS--YDRTRNRG 722
++S+ + + APE G + +D +SFG +LE+ + +RT +
Sbjct: 173 TALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
E+F + + P S A +IS+C+ EP RP ++
Sbjct: 231 ERFYEK--------------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
Query: 783 QDL 785
+DL
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 13/23 (56%), Positives = 13/23 (56%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVV 467
P PPP P PP P PPP P V
Sbjct: 2 AAPVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPPP P P PPPP
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPP 63
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+A+ + +A+KK+ + + ++ + ++H NIV L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ L++EY + M S D KN T + L R + Y H +
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH---SHRV 123
Query: 636 VHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI--Y 692
+HR+ K N+L+D A+ ++D GLA + G + H + Y APE G Y
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 693 TCQSDVYSFGVVMLELLTGR 712
+ D++S G + E++ +
Sbjct: 182 STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 564 IRHANIVELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
++HANIV L H ++ L ++EY Q M L + N R+ +
Sbjct: 60 LKHANIVTLHDII--HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH---NVRLFL-FQLL 113
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAY 680
R L Y H Q ++HR+ K N+L+ + + ++D GLA + SV S+ + +
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVVTL 167
Query: 681 GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y P+ S Y+ D++ G + E+ TGR
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 514 ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+ +IG G G V A G+ +A+KK++ L + + +RH +IVE+
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
K +R Y ++ LH + ++L+ RAL+Y+H
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---T 121
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL--SGHLLTAYGYGAPEFES- 689
+ HR+ K NIL + D + + D GLA + + + + + + ++ T + Y APE
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-YRAPELCGS 180
Query: 690 --GIYTCQSDVYSFGVVMLELLTGR 712
YT D++S G + E+LTG+
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
++G G G V A+L G+L AVK L K Q D E L L N H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HP 56
Query: 568 NIVELKGYCAEHGQRLL-IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALE 625
+ +L C + RL + E+ + G L M H + + R R A AL
Sbjct: 57 FLTQLY-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD---EARARFYAAEITSALM 110
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYGYGA 684
+LH+ I++R+ K N+LLD + ++D G+ I +G + + Y A
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYIA 164
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLTGRKSYD 716
PE + +Y D ++ GV++ E+L G ++
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPP P P PPPPPP
Sbjct: 45 PPPPSTAAAAPAPAAPPPPPP 65
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 26/79 (32%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-YT 693
I+HR+ K +NI++ D + + D GLA ++G+ ++ +++T Y Y APE G+ Y
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYK 203
Query: 694 CQSDVYSFGVVMLELLTGR 712
D++S G +M E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 46/243 (18%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDG-KLLAVKKLDK-----RASSQQKDDEFLELVNNIDRI 564
F +IG G G V +L + K+ A+K L+K RA + +E LVN ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARA 623
I L + L+ +Y G L +L +D L +++ M + A
Sbjct: 63 ----ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI----A 114
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG-LAPLISSGSVSQLSGHLLTAYGY 682
++ +H++ VHR+ K NIL+D + + ++D G L+ G+V ++
Sbjct: 115 IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-------SSVAV 164
Query: 683 GAPEFES-----------GIYTCQSDVYSFGVVMLELLTGR---------KSYDRTRNRG 722
G P++ S G Y + D +S GV M E+L G ++Y + N
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
Query: 723 EQF 725
E+F
Sbjct: 225 ERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 12/18 (66%), Positives = 13/18 (72%)
Query: 449 PPPPPPPPPPPPPPPPPV 466
P PPPPPPPPPP P +
Sbjct: 230 PSAPPPPPPPPPPSVPTI 247
|
Length = 313 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LISSGSVSQLSGHLLTAY 680
AL +LHE I++R+ K N+LLD + + ++D G+ + + S G
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG----TP 160
Query: 681 GYGAPEFESG-IYTCQSDVYSFGVVMLELLTGRKSYD 716
Y APE G Y D ++ GV+M E++ GR +D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPP P P PPPPP
Sbjct: 44 PPPPPSTAAAAPAPAAPPPPP 64
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 12/22 (54%), Positives = 12/22 (54%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
PPP P P PPPPPPP
Sbjct: 46 PPPSTAAAAPAPAAPPPPPPPA 67
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 69/298 (23%), Positives = 112/298 (37%), Gaps = 68/298 (22%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN---IVE 571
+IG G G V+ + D G++ A+K L K ++ + +I + A+ IV+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LADADSPWIVK 65
Query: 572 LKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAARALEY 626
L Y + + L + EY G L ++L D R + L AL+
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVL----ALDS 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA------------------------P 662
+H++ +HR+ K NIL+D D + ++D GL
Sbjct: 117 VHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 663 LISSGSVSQLSGHLLTAYG---YGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKS-YDR 717
L+ Q + G Y APE G Y + D +S GV++ E+L G Y
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 718 TRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
T ++ W +L DP +S D+I R + +PE R
Sbjct: 234 TLQETYNKIINWKE-------SLRFPPDPPVS--------PEAIDLICRLLC-DPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 32/113 (28%), Positives = 41/113 (36%), Gaps = 28/113 (24%)
Query: 131 FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
LS N +G IP L +L GL LDLS N L +
Sbjct: 57 CLSLN-ETGRIPRGLQSL-----------------LQGLTKGCGLQELDLSDNALGPDGC 98
Query: 191 PSLENLSQLTTL---HLQNNQLSGT-----LDVLQDLP--LRDLNIENNLFSG 233
LE+L + ++L L NN L L+DLP L L + N G
Sbjct: 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG 151
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-04
Identities = 31/128 (24%), Positives = 42/128 (32%), Gaps = 11/128 (8%)
Query: 373 EARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDH 432
E + +P + +D + RR+G A + +R PRR
Sbjct: 2637 EPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQR--------PRRRAA 2688
Query: 433 EIDMSSLDMMMMPPPPPP---PPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKT 489
+ SL + PPPPPP P P P PP P +PA
Sbjct: 2689 RPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGP 2748
Query: 490 AKPFTTAR 497
A P AR
Sbjct: 2749 ATPGGPAR 2756
|
Length = 3151 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 25/76 (32%), Positives = 46/76 (60%), Gaps = 4/76 (5%)
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-YT 693
I+HR+ K +NI++ D + + D GLA ++G+ ++ +++T Y Y APE G+ Y
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYK 196
Query: 694 CQSDVYSFGVVMLELL 709
D++S G +M E++
Sbjct: 197 ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 14/23 (60%), Positives = 14/23 (60%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVE 468
P PPPPPPPPPP P VE
Sbjct: 230 PSAPPPPPPPPPPSVPTISNSVE 252
|
Length = 313 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+A+ GKL+A+KK R D+E + +R +++++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK--TRLEM---DEEGIPPTA----LREISLLQMLSE 59
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLH-----SDDELKNNLSWNTRIRMALGAARALE----- 625
+ RLL E+ + L+ D +LK + N R G R L
Sbjct: 60 S-IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGR-----GPGRPLPAKTIK 113
Query: 626 -YLHEICQP-------PIVHRNFKSANILLDDDLAV-SVSDCGL--APLISSGSVSQLSG 674
+++++ + ++HR+ K N+L+D + ++D GL A I S +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT---- 169
Query: 675 HLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTG 711
H + Y APE G Y+ D++S G + E+
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 11/21 (52%), Positives = 11/21 (52%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
P PPPPPP P P PP
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPP 61
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-04
Identities = 12/22 (54%), Positives = 13/22 (59%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPP 465
+PP P PP P PPPP P P
Sbjct: 2900 LPPDQPERPPQPQAPPPPQPQP 2921
|
Length = 3151 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 26/66 (39%), Positives = 31/66 (46%)
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQ 595
+AVK L A S +K EL H NIV L G C + G +I EYC G L
Sbjct: 70 VAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLV 129
Query: 596 DMLHSD 601
D LH +
Sbjct: 130 DYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 14/46 (30%), Positives = 17/46 (36%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTA 490
P P P PP P P P P P ++ + P P K A
Sbjct: 99 PEPAPVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAA 144
|
Length = 226 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 13/24 (54%), Positives = 13/24 (54%)
Query: 447 PPPPPPPPPPPPPPPPPPPVVEKV 470
P P PPP P PP P PPP V
Sbjct: 1 PAAPVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 14/47 (29%), Positives = 15/47 (31%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PP P PP P P +K P K K
Sbjct: 69 PPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKPKPKVKPQP 115
|
Length = 244 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 13/29 (44%), Positives = 15/29 (51%)
Query: 437 SSLDMMMMPPPPPPPPPPPPPPPPPPPPP 465
++ P PPPPPPPP PP P P
Sbjct: 263 ATRLPEPEPQPPPPPPPPEPPEPEEEPDE 291
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 12/35 (34%), Positives = 12/35 (34%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEG 480
P PPPPPP P P P P P
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPD 75
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 12/17 (70%), Positives = 12/17 (70%)
Query: 445 PPPPPPPPPPPPPPPPP 461
P PPPPPPPPPP P
Sbjct: 230 PSAPPPPPPPPPPSVPT 246
|
Length = 313 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 13/32 (40%), Positives = 15/32 (46%)
Query: 436 MSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVV 467
+ +P P PPPPPPPPPP V
Sbjct: 214 PVAAAKSALPAVSSSAPSAPPPPPPPPPPSVP 245
|
Length = 313 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 13/34 (38%), Positives = 14/34 (41%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
PP P PP P PPPP P +P P
Sbjct: 2901 PPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPP 2934
|
Length = 3151 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 63/245 (25%), Positives = 95/245 (38%), Gaps = 52/245 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ F +IG G G V Q D G + A+KKL K S + ++ + D + A
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK--SEMLEKEQVAHVRAERDILAEA 58
Query: 568 N---IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ +V+L Y + L LI EY G + +L D TR +A A
Sbjct: 59 DNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---TRFYIA-ETILA 113
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL-------------------APLI 664
++ +H++ +HR+ K N+LLD + +SD GL P
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 665 SSGSVSQ--LSGHLLT---------AYG------YGAPE-FESGIYTCQSDVYSFGVVML 706
+S+ S AY Y APE F Y + D +S GV+M
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 707 ELLTG 711
E+L G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/121 (25%), Positives = 49/121 (40%), Gaps = 20/121 (16%)
Query: 603 ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662
+ L I + AL YLH I+HR+ K+ NI LD+ + D G A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA- 232
Query: 663 LISSGSVSQLSGHLLTAYGYG--------APEFES-GIYTCQSDVYSFGVVMLELLTGRK 713
+L H T YG +PE + Y ++D++S G+V+ E+
Sbjct: 233 -------CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 714 S 714
+
Sbjct: 286 T 286
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA--PL-ISSGSVSQLSGHLLT 678
RA++YLHE I+HR+ K+ NI ++ V + D G A P+ I++ +G + T
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 679 AYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKS 714
APE Y D++S G+V+ E+ T S
Sbjct: 250 ----NAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 60/288 (20%), Positives = 113/288 (39%), Gaps = 47/288 (16%)
Query: 517 IGAGMLGSVYRAQ--LPDGKLLAVKKLDKRASSQQKDDEFLE---LVNNIDRIRHANIVE 571
IG G G V++A+ G+ +A+K++ + + + ++ +++ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 572 LKGYCA-----EHGQRLLIYEYCSNGTLQDMLHSDDELKN-NLSWNTRIRMALGAARALE 625
L C + L++E+ QD+ D++ + T M R L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
+LH +VHR+ K NIL+ + ++D GLA + S ++ Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
E Y D++S G + E+ + + RG D+D L +++
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLF-----RGSS-----------DVDQLGKIL 222
Query: 745 D------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
D + A F S+ Q +F + E+ +DL+
Sbjct: 223 DVIGLPGEEDWPRDVALPRQAFH---SKSAQPIEKFVTDIDELGKDLL 267
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 12/25 (48%), Positives = 13/25 (52%)
Query: 441 MMMMPPPPPPPPPPPPPPPPPPPPP 465
+ PP PP PPPPPPPP
Sbjct: 256 TRLPAPPQPPEEEPPPPPPPPEDDD 280
|
Length = 584 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 14/34 (41%), Positives = 15/34 (44%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPA 478
P PP P PPPP P P PP + P P
Sbjct: 2904 QPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 13/36 (36%), Positives = 14/36 (38%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEG 480
P P PP P PPPP P P +P P
Sbjct: 2902 PDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|204405 pfam10146, zf-C4H2, Zinc finger-containing protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 17/91 (18%)
Query: 385 NQMEKDASVKPKEDHRSEM---RRMGAIPHAQNEQERNKQRMSTIPR--------RDDHE 433
Q+ D + E +S+ RRMG I E K+ ++ + + HE
Sbjct: 56 RQIHADINDMETEIKQSKSELERRMGKIARMHGEYNPLKESINEMRKLELGLEELPQLHE 115
Query: 434 IDMSSLDMMMMPPPPPPPPPPPPPPPPPPPP 464
+ + P P PP P P PP P
Sbjct: 116 EERQKIS------PATSPVPPVPLPDPPAFP 140
|
This is a family of proteins which appears to have a highly conserved zinc finger domain at the C terminal end, described as -C-X2-CH-X3-H-X5-C-X2-C-. The structure is predicted to contain a coiled coil. Members are annotated as being tumour-associated antigen HCA127 in humans but this could not confirmed. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 24/158 (15%)
Query: 584 LIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKS 642
L+ +Y G L +L +D L +++ M L +H I Q VHR+ K
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA-------IHSIHQLHYVHRDIKP 130
Query: 643 ANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FESGI--YTCQS 696
N+LLD + + ++D G ++ Q S + T Y +PE E G+ Y +
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP-DYISPEILQAMEDGMGKYGPEC 189
Query: 697 DVYSFGVVMLELLTGR---------KSYDRTRNRGEQF 725
D +S GV M E+L G ++Y + N E+F
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 13/22 (59%), Positives = 13/22 (59%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPP 464
M P PP P PP PP PP PP
Sbjct: 113 PMQPQPPVHPIPPLPPQPPLPP 134
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 12/23 (52%), Positives = 12/23 (52%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPP 465
P PP PPPPPPPP P
Sbjct: 260 APPQPPEEEPPPPPPPPEDDDDP 282
|
Length = 584 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 13/21 (61%), Positives = 13/21 (61%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPPPPP PP P P P
Sbjct: 273 PPPPPPPPEPPEPEEEPDEPD 293
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 13/38 (34%), Positives = 19/38 (50%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGT 481
PP PP PP PP P P PP++ + ++ + T
Sbjct: 122 PIPPLPPQPPLPPMFPMQPLPPLLPDLPLEAWPATDKT 159
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 42/170 (24%), Positives = 63/170 (37%), Gaps = 39/170 (22%)
Query: 83 AIILNGANLGGELGENL-GAFSSIR---VIDLSNNHIGGS-IPSILPVTMQNFFLSDNQF 137
++L L G E L A + R ++L+NN IG + I ++
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE------------- 187
Query: 138 SGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----- 188
L L + LNNN L+ E + + SL L L+L NNL+
Sbjct: 188 ------GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 189 LPPSLENLSQLTTLHLQNNQL--SGTLDVLQDLP----LRDLNIENNLFS 232
L L TL L N + G D+ + L L +L++ N F
Sbjct: 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 14/69 (20%), Positives = 18/69 (26%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
PP P PP P P P P K KP + K
Sbjct: 76 PPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKPKPKVKPQPKPKKPPSKTAAKAPAAPNQP 135
Query: 505 QQYTNSFSQ 513
+ ++ S
Sbjct: 136 ARPPSAASA 144
|
Length = 244 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 14/34 (41%), Positives = 14/34 (41%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPA 478
PPPPPPP PP P P P P P
Sbjct: 59 APPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPP 92
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 11/32 (34%), Positives = 15/32 (46%)
Query: 435 DMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPV 466
+++ + P PPPPPPPPPP
Sbjct: 214 PVAAAKSALPAVSSSAPSAPPPPPPPPPPSVP 245
|
Length = 313 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.004
Identities = 23/76 (30%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKP------IVPAEGTAVKTSTKTAKPFTTAR 497
+PPP P PPPPP PPPP + V P P+ A K + P R
Sbjct: 2828 LPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPP---VR 2884
Query: 498 SFTIASLQQYTNSFSQ 513
++ + T SF+
Sbjct: 2885 RLARPAVSRSTESFAL 2900
|
Length = 3151 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 14/42 (33%), Positives = 19/42 (45%)
Query: 436 MSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVP 477
+ P PP P PP PP PP PP+ + P++P
Sbjct: 105 LQPPQPQQPMQPQPPVHPIPPLPPQPPLPPMFPMQPLPPLLP 146
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 14/23 (60%), Positives = 15/23 (65%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVV 467
P PPPPPPPPPPPPP +
Sbjct: 177 EEPVLEVPPPPPPPPPPPPPSLQ 199
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 14/22 (63%), Positives = 14/22 (63%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
P P PPPPPPPPPPPP
Sbjct: 175 PTEEPVLEVPPPPPPPPPPPPP 196
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQLPDG-KLLAVKKLDKRASSQQKDDEFLELVN 559
I L+ F +IG G G V + ++ A+K L K ++ D F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 560 NIDRIRHAN---IVELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDD-ELKNNLSWNTR 613
+I + HAN IV+L + A + L + EY G L +++ + D K +
Sbjct: 95 DI--MAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE 150
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQL 672
+ +AL A ++ + +HR+ K N+LLD + ++D G + ++G V
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--- 198
Query: 673 SGHLLTAYG---YGAPEF-----ESGIYTCQSDVYSFGVVMLELLTG 711
TA G Y +PE G Y + D +S GV + E+L G
Sbjct: 199 --RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 41/179 (22%), Positives = 59/179 (32%), Gaps = 31/179 (17%)
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG-- 674
L AL LH R KS NILL D + GSV+ +
Sbjct: 23 CLQCLGALRELH---------RQAKSGNILLTWDGLLK----------LDGSVAFKTPEQ 63
Query: 675 HLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
Y + APE G YT ++D+YS G+ + E L Y+ R +
Sbjct: 64 SRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122
Query: 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
D +L G A+S F D + C P+ R + + +
Sbjct: 123 ADDPRD-----RSNLEGVSAARS---FEDFMRLCASRLPQRREAANHYLAHCRALFAET 173
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 801 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.54 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.53 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.52 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.43 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.25 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.22 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.18 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.9 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.52 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.3 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.3 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-60 Score=591.00 Aligned_cols=541 Identities=28% Similarity=0.476 Sum_probs=360.3
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEcc
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
+++.|+|++|++++.+|..|.++++|+.|+|++|.|++.+|..+. ++|+.|+|++|++.+.+|..+ .+++|+.|+|+
T Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls 483 (968)
T PLN00113 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLS 483 (968)
T ss_pred CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECc
Confidence 445555555555555555555555555566666655555554443 566666666666666666654 34678888888
Q ss_pred CCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccccccc-ccCCC-CCCEEEccCCCCCCCc
Q 003704 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDL-PLRDLNIENNLFSGPI 235 (801)
Q Consensus 158 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~-~L~~L~ls~N~l~g~~ 235 (801)
+|++++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|.|+|.++ .+..+ .|+.|+|++|+++|.+
T Consensus 484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 563 (968)
T PLN00113 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563 (968)
T ss_pred CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccC
Confidence 888888888889999999999999999999999999999999999999999998774 45554 4999999999999999
Q ss_pred cccCCC---CCCccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 003704 236 PEKMLQ---IPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSNSG 312 (801)
Q Consensus 236 p~~l~~---l~~l~~~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (801)
|..+.. |..|++++|++.+..|.. .......+..+.+++.+|+..+...-+ .+ ..
T Consensus 564 p~~l~~l~~L~~l~ls~N~l~~~~p~~----~~~~~~~~~~~~~n~~lc~~~~~~~~~-------------~c-----~~ 621 (968)
T PLN00113 564 PKNLGNVESLVQVNISHNHLHGSLPST----GAFLAINASAVAGNIDLCGGDTTSGLP-------------PC-----KR 621 (968)
T ss_pred ChhHhcCcccCEEeccCCcceeeCCCc----chhcccChhhhcCCccccCCccccCCC-------------CC-----cc
Confidence 977554 566788999998876642 122234456677777777643211100 00 00
Q ss_pred CCCCCCCCceeeehhhHH-HHHHHHHHHHHHHhhhhhhcccchhhhhhccccccccCCCcccccCCCCcCCCcccccccc
Q 003704 313 KKKSSTTKKIVWISIAGV-LLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEKDA 391 (801)
Q Consensus 313 ~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (801)
..+ .... +++++++ ++++++++++++++ ++++|+... .++ .. ..
T Consensus 622 ~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~------~~--------------------~~- 666 (968)
T PLN00113 622 VRK--TPSW--WFYITCTLGAFLVLALVAFGFV-FIRGRNNLE---LKR------VE--------------------NE- 666 (968)
T ss_pred ccc--ccee--eeehhHHHHHHHHHHHHHHHHH-HHHhhhccc---ccc------cc--------------------cc-
Confidence 001 1111 2222222 22222222222222 222221000 000 00 00
Q ss_pred cCCCcchhhHHHhhhccCcchhhhhhhhccccCCCCCCcccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 003704 392 SVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVI 471 (801)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 471 (801)
. ..+.+ ..
T Consensus 667 ----~-----------------------------------~~~~~---------------------------------~~ 674 (968)
T PLN00113 667 ----D-----------------------------------GTWEL---------------------------------QF 674 (968)
T ss_pred ----c-----------------------------------ccccc---------------------------------cc
Confidence 0 00000 00
Q ss_pred ccccCCCCCCccccCCCCCCCCCccccchhhhHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhh
Q 003704 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQK 550 (801)
Q Consensus 472 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~ 550 (801)
. .. .....+++.+ ....|...++||+|+||.||+|+. .+|..||||++......
T Consensus 675 ~------~~-------------~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--- 729 (968)
T PLN00113 675 F------DS-------------KVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--- 729 (968)
T ss_pred c------cc-------------ccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---
Confidence 0 00 0001122222 234567788999999999999975 68999999998643221
Q ss_pred HHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 003704 551 DDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630 (801)
Q Consensus 551 ~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 630 (801)
..+|++.+++++|||||+++++|.+.+..++||||+++|+|.++++ .++|..+.+|+.|+++||+|||+.
T Consensus 730 ---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 730 ---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred ---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccC
Confidence 1245788899999999999999999999999999999999999996 278999999999999999999987
Q ss_pred CCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHH
Q 003704 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELL 709 (801)
Q Consensus 631 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ell 709 (801)
+.++|+||||||+||+++.++..++. ||........ ....++.+|+|||+ ....++.++|||||||++|||+
T Consensus 800 ~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872 (968)
T ss_pred CCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence 67899999999999999999988875 6665433221 22356788999994 4556999999999999999999
Q ss_pred hCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC--CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 710 TGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ--YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 710 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
||+.||+..... ....+.|......+ ......+++..... .+.....++.+++.+||+.||++||+|.|+++.|++
T Consensus 873 tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 873 TGKSPADAEFGV-HGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred hCCCCCCcccCC-CCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 999999643321 22233333221111 12223344443322 233445678899999999999999999999999999
Q ss_pred HHHhhhc
Q 003704 788 MIRRERC 794 (801)
Q Consensus 788 ~~~~~~~ 794 (801)
+.+....
T Consensus 951 ~~~~~~~ 957 (968)
T PLN00113 951 ASRSSSS 957 (968)
T ss_pred hhccccc
Confidence 8775443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=444.22 Aligned_cols=288 Identities=48% Similarity=0.865 Sum_probs=250.0
Q ss_pred ccccchhhhHhhhccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccce
Q 003704 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574 (801)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~ 574 (801)
..+.|++.++..++++|+..++||+|+||.||+|.+.+|..||||++....... ..+|..|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 346799999999999999999999999999999999999999999886543322 456999999999999999999999
Q ss_pred EEEecC-eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcE
Q 003704 575 YCAEHG-QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (801)
Q Consensus 575 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 653 (801)
||.+.+ +.+||||||++|+|+++|+..... .++|..|++||.++|+||+|||..+.+.|||||||++|||||+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999988 599999999999999999975432 88999999999999999999999988899999999999999999999
Q ss_pred EEeeccCCCCcCC-CCcccccccc-ccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc
Q 003704 654 SVSDCGLAPLISS-GSVSQLSGHL-LTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 654 kl~DFGla~~~~~-~~~~~~~~~~-~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 730 (801)
||+|||+|+.... ... .... .||++|+|||+ ..+..+.|+|||||||+|+||+||+.+.+.........++.|.
T Consensus 217 KlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred EccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999976554 211 1111 78999999994 5678999999999999999999999999876655666688888
Q ss_pred cccccchhhhhhhcCCCCC-CCCCc-ccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPSLS-GQYPA-KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
.+.+.+. .+.+++|+.+. ..++. .....+..++.+|++.+|++||+|.||++.|+.+..
T Consensus 294 ~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 294 KPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 7666654 78889999987 66664 577789999999999999999999999999965543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=388.27 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=213.1
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-eEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-QRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~ 588 (801)
.+..+.||+|..|+|||+++ .+++.+|+|.+. ........+++.+|+++++..+||+||.+||.|...+ ...++|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34468899999999999965 578999999994 3455667889999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
|++|||++++... +.+++...-+|+.+|++||.|||+. .+||||||||+|||++..|+|||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999753 5689999999999999999999974 38999999999999999999999999999887654
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
......||..|||||. ....|+.++||||||+.++|+.+|+.||...... ...-.+.+..+++ .
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----------~~~~~~Ll~~Iv~-~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----------YLDIFELLCAIVD-E 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-----------CCCHHHHHHHHhc-C
Confidence 3567789999999994 4557999999999999999999999999764110 1111123333333 3
Q ss_pred CCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 748 LSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 748 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+..|.. +++++++|+..||++||.+||+++|+++|-.
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 34456665 8899999999999999999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=402.74 Aligned_cols=259 Identities=31% Similarity=0.535 Sum_probs=221.4
Q ss_pred ccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-eEEEEEeccC
Q 003704 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-QRLLIYEYCS 590 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~ 590 (801)
...+.||+|+||+||+|.+.....||||++..........+.|.+|+.++.+++|||||+++|+|.+.. ...+|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 334569999999999999955555999999876555555789999999999999999999999999887 7899999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEECCCC-cEEEeeccCCCCcCCCC
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP-IVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGS 668 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 668 (801)
+|+|.++++.. ....+++..+++|+.|||+||+|||+. + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999863 256899999999999999999999997 5 99999999999999998 99999999998765432
Q ss_pred ccccccccccccCcCCcccccC---CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 669 VSQLSGHLLTAYGYGAPEFESG---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.......||+.|||||.+.+ .|+.|+|||||||++|||+||+.||..... ......++.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~ 260 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVV 260 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHh
Confidence 12334688999999996664 499999999999999999999999986432 234444555
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
...+...|..++..+..++.+||+.||++||++.|++..|+.+.....
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 666667777788999999999999999999999999999998876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=397.53 Aligned_cols=250 Identities=23% Similarity=0.445 Sum_probs=214.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..|...+.||+|||+.||+++. ..|..||+|++.+... .....+.+.+|+++.+.++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999976 8999999999976443 3344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|+|.+++|..+++. .+.+++.+++.++.||+.||.|||+. +|||||||-.|+||+++++|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999874 57899999999999999999999997 899999999999999999999999999998864
Q ss_pred CCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. ......+||+.|+|||++ ...++..+||||+|||||-||+|++||+...-. +.+..+..
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------------ety~~Ik~ 232 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------------ETYNKIKL 232 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------------HHHHHHHh
Confidence 42 224568999999999954 456999999999999999999999999854211 11122221
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.. -..|...+.+..+||.++|+.||.+|||+++|+.+-
T Consensus 233 ~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 233 NE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 11 134677788999999999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=381.86 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=207.3
Q ss_pred hccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchh-----hHHHHHHHHHHhhccCCCCccccceEEEecC
Q 003704 507 YTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQ-----KDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (801)
+.+.|.+.+.||+|+||.|-+| ...+|+.||||++.+...... ......+|+++|++++|||||+++++|.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4466888999999999999999 567899999999987653331 1234579999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---CcEEEee
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD---LAVSVSD 657 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~D 657 (801)
..|+||||++||+|.+.+-.. +.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999763 4567777888999999999999997 99999999999999765 7899999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCcccccC-C---CCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG-I---YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~---~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
||+|+....... ....+||+.|.|||++.. . +..++|+||+||+||-+|+|.+||.......
T Consensus 323 FGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----------- 388 (475)
T KOG0615|consen 323 FGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----------- 388 (475)
T ss_pred cchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------
Confidence 999998875533 456789999999995443 2 4458999999999999999999997532211
Q ss_pred ccchhhhhhhcCCCC--CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 734 LHDIDALSRMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
....++....+ .+.+....+++..+||.+||..||++||++.|++++-+
T Consensus 389 ----sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 389 ----SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ----cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 01111111111 12234567788999999999999999999999998754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=362.21 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=217.0
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceE-EEecC-eEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY-CAEHG-QRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~-~~~~~-~~~lV 585 (801)
.+|.+.++||+|.||+|||+ ...+|..+|.|.+.-.............|+.+|++++|||||+++++ +.++. .++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45778899999999999999 57899999999998777777888899999999999999999999994 44444 48999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ-PPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||.+|+|..+|+..+..+..+++.++++++.|++.||.++|+... .-|+||||||.||+|+.+|.||++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998776667889999999999999999999998421 13999999999999999999999999999998
Q ss_pred CCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.... .......||+.||+|| +....|+.|+||||+||++|||..-++||.+.+- ..+.+.
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----------------~~L~~K 239 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----------------LSLCKK 239 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----------------HHHHHH
Confidence 7653 2345678999999999 5566799999999999999999999999986421 222333
Q ss_pred cCCCCCCCCC-cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 744 VDPSLSGQYP-AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 744 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
+...--+..| +..+.++..||..|+..||+.||+.-.+++.+..
T Consensus 240 I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3332222234 5667889999999999999999997666666654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=371.74 Aligned_cols=203 Identities=28% Similarity=0.501 Sum_probs=182.3
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|...+.||+|+||+||+|+. +++..||||.+.+........+.+..|+.+|+.++|||||.+++++...+..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35688888899999999999975 56899999999877666777788899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC------CcEEEeeccC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD------LAVSVSDCGL 660 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGl 660 (801)
|||.||+|.++|+. ...+++.++..++.|||.||++||+. +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999996 35799999999999999999999996 89999999999999764 4689999999
Q ss_pred CCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRN 720 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~ 720 (801)
|+.+.++. .....+|++-|||||+ ..+.|+.|+|+||+|+|+|+|++|+.||+....
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99998654 3456789999999995 578899999999999999999999999986443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=364.08 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=204.3
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchh-hHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ-KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.++||+|+||.||.++. ++++.||+|++++...... ..+...+|..++.+++||.||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5789999999999999999954 5799999999987664443 5677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+.||.|+.+|.. ...+++..+.-++..|+.||.|||+. +||||||||+|||||++|+++|+|||+++....
T Consensus 105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999986 45688999999999999999999996 999999999999999999999999999986543
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. ......+||+.||||| +....|+..+|+||+||++|||++|.+||...+.. +.+..+..
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I~~ 239 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKILK 239 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHHhc
Confidence 32 2244578999999999 56678999999999999999999999999864321 11111222
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCC
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 776 (801)
.. ....|...+.+.++++.++|..||++|.
T Consensus 240 ~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 240 GK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred Cc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 2234555778899999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=381.06 Aligned_cols=257 Identities=27% Similarity=0.486 Sum_probs=220.2
Q ss_pred CccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+...+.||+|.||.||.|.+.....||||.++.. ....+.|.+|+++|++++|+|||+++++|..++.++||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3456789999999999999988889999999754 2344678899999999999999999999999889999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
.|+|.++|+... ...+...+.+.++.|||+|++||+++ ++|||||-..|||++++..+||+|||+|+...++.+.
T Consensus 285 ~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999998632 46788999999999999999999996 8999999999999999999999999999965554432
Q ss_pred ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 671 QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
. .....-+..|.||| +..+.++.|+|||||||+||||+| |+.||..+.. ..+.+.++.+.
T Consensus 360 ~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le~Gy 421 (468)
T KOG0197|consen 360 A-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLERGY 421 (468)
T ss_pred e-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHhccC
Confidence 2 22222345699999 667889999999999999999999 9999886543 33445567777
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
+-..|..|+.++.+|+..||+.+|++|||+..+...|+++.....
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 777899999999999999999999999999999999988876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=352.18 Aligned_cols=264 Identities=21% Similarity=0.410 Sum_probs=208.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+.|+...++|+|+||+|||++. ++|+.||||++..........+-.++|++++++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577888999999999999975 569999999998777667777778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||+..-|.++-+ ....++...+.+++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHELER----YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 998755544332 256789999999999999999999996 8999999999999999999999999999998732
Q ss_pred CccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. ........|.+|+|||.+-| .|+..+||||+||++.||++|.+.|.+..+.+....+......+.. .-..++.
T Consensus 155 g--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p--rhq~iF~ 230 (396)
T KOG0593|consen 155 G--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP--RHQSIFS 230 (396)
T ss_pred c--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH--HHHHHhc
Confidence 1 12344567888999996554 6999999999999999999999999876655444333222111110 0011111
Q ss_pred ----------------CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 ----------------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+.++..||. ....+.+|+..||+.||++|++.+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 011122332 23467899999999999999999999853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.78 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=212.7
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhh-HHHHHHHHHHhhcc-CCCCccccceEEEecCeEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQK-DDEFLELVNNIDRI-RHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 583 (801)
-.++|..++.||+|+|++||+|+ .+.++.||||++.++....+. .+.+.+|-+.|.+| .||.|++|+..|+|+..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999995 567999999999876654433 35566788888888 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+|+||+++|+|.++|+.. ..+++..+..++.+|+.||+|||+. |||||||||+|||||.||++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999873 5689999999999999999999997 999999999999999999999999999999
Q ss_pred cCCCCcc---------ccc--cccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccc
Q 003704 664 ISSGSVS---------QLS--GHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731 (801)
Q Consensus 664 ~~~~~~~---------~~~--~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 731 (801)
+.+.... ... ...+||..|.+||++ .+..+..+|+|+||||+|+|+.|++||...++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---------- 293 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---------- 293 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----------
Confidence 8654322 111 347899999999955 556889999999999999999999999865431
Q ss_pred ccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
-..+++++- .-.+|...++.+.+|+.+.|..||.+|+|.+||.+|.
T Consensus 294 ------liFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 ------LIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ------HHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 122222222 1235677778899999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.79 Aligned_cols=266 Identities=29% Similarity=0.459 Sum_probs=214.8
Q ss_pred HhhhccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
.+...+.+.+.+.||+|.||+||+|++.. .||||+++.........+.|+.|+.++++-+|.||+-+.|||..... .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 33344566778999999999999999854 69999999888888888999999999999999999999999999877 9
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
||..+|+|.+|+.+||.. +..++..+.+.||.||++|+.|||.. +|||||||..||+|++++.|||+|||++..
T Consensus 464 IiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999975 46799999999999999999999985 999999999999999999999999999865
Q ss_pred cCCCCccccccccccccCcCCccccc----CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEFES----GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
-..-..........+...|||||++. ..|++.+|||||||++|||+||..||. ....+ +.+-......+ ...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d-qIifmVGrG~l--~pd 613 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD-QIIFMVGRGYL--MPD 613 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh-heEEEeccccc--Ccc
Confidence 43221112223345667799999433 349999999999999999999999998 33322 21111111000 000
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
+ ......++.++.+|+..||..++++||.+.+|+..|++++++
T Consensus 614 ~---------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 L---------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred c---------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0 012346778999999999999999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=366.91 Aligned_cols=270 Identities=23% Similarity=0.375 Sum_probs=213.0
Q ss_pred hhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeE
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (801)
...+.|+.++.||+|+||.||+|+ ..+|+.||+|++..............+|+.+|+++.||||+++.+.+.+. +.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 344678888999999999999995 67899999999987766666777888999999999999999999998876 789
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
|||+|||+. +|.-++... .-.+++.++..++.|++.||+|||+. ||+|||||.+|||||.+|.+||+|||+|+
T Consensus 194 YlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999999987 888888753 34689999999999999999999996 99999999999999999999999999999
Q ss_pred CcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceee--cccccccchh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR--WAIPQLHDID 738 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~ 738 (801)
++.......+ .....|.+|+|||++.| .|+.++|+||.||||.||++|++.|.+....+....+. ...|....|.
T Consensus 267 ~y~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 8877654333 34556889999996655 49999999999999999999999998766544332211 1112222222
Q ss_pred hhhhhcC-CCCC--CCCC-------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVD-PSLS--GQYP-------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~-~~~~--~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..++-. ..+. ..|. ...+....+|+..+|..||++|.|+.++++.
T Consensus 346 -~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 -VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred -cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111110 0001 1111 2334567899999999999999999998853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=366.84 Aligned_cols=268 Identities=23% Similarity=0.393 Sum_probs=216.5
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecC-eEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHG-QRL 583 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~-~~~ 583 (801)
+.++|...+.||.|+||.||+|+ ..+|..||||++++.... ..+..-.||++.|+++. |||||++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45678889999999999999995 567999999999876554 44555678999999998 999999999999988 999
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+|||||+. +|+++++.+ ...+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999965 999999875 57899999999999999999999986 999999999999999999999999999998
Q ss_pred cCCCCccccccccccccCcCCccc--ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceee--cccccccch--
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR--WAIPQLHDI-- 737 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~--~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~-- 737 (801)
+.+... -.....|.+|+|||+ .++.|+.+.||||+|||++|+.+-++.|.+..+.++..-+- ...|....+
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 876532 345667888999993 45679999999999999999999999998776544332111 112222222
Q ss_pred -hhhhhhcCCCCCCC--------CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 738 -DALSRMVDPSLSGQ--------YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 738 -~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+...+.-.+... .+ ..+.++.++|.+|+.+||++|||+.|++++-.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 23333333333221 12 26678999999999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.56 Aligned_cols=267 Identities=23% Similarity=0.378 Sum_probs=212.7
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.+|...++||+|.||.||+|+ ..+|+.||||+++.....+.......+|++.++.++|+||+.+++.|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357788999999999999995 5789999999998776666667788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||+. +|+.+|+.. ...++...+..++.++++||+|||.. .|+||||||.|+|++.+|.+||+|||+|+.+.+.
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9975 999999864 45788999999999999999999986 8999999999999999999999999999998766
Q ss_pred CccccccccccccCcCCcccc--cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--ecccccccchhhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 743 (801)
.... .+..-|.+|+|||.+ ...|+..+||||.|||+.||+-|.+-|.+..+-++...+ ...+|....+..+..+
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4432 223667889999943 446999999999999999999998877765543322211 1122222222222222
Q ss_pred cC---------CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 744 VD---------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 744 ~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
-| +.+..-++ .++.++.+|+.+|+..||.+|++++|++++=
T Consensus 233 pdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11 11111122 3456679999999999999999999998763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.48 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=210.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC--eEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG--QRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 585 (801)
.+|...+.||+|+||+||++.. ++|...|||.+....... .+.+.+|+.++.+++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 3577789999999999999965 459999999987552222 567889999999999999999999855444 68999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeeccCCCCc
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLI 664 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 664 (801)
|||+++|+|.+++...+ ..+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||+++..
T Consensus 95 mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999999999998643 2699999999999999999999986 9999999999999999 799999999999877
Q ss_pred CC-CCccccccccccccCcCCccccc-CCC-CCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 665 SS-GSVSQLSGHLLTAYGYGAPEFES-GIY-TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 665 ~~-~~~~~~~~~~~~~~~y~aPE~~~-~~~-~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.. ...........||+.|||||... +.. ..++|||||||++.||+||+.||.... .....+.
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~ 233 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALL 233 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHH
Confidence 64 11122234567899999999655 432 349999999999999999999997520 1112222
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+......+.+|...+.+..+++.+|+..||++|||+.|++++......+
T Consensus 234 ~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 234 LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 23333333467888889999999999999999999999999998765433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.80 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=214.3
Q ss_pred ccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
...|...+.||+|+.|.||.| +..+++.||||++.... +..++-+.+|+.+|+..+|+|||.+++.|...+++|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 356788889999999999999 56789999999997543 445677889999999999999999999999889999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|||+||+|.|++.. ..+++.++..|.+++++||+|||.. +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 350 Eym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999974 4589999999999999999999996 999999999999999999999999999988776
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......||+.||||| +....|++|+||||||++++||+-|++||....+. ..+..+.+
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----------------rAlyLIa~ 483 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------------RALYLIAT 483 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----------------HHHHHHhh
Confidence 543 345678999999999 66778999999999999999999999999764332 22222222
Q ss_pred CC-CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PS-LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+ ..-+.++..+.+|.+|+.+||+.|+++|+++.|+|+|
T Consensus 484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22 2234577888999999999999999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=376.83 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=223.0
Q ss_pred ccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 512 SQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
...+.||+|+||.||+|+. .+...||||.+++. ...+...+|++|++++..++|||||+++|.|.+.+-.++|
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 3457899999999999964 34568999999754 4455778999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEE
Q 003704 586 YEYCSNGTLQDMLHSDDE----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 655 (801)
+|||..|+|.++|..... ...+++..+.+.||.|||.|++||-++ .+|||||-.+|+|+.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999975321 123488999999999999999999997 7999999999999999999999
Q ss_pred eeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccc
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
+|||+++..-..+++...++..-..+||+|| ++.+.|+.++|||||||+|||+++ |+.||.+..+
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------------- 711 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------------- 711 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------------
Confidence 9999999877776666565666678999999 888999999999999999999998 9999976433
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
.+.+..+....+ -..|+.+|.++..|+..||+.+|.+||+++||-..|+...+..
T Consensus 712 ---~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 ---QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 234444444444 4678999999999999999999999999999999999886543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=355.33 Aligned_cols=261 Identities=24% Similarity=0.427 Sum_probs=219.4
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+...+.++||+|-||.|.++....+..||||.++... ......+|.+|+++|.+++|||||+++|+|..++-+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567789999999999999999888999999997543 344568999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
|++|+|.+++..+.. ..+.-...+.|+.||+.|++||.+. ++|||||.+.|+|+|.++++||+|||+++-+-.+.
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999987532 2245666778999999999999998 89999999999999999999999999999887777
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh--CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT--GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
+....+...-+.+|||+| ++.+.++.++|||+||+++||+++ ...||....+..- .+...++.+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-------------ven~~~~~~ 758 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-------------VENAGEFFR 758 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-------------HHhhhhhcC
Confidence 766667777788999999 889999999999999999999876 7788875433210 112222333
Q ss_pred CCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 746 PSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 746 ~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
..-.. ..|..++..+.+++.+||..|-++||+++++...|.+.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22222 24677889999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=365.79 Aligned_cols=264 Identities=27% Similarity=0.471 Sum_probs=207.0
Q ss_pred ccCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec-
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH- 579 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~- 579 (801)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 35788899999999999999963 245789999986432 233456788999999999 899999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccc-------------------------------------------------------
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDEL------------------------------------------------------- 604 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 604 (801)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4678999999999999999753210
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccC
Q 003704 605 ---KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681 (801)
Q Consensus 605 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 681 (801)
...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23578889999999999999999986 999999999999999999999999999986644322222233445678
Q ss_pred cCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHH
Q 003704 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSH 759 (801)
Q Consensus 682 y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 759 (801)
|+||| +....++.++|||||||++|||++ |..||....... .+...+........+...+.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCCHH
Confidence 99999 455679999999999999999997 999997532210 011111111112234556678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 760 FADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 760 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
+.+|+.+||+.||++|||+.|+++.|++++++
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=348.30 Aligned_cols=263 Identities=22% Similarity=0.383 Sum_probs=209.2
Q ss_pred ccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.+.|+..++||.|..++||+|+ .+.+..||||++.-+..... .+.+.+|+..++.++||||++++..|..+..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3578899999999999999995 56789999999986654443 688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
.||.+||+.+++... ....+++..+..|.+++++||.|||++ |.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999863 356799999999999999999999987 999999999999999999999999998655433
Q ss_pred -CCccccc-cccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 667 -GSVSQLS-GHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 667 -~~~~~~~-~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+...... .+..+++.|||||.+. ..|+.|+||||||++..||.+|..||....+.....+.-...+.... .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~----t 254 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL----T 254 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----c
Confidence 3332333 5678999999999633 24999999999999999999999999866543211110000000000 0
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. .+...........+++++..||++||.+|||+++++++
T Consensus 255 ~----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 S----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 00001112334579999999999999999999999965
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.33 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=214.8
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|.+.+.||+|.||.||||+ ..+.+.||+|.+.+....+...+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999995 5678999999999888888888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+.| +|+.+|.. ...++++.+..++.+++.||.|||+. +|+|||+||.|||++.+|.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999986 46799999999999999999999997 8999999999999999999999999999988654
Q ss_pred CccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. .......||+-||||| +..+.|+..+|+||+|||+|||++|++||..... ..+.+.+..
T Consensus 154 t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------------~~Lv~~I~~ 214 (808)
T KOG0597|consen 154 T--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------------TQLVKSILK 214 (808)
T ss_pred c--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------------HHHHHHHhc
Confidence 2 3345678999999999 5566799999999999999999999999964311 111111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
. ...+|...+..+.+++...|.+||.+|.+-.+++.|-
T Consensus 215 d-~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 215 D-PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred C-CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1 1235667888999999999999999999999998763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=364.85 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=214.8
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccc-cCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-ASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..|+.++-||.|+.|.|-.|+ ..+|+.+|||++.+. .........+.+|+-+|+.+.||||+++|+++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 468889999999999999995 478999999999876 445555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|.|++++-. ++++.+.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999986 56789999999999999999999997 899999999999999999999999999988766
Q ss_pred CCccccccccccccCcCCcccccCC-C-CCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESGI-Y-TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
+.. -..-+|.+.|.|||+..|. | +.++||||.|||||.||||+.||+..+- ..+...+
T Consensus 165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----------------r~LLlKV 224 (786)
T KOG0588|consen 165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----------------RVLLLKV 224 (786)
T ss_pred Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----------------HHHHHHH
Confidence 643 3456799999999976664 4 6899999999999999999999984321 1111111
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
..+ .-..|...+.+.++|+.+|+..||++|.|+.||++|-.-
T Consensus 225 ~~G-~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 225 QRG-VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred HcC-cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 111 113577888999999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.42 Aligned_cols=237 Identities=24% Similarity=0.391 Sum_probs=204.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||.|+||+|.+++. .+|..+|+|++.+...-. ...+...+|-.+|+.+.||+++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4677889999999999999975 578999999997654322 23456678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||++||.|+.+++. ...+++..++.+|.+|+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999986 35789999999999999999999997 899999999999999999999999999988765
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .-..+||+.|+||| +.+..|+.++|.|||||++|||+.|.+||...+. .....+++.
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~ 255 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILE 255 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHh
Confidence 4 34678999999999 6677899999999999999999999999975432 123333443
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCC
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFR 775 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 775 (801)
..+ .+|.....++.+|+.+.|+.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 333 4788888999999999999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=335.88 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=210.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 585 (801)
+.|+..+.|++|+||.||+|+. .+++.||+|+++.........-...+|+.++.+++|||||.+..++.. -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4677889999999999999964 578999999998666555555667899999999999999999998764 4679999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
||||+. +|..+++.. .+++...++..++.|+++|++|||+. .|+|||||++|+|+...|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999986 999999864 46899999999999999999999997 79999999999999999999999999999987
Q ss_pred CCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--------eccccccc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--------RWAIPQLH 735 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--------~~~~~~~~ 735 (801)
+... .......|.+|+|||++.+ .|+...||||+|||+.||+++++.|.+....++.+.+ +..++.+.
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 6532 2344567889999995544 5999999999999999999999999876544332211 11222222
Q ss_pred chhhhhhhc-----CCCCCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 DIDALSRMV-----DPSLSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 ~~~~~~~~~-----~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+. ...++..++.. ..+.-.+|+..+|..||.+|.|+.|.+++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 222211111 11122233333 45778899999999999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=355.36 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=196.3
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|+. .+|+.||||++.... .......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 4567788999999999999965 578999999986432 33445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999986532 345677888999999999999986 8999999999999999999999999999766432
Q ss_pred CccccccccccccCcCCcccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFESG------IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.. ......|+..|+|||.+.. ..+.++|||||||++|||++|+.||....... +..+.
T Consensus 222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------------~~~~~ 285 (353)
T PLN00034 222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--------------WASLM 285 (353)
T ss_pred cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--------------HHHHH
Confidence 11 1233467889999995432 23568999999999999999999997322111 11111
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+........+...+.++.+|+.+||+.||++||++.|++++-.
T Consensus 286 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 286 CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred HHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 111111122234456678999999999999999999999998743
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.73 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=206.8
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCc---hhhHHHHHHHHHHhhccC-CCCccccceEEEecCe
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ 581 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~ 581 (801)
....|...+.||+|+||.||.|. ..+|..||||++.+.... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35678999999999999999995 457899999977654221 234566778999999999 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEeeccC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGL 660 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGl 660 (801)
.++||||+.||+|++++.. ...+.+..+.+++.|++.|++|||+. ||+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999986 35688899999999999999999996 99999999999999999 9999999999
Q ss_pred CCCcC-CCCccccccccccccCcCCcccccC-C-CC-CcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 661 APLIS-SGSVSQLSGHLLTAYGYGAPEFESG-I-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 661 a~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~-~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
+.... .+ ......+|++.|+|||++.+ . |+ .++||||+||+||.|++|+.||+.....
T Consensus 168 s~~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------------- 229 (370)
T KOG0583|consen 168 SAISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------------- 229 (370)
T ss_pred ccccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---------------
Confidence 98873 22 22456789999999996554 4 54 7899999999999999999999863221
Q ss_pred hhhhhh-hcCCCCCCCCCccc-HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 IDALSR-MVDPSLSGQYPAKS-LSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 ~~~~~~-~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.+.. +... .-.+|... +.++.+|+.+|+..||.+|+++.|++.+=
T Consensus 230 --~l~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 230 --NLYRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred --HHHHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 1111 1111 12355656 78999999999999999999999999443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.44 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=201.4
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEe----cCeEEEEEec
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLIYEY 588 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 588 (801)
...||+|++|.||+|.. +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 78999999997543322 224678899999999999999999999876 3578899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++|+|.+++.. ...+++.....++.+++.||+|||+. .+++||||||+|||++.++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999975 34688999999999999999999974 278899999999999999999999999987654321
Q ss_pred ccccccccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 669 VSQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
....++..|+|||... ..++.++|||||||++|||++|+.||...... +....+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------------~~~~~i~~ 236 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------------EIYDLIIN 236 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHh
Confidence 1234677899999654 46899999999999999999999999754221 11111212
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.......+..++.++.+++.+||+.||++|||++|+++.|..+.
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22223345566788999999999999999999999999998753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.49 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=206.6
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (801)
++|++.+.||+|+||.||+|.. .++..||||++..... ......+.+|+++++.+ +|+|||++++++.+.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4688899999999999999863 2345899999975432 33456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 603 (801)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864210
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccc
Q 003704 604 --------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675 (801)
Q Consensus 604 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 675 (801)
....+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.........+.
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 013478899999999999999999986 999999999999999999999999999976544322222223
Q ss_pred cccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 676 LLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 676 ~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
..++..|+||| .....++.++|||||||++|||++ |+.||....... .+............+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCccCC
Confidence 34556799999 556679999999999999999997 999997532211 111112222222234
Q ss_pred cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
...+.++.+++.+||+.||++||++.||++.|++++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.60 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=204.8
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (801)
++|++.+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|++++..+ +||||+++++++.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4688899999999999999953 3466899999864432 23456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 603 (801)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999964321
Q ss_pred -------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 604 -------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 604 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012478899999999999999999986 8999999999999999999999999999866543221
Q ss_pred ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 671 QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
...+...++..|+||| .....++.++|||||||++|||++ |..||...... ..+.+.+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIKEGY 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHHhCc
Confidence 2222334456799999 455679999999999999999998 88898653221 01111122222
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
....+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 2223344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.73 Aligned_cols=254 Identities=23% Similarity=0.330 Sum_probs=203.0
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
.++|+.++.||+|+||.||+|+. .+|..+|+|++++..... ...+.++.|-.+|....+++||++|..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46889999999999999999964 579999999998765432 3346778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||++||++..+|.. ...|++..+..++.+++.|++-||+. |||||||||+|+|||..|++||+|||++.-+.
T Consensus 220 MEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999986 46799999999999999999999997 99999999999999999999999999985432
Q ss_pred CC----------------------Ccc-----------------------ccccccccccCcCCcc-cccCCCCCcchHH
Q 003704 666 SG----------------------SVS-----------------------QLSGHLLTAYGYGAPE-FESGIYTCQSDVY 699 (801)
Q Consensus 666 ~~----------------------~~~-----------------------~~~~~~~~~~~y~aPE-~~~~~~~~k~Dvw 699 (801)
.. ... .......||+.|+||| ++...|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 0011246899999999 5556699999999
Q ss_pred HHHHHHHHHHhCCCCccccccccc-cceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCC-
Q 003704 700 SFGVVMLELLTGRKSYDRTRNRGE-QFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP- 777 (801)
Q Consensus 700 SlGvil~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt- 777 (801)
|||||+||||.|.+||....+... ..++.|.. .+...-......+..+||.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999987655332 12222221 01111112344789999999999 9999975
Q ss_pred --HHHHHHH
Q 003704 778 --MSEVVQD 784 (801)
Q Consensus 778 --~~evl~~ 784 (801)
++||-+|
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 6666544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.58 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=206.1
Q ss_pred hhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchh------------hHHHHHHHHHHhhccCCCCccc
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ------------KDDEFLELVNNIDRIRHANIVE 571 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~HpnIv~ 571 (801)
....++|++.+.||+|.||.|-+|+. .+++.||||++.+.....+ ..+...+|+.++++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568999999999999999999964 6899999999976532211 1257889999999999999999
Q ss_pred cceEEEe--cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 003704 572 LKGYCAE--HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD 649 (801)
Q Consensus 572 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 649 (801)
|+.+..+ .+.+|||+|||..|.+...=. .+..+++.++++|+.+++.||+|||.+ |||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9999876 468999999999988754321 123389999999999999999999997 9999999999999999
Q ss_pred CCcEEEeeccCCCCcCCCCc---cccccccccccCcCCcccccC-C----CCCcchHHHHHHHHHHHHhCCCCccccccc
Q 003704 650 DLAVSVSDCGLAPLISSGSV---SQLSGHLLTAYGYGAPEFESG-I----YTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721 (801)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~----~~~k~DvwSlGvil~elltG~~pf~~~~~~ 721 (801)
+|++||+|||.+..+..+.. ........||+.|+|||...+ . .+.+.||||+||+||.|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999877643321 111223578999999995443 2 357889999999999999999999754321
Q ss_pred cccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
+-..+++...+......+..+++.+||.+||.+||++|.+..+|..|.+-..
T Consensus 326 ----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 326 ----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 2223344444432222245678999999999999999999999998876443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=344.06 Aligned_cols=261 Identities=24% Similarity=0.438 Sum_probs=202.6
Q ss_pred cCCccCCeeeecCccEEEEEEeCC-----------------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccc
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD-----------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~ 571 (801)
++|.+.+.||+|+||.||+|.+.+ +..||||.+.... .......+.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 568888999999999999997532 3479999986532 3344567899999999999999999
Q ss_pred cceEEEecCeEEEEEeccCCCCHHHHHhcCcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 003704 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE---------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636 (801)
Q Consensus 572 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 636 (801)
+++++.+.+..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 113478889999999999999999986 899
Q ss_pred ecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh--CCC
Q 003704 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT--GRK 713 (801)
Q Consensus 637 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt--G~~ 713 (801)
||||||+|||++.++.+||+|||+++.+.............++..|+||| ...+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998765443222233444567899999 556679999999999999999987 566
Q ss_pred CccccccccccceeecccccccchhhhhhhcC---CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 714 SYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD---PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 714 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
||....... .. ........ .......+..++..+.+|+.+||+.||++|||+.||.+.|+
T Consensus 241 p~~~~~~~~---~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ---VI----------ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH---HH----------HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776432211 00 00000000 01111123456678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.75 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=212.7
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
.++|++++.||+|-||.||.|+. +++-.||+|++.+.... .+...++.+|+++-..++||||+++|+||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 36788999999999999999964 57889999998765432 23467889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
+||..+|+|+..|.+.. ...+++.....++.|+|.||.|+|.. +||||||||+|+|++.++.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998543 45688889999999999999999985 89999999999999999999999999986654
Q ss_pred CCCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
.. .....+||..|.+||.. ...++..+|+|++|++.||++.|.+||...... +...++.
T Consensus 176 ~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~ 235 (281)
T KOG0580|consen 176 SN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR 235 (281)
T ss_pred CC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH
Confidence 32 24567899999999954 556999999999999999999999999865421 1222222
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
... -.+|...+.+..++|.+|+.++|.+|.+..|++++-.
T Consensus 236 k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 236 KVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred Hcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 222 2356777889999999999999999999999998864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.46 Aligned_cols=269 Identities=22% Similarity=0.349 Sum_probs=210.3
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe-----cC
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-----HG 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-----~~ 580 (801)
....|...+.||+|+||.|+.+. ..+|..||||++..........++-.+|++.++.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34556667899999999999995 4689999999998666666677888899999999999999999999754 45
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
..|+|+|+| +.+|...|+. .+.++...+..++.|+++||+|+|+. +|+||||||+|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 789999999 5699999986 34588999999999999999999997 999999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCccc-c-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchh
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEF-E-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~-~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
|+...........+....|.+|.|||+ + ...|+...||||.|||+.||++|++.|.+.+......++....+.- +.+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 998865422222345667889999993 3 3469999999999999999999999998766544333222211111 111
Q ss_pred hhhhhc--------C-------CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 739 ALSRMV--------D-------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 739 ~~~~~~--------~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.+..+. . ..+...+| .......+|+.+||..||.+|+|++|.++|-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 222111 0 00111123 4456788999999999999999999999764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.39 Aligned_cols=240 Identities=28% Similarity=0.480 Sum_probs=202.4
Q ss_pred cCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.++-||.|+.|.||+|++ .++.||||+++.- -..+++.|++|+|+||+.+.|+|.....++||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 457899999999999999 4578999988521 124678899999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
-|+.+|+. ...+.......|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++...... .
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---T 267 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---T 267 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---h
Confidence 99999986 45677888899999999999999986 89999999999999999999999999998776542 2
Q ss_pred ccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.-.+.||..|||||++ ....+.|+|||||||+|||||||..||..... ..+-|.. -...+.-.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGV------------GsNsL~Lp 331 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGV------------GSNSLHLP 331 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEec------------cCCccccc
Confidence 3457899999999955 55689999999999999999999999975432 1222221 12233445
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
.|..+++-|.-|+++||+..|..||++.+++.||...
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 6788899999999999999999999999999999654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.67 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=202.2
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|+..+.||+|+||.||+|.. .+|+.||||.+...... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999964 68999999998654322 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998886432 34689999999999999999999986 89999999999999999999999999997654332
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. .....|+..|+|||. ....++.++|||||||++|||++|+.||......... ..+...+. .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~ 219 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEVDRRVK-E 219 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHHhh-c
Confidence 1 223467889999994 4567999999999999999999999999754321100 11111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 784 (801)
....++...+.++.+|+.+||+.||++||+ ++|++++
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 112345566778999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.34 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=212.5
Q ss_pred hccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
+++.|++.+.||+|.|+.||++ ...+|+.+|+|+++.........+.+.+|+.+-+.++|||||++++.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 5678888999999999999999 567899999999876666666778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCCcEEEeeccCCC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~ 662 (801)
+|+|.|++|..-|-. +..+++..+-.++.||+++|.|+|.. +|||||+||+|+|+- ....+|++|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876654 35578888999999999999999996 999999999999994 34579999999998
Q ss_pred CcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.+..+. ......||++|||||+ ....|+..+|||+.|||||-|+.|.+||...... ...+
T Consensus 162 ~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----------------rlye 222 (355)
T KOG0033|consen 162 EVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLYE 222 (355)
T ss_pred EeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----------------HHHH
Confidence 887432 3445679999999995 4567999999999999999999999999753211 1111
Q ss_pred hhcC--CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 742 RMVD--PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 742 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
++.. -...+.+....+++..+|+++||..||.+|.|+.|.+++-+-.
T Consensus 223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 1211 1233345567778999999999999999999999999776544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.45 Aligned_cols=268 Identities=20% Similarity=0.345 Sum_probs=205.1
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|+..+.||+|+||.||+++. .+|..||+|.+.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 46789999999999999999965 468899999986432 3344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999975 34588999999999999999999985 2699999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeec------------cc--
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW------------AI-- 731 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~------------~~-- 731 (801)
.. .....++..|+|||. ....++.++|||||||++|||++|+.||.............. ..
T Consensus 157 ~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred cc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 22 233467889999995 445689999999999999999999999965432111000000 00
Q ss_pred ----------------ccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 732 ----------------PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 732 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+.....+....+.............+.++.+|+.+||+.||++|||+.|++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000000111111111111234678999999999999999999999998864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.08 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=198.5
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-----eEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (801)
.|...+++|.|+||.||+|.. .+++.||||++-.+.. .-.+|+++|+.+.|||||++..+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 466789999999999999965 4579999999854332 2237899999999999999999886432 335
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEeeccCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAP 662 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 662 (801)
||||||+. +|+++++........++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 99999986433456778888889999999999999995 99999999999999986 899999999999
Q ss_pred CcCCCCccccccccccccCcCCcccc--cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--ecccccccchh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWAIPQLHDID 738 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~~~ 738 (801)
.+..+.. ......+..|+|||.+ ...|+.+.||||.||++.||+-|++-|.+....+....+ -...|..++..
T Consensus 175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9887654 2345567789999944 346999999999999999999999999875543322111 11122222211
Q ss_pred hhhhh----cCCCCC-----CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRM----VDPSLS-----GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~----~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.-. ..+.+. ..+....+.+..+|+.++++.+|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11100 001111 11334567889999999999999999999999865
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.15 Aligned_cols=268 Identities=21% Similarity=0.347 Sum_probs=202.6
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||+|+||.||+|+.. +++.||||++............+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999764 68899999997654444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9999877665432 34688999999999999999999986 8999999999999999999999999999876443
Q ss_pred CccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc--hh------
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD--ID------ 738 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~------ 738 (801)
... ......++..|+||| .....++.++|||||||++|||++|+.||......+...........+.. ..
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 211 122345788899999 44556899999999999999999999999764322111100000000000 00
Q ss_pred hhhhhcCC------CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVDP------SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+ .....+....+.++.+|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 00011122356779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.08 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=201.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+|.. .+|+.||||++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999999965 4789999999864322 2233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999975 34688999999999999999999986 999999999999999999999999999876643
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .....|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~ 212 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----------------GIYEKILA 212 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHh
Confidence 2 123457888999994 4556899999999999999999999999753221 11111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 785 (801)
.. ..++...+..+.+++.+||+.||.+||+ ++|++++-
T Consensus 213 ~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 213 GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11 1234455678999999999999999995 89988774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=372.34 Aligned_cols=262 Identities=29% Similarity=0.505 Sum_probs=219.2
Q ss_pred CCccCCeeeecCccEEEEEEeC--CCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP--DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
.....+.||+|+||.||.|... +|. .||||.+.+. .+.+...+|.+|..+|++++|||||+++|++.+.+..+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3455778999999999999753 343 4899998653 45677889999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 584 LIYEYCSNGTLQDMLHSDDE---LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
|++|||++|+|..+|++.+. ....+...+.+.++.|||+|++||++. ++|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987521 135689999999999999999999996 899999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchh
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
|+.+....+........-...||||| +..+.++.|+|||||||++||++| |..||...++. +
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----------------~ 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----------------E 912 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------H
Confidence 99665555544444434456899999 666899999999999999999999 89999765432 2
Q ss_pred hhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
.+...+..+ +-..|..+++.+.++|.+||+.+|++||++..+++.+..++..-
T Consensus 913 v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 222233333 44678899999999999999999999999999999998887543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.89 Aligned_cols=258 Identities=26% Similarity=0.470 Sum_probs=207.6
Q ss_pred cCCccCCeeeecCccEEEEEEeCC------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++.+++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888999999999999996532 2579999986433 334456788999999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 650 (801)
+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999975321 114588899999999999999999986 89999999999999999
Q ss_pred CcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceee
Q 003704 651 LAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 728 (801)
+.+||+|||+++...............++..|+||| ...+.++.++|||||||++|||++ |..||......
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------- 233 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 999999999997654433222233345567899999 556679999999999999999998 99998753221
Q ss_pred cccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.+.+.+........+..++.++.+|+.+||+.||++||+++||+++|+.
T Consensus 234 ----------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ----------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1112222222223456677899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=332.09 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=203.6
Q ss_pred cCCccCCeeeecCccEEEEEEe----CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
++|++.+.||+|+||.||+|.+ ..+..||+|.++... .......+.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 4678889999999999999964 246789999987543 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999753 24689999999999999999999986 8999999999999999999999999987654
Q ss_pred CCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
...... ......++..|+||| ...+.++.++|||||||++||+++ |+.||...... ..+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~~~~~ 220 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------DVIKA 220 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHH
Confidence 322111 111223456799999 556678999999999999999775 99999754221 01111
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
+........+..++..+.+++.+||+.+|++||++.|+++.|.++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 -VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111112223556678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=349.08 Aligned_cols=262 Identities=26% Similarity=0.503 Sum_probs=218.0
Q ss_pred ccCCccCCeeeecCccEEEEEEeC--CC--cE-EEEEEecc-ccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP--DG--KL-LAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~--~g--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
.++-...++||+|+||.||+|++. ++ .. ||||..+. .........+|.+|.+++++++|||||++||++....-
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 344555689999999999999653 33 23 89999875 33566778899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
+++|||+|.||+|.++|...+ ..++..+++.++.+.|.||+|||+. ++|||||-.+|+|++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999998743 3699999999999999999999986 8999999999999999999999999998
Q ss_pred CCcCCCCcccccc-ccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchh
Q 003704 662 PLISSGSVSQLSG-HLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 662 ~~~~~~~~~~~~~-~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
+.-..- .... ...-+..|+||| +..+.|+.++|||||||++||+++ |..||.+.... +
T Consensus 310 ~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------~ 370 (474)
T KOG0194|consen 310 RAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------E 370 (474)
T ss_pred cCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------H
Confidence 764411 1111 223456799999 667789999999999999999999 88899765431 2
Q ss_pred hhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhc
Q 003704 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (801)
....++....+...|...+.++..++.+||..||++||+|.++.+.|+.+......
T Consensus 371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 23334355556667778889999999999999999999999999999999876553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.67 Aligned_cols=263 Identities=29% Similarity=0.474 Sum_probs=206.4
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEe-cC
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE-HG 580 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~-~~ 580 (801)
++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|++++.++ +|+||+++++++.. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4688899999999999999953 235789999986433 233345677899999999 89999999998865 45
Q ss_pred eEEEEEeccCCCCHHHHHhcCcc---------------------------------------------------------
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDE--------------------------------------------------------- 603 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 603 (801)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864211
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcC
Q 003704 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683 (801)
Q Consensus 604 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~ 683 (801)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 013689999999999999999999986 99999999999999999999999999998765433222233445567899
Q ss_pred Ccc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHH
Q 003704 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFA 761 (801)
Q Consensus 684 aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 761 (801)
||| +....++.++|||||||++|||++ |+.||......+ .+...+........+.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCHHHH
Confidence 999 556679999999999999999998 999996532211 11111111112223445567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 762 DIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 762 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
+++.+||+.+|++||++.|++++|.++++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=361.44 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=208.1
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~----- 580 (801)
..++|.+.+.||+|+||+||+|+ ..+|+.||||++............+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34689999999999999999995 467999999999766555566677889999999999999999988765432
Q ss_pred ---eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEee
Q 003704 581 ---QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (801)
Q Consensus 581 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 657 (801)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36799999999999999976443345789999999999999999999986 899999999999999999999999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
||+++.+.............|+..|+|||. ....++.++|||||||++|||++|+.||......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------------- 251 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------------- 251 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------------
Confidence 999987654322222344568899999995 4556999999999999999999999999753211
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+...... .....+...+.++.+++.+||+.||++||++.+++++
T Consensus 252 -~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 -EVMHKTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011111111 1112355667889999999999999999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.32 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=205.7
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
.+|+..+.||+|+||.||+|.+. +|. .||||++... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46888999999999999999753 444 3899998643 2334556788999999999999999999998764 567
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999853 34588999999999999999999986 899999999999999999999999999987
Q ss_pred cCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+..............+..|+||| .....++.++|||||||++|||++ |+.||...... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~~ 221 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EIS 221 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence 75443222222233456799999 455678999999999999999998 99999643211 111
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
.++........+..++.++.+++.+||..||++||++.+++..+..+.++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 122222222234455678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.02 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=197.1
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
++||+|+||.||+++. .+|+.||||++.+... .......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 5799999999875432 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99999875 34689999999999999999999986 89999999999999999999999999987542221 11
Q ss_pred ccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....|+..|+|||.. ...++.++|||||||++|||++|+.||...... .....+... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----------------~~~~~~~~~--~~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILME--EIR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHcC--CCC
Confidence 2335688899999954 556899999999999999999999999643211 011111111 123
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
+|...+.++.+++.+||+.||++|| ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 4556678899999999999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=348.89 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=207.1
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecC
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHG 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~ 580 (801)
.++|.+.++||+|+||.||+|... .+..||||++.... .......+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 457888999999999999999642 24579999996533 2334567889999999996 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCcc---------------------------------------------------------
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDE--------------------------------------------------------- 603 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 603 (801)
..++|||||++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875311
Q ss_pred -----------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 003704 604 -----------------------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (801)
Q Consensus 604 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 648 (801)
....+++..+..++.|+++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012478888999999999999999986 899999999999999
Q ss_pred CCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccce
Q 003704 649 DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFL 726 (801)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 726 (801)
.++.+||+|||+++.+.............++..|+||| +....++.++|||||||++|||++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 99999999999997654332222223334567799999 555678999999999999999997 999987532110
Q ss_pred eecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 727 VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
.+...+........+...+.++.+++.+||+.||++||++.+|.+.|+++++
T Consensus 348 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 ------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111111112222345567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.26 Aligned_cols=246 Identities=21% Similarity=0.293 Sum_probs=201.8
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||.||+|+. .+|+.||||++.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688899999999999999976 4689999999865432 2233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999975 34678889999999999999999986 899999999999999999999999999976644
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. ....|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+..
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~~~~i~~ 229 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----------------RIYEKILA 229 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----------------HHHHHHhc
Confidence 32 23467889999994 4556899999999999999999999999643211 11111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 784 (801)
.. ..+|...+..+.+|+.+||+.||++||+ +.|++.|
T Consensus 230 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 230 GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 1234455678999999999999999997 6888866
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.57 Aligned_cols=258 Identities=26% Similarity=0.479 Sum_probs=219.7
Q ss_pred CccCCeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+.++||.|.||.||+|+++ ....||||.++.. ..+....+|+.|..+|.++.||||++|.|++....-.+||.
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 456789999999999999864 3458999999643 45566789999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|||++|+|+.+|+... ..+++.+...|+++||.|++||-+. ++|||||-.+|||++.+..+||+|||+++.+.+
T Consensus 710 EyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999998753 5689999999999999999999997 999999999999999999999999999998866
Q ss_pred CCcccccccccc--ccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLT--AYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~--~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
+.... .....| ..+|.||| +....++.++|||||||+|||.++ |..||-.+.+ +++.+
T Consensus 784 d~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------QdVIk 845 (996)
T KOG0196|consen 784 DPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVIK 845 (996)
T ss_pred CCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------HHHHH
Confidence 54221 112222 35799999 556779999999999999999887 9999865443 23334
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
.++.+++-.-|.+++..+.+|+..||++|-.+||++.||+..|.+++++-.
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 455666666788999999999999999999999999999999999997543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.28 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=210.2
Q ss_pred ccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
..+|++.+.||+|+||.|-+|. ...|+.||||.+++..... ++.-.+.+|+++|..++||||+.+|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3468888999999999999995 4789999999998766543 4456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||..+|.|+|++.+ ...+++.++..+++||..|+.|+|.+ +++|||||-+|||||+++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987 46799999999999999999999986 89999999999999999999999999998887
Q ss_pred CCCccccccccccccCcCCcccccCC-C-CCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFESGI-Y-TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.... ...++|++-|.+||+.+|. | ++.+|-|||||+||-|+.|..||++.+. ..+.+.
T Consensus 205 ~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------------k~lvrQ 264 (668)
T KOG0611|consen 205 DKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------------KRLVRQ 264 (668)
T ss_pred cccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------------HHHHHH
Confidence 6643 3456788889999977664 4 6889999999999999999999987432 111111
Q ss_pred cCCCCCCCC-CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 744 VDPSLSGQY-PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 744 ~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+.. +.| ....+....-||+.||..||++|-|+.+|..+.+
T Consensus 265 Is~---GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 265 ISR---GAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hhc---ccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111 111 1233456788999999999999999999988865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.69 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=207.3
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
..|+..++||+|.||.||||. ...++.||+|++..... ....+.+.+|+.++.+++++||.++|+.|.....++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 457778999999999999995 46799999999976543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||.||++.+.+... ..+++..+..|+++++.||.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus 92 y~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999752 3347777888999999999999997 8999999999999999999999999999777654
Q ss_pred CccccccccccccCcCCcccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....||+.|||||++.+ .|+.|+||||||++.|||.+|.+|+....+..-.. .+.+
T Consensus 165 ~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------lIpk 225 (467)
T KOG0201|consen 165 VKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------LIPK 225 (467)
T ss_pred hhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------eccC
Confidence 322 356789999999995545 79999999999999999999999998665522111 1122
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...+.+....+..+.+|+..||++||+.||++.+++++
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22233334566779999999999999999999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=342.70 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=201.0
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (801)
.++|...++||+|.||.|+++.. .+++.+|||++++...-. ...+..+.|-+++... +||.++.++..|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46789999999999999999965 468899999998876433 3345566666666555 59999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+.||++..+++ ...+++..+..++..|+.||+|||++ +|||||||-+|||||.+|.+||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999655544 36789999999999999999999986 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
--. ....+..+||+.|||||++ ...|+..+|+|||||+|||||.|..||.+.+.. +....+
T Consensus 519 m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----------------e~FdsI 580 (694)
T KOG0694|consen 519 MGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----------------EVFDSI 580 (694)
T ss_pred CCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence 422 1235678999999999955 456999999999999999999999999864332 111222
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 778 (801)
+.. ...||..++.+..+|++++|.+||++|.-+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222 234788889999999999999999999866
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.81 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=205.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
++|+..+.||+|+||.||+|.+. +...||||.+.... .......+.+|+..+++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 46888999999999999999764 24589999886433 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999753 23689999999999999999999986 8999999999999999999999999999877
Q ss_pred CCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.............++..|+|||. ....++.++||||||+++|||++ |..||...... .+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~ 219 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----------------DVIK 219 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----------------HHHH
Confidence 52221111122234567999994 44668999999999999999998 99998643211 0111
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.+........+...+..+.+++.+||+.+|++||++.||+++|.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 220 AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11111111223456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.66 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=215.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe-EEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ-RLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 586 (801)
++|...+.+|+|+||.++.++. .+++.|++|.+..........+....|+.++++++|||||.+++.|.+.+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999854 578899999998777666677788899999999999999999999998888 99999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
+||+||+|.+.|.+.+ ...++++.+..|+.|++.|+.|||+. +|+|||||+.|||++.++.|||+|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 46789999999999999999999975 899999999999999999999999999999876
Q ss_pred CCccccccccccccCcCCccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. .......||+.|+.||++. ..|+.|+|||||||++|||++-+++|...+.. .+...+.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----------------~Li~ki~ 219 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----------------ELILKIN 219 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----------------HHHHHHh
Confidence 64 2345678999999999655 46999999999999999999999999864321 1111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...-...|...+.++..++..|+..+|+.||++.+++.+
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222234566777899999999999999999999999987
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.52 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=200.2
Q ss_pred CccCCeeeecCccEEEEEEeCC-Cc--EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------Ce
Q 003704 511 FSQENLIGAGMLGSVYRAQLPD-GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQ 581 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------~~ 581 (801)
|.+.+.||+|+||.||+|+..+ +. .+|||.+............+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457899999999999997654 33 689998876544555567888999999999999999999987432 24
Q ss_pred EEEEEeccCCCCHHHHHhcCc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 582 RLLIYEYCSNGTLQDMLHSDD--ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
.++||||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885322 1134589999999999999999999985 89999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccch
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDI 737 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 737 (801)
+++.+.............++..|++||. ....++.++|||||||++|||++ |+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------------- 221 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------------- 221 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----------------
Confidence 9987654332222223345667999994 45568999999999999999999 88898643211
Q ss_pred hhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
.+.+.+........+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 -EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111111111123345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=342.22 Aligned_cols=254 Identities=19% Similarity=0.277 Sum_probs=201.6
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999764 6899999999754322 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 34688999999999999999999986 899999999999999999999999999976543
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||.......... ..........
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----------~i~~~~~~~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE----------NLKYWKETLQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH----------HHHhcccccc
Confidence 1234568889999995 45568999999999999999999999997543211100 0000000000
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...........+.++.+++.+||..+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000011346789999999999999999999999977
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.37 Aligned_cols=268 Identities=19% Similarity=0.334 Sum_probs=202.8
Q ss_pred ccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|+..+.||+|+||.||++... +|..+|+|.+.... .......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467899999999999999999764 68899999886432 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999975 34578899999999999999999974 2799999999999999999999999999876533
Q ss_pred CCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceee----ccc----------
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR----WAI---------- 731 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~----~~~---------- 731 (801)
.. .....++..|+|||.. ...++.++|||||||++|||++|+.||............. ...
T Consensus 157 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 21 2234577889999954 4568999999999999999999999997543211110000 000
Q ss_pred ----------ccc---cchhhhhhhcCCCCCCCCC-cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 732 ----------PQL---HDIDALSRMVDPSLSGQYP-AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 732 ----------~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+.. .....+...+........+ ...+.++.+|+.+||+.||++|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000 0000000000011111111 124567999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.78 Aligned_cols=253 Identities=20% Similarity=0.289 Sum_probs=202.0
Q ss_pred CCccCCeeeecCccEEEEEEe-CC-CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.|...+.||+|+||.||+|.. .+ +..||+|.+... .......+.+|+++++.++|||||++++++...+..+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 478889999999999999954 34 678888876432 23344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++|+|.++++........+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998865332345688999999999999999999986 8999999999999999999999999999876543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
..........||.+|+|||. ....++.++|||||||++|||++|+.||...... ..+..+...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----------------~~~~~~~~~ 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----------------EIMQQVLYG 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC
Confidence 32222344568899999995 4556999999999999999999999999643211 111111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.. ...+...+.++.+++.+||+.||++||++.+++.+
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11 12344566789999999999999999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.59 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=209.1
Q ss_pred ccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----Ce
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~ 581 (801)
.++|++.+.||+|||.-||.++ ..+++.||+|++.-. ..+..+..++|++..++++||||++++++...+ .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 5789999999999999999995 678999999998643 355677888999999999999999999987543 45
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.||+++|...|+|.+.+.........+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999876555568999999999999999999999973 45999999999999999999999999998
Q ss_pred CCcCCCCccc-------cccccccccCcCCcccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc
Q 003704 662 PLISSGSVSQ-------LSGHLLTAYGYGAPEFESG----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 662 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 730 (801)
+...-..... .......|..|+|||.+.- ..++++|||||||++|+|+.|..||+.....+.-......
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7654321110 0111235667999995443 3789999999999999999999999875542221111101
Q ss_pred cccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.+++ .-......++.+.+++..|++.||.+||++.|++.++.+++
T Consensus 257 n~q~--------------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 257 NAQI--------------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cccc--------------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 00011125678999999999999999999999999998764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=355.16 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=207.1
Q ss_pred cCCccCCeeeecCccEEEEEEeCCC-cEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccce-EEEe------c
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDG-KLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKG-YCAE------H 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~-~~~~------~ 579 (801)
.++++.++|.+|||+.||.|+...+ ..||+|++... .+.....+.+|+++|++|+ |+|||.++| .... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567789999999999999987665 99999998644 5667788999999999997 999999999 3321 2
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
-+++|.||||.||.|-|++..+. ...|++.++++|+.|+++|+++||.. +++|||||||-+||||+.++..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 46789999999999999998643 35599999999999999999999986 6789999999999999999999999999
Q ss_pred CCCCcCCCCccc-------cccccccccCcCCcccc---c-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceee
Q 003704 660 LAPLISSGSVSQ-------LSGHLLTAYGYGAPEFE---S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 660 la~~~~~~~~~~-------~~~~~~~~~~y~aPE~~---~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~ 728 (801)
.|.......... ..-...+|+.|+|||++ + ..+++|+|||||||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 986543221100 01123678899999942 3 35899999999999999999999999853211
Q ss_pred cccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
.+++..+...-....+..+.+||..||+.||++||++.||+..+.++..+.
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 112222211112356678999999999999999999999999999887543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.91 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=203.2
Q ss_pred hccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (801)
..++|+..+.||+|+||.||+|... ++..||||++.... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3467899999999999999998642 35689999986432 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEE
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDEL------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 654 (801)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999999753211 23467889999999999999999986 899999999999999999999
Q ss_pred EeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccc
Q 003704 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 732 (801)
|+|||+++...............++..|+|||. ..+.++.++|||||||++|||++ |..||......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----------- 228 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----------- 228 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 999999876544332222222345678999994 45668999999999999999999 78888643221
Q ss_pred cccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+..+.... ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 229 -----~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 -----QVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -----HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0111111111 11234456678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=342.50 Aligned_cols=247 Identities=20% Similarity=0.287 Sum_probs=201.4
Q ss_pred ccCCccCCeeeecCccEEEEEEeC--CCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP--DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~--~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
.++|.+.+.||+|+||.||+|... ++..||+|++.+... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356888999999999999999653 346899999864332 22334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999975 34688999999999999999999986 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
... .....|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------------~~~~~i 240 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----------------LIYQKI 240 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence 432 223467889999995 4556899999999999999999999999753221 111111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
.... ..+|...+..+.+++.+|++.||++|+ +++|++++
T Consensus 241 ~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 LEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 124555667899999999999999995 89999876
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.76 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=204.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-----CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
++|++.+.||+|+||.||+|.. .++..||+|.+.... .......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577789999999999999964 356789999986433 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 003704 584 LIYEYCSNGTLQDMLHSDD-------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 650 (801)
+||||+++++|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 9999999999999986321 0123578899999999999999999986 89999999999999999
Q ss_pred CcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceee
Q 003704 651 LAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 728 (801)
+.+||+|||+++...............++..|+|||. ..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999987644332222333445667999994 45678999999999999999998 9999864321
Q ss_pred cccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
..+.+.+........+...+.++.+++.+||+.||++||++.+++++|..
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ---------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112222222222345567789999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.33 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=202.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
++|+..+.||+|+||+||+|.+ .+|. .+++|.+... .......++..|+..++++.||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 4677889999999999999975 3454 4777776432 223334567788888999999999999998764 4578
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 899999999999999753 34689999999999999999999986 899999999999999999999999999987
Q ss_pred cCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+.............++..|+||| ...+.++.++|||||||++|||++ |+.||...... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~ 221 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----------------EVP 221 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence 65443222233445667899999 455679999999999999999998 99999754221 111
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
+.+........+..++..+.+++.+||..||++||++.|+++.|..+.++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11122212222334556788999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.02 Aligned_cols=261 Identities=25% Similarity=0.444 Sum_probs=206.6
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
++|.+.+.||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4678889999999999999964 23567899988643 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcE
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE---------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 653 (801)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999975321 123589999999999999999999986 89999999999999999999
Q ss_pred EEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccc
Q 003704 654 SVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAI 731 (801)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~ 731 (801)
||+|||+++...............++..|+|||. ....++.++|||||||++|||++ |+.||.......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------- 230 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 230 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 9999999976644322222233345677999995 44568999999999999999998 999986543211
Q ss_pred ccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+..+.. ......+...+.++.+|+.+||+.||.+|||+.|+++.|+++...
T Consensus 231 -------~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -------VIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------HHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 111122334567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.96 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=206.6
Q ss_pred CCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
+|++.+.||+|+||.||+|... ....+++|.+.... .......+.+|+++++.++||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3677899999999999999642 23578888886433 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcc--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDE--------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSA 643 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 643 (801)
+||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999999864211 123578999999999999999999986 8999999999
Q ss_pred cEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccc
Q 003704 644 NILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNR 721 (801)
Q Consensus 644 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~ 721 (801)
|||+++++.+||+|||+++...............++..|+||| .....++.++||||||+++|||++ |+.||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999997654332211122234456799999 555668999999999999999998 99998643211
Q ss_pred cccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+.+..........+...+.++.+++.+||+.||++||++.|+++.|++++.+
T Consensus 237 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11122222222233455667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.49 Aligned_cols=250 Identities=23% Similarity=0.444 Sum_probs=200.3
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|+..+.||+|+||.||+++..++..+|+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3577788999999999999998888899999886432 2245788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999999753 23588999999999999999999986 89999999999999999999999999987654332
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....++..|+|||. ....++.++||||||+++|||++ |+.||...... +.+..+..
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----------------~~~~~i~~- 216 (256)
T cd05114 155 YTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----------------EVVEMISR- 216 (256)
T ss_pred eec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHHHHC-
Confidence 211 112234557999995 44568999999999999999999 89999654321 11111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+...+.++.+++.+||+.||++||++.|+++.|
T Consensus 217 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111122334456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.43 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=205.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.+|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+|++.+++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3477788999999999999965 46889999998643 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999997532 34689999999999999999999986 8999999999999999999999999999876543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... ......+..|+|||. ....++.++|||||||++|||++ |..||...... ...+.+.
T Consensus 158 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~~~~~ 219 (263)
T cd05052 158 TYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLE 219 (263)
T ss_pred eeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHH
Confidence 2211 112233557999994 45668999999999999999998 99998643211 1111122
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.......+...+.++.+++.+||+.||++||++.|+++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 22233445566788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.58 Aligned_cols=250 Identities=36% Similarity=0.619 Sum_probs=194.7
Q ss_pred cCCeeeecCccEEEEEEeC-----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 513 QENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
..+.||.|.||.||+|.+. .+..|+||.+.. .......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3578999999999999765 367899999954 3334457889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++|+|.++|.... ...+++..+..|+.||++||+|||+. +|+|+||+++|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999998641 35789999999999999999999996 8999999999999999999999999998776333
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
..............|+|||. ....++.++||||||+++|||++ |+.||...... +....+ .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----------------~~~~~~-~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----------------EIIEKL-K 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----------------HHHHHH-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccc-c
Confidence 22222333456677999995 45568999999999999999999 78888643211 111122 2
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.......+..++..+.+++.+||+.||++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2222234556678899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.63 Aligned_cols=257 Identities=26% Similarity=0.464 Sum_probs=205.0
Q ss_pred cCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
++|.+.+.||+|+||.||+|... ++..||||.+.... .......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45778899999999999999753 35789999986543 233457889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 652 (801)
++||||+++++|.+++...+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 134578999999999999999999986 8999999999999999999
Q ss_pred EEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecc
Q 003704 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 730 (801)
+||+|||+++...............++..|+||| ...+.++.++|||||||++|||++ |+.||.......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------- 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------- 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 9999999987654332222223334567899999 455678999999999999999998 999986432211
Q ss_pred cccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+..+ ........+...+..+.+++.+||+.||++||++.||++.|.
T Consensus 233 --------~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 --------VIECI-TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --------HHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 111122234456678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.60 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=204.1
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 5688899999999999999988888899999886432 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999997532 35688999999999999999999986 89999999999999999999999999998765432
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....++..|+||| ...+.++.++|||||||++|||++ |+.||........ ...+.+
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------------~~~~~~---- 219 (261)
T cd05072 158 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-------------MSALQR---- 219 (261)
T ss_pred eec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-------------HHHHHc----
Confidence 211 12233456799999 445668899999999999999998 9999964322110 011111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
..........+.++.+++.+||..+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=330.75 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=205.7
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCc--EEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (801)
++|++.+.||+|+||.||+|... ++. .+++|.+... ........+.+|++++.++ +||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 46888999999999999999764 343 4788887532 2333456788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 652 (801)
||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999975321 123588999999999999999999986 8999999999999999999
Q ss_pred EEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecc
Q 003704 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 730 (801)
+||+|||++....... .......+..|+|||. ....++.++|||||||++|||++ |..||......
T Consensus 158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------- 225 (297)
T cd05089 158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------- 225 (297)
T ss_pred EEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 9999999986432111 1111223456999994 45668999999999999999997 99999653221
Q ss_pred cccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhc
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (801)
.+.+..........+...+.++.+|+.+||+.||.+||++.++++.|.++.+.++.
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 226 --------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred --------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111112222233445667899999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.13 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=203.4
Q ss_pred CccCCeeeecCccEEEEEEeC-C---CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe-----
Q 003704 511 FSQENLIGAGMLGSVYRAQLP-D---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ----- 581 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~----- 581 (801)
|.+.+.||+|+||.||+|... + +..||||++............+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 466789999999999999653 2 3689999987654445556778999999999999999999998866543
Q ss_pred -EEEEEeccCCCCHHHHHhcCc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 582 -RLLIYEYCSNGTLQDMLHSDD--ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 582 -~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
.++||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999986432 1234689999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
|+++.+..............+..|+|||.. ...++.++|||||||++|||++ |..||......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------------- 222 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------------- 222 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------------
Confidence 999876544322222223345679999954 4568999999999999999999 88988643221
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
+....+.. ......+...+.++.+++.+||+.||++||++.|+++.|.++
T Consensus 223 -~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 -EIYDYLRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHHHHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 112234556678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.98 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=207.4
Q ss_pred hhccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCc------hhhHHHHHHHHHHhhcc-CCCCccccceEEE
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASS------QQKDDEFLELVNNIDRI-RHANIVELKGYCA 577 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~ 577 (801)
.+.+.|...++||.|..++|-++ ...+|+.+|+|++...... ....+.-..|+.+++++ .||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888899999999999988 4568999999998643221 11234456789999988 6999999999999
Q ss_pred ecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEee
Q 003704 578 EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (801)
Q Consensus 578 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 657 (801)
.....++|+|.|+.|.|+|++.+ .-.+++....+|+.|+.+|++|||.. +||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999986 46789999999999999999999986 899999999999999999999999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCccccc-------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEFES-------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 730 (801)
||+++.+.++.. ....+||++|+|||.+. ..|+..+|+||+|||+|-|+.|.+||-.....
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------- 234 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------- 234 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---------
Confidence 999999887753 45678999999999533 24888999999999999999999999643211
Q ss_pred cccccchhhhhhhcCCC--CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPS--LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
- .+.-+.... +......+.+.+..+||.+||+.||.+|.|++|+++|-.
T Consensus 235 ----l---MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 235 ----L---MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ----H---HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 0 011111111 122223455677899999999999999999999998743
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.72 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=196.4
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
+.||+|+||.||+++. .+|+.||+|++..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 5799999999875432 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 99998875 34689999999999999999999986 899999999999999999999999999875322211 1
Q ss_pred ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....|+..|+|||. ..+.++.++|||||||++|||++|+.||...... .....+.... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~~~~~~--~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILMEE--IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcCC--CC
Confidence 223467889999995 4567899999999999999999999999653221 1111111111 12
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
+|...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 4556678899999999999999998 89988865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.36 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=198.2
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 593 (801)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999965 578999999876432 33445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccc
Q 003704 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673 (801)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 673 (801)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++............
T Consensus 80 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99999753 24588999999999999999999986 8999999999999999999999999998765433211111
Q ss_pred cccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 674 GHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 674 ~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....+..|+||| ...+.++.++|||||||++|||++ |..||...... .....+.......
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~~~ 216 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVRLP 216 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCCCC
Confidence 1222345699999 455668999999999999999998 88888643221 1111111222223
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+...+..+.+++.+||+.||++||++.|+++.|.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 45556778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.84 Aligned_cols=261 Identities=26% Similarity=0.468 Sum_probs=207.3
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecC
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~ 580 (801)
.++|+..+.||+|+||.||++... +...+|+|.+..... ......+.+|++++.++ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356888899999999999999653 346899999875432 33446688999999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 648 (801)
..++||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999997421 1245689999999999999999999986 899999999999999
Q ss_pred CCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccce
Q 003704 649 DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFL 726 (801)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~ 726 (801)
.++.+||+|||+++.+.............++..|+||| .....++.++|||||||++|||++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 99999999999998765433222222223456799999 455678999999999999999997 99988643211
Q ss_pred eecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 727 VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.+.+.+........+...+..+.+|+.+||..||++|||+.|+++.|.+++
T Consensus 242 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111112222334556678999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.61 Aligned_cols=267 Identities=19% Similarity=0.320 Sum_probs=193.9
Q ss_pred cCCccCCeeeecCccEEEEEEe--CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc---CCCCccccceEEE-----e
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI---RHANIVELKGYCA-----E 578 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~-----~ 578 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999975 3478899999875443333334555666666554 6999999999885 2
Q ss_pred cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 58999987532 34589999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccc-cccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAI-PQLH 735 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~-~~~~ 735 (801)
|+++...... ......++..|+||| .....++.++|||||||++|||++|++||......+... +..... +...
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9997654331 223456788899999 445678999999999999999999999997643321100 000000 0000
Q ss_pred chhhhhhhcCCCCC-------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 DIDALSRMVDPSLS-------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
++..........+. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000000000000 00112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.64 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=206.9
Q ss_pred cCCccCCeeeecCccEEEEEEeCC-CcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.|+..+.||.|.-|+||++++.+ +..+|+|++.+.... .....+...|-++|+.+.||.+..||+.++..+..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999998754 689999999876543 344566778889999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|||+||+|..+.+.+. ...+++..+..++..|+-||+|||-. |||+|||||+|||+.++|++-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999998754 57799999999999999999999997 999999999999999999999999999754311
Q ss_pred C--------------------------------C-c---------------------cccccccccccCcCCcccccC-C
Q 003704 667 G--------------------------------S-V---------------------SQLSGHLLTAYGYGAPEFESG-I 691 (801)
Q Consensus 667 ~--------------------------------~-~---------------------~~~~~~~~~~~~y~aPE~~~~-~ 691 (801)
. . . ...+....||-.|+|||++.| .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 011123467888999997666 4
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccC
Q 003704 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSE 771 (801)
Q Consensus 692 ~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 771 (801)
.+.++|+|+|||++|||+.|+.||.+..... .+..++...+.-......+..+.|||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 8999999999999999999999998765432 233344433332222255678999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 003704 772 PEFRPP----MSEVVQD 784 (801)
Q Consensus 772 P~~RPt----~~evl~~ 784 (801)
|.+|.. +.||-+|
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999988 7777655
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.28 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=204.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.++|++.+.||+|+||.||+|...+++.||||.+.... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688889999999999999988788899999986432 234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997532 34689999999999999999999986 8999999999999999999999999999876533
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... ......+..|+|||. ....++.++||||||+++|||++ |+.||...... .+...+.
T Consensus 157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~~~ 218 (261)
T cd05068 157 IYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----------------EVLQQVD 218 (261)
T ss_pred cccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHH
Confidence 2111 111122357999994 45568999999999999999999 99999653211 0111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+..+.+++.+|++.||++||++.++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111122344566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.69 Aligned_cols=270 Identities=23% Similarity=0.336 Sum_probs=205.0
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCC-ccccceEEEecC------
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-IVELKGYCAEHG------ 580 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~Hpn-Iv~l~~~~~~~~------ 580 (801)
..|...++||+|+||+||+|+ ..+|+.||+|++......+.......+|+.+++.++|+| ||.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345667889999999999995 568999999999765544445566789999999999999 999999998766
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
..++||||++. +|.+++.........++...+..++.||+.||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 99999986542224677788999999999999999997 999999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--ecccccccc
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWAIPQLHD 736 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~ 736 (801)
|+.+.-... ......+|..|.|||.+-| .|+...||||+|||++||++++..|.+..+.+....+ ...+|....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 997653322 2344567888999995443 5999999999999999999999999876553222111 111222222
Q ss_pred hhhhhhhcCCCC--CCCC-Cc-------ccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 737 IDALSRMVDPSL--SGQY-PA-------KSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~~--~~~~-~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+..+....+-.. .... +. .......+++.+|++.+|.+|.+++.+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222222211111 0000 11 112467899999999999999999999987
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.20 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=208.2
Q ss_pred cCCccCCeeeecCccEEEEEEeC--------CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (801)
++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .......+.+|+++++++ +|+||+++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 56888999999999999999642 23579999987543 233446688899999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975321 123588999999999999999999986 99999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 725 (801)
+.++.+||+|||+++...............++..|+|||. ....++.++|||||||++|||++ |+.||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999876543221111111223457999994 45668999999999999999998 8888854221
Q ss_pred eeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhc
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (801)
..+.+.+........+...+.++.+++.+||+.+|++||++.|+++.|.++++...+
T Consensus 249 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 249 ------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred ------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 111111222222234455677899999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.76 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=206.6
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
.+|...+.||+|+||.||+|.. .++..+++|.+... .......+.+|++.+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 3577789999999999999964 24567899988532 233446788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 650 (801)
++||||+++++|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999975321 123589999999999999999999986 89999999999999999
Q ss_pred CcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceee
Q 003704 651 LAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 728 (801)
+.+||+|||++................++..|+||| .....++.++|||||||++|||+| |+.||.......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------ 233 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 233 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999997665433222233445567899999 455668999999999999999999 999986533211
Q ss_pred cccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
.+.. +........+...+..+.+++.+||+.||++||++.+|++.|.++..
T Consensus 234 ----------~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 ----------VIEC-ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----------HHHH-HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111 11111112234456789999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.01 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=197.0
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
+.||+|+||.||+++. .+|+.||||++.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 5799999999975432 2233467788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99998875 34689999999999999999999986 89999999999999999999999999987543221 11
Q ss_pred ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....|+..|+|||. ....++.++|||||||++|||++|+.||....... ....+... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----------------~~~~~~~~--~~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILME--DIK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----------------HHHHhccC--Ccc
Confidence 233468889999995 45568999999999999999999999996432210 01111111 113
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
+|...+.++.+++.+||+.||++|+ ++.|++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4556677899999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.58 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=194.3
Q ss_pred eeecCccEEEEEEe-CCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||.||+|+. .+++.||+|++.+.. ........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999965 468899999986532 2233446678899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 999975 34689999999999999999999986 899999999999999999999999999876433211 123
Q ss_pred ccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+... ...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----------------~~~~~~~~~--~~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----------------EMYRKILQE--PLRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcC--CCCCC
Confidence 4568889999994 4556899999999999999999999999743211 111111111 11345
Q ss_pred cccHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRPP---MSEVVQD 784 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 784 (801)
...+.++.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 566778999999999999999975 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.17 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=206.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ........+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688899999999999999965 578999999876432 23344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.........+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864332235578899999999999999999986 999999999999999999999999999877654
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......++..|+|||. ....++.++||||||+++|||++|+.||....... ......+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~~~~~~~~~ 222 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------FSLCQKIEQ 222 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--------------HHHHHHHhc
Confidence 321 1223456778999994 45568899999999999999999999986432110 000111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
.......+...+..+.+++.+||+.+|++||++.|+++.++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111112234557799999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=332.01 Aligned_cols=255 Identities=21% Similarity=0.365 Sum_probs=216.1
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (801)
...|++.+.||+||.+.||++...+.+.||+|++.......+....|..|+..|.+++ |.+||.+++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568899999999999999999888999999998777777888899999999999995 999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||= ..+|..+|..... ....| .+..+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|..+.+
T Consensus 440 E~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 985 5699999986432 22334 6778999999999999997 9999999999999974 6899999999999998
Q ss_pred CCccccccccccccCcCCcccccC------------CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccc
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG------------IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 734 (801)
+.........+||+.||+||.+.. ..+.++||||+|||||+|+.|+.||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------------- 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------------- 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------------
Confidence 887777788899999999994321 15678999999999999999999997532
Q ss_pred cchhhhhhhcCCCCCCCCCcccH-HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 735 HDIDALSRMVDPSLSGQYPAKSL-SHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..+..+..+.++.....||.... .++.+++..||..||++||++.|+|++-
T Consensus 577 n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 577 NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 12345666777766666665433 3499999999999999999999999763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=343.22 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=203.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||+||+|+. .+|+.||||++.+..... .....+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688899999999999999975 479999999997543222 34567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999753 5688999999999999999999986 999999999999999999999999999987654
Q ss_pred CCc---------------------------cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 003704 667 GSV---------------------------SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718 (801)
Q Consensus 667 ~~~---------------------------~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~ 718 (801)
... ........|+..|+|||. ....++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 320 011223467889999994 4556899999999999999999999999754
Q ss_pred ccccccceeecccccccchhhhhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 003704 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEFRPP-MSEVVQDL 785 (801)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 785 (801)
.... ....+.........|. ..+.++.+++.+|+. ||++||+ +.|++++.
T Consensus 234 ~~~~----------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQE----------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHH----------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 3211 1111111000011122 246789999999997 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.64 Aligned_cols=266 Identities=20% Similarity=0.322 Sum_probs=198.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|...+.||+|+||.||+|+. .+++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4688899999999999999965 4789999999864332 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9985 899988643 24578899999999999999999986 9999999999999999999999999998754332
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeec--------ccccccch
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW--------AIPQLHDI 737 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~--------~~~~~~~~ 737 (801)
.. ......++..|+|||... ..++.++||||+||++|||++|+.||.............. ..+.....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 11 122345678899999543 3589999999999999999999999975433221110000 00000011
Q ss_pred hhhhhhcCCCCCCC----CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 738 DALSRMVDPSLSGQ----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
........+..... .....+.++.+|+.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111111000 012345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.30 Aligned_cols=254 Identities=29% Similarity=0.498 Sum_probs=207.5
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
..+|+..+.||.|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45688899999999999999988889999999986533 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999997642 35689999999999999999999986 8999999999999999999999999999776443
Q ss_pred CccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... .....++..|+||| ...+.++.++||||||+++|+|++ |+.||...... +.+.. +.
T Consensus 158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----------------~~~~~-~~ 218 (261)
T cd05148 158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----------------EVYDQ-IT 218 (261)
T ss_pred ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHH-HH
Confidence 221 11233456799999 455678999999999999999998 89999653311 11111 11
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 222223345667889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=321.30 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=198.5
Q ss_pred eeeecCccEEEEEEe---CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 516 LIGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.||+|+||.||+|.+ .++..+|+|++..........+.+.+|+.+++.+.|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999954 467899999987554444556788999999999999999999998864 5678999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc-
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ- 671 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 671 (801)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.......
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999975 34688999999999999999999986 89999999999999999999999999998765432211
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (801)
......++..|+|||. ....++.++|||||||++|||++ |+.||...... .+.+.+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHCCCC
Confidence 1112233467999994 44568889999999999999998 99999753221 11122222223
Q ss_pred CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 750 GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 750 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
...+...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 33456677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.70 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=208.6
Q ss_pred ccCCccCCeeeecCccEEEEEEeCC-----CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe-cCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD-----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~ 581 (801)
.++|...+.||+|+||.||+|...+ +..|++|++... ........+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3578889999999999999997654 788999988643 334456778899999999999999999998766 577
Q ss_pred EEEEEeccCCCCHHHHHhcCccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEee
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDEL----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 657 (801)
.++++||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999754221 14689999999999999999999986 899999999999999999999999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccccc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 735 (801)
||+++.+.............++..|+|||. ....++.++|||||||++||+++ |+.||.......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------------- 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------------- 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------------
Confidence 999987654432222223345667999994 45568999999999999999999 999997532210
Q ss_pred chhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
+...+........+..++.++.+++.+||..||++|||+.|+++.|.++.++
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 228 ----MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ----HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111111111122344567899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.19 Aligned_cols=243 Identities=25% Similarity=0.341 Sum_probs=195.5
Q ss_pred CeeeecCccEEEEEEe----CCCcEEEEEEeccccC--chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 515 NLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+.||+|+||.||+++. .+++.||||++.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 3688999999875322 122345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ...+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999975 34578888899999999999999986 89999999999999999999999999987543221
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......|+..|+|||. ....++.++|||||||++|||++|+.||...... ..+..+....
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~~~~~ 216 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKILKGK 216 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 1 1233468889999995 4456889999999999999999999999753211 1112222211
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
...+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 123455667899999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.75 Aligned_cols=267 Identities=23% Similarity=0.362 Sum_probs=197.0
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----CeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 583 (801)
+|++.+.||+|+||.||+|.. .+|..||||++............+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999964 5789999999875433334456788999999999999999999988543 3579
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998875 34689999999999999999999986 899999999999999999999999999976
Q ss_pred cCCCCc-cccccccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-ecc-cccccc-
Q 003704 664 ISSGSV-SQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-RWA-IPQLHD- 736 (801)
Q Consensus 664 ~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-~~~~~~- 736 (801)
...... ........++..|+|||... ..++.++|||||||++|||++|+.||...........+ ... .+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 11123356788899999543 46899999999999999999999999754321110000 000 000000
Q ss_pred --------hhhhhhhcCC---CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 --------IDALSRMVDP---SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 --------~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
...+..+... .....+ ...+.++.+++.+||+.||++||++.|++++-
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 0000000000 000011 12356788999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.89 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=196.8
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.|...+.||+|+||+||+|+. .+++.||||++.+... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999954 6789999999975432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999975 34588889999999999999999986 9999999999999999999999999997643210
Q ss_pred Ccc---------------------------------------------ccccccccccCcCCccc-ccCCCCCcchHHHH
Q 003704 668 SVS---------------------------------------------QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSF 701 (801)
Q Consensus 668 ~~~---------------------------------------------~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSl 701 (801)
... .......||..|+|||. ....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 00112468899999994 45568999999999
Q ss_pred HHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC--CCCCCCCCcccHHHHHHHHHHh--cccCCCCCCC
Q 003704 702 GVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD--PSLSGQYPAKSLSHFADIISRC--VQSEPEFRPP 777 (801)
Q Consensus 702 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~c--l~~dP~~RPt 777 (801)
||++|||++|+.||........ ...+.. ...........+.++.+++.+| +..++..|++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET----------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH----------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999975432111 011111 0111111123467889999884 4556666999
Q ss_pred HHHHHHHH
Q 003704 778 MSEVVQDL 785 (801)
Q Consensus 778 ~~evl~~L 785 (801)
+.|++++-
T Consensus 299 ~~~~l~hp 306 (381)
T cd05626 299 ADDIKAHP 306 (381)
T ss_pred HHHHhcCc
Confidence 99999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.66 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=205.8
Q ss_pred cCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~ 581 (801)
++|.+.+.||+|+||.||+|++. .+..||||++..... ......+.+|++++.++. |||||++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45777899999999999999753 356899999975432 233456889999999997 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 603 (801)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred ------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 604 ------------------------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 604 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
....+++...+.++.|++.||+|||+. +|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 012467888899999999999999985 89999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 725 (801)
++++.+||+|||+++.+.............++..|+||| .....++.++|||||||++|||++ |+.||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 999999999999997654322111122334567899999 455668999999999999999998 88998643211
Q ss_pred eeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
+...+.+........+...+.++.+|+.+||+.+|++||+++||++.|+.++
T Consensus 349 ------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111222222223345556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.09 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=203.6
Q ss_pred CCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
+|++.+.||+|+||.||+|... ++..||||++.... .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667789999999999999753 35789999987433 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123578889999999999999999986 899999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeec
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW 729 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 729 (801)
.+||+|||+++...............++..|+||| ...+.++.++|||||||++|||++ |..||......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 99999999988664433222223344567899999 556778999999999999999998 88888643211
Q ss_pred ccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 730 AIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
+.+..+.+. ....++..++..+.+++.+||+.||++||++.||++.|+.
T Consensus 234 --------~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 --------DVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111121 1223456677889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=335.36 Aligned_cols=263 Identities=27% Similarity=0.461 Sum_probs=203.6
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec-C
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH-G 580 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~-~ 580 (801)
++|++.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5788999999999999999963 357899999996433 233346788899999999 689999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHhcCcc---------------------------------------------------------
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDE--------------------------------------------------------- 603 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 603 (801)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999875311
Q ss_pred ------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccc
Q 003704 604 ------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677 (801)
Q Consensus 604 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 677 (801)
....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012468888999999999999999986 99999999999999999999999999987654332211222334
Q ss_pred cccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcc
Q 003704 678 TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAK 755 (801)
Q Consensus 678 ~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (801)
++..|+||| .....++.++|||||||++|||++ |..||....... .+...+........+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEGTRMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----------------HHHHHHhccCCCCCCCC
Confidence 556799999 556678999999999999999997 999986432110 01111111111222334
Q ss_pred cHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 756 SLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 756 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+.++.+++.+||+.||++||++.||+++|+.+++.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.38 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=203.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
++|+..+.||+|+||+||+|++ .+|. .||+|.+.... .......+.+|+.+++.+.|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 5678889999999999999964 4555 48999886432 334456788899999999999999999998754 567
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
++|||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999753 34689999999999999999999986 899999999999999999999999999987
Q ss_pred cCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+.............++..|+||| .....++.++|||||||++|||++ |..||...... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~ 221 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----------------EIP 221 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence 65432221122223456799999 455678999999999999999998 89998643211 111
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
..+........+...+.++.+++.+||+.||++||++.|+++.|+++.++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111111223445678999999999999999999999999998887655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=334.57 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=194.1
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHH---hhccCCCCccccceEEEecCeEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNN---IDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~---l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
|++.+.||+|+||.||+|.. .+|+.||||++.+.... ....+.+.+|.++ +++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999999965 57899999999754321 2223445555544 4667899999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|..+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988863 4689999999999999999999986 89999999999999999999999999986533
Q ss_pred CCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
... .......|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+.
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----------------~~~~~i~ 214 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----------------EVFDSIV 214 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Confidence 221 11234568889999994 4556899999999999999999999999753221 1111111
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
... ..+|...+..+.+++.+||+.||++|| ++.+++++
T Consensus 215 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 215 NDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111 124556677899999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.63 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=199.2
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+|+. .+|+.||||++..... .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999965 4789999999975422 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999975 34689999999999999999999986 899999999999999999999999999876532
Q ss_pred CCccc------------------------------------cccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHH
Q 003704 667 GSVSQ------------------------------------LSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELL 709 (801)
Q Consensus 667 ~~~~~------------------------------------~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ell 709 (801)
..... ......||+.|+||| +....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21000 001235888999999 45567899999999999999999
Q ss_pred hCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC--cccHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 003704 710 TGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP--AKSLSHFADIISRCVQSEPEFRPP---MSEVVQD 784 (801)
Q Consensus 710 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 784 (801)
+|+.||....... ....+........++ ...+.++.+++.+|+. +|.+|++ +.|++++
T Consensus 234 ~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQE----------------TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHH----------------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999997543211 111111111011111 1345788999999996 9999998 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.98 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=205.2
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (801)
++|...+.||+|+||.||++.. .++..||||.+..... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 4688899999999999999963 2356899998865432 33446788999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+.+|+|.++++... ...+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+|++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999997532 23489999999999999999999986 8999999999999999999999999999
Q ss_pred CCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhh
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
+.+.............++..|+||| ...+.++.++|||||||++|||++ |+.||...... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----------------~~ 252 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----------------SK 252 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----------------HH
Confidence 8664432211222334566799999 455668999999999999999998 99998653221 11
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
..+..........+...+.++.+++.+||+.+|++||++.|+++.|.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111222222223344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.63 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred eeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||+||++.. .+|+.||||++....... .....+..|++++++++|+||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999965 578999999986543222 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988864333345689999999999999999999986 899999999999999999999999999876544321 122
Q ss_pred ccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...++..|+||| +....++.++|||||||++|||++|+.||........ .......+... ...++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~------------~~~~~~~~~~~--~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------------NKELKQRILND--SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh------------HHHHHHhhccc--CCCCc
Confidence 346788999999 4556789999999999999999999999975322100 00111111111 11345
Q ss_pred cccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
...+.++.+++.+||+.||++|| +++|++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 56678899999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.06 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=199.4
Q ss_pred CCccCCeeeecCccEEEEEEe----CCCcEEEEEEeccccC--chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (801)
+|++.+.||+|+||.||+++. .+|+.||+|++.+... .....+.+.+|++++..+ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999864 3688999999865322 122345677899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999975 34688999999999999999999986 89999999999999999999999999997
Q ss_pred CcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
.+...... ......|+..|+|||.+.+ .++.++|||||||++|||++|+.||.......... ...
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------------~~~ 220 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS------------EVS 220 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH------------HHH
Confidence 65433211 1223468889999996543 37889999999999999999999996432211100 001
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
..+.. ....++...+..+.+++.+||+.||++|| +++|++++
T Consensus 221 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111 11234455667899999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.02 Aligned_cols=264 Identities=25% Similarity=0.446 Sum_probs=207.5
Q ss_pred ccCCccCCeeeecCccEEEEEEe--------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL--------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~ 578 (801)
.++|.+.+.||+|+||.||+|+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 35678889999999999999963 134579999886432 234456788999999999 89999999999999
Q ss_pred cCeEEEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 646 (801)
.+..++||||+++|+|.+++..... ....+++..++.++.||++||+|||+. +|+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999975321 124578899999999999999999986 8999999999999
Q ss_pred ECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccc
Q 003704 647 LDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724 (801)
Q Consensus 647 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 724 (801)
++.++.+||+|||+++.+.............++..|+|||. ....++.++|||||||++|||++ |..||......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 99999999999999987654332222222334567999994 45568999999999999999998 78888543211
Q ss_pred ceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
.+.+.+........+...+.++.+++.+||+.+|++||++.|+++.|.+++.-.
T Consensus 247 --------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 --------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111111111122234556778999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.38 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=196.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||.||+++. .+|+.||||++.+... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999964 5799999999865332 2233466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999975 34678889999999999999999986 899999999999999999999999999864321
Q ss_pred CCcc---------------------------------------------ccccccccccCcCCccc-ccCCCCCcchHHH
Q 003704 667 GSVS---------------------------------------------QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYS 700 (801)
Q Consensus 667 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwS 700 (801)
.... .......||..|+|||. ....++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 00012358889999994 4556999999999
Q ss_pred HHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCCC---
Q 003704 701 FGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEFR--- 775 (801)
Q Consensus 701 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~R--- 775 (801)
|||++|||++|+.||....... ....+........+|. ..+.++.+++.+|+. +|.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE----------------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH----------------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999997543211 0111111000111222 345688999999997 77765
Q ss_pred CCHHHHHHHH
Q 003704 776 PPMSEVVQDL 785 (801)
Q Consensus 776 Pt~~evl~~L 785 (801)
+++.|++++-
T Consensus 297 ~~~~~~l~hp 306 (377)
T cd05629 297 GGAHEIKSHP 306 (377)
T ss_pred CCHHHHhcCC
Confidence 5999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.43 Aligned_cols=267 Identities=21% Similarity=0.339 Sum_probs=196.5
Q ss_pred ccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367899999999999999999764 789999999864432 223345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 83 EYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred ECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9996 5888877643 34588899999999999999999986 899999999999999999999999999875432
Q ss_pred CCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee--cccccccchh---
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR--WAIPQLHDID--- 738 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~--~~~~~~~~~~--- 738 (801)
.. .......++..|+|||... ..++.++|||||||++|||++|+.||.......... ... ...+....+.
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 156 PS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred CC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 21 1122345678899999543 358899999999999999999999997543211100 000 0000000000
Q ss_pred hhhhhcCCCCCCCCC---------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVDPSLSGQYP---------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..............+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000000 0123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.01 Aligned_cols=269 Identities=29% Similarity=0.459 Sum_probs=205.6
Q ss_pred ccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhh--ccCCCCccccceEEEecC----eEEEE
Q 003704 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID--RIRHANIVELKGYCAEHG----QRLLI 585 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~HpnIv~l~~~~~~~~----~~~lV 585 (801)
...++||+|.||.||||++ +++.||||++. .+....|..|-++.+ .++|+||++++++-.... +++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3467899999999999999 45999999985 345567777777665 458999999999865544 88999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI------CQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
+||.+.|+|.++|.. ..++|....+|+.-+++||+|||+. ++++|+|||||++|||+..|++..|+|||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999984 5799999999999999999999975 46689999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCcccccCCCCC-------cchHHHHHHHHHHHHhCCCCccccccccccc-ee-e-c
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTC-------QSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LV-R-W 729 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-------k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~-~-~ 729 (801)
+|..+.++......-...||.+|||||++.+.... +.||||+|.+||||+++..-++.....+-+. +. . .
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99998876543333346899999999987775433 4899999999999999765543211111010 00 0 0
Q ss_pred ccccccchhhhhhhcCCCCCCCCCc-----ccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 730 AIPQLHDIDALSRMVDPSLSGQYPA-----KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
..|.+++.+.+ ++.+..++.+|+ ..+..+.+.+..||..|++.|.|+.=+-+++.++..-.+
T Consensus 442 ~hPt~e~mq~~--VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQEL--VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHH--HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11222222221 233344444443 345678899999999999999999999999998876544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.71 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=202.4
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
..++|++.+.||+|+||.||+++. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346788999999999999999965 5689999999864322 22334557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999864 3578888999999999999999986 8999999999999999999999999999766
Q ss_pred CCCCccccccccccccCcCCcccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFESG-----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
..... .......|+..|+|||.+.+ .++.++|||||||++|||++|+.||...... ..
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~ 255 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------------GT 255 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----------------HH
Confidence 43321 11234568889999995432 3789999999999999999999999753221 11
Q ss_pred hhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEF--RPPMSEVVQDL 785 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 785 (801)
...+........++. ..+.++.+++.+||+.+|++ |+++.|++++-
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 122222111112232 35678999999999999998 99999998774
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.97 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=204.3
Q ss_pred ccCCeeeecCccEEEEEE-----eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEEE
Q 003704 512 SQENLIGAGMLGSVYRAQ-----LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLL 584 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 584 (801)
...+.||+|+||+||++. ..++..||+|.+.... .......+.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 778999999999998764 2468899999986542 233456788999999999999999999988653 46789
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999974 3589999999999999999999986 8999999999999999999999999999876
Q ss_pred CCCCccc-cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQ-LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~-~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
....... ......++..|+|||. ....++.++|||||||++|||+||+.||........ ....+..... ....+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhhh
Confidence 5432211 1122234556999994 456789999999999999999999999865432111 0111111111 1112222
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
..+.......+...+.++.+++.+||+.||++|||++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22333333345566788999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=338.54 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=196.0
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||+||+|+. .+++.||||++.+... .......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999964 5689999999965332 2223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999975 35689999999999999999999986 999999999999999999999999999876532
Q ss_pred CCcc---------------------------------ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCC
Q 003704 667 GSVS---------------------------------QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGR 712 (801)
Q Consensus 667 ~~~~---------------------------------~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~ 712 (801)
.... .......||..|+|||. ....++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 00113468899999994 4566899999999999999999999
Q ss_pred CCccccccccccceeecccccccchhhhhhhcCCCCCCCCCc--ccHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 003704 713 KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQ--SEPEFRPPMSEVVQD 784 (801)
Q Consensus 713 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 784 (801)
.||....... ....+........+|. ..+.++.+++.+++. .++..||++.|++++
T Consensus 234 ~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQE----------------TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHH----------------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997543211 1111111000011121 245678888888654 233456899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.97 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=201.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||.||+++. .+|+.||||++..... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999965 5789999999975432 2334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999753 24689999999999999999999986 899999999999999999999999999977654
Q ss_pred CCccccccccccccCcCCccccc-------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES-------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
.... ......++..|+|||.+. ..++.++|||||||++|||++|+.||....... .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------------~ 217 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------------T 217 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----------------H
Confidence 3221 122346788999999543 457899999999999999999999997532211 1
Q ss_pred hhhhcCCCCCCCCC--cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVDPSLSGQYP--AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+..+........++ ...+.++.+|+.+|+. ||++||++.+++++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111111111122 2346789999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=321.01 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=200.3
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|...+.||+|+||.||+|+..++..+|||.+..... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35777899999999999999887777899998864322 245688999999999999999999999988899999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+.+++|.+++... ...+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999753 23689999999999999999999986 89999999999999999999999999987654432
Q ss_pred ccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|++||.. .+.++.++|||||||++|||++ |+.||....... ....+..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~~- 216 (256)
T cd05113 155 YT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----------------TVEKVSQ- 216 (256)
T ss_pred ee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHhc-
Confidence 11 11122345679999954 4568999999999999999999 999986433210 0111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+...+..+.+++.+||+.||++||++.++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=328.68 Aligned_cols=262 Identities=24% Similarity=0.432 Sum_probs=204.2
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCc--EEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (801)
++|++.+.||+|+||.||+|.. .+|. .+|+|.+... ........+.+|++++.++ +|+||+++++++.+.+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 5678889999999999999975 3454 4577776532 2334456788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 652 (801)
||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975421 123578999999999999999999986 9999999999999999999
Q ss_pred EEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecc
Q 003704 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 730 (801)
+||+|||++....... .......+..|+|||. ....++.++|||||||++|||+| |..||.......
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 231 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 231 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence 9999999986432111 1111223567999994 44568899999999999999998 999996432210
Q ss_pred cccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhc
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (801)
..+.+........+...+.++.+|+.+||+.+|++||++.++++.|.++++.+..
T Consensus 232 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 232 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred ---------HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 1111111112223344567899999999999999999999999999998876653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.34 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=200.2
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
+|++.+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4778899999999999999887788999999864322 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999997532 3689999999999999999999986 899999999999999999999999999876543221
Q ss_pred cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 670 SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.. .....++..|+|||. ....++.++|||||||++|||++ |+.||....... ....+...
T Consensus 156 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~ 217 (256)
T cd05059 156 TS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----------------VVESVSAG 217 (256)
T ss_pred cc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 11 111123457999994 45678999999999999999999 899986432210 01111112
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.....+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 22233445677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.68 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=205.1
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|++|.||+|.. .+|+.|++|.+............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999965 5789999999876555556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.++++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998632 35688999999999999999999986 99999999999999999999999999988665432
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+||| .....++.++|||||||++|||++|+.||...... .....+.. .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~-~ 216 (256)
T cd08529 156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----------------ALILKIIR-G 216 (256)
T ss_pred c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc-C
Confidence 1 122345677899999 45566889999999999999999999999754311 01111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+.++.+++.+||+.+|++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122333556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.96 Aligned_cols=261 Identities=18% Similarity=0.217 Sum_probs=192.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
..|.+.+.||+|+||.||+|.. ..++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4688999999999999999965 4588999996421 235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+. ++|.+++... ...+++..++.|+.||++||+|||+. +||||||||+|||++.++.+||+|||+++.+...
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6888888643 24689999999999999999999986 8999999999999999999999999999876433
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccc-----cc---eeeccccc---c-
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGE-----QF---LVRWAIPQ---L- 734 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~-----~~---~~~~~~~~---~- 734 (801)
..........||..|+|||+ ....++.++|||||||++|||++|..++........ .. .+.+.... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 22222223568899999994 455699999999999999999998876543221100 00 00000000 0
Q ss_pred --cchhhhhhhc---CCCCCCCCC-------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 735 --HDIDALSRMV---DPSLSGQYP-------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 735 --~~~~~~~~~~---~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......... .......+. ......+.+|+.+||+.||.+|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 000000000 0223468899999999999999999999986
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.04 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=196.0
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
+.||+|+||.||++.. .+|+.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999964 5799999999975432 2233456778899999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.+++.. ...+++..+..++.||+.||+|||+. ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 99998875 34689999999999999999999973 3899999999999999999999999999875332211 1
Q ss_pred ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....|+..|+|||. ..+.++.++|||||||++|||++|+.||...... .....+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----------------~~~~~i~~~--~~~ 214 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILME--EIR 214 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----------------HHHHHHhcC--CCC
Confidence 223468889999994 4567899999999999999999999999643211 001111111 112
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
+|...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 4555677899999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.41 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=203.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc---hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
++|...+.||+|++|.||+|.. .+++.||+|.+...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999964 57899999998644322 1223568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999875 34578899999999999999999986 8999999999999999999999999998765
Q ss_pred CCCCcccc-ccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQL-SGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
........ .....++..|+|||.. ...++.++||||||+++|||++|+.||...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------------AAIFK 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----------------HHHHH
Confidence 43211111 1233466789999954 455889999999999999999999999643211 11112
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..........+...+..+.+++.+||..+|++|||+.|++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 2222223345566778899999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.72 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=193.2
Q ss_pred CeeeecCccEEEEEEe----CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 515 NLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+.||+|+||.||+++. .+|+.||+|++............+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 468999999997544333344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999975 34689999999999999999999986 899999999999999999999999999876543311
Q ss_pred ccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCC
Q 003704 671 QLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (801)
......|+..|+|||.. ...++.++|||||||++|||++|+.||...... ..+..+....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----------------~~~~~i~~~~-- 214 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----------------ETMTMILKAK-- 214 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----------------HHHHHHHcCC--
Confidence 12234678899999954 456889999999999999999999999753211 1111111111
Q ss_pred CCCCcccHHHHHHHHHHhcccCCCCCCCHHH
Q 003704 750 GQYPAKSLSHFADIISRCVQSEPEFRPPMSE 780 (801)
Q Consensus 750 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 780 (801)
...|...+..+.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1245556678999999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.93 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=207.7
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999765 899999998864332 2333577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.........+++..+..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875433345689999999999999999999986 999999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... .....++..|+||| .....++.++|||||||++|+|++|+.||...... ...+.+...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~ 221 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LYSLCKKIE 221 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------------HHHHHhhhh
Confidence 3211 12235677899999 44556899999999999999999999998643210 000111111
Q ss_pred CCCCCCCCc-ccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 746 PSLSGQYPA-KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 746 ~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.......+. ..+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111222 45568999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.89 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=201.1
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
..++|+..+.||+|+||.||+++. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 457899999999999999999975 4688999999865322 22334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999964 3578889999999999999999986 8999999999999999999999999999876
Q ss_pred CCCCccccccccccccCcCCcccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFESG-----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
..... .......||..|+|||.+.+ .++.++|||||||++|||++|+.||...... ..
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----------------~~ 255 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----------------GT 255 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 43321 11234568899999995432 3788999999999999999999999753221 11
Q ss_pred hhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEF--RPPMSEVVQDL 785 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 785 (801)
...+.+......+|. ..+..+.+++.+|+..++.+ |+++.|++++-
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 122222211112232 34677899999999865544 89999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=324.09 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=204.8
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357888999999999999999653 34689999986433 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEE
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDEL------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 655 (801)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999753221 23478899999999999999999986 8999999999999999999999
Q ss_pred eeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccc
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
+|||+++.+.............++..|+||| ...+.++.++|||||||++|||++ |+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------------ 228 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------------ 228 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH------------
Confidence 9999987664433222223344567899999 455678999999999999999998 99998643221
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+.+.+........+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 -----EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111122345556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.72 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=203.5
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 456888999999999999999764 46788999875432 23345678899999999999999999999999889
Q ss_pred EEEEEeccCCCCHHHHHhcCcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---cEEE
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE---LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSV 655 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl 655 (801)
.++||||+++++|.++++.... ....+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999975421 123589999999999999999999986 899999999999998754 5999
Q ss_pred eeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccc
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
+|||+++.+..............+..|+||| .....++.++|||||||++|||++ |+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------------ 228 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------------ 228 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence 9999998764332211122223346799999 455679999999999999999997 99999753321
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+.+.+........+...+..+.+++.+||+.||++||++.+|+++|.
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111122222222345566778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.88 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=207.3
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+++. .+|+.+|||.+..... .......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999974 6899999998864332 2334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.........+++..++.++.||+.||+|||+. +|+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875333345689999999999999999999986 899999999999999999999999999876644
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......++..|+|||. ....++.++||||||+++|||++|..||........ .....+..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~ 222 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------SLCKKIEQ 222 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--------------HHhhhhhc
Confidence 321 1123456778999994 455688999999999999999999999864321100 00011111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.......+...+.++.+++.+||+.||++|||+.+|++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111112345678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.47 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=202.4
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|+..++..||+|++..... ....+.+|++++++++|+||+++++++.+ +..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 56888999999999999999877777899999875332 33578899999999999999999998754 567899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+..+....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 34578999999999999999999986 89999999999999999999999999997665432
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ..+.++.++|||||||++|||+| |+.||....... .+.. ...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----------------~~~~-~~~ 218 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQ-VER 218 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----------------HHHH-Hhc
Confidence 21 1122345667999994 55678999999999999999999 888886432210 0111 111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
......+...+..+.+++.+|++.||++||++.++++.|++.+
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111223456678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.17 Aligned_cols=249 Identities=23% Similarity=0.397 Sum_probs=214.9
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.-|...+.||+|.|..|-+|+ .-+|..||||++.+..........+..|++.|+.++|||||++|.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457778999999999999995 4589999999999888777778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-CCCCcEEEeeccCCCCcCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL-DDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~ 666 (801)
.-++|+|+|+|..+ ...+.+.-+.+++.||+.|+.|+|+. ++|||||||+||.+ ..-|-||++|||++..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999865 56799999999999999999999998 69999999999877 4578999999999988877
Q ss_pred CCccccccccccccCcCCcccccC-CCC-CcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG-IYT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~-~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
+.. ....+|+..|.|||++.| .|+ +++||||||||||.|++|++||...++. +.+..++
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmIm 232 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIM 232 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhh
Confidence 643 345678889999996554 565 6899999999999999999999865543 3334445
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
|..+ ..|...+.+.++||..||..||.+|-+.+||...
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 5443 3577888999999999999999999999998754
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.87 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=203.8
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
.++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+..+++++|+||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467889999999999999998542 35589999886443 22334567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEE
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 655 (801)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 123456778899999999999999986 8999999999999999999999
Q ss_pred eeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccc
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
+|||+++...............++..|+|||. ..+.++.++|||||||++|||++ |..||......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------------ 228 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------------ 228 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99999886544332222222344667999994 55678999999999999999998 78888643211
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
+....+.+.. ....+...+..+.+++.+||+.||++||++.|+++.|.+.+
T Consensus 229 ----~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 229 ----QVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111111 11233455678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=325.68 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=201.2
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|+..++||+|+||+||++.. .+++.||||++...... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 67788999999999999965 57899999998654322 22335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999886432 34689999999999999999999986 89999999999999999999999999987654332
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. .....++..|+||| +....++.++|||||||++|||++|+.||........ .+.+...+..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------------~~~~~~~~~~- 219 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------------REEVERRVKE- 219 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------------HHHHHHHhhh-
Confidence 1 12345788899999 4456689999999999999999999999975322110 0111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
....++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 12234555677899999999999999999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.17 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=202.0
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+||+++++++.+ +..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 56888999999999999999888888999999875433 23568899999999999999999998854 567899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999997532 34589999999999999999999986 89999999999999999999999999997664432
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....++..|+|||. ....++.++||||||+++|||++ |+.||...... +... .+..
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------------~~~~-~~~~ 218 (260)
T cd05070 157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----------------EVLE-QVER 218 (260)
T ss_pred ccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHH-HHHc
Confidence 111 112234567999994 55668999999999999999999 89999643211 1111 1111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
......+...+..+.+++.+|+..||++|||+.++.+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22223345566789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=348.04 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=195.0
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-------
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------- 579 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------- 579 (801)
..+|...++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|+|||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 45789999999999999999965 578999999885322 2234789999999999999999987432
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-cEEEee
Q 003704 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSD 657 (801)
Q Consensus 580 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~D 657 (801)
...++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999985 78777754322346789999999999999999999986 899999999999999664 799999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee-ccccc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR-WAIPQ 733 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~-~~~~~ 733 (801)
||+++.+..... .....++..|+|||.+. ..|+.++|||||||++|||++|++||.......... ... ...+.
T Consensus 215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987654321 22345688899999543 358999999999999999999999997643321110 000 00000
Q ss_pred ccchhhh----h-----hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 734 LHDIDAL----S-----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 734 ~~~~~~~----~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
......+ . ......+...+|...+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000000 0 000011112234456678999999999999999999999997643
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.86 Aligned_cols=261 Identities=23% Similarity=0.396 Sum_probs=200.9
Q ss_pred cCCccCCeeeecCccEEEEEEeCC---------------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccc
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD---------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~ 573 (801)
++|++.+.||+|+||.||+++..+ ...||||.+.... .......+.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 578889999999999999986532 2358999986542 334456789999999999999999999
Q ss_pred eEEEecCeEEEEEeccCCCCHHHHHhcCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 003704 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDE--------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANI 645 (801)
Q Consensus 574 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 645 (801)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999964321 012468899999999999999999986 899999999999
Q ss_pred EECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh--CCCCcccccccc
Q 003704 646 LLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT--GRKSYDRTRNRG 722 (801)
Q Consensus 646 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt--G~~pf~~~~~~~ 722 (801)
+++.++.+||+|||++................++..|+||| ...+.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999997654433222223334566899999 556679999999999999999998 667776432211
Q ss_pred ccceeecccccccchhhhhhhcC---CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 723 EQFLVRWAIPQLHDIDALSRMVD---PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
. . ....+... .......+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 241 ~---~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 V---I----------ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---H----------HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 0 00000000 00111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.60 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=192.6
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||||++.+... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999975 4689999999875432 222345566777777766 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999999875 34688999999999999999999986 89999999999999999999999999987542221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... ..+..+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~~~--~~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEAILND--EV 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcC--CC
Confidence 1233468889999995 4456899999999999999999999999753321 111111111 11
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPM------SEVVQD 784 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 784 (801)
.++...+.++.+++.+||+.||++||++ ++++++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 2345566789999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.98 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=198.5
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
++||+|+||.||+|...+++.+|+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999988889999999986543 333445788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++... ...+++..++.++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++......... ...
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 9998753 24578999999999999999999986 8999999999999999999999999998754432211 111
Q ss_pred ccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCC
Q 003704 675 HLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752 (801)
Q Consensus 675 ~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (801)
...++..|+|||. ..+.++.++||||||+++|||++ |..||....... ....+........
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEKGYRMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHcCCCCCC
Confidence 2234567999994 55668999999999999999998 999996432210 0011111122233
Q ss_pred CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 753 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+...+.++.+++.+|++.+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.32 Aligned_cols=247 Identities=21% Similarity=0.380 Sum_probs=196.0
Q ss_pred eeecCccEEEEEEeC---CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCC
Q 003704 517 IGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 593 (801)
||+|+||.||+|.+. ++..||||++.... .....+.+.+|+.++++++|+||+++++++.. +..++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999653 45679999986442 33445678899999999999999999998754 57899999999999
Q ss_pred HHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc-
Q 003704 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL- 672 (801)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 672 (801)
|.+++... ...+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..+........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998743 34689999999999999999999986 899999999999999999999999999976544322111
Q ss_pred ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
.....++..|+|||. ....++.++|||||||++|||++ |+.||...... .+...+......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------EVMSFIEQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHCCCCC
Confidence 111223467999994 45568999999999999999996 99999754321 111122222223
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
..+...+.++.+++.+||..||++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34556678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.30 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=189.9
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhc-cCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||||++...... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999975 46889999998754321 2223344555566654 4899999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999875 34688999999999999999999986 89999999999999999999999999987543322 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... +....+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~~--~~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----------------ELFDSILN--DRP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc--CCC
Confidence 2234568889999995 4456899999999999999999999999753221 11111111 112
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMS-EVVQ 783 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 783 (801)
.++...+.++.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 34555677899999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.62 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=196.4
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCC-CccccceEEEecCeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 586 (801)
+|++.+.||+|+||.||+|+. .+++.||||++.+... .......+..|.+++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999965 4678999999875432 223345677888888888765 5888999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999875 34578999999999999999999986 999999999999999999999999999864322
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. .......|+..|+|||. ....++.++|||||||++|||+||+.||...... ..+..+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~i~~ 215 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQSIME 215 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc
Confidence 11 11223467889999995 4556899999999999999999999999753221 11111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM-----SEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 784 (801)
. ...++...+.++.+++.+||+.||.+|++. .+++++
T Consensus 216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 216 H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 123455667789999999999999999986 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.72 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=194.4
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||+|++.+.... ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999975 56889999999754322 23345567788887766 799999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999998865 34689999999999999999999986 89999999999999999999999999987532221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh-hcCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR-MVDPSLS 749 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 749 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||.......... ......+.+ +... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~~~~~~~~~~i~~~--~ 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--------QNTEDYLFQVILEK--Q 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--------cccHHHHHHHHhcC--C
Confidence 1234567889999994 45568999999999999999999999996422111000 000011111 1111 1
Q ss_pred CCCCcccHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 003704 750 GQYPAKSLSHFADIISRCVQSEPEFRPP------MSEVVQD 784 (801)
Q Consensus 750 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 784 (801)
..+|...+.++.+++.+||+.||++||+ +.+++++
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2355666788999999999999999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=339.36 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=195.5
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.|+..+.||+|+||+||+|+. .+++.||||++.+... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999965 5788999999865332 22334678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999752 4578888999999999999999986 8999999999999999999999999997543210
Q ss_pred Cc---------------------------------------------cccccccccccCcCCcc-cccCCCCCcchHHHH
Q 003704 668 SV---------------------------------------------SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSF 701 (801)
Q Consensus 668 ~~---------------------------------------------~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSl 701 (801)
.. ........||..|+||| +....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00011246888999999 445679999999999
Q ss_pred HHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC--CCCCCCCCcccHHHHHHHHHHhcccCCCCCCC--
Q 003704 702 GVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD--PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-- 777 (801)
Q Consensus 702 Gvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-- 777 (801)
||++|||++|+.||........ ...+.. ...........+.++.+++.+|+ .||++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET----------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH----------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 9999999999999975432111 111111 11111111234567889998876 59999997
Q ss_pred -HHHHHHH
Q 003704 778 -MSEVVQD 784 (801)
Q Consensus 778 -~~evl~~ 784 (801)
+.|+++|
T Consensus 298 ~~~ei~~h 305 (382)
T cd05625 298 GADEIKAH 305 (382)
T ss_pred CHHHHhcC
Confidence 8888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.57 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=204.8
Q ss_pred cCCccCCeeeecCccEEEEEEe--------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL--------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (801)
++|.+.+.||+|+||.||+|+. ..+..+|+|.+.... .......+..|+++++++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 5677899999999999999963 134579999886433 233456788899999999 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999975321 124589999999999999999999986 99999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 725 (801)
+.++.+||+|||+++...............++..|+||| ...+.++.++|||||||++|||++ |+.||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999999999998664322211111222345699999 455668999999999999999999 88888643211
Q ss_pred eeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+.+.+........+...+.++.+++.+||+.||++||++.|+++.|.++...
T Consensus 244 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 -------------ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 01111111111223455667899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.17 Aligned_cols=264 Identities=24% Similarity=0.423 Sum_probs=202.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC-----------------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccc
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-----------------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~ 571 (801)
++|++.+.||+|+||.||+++.. ++..||+|++.... .......+.+|++++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 56888999999999999998532 24478999986432 3344568889999999999999999
Q ss_pred cceEEEecCeEEEEEeccCCCCHHHHHhcCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 003704 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL-------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSAN 644 (801)
Q Consensus 572 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 644 (801)
+++++...+..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999753211 13478889999999999999999986 89999999999
Q ss_pred EEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh--CCCCccccccc
Q 003704 645 ILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT--GRKSYDRTRNR 721 (801)
Q Consensus 645 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt--G~~pf~~~~~~ 721 (801)
||++.++.++|+|||+++.+.........+...++..|++|| ...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998664433222223334456799999 566779999999999999999998 77888643221
Q ss_pred cccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.. . ..................+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 241 ~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---I-------ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---H-------HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 10 0 0000000000000011123445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.88 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=193.7
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
++||+|+||.||+|+. .+++.||||++.+... .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999965 4688999999875432 223345566788888765 799999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 999999875 34688999999999999999999986 899999999999999999999999999875432211
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... ..+..+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----------------~~~~~i~~~~--~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----------------DLFESILHDD--V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----------------HHHHHHHcCC--C
Confidence 1233457889999994 4556899999999999999999999999754321 1111111111 1
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRP-------PMSEVVQD 784 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 784 (801)
.+|...+.++.+++.+||+.||++|| ++.+++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23445567899999999999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=340.13 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=196.4
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+|++.+.||+|+||.||+|+. .+++.||||++.+... .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999964 5689999999864322 12234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999975 34578888899999999999999986 8999999999999999999999999997533210
Q ss_pred Cc-----------------------------------------cccccccccccCcCCccc-ccCCCCCcchHHHHHHHH
Q 003704 668 SV-----------------------------------------SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVM 705 (801)
Q Consensus 668 ~~-----------------------------------------~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil 705 (801)
.. ........||..|+|||. ....++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 000112468889999995 455689999999999999
Q ss_pred HHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC---CHHHHH
Q 003704 706 LELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP---PMSEVV 782 (801)
Q Consensus 706 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl 782 (801)
|||++|+.||.......... .+.. .............+.++.+++.+|+ .+|.+|+ ++.|++
T Consensus 235 yell~G~~Pf~~~~~~~~~~-------------~i~~-~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL-------------KVIN-WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH-------------HHhc-cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999997643221100 0000 0011111112245567889999876 5999999 899998
Q ss_pred HH
Q 003704 783 QD 784 (801)
Q Consensus 783 ~~ 784 (801)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 77
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.33 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=203.2
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.+.|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 467888999999999999999988999999999875432 3457889999999999999999999874 457899999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999987533 34689999999999999999999986 8999999999999999999999999998766532
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... .....++..|+|||. ..+.++.++||||||+++|||++ |+.||....... +...+.
T Consensus 156 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~ 217 (260)
T cd05067 156 EYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----------------VIQNLE 217 (260)
T ss_pred Cccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----------------HHHHHH
Confidence 2111 122334567999994 45668899999999999999999 999997533211 111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+.++.+++.+||..+|++||++++++..|++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111222344556789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.32 Aligned_cols=248 Identities=19% Similarity=0.280 Sum_probs=196.0
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+|...+.||+|+||.||+|+. .+++.||||++.+.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999965 46789999998754321 22234456677777666 5899999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999875 34588999999999999999999986 899999999999999999999999999875432
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. .......|+..|+||| +....++.++|||||||++|||+||+.||...... .....+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----------------~~~~~i~~ 215 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------ELFQSIME 215 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHh
Confidence 21 1123456788999999 45566999999999999999999999999753221 11111121
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM-----SEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 784 (801)
. ...+|...+.++.+++.+|++.||++|++. .+++++
T Consensus 216 ~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 216 H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1 123455667889999999999999999984 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.42 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=201.7
Q ss_pred cCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
.+|...+.||+|+||.||++.. .++..+|+|.+... .......+.+|++.+++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3567789999999999999953 24668999987633 344456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE-----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999975321 013588999999999999999999986 899999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeec
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW 729 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 729 (801)
.+||+|||++................++..|+||| .....++.++|||||||++|||++ |++||......
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------- 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------- 231 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------
Confidence 99999999987654332222222333457799999 455668999999999999999998 99998643221
Q ss_pred ccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 730 AIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+.+..+ ........+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 232 --------~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 --------EAIECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------HHHHHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111 111111234456678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.73 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=192.1
Q ss_pred eeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||.||+++. .+|+.||+|++....... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 569999999986533222 2234556799999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 99886532 34588999999999999999999986 999999999999999999999999999876654321 12
Q ss_pred ccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...++..|+||| .....++.++|||||||++|||++|+.||........ ............... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~~-~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA------------KEELKRRTLEDEVKF-EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh------------HHHHHHHhhcccccc-cc
Confidence 345778899999 4455689999999999999999999999964322110 001111111111110 11
Q ss_pred cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...+.++.+++.+||+.||++||++.|+++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 2356779999999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.74 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=195.3
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
++||+|+||.||+|+. .+++.||||++.+.... ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999965 57899999999754322 22345677888888888 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999998864 35689999999999999999999986 99999999999999999999999999987432211 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh-hhhcCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL-SRMVDPSLS 749 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 749 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||+........ .....+.+ ..+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~-- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP--------DQNTEDYLFQVILEKQ-- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc--------cccchHHHHHHHHcCC--
Confidence 1234567889999994 4556899999999999999999999999743211100 00000111 1111111
Q ss_pred CCCCcccHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 003704 750 GQYPAKSLSHFADIISRCVQSEPEFRPP------MSEVVQD 784 (801)
Q Consensus 750 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 784 (801)
...|...+.++.+++.+||+.||.+|++ +.|++++
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1345566778999999999999999997 6777755
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.12 Aligned_cols=262 Identities=25% Similarity=0.414 Sum_probs=203.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeCC-----------------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCcc
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD-----------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv 570 (801)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... ......+.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578889999999999999986532 34689999865432 34557788999999999999999
Q ss_pred ccceEEEecCeEEEEEeccCCCCHHHHHhcCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 003704 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE-------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSA 643 (801)
Q Consensus 571 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 643 (801)
++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999975431 112589999999999999999999986 8999999999
Q ss_pred cEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh--CCCCcccccc
Q 003704 644 NILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT--GRKSYDRTRN 720 (801)
Q Consensus 644 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt--G~~pf~~~~~ 720 (801)
||+++.++.++|+|||+++...............++..|+|||. ..+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876544432222334455678999994 55579999999999999999998 6777764321
Q ss_pred ccccceeecccccccchhhhhhhc---CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 721 RGEQFLVRWAIPQLHDIDALSRMV---DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.. .. ....... ........+...+.++.+++.+||+.||++|||+.||++.|+
T Consensus 240 ~~---~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ---VI----------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HH----------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 10 00 0111110 011111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.19 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=212.1
Q ss_pred hccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCch-hhHHHHHHHHHHhhccC-CCCccccceEEEecCeEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRL 583 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~ 583 (801)
....|+..+.||+|.||.||+++.+ +|+.+|+|.+.+..... .....+.+|+++|+++. |||||.+++.|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567888899999999999999654 59999999997665432 24568889999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC----CcEEEeecc
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD----LAVSVSDCG 659 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFG 659 (801)
+|||++.||.|++.|... .+++..+..++.|++.+++|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999763 389999999999999999999996 99999999999999543 579999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchh
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
++.....+ ......+||++|+|||.+. ..|+..+||||+||++|.|++|.+||.........
T Consensus 185 la~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------------- 247 (382)
T KOG0032|consen 185 LAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------------- 247 (382)
T ss_pred CceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--------------
Confidence 99988763 2345678999999999666 68999999999999999999999999865432111
Q ss_pred hhhhhcCC--CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 739 ALSRMVDP--SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 739 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+... .+...+....+..+.+++.+|+..||.+|+|+.++++|-+
T Consensus 248 --~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 248 --LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 111111 2233344566788999999999999999999999999843
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.47 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=189.9
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhc-cCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
++||+|+||.||+|+. .+|+.||||++.+.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999975 46899999998754321 1223445566677664 4899999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999999875 34688999999999999999999986 99999999999999999999999999986432221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----------------~~~~~~~~~--~~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----------------ELFESIRVD--TP 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--CC
Confidence 1234567889999994 4556899999999999999999999999743211 001111111 12
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMS-EVVQ 783 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 783 (801)
.++...+.++.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 34455667899999999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.05 Aligned_cols=257 Identities=26% Similarity=0.490 Sum_probs=202.9
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CC---cEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.... .......+..|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46777899999999999999764 33 379999886432 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999753 24689999999999999999999986 8999999999999999999999999998766
Q ss_pred CCCCccccc-cccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 665 SSGSVSQLS-GHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 665 ~~~~~~~~~-~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
......... .....+..|+||| ...+.++.++|||||||++|||++ |+.||...... + +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----------------~-~~ 220 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----------------E-VM 220 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----------------H-HH
Confidence 433211111 1122345699999 445668999999999999999997 99999643211 1 11
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
..+........+...+.++.+++.+||+.||++||++.+|++.|.+++
T Consensus 221 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111122234456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.05 Aligned_cols=248 Identities=27% Similarity=0.473 Sum_probs=199.6
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
++||+|+||.||++...+++.||+|.+...... .....+.+|+++++++.|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999998766999999988654332 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++... ...+++..+..++.+++.+|+|||+. +++||||||+||+++.++.+||+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999753 23578999999999999999999986 89999999999999999999999999987654332211112
Q ss_pred ccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCCCCCCC
Q 003704 675 HLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752 (801)
Q Consensus 675 ~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (801)
....+..|+||| ...+.++.++|||||||++|||+| |..||...... .....+........
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------QTRERIESGYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----------------HHHHHHhcCCCCCC
Confidence 223356699999 455678999999999999999999 88888643221 11111111122233
Q ss_pred CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 753 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+...+.++.+++.+||..+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5566778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.61 Aligned_cols=248 Identities=27% Similarity=0.471 Sum_probs=202.8
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|+..+.||+|+||.||+|.. .|+.||||.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678889999999999999986 478999999865432 456788999999999999999999999989999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997532 23689999999999999999999986 89999999999999999999999999998764321
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. ....+..|+||| ...+.++.++||||||+++|||++ |+.||...... .+...+..
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~ 214 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPHVEK 214 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhc
Confidence 1 223355799999 455678899999999999999997 99998643211 11111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
......+...+.++.+++.+||..+|++||++.|+++.|.+
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 12222344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.55 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=198.2
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEE-ecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCA-EHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E 587 (801)
++|...+.||+|+||.||++.. .|..||+|.+... ...+.+.+|+.++++++|+|++++++++. +.+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4678889999999999999976 4788999988532 23457889999999999999999999764 4567899999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999997532 24588999999999999999999986 8999999999999999999999999998754332
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .....+..|+|||. ....++.++|||||||++|||++ |+.||..... ..+...+.
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~ 213 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVE 213 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHh
Confidence 1 22334457999994 45568999999999999999997 9999864321 11111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+..+.+++.+||+.||++|||+.++++.|.+
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 122223345567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=315.47 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=200.5
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|.+.+.||+|+||.||+|...++..+|+|++.... ...+.+.+|++++++++|+|++++++++.. +..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 4578889999999999999988777789999876432 234568889999999999999999998754 567899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 34588999999999999999999986 89999999999999999999999999997664332
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ..+.++.++|||||||++|||++ |+.||....... ....+ ..
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~-~~ 218 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE----------------VLEQV-ER 218 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH-Hc
Confidence 11 1122335567999994 45678999999999999999999 899997532211 11111 11
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
......+...+..+.+++.+||+.||++||+++++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.68 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=195.3
Q ss_pred CeeeecCccEEEEEEeC-CCc--EEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccC
Q 003704 515 NLIGAGMLGSVYRAQLP-DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
++||+|+||.||+|... +|. .+++|.+... ........+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46899999999999764 444 4688887632 2233456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 591 NGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 591 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
+|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999975321 123578999999999999999999985 9999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
|++....... .......+..|+|||. ....++.++|||||||++|||++ |..||......
T Consensus 157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------------- 218 (270)
T cd05047 157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------------- 218 (270)
T ss_pred CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---------------
Confidence 9985322110 1111223557999994 45568999999999999999997 99999643211
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
...+.+........+...+.++.+++.+||+.||.+||++.|+++.|.++++
T Consensus 219 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 219 --ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred --HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 0111111111112334456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=318.70 Aligned_cols=271 Identities=24% Similarity=0.349 Sum_probs=201.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-----CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~ 581 (801)
++|++.+.||+|+||.||++.. .++..||||++... .......+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4688889999999999999964 35889999998643 23445678899999999999999999998754 356
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 88999999999999999753 24589999999999999999999986 8999999999999999999999999999
Q ss_pred CCcCCCCcccc-ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 662 PLISSGSVSQL-SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 662 ~~~~~~~~~~~-~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
+.......... .....++..|+|||. ..+.++.++|||||||++|||++|..++................ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ-GQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc-cccchHH
Confidence 87654321111 111123345999994 45568999999999999999999887764322110000000000 0000111
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
+.+.+........+...+.++.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2222222222223445667899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.32 Aligned_cols=251 Identities=31% Similarity=0.522 Sum_probs=203.1
Q ss_pred CeeeecCccEEEEEEeCC----CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 515 NLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+.||+|+||.||+|.... +..|+||.+....... ....+.+|++.++.++|+||+++++++.+.+..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997643 8899999987554333 46788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCccc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 591 NGTLQDMLHSDDEL-----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 591 ~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
+++|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999864211 36789999999999999999999986 89999999999999999999999999998776
Q ss_pred CCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
............++..|+|||. ....++.++|||||||++|||++ |..||...... .....+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~ 220 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----------------EVLEYL 220 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence 5432222333456778999994 44578999999999999999999 69999754211 111111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+ ......+...+.++.+++.+||+.||++||++.|++++|+
T Consensus 221 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred Hc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 2222345566788999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.71 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=186.5
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHH-HhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVN-NIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||+||+|+. .+|+.||||++.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999965 57999999998654321 122234444444 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999999875 34688999999999999999999986 89999999999999999999999999987543221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... +....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----------------EMYDNILNKPL-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHcCCC--
Confidence 1234467889999994 4556899999999999999999999999753211 01111111111
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMS 779 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 779 (801)
..+...+..+.+++.+||+.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12334567899999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.17 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=202.9
Q ss_pred ccCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
.++|+..+.||+|+||.||+|... ++..||+|++.... .......+.+|++++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357888999999999999999753 57889999986433 23445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSA 643 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 643 (801)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999974211 123478889999999999999999986 8999999999
Q ss_pred cEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccc
Q 003704 644 NILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNR 721 (801)
Q Consensus 644 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~ 721 (801)
||+++.++.+||+|||++..+..............+..|+||| .....++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654332211122233456799999 455679999999999999999997 88888643211
Q ss_pred cccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+....+.+... ...+...+.++.+++.+||+.||++||++.|+++.|+
T Consensus 240 ----------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 ----------------EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ----------------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111111111 1223455678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.47 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=199.9
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35788999999999999999975 678999999986432 223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999875 34688999999999999999999986 899999999999999999999999999876643
Q ss_pred CCccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
... ......++..|+|||.. ...++.++|||||||++|||++|+.||............ ....
T Consensus 159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~--------- 225 (267)
T cd06646 159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSN--------- 225 (267)
T ss_pred ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCC---------
Confidence 211 11234567789999954 234788999999999999999999998644322111100 0000
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
...+.. ......+..+.+++.+||..||++||++++++++|
T Consensus 226 ~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 01123456899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=334.12 Aligned_cols=267 Identities=20% Similarity=0.301 Sum_probs=199.7
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-----eEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (801)
+|+..+.||+|+||.||++.. .+|+.||||++............+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999965 57999999998654434444567889999999999999999999998766 789
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 578888764 35689999999999999999999986 899999999999999999999999999976
Q ss_pred cCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeec--ccccccchhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW--AIPQLHDIDA 739 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 739 (801)
....... ......++..|+|||.+.+ .++.++|||||||++|||++|+.||...........+.. ..+...+...
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 5433211 1223356778999995443 478999999999999999999999976543211110000 0000000000
Q ss_pred ----hh-hhcCCCCCC-------CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 740 ----LS-RMVDPSLSG-------QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 740 ----~~-~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.. .+....... ......+.++.+|+.+||+.||++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00 000000000 11223457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.91 Aligned_cols=242 Identities=23% Similarity=0.331 Sum_probs=189.6
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhc-cCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||||++..... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999975 4688999999875432 12223445566677765 4899999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999999975 34688999999999999999999986 899999999999999999999999999865322211
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||....... ....+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~i~~~--~~ 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----------------LFQSIRMD--NP 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhC--CC
Confidence 1223467889999995 45568999999999999999999999997532210 00111000 11
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMS-EVVQ 783 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 783 (801)
.++...+.++.+++.+||+.||++||++. ++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 23445567899999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.99 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=193.6
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||||++.+... .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 4688999999975432 222345566788888777 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 999999875 34689999999999999999999986 999999999999999999999999999865322211
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......++..|+|||. ....++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----------------~~~~~i~~~--~~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----------------ELFQSILED--EV 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHcC--CC
Confidence 1223457889999994 4557899999999999999999999999743211 111111111 11
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPM-----SEVVQD 784 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 784 (801)
.++...+.++.+|+.+||+.||++||++ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2455567789999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=334.44 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=194.5
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 35799999999999999999964 578999999753 234678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 689888865 34688999999999999999999986 899999999999999999999999999975432
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc--------eeeccc--c-c-
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--------LVRWAI--P-Q- 733 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--------~~~~~~--~-~- 733 (801)
... .......||..|+|||+ ....++.++|||||||++|||++|+.||.......... +..... + .
T Consensus 235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 235 INA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 211 11223568899999994 45569999999999999999999998875432211000 000000 0 0
Q ss_pred -ccchhhhhhh----cCCCC-C-CCCC-----cccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 734 -LHDIDALSRM----VDPSL-S-GQYP-----AKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 734 -~~~~~~~~~~----~~~~~-~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+... ..... . ...+ ...+.++.+|+.+||+.||++|||+.|++++-
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000000000 00000 0 0000 12356789999999999999999999999754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.33 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=205.5
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
.+|+..+.||+|+||.||+|... +|. .+|+|.+.... .......+.+|+..+++++|+||+++++++.. +..+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46778899999999999999753 343 58999876443 24455678899999999999999999999987 7889
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999753 23589999999999999999999986 999999999999999999999999999987
Q ss_pred cCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
..............++..|+||| ...+.++.++|||||||++||+++ |+.||...... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~ 221 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----------------EIP 221 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHH
Confidence 65432221111222356799999 445678999999999999999998 99999753221 111
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
..+........+..++..+.+++.+||..||.+||++.++++.|.++.++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 111111122234445678899999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=340.22 Aligned_cols=267 Identities=18% Similarity=0.264 Sum_probs=189.0
Q ss_pred hhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC------CCCccccceEEE
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR------HANIVELKGYCA 577 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------HpnIv~l~~~~~ 577 (801)
....++|++.++||+|+||+||+|.. .+++.||||+++... .....+..|+++++.++ |.+++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 33467899999999999999999965 568899999986421 12233445666665554 456888999887
Q ss_pred ec-CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-----
Q 003704 578 EH-GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL----- 651 (801)
Q Consensus 578 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----- 651 (801)
.. +..++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 54 5788999988 7789888875 34689999999999999999999973 3899999999999998765
Q ss_pred -----------cEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccc
Q 003704 652 -----------AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTR 719 (801)
Q Consensus 652 -----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~ 719 (801)
.+||+|||.+...... .....+|..|+||| +....|+.++|||||||++|||++|+.||+...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4999999987543222 23456889999999 455579999999999999999999999997644
Q ss_pred cccccceeeccccccc-c------hhhhhhhcCC--CCCCCC---------------CcccHHHHHHHHHHhcccCCCCC
Q 003704 720 NRGEQFLVRWAIPQLH-D------IDALSRMVDP--SLSGQY---------------PAKSLSHFADIISRCVQSEPEFR 775 (801)
Q Consensus 720 ~~~~~~~~~~~~~~~~-~------~~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~R 775 (801)
..+....+......+. . ......+.+. .+...+ .......+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 3221111100000000 0 0000000000 000000 00113467899999999999999
Q ss_pred CCHHHHHHHHH
Q 003704 776 PPMSEVVQDLV 786 (801)
Q Consensus 776 Pt~~evl~~L~ 786 (801)
||+.|+++|-.
T Consensus 430 ~ta~e~L~Hp~ 440 (467)
T PTZ00284 430 LNARQMTTHPY 440 (467)
T ss_pred CCHHHHhcCcc
Confidence 99999998643
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.77 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=201.4
Q ss_pred CCccCCeeeecCccEEEEEEeC-CC---cEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
.|++.+.||+|+||.||+|... ++ ..||||.+.... .......|..|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4677899999999999999754 33 369999986532 344557899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999753 24589999999999999999999986 99999999999999999999999999987654
Q ss_pred CCCccc-cccccc--cccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhh
Q 003704 666 SGSVSQ-LSGHLL--TAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 666 ~~~~~~-~~~~~~--~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
...... ...... .+..|+|||. ..+.++.++|||||||++|||++ |..||....... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----------------~ 220 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----------------V 220 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----------------H
Confidence 332111 111111 2346999994 45678999999999999999886 999986532210 0
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
.+.+........+...+..+.+++.+||+.+|++||++.+++..|++++
T Consensus 221 ~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1111111111223455678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.83 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=200.7
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|+..+.||+|+||.||++.. .+++.||||.+....... .....+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999965 578999999986543322 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999986432 34689999999999999999999986 99999999999999999999999999987654332
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. .....++..|+|||. ....++.++|||||||++|||++|+.||........ ......... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-------------~~~~~~~~~-~ 219 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------------REEVERLVK-E 219 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-------------HHHHHhhhh-h
Confidence 1 123467889999994 456689999999999999999999999975322100 011111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 785 (801)
....++...+.++.+|+.+||+.||++||| +.|++++-
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 112234455678999999999999999999 88998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.58 Aligned_cols=262 Identities=26% Similarity=0.444 Sum_probs=205.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC--------CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (801)
.+|.+.+.||+|+||.||+|+.. .+..||+|.+... ........+.+|+++++++ +|+||+++++++.+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46888999999999999999642 1236899987643 2334456788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 999999999999999999975321 124588999999999999999999986 99999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~ 725 (801)
+.++.+||+|||+++...............++..|+||| .....++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 243 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 999999999999987664432211112223345799999 455678999999999999999998 88888643211
Q ss_pred eeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.+...+........+...+.++.+++.+||+.+|++||++.|+++.|.++...
T Consensus 244 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 -------------ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 11111111122223445567899999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.10 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=201.8
Q ss_pred cCCccCCeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
.+|++.+.||+|+||.||+|... .+..+|+|.+.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778899999999999999653 23479999886533 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999753 24589999999999999999999986 8999999999999999999999999999876
Q ss_pred CCCCcccc-ccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 665 SSGSVSQL-SGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 665 ~~~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
........ ......+..|+|||.. .+.++.++|||||||++||+++ |+.||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----------------~~~ 220 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----------------VIK 220 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----------------HHH
Confidence 54321111 1112224579999944 4578999999999999999886 999986532211 011
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
.+.+ ......+...+..+.+++.+|++.+|++||++.++++.|.++
T Consensus 221 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 111122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.69 Aligned_cols=255 Identities=26% Similarity=0.335 Sum_probs=191.6
Q ss_pred CeeeecCccEEEEEEeC---CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999754 346799998865432 33445788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 592 GTLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 592 gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
|+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975322 123467788889999999999999986 8999999999999999999999999998765433222
Q ss_pred ccccccccccCcCCcccccC--------CCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 671 QLSGHLLTAYGYGAPEFESG--------IYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE~~~~--------~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.......++..|+|||...+ .++.++|||||||++|||++ |+.||........... .+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~------------~~~ 224 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------------TVR 224 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH------------Hhh
Confidence 22233456678999995432 25789999999999999996 9999965432111000 000
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
........+......+..+.+++.+|+ .+|++|||++||++.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000011112234567889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.79 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=195.8
Q ss_pred CeeeecCccEEEEEEeC--C--CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 515 NLIGAGMLGSVYRAQLP--D--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
++||+|+||.||+|... + +..+|+|.+...... ...+.+.+|+++++++.|+||+++++++.. +..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46999999999999642 2 368999998755433 455778899999999999999999998764 46799999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999999753 3689999999999999999999986 8999999999999999999999999999866443221
Q ss_pred cc-ccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 671 QL-SGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 671 ~~-~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.. .....++..|+||| .....++.++|||||||++|||++ |+.||....... +...+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----------------~~~~~~~~ 214 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----------------VIAMLESG 214 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----------------HHHHHHcC
Confidence 11 11112345699999 555668999999999999999998 999997543210 11111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
.....+...+..+.+++.+||..||++||++.++++.|+++
T Consensus 215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11223455667899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.84 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=200.8
Q ss_pred HhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
+....++|++.+.||+|+||.||+++. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 344457899999999999999999965 4688999999864322 22334567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999864 3478888999999999999999986 9999999999999999999999999999
Q ss_pred CCcCCCCccccccccccccCcCCcccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPEFESG-----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
+....... .......||..|+|||.+.+ .++.++|||||||++|||++|+.||......
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------------- 253 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------------- 253 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------------
Confidence 76643321 11234568899999995432 3789999999999999999999999753221
Q ss_pred hhhhhhhcCCCCCCCCC--cccHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYP--AKSLSHFADIISRCVQSEPEF--RPPMSEVVQDL 785 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 785 (801)
.....+........++ ...+.++.+++.+|+..++.+ |+++.|++++.
T Consensus 254 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111111122 245678999999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=313.70 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=197.9
Q ss_pred CeeeecCccEEEEEEeCC--Cc--EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 515 NLIGAGMLGSVYRAQLPD--GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~--g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+.||+|++|.||+|.+.+ ++ .||||.+...... ...+.+.+|++.+++++|+||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997633 33 6899998765443 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999986431 4689999999999999999999986 9999999999999999999999999999876543211
Q ss_pred -ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 671 -QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 671 -~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.......++..|+|||. ....++.++|||||||++|||++ |+.||....... ....+....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~ 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKKIDKEG 217 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHhcC
Confidence 11223445678999995 45578999999999999999998 999996432211 011111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.....+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111233455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.48 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=197.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3577889999999999999964 678999999986442 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 99999996542 367788899999999999999986 9999999999999999999999999998765432
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. .....++..|+|||. ....++.++|||||||++|+|++|+.||.......... ........+.+.
T Consensus 149 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~ 215 (279)
T cd06619 149 I----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MPLQLLQCIVDE 215 (279)
T ss_pred c----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------chHHHHHHHhcc
Confidence 1 233467788999994 45568999999999999999999999997533211110 000111111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..........+.++.+++.+||+.||++||++.|++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111111223456799999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=354.36 Aligned_cols=260 Identities=18% Similarity=0.312 Sum_probs=202.9
Q ss_pred hhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCe
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQ 581 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~ 581 (801)
....++|.+.+.||+|+||+||+|.. .++..||+|.+............+..|+.++++++|||||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34557899999999999999999965 467889999987655555566788999999999999999999998854 457
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCcEEECC--------
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC----QPPIVHRNFKSANILLDD-------- 649 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivHrDlkp~NILl~~-------- 649 (801)
+||||||+++|+|.++|.........+++..++.|+.||+.||+|||+.. .++||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753322356899999999999999999999852 136999999999999964
Q ss_pred ---------CCcEEEeeccCCCCcCCCCccccccccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 003704 650 ---------DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDR 717 (801)
Q Consensus 650 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~ 717 (801)
.+.+||+|||++..+..... .....++..|+|||++. ..++.++||||||||||||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999987644321 23456888999999543 3488999999999999999999999964
Q ss_pred cccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 718 TRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..... .+...+..... ......+.++.+||..||+.+|++||++.|++++
T Consensus 246 ~~~~~----------------qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFS----------------QLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHH----------------HHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 32210 11111111100 0012345679999999999999999999999964
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.55 Aligned_cols=254 Identities=29% Similarity=0.497 Sum_probs=204.4
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.++|.+.+.||+|+||.||+|...+++.||||.+..... ....+.+|++++++++|+||+++++++.+....++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 467888999999999999999888888999999875432 34578899999999999999999999998889999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997632 34689999999999999999999986 8999999999999999999999999998766532
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... ......+..|+|||. ....++.++|||||||++|||++ |+.||...... ..+..+ .
T Consensus 157 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~~-~ 218 (261)
T cd05034 157 EYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----------------EVLEQV-E 218 (261)
T ss_pred hhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHH-H
Confidence 2111 112223457999994 45568999999999999999998 99999643211 111111 1
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+.++.+++.+|+..+|++||+++++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111122334456789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=326.87 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=196.8
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+++. .+++.||||++.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999975 5689999999864322 2223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999742 34688999999999999999999986 899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
.... ......|+..|+|||.+. +.++.++|||||||++|||++|+.||....... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------------~~ 217 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----------------TY 217 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH----------------HH
Confidence 3211 122345888999999543 347889999999999999999999996532110 01
Q ss_pred hhhcCCCCC---CCCCcccHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003704 741 SRMVDPSLS---GQYPAKSLSHFADIISRCVQSEPEF--RPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 784 (801)
..+...... .......+.++.+++.+|+..++++ |+++.+++++
T Consensus 218 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 218 GKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111110000 0111235678899999988654443 7899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=330.16 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=197.6
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (801)
..++|+..+.||+|+||.||++.. .+|+.||||++............+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999965 5689999999976554455567788999999999999999999998643
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...++||||+++ +|.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999976 5666664 2478888999999999999999986 99999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee-cccccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR-WAIPQLHD 736 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~-~~~~~~~~ 736 (801)
+++...... ......++..|+|||. ....++.++|||||||++|||++|+.||.......... ... ...+....
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 997643321 1223467888999995 45568999999999999999999999997543211000 000 00000000
Q ss_pred hh----hhhhhcC--CCCC----------------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 737 ID----ALSRMVD--PSLS----------------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 737 ~~----~~~~~~~--~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.. .+..... +... .......+.++.+|+.+||+.||++|||+.|++++-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00 0000000 0000 0011123467899999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.17 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=191.1
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc---CCCCccccceEEEe-----cC
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI---RHANIVELKGYCAE-----HG 580 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~~-----~~ 580 (801)
+|+..+.||+|+||+||+|+. .+|+.||+|.+............+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999965 5789999999875433332233455566665554 79999999998864 34
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999985 8988887532 34589999999999999999999986 899999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-cccccch
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQLHDI 737 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~~~~~ 737 (801)
++....... .....++..|+||| .....++.++|||||||++|||++|++||.......... ..... .+....+
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 987653321 22345678899999 455678999999999999999999999996543211100 00000 0000000
Q ss_pred hhhhhhcCCCCCC-------CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 738 DALSRMVDPSLSG-------QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............. ......+.++.+++.+||+.||++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 0112345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=348.57 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=204.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.++||+|+||.||+|.. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788899999999999999965 46899999998754322 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 587 EYCSNGTLQDMLHSDD-------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
||++|++|.+++.... ......++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1123467788899999999999999986 89999999999999999999999999
Q ss_pred CCCCcCCCCc----------------cccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCcccccccc
Q 003704 660 LAPLISSGSV----------------SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRG 722 (801)
Q Consensus 660 la~~~~~~~~----------------~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~ 722 (801)
+++....... ........||..|+||| .....++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621100 00112346889999999 445568999999999999999999999997532211
Q ss_pred ccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHh
Q 003704 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-PMSEVVQDLVDMIRR 791 (801)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 791 (801)
... . ..+..+. ........+..+.+++.+|++.||++|+ +++++++.|+..++.
T Consensus 239 i~~-----------~---~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISY-----------R---DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh-----------h---hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 0 0000000 0000124456789999999999999995 577788888877653
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.64 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=186.9
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHH-HHhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELV-NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||+|++.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999965 46789999998653321 12223334443 456788999999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
++|.+++.. ...+.+..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 999999975 34577888889999999999999986 89999999999999999999999999987543221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||....... .+..+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~~--~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNKP--L 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhCC--c
Confidence 1234568889999994 45568999999999999999999999997533211 111111111 1
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 782 (801)
..+...+..+.+++.+||+.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 22334567899999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.00 Aligned_cols=252 Identities=21% Similarity=0.371 Sum_probs=200.5
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCc----hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
+|...+.||+|+||.||+|...+|+.+|||.+...... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998888999999988643221 22335688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999752 4578899999999999999999986 89999999999999999999999999987653
Q ss_pred CCC----ccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 666 SGS----VSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 666 ~~~----~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
... .........++..|+|||.. ...++.++|||||||++|||++|+.||........ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------------~ 217 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----------------M 217 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----------------H
Confidence 211 11112234577889999954 45688999999999999999999999975322110 0
Q ss_pred hhhcCC-CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDP-SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+... ......+...+.++.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 218 FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 11122344566789999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=317.08 Aligned_cols=271 Identities=22% Similarity=0.372 Sum_probs=207.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC-----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~ 581 (801)
..|...+.||+|+||.||+|... ++..||||++...... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677789999999999999753 4789999998754433 356788999999999999999999999877 557
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 89999999999999999753 23589999999999999999999986 8999999999999999999999999999
Q ss_pred CCcCCCCccc-cccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 662 PLISSGSVSQ-LSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 662 ~~~~~~~~~~-~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
.......... .......+..|++|| .....++.++||||||+++|||++|+.|+............. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHH
Confidence 8775332111 111123345699999 445678999999999999999999999986532211110000 000011122
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
+.+.+........+..++.++.+++.+||+.+|++||++.||++.|..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222332222233455667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.64 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+++. .+++.||||++..... .......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999965 5789999999864322 2233466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999975 34688999999999999999999986 999999999999999999999999999875532
Q ss_pred CCcc---------------------------------ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCC
Q 003704 667 GSVS---------------------------------QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGR 712 (801)
Q Consensus 667 ~~~~---------------------------------~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~ 712 (801)
.... .......||..|+|||+ ....++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 00112468889999994 5566999999999999999999999
Q ss_pred CCccccccccccceeecccccccchhhhhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 003704 713 KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEFRPP---MSEVVQD 784 (801)
Q Consensus 713 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 784 (801)
.||....... ....+........+|. ..+.++.+++.+|+. ||++|++ +.|+++|
T Consensus 234 ~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQE----------------TYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHH----------------HHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9997543211 1111111010111221 245678899998774 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.98 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=197.4
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec-----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH----- 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~----- 579 (801)
+++.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456788889999999999999965 568899999986432 2345677889999888 699999999998753
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 580 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
...++||||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 46899999999999999997532 34688999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 732 (801)
|++....... .......++..|+|||... ..++.++|||||||++|||++|+.||.........
T Consensus 156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------- 225 (272)
T cd06637 156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------- 225 (272)
T ss_pred CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--------
Confidence 9987654321 1123456778899999542 34888999999999999999999999643221100
Q ss_pred cccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............+...+.++.+|+.+||..||.+|||+.|++++
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 --------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00001111111223455689999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.79 Aligned_cols=242 Identities=19% Similarity=0.288 Sum_probs=192.4
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+|+..+.||+|+||.||+|+. .+|+.||||++.+... .......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366788999999999999965 5789999999875432 2223355677888887775 577888999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999875 34689999999999999999999986 899999999999999999999999999875432
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......|+..|+|||. ....++.++|||||||++|||++|+.||...... .....+..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~i~~ 215 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------------ELFQSIME 215 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHh
Confidence 211 1233457889999994 4556899999999999999999999999754221 11111221
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 778 (801)
.. ..+|...+.++.+++.+||+.||.+|++.
T Consensus 216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11 23455667789999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.31 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=202.0
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
++|+..+.||+|+||.||+|.. .+|. .||+|.+.... .......+.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 5677889999999999999965 3454 47888876432 233345688999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999998753 23588999999999999999999986 899999999999999999999999999987
Q ss_pred cCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+.............++..|+|||. ....++.++|||||||++|||++ |+.||....... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----------------~~ 221 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----------------IP 221 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HH
Confidence 654332211222334567999994 45568999999999999999997 899986532111 11
Q ss_pred hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
+.+........+...+..+.+++.+||..||++||++.|+++.|.++.+..+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 222 DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 1111111112233455678999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.52 Aligned_cols=251 Identities=24% Similarity=0.444 Sum_probs=201.0
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe-cCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 587 (801)
+|++.+.||+|++|.||++.. .+++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999964 468899999987655445556678899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997532 34589999999999999999999986 8999999999999999999999999998766432
Q ss_pred CccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. .......++..|+||| .....++.++|||||||++|||++|+.||....... .......
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----------------~~~~~~~- 216 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----------------LVYRIIE- 216 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHHh-
Confidence 2 1123345678899999 455668899999999999999999999997432110 0011111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
......+...+.++.+++.+|++.||++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.23 Aligned_cols=270 Identities=23% Similarity=0.388 Sum_probs=202.9
Q ss_pred CCccCCeeeecCccEEEEEEe-----CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (801)
-|.+.+.||+|+||.||+++. .++..||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 367789999999999999963 358899999986432 334456789999999999999999999998775 568
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999653 23589999999999999999999986 99999999999999999999999999998
Q ss_pred CcCCCCcc-ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 663 LISSGSVS-QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 663 ~~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
.+...... .......++..|+||| .....++.++|||||||++|||++++.|+......... ......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~ 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQM-TVTRL 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccccc-cHHHH
Confidence 76543211 1112344566799999 45566899999999999999999988765432110000 000000000 00111
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
............+...+..+.+|+.+||+.||++||++.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111112223445678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.98 Aligned_cols=259 Identities=18% Similarity=0.255 Sum_probs=188.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++.+.+..++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 457999999999999999999654 5788999975432 2346888999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. ++|.+++... ...+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 5888888643 35689999999999999999999986 899999999999999999999999999875432
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc--------eeeccc-----c
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--------LVRWAI-----P 732 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--------~~~~~~-----~ 732 (801)
.. ......|+..|+|||. ....++.++|||||||++|||+++..++.......... +..... +
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 21 1223457889999994 45679999999999999999998655543221111000 000000 0
Q ss_pred -ccc---chhhhhhhcCCC--CCCC---C----CcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 733 -QLH---DIDALSRMVDPS--LSGQ---Y----PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 -~~~---~~~~~~~~~~~~--~~~~---~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+. ........++.. .... + ....+.++.++|.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 000000000000 0000 0 01234467789999999999999999999976
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=308.89 Aligned_cols=249 Identities=24% Similarity=0.450 Sum_probs=208.5
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+-|.+.++||+|+||.|||| ....|+.+|||++.. +.+..++..|+.+++++..|++|++||.|.....+++|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 44677889999999999999 456899999999853 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||..|++.+.++.+ .+++++.++..++...++||+|||.. .-||||||..|||++.+|.+|++|||.|-.+...
T Consensus 109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999999864 57899999999999999999999997 6799999999999999999999999998766543
Q ss_pred CccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
- .......||+.|||||++ .-.|++++||||||+...||..|++||....+....+.+ | ..+
T Consensus 183 M--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----P-----------T~P 245 (502)
T KOG0574|consen 183 M--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----P-----------TKP 245 (502)
T ss_pred H--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----c-----------CCC
Confidence 2 224567899999999954 456999999999999999999999999765443221111 0 011
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...-..|+..+.++.+++++||.+.|++|-|+-++++|
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11123466778899999999999999999999999876
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=325.92 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=194.7
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+++.||||++.+.... ......+.+|..++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 56889999999754322 23345677888888887 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999998864 34689999999999999999999986 89999999999999999999999999987532211 1
Q ss_pred cccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh-hcCCCCC
Q 003704 672 LSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR-MVDPSLS 749 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 749 (801)
......|+..|+||| +....++.++|||||||++|||++|+.||.......... ....+.+ +... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~--~ 219 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN----------TEDYLFQVILEK--P 219 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc----------cHHHHHHHHHhC--C
Confidence 123456888999999 455678999999999999999999999996432211110 0011111 1111 1
Q ss_pred CCCCcccHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 003704 750 GQYPAKSLSHFADIISRCVQSEPEFRPPM------SEVVQD 784 (801)
Q Consensus 750 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 784 (801)
...|...+..+.+++.+||+.||++|+++ .+++++
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 22455667789999999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.15 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=202.6
Q ss_pred cCCccCCeeeecCccEEEEEEeCC----CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
++|...+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457788999999999999997543 3468999876432 23455688899999999999999999999876 45689
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999753 23589999999999999999999986 8999999999999999999999999998766
Q ss_pred CCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
....... .....++..|+|||. ....++.++|||||||++|||++ |+.||........ ...
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----------------~~~ 220 (270)
T cd05056 158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV----------------IGR 220 (270)
T ss_pred cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHH
Confidence 5432211 112233457999994 45568999999999999999996 9999965432110 000
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
+ ........+...+.++.+++.+|+..+|++|||+.++++.|.++..++
T Consensus 221 ~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 221 I-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred H-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 111111234556678999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.33 Aligned_cols=266 Identities=21% Similarity=0.365 Sum_probs=202.3
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||+|+||.||++.. .+|..+|+|.+.... .......+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3688899999999999999965 468889999886432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.++++.. ..+++..+..++.|+++||+|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 80 y~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999999753 4688999999999999999999974 28999999999999999999999999998765332
Q ss_pred CccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccccc-----------
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH----------- 735 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----------- 735 (801)
. .....++..|+|||.. ...++.++|||||||++|||++|+.||....................
T Consensus 154 ~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 M----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred c----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1 2334677889999954 44588999999999999999999999965432111100000000000
Q ss_pred ---------chhhhhhhcCCCCCCCCC-cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 736 ---------DIDALSRMVDPSLSGQYP-AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 736 ---------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
-.+....+.. ......+ ...+.++.+++.+||..||++||++.|++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVN-EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhc-CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000001111 1111111 124567999999999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.97 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=192.4
Q ss_pred CeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEE-ecCeEEEEEecc
Q 003704 515 NLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCA-EHGQRLLIYEYC 589 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~ 589 (801)
+.||+|+||.||+|... ++..||+|++... ........+.+|+.+++.++||||+++++++. ..+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999643 3457999987532 22334567888999999999999999999875 455688999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
.+++|.+++... ...+.+..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999753 23467788899999999999999986 899999999999999999999999999876543221
Q ss_pred c--ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhC-CCCccccccccccceeecccccccchhhhhhhcC
Q 003704 670 S--QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG-RKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 670 ~--~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .......++..|+||| .....++.++|||||||++|||++| .+||...... . +...+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----------------~-~~~~~~ 216 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----------------D-ITVYLL 216 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----------------H-HHHHHh
Confidence 1 1112234566799999 4456789999999999999999995 5556432111 0 111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
.......+...+..+.+++.+||+.+|++||++.|+++.|++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111112233456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.71 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=205.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 586 (801)
+|+..+.||.|+||.||++.. .+|..||+|++..........+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999954 578999999987655556666788899999999999999999998754 45678999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||+++++|.+++.........+++..++.++.|++.||+|||..+ ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764333467899999999999999999999332 348999999999999999999999999999876
Q ss_pred CCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..... ......++..|+|||. ....++.++||||||+++|+|++|+.||...... .+.+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~ 221 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----------------QLASK 221 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----------------HHHHH
Confidence 54321 1223456778999994 4556889999999999999999999999753211 11111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+........+...+..+.+++.+|++.+|++||++.||+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122223445566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.56 Aligned_cols=251 Identities=29% Similarity=0.470 Sum_probs=197.2
Q ss_pred CeeeecCccEEEEEEeCC-------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 515 NLIGAGMLGSVYRAQLPD-------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+.||+|+||.||+|+..+ +..+|||.+.... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997532 3579999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-----cEEEeecc
Q 003704 588 YCSNGTLQDMLHSDDE---LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-----AVSVSDCG 659 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFG 659 (801)
|+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975321 124478999999999999999999985 899999999999999877 89999999
Q ss_pred CCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccch
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDI 737 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 737 (801)
+++................+..|+||| ...+.++.++|||||||++|||++ |+.||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------------- 221 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------------- 221 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---------------
Confidence 987664433222222334456799999 555678999999999999999998 999986432211
Q ss_pred hhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
....+........+...+..+.+++.+||..+|++||+++++++.|+
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 222 --VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111122234556778999999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.49 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=186.4
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHH-HHhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELV-NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
++||+|+||.||+|+. .+|+.||+|++.+... .......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 5789999999865432 122233444444 457889999999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
++|.+++.. ...+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 999998864 34678888999999999999999986 89999999999999999999999999987532221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......++..|+|||. ....++.++|||||||++|||++|+.||...... .....+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----------------QMYDNILHKP--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHhcCC--C
Confidence 1234567889999994 4556899999999999999999999999753211 0111111111 1
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMS 779 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 779 (801)
..+...+.++.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23445567899999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.53 Aligned_cols=249 Identities=24% Similarity=0.495 Sum_probs=199.1
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
+|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 5677899999999999999877788999998864332 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999753 24578999999999999999999986 899999999999999999999999999876543321
Q ss_pred cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 670 SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.. ......+.+|+|||. ..+.++.++|||||||++|||++ |+.||....... +.+.+...
T Consensus 156 ~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~ 217 (256)
T cd05112 156 TS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----------------VVETINAG 217 (256)
T ss_pred cc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----------------HHHHHhCC
Confidence 11 112234567999994 44678999999999999999998 999996432210 11111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.....+...+.++.+|+.+||+.+|++||++.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11112334567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.95 Aligned_cols=252 Identities=21% Similarity=0.372 Sum_probs=204.9
Q ss_pred CCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||.|+||.||.++ ..+++.+++|.+............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999985 45789999999876554555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997532 34689999999999999999999986 89999999999999999999999999987664432
Q ss_pred ccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||.. ...++.++||||||+++|||++|+.||...... +....+....
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~ 217 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----------------NLVVKIVQGN 217 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 1 12334577889999954 445889999999999999999999999643211 1111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.. ..+...+.++.+++.+||+.+|++||++.|+++++
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 12344567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.89 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=200.8
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 35788899999999999999964 57899999998654322 3466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999999863 3578899999999999999999986 899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......++..|+|||. ....++.++|||||||++|+|++|+.||.......... .....
T Consensus 169 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---------------~~~~~ 231 (296)
T cd06654 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------LIATN 231 (296)
T ss_pred ccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---------------HHhcC
Confidence 321 1223457778999994 45568899999999999999999999997543211000 00001
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+...+..+.+++.+||..||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111112234455778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.88 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=200.1
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|++.+.||+|+||.||+++. .+++.+|+|.+.... .....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 477789999999999999965 478999999986433 233456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999886432 34578899999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ....++.++||||||+++|+|++|+.||....... ....+. ..
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~~~~-~~ 215 (255)
T cd08219 155 A--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------------LILKVC-QG 215 (255)
T ss_pred c--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----------------HHHHHh-cC
Confidence 1 1223457778999995 44568999999999999999999999997532110 011111 11
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+..+.+++.+||+.||++||++.|++..
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112344556779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.93 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=199.3
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|+..+.||+|+||+||++.. .+++.||+|.+....... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999965 578999999986543222 2335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999886532 34689999999999999999999986 89999999999999999999999999987654322
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. .....++..|+|||. ....++.++|+|||||++|||++|+.||......... ..+...+..
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-------------~~~~~~~~~- 219 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-------------EEVDRRVLE- 219 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHHhhhc-
Confidence 1 123467889999994 4567899999999999999999999999753221100 011111110
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 784 (801)
....++...+.++.+|+.+||+.||++||+ +.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 011234455678899999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.00 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=202.0
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.++|+..+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++|+||+++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4678889999999999999998878888999988643 2234678899999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997532 34578899999999999999999986 8999999999999999999999999998765433
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... .....++..|+|||. ..+.++.++|||||||++|+|++ |+.||....... +...+.
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----------------~~~~~~ 217 (260)
T cd05073 156 EYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----------------VIRALE 217 (260)
T ss_pred Cccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHh
Confidence 2111 112234567999994 45568899999999999999999 999996432210 111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.......+...+.++.+++.+|++.||++||++.++++.|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111112234556789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=328.60 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=197.3
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (801)
..++|+..+.||+|+||.||++.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999964 5689999999976554455566788899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999975 6766664 2478889999999999999999986 99999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee-cccccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR-WAIPQLHD 736 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~-~~~~~~~~ 736 (801)
+++...... ......++..|+|||. ....++.++|||||||++|||++|+.||.......... ... ...+....
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 997654332 1233467888999995 44568999999999999999999999997543211100 000 00000000
Q ss_pred hh----hhhhhcC---------------CCC---CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 ID----ALSRMVD---------------PSL---SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 ~~----~~~~~~~---------------~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.. .+...++ ... ....+.....++.+|+.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00 0000000 000 0011222346789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.85 Aligned_cols=268 Identities=21% Similarity=0.333 Sum_probs=195.2
Q ss_pred cCCeeeec--CccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 513 QENLIGAG--MLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 513 ~~~~iG~G--~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
+.++||+| +||+||+++. .+|+.||||++............+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 6789999954 68999999999765544555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996432 24589999999999999999999986 899999999999999999999999986543321110
Q ss_pred -----cccccccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecccccccc----
Q 003704 670 -----SQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIPQLHD---- 736 (801)
Q Consensus 670 -----~~~~~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~---- 736 (801)
........++..|+|||.+. ..++.++|||||||++|||++|+.||.......... ......+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 00112234566799999543 348899999999999999999999997532211000 00000000000
Q ss_pred -hhhhh-----hhcCC-----------------CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 -IDALS-----RMVDP-----------------SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 -~~~~~-----~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.+.+. ...+. .....+....+.++.+++.+||+.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00000 00000 000011223456899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.92 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=200.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-------hhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-------QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
+|.+...||+|+||.||+|.. .+++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999965 568999999886543221 123567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999752 4578889999999999999999986 8999999999999999999999999998
Q ss_pred CCcCCCCcc----ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 662 PLISSGSVS----QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 662 ~~~~~~~~~----~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
+........ .......++..|+|||. ..+.++.++|||||||++|+|++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------- 218 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------------- 218 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------------
Confidence 876532111 01122346778999994 4556889999999999999999999999753211
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+..+.. ......+...+..+.+++.+||+.||++||++.|++++
T Consensus 219 -~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 219 -QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11111111 11223345566789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.80 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=204.6
Q ss_pred chhhhHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEE
Q 003704 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYC 576 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~ 576 (801)
+.++++....++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 45567777889999999999999999999965 568899999875422 2235677899999998 699999999987
Q ss_pred E-----ecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 577 A-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 577 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
. ..+..++||||+++++|.++++........+++..+..++.|+++||.|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34578999999999999998864322245688999999999999999999986 899999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~ 725 (801)
.+||+|||+++.+..... ......++..|+|||.+. ..++.++|||||||++|||++|+.||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL- 238 (286)
T ss_pred CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence 999999999876543221 122345788899999542 34788999999999999999999999754321100
Q ss_pred eeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
........ .....+...+.++.+++.+||+.||++||++.|+++++
T Consensus 239 ------------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 ------------FKIPRNPP--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ------------hhccccCC--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000 00112333456799999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=329.18 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=197.0
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (801)
..++|...+.||+|+||.||++.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356899999999999999999964 5689999999976544445556788899999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 7777764 2478889999999999999999986 99999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeec-ccccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRW-AIPQLHD 736 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~-~~~~~~~ 736 (801)
+++...... ......++..|+|||. ....++.++|||||||++|||++|+.||.......... .... ..+....
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997654322 1233467888999994 45568999999999999999999999997543221100 0000 0000000
Q ss_pred hhhh----h---------------hhcCCCC---CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 IDAL----S---------------RMVDPSL---SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 ~~~~----~---------------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
...+ . ....... ..........++.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000 0 0000000 0001112345788999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.80 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=196.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc---hhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~ 582 (801)
.+|...+.||+|+||.||+|.. .+++.|++|++...... ......+.+|++++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999965 56899999988643221 2234568889999999999999999998875 3677
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999752 4578899999999999999999986 89999999999999999999999999987
Q ss_pred CcCCCCcc-ccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 663 LISSGSVS-QLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 663 ~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
........ .......++..|+|||.. ...++.++|||||||++|||++|+.||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------------~~~ 218 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------------AAI 218 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----------------HHH
Confidence 65432111 111224467889999944 456889999999999999999999999743211 111
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............+......+.+++ +||..+|++||+++||+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 112111222334455566778888 6888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.07 Aligned_cols=239 Identities=24% Similarity=0.317 Sum_probs=186.9
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHH-HhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVN-NIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|+. .+|+.||||++.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999964 5799999999865432 1222344455544 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 999998875 35689999999999999999999986 99999999999999999999999999987542221 1
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
......|+..|+|||. ....++.++|||||||++|||++|+.||...... +....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~~~~~~~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----------------EMYDNILHKPL-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------HHHHHHHcCCc--
Confidence 1234567889999994 4556899999999999999999999999753211 01111111111
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMSE 780 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 780 (801)
..+...+..+.+++.+|++.||.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 122345567889999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.18 Aligned_cols=252 Identities=29% Similarity=0.521 Sum_probs=199.1
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|+..+.||+|+||+||+++. .+++.||+|++..............+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56678999999999999965 45679999999866544444445566999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++++|.+++.. ...+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-- 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-- 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 99999999983 46789999999999999999999996 9999999999999999999999999998754111
Q ss_pred cccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 670 SQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
........++..|+|||... ..++.++||||+|+++|+|++|..||.......... .+.+.....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-------------~~~~~~~~~ 218 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-------------IIEKILKRP 218 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-------------HHHHHHHTH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-------------hhhhccccc
Confidence 12234456778899999544 678999999999999999999999998652111110 000000000
Q ss_pred CC--CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LS--GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.. .........++.+++.+||+.||++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00111223789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=321.77 Aligned_cols=267 Identities=19% Similarity=0.319 Sum_probs=198.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|...+.||+|+||.||+|+. .+++.||+|++..... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 5688899999999999999965 4688999999865432 2233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 888887643 34578899999999999999999986 9999999999999999999999999998764332
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc--c------ccccch
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA--I------PQLHDI 737 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--~------~~~~~~ 737 (801)
.. ......++..|+|||... ..++.++|||||||++|||+||+.||......+........ . +.+...
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 TK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred cc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 21 122335677899999543 35889999999999999999999999764432211111000 0 000000
Q ss_pred hhhhhhcCCCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 738 DALSRMVDPSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 738 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......-.+.... ......+.++.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000000000 01123456789999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.71 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=189.3
Q ss_pred eeeecCccEEEEEEeCC---CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 516 LIGAGMLGSVYRAQLPD---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.||+|+||.||+|...+ ...+++|.+... ........+.+|++.++.++|+||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996533 457888877543 23344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 593 TLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 593 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
+|.+++...... ....++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764321 23356788899999999999999986 89999999999999999999999999986543332211
Q ss_pred cccccccccCcCCccccc--------CCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 672 LSGHLLTAYGYGAPEFES--------GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~~~--------~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
......++..|+|||... ..++.++|||||||++|||++ |..||......... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------------~~~~~ 224 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL-------------KQVVR 224 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------------HHHhh
Confidence 122334556799999532 246789999999999999999 78888643221100 00000
Q ss_pred hcCCC-CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 743 MVDPS-LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 743 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..... .....+...+..+.+++..|+ .||++||+++||++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 225 EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00101 111233455677888999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.91 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=197.8
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999754 578899999864322 2223345788899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 34688999999999999999999986 899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
... .......|+..|+|||++. +.++.++|||||||++|||++|+.||...... +.+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----------------~~~ 217 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETY 217 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----------------HHH
Confidence 221 1122346889999999543 35889999999999999999999999753221 111
Q ss_pred hhhcCCCCCCCC---CcccHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003704 741 SRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEF--RPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 784 (801)
..+........+ ....+.++.+++.+|+..++++ |+++.|++++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 112111111112 2345678999999998665544 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.82 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=198.8
Q ss_pred CccCCeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC------
Q 003704 511 FSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------ 580 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------ 580 (801)
|.+.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999642 4689999999765555556677889999999999999999999886432
Q ss_pred eEEEEEeccCCCCHHHHHhcCc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDD--ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
..++++||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875321 1123578899999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
|+++...............++..|++||. ....++.++|||||||++|||++ |+.||....... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~---------- 224 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I---------- 224 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----------
Confidence 99987644322111222334567999994 45568899999999999999999 888886432211 0
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
...+.... ....+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 225 ---~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 ---YNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011100 1112234557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.60 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=197.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||.||+++. .+++.||+|++.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999975 4688999999865322 2223455778899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 24688999999999999999999986 999999999999999999999999999876644
Q ss_pred CCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
.... ......|+..|+|||.+. +.++.++|||||||++|||++|+.||...... +..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~ 217 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETY 217 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------------HHH
Confidence 3211 122346889999999544 35788999999999999999999999743221 111
Q ss_pred hhhcCCCCCCCCC---cccHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYP---AKSLSHFADIISRCVQSEPEF--RPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 784 (801)
..+........+| ...+.++.+++.+|+..++.+ |+++++++++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111111111112 234678999999999876554 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.39 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=187.5
Q ss_pred eeeecCccEEEEEEeCCC---cEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 516 LIGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.||+|+||.||+|+..++ ..+++|.+.... .......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999965443 345666665432 2344578899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.++++..........+..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986433234567778889999999999999986 899999999999999999999999999864322211111
Q ss_pred ccccccccCcCCccccc--------CCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhh
Q 003704 673 SGHLLTAYGYGAPEFES--------GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~~~--------~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.....++..|+|||... ..++.++|||||||++|||++ |..||.......... ..+.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------------~~~~~~ 225 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------------HVIKDQ 225 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------HHHhhc
Confidence 23345677899999542 235789999999999999997 567775432211000 000000
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
......+..+......+.+++..|| .+|++||+++||++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0000112223334567889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.32 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=196.9
Q ss_pred hhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH----- 579 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~----- 579 (801)
...++|...+.||+|+||.||+|.. .+++.||||++............+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999964 5788999999875443334456677899999999999999999987542
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 580 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
...+++||++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 4568999988 7899988763 4589999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-cccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQL 734 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~~ 734 (801)
|+++..... .....++..|+|||...+ .++.++|||||||++|||++|+.||.......... ..... .+..
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999865433 223457888999995443 58899999999999999999999996533211000 00000 0000
Q ss_pred cchhh-----hhhhcC--CCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 735 HDIDA-----LSRMVD--PSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 735 ~~~~~-----~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..... ...... +.... .........+.+|+.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000 000000 00000 00012334678999999999999999999999773
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.63 Aligned_cols=262 Identities=21% Similarity=0.354 Sum_probs=204.0
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||+||++.. .+|+.||+|++.... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 4677889999999999999965 568999999886432 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.. ...+++..+..++.+++.+|.|||+. .+|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999875 24689999999999999999999974 37999999999999999999999999998654322
Q ss_pred CccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. .....++..|+||| +..+.++.++|||||||++|||++|+.||............ ...+ ...+..+...
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~--~~~~~~~~~~ 228 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---PMGI--LDLLQQIVQE 228 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---hhHH--HHHHHHHhhc
Confidence 1 22346788899999 45667899999999999999999999999854332110000 0000 0111111111
Q ss_pred CCCCCCCc-ccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 747 SLSGQYPA-KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.. ...+. ..+.++.+++.+||+.||++||++.|++++..-
T Consensus 229 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 229 PP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred cC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 11 11122 255679999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.58 Aligned_cols=199 Identities=25% Similarity=0.374 Sum_probs=169.2
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-C-----CCccccceEEEecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-H-----ANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H-----pnIv~l~~~~~~~~~ 581 (801)
-+|.+.++||+|+||.|.+| ...+++.||||+++... ....+-..|+.+|..++ | -|+|++++||...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 37899999999999999999 55789999999997543 33455567888888886 4 389999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC--CcEEEeecc
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD--LAVSVSDCG 659 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFG 659 (801)
.+||+|.+. .+|+++|+... ..+++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||
T Consensus 263 lciVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999985 49999998754 46799999999999999999999986 99999999999999653 379999999
Q ss_pred CCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~ 721 (801)
.|.+...... ....+..|+||| ++...|+.+.||||||||++||++|.+.|.+....
T Consensus 337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 9988765432 344556799999 66778999999999999999999999888766543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.89 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=200.9
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccC---chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS---SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
+|+..+.||+|+||.||+|... +++.|++|.+..... .....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999765 799999998864332 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999752 4588999999999999999999986 89999999999999999999999999987654
Q ss_pred CCCccccccccccccCcCCccc-ccCC-CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEF-ESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~-~~~~-~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
... ......++..|++||. .... ++.++|+|||||++|+|++|+.||...... ......
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~ 214 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----------------AAVFKI 214 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----------------HHHHHH
Confidence 432 1233456778999994 4444 889999999999999999999999753211 011111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11111123344566789999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.23 Aligned_cols=251 Identities=22% Similarity=0.402 Sum_probs=202.9
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|+||.||++.. .+|+.||+|++............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999954 5789999999875444444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987532 23578999999999999999999986 89999999999999999999999999987654432
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ..+.++.++|||||||++|+|++|+.||...... +....+....
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~~~~ 217 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKIIRGS 217 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHhcCC
Confidence 1 1223456778999994 4556889999999999999999999998643211 1111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+...+.++.+++.+||+.+|++||++.||+++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112344556789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.97 Aligned_cols=245 Identities=26% Similarity=0.473 Sum_probs=196.5
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++|+||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4578889999999999999975 67889999985422 345788999999999999999999998764 47899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999997542 34578999999999999999999986 99999999999999999999999999987543221
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.....+..|+||| ...+.++.++|||||||++|||++ |+.||....... ....+..
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~ 212 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVEK 212 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhC
Confidence 1222345699999 445678999999999999999998 999986532211 1111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
......+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 2222234455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.20 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=202.6
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||+|+||.||++... +|..||+|.+.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788899999999999999764 78999999886432 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999887531 134689999999999999999999974 38999999999999999999999999998765432
Q ss_pred CccccccccccccCcCCcccccC-------CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFESG-------IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
. .....++..|+|||...+ .++.++|||||||++|||++|+.||....... ....+
T Consensus 157 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------------~~~~~ 219 (286)
T cd06622 157 L----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------------IFAQL 219 (286)
T ss_pred c----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------------HHHHH
Confidence 1 223346778999995432 25789999999999999999999996432110 00111
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+... .....+...+.++.+++.+||+.+|++||++.+++.+-.
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 220 SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111111 112334456788999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.14 Aligned_cols=248 Identities=21% Similarity=0.389 Sum_probs=199.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
.|+..+.||+|+||.||+|.. .++..||+|.+..... ......+.+|++++++++|+||+++++++......++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 456678899999999999965 5688999998864432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999999863 4588999999999999999999985 89999999999999999999999999987665432
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ....++.++|||||||++|||++|+.||........ . ..+...
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~-~~~~~~ 216 (277)
T cd06642 156 I--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----------------L-FLIPKN 216 (277)
T ss_pred h--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----------------H-hhhhcC
Confidence 1 1222356778999994 455688999999999999999999999864322110 0 001111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.....+...+.++.+++.+||+.+|++||++.|++++-
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 11223344567799999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.03 Aligned_cols=250 Identities=21% Similarity=0.376 Sum_probs=202.0
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|+||.||++.. .+++.+|||.+............+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999964 5789999999876554555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEeeccCCCCcCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAPLISSG 667 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 667 (801)
+++++|.+++.... ...+++..+..++.+++++|+|||+. +|+|+||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997532 34588999999999999999999986 99999999999999865 46899999999876543
Q ss_pred CccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. .....++..|+|||.. ...++.++||||||+++|+|++|+.||....... .......
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----------------~~~~~~~- 215 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----------------LVLKIMS- 215 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----------------HHHHHHh-
Confidence 21 2234567789999954 4557899999999999999999999986532210 0111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
......+...+.++.+++.+||+.||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122344566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=329.04 Aligned_cols=263 Identities=18% Similarity=0.226 Sum_probs=197.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeC---CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
..+|.+.+.||+|+||.||++... .+..||||.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357899999999999999999643 4678999987532 234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 588888843 35689999999999999999999986 8999999999999999999999999999776
Q ss_pred CCCCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc----------ccc
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA----------IPQ 733 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~----------~~~ 733 (801)
.............||..|+|||++ ...|+.++|||||||++|||++|+.||............... .+.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 544332223345688999999954 456899999999999999999999999764332110000000 000
Q ss_pred ccc---hhhhhhhcCCCCCCCCC-------cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 734 LHD---IDALSRMVDPSLSGQYP-------AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 734 ~~~---~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
... ...... ........+. ...+.++.++|.+||..||++||++.|++.+-.
T Consensus 316 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 316 NGSTNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred ccchhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 000 000000 0001111111 123457889999999999999999999998743
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.46 Aligned_cols=268 Identities=18% Similarity=0.289 Sum_probs=199.1
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|++|.||+|.. .++..||||++............+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477789999999999999975 4789999999865443334456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589888865322 35689999999999999999999986 89999999999999999999999999987554321
Q ss_pred ccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccce--eecc------cccccchh
Q 003704 669 VSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL--VRWA------IPQLHDID 738 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~--~~~~------~~~~~~~~ 738 (801)
. ......++..|+|||... ..++.++|||||||++|||+||+.||........... ..+. .+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 112234567899999543 3478899999999999999999999975432111000 0000 00000001
Q ss_pred hhhhhcCCCC---CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVDPSL---SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......... ........+.++.+++.+||+.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1111111000 001122356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.50 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=204.3
Q ss_pred CCccCCeeeecCccEEEEEE-eCCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.|...+.||.|+||.||-|+ ..+...||||++.... .......+++.|+..+++++|||+|.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667889999999999996 4678899999986432 334445788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||-| +-.|++... ++++.+-.+..|..+.++||+|||+. +.||||||..|||+++.|.||++|||.|.+..+.
T Consensus 107 YClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9954 778887643 57889999999999999999999997 8999999999999999999999999999877654
Q ss_pred CccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..++||+.|||||++ .|.|+-|+||||||++..||...++|+..++... .+..+
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----------------ALYHI 237 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHI 237 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----------------HHHHH
Confidence 467899999999932 4679999999999999999999999998765432 22222
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
....-..-.....+..|++|+..||++-|.+|||..+++++-
T Consensus 238 AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 238 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 211111011235567899999999999999999999999764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=291.72 Aligned_cols=249 Identities=22% Similarity=0.424 Sum_probs=194.8
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+......||.|+.|+|++++. ..|..+|||.+.+.. ..+..+++..-+.++... ..|.||+.+|||......++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344567799999999999975 569999999997654 334445566666665554 48999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
.|.. -++.++.. ...++++...-++...++.||.||.+.| +|||||+||+|||+|+.|++|+||||++-++.+.
T Consensus 172 lMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9854 45555543 2467888888899999999999999975 8999999999999999999999999999877654
Q ss_pred CccccccccccccCcCCcccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFESG----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.. ...-.|-..|||||.+.. .|+-++||||||+.++||.||+.||..-.. +.+.+..+
T Consensus 246 kA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---------------dFe~ltkv 307 (391)
T KOG0983|consen 246 KA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---------------DFEVLTKV 307 (391)
T ss_pred cc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---------------cHHHHHHH
Confidence 32 334456677999995432 489999999999999999999999986322 23344444
Q ss_pred cCCCCCCCCC--cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYP--AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
++.. .+..+ ...+..|++++..||.+|+.+||...+++++
T Consensus 308 ln~e-PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 308 LNEE-PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HhcC-CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 4422 12222 2367889999999999999999999999876
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.10 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=194.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHH-hhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNN-IDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+++. .+|+.||+|++........ ...+..|+.. ++...|+||+++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 3688889999999999999965 4799999999875443333 3344445554 66678999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||++ |+|.+++.........+++..+..++.||+.||+|||+. .+++||||||+||+++.++.+||+|||++..+..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 688888865333345789999999999999999999974 2799999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES-----GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
... .....++..|+|||... ..++.++|+|||||++|||++|+.||...... .+.+.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~ 218 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------------FQQLK 218 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------------HHHHH
Confidence 211 12235677899999543 34688999999999999999999999642211 01111
Q ss_pred hhcCCCCCCCCC-cccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 742 RMVDPSLSGQYP-AKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 742 ~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..... .....+ ...+.++.+++.+||..||++||++.+++++-
T Consensus 219 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 219 QVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred HHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11111 111112 23457899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=319.63 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=219.2
Q ss_pred CCccCCeeeecCccEEEEEEeCC-CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+....++||-|.||.||.|.|+. .-.||||.++.+ .-..++|+.|..+|+.++|||+|+++|+|..+.-.|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34456789999999999998754 668999999643 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
|..|+|.++|++.. +..++.-..+.|+.||+.|++||... ++|||||-..|.|+.++..|||+|||+++++..+.
T Consensus 345 M~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999998754 34566777889999999999999985 89999999999999999999999999999988765
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
++...+ ..-..-|.||| +....++.|+|||+|||+|||+.| |-.||.+.+ ...+..++..
T Consensus 420 YTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LLEk 481 (1157)
T KOG4278|consen 420 YTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLLEK 481 (1157)
T ss_pred eecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHHhc
Confidence 433222 12234699999 566779999999999999999998 777876532 2345566777
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhhc
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 794 (801)
.++...|+.|++.+.+|++.||+++|.+||++.|+-+.++.++.+..-
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 788888999999999999999999999999999999999999875443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=355.98 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=214.2
Q ss_pred HhhhccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
+...+-+|.....||.|.||.||.| ..++|...|||.+..............+|+.++..++|||+|++||+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 4456678888999999999999999 567899999998876655556667788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
+|.||||++|+|.+++.. ....++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999999975 23456666777889999999999997 99999999999999999999999999998
Q ss_pred CcCCCCcc--ccccccccccCcCCcccccCC----CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 663 LISSGSVS--QLSGHLLTAYGYGAPEFESGI----YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 663 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
.+...... ..-....||+.|||||.+.+. ...+.||||+||++.||.||+.||...++.
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------------- 1447 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------------- 1447 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------------
Confidence 77654211 112346799999999966543 567899999999999999999999765431
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+ .+.--+..+-.++.|+..+.+-.+++..||+.||++|+++.|++++=
T Consensus 1448 ~-aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1448 W-AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred h-HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1 12222334455678888889999999999999999999999887653
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.34 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCccCCeeeecCccEEEEEEeCC--CcEEEEEEecccc--------CchhhHHHHHHHHHHhhc-cCCCCccccceEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPD--GKLLAVKKLDKRA--------SSQQKDDEFLELVNNIDR-IRHANIVELKGYCAE 578 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~--g~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~ 578 (801)
.|++.+.||+|+||.||+|.... ++.+|||.+.... ........+..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778999999999999997654 7889999875322 122234556778887764 799999999999999
Q ss_pred cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+. .+|+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998864332345689999999999999999999963 37999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccch
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 737 (801)
|++....... ......++..|++|| ...+.++.++||||||+++|||++|+.||......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---------------- 219 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---------------- 219 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----------------
Confidence 9997655432 123445778899999 44556899999999999999999999998643211
Q ss_pred hhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.....+.............+.++.+++.+||+.||++||++.|+..++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0111111111111112234578999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.19 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=201.4
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46788999999999999999964 6799999999864332 23466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999863 4578899999999999999999986 899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......++..|+|||. ....++.++|||||||++|+|++|+.||.......... ..+ ..
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~--------------~~ 230 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIA--------------TN 230 (297)
T ss_pred Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eec--------------cC
Confidence 321 1223456778999994 45568899999999999999999999997543211110 000 00
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+...+..+.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111234455678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.53 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=196.6
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc--------hhhHHHHHHHHHHhhccCCCCccccceEEEecC
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS--------QQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (801)
+|...+.||+|+||.||+|.. .+|+.||||.+...... ....+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999954 57899999988532111 112346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999753 4688899999999999999999986 899999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCcccc-cC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccch
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEFE-SG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 737 (801)
++...............++..|+|||.. .. .++.++||||||+++|||++|..||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------------ 222 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------------ 222 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------------
Confidence 8765432211112234567789999943 33 37899999999999999999999996432210000
Q ss_pred hhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+..................+.++.+++.+||..||++||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000011111122345789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.85 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=200.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||.|+||.||+|+. .+++.||+|.+.... .......+.+|+++++.++|+||+++++++.+....++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3678889999999999999965 468999999986543 23344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||+++.+...
T Consensus 80 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 80 YCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999999974 2689999999999999999999986 8999999999999999999999999999876543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ....++.++|||||||++|||+||+.||....... .... +..
T Consensus 152 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----------------~~~~-~~~ 212 (274)
T cd06609 152 MS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----------------VLFL-IPK 212 (274)
T ss_pred cc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----------------HHHH-hhh
Confidence 21 1223456778999994 45568999999999999999999999997533211 0000 111
Q ss_pred CCCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
......+.. .+.++.+++.+||..||++|||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 213 NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111112222 55679999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.96 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=202.0
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
.+|+..+.||.|+||.||+|. ..+|+.|++|.+.... ......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 568889999999999999996 4679999999986432 2334678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999863 4589999999999999999999986 8999999999999999999999999998765443
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ....++.++|||||||++|+|++|+.||......... ..+.. ..
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------------~~~~~--~~ 231 (296)
T cd06655 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------------YLIAT--NG 231 (296)
T ss_pred cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHh--cC
Confidence 21 1223457778999994 4556889999999999999999999999754321110 00000 00
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+...+..+.+++.+||..||++||++.+++++=
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 111123445567899999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.65 Aligned_cols=249 Identities=23% Similarity=0.440 Sum_probs=200.8
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|... +++.+++|.+.... ....+.+|++++++++|+||+++++++.+....+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57888999999999999999765 48899999986432 15788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999753 35689999999999999999999986 8999999999999999999999999998876543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ....++.++|||||||++|+|++|+.||........... +......
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~ 217 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKPPP 217 (256)
T ss_pred cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCCCC
Confidence 21 1223446778999994 445688999999999999999999999975432211100 0000000
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+...+.++.+++.+||+.||++||++.|++++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 --TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011223345679999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.84 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=199.7
Q ss_pred eeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
+||+|+||+||.|+.. +...+|||.+..... ....-+.+|+...++++|.|||+++|.+.+.+..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999764 556789999865432 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCcEEEeeccCCCCcCCCCccc
Q 003704 595 QDMLHSDDELKNNL--SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 595 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
.++++..- .++ .+.+.-.+..||++||.|||+. .|||||||-+|||++ -.|.+||+|||.++.+..- ..
T Consensus 660 SsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP 731 (1226)
T KOG4279|consen 660 SSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NP 731 (1226)
T ss_pred HHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cc
Confidence 99998642 334 6778888999999999999997 799999999999995 5899999999999876432 23
Q ss_pred cccccccccCcCCcccc-cC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 672 LSGHLLTAYGYGAPEFE-SG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~~-~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
......||..|||||++ .| .|+..+|||||||++.||.||++||........ .+.++---..
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyKv 796 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYKV 796 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcceec
Confidence 35567899999999954 44 399999999999999999999999975432111 1111111123
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+..|+..+.+...+|.+|+..||.+||+++++++.
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 456788889999999999999999999999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.97 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=197.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4677889999999999999965 578999999986432 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999875 34689999999999999999999986 8999999999999999999999999998765432
Q ss_pred CccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
. .......++..|+|||.. .+.++.++|||||||++|||++|+.||.............. ...
T Consensus 160 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-----------~~~ 226 (267)
T cd06645 160 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------SNF 226 (267)
T ss_pred c--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----------cCC
Confidence 1 112334678889999954 34588999999999999999999999864332111000000 000
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...... .....+..+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000 011234678999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.02 Aligned_cols=249 Identities=20% Similarity=0.379 Sum_probs=201.8
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
..|+..+.||.|+||.||+|.. .++..||||.+.... .......+.+|+++++++.|+||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788999999999999975 468899999986433 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999999863 3578889999999999999999986 8999999999999999999999999998766443
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ....++.++|||||||++|||++|+.||......... .....
T Consensus 155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~~ 215 (277)
T cd06640 155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLIPK 215 (277)
T ss_pred cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhhhc
Confidence 21 1223456778999995 4556899999999999999999999999754321100 01111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+...+..+.+++.+||+.+|++||++.+++++-
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 112233445667899999999999999999999998773
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=312.30 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=204.2
Q ss_pred chhhhHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEE
Q 003704 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYC 576 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~ 576 (801)
+++.++....++|...+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 55566777789999999999999999999965 578999999986432 2345677888889888 799999999998
Q ss_pred Eec-----CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 577 AEH-----GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 577 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
... +..++||||+++++|.++++........+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 753 358999999999999999874332345689999999999999999999986 899999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCcccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccccccc
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG------IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~ 725 (801)
.+||+|||++........ ......++..|+|||.... .++.++|||||||++|||++|+.||.......
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--- 240 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--- 240 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---
Confidence 999999999876543321 1223456778999995432 26789999999999999999999997532211
Q ss_pred eeecccccccchhhhhhhcCC-CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 726 LVRWAIPQLHDIDALSRMVDP-SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.++... ......+......+.+++.+||+.||++||++.|++++
T Consensus 241 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 -------------TLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -------------HHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111100 00111233445679999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.36 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=201.4
Q ss_pred cCCccCCeeeecCccEEEEEEeC------CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (801)
++|+..+.||+|+||.||+|+.. +.+.|++|.+.... .......+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46788899999999999999753 35679999885432 222456788999999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHhcCccc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEee
Q 003704 583 LLIYEYCSNGTLQDMLHSDDEL-----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 657 (801)
++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999754311 12689999999999999999999986 899999999999999999999999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccccc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 735 (801)
||++.......... .....++..|+|||. ..+.++.++||||||+++|+|++ |..||......
T Consensus 161 ~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------------- 225 (275)
T cd05046 161 LSLSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------------- 225 (275)
T ss_pred cccccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------------
Confidence 99987543322111 122345667999994 55668899999999999999999 78888543211
Q ss_pred chhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
..+............+...+..+.+++.+||+.||++||++.|+++.|.
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 --EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111111111234456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.00 Aligned_cols=268 Identities=25% Similarity=0.419 Sum_probs=202.0
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|... +++.||||++............+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999754 68899999987654445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|++++.+..++.. ...+++..+..++.||+.||+|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777766643 34589999999999999999999986 8999999999999999999999999998776544
Q ss_pred CccccccccccccCcCCccc-ccC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc--------h
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD--------I 737 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 737 (801)
... ......++..|+|||. ... .++.++||||||+++|+|++|+.||......+...........+.. .
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 321 1223456778999994 444 6889999999999999999999999754321110000000000000 0
Q ss_pred hh-----hhhhcCC-CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 738 DA-----LSRMVDP-SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~-----~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.. .....+. .....++...+.++.+++.+||..||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 00112334457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.89 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=196.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc---hhhHHHHHHHHHHhhccCCCCccccceEEEec--CeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (801)
++|+..+.||+|+||.||+|.. .+|+.||||.+...... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999965 56899999988543222 22346788899999999999999999998763 467
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998752 4578888999999999999999986 89999999999999999999999999987
Q ss_pred CcCCCCccc-cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 663 LISSGSVSQ-LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 663 ~~~~~~~~~-~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
......... ......++..|+|||. ....++.++|||||||++|||++|+.||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------------AAI 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------------HHH
Confidence 654321111 1122356778999994 4456889999999999999999999999643211 111
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+..........|......+.+++.+|+. +|++||+++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111111223345556778899999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=310.37 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=198.8
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
.|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3567788999999999999764 5788899988543 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|..++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 84 CAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred cCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999999988642 34689999999999999999999986 99999999999999999999999999987654321
Q ss_pred ccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 669 VSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.......++..|+|||.+. ..++.++|||||||++|||++|+.||....... ....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----------------~~~~ 219 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----------------VLLK 219 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----------------HHHH
Confidence 1123345778899999542 347789999999999999999999986532210 1111
Q ss_pred hcCC-CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 743 MVDP-SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 743 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+... ......+...+.++.+++.+||+.||++||++.+++++-.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 220 IAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 1100 0011123445678999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=325.02 Aligned_cols=241 Identities=23% Similarity=0.304 Sum_probs=185.6
Q ss_pred eeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhcc---CCCCccccceEEEecCeEEEEEeccCC
Q 003704 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI---RHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
||+|+||+||+|+. .+|+.||||++.+.... ......+..|..++.+. .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999965 56899999998643221 12223444566666554 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999999875 35688999999999999999999986 89999999999999999999999999987543221 1
Q ss_pred cccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCC
Q 003704 672 LSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (801)
......|+..|+|||.+.+ .++.++|||||||++|||++|+.||....... ....+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------------MYRNIAFGKV- 214 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----------------HHHHHHcCCC-
Confidence 1234568889999995433 47899999999999999999999997532210 0111111111
Q ss_pred CCCC-cccHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 003704 750 GQYP-AKSLSHFADIISRCVQSEPEFRP----PMSEVVQD 784 (801)
Q Consensus 750 ~~~~-~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~ 784 (801)
.++ ...+.++.+++.+||+.||++|| ++.|++++
T Consensus 215 -~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 215 -RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112 23456789999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.48 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
.++.+.....||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344555567899999999999964 568889999886432 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeeccCCC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNL--SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 662 (801)
|||+++++|.+++.... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999997531 234 7888889999999999999986 9999999999999986 6799999999987
Q ss_pred CcCCCCccccccccccccCcCCccccc-C--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFES-G--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
....... ......++..|+|||... . .++.++||||||+++|+|++|+.||........ .
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---------------~ 220 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---------------A 220 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---------------h
Confidence 6543221 122234677899999543 2 378899999999999999999999964321100 0
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.............+.....++.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000011223455566789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=306.86 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=203.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||.|+||+||+|.. .++..+++|++....... ....+.+|++.++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688899999999999999964 578899999986544333 55778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999975321 24689999999999999999999986 8999999999999999999999999998766543
Q ss_pred Cccc--cccccccccCcCCcccc-cC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 668 SVSQ--LSGHLLTAYGYGAPEFE-SG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~--~~~~~~~~~~y~aPE~~-~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.... ......++..|+|||.+ .. .++.++|||||||++|||++|+.||........ ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~-----------~~~~ 222 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML-----------TLQN 222 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH-----------HhcC
Confidence 3211 22334577889999944 34 588999999999999999999999975432110 000 0000
Q ss_pred cCCCCCCC-CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQ-YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+... .....+.++.+++.+||+.||++||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00011100 112455788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.23 Aligned_cols=266 Identities=20% Similarity=0.327 Sum_probs=196.9
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|+||.||+|+. .+|+.||+|++............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477788999999999999965 5789999999875443333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++ +|.+++... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 788877643 34589999999999999999999986 89999999999999999999999999987654332
Q ss_pred ccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc--eeec-ccccccchhhhhhh
Q 003704 669 VSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--LVRW-AIPQLHDIDALSRM 743 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~ 743 (801)
. ......++..|+|||.+.+ .++.++|||||||++|||+||+.||.......... +... ..+....+..+...
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 1 1122345678999995433 37899999999999999999999875432211100 0000 00000000011111
Q ss_pred cCCCCC---------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLS---------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.... .......+.++.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 110000 01112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.59 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=198.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+.|++.+.||.|+||.||+|+. .++..|++|.+... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 5688899999999999999976 45899999998643 33445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|..++... ...+++..+..++.|++.+|+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999888643 34689999999999999999999986 8999999999999999999999999998654322
Q ss_pred CccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
. .......++..|+|||.+. ..++.++|||||||++|||++|+.||...... ....
T Consensus 164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~~ 225 (292)
T cd06644 164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLL 225 (292)
T ss_pred c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----------------HHHH
Confidence 1 1122345677899999542 34688999999999999999999998643211 0111
Q ss_pred hhcCCCC-CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 742 RMVDPSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+..... ....+...+.++.+++.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 226 KIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111100 111233455678999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.20 Aligned_cols=238 Identities=23% Similarity=0.370 Sum_probs=185.7
Q ss_pred CeeeecCccEEEEEEeCC-------------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 515 NLIGAGMLGSVYRAQLPD-------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
+.||+|+||.||+|...+ ...|++|.+... .......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999996432 235888887543 23344578889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc-------EE
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA-------VS 654 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~k 654 (801)
.++||||+++++|..++... ...+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999999988743 24589999999999999999999986 8999999999999987664 89
Q ss_pred EeeccCCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHH-hCCCCccccccccccceeeccc
Q 003704 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELL-TGRKSYDRTRNRGEQFLVRWAI 731 (801)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~ 731 (801)
++|||++...... ....++..|+|||... ..++.++|||||||++|||+ +|+.||.......
T Consensus 153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------- 217 (262)
T cd05077 153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------- 217 (262)
T ss_pred eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------
Confidence 9999998655322 2334667899999543 45899999999999999998 5888876432110
Q ss_pred ccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
... ...... ........++.+|+.+||+.||++||++.+|++.|
T Consensus 218 -----~~~---~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 -----KER---FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----HHH---HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 001 011111 11122346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.29 Aligned_cols=255 Identities=24% Similarity=0.458 Sum_probs=201.8
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc----hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
+|+..+.||+|+||.||++.. .+++.||+|++...... ......+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999964 67899999998643321 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-cEEEeeccCCCC
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~ 663 (801)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999975 34688999999999999999999986 999999999999998776 599999999877
Q ss_pred cCCCCcc--ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 664 ISSGSVS--QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 664 ~~~~~~~--~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
+...... .......++..|+|||. ....++.++||||+||++|+|++|+.||........ ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------------~~~~ 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------------LALI 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------------HHHH
Confidence 6543211 11223457788999994 445688999999999999999999999964321110 0111
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+..........+...+.++.+++.+|+..||++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111122233455566789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.60 Aligned_cols=267 Identities=19% Similarity=0.345 Sum_probs=200.0
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999764 68999999986544333344567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999887754 34589999999999999999999986 8999999999999999999999999999876543
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-ecccccccchhhh----
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-RWAIPQLHDIDAL---- 740 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~---- 740 (801)
.. ......++..|+|||... ..++.++|||||||++|||++|+.||......+..... ............+
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 112334667899999543 35789999999999999999999999754432111000 0000000000000
Q ss_pred ---hhhcCCCCCCC-----CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 ---SRMVDPSLSGQ-----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ---~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+..... .-...+..+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000 011235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.61 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=201.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|...+.||+|+||.||+|.. .+++.|++|.+............+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999965 4789999999876554445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ...+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999975 23578889999999999999999986 89999999999999999999999999988765443
Q ss_pred cccc--ccccccccCcCCcccccC-C---CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 669 VSQL--SGHLLTAYGYGAPEFESG-I---YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 669 ~~~~--~~~~~~~~~y~aPE~~~~-~---~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.... .....++..|+|||...+ . ++.++||||||+++|||++|+.||........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---------------~~~~ 218 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---------------IMFH 218 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---------------HHHH
Confidence 2111 112456778999995443 3 78899999999999999999999975321100 0000
Q ss_pred hcCCCCCCCCCcc--cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 743 MVDPSLSGQYPAK--SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+. .......|.. .+..+.+++.+||+.||++||++.|++.+
T Consensus 219 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 VG-AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred Hh-cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0111122222 36778999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.68 Aligned_cols=267 Identities=20% Similarity=0.375 Sum_probs=200.6
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999764 68999999987654444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.++... ...+++..+..++.||++||+|||+. +|+||||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999888764 24589999999999999999999986 8999999999999999999999999998765443
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccccc-------ccch
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIPQ-------LHDI 737 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~-------~~~~ 737 (801)
.. ......++..|+|||... ..++.++|||||||++|||++|+.||.......... +..+.... ....
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 21 122345677899999543 347889999999999999999999986433211000 00000000 0000
Q ss_pred hhhhhhcCCCCCC-----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 738 DALSRMVDPSLSG-----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+..+.... ......+..+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0112345779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.71 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=186.9
Q ss_pred CCeeeecCccEEEEEEeC---CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeEEEEEec
Q 003704 514 ENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIYEY 588 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 588 (801)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999754 568899999864322 2456789999999999999999998854 4568899999
Q ss_pred cCCCCHHHHHhcCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCcEEEeecc
Q 003704 589 CSNGTLQDMLHSDDE-----LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCG 659 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFG 659 (801)
+.+ +|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 864 88888753211 123588999999999999999999986 89999999999999 456789999999
Q ss_pred CCCCcCCCCcc-ccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccce------ee--
Q 003704 660 LAPLISSGSVS-QLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL------VR-- 728 (801)
Q Consensus 660 la~~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~------~~-- 728 (801)
+++.+...... .......+|..|+|||.+. ..++.++||||+||++|||++|++||........... ..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99876543211 1123356788999999543 3489999999999999999999999975432111000 00
Q ss_pred ---cccccccchhhhhhhcC---------C-CCC--------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 729 ---WAIPQLHDIDALSRMVD---------P-SLS--------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 729 ---~~~~~~~~~~~~~~~~~---------~-~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...+...+++.+..+.. . ... .........++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000001111100000 0 000 00001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.90 Aligned_cols=258 Identities=22% Similarity=0.381 Sum_probs=198.7
Q ss_pred hhhHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEe
Q 003704 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (801)
Q Consensus 501 ~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~ 578 (801)
+.++......|+..+.||.|+||.||+|.. .+++.+|+|++... ......+..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 334444567888999999999999999965 57899999988542 23345677888888888 69999999999853
Q ss_pred ------cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc
Q 003704 579 ------HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (801)
Q Consensus 579 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 652 (801)
....++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 457899999999999999997532 34578888999999999999999986 8999999999999999999
Q ss_pred EEEeeccCCCCcCCCCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccce
Q 003704 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL 726 (801)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 726 (801)
++|+|||++....... .......++..|+|||.+. ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-- 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-- 235 (282)
T ss_pred EEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence 9999999987653221 1122345778899999543 34788999999999999999999999643221110
Q ss_pred eecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 727 VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+.............+.++.+++.+||+.||.+||++.|++++
T Consensus 236 --------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00011111111122455789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.47 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=200.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|+||.||+|.. .+++.+++|.+..... .....+.+|++++++++||||+++++++.+.+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 5788899999999999999965 4678999999864432 245778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999998753 24688999999999999999999986 8999999999999999999999999998765432
Q ss_pred CccccccccccccCcCCcccc-cC---CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE-SG---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~-~~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.. ......++..|+|||.. .. .++.++|||||||++|||++|+.||.......... .+...
T Consensus 155 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-------------~~~~~ 219 (262)
T cd06613 155 IA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-------------LISKS 219 (262)
T ss_pred hh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhc
Confidence 11 12234567789999954 33 68889999999999999999999997533211100 00000
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.-.......+...+.++.+++.+||..||.+|||+.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000111223445679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=308.48 Aligned_cols=237 Identities=24% Similarity=0.402 Sum_probs=183.9
Q ss_pred eeeecCccEEEEEEeCC-------------------------CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCcc
Q 003704 516 LIGAGMLGSVYRAQLPD-------------------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv 570 (801)
.||+|+||.||+|.... ...|++|++.... ......+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999986311 1358888885432 23345688889999999999999
Q ss_pred ccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 003704 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (801)
Q Consensus 571 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 650 (801)
++++++.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+. +|+||||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 9999999999999999999999999998653 34688999999999999999999985 89999999999999764
Q ss_pred C-------cEEEeeccCCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHH-hCCCCcccccc
Q 003704 651 L-------AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELL-TGRKSYDRTRN 720 (801)
Q Consensus 651 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~ell-tG~~pf~~~~~ 720 (801)
+ .+|++|||++...... ....++..|+|||... ..++.++|||||||++|||+ +|+.||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3 3899999987544322 1234566799999543 35889999999999999995 69999865322
Q ss_pred ccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 721 RGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
... ....... ...+.....++.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~~-----------------~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEK-----------------ERFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-----------------HHHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 110 0001110 012223345789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.35 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=201.6
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999654 59999999997654332 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987432 35689999999999999999999986 899999999999999999999999999875532
Q ss_pred CCcc---------------------------ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 003704 667 GSVS---------------------------QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718 (801)
Q Consensus 667 ~~~~---------------------------~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~ 718 (801)
.... .......++..|+||| .....++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 0112235677899999 44556889999999999999999999999754
Q ss_pred ccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 003704 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP----MSEVVQD 784 (801)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 784 (801)
... ..+.++.............+.++.+++.+||+.||++||+ +.|++++
T Consensus 236 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 321 1111122211111111225678999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.64 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=198.6
Q ss_pred CccCCeeeecCccEEEEEEeCC-----CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQLPD-----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
|++.+.||.|+||.||++...+ +..||+|++..... ......+..|++.++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3457889999999999997643 48899999864432 22557888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999997532 12289999999999999999999986 89999999999999999999999999998765
Q ss_pred CCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
........ ...++..|+|||. ....++.++||||||+++|||++ |+.||...... .+.+.
T Consensus 155 ~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----------------~~~~~ 216 (258)
T smart00219 155 DDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----------------EVLEY 216 (258)
T ss_pred cccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHH
Confidence 54222111 1225678999994 45568999999999999999998 78888642211 11111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+........+...+.++.+++.+|+..||++|||+.|+++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111223344667899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.51 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=212.6
Q ss_pred CCccCCeeeecCccEEEEEEeC---CC--cEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP---DG--KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~---~g--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
.....++||+|.||.||+|... .| -.||||.-+.+...+ ..+.|..|.-++++++|||||+++|+|.+. -.++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 3455688999999999999653 23 368888876554443 478899999999999999999999999875 5689
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
|||.++-|.|..++... +..++......+..||+.+|+|||+. .+|||||-..|||+...--||++|||+++.+
T Consensus 468 vmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999865 46789999999999999999999996 8999999999999999999999999999998
Q ss_pred CCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
....+...+ ...-+.-||||| +.-..++.++|||-|||.+||++. |..||.+-.+.+- ..
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~ 603 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IG 603 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EE
Confidence 876554322 333345699999 555679999999999999999997 9999986544321 11
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
.++.+-+...|+.|+..+..|+.+||.+||.+||.+.|+...|.++.+.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2233344567889999999999999999999999999999999998873
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.97 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=211.5
Q ss_pred CccCCeeeecCccEEEEEEeC--CCc--EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQLP--DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
....++||+|.||.|++|.|. .|+ .||||.+....... ....|++|+.+|.+++|+|+|+|||++.+ ....+||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 345688999999999999764 344 68999997654433 67889999999999999999999999988 5678999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|.++.|+|.+.|+. ..+..+.......++.|||.|+.||... ++|||||-..|||+-....|||+|||+++-+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999997 3356788888999999999999999986 899999999999999999999999999998876
Q ss_pred CCc-cccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhh
Q 003704 667 GSV-SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 667 ~~~-~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
... +.+.....-.+.|.||| +....++.++|||+|||+||||+| |..||.+... ..+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHh
Confidence 543 33444555667899999 556779999999999999999998 7888876432 123344
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
+|.+-+-..|..|++.+.+++..||..+|++|||+..|.+.+...
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 555555566889999999999999999999999999998555433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.13 Aligned_cols=267 Identities=20% Similarity=0.325 Sum_probs=197.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|...+.||+|+||.||+|+. .+++.||+|.+..... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5688899999999999999965 4688999999864432 2233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 5898888653 34578999999999999999999986 9999999999999999999999999998764432
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-cccccchhhh---
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQLHDIDAL--- 740 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~--- 740 (801)
.. ......++..|+|||... ..++.++|||||||++|||++|+.||.......... ..... .+....+..+
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 21 112234577899999543 347889999999999999999999997543211100 00000 0000000000
Q ss_pred hhhcC---CCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 741 SRMVD---PSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 741 ~~~~~---~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..... +.... ......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000 00000 01123456789999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.02 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=201.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||++.. .+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688889999999999999965 4689999999864332 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999753 5688999999999999999999986 999999999999999999999999999877654
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .....++..|+||| +....++.++||||||+++|+|++|+.||...... .....+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~ 212 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------------QIYEKILE 212 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhc
Confidence 3 22345778899999 44556889999999999999999999999653210 11111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
. ...++...+..+.+++.+||..||.+|+ +++|++++
T Consensus 213 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 213 G--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred C--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1 1123445567899999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.85 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=199.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 585 (801)
++|+..+.||.|++|.||++.. .+++.+|+|.+..... ......+.+|++++++++||||+++++++.+ .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3577889999999999999976 5688999999865432 2445778899999999999999999999865 3478999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998764332345688899999999999999999986 89999999999999999999999999987654
Q ss_pred CCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
... .....++..|+||| .....++.++|||||||++|+|++|+.||......... .......+....
T Consensus 157 ~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~ 224 (287)
T cd06621 157 NSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--------PIELLSYIVNMP 224 (287)
T ss_pred ccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--------hHHHHHHHhcCC
Confidence 322 12334667899999 45567899999999999999999999999754220000 000000011100
Q ss_pred CCCCCCCCC--cccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 745 DPSLSGQYP--AKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 745 ~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
...+..... ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 011111111 23356789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.64 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=205.0
Q ss_pred CCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|++.+.||+|+||.||++. ..+++.+++|.+............+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999995 45788999999876554555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876433346789999999999999999999986 89999999999999999999999999997765441
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.....++..|++|| .....++.++|+||||+++|||++|+.||...... .+...+...
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~ 216 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRG 216 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcC
Confidence 22344677899999 44556888999999999999999999999754321 111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+.++.+++.+|++.+|++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122334556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.81 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=200.8
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||.|+||.||++.. .++..+|+|.+... .......+.+|++++++++|+||+++++++......++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5688889999999999999975 46899999998633 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999998753 34689999999999999999999986 8999999999999999999999999998655332
Q ss_pred CccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.. ......++..|+|||... ..++.++|||||||++|||++|+.||....... .+.
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----------------~~~ 218 (280)
T cd06611 157 LQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----------------VLL 218 (280)
T ss_pred cc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----------------HHH
Confidence 11 122345777899999532 346789999999999999999999997532211 111
Q ss_pred hhcCCC-CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 742 RMVDPS-LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 742 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.+.... .....+...+.++.+++.+||+.||++||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 111100 01112344567899999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.76 Aligned_cols=236 Identities=25% Similarity=0.442 Sum_probs=184.9
Q ss_pred CeeeecCccEEEEEEeCCCc-----------EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEE
Q 003704 515 NLIGAGMLGSVYRAQLPDGK-----------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (801)
+.||+|+||.||+|...+.. .+++|.+..... ....+.+|+.++++++|+||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999765432 577787653321 15788899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-------cEEEe
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-------AVSVS 656 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~ 656 (801)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999999998632 2689999999999999999999986 899999999999999888 79999
Q ss_pred eccCCCCcCCCCccccccccccccCcCCcccccC---CCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccc
Q 003704 657 DCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG---IYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 732 (801)
|||++...... ....++..|+|||.+.+ .++.++|||||||++|||++ |..||.........
T Consensus 151 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------- 216 (259)
T cd05037 151 DPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------- 216 (259)
T ss_pred CCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--------
Confidence 99998765431 22334567999995443 58899999999999999999 57777543211100
Q ss_pred cccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.... .. ...+......+.+++.+||..+|++||++.|+++.|
T Consensus 217 ------~~~~--~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 217 ------RFYQ--DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------HHHh--cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 00 011122226789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.72 Aligned_cols=238 Identities=24% Similarity=0.443 Sum_probs=186.6
Q ss_pred CeeeecCccEEEEEEeC-CC-------cEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 515 NLIGAGMLGSVYRAQLP-DG-------KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.||+|+||.||+|... .+ ..|++|.+... .....+.+.+|+.+++.+.||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46899999999999653 22 34788877532 2334467888999999999999999999999989999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc--------EEEeec
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA--------VSVSDC 658 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DF 658 (801)
||+++|+|.++++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999997542 3688999999999999999999986 9999999999999987765 699999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCC-CCccccccccccceeeccccccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGR-KSYDRTRNRGEQFLVRWAIPQLH 735 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~ 735 (801)
|++...... ....++..|+|||...+ .++.++|||||||++|||++|. .||.......
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------------- 213 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------------- 213 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------------
Confidence 998655432 23456778999995543 4789999999999999999985 5554322110
Q ss_pred chhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
....... ...+|.....++.+++.+||+.||++|||++++++.|
T Consensus 214 ----~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 ----KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0001111 1123444557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.90 Aligned_cols=252 Identities=24% Similarity=0.429 Sum_probs=201.1
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|+||.||++... +++.+|+|++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999764 689999999875432 34557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997532 568899999999999999999998 5 8999999999999999999999999998665432
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ....++..|+|||. ....++.++||||||+++|+|++|+.||......... ....+......
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~ 219 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----------IFELLQYIVNE 219 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----------HHHHHHHHhcC
Confidence 11 11556778999994 4556899999999999999999999999754221000 00111111111
Q ss_pred CCCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. ....+.. .+.++.++|.+||..||++|||+.|++.+
T Consensus 220 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 P-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 1112222 56779999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.47 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=199.1
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecC----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG---- 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~---- 580 (801)
..++|+..+.||+|+||.||+|.. .+++.+++|++.... .....+.+|+.+++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457899999999999999999976 468899999986432 2346788999999998 6999999999997644
Q ss_pred --eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 581 --QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 581 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999875332245789999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccc
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 732 (801)
|++....... .......++..|+|||... ..++.++|||||||++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------- 225 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---------- 225 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----------
Confidence 9987654322 1122345778899999542 236789999999999999999999996432211
Q ss_pred cccchhhhhhhcCCCC-CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 733 QLHDIDALSRMVDPSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.++..... ....+...+.++.+++.+||..||++|||+.|++++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 ------ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111100 111223355689999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.95 Aligned_cols=251 Identities=21% Similarity=0.376 Sum_probs=200.2
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|+||.||++.. .+|..+|+|.+..........+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477789999999999999965 4689999999865443334556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-cEEEeeccCCCCcCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSG 667 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 667 (801)
+++++|.+++.... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997532 23579999999999999999999986 899999999999999875 4699999998766543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ......++..|+|||. ....++.++|||||||++|||++|+.||...... +.+......
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~ 217 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----------------QLVLKICQG 217 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHhcc
Confidence 21 1223457788999994 4556899999999999999999999998643211 111111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
... ..+...+.++.+++.+||..+|++|||+.|++++
T Consensus 218 ~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 YFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111 1223445679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.34 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=201.4
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999975 5789999999876554444567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+ +++|.+++... ...+++..+..++.||++||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998753 25689999999999999999999986 89999999999999999999999999988765432
Q ss_pred ccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee-c------ccccccchh
Q 003704 669 VSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR-W------AIPQLHDID 738 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~-~------~~~~~~~~~ 738 (801)
. .......++..|+|||... ..++.++||||+||++|||++|+++|.......... ... . ..+...+..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 1122345777899999543 346899999999999999999988886543211000 000 0 000000000
Q ss_pred hhhhhcCCCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVDPSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+....... ......+.++.+++.+||+.||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0112334788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.52 Aligned_cols=252 Identities=23% Similarity=0.447 Sum_probs=204.5
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|++|.||+|... +++.|+||++...... .....+.+|++.+.+++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36788899999999999999765 5999999998754432 456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|+++++|.+++... ..+++..+..++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999753 568999999999999999999998 6 899999999999999999999999999887654
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.... .....++..|+||| .....++.++||||||+++|+|++|+.||........ ......+..
T Consensus 153 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-------------~~~~~~~~~ 217 (264)
T cd06623 153 TLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-------------FELMQAICD 217 (264)
T ss_pred CCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-------------HHHHHHHhc
Confidence 3221 12345677899999 4555688999999999999999999999976432100 011111111
Q ss_pred CCCCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. .....+.. .+..+.+++.+||..+|++||++.|++++
T Consensus 218 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 G-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 11122333 56789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=321.62 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=214.7
Q ss_pred CccCCeeeecCccEEEEEEe-CCCc----EEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
....++||+|+||+||||.+ +.|+ +||||++.. ....+...++.+|+-+|.++.|||+++++++|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34468999999999999954 4554 688888864 345556788999999999999999999999998765 7899
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
++||+.|.|.++++.. +..+.....+.|..|||+||.|||.+ ++|||||-.+|||+.....+||.|||+++.+.
T Consensus 776 tq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999874 56788899999999999999999986 89999999999999999999999999999988
Q ss_pred CCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.+............+-|||=| +....|+.++|||||||.+||++| |..||++... +.+.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dl 912 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDL 912 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHH
Confidence 776544444444455688888 556679999999999999999998 9999986532 334444
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
++...+-..|..++.++..++.+||..|++.||+++++...+.++.+
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 55554555688899999999999999999999999999999988764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.08 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=207.2
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 586 (801)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++.+++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999765 799999999876554445667889999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999753 3789999999999999999999986 899999999999999999999999999887665
Q ss_pred CCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
...........++..|++||.. ...++.++||||||+++|+|++|+.||...... ...+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------------MAALYKIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHHHHhccc
Confidence 4321112334567789999954 445899999999999999999999999754310 011111222
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+...+..+.+++.+|++.||++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 222234455667889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.32 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=202.2
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+|+..+.||.|+||.||+|... ++..||+|.+.+..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999764 68999999987543322 445788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+.+++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999752 4688999999999999999999986 8999999999999999999999999998766543
Q ss_pred CccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
. ......++..|+|||. ....++.++|+||||+++|+|++|+.||........ ..+......
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~ 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--------------DQIRAKQET 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--------------HHHHHHhcc
Confidence 2 1223456678999994 445589999999999999999999999975432100 111111111
Q ss_pred CCCCCCCcccHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPM--SEVVQ 783 (801)
Q Consensus 747 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~ 783 (801)
.....+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 2233455667889999999999999999999 76654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.68 Aligned_cols=247 Identities=21% Similarity=0.394 Sum_probs=199.2
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
-|+..+.||+|+||.||+|.. .++..||||.+..... ......+.+|++.+++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788999999999999965 5789999998864332 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ..+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999863 4588999999999999999999985 99999999999999999999999999987654332
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ....++.++|||||||++|+|++|..||....... ... .+...
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----------------~~~-~~~~~ 216 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----------------VLF-LIPKN 216 (277)
T ss_pred h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----------------HHH-HHhcC
Confidence 1 1223456778999995 44567889999999999999999999986432110 000 11111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122334456789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.91 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=197.7
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
..+.|+..+.||+|+||.||+|.. .+|+.||+|++.... ........+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 345688899999999999999965 478999999986433 233344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999997 5777776532 34689999999999999999999986 8999999999999999999999999998765
Q ss_pred CCCCccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
... ....++..|+|||.. .+.++.++||||||+++|||++|+.||........ .
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----------------~ 223 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------L 223 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----------------H
Confidence 432 234566789999954 34588999999999999999999999865432110 0
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..+.........+...+.++.+++.+||+.||++||++.+++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 224 YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 011110001111223456799999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.34 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=196.4
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
.|.....||+|+||.||++.. .++..||||.+... .....+.+.+|+..++.++|+||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344457799999999999965 57899999998543 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 101 LEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999998853 3588999999999999999999986 89999999999999999999999999987553321
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ....++.++|||||||++|||++|+.||....... ....+.......
T Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------------~~~~~~~~~~~~ 237 (292)
T cd06658 173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------------AMRRIRDNLPPR 237 (292)
T ss_pred c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHhcCCCc
Confidence 1 1223457788999994 45568999999999999999999999996432210 001111111111
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.. .....+..+.+++.+||..||.+|||+.|++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 122345678899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.45 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=211.6
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
-...|.+...||+|.|+.|..|+. .+|..||||.+++..........+.+|++++..+.|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456789999999999999999964 5799999999998877777767789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+.+|.+++++...+ ...+..+..++.|+.++++|||+. .|||||||.+||||+.++++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999998754 344578888999999999999986 89999999999999999999999999999887
Q ss_pred CCCccccccccccccCcCCcccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.+. .....+|++.|.|||+..+. .++++|+||+|+++|-|+.|..||++..-..-.. +.
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~----------------rv 267 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP----------------RV 267 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc----------------hh
Confidence 653 34567889999999965553 5689999999999999999999998643211100 01
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
+...+ ..|.....+..++|.+++..+|.+|++++++.++-+.
T Consensus 268 l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 268 LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 11111 1344556678899999999999999999999877543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.72 Aligned_cols=267 Identities=19% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||.|++|.||+|+. .+|+.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999965 4789999999875444444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68999887532 35689999999999999999999986 89999999999999999999999999987654322
Q ss_pred ccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccc-------ccccchh
Q 003704 669 VSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAI-------PQLHDID 738 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~-------~~~~~~~ 738 (801)
. ......++..|+|||...+ .++.++|||||||++|||+||+.||.......... ...+.. +......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 1122345678999995433 36889999999999999999999996533211100 000000 0000000
Q ss_pred hhhhhcCCCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALSRMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............ ........++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0012234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.77 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=197.5
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc---hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
+|+..+.||+|+||.||+|.. .+|+.||||++...... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367788999999999999975 47899999999755433 33345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997532 3689999999999999999999986 89999999999999999999999999997665
Q ss_pred CCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeec-ccccccchhh--
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRW-AIPQLHDIDA-- 739 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~-~~~~~~~~~~-- 739 (801)
.... ......++..|+|||.+. ..++.++|||||||++|||++|.++|.......... .... ..+.......
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 4321 112223466799999543 357899999999999999999988876433211000 0000 0000000000
Q ss_pred -hhhhcCCCCCCC-----CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 -LSRMVDPSLSGQ-----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 -~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............ .....+.++.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.38 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=195.9
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||++.. .+++.|++|.+...... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688889999999999999965 46889999998654321 233457788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999752 4588999999999999999999986 899999999999999999999999999864211
Q ss_pred CCc-------------cccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccc
Q 003704 667 GSV-------------SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 667 ~~~-------------~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 732 (801)
... ........++..|+||| +....++.++|||||||++|||++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----------- 222 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------- 222 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence 100 00111234677899999 45567899999999999999999999999643211
Q ss_pred cccchhhhhhhcCCCC-CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 733 QLHDIDALSRMVDPSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
+.......... ........+.++.+++.+||+.||++||++.++.+.|.
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 223 -----ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -----HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 01111111110 01111245677999999999999999999544444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.82 Aligned_cols=253 Identities=25% Similarity=0.444 Sum_probs=206.9
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||.|+||.||++.. .++..|++|++............+.+|++.+++++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477789999999999999965 4689999999976555556667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986432236789999999999999999999986 99999999999999999999999999987765432
Q ss_pred ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.......++..|+||| .....++.++||||+|+++|+|++|+.||...... ........ .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~-~ 218 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------ELALKILK-G 218 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HHHHHHhc-C
Confidence 1223345677899999 45556889999999999999999999999653211 01111111 1
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+.++.+++.+||..+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1223444566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.65 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=198.1
Q ss_pred cCCeeeecCccEEEEEEe-CCCcEEEEEEecccc--CchhhHHHHHHHHHHhhccCCCCccccceEEEecCe--EEEEEe
Q 003704 513 QENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA--SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ--RLLIYE 587 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~E 587 (801)
..++||+|+|-+||||.+ .+|..||--.++... ........|..|+.+|+.|+|+|||++|+++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 357899999999999954 568777754333222 233445889999999999999999999999987554 779999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeeccCCCCcCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISS 666 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 666 (801)
.|..|+|..|+.+. ..++......|++||++||.|||++ .++|||||||.+||+++. .|.|||+|.|+|+....
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999863 5678889999999999999999997 689999999999999975 68999999999988765
Q ss_pred CCccccccccccccCcCCcccccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. ..++.||+.|||||+....|+..+||||||+.++||+|+..||..-.+. ..+.+.+-.
T Consensus 199 s~----aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----------------AQIYKKV~S 258 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----------------AQIYKKVTS 258 (632)
T ss_pred cc----cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCH----------------HHHHHHHHc
Confidence 42 3447899999999988899999999999999999999999999753321 112222222
Q ss_pred CCCC-CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 747 SLSG-QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 747 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+..+ .+..-..+++++||.+|+.. .++|||+.|+|++=
T Consensus 259 GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 259 GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 2111 12223346899999999999 99999999999753
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.40 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=200.9
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36788899999999999999964 578899999985432 233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred ecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999999874 3578899999999999999999986 899999999999999999999999999876544
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......++..|++|| ...+.++.++|||||||++|+|++|+.||.......... ... ..
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~~-------------~~ 230 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIA-------------TN 230 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--ehh-------------cC
Confidence 321 123345777899999 455668899999999999999999999997543221110 000 00
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.......+...+..+.+++.+||..+|++||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0001112334456789999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.53 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=188.6
Q ss_pred eeeecCccEEEEEEe-CCCcEEEEEEeccccCchh-hHHHHHHHHHH---hhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 516 LIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ-KDDEFLELVNN---IDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+||+|+||.||++.. .+++.+|||.+.+...... ....+.+|..+ +....|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 5689999999865433222 22233344333 334479999999999999999999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999875 34689999999999999999999986 89999999999999999999999999987554321
Q ss_pred ccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 671 QLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
.....++..|+|||... ..++.++|||||||++|||++|+.||........ ..+.+.. ...
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~-~~~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMT-LTV 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------------HHHHHHh-hcC
Confidence 12345788999999543 3478999999999999999999999975322110 1111111 111
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQDL 785 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 785 (801)
....+...+.++.+++.+||+.||++|| +++|++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 2234455667899999999999999999 699998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.64 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=186.0
Q ss_pred CCeeeecCccEEEEEEeC---CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--cCeEEEEEec
Q 003704 514 ENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIYEY 588 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 588 (801)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999754 45789999986432 22456789999999999999999998854 5678899999
Q ss_pred cCCCCHHHHHhcCc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCcEEEeecc
Q 003704 589 CSNGTLQDMLHSDD-----ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCG 659 (801)
Q Consensus 589 ~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFG 659 (801)
+.+ +|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 7877775321 1123588999999999999999999986 89999999999999 566799999999
Q ss_pred CCCCcCCCCcc-ccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee---------
Q 003704 660 LAPLISSGSVS-QLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--------- 727 (801)
Q Consensus 660 la~~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--------- 727 (801)
+++.+...... .......++..|+|||... ..++.++|||||||++|||+||++||............
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99876543221 1123346788899999543 34789999999999999999999999754321110000
Q ss_pred --ecccccccchhhhhhh---------cCCC------C---CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 728 --RWAIPQLHDIDALSRM---------VDPS------L---SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 728 --~~~~~~~~~~~~~~~~---------~~~~------~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+...++..+... .... . ...........+.+|+.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000000000 0000 0 000011223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.28 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=193.6
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+|...+.||+|+||.||++.. .+|+.||+|++...... .....+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 455567899999999999965 56899999998754332 44567888999999986 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 588 YCSNGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 588 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|+.. ++.++.... ......+++..+..++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||++..+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 555543210 11135689999999999999999999974 3899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCccccc-C---CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFES-G---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~-~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
... .....++..|+|||.+. . .++.++|||||||++|||++|+.||...... ...+.+
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~~ 222 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---------------FDQLTQ 222 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---------------HHHHhh
Confidence 211 12335677899999543 3 4889999999999999999999999643210 011111
Q ss_pred hcC---CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 743 MVD---PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 743 ~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
... +.+....+...+.++.+|+.+||+.||++|||+.||+++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 223 VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred hcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 1111122234667899999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=307.00 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=199.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.|...+.||+|+||.||+++. .+|..||+|++..... .......+.+|++++++++|+|++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477788999999999999975 5789999999864322 2334467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+.+ +|.+.+... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 787777542 34689999999999999999999986 899999999999999999999999999875443
Q ss_pred CCccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
. ....++..|+|||.. .+.++.++|||||||++|||++|+.||...... ..+..
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~~~ 235 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYH 235 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHH
Confidence 2 233567789999953 345889999999999999999999998643211 11111
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
+.............+..+.+++.+||+.+|++||++.++++++....
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 11111111112344567899999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.40 Aligned_cols=267 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 585 (801)
++|+..+.||+|+||.||+|... +++.+|+|.+............+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999764 689999999875443333445677899999999999999999998877 899999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+.+ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+.
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 999988753 23689999999999999999999986 89999999999999999999999999987665
Q ss_pred CCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccce-e-ecccccccchhhh-
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL-V-RWAIPQLHDIDAL- 740 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~-~~~~~~~~~~~~~- 740 (801)
.... ......++..|+|||...+ .++.++||||||+++|||++|+.||........... . .+..+.-..+...
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4321 1122345678999995433 368999999999999999999999975432111000 0 0000000000000
Q ss_pred ----------hhhcCCCCCCCCCcc-cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 ----------SRMVDPSLSGQYPAK-SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ----------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.......+...++.. .+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000001111223333 46778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=301.50 Aligned_cols=248 Identities=23% Similarity=0.433 Sum_probs=197.5
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC---CCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~~~~~~lV 585 (801)
.|+..+.||+|+||.||+|.. .+++.||||.+.... .......+.+|++++++++ |+|++++++++.+....++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999975 678999999986432 2334456778888888886 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999999864 3688999999999999999999986 89999999999999999999999999987765
Q ss_pred CCCccccccccccccCcCCccccc-C-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFES-G-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
.... ......++..|+|||... + .++.++|||||||++|+|++|+.||.......... .+..
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~~~~- 216 (277)
T cd06917 153 QNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------LIPK- 216 (277)
T ss_pred CCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------cccc-
Confidence 4431 122345777899999543 3 36889999999999999999999997532211100 0000
Q ss_pred cCCCCCCCCCc-ccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 744 VDPSLSGQYPA-KSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 744 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
......+. ..+.++.+++.+||+.||++||++.|++++-
T Consensus 217 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 217 ---SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred ---CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 00011111 2456899999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.14 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=206.2
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.|+.-++||+|+||.||-++. .+|+.||.|++.+..... ........|-+++.+++.+.||.+-..|+..+.++|||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688899999999999999964 579999999987654332 23455678889999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
..|+||+|.-+|...+ ...+++..++.++.+|+.||++||+. +||+|||||+|||||++|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999998887654 36899999999999999999999997 899999999999999999999999999998877
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
+.. .....||.|||||| +..+.|+...|.||+||+||||+.|+.||........ .+.+.+.+.
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-------------~eEvdrr~~ 403 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-------------REEVDRRTL 403 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-------------HHHHHHHHh
Confidence 643 33447999999999 4556799999999999999999999999975432110 112222211
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 779 (801)
.....|++..++++.+|....|++||++|....
T Consensus 404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 112357888899999999999999999996543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=306.81 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=195.8
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|+....||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33455799999999999965 578999999986432 233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999998753 4588999999999999999999986 899999999999999999999999999875543321
Q ss_pred cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 670 SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
......++..|+|||. ....++.++|||||||++|||++|+.||........ ...+......
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~~~~~~-- 235 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------------MKRLRDSPPP-- 235 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHhccCCC--
Confidence 1233567788999994 455689999999999999999999999974322110 0001000000
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+...+..+.+++.+||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011123345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.68 Aligned_cols=267 Identities=20% Similarity=0.298 Sum_probs=194.5
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46788999999999999999964 5789999999865432 223346678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. ++|.+++... ...+.+..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777776532 24577888899999999999999986 899999999999999999999999999875433
Q ss_pred CCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccc---ccccchhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI---PQLHDIDALS 741 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 741 (801)
... ......++..|+|||...+ .++.++|||||||++|||++|+.||.......+.....|.. +.-.....+.
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 211 1223345778999996543 47889999999999999999999997543211110000000 0000000000
Q ss_pred ---hhcCCCCCCCCC---------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 742 ---RMVDPSLSGQYP---------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ---~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...........+ .....++.+++.+|+..||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000 0124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=287.14 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=193.9
Q ss_pred hccCCccC-CeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHh-hccCCCCccccceEEEe----c
Q 003704 507 YTNSFSQE-NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKGYCAE----H 579 (801)
Q Consensus 507 ~~~~~~~~-~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~HpnIv~l~~~~~~----~ 579 (801)
++++|++. ++||-|-.|.|-.+. ..+|+.+|+|++... ...++|++.. ..-.|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45666543 689999999999984 568999999998532 2234666654 34479999999999854 4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCcEEEe
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVS 656 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 656 (801)
..+.+|||.|+||.|++.|.+.+ ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|+.. +..+||+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 57789999999999999998765 56799999999999999999999997 8999999999999964 5579999
Q ss_pred eccCCCCcCCCCccccccccccccCcCCccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccccc
Q 003704 657 DCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735 (801)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 735 (801)
|||+|+.-.... .....+-|+.|.|||.+. ..|+-..|+||+||++|-|++|.+||.+..... + .+.
T Consensus 207 DfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i----spg-- 274 (400)
T KOG0604|consen 207 DFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I----SPG-- 274 (400)
T ss_pred ccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C----Chh--
Confidence 999998765321 123345677899999654 569999999999999999999999998754321 0 011
Q ss_pred chhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.+.-...-.-.+........+++..++|+++|..+|.+|.|+.|++.+-+
T Consensus 275 -Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 275 -MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred -HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 11100000111111223355678899999999999999999999987653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.85 Aligned_cols=270 Identities=20% Similarity=0.298 Sum_probs=195.5
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCe-----
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ----- 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~----- 581 (801)
++|+..+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999975 47899999998654433334467788999999995 6999999999877655
Q ss_pred EEEEEeccCCCCHHHHHhcCccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeecc
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCG 659 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG 659 (801)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888653321 34689999999999999999999986 8999999999999998 8899999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeec-cccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRW-AIPQLH 735 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~-~~~~~~ 735 (801)
++..+...... .....++..|+|||... ..++.++|||||||++|||++|+.||.......... +... ..+...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 98765432111 12234567799999543 347899999999999999999999997543211100 0000 000000
Q ss_pred chhhhhhhcC----CCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 DIDALSRMVD----PSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 ~~~~~~~~~~----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.........+ +.... ......+.++.++|.+||..||.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 00000 0012345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.48 Aligned_cols=266 Identities=21% Similarity=0.358 Sum_probs=194.2
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|++|.||+|... +++.||||.+..... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999654 789999999865332 2223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+.+ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 999988753 23688999999999999999999986 8999999999999999999999999998654322
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccce-e-ec-ccccccchhhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL-V-RW-AIPQLHDIDALSR 742 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~-~~-~~~~~~~~~~~~~ 742 (801)
.. ......++..|+|||... ..++.++|||||||++|||++|+.||........... . .. ..+.-.....+..
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11 112223567799999543 3478999999999999999999999965432111000 0 00 0000000000000
Q ss_pred ---hcC--------CCCCCCCC-cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 743 ---MVD--------PSLSGQYP-AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ---~~~--------~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
... ..+....+ .....++.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000000 0112577899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.49 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=198.4
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||.|+||.||+++.. +++.||+|++.+.... ....+.+.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999764 5899999998754432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999753 4588999999999999999999986 89999999999999999999999999998765432 122
Q ss_pred ccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...++..|++||. ....++.++|+||||+++|+|++|+.||...... .......+........+|
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--------------PMEIYNDILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--------------HHHHHHHHhccCCCCCCC
Confidence 3456778999994 4556899999999999999999999999754320 111222222222233455
Q ss_pred cccHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 784 (801)
...+.++.+++.+||+.||++||+ +.|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 556788999999999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.59 Aligned_cols=271 Identities=22% Similarity=0.338 Sum_probs=195.3
Q ss_pred CCccCCeeeecCccEEEEEEeC---CCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~ 583 (801)
+|+..+.||+|+||.||+|... +++.||+|.+.... ........+.+|++++.+++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999653 58999999987533 1122335677899999999999999999999887 8899
Q ss_pred EEEeccCCCCHHHHHhcCccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC----CCcEEEeec
Q 003704 584 LIYEYCSNGTLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD----DLAVSVSDC 658 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF 658 (801)
+||||+++ +|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677776543221 23688999999999999999999986 8999999999999999 999999999
Q ss_pred cCCCCcCCCCc-cccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--------
Q 003704 659 GLAPLISSGSV-SQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-------- 727 (801)
Q Consensus 659 Gla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-------- 727 (801)
|++........ ........++..|+|||... ..++.++|||||||++|||++|+.||............
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 11122345677899999443 34789999999999999999999999754432200000
Q ss_pred --e-cccc------cccchhhhhhhcCCCCCCCCC-----------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 728 --R-WAIP------QLHDIDALSRMVDPSLSGQYP-----------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 728 --~-~~~~------~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. ...+ ............+......++ .....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 000000000000000001111 1344578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.09 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEecccc---CchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA---SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (801)
.+|++.+.||+|+||.||+|.. .+|+.||+|.+.... ........+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999964 579999999875322 1223446788999999999999999999998764 467
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998752 4578899999999999999999986 89999999999999999999999999997
Q ss_pred CcCCCCcc-ccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhh
Q 003704 663 LISSGSVS-QLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 663 ~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
........ .......++..|+|||.. ...++.++|||||||++|||++|+.||..... ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------------MAAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------------HHHH
Confidence 65432111 111234577889999954 44588999999999999999999999964321 1122
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+..........|.....++.+++.+||+ +|.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 22222222334566777889999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=327.23 Aligned_cols=275 Identities=16% Similarity=0.232 Sum_probs=187.5
Q ss_pred hhccCCccCCeeeecCccEEEEEEeC--CCcEEEEEEe--------------cc-ccCchhhHHHHHHHHHHhhccCCCC
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQLP--DGKLLAVKKL--------------DK-RASSQQKDDEFLELVNNIDRIRHAN 568 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~~~--~g~~vavK~~--------------~~-~~~~~~~~~~~~~e~~~l~~l~Hpn 568 (801)
.+.++|++.+.||+|+||+||++... ++..+++|.+ .+ ..........+.+|++++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35678999999999999999998542 2222222211 11 0112223456789999999999999
Q ss_pred ccccceEEEecCeEEEEEeccCCCCHHHHHhcCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 569 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
||++++++.+.+..|+|+|++. ++|.+++..... .........+..|+.||+.||+|||+. +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 477777653221 122334566778999999999999986 89999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCC-ccccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKS-YDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~p-f~~~~~~~~~~ 725 (801)
+.++.+||+|||+++.+..... .......|+..|+|||. ....++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987654322 11223568899999995 455699999999999999999998754 43221111111
Q ss_pred eeecc------cccccc-hhhhhhhcCCC-C---CCCC-----CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 726 LVRWA------IPQLHD-IDALSRMVDPS-L---SGQY-----PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 726 ~~~~~------~~~~~~-~~~~~~~~~~~-~---~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+.... ...+.+ ...+.+.++.. . .... ....+..+.+++.+||+.||++|||+.|++++-
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 00000 000000 00111111100 0 0000 012345678899999999999999999999763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=303.76 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=197.6
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|+..+.||.|++|.||+|.. .+|..||||++............+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999965 57999999998755433444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999987532 24689999999999999999999986 899999999999999999999999999876543211
Q ss_pred cccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccc-ceeeccc-c------cccchhh
Q 003704 670 SQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ-FLVRWAI-P------QLHDIDA 739 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~-~------~~~~~~~ 739 (801)
. .....++..|+|||...+ .++.++|||||||++|||++|+.||......... ...++.. + .......
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 122345678999995433 4788999999999999999999999754321110 0000000 0 0000000
Q ss_pred hhhhcCC---CCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVDP---SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....... ..........+.++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00001123345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.53 Aligned_cols=247 Identities=28% Similarity=0.507 Sum_probs=200.3
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999764 789999999865433 3557888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++... ...+++..+..++.|++.+|+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999753 25689999999999999999999985 89999999999999999999999999987765543
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. .....++..|++||. ....++.++||||||+++|+|++|+.||....... .+..... .
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~~-~ 212 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK----------------ALFKIAT-N 212 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH----------------HHHHHHh-c
Confidence 1 234457778999994 44558899999999999999999999997532111 0000000 0
Q ss_pred CCCCC--CcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQY--PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..... +...+..+.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 11225779999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.33 Aligned_cols=266 Identities=20% Similarity=0.280 Sum_probs=197.5
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (801)
..++|+..+.||+|+||.||+|.. .+|+.||||++.+..........+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999964 5799999999865444444456677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 88888753 278889999999999999999986 89999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCcccccccccc-ceee-ccccccc-
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ-FLVR-WAIPQLH- 735 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~-~~~~~~~- 735 (801)
+++....... .....++..|+||| .....++.++|||||||++|+|++|+.||......... .+.. ...+...
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9976544321 22335677899999 45566899999999999999999999999754321100 0000 0000000
Q ss_pred ------------------chhhhhhhcCCCC----CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 736 ------------------DIDALSRMVDPSL----SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 736 ------------------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
....+.+...... ....+...+.++.+++.+||+.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000000000 0011223456789999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.13 Aligned_cols=274 Identities=21% Similarity=0.291 Sum_probs=202.1
Q ss_pred cCCccCCeeeecCccEEEEEEeC---C--CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe-cCeE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP---D--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQR 582 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~ 582 (801)
..|+....||+|+||.||+|... + .+.+|||+++.............+|+..++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999432 2 3479999998665444455566789999999999999999998876 7789
Q ss_pred EEEEeccCCCCHHHHHhcCcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC----CcEEEee
Q 003704 583 LLIYEYCSNGTLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD----LAVSVSD 657 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~D 657 (801)
++++||.+. +|.+.|+-... ....++...+..|+.||+.|+.|||+. =|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 88888875332 235688889999999999999999997 59999999999999877 8999999
Q ss_pred ccCCCCcCCCCccc-cccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc---e-----
Q 003704 658 CGLAPLISSGSVSQ-LSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF---L----- 726 (801)
Q Consensus 658 FGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~---~----- 726 (801)
||+++.+...-... ....+..|+.|+|||++.| .|+.+.||||.|||+.||+|-++.|......-... .
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999987653322 2345678899999995544 49999999999999999999988887543321110 0
Q ss_pred ---eecccccccchhhhhhhcCC-----CCCCCCC------------cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 727 ---VRWAIPQLHDIDALSRMVDP-----SLSGQYP------------AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 727 ---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~------------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
.-...|...++..+.++-+- .++..+. ...+....+|+.++|..||-+|.|+.+.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 00011222222222221110 0000000 011233679999999999999999999998753
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.26 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=202.5
Q ss_pred hhccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEE
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (801)
...+.|+..+.||+|+||.||+|... ++..|++|++..... ....+.+|++.+++++|+||+++++++...+..++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 35567888899999999999999765 789999999864332 45678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999999998632 3789999999999999999999985 9999999999999999999999999998655
Q ss_pred CCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..... ......++..|++||. ....++.++|||||||++|+|++|+.||....... ....+
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----------------~~~~~ 228 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----------------ALFLI 228 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHH
Confidence 43211 1123346678999994 45568999999999999999999999986432211 00111
Q ss_pred cCCCC-CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 744 VDPSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 744 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..... ....+...+..+.+++.+||+.+|.+||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 11111 0111223567899999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.06 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=196.5
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
.|...+.||+|++|.||++.. .+++.+++|++... .....+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 355567999999999999964 57899999988532 233446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999874 3588999999999999999999986 89999999999999999999999999886554322
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
. ......++..|+|||. ....++.++|||||||++|||++|+.||........ ...+......
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-------------~~~~~~~~~~- 233 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-------------MKRIRDNLPP- 233 (285)
T ss_pred c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-------------HHHHHhcCCC-
Confidence 1 1223457788999994 445689999999999999999999999864321100 0011111000
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....+...+..+.+++.+||+.||++||++.|++++
T Consensus 234 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 234 -KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111122355789999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.37 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=190.8
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEec--CeEEEEE
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEH--GQRLLIY 586 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~ 586 (801)
|+..+.||+|+||.||+|.. .+++.||+|++........ .....+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56678899999999999964 5789999999875432222 233456788888885 99999999999887 8999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||++ ++|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. +.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9997 4888887643 24689999999999999999999986 8999999999999999 9999999999976643
Q ss_pred CCccccccccccccCcCCccc-cc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecccccccchhhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 743 (801)
... .....++..|+|||. .. +.++.++|||||||++|||++|+.||......+... .......... .+...
T Consensus 152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 225 (282)
T cd07831 152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA---EVLKK 225 (282)
T ss_pred CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH---HHHHh
Confidence 321 122346778999994 33 457889999999999999999999997543221100 0000000000 00000
Q ss_pred cCCC--CCCCC-----------CcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPS--LSGQY-----------PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~--~~~~~-----------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.... ....+ ....+.++.+++.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 00001 12346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.49 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=203.6
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||+|++|.||++.. .+++.|++|.+............+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477789999999999999965 4688999999976655445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998753 5689999999999999999999986 89999999999999999999999999998765443
Q ss_pred ccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.. .....++..|+|||. ....++.++||||||+++|+|++|+.||...... ....... ..
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~-~~ 214 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----------------AALFRIV-QD 214 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHh-cc
Confidence 21 223456778999994 4445789999999999999999999998643211 0111111 11
Q ss_pred CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 748 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+..+.+++.+||..+|++||++.|++.+
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1123345566789999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.23 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=193.6
Q ss_pred eeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||+||++.. .+|+.||+|.+...... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999964 57899999998653322 22345567899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++.... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 99997533 24689999999999999999999986 89999999999999999999999999987654321 122
Q ss_pred ccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...++..|+|||. ..+.++.++|||||||++|+|++|+.||........ ...+.+... .....++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~-~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------------KEELKRRTL-EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------------HHHHHhccc-cccccCC
Confidence 3456678999994 455688999999999999999999999975432110 011111111 1112244
Q ss_pred cccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
...+..+.+++.+||+.||++|| ++.+++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 45577899999999999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=331.63 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=193.1
Q ss_pred hhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec----
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH---- 579 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~---- 579 (801)
-++.++|+..++||+||||.|||++. -||+.||||++.... .......+.+|+..+.+++|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 45778899999999999999999974 499999999998765 566677889999999999999999987531000
Q ss_pred --------------------------------------------------------------------------------
Q 003704 580 -------------------------------------------------------------------------------- 579 (801)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (801)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHH
Q 003704 580 -----------------------------------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624 (801)
Q Consensus 580 -----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L 624 (801)
-.+||-||||+..+|.++++..... -.....++++.+|++||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHH
Confidence 1237899999999998888753211 14567889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC----C------------CCccccccccccccCcCCcccc
Q 003704 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS----S------------GSVSQLSGHLLTAYGYGAPEFE 688 (801)
Q Consensus 625 ~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~ 688 (801)
+|+|+. |||||||||.||+||++..|||+|||+|+... . +......+...||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999997 89999999999999999999999999998721 0 0111123345788889999954
Q ss_pred cC----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC--CCcccHHHHHH
Q 003704 689 SG----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ--YPAKSLSHFAD 762 (801)
Q Consensus 689 ~~----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 762 (801)
.+ .|+.|+||||+|||++||+. ||..... ....+..+.+..+... +.......-..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCcccccccchHHHH
Confidence 33 49999999999999999995 5653221 1122333332222221 22333445568
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 003704 763 IISRCVQSEPEFRPPMSEVVQ 783 (801)
Q Consensus 763 li~~cl~~dP~~RPt~~evl~ 783 (801)
+|..|++.||.+|||+.|+|+
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999985
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.25 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=202.2
Q ss_pred cCCccCCeeeecCccEEEEEEeCC-CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+.|.++..||.|+||.||+|..++ +-..|.|++.. .+....+.|+-|+++|..+.||+||++++.|.-.+.++++.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 456777889999999999997655 44456677642 234556788999999999999999999999988899999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
||.||-...++-+- ...+.+.++..+.+|++.||.|||+. +|||||||..|||++.+|.++|+|||.+......
T Consensus 110 FC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred ecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999988753 56799999999999999999999996 8999999999999999999999999987543321
Q ss_pred CccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
......+.||++|||||+.. ..|++++||||||++|.||.-+.+|-...++ +..+.
T Consensus 184 --~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------MRVll 245 (1187)
T KOG0579|consen 184 --RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLL 245 (1187)
T ss_pred --HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------HHHHH
Confidence 22345678999999999422 3599999999999999999999998653322 22333
Q ss_pred hhcCCCCC-CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 742 RMVDPSLS-GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 742 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.+...... --.|...+..|.+|+.+||.+||+.||++.++++|-
T Consensus 246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 33222111 113667778899999999999999999999999753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.45 Aligned_cols=273 Identities=25% Similarity=0.409 Sum_probs=205.9
Q ss_pred CccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------CeEE
Q 003704 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQRL 583 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 583 (801)
|...+.||+|+||.||+|+ ..+|+.||||.++... .....+...+|++++++++|+|||++++.-++. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4456889999999999997 6789999999997644 334456778999999999999999999985443 3568
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC--CCC--cEEEeecc
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDL--AVSVSDCG 659 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFG 659 (801)
+|||||.+|||+.++.+..+ ..++++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999987554 57899999999999999999999986 999999999999983 344 47999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccc-c-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccch
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-E-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 737 (801)
.|+.++.+. ......||..|.+||+ . .+.|+..+|.|||||++|+..||..||..........-+.|..-.-..
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp- 245 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP- 245 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC-
Confidence 999988765 3567889999999994 4 377999999999999999999999999865443221111111000000
Q ss_pred hhhhhhcCCCC------CCCC--Ccc----cHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHHhh
Q 003704 738 DALSRMVDPSL------SGQY--PAK----SLSHFADIISRCVQSEPEFRP--PMSEVVQDLVDMIRRE 792 (801)
Q Consensus 738 ~~~~~~~~~~~------~~~~--~~~----~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~~~ 792 (801)
..+.-...... ...+ |.. .-..+...+..+|..+|++|. .+.+....+.++++..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 00000000000 1111 222 223456788999999999999 8888888887777643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.66 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=194.3
Q ss_pred Ceeeec--CccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAG--MLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G--~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+| +||+||++.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999965 5899999999876554455567888999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc-
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS- 670 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 670 (801)
++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987532 24588999999999999999999986 8999999999999999999999999865332211100
Q ss_pred ----ccccccccccCcCCcccccC---CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee------cccccccc
Q 003704 671 ----QLSGHLLTAYGYGAPEFESG---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR------WAIPQLHD 736 (801)
Q Consensus 671 ----~~~~~~~~~~~y~aPE~~~~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~------~~~~~~~~ 736 (801)
.......++..|+|||...+ .++.++|||||||++|||++|+.||.......... ... +.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00111223456999995543 37899999999999999999999997543211100 000 00000000
Q ss_pred hh-----------------hhh-----hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 737 ID-----------------ALS-----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 737 ~~-----------------~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.. .+. .+....+....+.....++.+|+.+||+.||++|||+.|++++-.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00 000 0000111111233456789999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.52 Aligned_cols=270 Identities=21% Similarity=0.360 Sum_probs=194.7
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC------
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------ 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------ 580 (801)
.++|+..+.||+|+||.||+|.. .+++.||||.+............+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35688899999999999999965 57999999998654433334455678999999999999999999987643
Q ss_pred --eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 581 --QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 581 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
..++||||+.+ +|.+++... ...+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999965 888887643 24689999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCcc--ccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeec-----
Q 003704 659 GLAPLISSGSVS--QLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW----- 729 (801)
Q Consensus 659 Gla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~----- 729 (801)
|++..+...... .......++..|+|||...+ .++.++||||||+++|||++|+.||..............
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999766433211 11122345678999995433 378899999999999999999999975432211100000
Q ss_pred ---ccccccchhhhhhhcCCC-----CCCCC-CcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 730 ---AIPQLHDIDALSRMVDPS-----LSGQY-PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 730 ---~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+.............+. ..... +......+.+++.+||..||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000000000 00000 11123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.82 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=188.1
Q ss_pred eeeecCccEEEEEEe-CCCcEEEEEEeccccCch-hhHHHHHHH---HHHhhccCCCCccccceEEEecCeEEEEEeccC
Q 003704 516 LIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLEL---VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
+||+|+||.||+|.. .+++.||+|.+.+..... .....+..| .+.++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 568999999987543221 112223333 334455689999999999999999999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998864 34689999999999999999999986 89999999999999999999999999987654321
Q ss_pred ccccccccccCcCCccccc-C-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 671 QLSGHLLTAYGYGAPEFES-G-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE~~~-~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
.....++..|+|||... + .++.++||||+||++|||++|+.||......... ...... ...
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------------~~~~~~-~~~ 214 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDRMT-LTM 214 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------------HHHHHh-hcc
Confidence 12345788899999543 3 5899999999999999999999999754221110 000000 011
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
....+...+.++.+++.+|+..||.+|| ++.|++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1223444567899999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.84 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=198.0
Q ss_pred hhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC----
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG---- 580 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~---- 580 (801)
...++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457889999999999999999976 46899999998754433444566778999999999999999999987654
Q ss_pred ------eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEE
Q 003704 581 ------QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (801)
Q Consensus 581 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 654 (801)
..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 777777642 34689999999999999999999986 899999999999999999999
Q ss_pred EeeccCCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-ecc-
Q 003704 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-RWA- 730 (801)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~- 730 (801)
|+|||++..+...... ......++..|+|||... ..++.++|||||||++|||++|+.||...........+ ...
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876543211 112223466799999543 34788999999999999999999999754321110000 000
Q ss_pred cccccchhhhhhh-----cC------CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 731 IPQLHDIDALSRM-----VD------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 731 ~~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.......+.+. .+ .... ......+..+.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000 00 0000 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.31 Aligned_cols=269 Identities=25% Similarity=0.339 Sum_probs=196.7
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLL 584 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 584 (801)
.++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35788999999999999999965 5699999999865443333334566899999999999999999998754 56899
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||||+.+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 888888753 35689999999999999999999996 8999999999999999999999999999776
Q ss_pred CCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccc-c---cccch
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAI-P---QLHDI 737 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~-~---~~~~~ 737 (801)
..... ......++..|+|||... ..++.++|||||||++|||++|+.||.......... ...... + .+...
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 54321 112223466799999543 357899999999999999999999997543321110 000000 0 00000
Q ss_pred hhhhhhcCCCCCCC-C------CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 738 DALSRMVDPSLSGQ-Y------PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 738 ~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.............. + ....+.++.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000000000000 0 011356788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=289.43 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=204.4
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchh-hHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQ-KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|...++||+|.||.|-+++ ..+|+.||+|++++...... ....-..|-++++..+||.+..+...|+..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 678889999999999999996 45799999999987654433 2345567888999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||..||.|+-++.. ...+++.....+-..|+.||.|||+. +||.||||-+|+|+|.||++||+|||+++.--.
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999988875 45688888888999999999999996 899999999999999999999999999875322
Q ss_pred CCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .......+||+.|+|||++ ...|+..+|+|.+||++|||++|+.||...+.. .+.+++-
T Consensus 321 ~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----------------kLFeLIl 381 (516)
T KOG0690|consen 321 Y--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----------------KLFELIL 381 (516)
T ss_pred c--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----------------HHHHHHH
Confidence 2 2234567899999999954 567999999999999999999999999764331 1111111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
.. .-.+|...+++...|+.-.|.+||.+|. .+.||.++
T Consensus 382 ~e-d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 ME-DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hh-hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 00 1246788888999999999999999995 35666554
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.82 Aligned_cols=265 Identities=22% Similarity=0.387 Sum_probs=197.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+|+..+.||.|++|.||+|+. .+|..||||++..... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 477889999999999999976 4689999999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+++ +|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 985 88888865332 34689999999999999999999986 89999999999999999999999999987654321
Q ss_pred ccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc--eeecccccccchhhhhhhc
Q 003704 669 VSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--LVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 744 (801)
. ......++..|++||... ..++.++|||||||++|||++|+.||......+... ...+..+.-..+..+...
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL- 231 (284)
T ss_pred c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC-
Confidence 1 112234567899999543 347889999999999999999999997543321100 000000000000001000
Q ss_pred CCCCCCC-----------CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 745 DPSLSGQ-----------YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+... .....+.++.+++.+|++.||++||++.|++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 -PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred -chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 112335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.19 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=199.6
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhc--cCCCCccccceEEEec----CeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR--IRHANIVELKGYCAEH----GQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~HpnIv~l~~~~~~~----~~~~ 583 (801)
+....+.||+|.||.||+|++ .|..||||++... +++.+.+|.++.+. ++|+||+.+++.-... .+++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 445678999999999999999 6889999999643 34556677777654 5999999999875432 3789
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI-----CQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
||.+|.+.|||+|+|.. ..++....++++.-+|.||+|||.. .++.|.|||||+.|||+..++...|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999984 6789999999999999999999963 5678999999999999999999999999
Q ss_pred cCCCCcCCCC--ccccccccccccCcCCcccccCCCC-------CcchHHHHHHHHHHHHhC----------CCCccccc
Q 003704 659 GLAPLISSGS--VSQLSGHLLTAYGYGAPEFESGIYT-------CQSDVYSFGVVMLELLTG----------RKSYDRTR 719 (801)
Q Consensus 659 Gla~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-------~k~DvwSlGvil~elltG----------~~pf~~~~ 719 (801)
|+|....... .........||.+|||||++..... ..+||||||.++||+... +.||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998776542 2233455789999999997665432 258999999999999863 35554332
Q ss_pred cccccceeecccccccchhhhhhhc-CCCCCCCCC-----cccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 720 NRGEQFLVRWAIPQLHDIDALSRMV-DPSLSGQYP-----AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
+.+ ...+.+.+++ ...+++..| ......+.++++.||..+|..|-|+--+-+.|.++.+
T Consensus 441 p~D------------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSD------------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCC------------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 211 1122222222 223333332 3455678899999999999999999999999988874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.67 Aligned_cols=268 Identities=21% Similarity=0.335 Sum_probs=195.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
++|+..+.||+|++|.||+|.. .+|+.||+|++............+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688899999999999999975 478999999986544333445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeeccCCCCcCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISS 666 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 666 (801)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888876432 23467888889999999999999986 8999999999999985 56799999999976543
Q ss_pred CCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-ec-ccc---cccchhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-RW-AIP---QLHDIDA 739 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~-~~~---~~~~~~~ 739 (801)
... ......++..|+|||...+ .++.++|||||||++|+|+||+.||......+..... .. ..+ .+.....
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 211 1122345678999995433 4789999999999999999999999754321111000 00 000 0000000
Q ss_pred hhhhcC--CCCCC----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVD--PSLSG----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+..... ..... ......+.++.+++.+|++.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0112345678999999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=309.78 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=198.3
Q ss_pred hccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec--CeE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH--GQR 582 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~--~~~ 582 (801)
+.++|+..+.||+|+||.||+|... +|+.+|||++............+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999754 688999999865433334445677899999999 999999999998653 468
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599998864 2678899999999999999999986 99999999999999999999999999998
Q ss_pred CcCCCCcc---ccccccccccCcCCcccc-c-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccc--c
Q 003704 663 LISSGSVS---QLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL--H 735 (801)
Q Consensus 663 ~~~~~~~~---~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~--~ 735 (801)
.+...... .......++..|+|||.. . ..++.++|||||||++|||++|+.||................... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543221 112234577889999944 3 457899999999999999999999996543221100000000000 0
Q ss_pred chhhh-----hhhcC----CCCC--CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 DIDAL-----SRMVD----PSLS--GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 ~~~~~-----~~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+...+ ..+.+ .... .......+.++.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 00010 0000 00111246789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.54 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=193.4
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|+..+.||+|+||.||+|... +++.||||++...... .....+.+|+.++.+. .|+||+++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 56888999999999999999775 4899999998754322 2344556677666666 4999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. ++|.+++... ...+++..+..++.|++.||+|||+. .+|+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 4777776542 34689999999999999999999974 3899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCcccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG-----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
... .....++..|+|||...+ .++.++||||||+++|||++|+.||...... .+.+.
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~ 229 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------------FEVLT 229 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------------HHHHH
Confidence 221 122245678999995432 3788999999999999999999999642211 01111
Q ss_pred hhcCCCCCC-CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 742 RMVDPSLSG-QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 742 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
......... ......+.++.+++.+||+.||++||++.+++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 111111110 111234678999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.71 Aligned_cols=271 Identities=21% Similarity=0.330 Sum_probs=199.9
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe----cCeE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQR 582 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~ 582 (801)
.++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46788899999999999999964 579999999987654433445677789999999999999999998753 3568
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 589998865 34589999999999999999999986 89999999999999999999999999987
Q ss_pred CcCCCCcc--ccccccccccCcCCcccc-c-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeec--ccccccc
Q 003704 663 LISSGSVS--QLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW--AIPQLHD 736 (801)
Q Consensus 663 ~~~~~~~~--~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~ 736 (801)
........ .......++..|+|||.+ . ..++.++|||||||++|||++|+.||.............. ..+...-
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65433211 111234577889999954 3 3588999999999999999999999975432111000000 0000000
Q ss_pred -----hhhhhhhcCC-CCCCC-----CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 737 -----IDALSRMVDP-SLSGQ-----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 737 -----~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
...+.+..+. ..... .....+.++.+++.+||+.||++||++.+++.+-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000000000 00000 11234678999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=299.86 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=193.2
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|...+.||+|+||.||+|+. .+|..|++|++..... .......+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999965 5789999999864432 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+. ++|.+++... ...+++..+..++.|++.+|+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5787777642 34689999999999999999999986 899999999999999999999999999864322
Q ss_pred ccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 669 VSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
.....++..|+|||.. .+.++.++|||||||++|||++|+.||........ +..+.
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~----------------~~~~~ 233 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIA 233 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH----------------HHHHH
Confidence 2234567789999954 34588899999999999999999999865432111 11111
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
............+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111122334578999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=284.14 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=198.5
Q ss_pred CCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEEeccCC
Q 003704 514 ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
.++||+|+|+.|-.+ .+.+|..||||++.+. ......++.+|++++.+.+ |+||+.+++||++++..|||||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 478999999999998 5789999999999765 3345677889999998885 99999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---cEEEeeccCCCCcCCCC
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAPLISSGS 668 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~ 668 (801)
|+|..+|++ ...+++.++.++..+|+.||.|||.. ||.||||||+|||..... .+||+||.+..-+....
T Consensus 161 GplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 161 GPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred chHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999987 45689999999999999999999985 999999999999997654 48999999875432211
Q ss_pred c-----cccccccccccCcCCccc---ccC---CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccccc--
Q 003704 669 V-----SQLSGHLLTAYGYGAPEF---ESG---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH-- 735 (801)
Q Consensus 669 ~-----~~~~~~~~~~~~y~aPE~---~~~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-- 735 (801)
. +.......|+..|||||+ ..+ .|+-+.|.||||||+|-||.|.+||.+....+-. |.....-
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~Cr~ 309 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEVCRV 309 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCccHH
Confidence 1 111123456778999993 223 3889999999999999999999999887654322 2111110
Q ss_pred -chhhhhhhcCCCC--CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 -DIDALSRMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 -~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...-...+-+..+ ...-....+.+..+++...+..|+.+|.++.+++.+
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 0011111111111 111233567788999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.74 Aligned_cols=268 Identities=19% Similarity=0.258 Sum_probs=194.0
Q ss_pred cCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
+.+.+|.|+++.||++.. +++.||||++............+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455566666666654 7999999999765445556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc---
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV--- 669 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 669 (801)
+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999997532 34588899999999999999999986 899999999999999999999999998865533211
Q ss_pred --cccccccccccCcCCcccccC---CCCCcchHHHHHHHHHHHHhCCCCccccccccccc--e----eeccc-ccccc-
Q 003704 670 --SQLSGHLLTAYGYGAPEFESG---IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--L----VRWAI-PQLHD- 736 (801)
Q Consensus 670 --~~~~~~~~~~~~y~aPE~~~~---~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--~----~~~~~-~~~~~- 736 (801)
........++..|+|||.+.. .++.++|||||||++|||++|+.||.......... . ..+.. .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 111122345667999995433 48899999999999999999999997543211000 0 00000 00000
Q ss_pred hhhhhh----hcC----CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 737 IDALSR----MVD----PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 737 ~~~~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
...... ..+ ......+......++.+++.+||+.||++|||++|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 000 00011122334567889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.58 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=202.8
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 585 (801)
++|...+.||+|+||.||+|.. .+|+.||+|++.+... .......+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999965 4799999999875332 2334567888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999753 3689999999999999999999986 89999999999999999999999999987665
Q ss_pred CCCcc------------------ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccce
Q 003704 666 SGSVS------------------QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL 726 (801)
Q Consensus 666 ~~~~~------------------~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~ 726 (801)
..... .......++..|+||| .....++.++||||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 43211 1122335677899999 45566889999999999999999999999754310
Q ss_pred eecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 003704 727 VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM----SEVVQD 784 (801)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 784 (801)
.....+.. ....++...+..+.+++.+||+.||++||++ .|++++
T Consensus 229 -----------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 -----------LTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -----------HHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111111 1123445556789999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.18 Aligned_cols=266 Identities=20% Similarity=0.306 Sum_probs=195.6
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----C
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----G 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~ 580 (801)
+.++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 356899999999999999999964 578999999986422 223445677899999999999999999987654 3
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
..++||||+.+ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 57999999975 88888763 4689999999999999999999986 899999999999999999999999999
Q ss_pred CCCcCCCCccc-cccccccccCcCCccc-cc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecccccccc
Q 003704 661 APLISSGSVSQ-LSGHLLTAYGYGAPEF-ES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIPQLHD 736 (801)
Q Consensus 661 a~~~~~~~~~~-~~~~~~~~~~y~aPE~-~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~ 736 (801)
+.......... ......++..|+|||. .. ..++.++|||||||++|+|++|+.||.......... ....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~--~~ 230 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT--PS 230 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC--CC
Confidence 87654332111 1123456788999994 33 358899999999999999999999996533211000 0000000 00
Q ss_pred hhhhhhhcCCCC---------CCC-----CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 737 IDALSRMVDPSL---------SGQ-----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.+..+.+... ... .....+.++.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111110000 000 001234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=294.28 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=191.4
Q ss_pred hhhHhhhccCCccCCee--eecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhc-cCCCCccccceEE
Q 003704 501 IASLQQYTNSFSQENLI--GAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYC 576 (801)
Q Consensus 501 ~~~~~~~~~~~~~~~~i--G~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~ 576 (801)
..+...+.+.|++.+.+ |+|+||.||++.. .++..+|+|.+........ |...... .+|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEE
Confidence 34455566777777776 9999999999964 5788999999864322111 1111111 2699999999999
Q ss_pred EecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-cEEE
Q 003704 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSV 655 (801)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl 655 (801)
...+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .++|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence 9999999999999999999999753 3789999999999999999999986 899999999999999998 9999
Q ss_pred eeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccc
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734 (801)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 734 (801)
+|||++...... ....++..|+|||. ....++.++|||||||++|||++|+.||....... .
T Consensus 152 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~---------- 214 (267)
T PHA03390 152 CDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-L---------- 214 (267)
T ss_pred ecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-h----------
Confidence 999998765432 22356778999994 45568999999999999999999999997432211 0
Q ss_pred cchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 003704 735 HDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSEVVQD 784 (801)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 784 (801)
+...+...... ....+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 215 -~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 215 -DLESLLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -hHHHHHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111111111 11223356678999999999999999996 6998864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.56 Aligned_cols=267 Identities=19% Similarity=0.305 Sum_probs=197.6
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----Ce
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~ 581 (801)
.++|...+.||+|+||+||+|+. .+|+.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999964 5789999999875433334455677899999999999999999988654 35
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 689888864 34689999999999999999999986 8999999999999999999999999999
Q ss_pred CCcCCCCccccccccccccCcCCcccc-c-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecccc------
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIP------ 732 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~------ 732 (801)
....... .......++..|+|||.. . ..++.++|||||||++|+|++|+.||.......... .......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7664332 112234567789999943 3 458899999999999999999999996542211000 0000000
Q ss_pred -ccc--chhhhhhhcCCCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 733 -QLH--DIDALSRMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 -~~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
... ......+........ ......+.++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 000000000000000 0112456778999999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.47 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=191.8
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||.||++... +|+.+++|.+..... .......+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999765 599999999865432 223456788899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc-----
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV----- 669 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 669 (801)
.+++... ..+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999753 3689999999999999999999986 899999999999999999999999999876543311
Q ss_pred -cccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCC
Q 003704 670 -SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 670 -~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
........++..|++|| .....++.++||||||+++|||++|+.||....... ....+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------IFQNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCC
Confidence 01122345667899999 455568899999999999999999999997543210 111111111
Q ss_pred CCCCCCcc--cHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 748 LSGQYPAK--SLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 748 ~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
. ..+.. .+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1 11222 267899999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=263.52 Aligned_cols=266 Identities=20% Similarity=0.341 Sum_probs=206.2
Q ss_pred CCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
.|...++||+|+||+||+|+ ..+++.||+|+++.....+.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999996 46789999999987776677777888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
|.. +|..+..+- ...++.+.+..++.|+++||.|+|++ ++.||||||.|+|++.+|++|++|||+++.+.-..
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 964 888887653 46789999999999999999999997 89999999999999999999999999999876543
Q ss_pred ccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeec--ccccccchhhhhhh
Q 003704 669 VSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW--AIPQLHDIDALSRM 743 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 743 (801)
.. ......|..|.+|..+- .-|+...|+||.|||+.|+.. |++.|.+.+-.+....+.| ..+.-..+..+.+.
T Consensus 156 rc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred Ee--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 21 12335678899999443 349999999999999999997 6666655433322211212 22222333444444
Q ss_pred cCCCCCCCCCcc---------cHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPSLSGQYPAK---------SLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~~~~---------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
-|-..-+.||.. ....-++++.+.+.-+|.+|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 443333334332 12234689999999999999999998875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.68 Aligned_cols=241 Identities=20% Similarity=0.234 Sum_probs=183.2
Q ss_pred CeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHH-hhccCCCCccccceEEEecCeEEEEEeccCC
Q 003704 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNN-IDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|.. .+|+.||||.+.+.... ......+..|..+ ....+|+||+++++++.+.+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999965 56899999998643321 1222233444433 4556899999999999999999999999999
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999975 24688999999999999999999986 899999999999999999999999999875432
Q ss_pred cccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
.....++..|+|||. ....++.++||||||+++|||++|..||........ ...+.. .......
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~-~~~~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------------FDNILS-RRINWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHh-cccCCCC
Confidence 223456778999994 444579999999999999999999999965322110 000000 0001111
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCHHHHH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 782 (801)
......+.++.+++.+||+.||++||++.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 12234567899999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=297.34 Aligned_cols=260 Identities=18% Similarity=0.226 Sum_probs=182.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeCC----CcEEEEEEeccccCchhh---------HHHHHHHHHHhhccCCCCccccce
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQK---------DDEFLELVNNIDRIRHANIVELKG 574 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~----g~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~HpnIv~l~~ 574 (801)
.++|.+.++||+|+||.||+|...+ +..+|+|+.......... ......+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999997644 455666654322111100 011223344566778999999999
Q ss_pred EEEecC----eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 003704 575 YCAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (801)
Q Consensus 575 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 650 (801)
++.... ..+++||++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 766543 44688888743 666666531 2356788899999999999999986 89999999999999999
Q ss_pred CcEEEeeccCCCCcCCCCcc-----ccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcccccccccc
Q 003704 651 LAVSVSDCGLAPLISSGSVS-----QLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724 (801)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~ 724 (801)
+.++|+|||+++.+...... .......||..|+|||. ....++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 11123468889999994 4556999999999999999999999999765321110
Q ss_pred ceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
... ...+.+.++..... ....++.++.+++..|+..+|++||++.++++.|
T Consensus 243 --~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 --IHA-----AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHH-----hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000 00011111111111 1233467899999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.73 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=196.1
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.|+..+.||+|+||.||+|+. .++..+|+|.+.... ........+.+|+++++.++|+|++++++++.+.+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466778899999999999975 468899999886432 22334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 5888877542 34588999999999999999999986 899999999999999999999999999876543
Q ss_pred CCccccccccccccCcCCcccc----cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE----SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
. ....++..|+|||.. .+.++.++|||||||++|||++|+.||....... ....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~ 225 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYH 225 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----------------HHHH
Confidence 2 234567789999953 2457889999999999999999999986432110 1111
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
..........+...+..+.+++.+||+.+|++||++.+++++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 111111111123455678999999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.83 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=197.4
Q ss_pred CccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec--CeEEEEEe
Q 003704 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLIYE 587 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 587 (801)
|++.+.||+|+||.||+|... +|+.+|+|++............+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999764 589999999976543344456788999999999999999999999887 89999999
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
|+++ +|.+++... ...+++..++.++.||++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 898888653 24689999999999999999999986 8999999999999999999999999998776544
Q ss_pred CccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-e-cccccccchhhhhh-
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-R-WAIPQLHDIDALSR- 742 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~-~~~~~~~~~~~~~~- 742 (801)
... ......++..|+|||... ..++.++||||||+++|||++|+.||............ . ...+....+.....
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 211 112234567799999443 34789999999999999999999999754322110000 0 00000000000000
Q ss_pred ----------hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 743 ----------MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+...+...++.++.+++.+||..||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011112236788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=305.94 Aligned_cols=273 Identities=19% Similarity=0.283 Sum_probs=201.5
Q ss_pred chhhhHhhhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEE
Q 003704 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCA 577 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~ 577 (801)
....++..+.++|...+.||+|+||.||+|. ..+|+.||||++............+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3455666788999999999999999999996 467999999998754433444567788999999999999999999885
Q ss_pred ec------CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 578 EH------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 578 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
.. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3467888876 7899988863 3589999999999999999999986 899999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eee
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVR 728 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~ 728 (801)
.+||+|||+++..... .....++..|+|||... ..++.++|||||||++|||++|+.||.......... ...
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998765332 22345677899999543 357889999999999999999999996433211100 000
Q ss_pred cc-------cccccch--hhhhhhcCCCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 729 WA-------IPQLHDI--DALSRMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 729 ~~-------~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.. ...+... ............. ......+.++.+++.+|++.||++||++.+++.+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00 0000000 0000000000000 01112456789999999999999999999999774
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=295.48 Aligned_cols=264 Identities=24% Similarity=0.348 Sum_probs=191.7
Q ss_pred CccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc---CCCCccccceEEEecCe-----
Q 003704 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI---RHANIVELKGYCAEHGQ----- 581 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~~~~~----- 581 (801)
|++.+.||+|+||.||+|+.. +++.||||++............+.+|+.+++++ .|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999765 589999999975443333344566677666555 69999999999988776
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+. +|+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8999887532 23589999999999999999999986 8999999999999999999999999998
Q ss_pred CCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-ee---------ecc
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LV---------RWA 730 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~---------~~~ 730 (801)
..+..... .....++..|+||| .....++.++|||||||++|||++|+.||......+... .. .|.
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 77644321 12234677899999 445568999999999999999999999987543211000 00 000
Q ss_pred cccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.................. .......+..+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000000000000 00011234677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=295.96 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCccCCeeeecCccEEEEEEe----CCCcEEEEEEeccccC--chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (801)
+|++.+.||+|+||.||++.. .+|..||+|++..... .....+.+.+|+++++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367789999999999999965 4789999999864322 122346678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999975 34578889999999999999999986 89999999999999999999999999987
Q ss_pred CcCCCCccccccccccccCcCCccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFES---GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
........ ......++..|+|||... ..++.++||||||+++|+|++|+.||........ ...
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------------~~~ 219 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------------QAE 219 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------------HHH
Confidence 66443211 112345677899999543 2467899999999999999999999964221100 011
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 784 (801)
+.+.+... ...++...+..+.+++.+||+.||++|| ++.+++.+
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 220 ISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111111 1224555667899999999999999997 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=305.45 Aligned_cols=268 Identities=20% Similarity=0.313 Sum_probs=195.6
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec------
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (801)
..++|...+.||+|+||.||+|.. .+|+.||||++.+..........+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 346899999999999999999975 5799999999875443344445678999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...++||||+.. +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 356899999964 7776652 3578899999999999999999986 89999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccc--c--c
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--P--Q 733 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~--~ 733 (801)
+++..... .....++..|+|||... ..++.++|||||||++|||++|+.||................ + .
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98765332 12335667899999543 358899999999999999999999997543211100000000 0 0
Q ss_pred ----ccc--hhhhhhhcCCCCCCC---CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH
Q 003704 734 ----LHD--IDALSRMVDPSLSGQ---YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD--LVDMI 789 (801)
Q Consensus 734 ----~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 789 (801)
+.+ ............... .....+.++.+++.+||+.||++||++.|++.+ ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 000000000000000 011234578899999999999999999999966 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=303.57 Aligned_cols=266 Identities=21% Similarity=0.308 Sum_probs=197.9
Q ss_pred hhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe-cCeE
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQR 582 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~ 582 (801)
..++++|+..+.||+|+||.||+|.. .+|+.||||++.+..........+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678899999999999999999964 589999999986544444445678889999999999999999998865 5678
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 5689988863 3578888889999999999999986 89999999999999999999999999987
Q ss_pred CcCCCCccccccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccc-ceeeccccccc----
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ-FLVRWAIPQLH---- 735 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~---- 735 (801)
..... .....++..|+|||... ..++.++|||||||++|||++|+.||......... .+.........
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54332 12234567799999543 35899999999999999999999999654321100 00000000000
Q ss_pred ---chhhhhhhcCCCCCCCCC-----cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 ---DIDALSRMVDPSLSGQYP-----AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 ---~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
......-..........+ ...+.++.+++.+||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000001111 2345789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.57 Aligned_cols=265 Identities=19% Similarity=0.309 Sum_probs=197.2
Q ss_pred hhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC----
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG---- 580 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~---- 580 (801)
...++|+..+.||+|+||.||++. ..+|..||||++............+.+|++++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999996 457999999998654444444567889999999999999999999886543
Q ss_pred --eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 581 --QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 581 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7799988863 4689999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccccc--
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIPQ-- 733 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~-- 733 (801)
|++...... .....++..|+|||...+ .++.++|||||||++|+|++|+.||.......... ........
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 998765432 123345778999995433 48899999999999999999999997543211000 00000000
Q ss_pred -----cc--chhhhhhhcCCCCC---CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 734 -----LH--DIDALSRMVDPSLS---GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 734 -----~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+. ........+..... .......+.++.+++.+|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000000000 00112345678899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.42 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=194.2
Q ss_pred CCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
...||+|+||.||++.. .+|..||||++... .......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46799999999999965 57899999988532 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (801)
+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........ .
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 99998753 3578999999999999999999986 899999999999999999999999999876543221 1
Q ss_pred ccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC
Q 003704 673 SGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751 (801)
Q Consensus 673 ~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (801)
.....++..|+|||. ....++.++|||||||++|||++|+.||........ ...+.......+.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------------~~~~~~~~~~~~~-- 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------------MKMIRDNLPPKLK-- 237 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhhCCcccC--
Confidence 223457788999994 455688999999999999999999999864321100 0111111111111
Q ss_pred CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 752 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.....+..+.+++.+||+.||.+||++.|++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 122345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=294.24 Aligned_cols=265 Identities=22% Similarity=0.358 Sum_probs=198.3
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|+..+.||+|++|.||+|.. .+|+.+++|++............+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678899999999999965 47899999998765544445677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++ +|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 888888653 24689999999999999999999986 89999999999999999999999999987765432
Q ss_pred cccccccccccCcCCcccc-cC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccce-ee-cccccccchhhhhh---
Q 003704 670 SQLSGHLLTAYGYGAPEFE-SG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL-VR-WAIPQLHDIDALSR--- 742 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~-~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~-~~~~~~~~~~~~~~--- 742 (801)
.......++..|+|||.. .. .++.++||||||+++|+|++|+.||......+.... .. ...+.......+..
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112223466779999944 33 588999999999999999999999965432111000 00 00000000000000
Q ss_pred hcCCCCC-------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 743 MVDPSLS-------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....... .......+.++.+++.+||+.||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 00112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=291.69 Aligned_cols=252 Identities=20% Similarity=0.346 Sum_probs=194.3
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEecccc---CchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRA---SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (801)
+|.+.+.||+|+||.||++... .+..+++|.++... ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999653 34556666554322 2223344566788999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875433346789999999999999999999986 9999999999999975 569999999987664
Q ss_pred CCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
.... ......++..|+||| .....++.++|+||||+++|+|++|..||...... .......
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----------------~~~~~~~ 218 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----------------SVVLRIV 218 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHH
Confidence 3321 122345677899999 44456888999999999999999999998632110 1111111
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. ......+...+.++.+++.+||..||++||++.|++++
T Consensus 219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 11122344556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.17 Aligned_cols=270 Identities=23% Similarity=0.339 Sum_probs=194.4
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-------
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------- 579 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------- 579 (801)
.++|++.+.||+|+||.||+|.. .+++.+|||++............+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46889999999999999999965 4789999999865443333345667899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeec
Q 003704 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 580 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 658 (801)
...++||||+.+ +|...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 677776642 34689999999999999999999986 8999999999999999999999999
Q ss_pred cCCCCcCCCCcccc---------ccccccccCcCCccccc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee
Q 003704 659 GLAPLISSGSVSQL---------SGHLLTAYGYGAPEFES--GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV 727 (801)
Q Consensus 659 Gla~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~--~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~ 727 (801)
|++........... .....++..|+|||... ..++.++|||||||++|||++|++||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99976643321111 11234567799999543 34789999999999999999999999754332111000
Q ss_pred e--ccc---ccccchhhhhhhcCCCCCCCCC-------cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 728 R--WAI---PQLHDIDALSRMVDPSLSGQYP-------AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 728 ~--~~~---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
. +.. ..+.....+....+.......+ ......+.+++.+||+.||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 000 0000000011000000000011 1223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.00 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=197.5
Q ss_pred CCccCCeeeecCccEEEEEEe----CCCcEEEEEEeccccC--chhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (801)
+|+..+.||+|+||.||+++. .++..||||.+.+... .......+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999864 3678999999864322 122345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++||||+++++|.+++.. ...+++..+..++.|++++|+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999874 24588999999999999999999985 89999999999999999999999999987
Q ss_pred CcCCCCccccccccccccCcCCcccccC-C--CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFESG-I--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~--~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
.+...... ......++..|+|||...+ . .+.++||||||+++|||++|+.||........ .. ..
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------~~--~~ 220 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----------QS--EI 220 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----------HH--HH
Confidence 65443211 1122356778999995433 3 68899999999999999999999963221100 00 00
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
...+... ....+...+..+.+++.+||+.||++|||+.++.+.|...
T Consensus 221 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 221 SRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111111 1123445567899999999999999999987776655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.35 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=199.4
Q ss_pred CCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecC-----eEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (801)
+|.+.+.||+|+||.||+|+.. +|+.||||++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999764 5899999998765433445577889999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 4899988752 3789999999999999999999986 899999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCcCCcccc-cC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-ccccc---
Q 003704 664 ISSGSVS-QLSGHLLTAYGYGAPEFE-SG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQLH--- 735 (801)
Q Consensus 664 ~~~~~~~-~~~~~~~~~~~y~aPE~~-~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~~~--- 735 (801)
....... .......++..|+|||.. .. .++.++||||||+++|+|++|+.||.......... +.... .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6544210 112234567789999954 44 58899999999999999999999997554211000 00000 00000
Q ss_pred --chhhhhhhcC---CCCC---CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 736 --DIDALSRMVD---PSLS---GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 --~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
......+.+. .... .......+.++.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0000 00112346778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.35 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=194.9
Q ss_pred CccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|.+.+.||+|+||+||+|... +++.|+||++...... .......+|+..+++++ |+||+++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567789999999999999764 5889999998654322 23334557888999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||+. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 789999887532 24689999999999999999999986 89999999999999999999999999987664432
Q ss_pred ccccccccccccCcCCcccc--cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecccc----cccchhhhh
Q 003704 669 VSQLSGHLLTAYGYGAPEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAIP----QLHDIDALS 741 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~----~~~~~~~~~ 741 (801)
. .....++..|+|||.. ...++.++|+||||+++|||++|+.||......+... ...+... .+.+...+.
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 P---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred C---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1 1234567789999954 3347899999999999999999999996543211100 0000000 000000000
Q ss_pred hhcCCCCC-------CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 742 RMVDPSLS-------GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...+.... .......+..+.+++.+||+.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00111224679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.26 Aligned_cols=264 Identities=20% Similarity=0.323 Sum_probs=197.0
Q ss_pred hccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCe----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ---- 581 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~---- 581 (801)
+.++|...+.||+|+||.||+|+. .+++.||||++............+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999976 468899999986543334445667789999999999999999998866554
Q ss_pred --EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 582 --RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 582 --~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6699998873 4689999999999999999999986 89999999999999999999999999
Q ss_pred CCCCcCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeeccc-c---
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWAI-P--- 732 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~-~--- 732 (801)
++...... .....++..|+|||...+ .++.++|||||||++|||++|+.||.......... +..... +
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98765433 223356677999995433 57899999999999999999999997543211100 000000 0
Q ss_pred ---ccc--chhhhhhhcCCCCCCCC---CcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 733 ---QLH--DIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 ---~~~--~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+. ........+.......+ ....+.++.+++.+||+.||++|||+.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 00000000000000001 11235689999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.27 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=192.3
Q ss_pred CCccCCeeeecCccEEEEEEeC-C--CcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEe----cCe
Q 003704 510 SFSQENLIGAGMLGSVYRAQLP-D--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE----HGQ 581 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~----~~~ 581 (801)
+|+..+.||+|+||.||+++.. + +..||||++............+.+|+++++++ .|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999753 4 78999999865433333456678899999998 59999999987543 245
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.+++|||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999986 689998864 35689999999999999999999986 8999999999999999999999999999
Q ss_pred CCcCCCCcc--ccccccccccCcCCcccc-c-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-ccc--
Q 003704 662 PLISSGSVS--QLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQ-- 733 (801)
Q Consensus 662 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~-- 733 (801)
+.+...... .......++..|+|||.. . ..++.++|||||||++|+|++|+.||.......... ..... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 866543221 111234577889999954 3 358899999999999999999999997543211000 00000 000
Q ss_pred ----ccc--hhhhhhhcCCCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 734 ----LHD--IDALSRMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 734 ----~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+.. .............. .........+.+++.+||+.||++|||+.|++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 00000000000000 01112356789999999999999999999998663
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=299.52 Aligned_cols=269 Identities=21% Similarity=0.276 Sum_probs=194.4
Q ss_pred ccCCc-cCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchh------------hHHHHHHHHHHhhccCCCCccccc
Q 003704 508 TNSFS-QENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ------------KDDEFLELVNNIDRIRHANIVELK 573 (801)
Q Consensus 508 ~~~~~-~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~HpnIv~l~ 573 (801)
.++|. +.+.||+|+||+||+|.. .+++.||||++........ ....+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 357799999999999965 4799999999864332210 112467899999999999999999
Q ss_pred eEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcE
Q 003704 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (801)
Q Consensus 574 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 653 (801)
+++...+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999997 589998864 34688999999999999999999986 89999999999999999999
Q ss_pred EEeeccCCCCcCCCCc------------cccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccc
Q 003704 654 SVSDCGLAPLISSGSV------------SQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTR 719 (801)
Q Consensus 654 kl~DFGla~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~ 719 (801)
||+|||++........ ........++..|+|||...+ .++.++|||||||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876652111 001112235677999995543 37899999999999999999999997543
Q ss_pred cccccc-eeecc-ccc---ccchhhhh------hhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 720 NRGEQF-LVRWA-IPQ---LHDIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 720 ~~~~~~-~~~~~-~~~---~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..+... +.... .+. +.....+. ........ ......+.++.+++.+||+.||++||++.|++.+-
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 321100 00000 000 00000000 00000000 01123356788999999999999999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.36 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred CCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.++||+|.||+||-|. .++|+.||||++.+..........+++|+.+++++.||.||.+.-.|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 5799999999999994 578999999999988888888899999999999999999999999999999999999999664
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCcEEEeeccCCCCcCCCCc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 669 (801)
-|+-.+.. . +..+++.....++.||+.||.|||.. +|+|+||||+|||+.. --++||||||+|+++.+...
T Consensus 649 MLEMILSs-E--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMILSS-E--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHHHh-h--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 44444443 2 56788888888999999999999985 9999999999999954 34799999999999987643
Q ss_pred cccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCC
Q 003704 670 SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
.....||+.|+||| +.++.|...-|+||.|||+|--++|..||....+-.++. +...-+..
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI------------QNAaFMyP--- 784 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI------------QNAAFMYP--- 784 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh------------hccccccC---
Confidence 55678999999999 556679999999999999999999999997543211110 01111111
Q ss_pred CCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 749 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..-..+...+..+||...|+..-.+|-+.+..+.+
T Consensus 785 -p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 -PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11223456678899999999999999998876644
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=317.27 Aligned_cols=263 Identities=26% Similarity=0.467 Sum_probs=214.3
Q ss_pred cCCccCCeeeecCccEEEEEEeC--------CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEec
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (801)
++..+.+.||+|.||.|++|... ....||||.++..... ...+.+..|++++..+ +|+||+.++|+|.+.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 34455669999999999999642 1457999999765554 6678899999999988 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCc---ccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDD---ELK---------NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
+..++|+||+..|+|.++++..+ ... ..+...+.+.++.|||.|++||++. ++|||||-.+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998754 111 2388999999999999999999986 89999999999999
Q ss_pred CCCCcEEEeeccCCCCcCCCCcccccccc-ccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccc
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHL-LTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~ 724 (801)
.++..+||+|||+|+.............. .-...||||| +....|+.|+|||||||+||||+| |..||....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----- 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----- 526 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----
Confidence 99999999999999876554433212111 1345699999 445679999999999999999999 889986421
Q ss_pred ceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
....+.+.+..+.+...|..+..++.++++.||+.+|++||++.|+.+.+...+..
T Consensus 527 -----------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 -----------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred -----------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 01222334556666677889999999999999999999999999999999997653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=322.19 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=209.2
Q ss_pred hHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecC
Q 003704 503 SLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (801)
Q Consensus 503 ~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (801)
.+.--.++|.+.++||+|+||.|..++. .+++.||.|++.+.... .....-|.+|-.+|.....+-|+.++..|++..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3444457899999999999999999975 56899999999875433 334567888899998888999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
++|+|||||+||+|-.++... ..+++..+..++..|+.||.-||+. |+|||||||+|||||..|++||+|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999853 2689999999999999999999997 999999999999999999999999999
Q ss_pred CCCcCCCCccccccccccccCcCCccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccc
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEFES------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 734 (801)
+-.+..+. ...+....||+.|++||++. +.|+..+|+||+||++|||+.|..||....-.
T Consensus 222 Clkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv------------- 287 (1317)
T KOG0612|consen 222 CLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV------------- 287 (1317)
T ss_pred HHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------------
Confidence 87776433 23456678999999999532 45999999999999999999999999753221
Q ss_pred cchhhhhhhcCCCCCCCCC--cccHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 003704 735 HDIDALSRMVDPSLSGQYP--AKSLSHFADIISRCVQSEPEFRPP---MSEVVQDLV 786 (801)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L~ 786 (801)
+.+.++++-.-.-.+| ...+++..+||.+.+ -+|+.|.. +.++-.|..
T Consensus 288 ---eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 288 ---ETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred ---HHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCcc
Confidence 1222333322223345 356788999998776 47888877 888776643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=283.01 Aligned_cols=240 Identities=29% Similarity=0.393 Sum_probs=193.8
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeccccCch-hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCH
Q 003704 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 594 (801)
||+|+||.||++... +++.+|+|.+....... .....+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999654 68999999987554322 2456788899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccc
Q 003704 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 9999753 3689999999999999999999986 89999999999999999999999999987664432 1123
Q ss_pred ccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCC
Q 003704 675 HLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753 (801)
Q Consensus 675 ~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (801)
...++..|++||. .....+.++|+||||+++|||++|+.||...... .....+.. ....++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~--~~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------------EIYEKILK--DPLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHhc--CCCCCC
Confidence 4456778999994 4455788999999999999999999999653210 11111111 112345
Q ss_pred cccHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 003704 754 AKSLSHFADIISRCVQSEPEFRPPM---SEVVQ 783 (801)
Q Consensus 754 ~~~~~~l~~li~~cl~~dP~~RPt~---~evl~ 783 (801)
...+..+.+++.+||..||++||++ .++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 5557789999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.65 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=193.2
Q ss_pred hccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (801)
+.+.|.....+|.|+|+.|-.+. ..+++..+||++.+.... -.+|+.++... +||||+++++.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 46778888889999999998884 567899999999765222 22455444444 69999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-CCCCcEEEeeccCCCC
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL-DDDLAVSVSDCGLAPL 663 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~ 663 (801)
|||++.|+-+.+.+... +.....+..|+.+|+.++.|||++ |||||||||+|||+ +..++++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999998888753 222267778999999999999996 99999999999999 6899999999999987
Q ss_pred cCCCCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.... ....+-|..|.|||+. ...|+.++||||||++||+||+|+.||...... .+...+
T Consensus 466 ~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~ 525 (612)
T KOG0603|consen 466 LERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTR 525 (612)
T ss_pred Cchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHh
Confidence 7654 2233456789999954 456999999999999999999999999754321 111112
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
+. .+.+....+.++.+|+..||+.||.+|++|.|+..+-.-
T Consensus 526 i~----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 526 IQ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hc----CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 122336667889999999999999999999999876543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=278.65 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=194.2
Q ss_pred ccchhhhHhhhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhh-ccCCCCccccce
Q 003704 497 RSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID-RIRHANIVELKG 574 (801)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~HpnIv~l~~ 574 (801)
..|+.++++. +..||.|+||+|+|-. .+.|+.+|||+++.... .....+++.|.+... .-..||||++||
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3455555554 4679999999999985 46799999999976554 345567777777654 447999999999
Q ss_pred EEEecCeEEEEEeccCCCCHHHHHhc-CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcE
Q 003704 575 YCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (801)
Q Consensus 575 ~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 653 (801)
.+..++..|+.||.|+- ||..+... ....+..+++...-+|..-.+.||.||...+ .|||||+||+|||+|..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 99999999999999964 66554331 1122456888888889999999999999874 79999999999999999999
Q ss_pred EEeeccCCCCcCCCCccccccccccccCcCCccccc--C-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecc
Q 003704 654 SVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFES--G-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 654 kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 730 (801)
||||||++-.+... .......|-..|||||.+. . .|+-++||||||++|||+.||+.||.......
T Consensus 208 KLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-------- 276 (361)
T KOG1006|consen 208 KLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-------- 276 (361)
T ss_pred eeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--------
Confidence 99999998665432 1233445666799999432 2 49999999999999999999999997643321
Q ss_pred cccccchhhhhhhcCCC---CCCC-CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 731 IPQLHDIDALSRMVDPS---LSGQ-YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+.+..++... +... .....+..+..++..|+.+|-..||.+.++.++-
T Consensus 277 -------eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 277 -------EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred -------HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 1222222111 1111 1123456799999999999999999999988653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=289.82 Aligned_cols=264 Identities=24% Similarity=0.409 Sum_probs=196.8
Q ss_pred CccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|+..+.||+|+||.||+|... +++.||+|.+............+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999654 6999999999765433444567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999998532 4689999999999999999999996 899999999999999999999999999876644321
Q ss_pred cccccccccccCcCCcccc-cC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccc-eeecc-cccccchhhhhhh--
Q 003704 670 SQLSGHLLTAYGYGAPEFE-SG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LVRWA-IPQLHDIDALSRM-- 743 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~-~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~-- 743 (801)
.......+..|+|||.. .. .++.++|||||||++|||++|+.||.......... ..... .+.-..+..+..+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 11223345679999943 44 68899999999999999999999996543211100 00000 0000000000000
Q ss_pred cCCC--------CCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 744 VDPS--------LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.. .....+ ..+..+.+++.+||+.||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 000111 225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=277.33 Aligned_cols=270 Identities=22% Similarity=0.366 Sum_probs=202.7
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe--------c
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--------H 579 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--------~ 579 (801)
..|....+||+|.||.||+|+. .+|+.||+|++--+...........+|++++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466678999999999999965 468888998764433344445667799999999999999999998753 3
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
...|+||++|+. +|..++... ...++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 457999999976 888888643 46788999999999999999999986 89999999999999999999999999
Q ss_pred CCCCcCCCCcc--ccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccce--------e
Q 003704 660 LAPLISSGSVS--QLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL--------V 727 (801)
Q Consensus 660 la~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~--------~ 727 (801)
+++.++..... ........|..|++||.+.| .|+.+.|||..|||+.||+||.+-+.+..+.....+ .
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99877543321 11223456888999995444 599999999999999999999998876554332222 2
Q ss_pred ecccccccchhhhhhhcCCCC-CCCC--------CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 728 RWAIPQLHDIDALSRMVDPSL-SGQY--------PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..++|.....+-+..+--+.+ .+++ |-....+..+|+.+++..||.+|+++++++.+.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 223344443333333211111 1111 112235788999999999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=275.91 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=222.6
Q ss_pred hhhHhhhccCCccCCeeeecCccEEEEEEe------CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccce
Q 003704 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574 (801)
Q Consensus 501 ~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~ 574 (801)
..++.....+++...++-+|.||.||.|.+ .+.+.|-||.++.. .++-....+..|--.+..+.|||+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 445555667788888999999999999944 23456778877544 34445567788888888999999999999
Q ss_pred EEEe-cCeEEEEEeccCCCCHHHHHhcC----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 003704 575 YCAE-HGQRLLIYEYCSNGTLQDMLHSD----DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD 649 (801)
Q Consensus 575 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 649 (801)
++.+ .+..+++|.++.-|+|..++..- ....+.++..+...++.|++.|++|||+. +|||.||-.+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9754 56778999999999999999821 12245577778889999999999999997 9999999999999999
Q ss_pred CCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccccee
Q 003704 650 DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLV 727 (801)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~ 727 (801)
..++||+|=.+++.+.+.++....+....+..||+|| +....|+..+|||||||+||||+| |+.||...++
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------- 504 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------- 504 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence 9999999999999998887766666666777899999 566779999999999999999998 9999975443
Q ss_pred ecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 728 RWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
..+..++..+.+-..|-.+++++..++..||..+|++||+++|++.-|.+...
T Consensus 505 ----------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 505 ----------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ----------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 23445556666666788999999999999999999999999999999987643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.95 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=200.4
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhh-----HHHHHHHHHHhhccCCCCccccceEEE-ecCe
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQK-----DDEFLELVNNIDRIRHANIVELKGYCA-EHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~HpnIv~l~~~~~-~~~~ 581 (801)
++|-.+++||+|+|+.|||| .+...+.||||+-.....+... -+...+|.++.+.+.||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45777889999999999999 5677899999986543332222 134467899999999999999999986 5678
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCcEEEeec
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSDC 658 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DF 658 (801)
.+-|+|||+|.+|.-+|+. ...+++.++..|++||+.||.||... .++|||-||||.||||.. -|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 8899999999999999986 35689999999999999999999987 579999999999999954 578999999
Q ss_pred cCCCCcCCCCcc-----ccccccccccCcCCcc-cccC----CCCCcchHHHHHHHHHHHHhCCCCccccccccccceee
Q 003704 659 GLAPLISSGSVS-----QLSGHLLTAYGYGAPE-FESG----IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 659 Gla~~~~~~~~~-----~~~~~~~~~~~y~aPE-~~~~----~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~ 728 (801)
|+++++..+... .......||++|++|| +.-+ ..+.|+||||+|||+|+.+.|+.||...... +.+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL- 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL- 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH-
Confidence 999999876543 2234467999999999 5443 3789999999999999999999999754221 1111
Q ss_pred cccccccchhhhhhhcCCCCCCCCCc--ccHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPA--KSLSHFADIISRCVQSEPEFRPPMSEVVQ 783 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~evl~ 783 (801)
.. ..++ .....++|. ..+.+..++|++||++--++|....++..
T Consensus 695 ------qe----NTIl-kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 ------QE----NTIL-KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------hh----hchh-cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 0111 111223332 34578899999999999999999888764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=318.53 Aligned_cols=147 Identities=24% Similarity=0.366 Sum_probs=130.8
Q ss_pred cCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
++|.+.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999764 789999999875432 2334467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
||+.+++|.+++... ..+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999752 4578899999999999999999986 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.37 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=191.9
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-------
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------- 579 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------- 579 (801)
..+|...+.||.|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46788999999999999999965 5789999999864432 3446788899999999999999999876543
Q ss_pred -------CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CC
Q 003704 580 -------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DL 651 (801)
Q Consensus 580 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~ 651 (801)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 589888853 3588999999999999999999986 8999999999999974 56
Q ss_pred cEEEeeccCCCCcCCCCcc-ccccccccccCcCCccc-cc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceee
Q 003704 652 AVSVSDCGLAPLISSGSVS-QLSGHLLTAYGYGAPEF-ES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~-~~~~~~~~~~~y~aPE~-~~-~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~ 728 (801)
.+||+|||+++........ .......++..|+|||. .. ..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7899999998765432111 11122345677999994 33 357889999999999999999999997543321111000
Q ss_pred ccccccc--chhhhh----hhcC-CCCCC-----CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 729 WAIPQLH--DIDALS----RMVD-PSLSG-----QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 729 ~~~~~~~--~~~~~~----~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
...+... +..... .... ..... ........++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 000000 0000 00000 0112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=303.60 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=211.9
Q ss_pred chhhhHhhhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEE
Q 003704 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYC 576 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~ 576 (801)
..++.+...++-|++.+.||.|.+|.||+++ .++|+..|||++... ...++++..|.++++.. .|||++.++|+|
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3455566667789999999999999999995 678999999998643 33456777888888877 599999999998
Q ss_pred Ee-----cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 577 AE-----HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 577 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
.. .+++|||||||.+||..|+++... ...+.|..+..|.+.++.||.|||.. .++|||||-.|||++.++
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA 160 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence 53 579999999999999999998654 67799999999999999999999986 799999999999999999
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCcccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccccccc
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG------IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~ 725 (801)
.||++|||.+..+.... .......||+.|||||+... .|+.++|+||||++..||--|.+|+..+.+...
T Consensus 161 ~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-- 236 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-- 236 (953)
T ss_pred cEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--
Confidence 99999999987765542 12455789999999995432 378899999999999999999999976654322
Q ss_pred eeecccccccchhhhhhhc-CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 726 LVRWAIPQLHDIDALSRMV-DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+..+. .+...-.-|.....+|.++|..||.+|.++||++.+++++
T Consensus 237 --------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 --------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 1122223466778899999999999999999999998864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=280.36 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=194.9
Q ss_pred cCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHH-HHHHHHHhhcc-CCCCccccceEEEecCeEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE-FLELVNNIDRI-RHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~-~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 585 (801)
.+|....+||+|+||.|.+|. ..+...||||++++....+.+.-+ -+.|-++|... +-|.++.++..|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 467788999999999999994 456789999999877654433222 22344444443 578999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
|||+.||+|--+|+.. ..+.+..+..+|..||-||-+||+. |||+||||-+|||||.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999988864 3466678889999999999999986 99999999999999999999999999987543
Q ss_pred CCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhc
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
-+. ......+||+.|+||| +....|+-++|+|||||+||||+.|++||++.+.. +....+.
T Consensus 502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI~ 563 (683)
T KOG0696|consen 502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAIM 563 (683)
T ss_pred cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHH
Confidence 222 2345678999999999 56678999999999999999999999999875432 1122222
Q ss_pred CCCCCCCCCcccHHHHHHHHHHhcccCCCCCCC
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777 (801)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 777 (801)
+. ...||...+.+...+....+.+.|.+|..
T Consensus 564 eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred Hc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 22 23588888999999999999999999953
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=278.49 Aligned_cols=218 Identities=22% Similarity=0.222 Sum_probs=172.7
Q ss_pred cCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHH
Q 003704 520 GMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML 598 (801)
Q Consensus 520 G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l 598 (801)
|.||.||+++. .+|+.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999965 578999999986432 1223444455567999999999999999999999999999999998
Q ss_pred hcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcccccccccc
Q 003704 599 HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678 (801)
Q Consensus 599 ~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 678 (801)
... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....+
T Consensus 77 ~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~ 144 (237)
T cd05576 77 SKF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV 144 (237)
T ss_pred HHh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence 752 4589999999999999999999986 89999999999999999999999999876554321 12234
Q ss_pred ccCcCCcccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccH
Q 003704 679 AYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSL 757 (801)
Q Consensus 679 ~~~y~aPE~~-~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (801)
+..|+|||.. .+.++.++||||+||++|||++|+.|+...... +.. ......|...+
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~----~~~~~~~~~~~ 202 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INT----HTTLNIPEWVS 202 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------ccc----ccccCCcccCC
Confidence 5569999954 456889999999999999999999887532110 000 00011234455
Q ss_pred HHHHHHHHHhcccCCCCCCCH
Q 003704 758 SHFADIISRCVQSEPEFRPPM 778 (801)
Q Consensus 758 ~~l~~li~~cl~~dP~~RPt~ 778 (801)
..+.+++.+|++.||++||++
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCC
Confidence 779999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=288.04 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=207.1
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCc-EEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~-~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++.....||-|+||.|=+++..... .+|+|.+++...- ....+.+..|-.+|...+.|.||++|-.|.+..+.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556677999999999998765433 4899998876543 344567778899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|-|-||.|...++. +..++..++..++..+++|++|||+. +||+|||||+|.|||.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999987 45678888889999999999999986 999999999999999999999999999999877
Q ss_pred CCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
+.. .-..+||+.|.||| ++....+.++|.||||+++|||++|.+||...++.....++ .+-+|
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------------LkGid 636 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------------LKGID 636 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------------Hhhhh
Confidence 643 33568999999999 67788999999999999999999999999876654322111 11111
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQDLV 786 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~ 786 (801)
.-.+|........+++++.+..+|.+|.. +.+|-+|-+
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 11356666778899999999999999975 666666654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.45 Aligned_cols=265 Identities=18% Similarity=0.311 Sum_probs=197.8
Q ss_pred hhccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-C-C----CccccceEEEe
Q 003704 506 QYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-H-A----NIVELKGYCAE 578 (801)
Q Consensus 506 ~~~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-H-p----nIv~l~~~~~~ 578 (801)
...++|.+...+|+|+||.|-++. ...+..||||+++.- ....+.-+-|+++++++. + | -+|.+.+||.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 347899999999999999999994 345899999998532 334455567888898883 2 2 37788888999
Q ss_pred cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---------
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD--------- 649 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--------- 649 (801)
.++.++|+|.+ |-|+++++.... ..+++...+..|+.|++++++|||+. +++|-||||+|||+..
T Consensus 163 rghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence 99999999988 669999998754 46788999999999999999999997 8999999999999831
Q ss_pred -----------CCcEEEeeccCCCCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 003704 650 -----------DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDR 717 (801)
Q Consensus 650 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~ 717 (801)
...+||+|||.|+.-... ......|..|.||| ++.-.++..+||||+||||+|+.||...|..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999875543 35567888999999 5566799999999999999999999999987
Q ss_pred cccccccceeecccccccchhhhhhh-----cCCC-C---------------CCC--------CCcccHHHHHHHHHHhc
Q 003704 718 TRNRGEQFLVRWAIPQLHDIDALSRM-----VDPS-L---------------SGQ--------YPAKSLSHFADIISRCV 768 (801)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~---------------~~~--------~~~~~~~~l~~li~~cl 768 (801)
..+.+...+.+.+...... ..+.+. .... + ... ..+....++.+|+.+||
T Consensus 312 Hen~EHLaMMerIlGp~P~-~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPS-RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CCcHHHHHHHHHhhCCCcH-HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 6544322222111111100 000000 0000 0 000 01223456889999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 003704 769 QSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 769 ~~dP~~RPt~~evl~~L 785 (801)
..||.+|+|+.|++++-
T Consensus 391 ~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 391 EFDPARRITLREALSHP 407 (415)
T ss_pred ccCccccccHHHHhcCH
Confidence 99999999999999764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=283.72 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=172.4
Q ss_pred CccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccC-chhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|..++.||-|+||.|.+++ .++...||.|.+++... ........+.|-.+|.....+-||+||..|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5667889999999999995 55677899999876542 223346677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC---
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS--- 665 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~--- 665 (801)
++||++-.+|... .-+.+.-+..++..++.|+++.|.. |+|||||||+|||||.||++||+|||++.-+.
T Consensus 711 IPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999998753 4567777888899999999999997 99999999999999999999999999985331
Q ss_pred ------CCC------------cc-------------------ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHH
Q 003704 666 ------SGS------------VS-------------------QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLE 707 (801)
Q Consensus 666 ------~~~------------~~-------------------~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~e 707 (801)
.+. .. .......||..|+||| +....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 100 00 0112347899999999 566779999999999999999
Q ss_pred HHhCCCCccccccccccc
Q 003704 708 LLTGRKSYDRTRNRGEQF 725 (801)
Q Consensus 708 lltG~~pf~~~~~~~~~~ 725 (801)
|+.|++||....+.+.+.
T Consensus 864 m~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HhhCCCCccCCCCCccee
Confidence 999999998777665543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=288.99 Aligned_cols=267 Identities=18% Similarity=0.220 Sum_probs=180.4
Q ss_pred ccCCccCCeeeecCccEEEEEEe-----------------CCCcEEEEEEeccccCchhhHH--------------HHHH
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-----------------PDGKLLAVKKLDKRASSQQKDD--------------EFLE 556 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~~~ 556 (801)
.++|++.++||+|+||+||+|.. .+++.||||++..... ...+ ....
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~--~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ--GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch--hhHHHHHhhhhhhhcccchhHH
Confidence 46899999999999999999953 2457899999864321 1112 2334
Q ss_pred HHHHhhccCCCCc-----cccceEEEe--------cCeEEEEEeccCCCCHHHHHhcCcc--------------------
Q 003704 557 LVNNIDRIRHANI-----VELKGYCAE--------HGQRLLIYEYCSNGTLQDMLHSDDE-------------------- 603 (801)
Q Consensus 557 e~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~-------------------- 603 (801)
|+.++.+++|.++ +++++||.. .+..+|||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5666677766554 677787753 3568999999999999999974211
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcC
Q 003704 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683 (801)
Q Consensus 604 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~ 683 (801)
....+++..+..++.|++.+|+|||+. +|+||||||+|||++.++.+||+|||++..+...... ......+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 012356788899999999999999986 8999999999999999999999999999765433211 111223467899
Q ss_pred Cccccc-CC--------------------CC--CcchHHHHHHHHHHHHhCCC-Cccccccccccceeecccccccchhh
Q 003704 684 APEFES-GI--------------------YT--CQSDVYSFGVVMLELLTGRK-SYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 684 aPE~~~-~~--------------------~~--~k~DvwSlGvil~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
|||.+. .. |+ .+.||||+||++|||++|.. ||......... +.. .. .+...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~-~~---~~~~~ 452 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQ-YD---NDLNR 452 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhh-cc---chHHH
Confidence 999432 11 11 24799999999999999875 66432111000 000 00 00000
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEP---EFRPPMSEVVQDL 785 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L 785 (801)
..................+...+|+.+||..+| .+|+|++|+++|-
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 000111111111223456778999999999866 6899999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=250.09 Aligned_cols=203 Identities=23% Similarity=0.346 Sum_probs=164.0
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhc-cCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+....+..||+|+||.|-+-++ .+|...|||++..... .+..++..+|+.+..+ ..+|.+|.+||.+.+.+..++.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3444567899999999988864 5899999999975543 4455667777776654 47999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|.|.. ||..+..+--.....+++...-+|+..+.+||.|||+. -.|||||+||+|||++.+|++||||||++-.+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99964 88776654323356788889999999999999999997 4799999999999999999999999999877654
Q ss_pred CCccccccccccccCcCCcccccC-----CCCCcchHHHHHHHHHHHHhCCCCcccc
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFESG-----IYTCQSDVYSFGVVMLELLTGRKSYDRT 718 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~k~DvwSlGvil~elltG~~pf~~~ 718 (801)
... .....|-..|||||.+.. .|+-|+||||||+.+.||.+++.||+..
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 321 222345566999995432 4899999999999999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=262.80 Aligned_cols=237 Identities=32% Similarity=0.473 Sum_probs=189.5
Q ss_pred CccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHHh
Q 003704 521 MLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599 (801)
Q Consensus 521 ~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 599 (801)
+||.||+|... +|+.+++|++........ .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999765 589999999875433221 5788899999999999999999999999999999999999999999987
Q ss_pred cCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccc
Q 003704 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679 (801)
Q Consensus 600 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~ 679 (801)
.. ..+++..+..++.++++++.|||+. +|+|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 80 ~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 149 (244)
T smart00220 80 KR----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGT 149 (244)
T ss_pred hc----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCC
Confidence 53 2388999999999999999999986 89999999999999999999999999998765432 12334567
Q ss_pred cCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCc--cc
Q 003704 680 YGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPA--KS 756 (801)
Q Consensus 680 ~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 756 (801)
..|++||. ....++.++||||||+++|+|++|..||...... ..+.+............ ..
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----------------LELFKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCccccccC
Confidence 78999994 4566888999999999999999999999652111 11111111111111111 15
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 757 LSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 757 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+.++.+++.+|+..+|++||++.+++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 5789999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=253.23 Aligned_cols=259 Identities=17% Similarity=0.311 Sum_probs=196.1
Q ss_pred ccCCccCCeeeecCccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEec--CeEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEH--GQRL 583 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~ 583 (801)
.++|++.+++|+|-|+.||.|. ..+...++||+++ ....+.+.+|++++..++ ||||+++++.+.++ ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4678999999999999999994 6788899999986 345678899999999997 99999999999875 4567
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEeeccCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAP 662 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 662 (801)
||+||+++.+...+. +.++...+..++.+++.||.|+|+. ||+|||+||.|+++|.. -.++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 999999998887664 4577788999999999999999997 99999999999999864 579999999999
Q ss_pred CcCCCCccccccccccccCcCCcccc--cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccc----ccc--
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI----PQL-- 734 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~----~~~-- 734 (801)
++.++... .....+..|.-||++ -..|+..-|+|||||++..|+..+.||.......++. +..+. ..+
T Consensus 182 FYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL-VkIakVLGt~el~~ 257 (338)
T KOG0668|consen 182 FYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VKIAKVLGTDELYA 257 (338)
T ss_pred hcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH-HHHHHHhChHHHHH
Confidence 98876421 223345568899944 4569999999999999999999999997655433321 11110 000
Q ss_pred -------cchhhhhhhcCCCCC---CCC-----CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 735 -------HDIDALSRMVDPSLS---GQY-----PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 735 -------~~~~~~~~~~~~~~~---~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
.-......++....+ ..+ ..-..++..+++.+.|..|..+|+|++|.+.+-
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 000111111111000 000 112246889999999999999999999998763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=298.47 Aligned_cols=263 Identities=19% Similarity=0.224 Sum_probs=168.2
Q ss_pred ccCCccCCeeeecCccEEEEEEeC-C----CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceE------E
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-D----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY------C 576 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~------~ 576 (801)
.++|+..+.||+|+||.||+|... + +..||||++..... .+....+ .++...+.++..+... .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 467899999999999999999764 4 78999998753221 1111111 1222223333332222 2
Q ss_pred EecCeEEEEEeccCCCCHHHHHhcCccc----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 003704 577 AEHGQRLLIYEYCSNGTLQDMLHSDDEL----------------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF 640 (801)
Q Consensus 577 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 640 (801)
......++||||+.+++|.+++...... ........+..++.||+.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 3566889999999999999998753210 00112334567899999999999986 8999999
Q ss_pred CCCcEEECC-CCcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccC----------------------CCCCcc
Q 003704 641 KSANILLDD-DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESG----------------------IYTCQS 696 (801)
Q Consensus 641 kp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~----------------------~~~~k~ 696 (801)
||+|||++. ++.+||+|||+++.+..... .......+++.|+|||. ... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 57999999999986644322 12234567889999993 221 134567
Q ss_pred hHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCC------CCcccHHHHHHHHHHhccc
Q 003704 697 DVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ------YPAKSLSHFADIISRCVQS 770 (801)
Q Consensus 697 DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~ 770 (801)
|||||||++|||+++..+++.........+. ..-.+...+........... ..+.......+|+.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLK----RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHH----hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999987765432100000000 00000111111111110000 0111123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 003704 771 EPEFRPPMSEVVQD 784 (801)
Q Consensus 771 dP~~RPt~~evl~~ 784 (801)
||++|||+.|+++|
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=257.05 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=192.8
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhH-HHHHHHHHHhh-ccCCCCccccceEEEecCeEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKD-DEFLELVNNID-RIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~-~~~~~e~~~l~-~l~HpnIv~l~~~~~~~~~~~l 584 (801)
.++|....+||+|+|..|..+++ ++.+.||+|++++....+... +=...|-.+.. ..+||.+|.++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46899999999999999999975 568899999997654333222 22223333333 3479999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
|.||++||+|--+++. ...++++.+..+...|..||.|||+. |||.||||-+|||+|..|.+|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999776664 45689999999999999999999997 9999999999999999999999999998753
Q ss_pred CCCCccccccccccccCcCCcccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh-
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR- 742 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 742 (801)
-.. .......+||+.|+|||++.+ .|+..+|+|++||+++||+.|+.||+-.... .+.....+-+.+
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~---------n~d~ntedylfqv 470 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD---------NPDMNTEDYLFQV 470 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC---------CcccchhHHHHHH
Confidence 222 223567889999999997766 5999999999999999999999999743211 011111111111
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCC
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 777 (801)
++...+ ..|...+.....++..-|.+||.+|..
T Consensus 471 ilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 471 ILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred Hhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 122222 246666777888999999999999954
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=289.84 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=185.5
Q ss_pred CccCCeeeecCccE-EEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGS-VYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
|...+++|.|+.|+ ||+|.. +|+.||||++-. ...+...+|+..++.. .|||||++|+.-.++...||+.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 45567899999986 699988 789999999853 2334566899998887 599999999998899999999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---C--CcEEEeeccCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---D--LAVSVSDCGLAPL 663 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~ 663 (801)
|. .+|.+++...............+.+..|++.||+|||+. +||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 599999986411111112144567889999999999997 8999999999999976 3 4689999999999
Q ss_pred cCCCCcccc-ccccccccCcCCcccccC-CCCCcchHHHHHHHHHHHHhC-CCCccccccccccceeecccccccchhhh
Q 003704 664 ISSGSVSQL-SGHLLTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLTG-RKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 664 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~k~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
+..+..+.. .....||.||+|||++.. .-+..+||||+||++|+.++| .+||...-.++...+ .....+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~~L 732 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNYTL 732 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCccce
Confidence 876643322 345689999999996554 456789999999999999996 999975432211100 000000
Q ss_pred hhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
..+ . +.. ..+..+||.+|++.||..||++.+|+.|
T Consensus 733 ~~L-----~---~~~-d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 733 VHL-----E---PLP-DCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eee-----c---cCc-hHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000 0 111 1178899999999999999999999843
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-31 Score=258.79 Aligned_cols=268 Identities=21% Similarity=0.338 Sum_probs=200.3
Q ss_pred CCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEec-----CeEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQRL 583 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 583 (801)
+.+..+.||-|+||.||.+.+ .+|+.||.|++..-...-...+.+.+|++++.-.+|.|++..++...-. .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345578899999999999965 5899999999875555555567888999999999999999999987543 3567
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+|+|.|. .+|...|-+ .+.++...+.-+..||++||+|||+. +|.||||||.|+|++.+..+||+|||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 8888885 478777764 46788888888999999999999997 999999999999999999999999999998
Q ss_pred cCCCCccccccccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccccee--ecccccccchhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWAIPQLHDIDA 739 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 739 (801)
...+....+ .....|..|.|||++.| .|+...||||.|||+.||+-.+..|....+.....++ -..++.++++..
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 766543222 23345667999996655 4999999999999999999999888765543322221 112233322211
Q ss_pred h-----hhhcCCCCCC-C--------CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 740 L-----SRMVDPSLSG-Q--------YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 740 ~-----~~~~~~~~~~-~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
. ..++....+. . .+.....+..+++.+++..||++|.+..+.+.++-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1 1122221111 0 12233346678899999999999999999887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=235.11 Aligned_cols=211 Identities=36% Similarity=0.632 Sum_probs=179.3
Q ss_pred eeecCccEEEEEEeCC-CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCHH
Q 003704 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQ 595 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 595 (801)
||+|.+|.||++...+ ++.++||++....... ....+.+|++.++.++|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997754 8999999987543221 3467889999999999999999999999989999999999999999
Q ss_pred HHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEeeccCCCCcCCCCcccccc
Q 003704 596 DMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGSVSQLSG 674 (801)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 674 (801)
+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 9987531 4688999999999999999999986 9999999999999999 89999999999876654321 122
Q ss_pred ccccccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCC
Q 003704 675 HLLTAYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752 (801)
Q Consensus 675 ~~~~~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (801)
...+...|++||.... .++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 3445667999995443 788999999999999998
Q ss_pred CcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 753 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
..+.+++.+|++.||++||++.++++++
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2477999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=245.93 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=191.3
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe------cCe
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE------HGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~------~~~ 581 (801)
.+|.....+|.|.- .|..+ ..-.++.||+|++..........+.-.+|...+..+.|+||++++.++.- ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 55555 44578999999987665555556677789999999999999999999853 246
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.|+|||||.. +|...++. .++-.+...|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 7999999964 89988873 367778899999999999999997 9999999999999999999999999999
Q ss_pred CCcCCCCccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccc-ee-ecccccccchh
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-LV-RWAIPQLHDID 738 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~-~~~~~~~~~~~ 738 (801)
+..... ...+....+..|.||| .+.-.|...+||||+||++.||++|+..|.+...-+... .+ ....+......
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 765433 2234455677799999 445559999999999999999999999887433211100 00 00111111111
Q ss_pred hhh-------------------hhc-CCCCCCC--CCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 739 ALS-------------------RMV-DPSLSGQ--YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 739 ~~~-------------------~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+. +.+ |..+... .+......+.+++.+||..||++|.+++++|+|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111 001 1111110 112234567899999999999999999999976
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=255.86 Aligned_cols=275 Identities=20% Similarity=0.300 Sum_probs=202.2
Q ss_pred chhhhHhhhccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC------CCCccc
Q 003704 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR------HANIVE 571 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------HpnIv~ 571 (801)
+.+.-.+....+|.+....|+|-|++|.+|.. ..|..||||++.... ...+.-+.|+++|++|. --|+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 33333445667888888899999999999964 458899999997543 33345668999999985 348999
Q ss_pred cceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-
Q 003704 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD- 650 (801)
Q Consensus 572 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~- 650 (801)
++-.|....+++||+|-+.. +|.++|...+. .-.|....+..++.|+.-||..|... +|+|.||||+|||+++.
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 99999999999999998854 89999987653 56788899999999999999999987 99999999999999875
Q ss_pred CcEEEeeccCCCCcCCCCccccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcccccccccccee-e
Q 003704 651 LAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-R 728 (801)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~ 728 (801)
..+||||||.|.+......+. . ..+..|.|||+ +.-.|+...|+||+||.||||.||+..|.+..+..+.-+. .
T Consensus 574 ~iLKLCDfGSA~~~~eneitP---Y-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITP---Y-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCccccccccccccH---H-HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 468999999998877665422 1 22335999994 5557999999999999999999999999876543221110 0
Q ss_pred ccc--------------c----cc----cchhhhh--------hhcCC------CCC--CCCCc---ccHHHHHHHHHHh
Q 003704 729 WAI--------------P----QL----HDIDALS--------RMVDP------SLS--GQYPA---KSLSHFADIISRC 767 (801)
Q Consensus 729 ~~~--------------~----~~----~~~~~~~--------~~~~~------~~~--~~~~~---~~~~~l~~li~~c 767 (801)
... . .+ .+.+.+. ..+.+ .+. ..+|. ....+|.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 000 0 00 0000000 00000 000 11333 2345788999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 003704 768 VQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 768 l~~dP~~RPt~~evl~~L 785 (801)
+..||++|.|..|.|+|-
T Consensus 730 l~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHP 747 (752)
T ss_pred hccChhhcCCHHHHhcCC
Confidence 999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=259.33 Aligned_cols=197 Identities=21% Similarity=0.311 Sum_probs=166.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc------hhhHHHHHHHHHHhhccC---CCCccccceEEEe
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS------QQKDDEFLELVNNIDRIR---HANIVELKGYCAE 578 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~ 578 (801)
.+|...+.+|+|+||.|+.|.. .+...|+||.+.+...- +...-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588899999999999999965 45678899988655421 111123456888888887 9999999999999
Q ss_pred cCeEEEEEecc-CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEee
Q 003704 579 HGQRLLIYEYC-SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (801)
Q Consensus 579 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 657 (801)
++++||+||-. ++-+|+++|.. ++.+++..+..|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 56699999975 67899999999999999999999997 999999999999999999999999
Q ss_pred ccCCCCcCCCCccccccccccccCcCCcccccCC-C-CCcchHHHHHHHHHHHHhCCCCcc
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-Y-TCQSDVYSFGVVMLELLTGRKSYD 716 (801)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~k~DvwSlGvil~elltG~~pf~ 716 (801)
||.|.....+. .....||.+|.|||.+.|. | +..-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998776654 3456899999999987775 4 556899999999999999888875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=244.14 Aligned_cols=131 Identities=19% Similarity=0.382 Sum_probs=111.8
Q ss_pred cCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-----C---CCccccceEEEe-
Q 003704 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----H---ANIVELKGYCAE- 578 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----H---pnIv~l~~~~~~- 578 (801)
.+|.+.++||-|.|++||+| ...+.+.||+|+.+. .+...+.-+.|+++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 68899999999999999999 456788999999863 2344556678899988874 2 479999999965
Q ss_pred ---cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 579 ---HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 579 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
..++++|+|++ |.+|..+|.... .+.++...+.+|++||+.||.|||..| +|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45889999998 678999998654 567999999999999999999999998 99999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=264.60 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=199.2
Q ss_pred ccCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.++|.....+|.|+||.|||++. ..++..|||+++.... .....+..|+-+++..+|||||.+++.|...+..+++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46788899999999999999964 5789999999875432 23455668888999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|||.+|+|++..+. ...+++.++..+.+..++||+|||+. +-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998875 46788889999999999999999997 789999999999999999999999999866543
Q ss_pred CCccccccccccccCcCCccc----ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF----ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~----~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.. .......||+.|||||+ ..+.|..++|||++|+...|+-.-++|.....+ ...+.-
T Consensus 165 ti--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------------mr~l~L 226 (829)
T KOG0576|consen 165 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------------MRALFL 226 (829)
T ss_pred hh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------------HHHHHH
Confidence 22 12345689999999994 346799999999999999999877776542221 112111
Q ss_pred hcCCCCCC---CCCcccHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003704 743 MVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783 (801)
Q Consensus 743 ~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 783 (801)
+....+.+ .-+....+.|.+|++.|+.++|++||++..+++
T Consensus 227 mTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 MTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111 123455678999999999999999999998775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=229.07 Aligned_cols=199 Identities=34% Similarity=0.512 Sum_probs=167.8
Q ss_pred CccCCeeeecCccEEEEEEeCC-CcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 511 FSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
|...+.||+|++|.||++...+ ++.+++|.+...... .....+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999997754 899999998754332 24568889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCc
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (801)
++++|.+++.... ..+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999997532 1178999999999999999999986 899999999999999999999999999887654420
Q ss_pred cccccccccccCcCCcccc--cCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 003704 670 SQLSGHLLTAYGYGAPEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDR 717 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~ 717 (801)
.......++..|++||.. ...++.++|||+||++++||++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012234566779999953 34577899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=228.69 Aligned_cols=256 Identities=16% Similarity=0.297 Sum_probs=185.7
Q ss_pred hccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceE-EEecCeEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGY-CAEHGQRL 583 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~-~~~~~~~~ 583 (801)
..+.|.+.+.+|+|.||.+-+++.. ..+.+++|.+... ....++|.+|...--.+ .|.||+.-|+. |+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4577899999999999999999764 5678899988643 44567888988764444 59999998775 67788899
Q ss_pred EEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC--CCCcEEEeeccCC
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLAVSVSDCGLA 661 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla 661 (801)
+++||++.|+|.+-+.. ..+.+....+++.|++.|+.|||+. ++||||||.+|||+- +...+|+||||+.
T Consensus 99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 99999999999988763 5678888999999999999999985 999999999999993 3447999999998
Q ss_pred CCcCCCCccccccccccccCcCCccccc----C--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccccc
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPEFES----G--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 735 (801)
+..... .....-+..|.+||... + ...+.+|||.||+++|.++||+.||..... .+....+|.
T Consensus 171 ~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~----- 239 (378)
T KOG1345|consen 171 RKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWE----- 239 (378)
T ss_pred cccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHH-----
Confidence 654332 11222345689999422 1 256789999999999999999999984322 222222221
Q ss_pred chhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 003704 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 788 (801)
....-....+...+ ...++.+..+.++-+..++++|=...++-++-...
T Consensus 240 ---~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 240 ---QWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ---HHhcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 11111111111111 23346678899999999999995555554444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=240.85 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=194.4
Q ss_pred HhhhccCCccCCeeeecCccEEEEEEeC----CCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEe
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~ 578 (801)
+....+.|...++||+|.|++||++.+. ..+.||+|.+... .....+..|++++..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3445678999999999999999999542 5789999998643 3345688999999888 49999999999999
Q ss_pred cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCcEEEee
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSD 657 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~D 657 (801)
++...+||||++.....++... ++...+..++..+..||+|+|.. |||||||||+|+|++. .+.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 9999999999999999888763 66888999999999999999986 9999999999999975 45678999
Q ss_pred ccCCCCcC-----------------C--C---------------Ccc--------ccccccccccCcCCcccc--cCCCC
Q 003704 658 CGLAPLIS-----------------S--G---------------SVS--------QLSGHLLTAYGYGAPEFE--SGIYT 693 (801)
Q Consensus 658 FGla~~~~-----------------~--~---------------~~~--------~~~~~~~~~~~y~aPE~~--~~~~~ 693 (801)
||+|.... . + ... ...-...||.||.|||++ .+.-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997221 0 0 000 001123689999999944 34578
Q ss_pred CcchHHHHHHHHHHHHhCCCCccccccccccc--e-------------------eecccccccc-------hhhh-hhhc
Q 003704 694 CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--L-------------------VRWAIPQLHD-------IDAL-SRMV 744 (801)
Q Consensus 694 ~k~DvwSlGvil~elltG~~pf~~~~~~~~~~--~-------------------~~~~~~~~~~-------~~~~-~~~~ 744 (801)
+++||||.|||++-+++++.||.......... + .-|....... .+.+ .+.+
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 89999999999999999999997654321110 0 0011000000 0001 0111
Q ss_pred CCCC----C-CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 745 DPSL----S-GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~----~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.+.. . ....+..+..+.+++.+|++.||.+|.|++|.|+|
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1100 0 01112234468899999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=274.62 Aligned_cols=216 Identities=31% Similarity=0.593 Sum_probs=143.0
Q ss_pred CHhHHHHHHHHHHhcCCC--CCCCCCCCCCCCCCCCCcceEeeC-CCeEEEEecCCCCccccCccccCCCCCCEEEccCC
Q 003704 37 NPNDVAAINSLYAALGSP--VLPGWVASAGDPCGESWQGVQCNA-SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNN 113 (801)
Q Consensus 37 ~~~d~~aL~~~~~~~~~~--~~~~w~~~~~~~C~~~w~gv~C~~-~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N 113 (801)
+++|+.||++||+++.++ .+.+|+.. .++| .|.||.|+. ++|+.|+|++|+++|.++..|..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 678999999999999766 57789643 5677 899999974 68999999999999888888888888888888888
Q ss_pred cCCCCCCCccc---ccccEEEccCCcCCC----------------------CCCcccccCCccCeEEccCCcccccCChh
Q 003704 114 HIGGSIPSILP---VTMQNFFLSDNQFSG----------------------SIPSSLATLTLLTDMSLNNNLLSGEIPDA 168 (801)
Q Consensus 114 ~l~~~~p~~~~---~~L~~L~L~~N~l~~----------------------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 168 (801)
+++|.+|..+. .+|++|+|++|++++ .+|..|+++++|++|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 88877776542 455555555555554 45555555555555555555555555555
Q ss_pred hhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccccccc-ccCCC-CCCEEEccCCCCCCCccccCCC---CC
Q 003704 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDL-PLRDLNIENNLFSGPIPEKMLQ---IP 243 (801)
Q Consensus 169 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~-~L~~L~ls~N~l~g~~p~~l~~---l~ 243 (801)
|.++++|++|+|++|++++.+|..++++++|+.|+|++|++++.++ .+..+ +|++|+|++|++++.+|..+.+ |.
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 263 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCC
Confidence 5555555555555555555555555555555666666555555442 23333 3666666666666666654433 34
Q ss_pred CccccCCCCCCC
Q 003704 244 NFRKDGNPFNST 255 (801)
Q Consensus 244 ~l~~~~N~~~~~ 255 (801)
.|.+.+|.+.+.
T Consensus 264 ~L~L~~n~l~~~ 275 (968)
T PLN00113 264 YLFLYQNKLSGP 275 (968)
T ss_pred EEECcCCeeecc
Confidence 445566655543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=217.02 Aligned_cols=247 Identities=21% Similarity=0.363 Sum_probs=197.9
Q ss_pred cCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCC
Q 003704 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
...+|.+...|..|+|++ .|..+++|++..........+.|.+|+-.++-..||||+.+++.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 445788899999999999 5666778888776666667788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe-cCCCCCcEEECCCCcEEEe--eccCCCCcCCCCc
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVH-RNFKSANILLDDDLAVSVS--DCGLAPLISSGSV 669 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH-rDlkp~NILl~~~~~~kl~--DFGla~~~~~~~~ 669 (801)
+|+.++|+.. .-..+..++.+++.++|+|++|||+.. +++- --|.+..+++|++.+++|+ |--++
T Consensus 273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs-------- 340 (448)
T KOG0195|consen 273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS-------- 340 (448)
T ss_pred HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee--------
Confidence 9999999753 345677889999999999999999973 4444 4689999999999988874 32221
Q ss_pred cccccccccccCcCCcccccC-C---CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcC
Q 003704 670 SQLSGHLLTAYGYGAPEFESG-I---YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 670 ~~~~~~~~~~~~y~aPE~~~~-~---~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.......-.+.||+||.+.. . .-.++|+|||++++|||.|...||....+. +.-.++.-
T Consensus 341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----------------ecgmkial 403 (448)
T KOG0195|consen 341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----------------ECGMKIAL 403 (448)
T ss_pred -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch----------------hhhhhhhh
Confidence 11112223456999995443 2 335789999999999999999999754332 22334445
Q ss_pred CCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 746 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 789 (801)
++++...|...+..+.+|+.-|+..||.+||.++.|+-.|++++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56677778888899999999999999999999999999998875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=267.78 Aligned_cols=196 Identities=19% Similarity=0.218 Sum_probs=136.2
Q ss_pred cCC-CCccccceEE-------EecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003704 564 IRH-ANIVELKGYC-------AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635 (801)
Q Consensus 564 l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 635 (801)
++| .||+++++++ .+.+..+++|||+ +++|+++|... ...+++..++.++.||++||+|||+. +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445 5888888877 2234567888987 56999999742 34589999999999999999999986 99
Q ss_pred EecCCCCCcEEECCC-------------------CcEEEeeccCCCCcCCCCc--------------cccccccccccCc
Q 003704 636 VHRNFKSANILLDDD-------------------LAVSVSDCGLAPLISSGSV--------------SQLSGHLLTAYGY 682 (801)
Q Consensus 636 vHrDlkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~~~~~y 682 (801)
|||||||+||||+.. +.+|++|||+++....... ........+|..|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653211000 0000113467789
Q ss_pred CCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHH
Q 003704 683 GAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFA 761 (801)
Q Consensus 683 ~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 761 (801)
+|||. ....|+.++|||||||+||||++|..|+...... ...+.... +..... .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---------------~~~~~~~~---~~~~~~-~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---------------MSSLRHRV---LPPQIL-LNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---------------HHHHHHhh---cChhhh-hcCHHHH
Confidence 99994 5567999999999999999999998886532100 00010000 001111 1123456
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 003704 762 DIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 762 ~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+++.+||+.||.+||++.|++++-
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhch
Confidence 889999999999999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=207.33 Aligned_cols=168 Identities=23% Similarity=0.283 Sum_probs=125.4
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (801)
|+|.++++.. ...+++..++.|+.||+.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999753 34699999999999999999999986 3 999999999999999 99987654321
Q ss_pred cccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 672 LSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 672 ~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
..++..|+||| +....|+.++|||||||++|||+||+.||......... ...+..........
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~------------~~~~~~~~~~~~~~ 127 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI------------LEILLNGMPADDPR 127 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH------------HHHHHHHhccCCcc
Confidence 24678899999 45567999999999999999999999999643221100 00111100100000
Q ss_pred --CCCcccHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 751 --QYPAKSLS--HFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 751 --~~~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
..+..... ++.+++.+||..||++||++.|+++++..+..+.
T Consensus 128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 11122222 6899999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=223.79 Aligned_cols=166 Identities=20% Similarity=0.216 Sum_probs=128.0
Q ss_pred hccCCccCCeeeecCccEEEEEEeC--CCcEEEEEEeccccC---chhhHHHHHHHHHHhhccCCCCccc-cceEEEecC
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLP--DGKLLAVKKLDKRAS---SQQKDDEFLELVNNIDRIRHANIVE-LKGYCAEHG 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~HpnIv~-l~~~~~~~~ 580 (801)
..+.|...+.||+|+||+||+|... +++.||||++..... .......+.+|++++++++|+|+++ +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 4578999999999999999999653 678889998753311 2334567899999999999999986 433 24
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEECCCCcEEEeecc
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF-KSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFG 659 (801)
..++||||++|++|.. +.. .. ...++.+++++|+|||+. ||+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 6799999999999973 211 01 145788999999999986 9999999 9999999999999999999
Q ss_pred CCCCcCCCCcccc------ccccccccCcCCcccccC
Q 003704 660 LAPLISSGSVSQL------SGHLLTAYGYGAPEFESG 690 (801)
Q Consensus 660 la~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~ 690 (801)
+|+.+........ -....+++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9987765432111 023456778999996543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-22 Score=214.60 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=195.9
Q ss_pred CCccCCeeeecCccEEEEEEeCCC--cEEEEEEeccccCchhhHHHHHHHHHHhhccCC----CCccccceEE-EecCeE
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDG--KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH----ANIVELKGYC-AEHGQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H----pnIv~l~~~~-~~~~~~ 582 (801)
.|.+.+.||+|+||.||++..... ..+|+|.......... ..+..|+.++..+.. .++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 789999999999999999976443 4788887654322211 156677777777762 6899999998 577889
Q ss_pred EEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-----CcEEEee
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-----LAVSVSD 657 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~D 657 (801)
++||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+. |++||||||+|++++.. ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999987 789999886543 46799999999999999999999986 99999999999999865 4699999
Q ss_pred ccCCC--CcCCCCc-----ccc-ccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceee
Q 003704 658 CGLAP--LISSGSV-----SQL-SGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728 (801)
Q Consensus 658 FGla~--~~~~~~~-----~~~-~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~ 728 (801)
||+++ .+..... ... .....||..|.++. ......+.+.|+||++.++.|++.|..||........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----- 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----- 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----
Confidence 99998 3322211 111 12345899999999 5566789999999999999999999999965432211
Q ss_pred cccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhhh
Q 003704 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 793 (801)
...+.+.........+....+.++.++...+-..+..++|....+...+.....+..
T Consensus 246 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 246 --------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred --------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 011111111111111233445678888888888999999999999999988877653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=202.85 Aligned_cols=261 Identities=15% Similarity=0.199 Sum_probs=202.8
Q ss_pred ccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCeEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 585 (801)
.-.|.++++||+|.||.++.| .+-+++.||||.-.... ..-++..|.+..+.| ..++|-.+|.|..+..+..||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 457899999999999999999 46789999999754322 223456666666666 478999999888888888999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-----cEEEeeccC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-----AVSVSDCGL 660 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl 660 (801)
||.+ |.||+|++.-. ...++..++..+|.|++.-++|+|+. .+|.|||||+|+||...+ .+.|+|||+
T Consensus 103 idLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9988 78999998753 46799999999999999999999996 899999999999997543 589999999
Q ss_pred CCCcCCCCcc-----ccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccc
Q 003704 661 APLISSGSVS-----QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734 (801)
Q Consensus 661 a~~~~~~~~~-----~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 734 (801)
|+.+.+.... .......||.+||+-- .+..+-+.+-|+-|+|-++++.|.|..||.+.......
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---------- 245 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---------- 245 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----------
Confidence 9998765442 2234568999999988 66677899999999999999999999999875432211
Q ss_pred cchhhhhhhcCCCCC---CCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHhh
Q 003704 735 HDIDALSRMVDPSLS---GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 735 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 792 (801)
+..+++-+.... ....+..+.++..-+...-..+-++-|+.+-+...+.+++++-
T Consensus 246 ---~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 246 ---EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ---HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 111222111111 1123456778888888888889999999988887777777643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=195.51 Aligned_cols=262 Identities=17% Similarity=0.219 Sum_probs=199.8
Q ss_pred ccCCccCCeeeecCccEEEEE-EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCC-CCccccceEEEecCeEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV 585 (801)
...|...+.||.|+||.+|.| ...+|..||||.-..... ..++..|.++.+.++| ..|..+..|..+..+..+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 467899999999999999999 568899999998654332 2346677888888864 5677778888888899999
Q ss_pred EeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---CcEEEeeccCCC
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD---LAVSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 662 (801)
||.+ |.||++++.-. ...++..+++..+-|++.-++|+|.. ++|||||||+|+|+.-+ ..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9988 78999998742 45789999999999999999999986 89999999999999653 468999999999
Q ss_pred CcCCCCc-----cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 663 LISSGSV-----SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 663 ~~~~~~~-----~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
.+.+... ........||.+|.+--. ....-+.+.|+-|+|.+|.++..|..||.+....... +.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----------QK 232 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----------QK 232 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH----------HH
Confidence 8765332 223445788999988774 3345678899999999999999999999876543211 12
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 790 (801)
.+.+.+..-...........|.++.-.+..|-..--++-|+..-+.+.+..+++
T Consensus 233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 222322222111222345567889999999999999999998877666655543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=238.47 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=187.4
Q ss_pred ccCCeeeecCccEEEEEE-eCCCcEEEEEEec----cccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 512 SQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD----KRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~-~~~g~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
...+++|.|++|.|+.+. ......++.|.+. ...........+..|+.+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 346789999999888773 4445555555443 22222222333677888888899999999998888877777779
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|||++ +|+.++... ..+...++..++.|++.|++|||+. ||.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999999853 3578888999999999999999997 999999999999999999999999999877654
Q ss_pred CCcc--ccccccccccCcCCcccc-cCCCCC-cchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhh
Q 003704 667 GSVS--QLSGHLLTAYGYGAPEFE-SGIYTC-QSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 667 ~~~~--~~~~~~~~~~~y~aPE~~-~~~~~~-k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
.... .......|+-.|+|||.. ...|+. ..||||.|++++.|++|+.||......+.++.... ... .
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----~~~-----~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----YSD-----Q 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----ccc-----c
Confidence 4322 233456778889999954 456765 57999999999999999999986654433210000 000 0
Q ss_pred hcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
.-...-........+.+.+.+|.+||+.||.+|.|+++|++.
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000001123455678899999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-21 Score=204.63 Aligned_cols=259 Identities=29% Similarity=0.463 Sum_probs=196.3
Q ss_pred CccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchh-hHHHHHHHHHHhhccCCC-CccccceEEEecCeEEEEEec
Q 003704 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ-KDDEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 588 (801)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|...++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999776 8899999876655443 567889999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-cEEEeeccCCCCcCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSG 667 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 667 (801)
+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777643211 2688899999999999999999997 899999999999999988 7999999999865544
Q ss_pred Cccc----cccccccccCcCCccccc----CCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 668 SVSQ----LSGHLLTAYGYGAPEFES----GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 668 ~~~~----~~~~~~~~~~y~aPE~~~----~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
.... ......++..|++||... ..+....|+||+|++++++++|..||........ .......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---------~~~~~~~ 226 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---------TSQTLKI 226 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---------HHHHHHH
Confidence 3221 235567888999999544 4688899999999999999999999765432100 0000001
Q ss_pred hhhhcCCCCCCCCC----cccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVDPSLSGQYP----AKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
+............. ......+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100000010111 1112568899999999999999999887765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=189.61 Aligned_cols=141 Identities=17% Similarity=0.176 Sum_probs=108.9
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhh------------------------HHHHHHHHHHhhccCCCCc
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK------------------------DDEFLELVNNIDRIRHANI 569 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~HpnI 569 (801)
...||+|+||.||+|...+|+.||||+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998779999999999754321111 1122358899999988877
Q ss_pred cccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEC
Q 003704 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHRNFKSANILLD 648 (801)
Q Consensus 570 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NILl~ 648 (801)
.....+.. ...++||||++++++...+.. ...+++.....++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 233899999999877655332 24678899999999999999999 564 899999999999998
Q ss_pred CCCcEEEeeccCCCCc
Q 003704 649 DDLAVSVSDCGLAPLI 664 (801)
Q Consensus 649 ~~~~~kl~DFGla~~~ 664 (801)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=220.34 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=176.6
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCc--hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEe
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS--QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (801)
+|...+.||++.|=.|.+|+.++|. |+||++-+.... -....+..+|++ ...++|||++++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666789999999999999998887 889998654422 112223333444 455689999999888777777788889
Q ss_pred ccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCc--C
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI--S 665 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~--~ 665 (801)
|+.. +|+|.|.. +..+...+...|+.|++.||.-+|.. ||+|||||.+|||++.-+-+.|+||..-+.. .
T Consensus 102 yvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9865 99999975 45677778888999999999999986 9999999999999999999999999875432 2
Q ss_pred CCCc---cccccccccccCcCCcc-cccCC-----------CCCcchHHHHHHHHHHHHh-CCCCccccccccccceeec
Q 003704 666 SGSV---SQLSGHLLTAYGYGAPE-FESGI-----------YTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW 729 (801)
Q Consensus 666 ~~~~---~~~~~~~~~~~~y~aPE-~~~~~-----------~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 729 (801)
.+.. ....+.-..-..|+||| +..+. .+++.||||+||+++||++ |+++|....- + .+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----~-aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----L-AY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----H-hH
Confidence 2211 11111111223599999 43311 4568899999999999998 7888864211 1 11
Q ss_pred ccccccchh-hhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 730 AIPQLHDID-ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 730 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
....-.+.+ .+.++-| ..+++++..|++.||++|.++++.++.
T Consensus 248 r~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 2222222 147899999999999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=189.06 Aligned_cols=173 Identities=13% Similarity=0.154 Sum_probs=133.3
Q ss_pred hccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhH-H------HHHHHHHHhhccCCCCccccceEEEec
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKD-D------EFLELVNNIDRIRHANIVELKGYCAEH 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~-~------~~~~e~~~l~~l~HpnIv~l~~~~~~~ 579 (801)
..++|+..+++|.|+||.||.+.. ++..+|||.+.......+.. . .+.+|++.+.++.|++|..+.+++.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 57789999997554333221 2 267899999999999999999986643
Q ss_pred --------CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 580 --------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 580 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
+..+|||||++|.+|.++.. ++. ....+++.+|..+|+. |++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999988742 122 2456899999999986 999999999999999988
Q ss_pred cEEEeeccCCCCcCCCCccccccccccccCcCCcccccCCCCCcchHHHHHHHHHHHH
Q 003704 652 AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELL 709 (801)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~k~DvwSlGvil~ell 709 (801)
++|+|||........... .. | .+...|..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~---d~------~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK---DR------I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH---HH------H----HHHhHhcccccccceeEeehHHH
Confidence 999999987655322110 00 0 22334678999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-20 Score=182.81 Aligned_cols=142 Identities=20% Similarity=0.183 Sum_probs=111.8
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchh------------------------hHHHHHHHHHHhhccCCCCc
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ------------------------KDDEFLELVNNIDRIRHANI 569 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~HpnI 569 (801)
...||+|+||.||+|...+|+.||||++........ ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999875421100 01223578899999999988
Q ss_pred cccceEEEecCeEEEEEeccCCCCHHHH-HhcCccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEE
Q 003704 570 VELKGYCAEHGQRLLIYEYCSNGTLQDM-LHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILL 647 (801)
Q Consensus 570 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl 647 (801)
.....+... ..++||||++++++... +. ...++......++.|++.++.|+|+ . ||+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655554433 24899999998865443 33 2356788899999999999999998 5 99999999999999
Q ss_pred CCCCcEEEeeccCCCCcCC
Q 003704 648 DDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~ 666 (801)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-20 Score=179.23 Aligned_cols=187 Identities=13% Similarity=0.041 Sum_probs=138.1
Q ss_pred cCCeeeecCccEEEEEEeCCCcEEEEEEeccccCch--hhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEEecc
Q 003704 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ--QKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
....|++|+||+||.+.. ++..++.+.+....... .....+.+|+++++++. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 467899999999998866 77788877775433211 11235789999999995 5889999886 4468999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEECCCCcEEEeeccCCCCcCCCC
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF-KSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (801)
.|.+|.+.+.. ....++.|++++|+++|+. ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999765421 1134678899999999997 9999999 7999999999999999999998655433
Q ss_pred cc----cc-------ccccccccCcCCccc--ccCCCC-CcchHHHHHHHHHHHHhCCCCcccc
Q 003704 669 VS----QL-------SGHLLTAYGYGAPEF--ESGIYT-CQSDVYSFGVVMLELLTGRKSYDRT 718 (801)
Q Consensus 669 ~~----~~-------~~~~~~~~~y~aPE~--~~~~~~-~k~DvwSlGvil~elltG~~pf~~~ 718 (801)
.. .. ......+..|++|+. +....+ ...+.++-|+-+|.++||..++-..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 00 011123456777772 222233 5679999999999999999886543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-21 Score=212.83 Aligned_cols=227 Identities=23% Similarity=0.320 Sum_probs=183.2
Q ss_pred eeeecCccEEEEEE----eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEEeccC
Q 003704 516 LIGAGMLGSVYRAQ----LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEYCS 590 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 590 (801)
.+|+|+||.|+.++ .+.|..+|.|++.+.............|..++...+ ||.+|+++..++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999863 356888999988765433333334556677777776 9999999999999999999999999
Q ss_pred CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCcc
Q 003704 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (801)
Q Consensus 591 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (801)
||.|...+.. ...+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988875 34567777777888899999999997 9999999999999999999999999999877654321
Q ss_pred ccccccccccCcCCcccccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCC
Q 003704 671 QLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (801)
+||+.|||||+.. .+...+|.||||++++||+||..||.. +.+..+... ..
T Consensus 154 ------cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~--~~ 204 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA--EL 204 (612)
T ss_pred ------ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh--cc
Confidence 7899999999776 568899999999999999999999974 111112211 12
Q ss_pred CCCcccHHHHHHHHHHhcccCCCCCCCH
Q 003704 751 QYPAKSLSHFADIISRCVQSEPEFRPPM 778 (801)
Q Consensus 751 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 778 (801)
.+|......+.+++..++..+|..|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3567777889999999999999999654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=186.80 Aligned_cols=234 Identities=22% Similarity=0.314 Sum_probs=147.4
Q ss_pred CccCCeeeecCccEEEEEEe-CCCcEEEEEEecccc-CchhhHHHHHHHHHHhhccCC----------CCccccceEEEe
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRH----------ANIVELKGYCAE 578 (801)
Q Consensus 511 ~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~H----------pnIv~l~~~~~~ 578 (801)
+...+.||.|+++.||.++. .+|+.+|||++.... ......+.+++|.-.+..+.+ -.++--++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34578899999999999976 569999999875433 233345677777655555332 233333333221
Q ss_pred ---------c---C-----eEEEEEeccCCCCHHHHHhc---CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 003704 579 ---------H---G-----QRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHR 638 (801)
Q Consensus 579 ---------~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr 638 (801)
. . ..+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||+. ||||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 235788877 4588887653 111112344555667778999999999997 99999
Q ss_pred CCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcccccC---------CCCCcchHHHHHHHHHHHH
Q 003704 639 NFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG---------IYTCQSDVYSFGVVMLELL 709 (801)
Q Consensus 639 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~k~DvwSlGvil~ell 709 (801)
||||+|++++.+|.++|+||+.......... . ...+..|.+||.... .++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999987655433211 1 223466999994321 3788999999999999999
Q ss_pred hCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCC
Q 003704 710 TGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775 (801)
Q Consensus 710 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 775 (801)
+|..||+......... | .+. .+. ..++.+.+||..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~---~-----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE---W-----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG---G-----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc---c-----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998653321110 0 011 122 667889999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=196.11 Aligned_cols=215 Identities=24% Similarity=0.439 Sum_probs=162.0
Q ss_pred hhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 003704 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF 640 (801)
Q Consensus 561 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 640 (801)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.|.+... ...++|.....++++|+.||+|||.. +-.+|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 45688999999999999999999999999999999999863 46789999999999999999999986 33399999
Q ss_pred CCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcccccCC--------CCCcchHHHHHHHHHHHHhCC
Q 003704 641 KSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI--------YTCQSDVYSFGVVMLELLTGR 712 (801)
Q Consensus 641 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~k~DvwSlGvil~elltG~ 712 (801)
++.|.++|....+||+|||+....................-|.|||.+.+. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998776431111111112233459999966553 467799999999999999999
Q ss_pred CCccccccccccceeecccccccchhhhhhhcC---CCCCCCCC-c-ccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 713 KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD---PSLSGQYP-A-KSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 713 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
.||+........ .+.+..+.+ ..+++... . ...+++..++.+||..+|++||++.++-..+..
T Consensus 156 ~~~~~~~~~~~~------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 156 GPFDLRNLVEDP------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred CccccccccCCh------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999864332211 011111111 11121111 1 344578899999999999999999999988877
Q ss_pred HHHhh
Q 003704 788 MIRRE 792 (801)
Q Consensus 788 ~~~~~ 792 (801)
+....
T Consensus 224 ~~~~~ 228 (484)
T KOG1023|consen 224 INKGG 228 (484)
T ss_pred hcccc
Confidence 76543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=203.82 Aligned_cols=136 Identities=35% Similarity=0.641 Sum_probs=90.1
Q ss_pred CCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCC---CCCcceEeeCC------CeEEEEecCCCCccccCccccCCCC
Q 003704 34 AVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCG---ESWQGVQCNAS------DIIAIILNGANLGGELGENLGAFSS 104 (801)
Q Consensus 34 ~~~~~~d~~aL~~~~~~~~~~~~~~w~~~~~~~C~---~~w~gv~C~~~------~l~~L~L~~n~l~~~~~~~l~~l~~ 104 (801)
..+.+.|..||+.+|++++++...+|. +++|. +.|.||.|+.. .++.|+|++|+|.|.+|..|+.|++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCC---CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 456788999999999999876445885 35663 47999999631 2556666666666666655555555
Q ss_pred CCEEEccCCcCCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCC
Q 003704 105 IRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184 (801)
Q Consensus 105 L~~L~Ls~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 184 (801)
|+.|+|++|+|+| .+|..+++|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+
T Consensus 444 L~~L~Ls~N~l~g----------------------~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 444 LQSINLSGNSIRG----------------------NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred CCEEECCCCcccC----------------------cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 5555555555443 334444666666666666666666666666666667777666666
Q ss_pred CCCCCCCCcc
Q 003704 185 LSGELPPSLE 194 (801)
Q Consensus 185 l~g~~p~~~~ 194 (801)
|+|.+|..+.
T Consensus 502 l~g~iP~~l~ 511 (623)
T PLN03150 502 LSGRVPAALG 511 (623)
T ss_pred ccccCChHHh
Confidence 6666666554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.3e-19 Score=182.68 Aligned_cols=192 Identities=20% Similarity=0.263 Sum_probs=136.5
Q ss_pred CCCCccccceEEEe---------------------------cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHH
Q 003704 565 RHANIVELKGYCAE---------------------------HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617 (801)
Q Consensus 565 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 617 (801)
+|||||++.++|.+ ....|+||...+. +|.+++-. ...+......|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 69999999887633 1256899988754 89998864 345666777889
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEE--CCCC--cEEEeeccCCCCcCCCCcc----ccccccccccCcCCccccc
Q 003704 618 LGAARALEYLHEICQPPIVHRNFKSANILL--DDDL--AVSVSDCGLAPLISSGSVS----QLSGHLLTAYGYGAPEFES 689 (801)
Q Consensus 618 ~~ia~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~ 689 (801)
.|+++|+.|||++ ||.|||+|++|||+ |+|+ .+.|+|||++-.-...... ...-...|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999987 99999999999998 3443 5789999987432221110 0011234555689999654
Q ss_pred CC-------CCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHH
Q 003704 690 GI-------YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFAD 762 (801)
Q Consensus 690 ~~-------~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 762 (801)
.. .-.|+|.|+.|.+.||++....||..... ..+. ... ..+.-.+..|+.++..+++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~---------~r~----Yqe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLD---------TRT----YQESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heec---------hhh----hhhhhCCCCcccCChHHHH
Confidence 33 23589999999999999999999976221 1111 011 1112223457788889999
Q ss_pred HHHHhcccCCCCCCCHHHH
Q 003704 763 IISRCVQSEPEFRPPMSEV 781 (801)
Q Consensus 763 li~~cl~~dP~~RPt~~ev 781 (801)
++...|+.||.+|++..-.
T Consensus 489 lV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred HHHHHhcCCccccCCccHH
Confidence 9999999999999986533
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=169.92 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=104.2
Q ss_pred ccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-----CCCCccccceEEEecC---eEE
Q 003704 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-----RHANIVELKGYCAEHG---QRL 583 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~HpnIv~l~~~~~~~~---~~~ 583 (801)
...+.||+|+||.||. .-.++.. +||++.... ....+.+.+|+++++.+ .||||++++|++++.. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4467899999999996 3234444 799886532 22456789999999999 5799999999998863 434
Q ss_pred -EEEec--cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEECC----CCcEEE
Q 003704 584 -LIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL-EYLHEICQPPIVHRNFKSANILLDD----DLAVSV 655 (801)
Q Consensus 584 -lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl 655 (801)
+|||| +.+++|.+++... .+++. ..++.+++.++ +|||+. +|+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5689999999642 24444 35677888777 999986 8999999999999974 347999
Q ss_pred eeccCC
Q 003704 656 SDCGLA 661 (801)
Q Consensus 656 ~DFGla 661 (801)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=198.19 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=176.8
Q ss_pred hhhccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC---CCCccccceEEEecCe
Q 003704 505 QQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQ 581 (801)
Q Consensus 505 ~~~~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~~~~ 581 (801)
+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+-. --.+++.+|+ -+.|+.+...+.-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3345678889999999999999998888999999987654433211 1122333333 3456666666666777
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-------CCcEE
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-------DLAVS 654 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~k 654 (801)
-+||+||.+.|+|.+++.. .+..+|.-++.++.|+++.+++||.. +|||+||||+|+||.. ...++
T Consensus 769 S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 8899999999999999984 46788999999999999999999997 8999999999999942 34589
Q ss_pred EeeccCCCCcCCCCccccccccccccCcCCcccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccc
Q 003704 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
|+|||.+-.+..-.....-...++|-++-.+|+..| .++...|.|.|+.+++-||.|+.-- ... + ..|..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~--g----~~~~~-- 912 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKN--G----SSWMV-- 912 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcC--C----cceec--
Confidence 999999866543322222334566778999996665 5899999999999999999997421 000 0 00100
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHh
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 791 (801)
...+.+ |... +...+|+..+|..|-..=|...++...+++.+.+
T Consensus 913 ---~~~~~R---------y~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 913 ---KTNFPR---------YWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ---cccchh---------hhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000111 1110 1244677777775555557777777777777654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.6e-17 Score=164.83 Aligned_cols=136 Identities=19% Similarity=0.312 Sum_probs=113.6
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCch------hhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ------QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
+.||+|++|.||+|.. +|..++||+........ .....+.+|++++..+.|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 77789999865332211 1224577899999999999998888888777888999999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 11 7888999999999999986 899999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=169.96 Aligned_cols=152 Identities=18% Similarity=0.104 Sum_probs=113.5
Q ss_pred HhhhccCCccCCeeeecCccEEEEEE--eCCCcEEEEEEeccccCch----------------------hhHHHHHHHHH
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRAQ--LPDGKLLAVKKLDKRASSQ----------------------QKDDEFLELVN 559 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~~--~~~g~~vavK~~~~~~~~~----------------------~~~~~~~~e~~ 559 (801)
+.+....|.+.+.||+|+||.||+|. ..+|+.||||++....... .....+.+|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444458889999999999999997 5789999999986432110 01234568999
Q ss_pred HhhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEec
Q 003704 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP-IVHR 638 (801)
Q Consensus 560 ~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHr 638 (801)
.+.++.+.+ +.+...+.. ...++||||+++++|...... ...+.......++.|++.+++|||+. + |+||
T Consensus 103 ~L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~ 173 (237)
T smart00090 103 NLQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHG 173 (237)
T ss_pred HHHHHHhcC-CCCCeeeEe-cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeC
Confidence 999997532 222222222 235899999999888765432 23355566788999999999999986 8 9999
Q ss_pred CCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 639 NFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 639 Dlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999986543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.2e-20 Score=169.65 Aligned_cols=172 Identities=27% Similarity=0.480 Sum_probs=151.8
Q ss_pred eCCCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeE
Q 003704 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154 (801)
Q Consensus 77 ~~~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 154 (801)
+.++++.|.|++|.|+ .+|+.+..|.+|+.|+|++|+|+ .+|..++ .+|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4578999999999998 57788999999999999999999 6777776 89999999999999 899999999999999
Q ss_pred EccCCccc-ccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCC-CCEEEccCCCCC
Q 003704 155 SLNNNLLS-GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232 (801)
Q Consensus 155 ~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-L~~L~ls~N~l~ 232 (801)
||..|+|. ..+|..|..|..|+.|+|++|.|. .+|..+++|++|+.|.|..|.|-..+..++.+. |++|++.+|+++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence 99999996 468999999999999999999999 999999999999999999999988886665554 999999999999
Q ss_pred CCccccCCCCCC------ccccCCCCC
Q 003704 233 GPIPEKMLQIPN------FRKDGNPFN 253 (801)
Q Consensus 233 g~~p~~l~~l~~------l~~~~N~~~ 253 (801)
.+|..+.++.. +++.+|||-
T Consensus 187 -vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 -VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred -ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 77776665532 455677774
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-19 Score=189.35 Aligned_cols=187 Identities=22% Similarity=0.272 Sum_probs=165.6
Q ss_pred cceEeeCCCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCC
Q 003704 72 QGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLT 149 (801)
Q Consensus 72 ~gv~C~~~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~ 149 (801)
.|++-...++.+|+|+.|+++..-...+.+|+.|+.||||+|.|..+-+..+. .+|++|+|++|+|+..-+..|..|.
T Consensus 262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 46666678899999999999999999999999999999999999988887766 8999999999999999999999999
Q ss_pred ccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCC---CccCCCCCcEEEeecccccccc-cccCCC-CCCEE
Q 003704 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP---SLENLSQLTTLHLQNNQLSGTL-DVLQDL-PLRDL 224 (801)
Q Consensus 150 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~-~L~~L 224 (801)
.|++|+|++|+|+..-...|..+++|+.|||++|.|++.|-+ .|..|++|+.|+|.+|+|..+. ..+..+ .|++|
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 999999999999987778899999999999999999987754 5788999999999999999888 445445 49999
Q ss_pred EccCCCCCCCccccCCC--CCCccccCCCCCCCCCC
Q 003704 225 NIENNLFSGPIPEKMLQ--IPNFRKDGNPFNSTVAP 258 (801)
Q Consensus 225 ~ls~N~l~g~~p~~l~~--l~~l~~~~N~~~~~~~~ 258 (801)
||.+|.|...-|+.|.. |+.|-+..-.|.|+|.-
T Consensus 422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred cCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 99999999888988765 45566777778888853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.7e-17 Score=161.71 Aligned_cols=141 Identities=18% Similarity=0.134 Sum_probs=109.1
Q ss_pred cCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCch--------------------hhHHHHHHHHHHhhccCCCC
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ--------------------QKDDEFLELVNNIDRIRHAN 568 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~Hpn 568 (801)
.-|...+.||+|+||.||++...+|+.||||++....... .....+.+|+..+..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3477789999999999999988889999999875432110 01123567888888887774
Q ss_pred --ccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 003704 569 --IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (801)
Q Consensus 569 --Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 646 (801)
+...++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||+||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 333333 2455899999999999765421 23457888999999999986 9999999999999
Q ss_pred ECCCCcEEEeeccCCCCcCC
Q 003704 647 LDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 647 l~~~~~~kl~DFGla~~~~~ 666 (801)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-18 Score=177.80 Aligned_cols=194 Identities=23% Similarity=0.366 Sum_probs=147.2
Q ss_pred CCCCCCCC---cceEeeC-----------CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccc
Q 003704 64 GDPCGESW---QGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTM 127 (801)
Q Consensus 64 ~~~C~~~w---~gv~C~~-----------~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L 127 (801)
+-+|.|+- .-|+|.. ...+.|+|..|+|+.+.+..|+.|.+|+.||||+|+|+.+-|..|. .+|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 45677666 5588875 3568899999999999999999999999999999999988898886 555
Q ss_pred cEEEc-cCCcCCCCCCcccccCCccCeEEccCCccc--------------------------------------------
Q 003704 128 QNFFL-SDNQFSGSIPSSLATLTLLTDMSLNNNLLS-------------------------------------------- 162 (801)
Q Consensus 128 ~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------------------------------------- 162 (801)
.+|-| ++|+|+...-..|++|..|+.|.|.-|++.
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~ 197 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQ 197 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhc
Confidence 55444 448888555555655555444444333332
Q ss_pred -----------------------------------------------------------------ccCC-hhhhCCCCCC
Q 003704 163 -----------------------------------------------------------------GEIP-DAFQSLTGLI 176 (801)
Q Consensus 163 -----------------------------------------------------------------~~~p-~~~~~l~~L~ 176 (801)
++-| ..|..|++|+
T Consensus 198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~ 277 (498)
T KOG4237|consen 198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR 277 (498)
T ss_pred CccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence 1111 1366788888
Q ss_pred eEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc-cccCCCC-CCEEEccCCCCCCCccccCC---CCCCccccCCC
Q 003704 177 NLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKML---QIPNFRKDGNP 251 (801)
Q Consensus 177 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~-L~~L~ls~N~l~g~~p~~l~---~l~~l~~~~N~ 251 (801)
.|+|++|+|++.-+.+|..+..|+.|.|..|+|...- ..|..++ |+.|+|.+|+|+...|..|. .+..|++..||
T Consensus 278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence 8888888888777888888888888888888887665 3455555 99999999999988887654 56778899999
Q ss_pred CCCCCC
Q 003704 252 FNSTVA 257 (801)
Q Consensus 252 ~~~~~~ 257 (801)
|+|.|.
T Consensus 358 ~~CnC~ 363 (498)
T KOG4237|consen 358 FNCNCR 363 (498)
T ss_pred ccCccc
Confidence 999885
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=160.00 Aligned_cols=132 Identities=20% Similarity=0.323 Sum_probs=107.9
Q ss_pred eeeecCccEEEEEEeCCCcEEEEEEeccccCc------hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEecc
Q 003704 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS------QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (801)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 589 (801)
.||+|+||.||+|.+ +|..+++|+....... ......+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986532211 112356778999999999988776666666777789999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+|++|.+++.... . .++.+++.+|.+||+. +++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999876421 0 7889999999999986 999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=183.98 Aligned_cols=139 Identities=17% Similarity=0.279 Sum_probs=111.7
Q ss_pred ccCCccCCeeeecCccEEEEEEeCCCcEEEEEE-eccccCc-----hhhHHHHHHHHHHhhccCCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASS-----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~-~~~~~~~-----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (801)
...|...+.||+|+||+||+|.+.+.. +++|+ +.+.... ......+.+|++++..++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566889999999999999875443 44443 2221111 1223568899999999999999988888877778
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCC
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 661 (801)
.++||||+++++|.+++. ....++.+++++|.|||+. +|+||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999875 2467899999999999986 89999999999999 6789999999998
Q ss_pred CC
Q 003704 662 PL 663 (801)
Q Consensus 662 ~~ 663 (801)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 65
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-17 Score=177.92 Aligned_cols=175 Identities=22% Similarity=0.358 Sum_probs=127.4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 659 (801)
.+.|+.|++|...+|.+||..... ....++...+.++.|++.|++| . +.+|||+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 357899999999999999975433 4567888999999999999999 2 89999999999999999999999999
Q ss_pred CCCCcCCCC----ccccccccccccCcCCccccc-CCCCCcchHHHHHHHHHHHHh-CCCCccccccccccceeeccccc
Q 003704 660 LAPLISSGS----VSQLSGHLLTAYGYGAPEFES-GIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 660 la~~~~~~~----~~~~~~~~~~~~~y~aPE~~~-~~~~~k~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
+........ .........||..||+||.+. ..|+.|+||||||+||+|+++ =...|+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------------- 466 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------------- 466 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------------
Confidence 987765544 122234457889999999555 679999999999999999997 22222111
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHH
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 781 (801)
..+.++.+..+.+.+-.+.+ +-..|+.+++...|.+||++.++
T Consensus 467 ----~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ----ATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----HhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 11111111111111111111 23589999999999999955444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=180.32 Aligned_cols=170 Identities=28% Similarity=0.438 Sum_probs=109.6
Q ss_pred CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc---ccccEEEccCCcCCCCCCcccccCCccCeEE
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 155 (801)
..++.|||++|+|. ..|..+.+-+++-+|+||+|+|. .||..+. ..|-.||||+|++. .+|..+.+|.+|+.|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 45677777777776 35666777777777777777777 5555554 45566777777776 5666667777777777
Q ss_pred ccCCccc-------------------------ccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccc
Q 003704 156 LNNNLLS-------------------------GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (801)
Q Consensus 156 L~~N~l~-------------------------~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 210 (801)
|++|-|. ..+|.++.+|.+|..+|||.|+|. .+|+.+.++.+|..|+||+|+|+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 7766543 235666666777777777777777 77777777777777777777776
Q ss_pred ccccccCCC-CCCEEEccCCCCCCCccccCCCCCC---ccccCCCCC
Q 003704 211 GTLDVLQDL-PLRDLNIENNLFSGPIPEKMLQIPN---FRKDGNPFN 253 (801)
Q Consensus 211 ~~~~~~~~~-~L~~L~ls~N~l~g~~p~~l~~l~~---l~~~~N~~~ 253 (801)
..--..... +|+.|+||.|+|+ .+|+.+++|+. |...+|.++
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 544222222 3677777777776 56665554433 334444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-16 Score=183.61 Aligned_cols=208 Identities=22% Similarity=0.273 Sum_probs=140.6
Q ss_pred ccCCccCCeeeecCccEEEEEEeC-CCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
..+|..++.|-.|+||.||.++.+ ..+.+|. ++++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee----------------
Confidence 467888999999999999999765 4567777 4432211 1110 22222333333
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
|+=.+.+... ..+... ++.+++|||+. +|+|||+||+|.+++.=|.+|++|||+++..-.
T Consensus 136 -----gDc~tllk~~----g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNI----GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccC----CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3434444321 122222 26789999986 999999999999999999999999999875422
Q ss_pred CC-------------ccccccccccccCcCCcc-cccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccc
Q 003704 667 GS-------------VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732 (801)
Q Consensus 667 ~~-------------~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 732 (801)
.. ........+||+.|+||| ++...|+-.+|+|++|+|+||.+.|+.||++..+.+-- -.
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--g~---- 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQ---- 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--hh----
Confidence 11 112233458999999999 66778999999999999999999999999876432110 00
Q ss_pred cccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCC
Q 003704 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776 (801)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 776 (801)
.+. |.....+..+..+.++++++.++|+.+|..|-
T Consensus 270 vis---------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VIS---------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhh---------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 000 00111112345567899999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=149.02 Aligned_cols=140 Identities=23% Similarity=0.255 Sum_probs=97.0
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHH----------------------HHHHHHhhccCCCC--c
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF----------------------LELVNNIDRIRHAN--I 569 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~Hpn--I 569 (801)
.+.||+|+||+||+|...+|+.||||++............+ ..|.+.+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999986533221111111 24455555554332 3
Q ss_pred cccceEEEecCeEEEEEeccCCCCHHH-HHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 003704 570 VELKGYCAEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (801)
Q Consensus 570 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 648 (801)
.+.+++ ...++||||++++.+.. .+... ... .....++.+++.++.++|.. .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence 333332 24589999999954321 11110 001 56778999999999999982 2899999999999999
Q ss_pred CCCcEEEeeccCCCCcCC
Q 003704 649 DDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 649 ~~~~~kl~DFGla~~~~~ 666 (801)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-15 Score=141.51 Aligned_cols=134 Identities=20% Similarity=0.242 Sum_probs=112.5
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCC--CCccccceEEEecCeEEEEEeccCC
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--ANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
.+.||+|.++.||++...+ ..++||....... ...+.+|+..++.++| .++.+++++....+..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 5679999999999998754 7899998864332 4568889999999876 5888998888888889999999998
Q ss_pred CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
+.+..+ +......++.+++++|++||..+..+++|+|++|+||+++.++.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 4456677899999999999987555899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.7e-16 Score=164.93 Aligned_cols=188 Identities=21% Similarity=0.310 Sum_probs=145.3
Q ss_pred CCCCCCCcceEeeC----------------CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--cc
Q 003704 65 DPCGESWQGVQCNA----------------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VT 126 (801)
Q Consensus 65 ~~C~~~w~gv~C~~----------------~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~ 126 (801)
.+|.|.-.-..|+. .....|+|++|.|..+.+..|.+|++|+.++|.+|.|+ .+|.... ..
T Consensus 48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sgh 126 (873)
T KOG4194|consen 48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGH 126 (873)
T ss_pred CcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccc
Confidence 45555666667764 24567999999999999999999999999999999999 7786665 56
Q ss_pred ccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeec
Q 003704 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206 (801)
Q Consensus 127 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 206 (801)
|+.|+|.+|.|+..-.+.+.-++.|+.||||.|.|+.+--..|..-.+|++|+|++|+|+..--..|.++.+|..|.|+.
T Consensus 127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 89999999999888888888888899999999988844445576667888888888888866667888888888888888
Q ss_pred ccccccc-cccCCCC-CCEEEccCCCCC---CCccccCCCCCCccccCCCCC
Q 003704 207 NQLSGTL-DVLQDLP-LRDLNIENNLFS---GPIPEKMLQIPNFRKDGNPFN 253 (801)
Q Consensus 207 N~l~~~~-~~~~~~~-L~~L~ls~N~l~---g~~p~~l~~l~~l~~~~N~~~ 253 (801)
|+|+..+ -.|..++ |+.|+|..|+|. |.--..+.+|++|++..|.+.
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~ 258 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS 258 (873)
T ss_pred CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc
Confidence 8888877 3455454 888888888875 222334455555666555543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.3e-14 Score=147.86 Aligned_cols=138 Identities=17% Similarity=0.195 Sum_probs=105.6
Q ss_pred CCeee-ecCccEEEEEEeCCCcEEEEEEeccccC-----------chhhHHHHHHHHHHhhccCCCCc--cccceEEEec
Q 003704 514 ENLIG-AGMLGSVYRAQLPDGKLLAVKKLDKRAS-----------SQQKDDEFLELVNNIDRIRHANI--VELKGYCAEH 579 (801)
Q Consensus 514 ~~~iG-~G~~G~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~HpnI--v~l~~~~~~~ 579 (801)
..+|| .|+.|+||++... +..++||++..... .......+.+|++++.+++|++| ...+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999874 67889998853211 11233567889999999998875 6667664432
Q ss_pred -Ce---EEEEEeccCC-CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEE
Q 003704 580 -GQ---RLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (801)
Q Consensus 580 -~~---~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 654 (801)
.. .++||||++| .+|.+++.. ..++.. .+.+|+++|.+||+. ||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 699998864 234433 356899999999986 999999999999999999999
Q ss_pred EeeccCCCCc
Q 003704 655 VSDCGLAPLI 664 (801)
Q Consensus 655 l~DFGla~~~ 664 (801)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.4e-16 Score=179.61 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=189.4
Q ss_pred CCccCCeeeecCccEEEEEEe--CCCcEEEEEEeccccCchhhHHHHHHHHHHhhccC-CCCccccceEEEecCeEEEEE
Q 003704 510 SFSQENLIGAGMLGSVYRAQL--PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (801)
.|...+-||+|+|+.|-.... .....+|+|.+...............|..+-..+. |.|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 455667799999999988754 34556677766543322333344455666666666 999999999999999999999
Q ss_pred eccCCCCHHHHH-hcCccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEECCCC-cEEEeeccCCCC
Q 003704 587 EYCSNGTLQDML-HSDDELKNNLSWNTRIRMALGAARALEYLH-EICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (801)
Q Consensus 587 E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~ 663 (801)
||..++++++-+ +.. ....+....-.+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 432 124556667788999999999999 54 899999999999999999 999999999988
Q ss_pred cCC-CCcccccccccc-ccCcCCcccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhh
Q 003704 664 ISS-GSVSQLSGHLLT-AYGYGAPEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 664 ~~~-~~~~~~~~~~~~-~~~y~aPE~~~~--~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
+.. ...........| ++.|+|||...+ ......|+||.|+++.-+++|..||+...... .....|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~------ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK------ 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc------
Confidence 876 444444444566 888999996555 45678999999999999999999998654432 1112221110
Q ss_pred hhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 784 (801)
................+++.+++..+|+.|.+.+++...
T Consensus 248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000111223444567889999999999999998887543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.3e-17 Score=166.24 Aligned_cols=182 Identities=21% Similarity=0.311 Sum_probs=149.8
Q ss_pred CCCCCCcceEe-eC-----CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc-ccccEEEccCCcCC
Q 003704 66 PCGESWQGVQC-NA-----SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFS 138 (801)
Q Consensus 66 ~C~~~w~gv~C-~~-----~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~L~~N~l~ 138 (801)
+|.|+.....| .. ..+..++..+|+++ .+|+.++++.+|..|++.+|++....|..+. +.|+.||...|-++
T Consensus 118 ~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 118 KLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred hhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh
Confidence 45555555444 22 35677788888888 4778899999999999999999977776666 88999999999998
Q ss_pred CCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCcc-CCCCCcEEEeecccccccccccC
Q 003704 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLE-NLSQLTTLHLQNNQLSGTLDVLQ 217 (801)
Q Consensus 139 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~ 217 (801)
.+|..++.|.+|.-|||.+|+|. .+| +|.++..|++|+++.|+|. .+|.... +|.+|..|||.+|+|+..++.+.
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~c 272 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEIC 272 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHH
Confidence 88999999999999999999998 777 7999999999999999998 8887765 89999999999999999987666
Q ss_pred CCC-CCEEEccCCCCCCCccccCCC--CCCccccCCCCC
Q 003704 218 DLP-LRDLNIENNLFSGPIPEKMLQ--IPNFRKDGNPFN 253 (801)
Q Consensus 218 ~~~-L~~L~ls~N~l~g~~p~~l~~--l~~l~~~~N~~~ 253 (801)
.+. |++||||+|.|++ +|-++++ ++.|.+.|||+.
T Consensus 273 lLrsL~rLDlSNN~is~-Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISS-LPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred HhhhhhhhcccCCcccc-CCcccccceeeehhhcCCchH
Confidence 665 9999999999995 5555555 566778899875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-16 Score=167.67 Aligned_cols=170 Identities=22% Similarity=0.395 Sum_probs=81.7
Q ss_pred eEEEEecCCCCc-cccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEcc
Q 003704 81 IIAIILNGANLG-GELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 81 l~~L~L~~n~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
|..+|+++|.++ +..|.....+++++.|-|...+|. .+|.+++ .+|+.|.+++|++. .+-..+..|+.|+.+++.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 344455555555 334444555555555555555554 4444444 45555555555554 333444455555555555
Q ss_pred CCccc-ccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc-cccCCCC-CCEEEccCCCCCCC
Q 003704 158 NNLLS-GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGP 234 (801)
Q Consensus 158 ~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~-L~~L~ls~N~l~g~ 234 (801)
+|+|. .-||..+..|..|..||||+|+|. ..|..+..-+++-.|+||+|+|..++ +.+-++. |-.||||+|+|...
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L 165 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML 165 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc
Confidence 55543 224444445555555555555555 45555555555555555555555444 2222222 44555555555422
Q ss_pred ccc--cCCCCCCccccCCCCC
Q 003704 235 IPE--KMLQIPNFRKDGNPFN 253 (801)
Q Consensus 235 ~p~--~l~~l~~l~~~~N~~~ 253 (801)
.|. .+..|.+|.+++||++
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhh
Confidence 221 2334444555555544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.9e-16 Score=144.54 Aligned_cols=153 Identities=26% Similarity=0.412 Sum_probs=135.4
Q ss_pred cccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCC
Q 003704 98 NLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGL 175 (801)
Q Consensus 98 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 175 (801)
.+.++++++.|-||+|+|+ .+|..+. .+|+.|++++|+|+ .+|..++.|++|+.|+++-|+|. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667889999999999999 6666665 89999999999999 78999999999999999999999 999999999999
Q ss_pred CeEEccCCCCCC-CCCCCccCCCCCcEEEeecccccccccccCCCC-CCEEEccCCCCCCCccccC---CCCCCccccCC
Q 003704 176 INLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKM---LQIPNFRKDGN 250 (801)
Q Consensus 176 ~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-L~~L~ls~N~l~g~~p~~l---~~l~~l~~~~N 250 (801)
+.|||.+|+++. .+|..|..+..|+.|+|++|.|.-.++..+.+. |+.|.+..|.+- .+|..+ .+++.|.+.||
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 999999999974 689999999999999999999998887666664 999999999988 677664 55677889999
Q ss_pred CCCC
Q 003704 251 PFNS 254 (801)
Q Consensus 251 ~~~~ 254 (801)
.+.-
T Consensus 184 rl~v 187 (264)
T KOG0617|consen 184 RLTV 187 (264)
T ss_pred eeee
Confidence 8864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.1e-13 Score=160.49 Aligned_cols=208 Identities=22% Similarity=0.328 Sum_probs=135.9
Q ss_pred hccCCCCHhHHHHHHHHHHhcCCC-CCCC----CCCCCCCCCCCC--------------CcceEeeCCC-----------
Q 003704 31 FSCAVTNPNDVAAINSLYAALGSP-VLPG----WVASAGDPCGES--------------WQGVQCNASD----------- 80 (801)
Q Consensus 31 ~~~~~~~~~d~~aL~~~~~~~~~~-~~~~----w~~~~~~~C~~~--------------w~gv~C~~~~----------- 80 (801)
-..+.+.+.+...+..+.+.+..| .+.+ |... .+.|.-. -..|.|....
T Consensus 55 ~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~ 133 (754)
T PRK15370 55 HPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQ 133 (754)
T ss_pred CCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCC-CcccccCCcchhhheeeecCCceEEecCCCcccccccccccc
Confidence 345677889999999999999887 3444 7754 6788421 2347775433
Q ss_pred ----------------------------------------------eEEEEecCCCCccccCccccCCCCCCEEEccCCc
Q 003704 81 ----------------------------------------------IIAIILNGANLGGELGENLGAFSSIRVIDLSNNH 114 (801)
Q Consensus 81 ----------------------------------------------l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~ 114 (801)
.+.|+|++++|+. +|..+. ++|+.|+|++|+
T Consensus 134 ~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~ 210 (754)
T PRK15370 134 ASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNE 210 (754)
T ss_pred cccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCC
Confidence 3556666666664 444332 467777777777
Q ss_pred CCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCcc
Q 003704 115 IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLE 194 (801)
Q Consensus 115 l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 194 (801)
|+ .+|..+..+|++|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+.
T Consensus 211 Lt-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~ 282 (754)
T PRK15370 211 LK-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP 282 (754)
T ss_pred CC-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC
Confidence 77 456555667777777777777 4555443 36777777777777 6666654 46777777777777 5666553
Q ss_pred CCCCCcEEEeecccccccccccCCCCCCEEEccCCCCCCCccc-cCCCCCCccccCCCCCC
Q 003704 195 NLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE-KMLQIPNFRKDGNPFNS 254 (801)
Q Consensus 195 ~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p~-~l~~l~~l~~~~N~~~~ 254 (801)
.+|+.|+|++|+|++.+..+. ..|+.|+|++|+|+. +|. ...+|..|.+.+|.+.+
T Consensus 283 --~sL~~L~Ls~N~Lt~LP~~lp-~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 283 --EELRYLSVYDNSIRTLPAHLP-SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTS 339 (754)
T ss_pred --CCCcEEECCCCccccCcccch-hhHHHHHhcCCcccc-CCccccccceeccccCCcccc
Confidence 467777777777776553322 246777777777774 343 33456667777776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.4e-14 Score=152.99 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=184.2
Q ss_pred ccCCccCCeeee--cCccEEEEEEe---CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecCe
Q 003704 508 TNSFSQENLIGA--GMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~--G~~G~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (801)
...|...+.+|. |.+|.||.++. .++..+|+|+-+...........-.+|+....++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345667788999 99999999864 5788999998544333333334444666666666 49999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEe
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVS 656 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~ 656 (801)
.++-+|++. .+|.++.+... ..++....+.+..+..+ ||.++|.. +|+|-|+||.||++..+ ...+++
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999985 68888887542 23555666666777777 99999986 89999999999999999 889999
Q ss_pred eccCCCCcCCCCcccccc---ccccccCcCCcccccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeeccccc
Q 003704 657 DCGLAPLISSGSVSQLSG---HLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 657 DFGla~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 733 (801)
|||+...+..+....... ...+..-|++||...+.++...|+|++|.++.+..+|..+....-.. .|
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W---- 335 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW---- 335 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc----
Confidence 999998887665322111 11345569999999999999999999999999999987665432111 11
Q ss_pred ccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 783 (801)
...+. .. +...+.+....++...+..|++.+|-.|++.+.+..
T Consensus 336 -~~~r~---~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 -SQLRQ---GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc---cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 00 122233334455667899999999999999886653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.6e-14 Score=163.72 Aligned_cols=160 Identities=28% Similarity=0.461 Sum_probs=128.2
Q ss_pred CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeEEccC
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.+++.|+|++|+|+. +|..+. .+|++|+|++|+|+ .+|..+..+|+.|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 578999999999995 555553 58999999999999 678778789999999999999 6777664 5899999999
Q ss_pred CcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCCCCEEEccCCCCCCCcccc
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238 (801)
Q Consensus 159 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p~~ 238 (801)
|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. .+|+.|++++|.|++ +|..
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~-~sL~~L~Ls~N~Lt~-LP~~ 343 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP-PGLKTLEAGENALTS-LPAS 343 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc-ccceeccccCCcccc-CChh
Confidence 9999 6787664 58999999999999 5676553 478889999999887654332 358888888888885 5654
Q ss_pred C-CCCCCccccCCCCC
Q 003704 239 M-LQIPNFRKDGNPFN 253 (801)
Q Consensus 239 l-~~l~~l~~~~N~~~ 253 (801)
+ .+|..|++++|.+.
T Consensus 344 l~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 344 LPPELQVLDVSKNQIT 359 (754)
T ss_pred hcCcccEEECCCCCCC
Confidence 4 46778888888775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.6e-13 Score=150.88 Aligned_cols=145 Identities=23% Similarity=0.275 Sum_probs=100.2
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchh--------------------------------------hHHHHH
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ--------------------------------------KDDEFL 555 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 555 (801)
.+.||.|++|+||+|++.+|+.||||+.+......- .+-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999864321100 001234
Q ss_pred HHHHHhhcc----CCCCccccceEEE-ecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHH-HHHHHHh
Q 003704 556 ELVNNIDRI----RHANIVELKGYCA-EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR-ALEYLHE 629 (801)
Q Consensus 556 ~e~~~l~~l----~HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~ 629 (801)
+|.+.+.++ +|.+-+.+-..+. ..+..+|||||++|++|.++..... ... ...+++..+++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 455544444 2333333333332 2445789999999999988765321 112 23456666665 4677787
Q ss_pred cCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 630 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
. |++|+|+||.||+++.++.++++|||++..+...
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 5 9999999999999999999999999999877543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.2e-13 Score=157.01 Aligned_cols=159 Identities=24% Similarity=0.397 Sum_probs=85.3
Q ss_pred CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCcccccccEEEccCCcCCC-------------------
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSG------------------- 139 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~L~~N~l~~------------------- 139 (801)
.+++.|+|.+|+|+. +|. .+++|++|+|++|+|+. +|.. ..+|+.|+|++|.|+.
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l-p~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt 295 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL-PPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT 295 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc-ccccceeeccCCchhhhhhchhhcCEEECcCCccc
Confidence 356777777777765 332 24667777777777773 3422 2344444444444331
Q ss_pred CCCcccccCCccCeEEccCCcccccCChhhhC-----------------CCCCCeEEccCCCCCCCCCCCccCCCCCcEE
Q 003704 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS-----------------LTGLINLDLSSNNLSGELPPSLENLSQLTTL 202 (801)
Q Consensus 140 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----------------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 202 (801)
.+|. .+++|+.|+|++|+|++ +|..... ..+|+.|+|++|+|+ .+|... .+|+.|
T Consensus 296 ~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L 367 (788)
T PRK15387 296 SLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTLP---SELYKL 367 (788)
T ss_pred cccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CCCCCC---ccccee
Confidence 1222 12456666666666663 2321110 024555555555555 344321 234445
Q ss_pred EeecccccccccccCCCCCCEEEccCCCCCCCccccCCCCCCccccCCCCCC
Q 003704 203 HLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254 (801)
Q Consensus 203 ~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p~~l~~l~~l~~~~N~~~~ 254 (801)
++++|+|++++... ..|+.|+|++|+|++ +|....++..|++++|.+..
T Consensus 368 ~Ls~N~L~~LP~l~--~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 368 WAYNNRLTSLPALP--SGLKELIVSGNRLTS-LPVLPSELKELMVSGNRLTS 416 (788)
T ss_pred hhhccccccCcccc--cccceEEecCCcccC-CCCcccCCCEEEccCCcCCC
Confidence 55555555433221 247788888888874 66666777788888888764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.3e-15 Score=154.57 Aligned_cols=168 Identities=24% Similarity=0.393 Sum_probs=127.3
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEcc
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
+++.++.++|.+. .++++++.+-.|+.|+..+|+++ ..|..+. .+|..|++.+|+++...|..+. ++.|++||..
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~ 191 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCN 191 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccc
Confidence 4555666666665 35556666777777777777777 3333333 6777788888888855444444 8888888888
Q ss_pred CCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc-cccCCCC-CCEEEccCCCCCCCc
Q 003704 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPI 235 (801)
Q Consensus 158 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~-L~~L~ls~N~l~g~~ 235 (801)
.|.|+ .+|+.++.|.+|..|+|..|+|. .+| +|.+|+.|++|+++.|+|.-.+ ..+..++ +..|||..|+++ .+
T Consensus 192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 SNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cC
Confidence 88887 88888999999999999999998 788 7888999999999999988777 4555665 999999999999 78
Q ss_pred cccCC---CCCCccccCCCCCC
Q 003704 236 PEKML---QIPNFRKDGNPFNS 254 (801)
Q Consensus 236 p~~l~---~l~~l~~~~N~~~~ 254 (801)
|+.++ ++..|++++|.+..
T Consensus 268 Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred chHHHHhhhhhhhcccCCcccc
Confidence 88755 45568899998865
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-12 Score=146.33 Aligned_cols=148 Identities=13% Similarity=0.166 Sum_probs=92.4
Q ss_pred ccCCccCCeeeecCccEEEEEEeCC-CcEEEEEEeccccCch--------------------------------hhHHH-
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQ--------------------------------QKDDE- 553 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~G~Vy~~~~~~-g~~vavK~~~~~~~~~--------------------------------~~~~~- 553 (801)
-..|+. +.||+|++|+||+|++++ |+.||||+.+...... +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999877 9999999997442100 11112
Q ss_pred -----HHHHHHHhhcc----CCCCccccceEEEe-cCeEEEEEeccCCCCHHHHH--hcCccccCCCCHHHHHHHHHHHH
Q 003704 554 -----FLELVNNIDRI----RHANIVELKGYCAE-HGQRLLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIRMALGAA 621 (801)
Q Consensus 554 -----~~~e~~~l~~l----~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia 621 (801)
|.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++- ...+.....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 23344333333 23334444344433 45668999999999998753 2111000112122222222222
Q ss_pred HHHHHHHhcCCCCeEecCCCCCcEEECCCC----cEEEeeccCCCCcCC
Q 003704 622 RALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSDCGLAPLISS 666 (801)
Q Consensus 622 ~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 666 (801)
+. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22 3899999999999999988 999999999866543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.8e-13 Score=153.93 Aligned_cols=122 Identities=25% Similarity=0.397 Sum_probs=87.3
Q ss_pred EeeCCCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeE
Q 003704 75 QCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154 (801)
Q Consensus 75 ~C~~~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 154 (801)
.|-..+-..|+|++|+|+ .+|+.+. .+|+.|+|++|+|+ .+|. +.++|++|+|++|+|+. +|.. .++|+.|
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~-lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L 267 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQLTS-LPVL---PPGLLEL 267 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC-CCCCCcEEEecCCccCc-ccCc---cccccee
Confidence 465566778999999999 5777775 48999999999999 4664 45899999999999994 5643 3577788
Q ss_pred EccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc
Q 003704 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213 (801)
Q Consensus 155 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 213 (801)
+|++|.|+ .+|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++.+
T Consensus 268 ~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp 318 (788)
T PRK15387 268 SIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLP 318 (788)
T ss_pred eccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCC
Confidence 88888777 445422 45666666666666 44542 345666666666666543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.7e-13 Score=135.06 Aligned_cols=211 Identities=21% Similarity=0.349 Sum_probs=144.1
Q ss_pred HHHHHHHhhccCCCCccccceEEEec-----CeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHH
Q 003704 554 FLELVNNIDRIRHANIVELKGYCAEH-----GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628 (801)
Q Consensus 554 ~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 628 (801)
....+..+-++.|-|||+++.|+.+. ....++.|||..|+|..+|++.......+......+|.-||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 33445566677899999999998653 3568999999999999999876655667788888899999999999999
Q ss_pred hcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC--CCccccccccccccCcCCcccc-cCCCCCcchHHHHHHHH
Q 003704 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS--GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVM 705 (801)
Q Consensus 629 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwSlGvil 705 (801)
+. .+.|+|+++..+-|++..+|-+||.--.-...... ...........+-.+|.+||.- ....+..+|||+||...
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 85 78999999999999999999888742111111000 0011111223455789999953 33466789999999999
Q ss_pred HHHHhCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 003704 706 LELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 706 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 785 (801)
+||-.+..--..... . ......+...+- .+... .-++++.+|++..|..||+|.+++.|.
T Consensus 273 lemailEiq~tnseS---~---------~~~ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 273 LEMAILEIQSTNSES---K---------VEVEENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHheeccCCCcc---e---------eehhhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 999887643211110 0 000011111110 00000 123688999999999999999998764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-14 Score=155.97 Aligned_cols=169 Identities=30% Similarity=0.451 Sum_probs=127.7
Q ss_pred CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEc
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 156 (801)
...+..||+.|++. .+|.++..+-.|+.|.|..|.|. .+|..+. ..|++|||+.|+++ .+|..+..|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 45566788888887 46777777778888888888877 5555555 67778888888887 6677777766 778888
Q ss_pred cCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCCCCEEEccCCCCCCCcc
Q 003704 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP 236 (801)
Q Consensus 157 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p 236 (801)
++|+|+ .+|+.++.+..|..||.+.|++. .+|..++.|.+|+.|.+..|++...++.+..++|..||+|.|+++ .||
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecc
Confidence 888887 77777777778888888888887 777778888888888888888887776666777888888888887 677
Q ss_pred ccCCCC---CCccccCCCCCC
Q 003704 237 EKMLQI---PNFRKDGNPFNS 254 (801)
Q Consensus 237 ~~l~~l---~~l~~~~N~~~~ 254 (801)
-.|.+| ..|.+.+||+..
T Consensus 228 v~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhhheeeeeccCCCCC
Confidence 665554 445677888763
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-14 Score=159.89 Aligned_cols=170 Identities=26% Similarity=0.403 Sum_probs=135.8
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc----------------------------ccccEEE
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP----------------------------VTMQNFF 131 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----------------------------~~L~~L~ 131 (801)
.++.|.+..|.+. .+|+.+..++.|++|||..|+|. .+|..+. ..|+.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 4556666677776 35666777778888888888777 3333211 3578899
Q ss_pred ccCCcCCCCCCcccccCCccCeEEccCCcccccCChh-hhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccc
Q 003704 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDA-FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (801)
Q Consensus 132 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 210 (801)
|.+|+|+...-..|-+..+|+.|+|++|+|. .+|+. +.++..|+.|+||+|+|+ .+|..+.++..|++|...+|+|.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 9999999888888899999999999999998 66664 788999999999999999 89999999999999999999999
Q ss_pred ccccccCCCCCCEEEccCCCCC-CCccccC--CCCCCccccCCCCC
Q 003704 211 GTLDVLQDLPLRDLNIENNLFS-GPIPEKM--LQIPNFRKDGNPFN 253 (801)
Q Consensus 211 ~~~~~~~~~~L~~L~ls~N~l~-g~~p~~l--~~l~~l~~~~N~~~ 253 (801)
..+.......|+.+|||.|+|+ ..+|... .+|+.|+++||.+.
T Consensus 444 ~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 444 SFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred echhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 8886555556999999999997 4555544 57889999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=152.58 Aligned_cols=107 Identities=31% Similarity=0.526 Sum_probs=86.8
Q ss_pred ccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccccccc-ccCCCC-CCEEEcc
Q 003704 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIE 227 (801)
Q Consensus 150 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~-L~~L~ls 227 (801)
.++.|+|++|.|+|.+|..|.+|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.++ .+..+. |+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37788888888888888888888888888888888888888888888888888888888888764 354444 8889999
Q ss_pred CCCCCCCccccCCC----CCCccccCCCCCCCC
Q 003704 228 NNLFSGPIPEKMLQ----IPNFRKDGNPFNSTV 256 (801)
Q Consensus 228 ~N~l~g~~p~~l~~----l~~l~~~~N~~~~~~ 256 (801)
+|+|+|.+|..+.. +..+.+.+|+..|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 99999989877643 345778888887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-11 Score=119.78 Aligned_cols=130 Identities=20% Similarity=0.119 Sum_probs=94.2
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccc-cceEEEecCeEEEEEeccCCC
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE-LKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~~g 592 (801)
.+.|+.|.++.||+++.. |..|++|....... ....+..|+++++.+.+.++++ ++.+. .+..++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356889999999999874 77899998754321 1234567888888876655544 44332 33457999999998
Q ss_pred CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCcEEEeeccCCC
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
++.+.- .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 876430 011245678999999999862 12369999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.25 E-value=8e-13 Score=143.28 Aligned_cols=177 Identities=23% Similarity=0.363 Sum_probs=133.6
Q ss_pred CCCeEEEEecCCCCccccCccccCCCC---CCEEEccCCcCCCCCC----Ccc---cccccEEEccCCcCCCC----CCc
Q 003704 78 ASDIIAIILNGANLGGELGENLGAFSS---IRVIDLSNNHIGGSIP----SIL---PVTMQNFFLSDNQFSGS----IPS 143 (801)
Q Consensus 78 ~~~l~~L~L~~n~l~~~~~~~l~~l~~---L~~L~Ls~N~l~~~~p----~~~---~~~L~~L~L~~N~l~~~----~p~ 143 (801)
..+++.|+|++|.+.+..+..+..+.+ |++|+|++|++++... ..+ ..+|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 459999999999998777777766666 9999999999984211 112 26899999999999943 345
Q ss_pred ccccCCccCeEEccCCccccc----CChhhhCCCCCCeEEccCCCCCCC----CCCCccCCCCCcEEEeecccccccc--
Q 003704 144 SLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGTL-- 213 (801)
Q Consensus 144 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~-- 213 (801)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. +...+..+++|++|++++|.+++..
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 677788999999999999842 444566778999999999999743 3455677899999999999998521
Q ss_pred cc---cC--CCCCCEEEccCCCCCC----Ccc---ccCCCCCCccccCCCCCC
Q 003704 214 DV---LQ--DLPLRDLNIENNLFSG----PIP---EKMLQIPNFRKDGNPFNS 254 (801)
Q Consensus 214 ~~---~~--~~~L~~L~ls~N~l~g----~~p---~~l~~l~~l~~~~N~~~~ 254 (801)
.. +. ...|++|++++|.++. .+. ..+.++..+++++|.+.-
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 21 11 2469999999999972 122 234567888899988763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.6e-12 Score=139.20 Aligned_cols=175 Identities=22% Similarity=0.324 Sum_probs=129.2
Q ss_pred CCeEEEEecCCCCcc------ccCccccCCCCCCEEEccCCcCCCCCCCccc--cc---ccEEEccCCcCCC----CCCc
Q 003704 79 SDIIAIILNGANLGG------ELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VT---MQNFFLSDNQFSG----SIPS 143 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~---L~~L~L~~N~l~~----~~p~ 143 (801)
.+++.|+++++.+.+ .++..|..+++|+.|+|++|.+.+..+..+. .+ |++|+|++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457888888887762 3455678889999999999999876655554 33 9999999999983 3344
Q ss_pred ccccC-CccCeEEccCCccccc----CChhhhCCCCCCeEEccCCCCCCC----CCCCccCCCCCcEEEeecccccccc-
Q 003704 144 SLATL-TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGTL- 213 (801)
Q Consensus 144 ~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~- 213 (801)
.+..+ ++|+.|+|++|.|++. +...+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.|++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 56677 8999999999999843 344577788999999999999852 3344566679999999999987543
Q ss_pred ----cccCC-CCCCEEEccCCCCCCCcc----cc----CCCCCCccccCCCCC
Q 003704 214 ----DVLQD-LPLRDLNIENNLFSGPIP----EK----MLQIPNFRKDGNPFN 253 (801)
Q Consensus 214 ----~~~~~-~~L~~L~ls~N~l~g~~p----~~----l~~l~~l~~~~N~~~ 253 (801)
..+.. ..|++|++++|.+++... .. ...+..|++.+|.+.
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 22332 349999999999986322 22 257888888888765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.7e-11 Score=148.65 Aligned_cols=79 Identities=23% Similarity=0.394 Sum_probs=35.4
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc-ccccEEEccCCcCCCCCCcccccCCccCeEEccC
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
+++.|+|.+|+|. .++..+..+++|+.|+|++|...+.+|.... ++|++|+|++|.....+|..+++|++|+.|+|++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~ 690 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence 4555555555544 2344444555555555554432223332111 4444444444443334444444444444444444
Q ss_pred C
Q 003704 159 N 159 (801)
Q Consensus 159 N 159 (801)
|
T Consensus 691 c 691 (1153)
T PLN03210 691 C 691 (1153)
T ss_pred C
Confidence 3
|
syringae 6; Provisional |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=114.62 Aligned_cols=138 Identities=15% Similarity=0.151 Sum_probs=96.1
Q ss_pred CCeeeecCccEEEEEEeCC-------CcEEEEEEeccccC-----------c---------hhhHHHHH----HHHHHhh
Q 003704 514 ENLIGAGMLGSVYRAQLPD-------GKLLAVKKLDKRAS-----------S---------QQKDDEFL----ELVNNID 562 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~-------g~~vavK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~ 562 (801)
..+||.|--+.||.|...+ +..+|||+.+.... . ......+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 57999998752210 0 01122333 7888888
Q ss_pred ccCC--CCccccceEEEecCeEEEEEeccCCCCHHH-HHhcCccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 003704 563 RIRH--ANIVELKGYCAEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHR 638 (801)
Q Consensus 563 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHr 638 (801)
++.. -++-..+++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|.+| |+. +|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8753 445555554 45679999998754422 2221 2344455667788999999999 664 99999
Q ss_pred CCCCCcEEECCCCcEEEeeccCCCCc
Q 003704 639 NFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 639 Dlkp~NILl~~~~~~kl~DFGla~~~ 664 (801)
||++.|||++ ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.3e-12 Score=137.40 Aligned_cols=251 Identities=18% Similarity=0.181 Sum_probs=177.7
Q ss_pred HhhhccCCccCCeeeecCccEEEEEEe--CCCcEEEEEEeccccCchhhHHHHHHHHHHhhcc-CCCCccccceEEEecC
Q 003704 504 LQQYTNSFSQENLIGAGMLGSVYRAQL--PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (801)
Q Consensus 504 ~~~~~~~~~~~~~iG~G~~G~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~ 580 (801)
......+|.....||.|.|+.||+... .++..|++|.+.+.......+..-..|+-+...+ .|.|++.++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 444667889999999999999999843 5788999998865544333333333444444444 5999999888888877
Q ss_pred eEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CcEEEeecc
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCG 659 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG 659 (801)
..|+--|||+++++...+. ....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 8889999999999887763 245677888999999999999999975 89999999999999886 788999999
Q ss_pred CCCCcCCCCccccccccccccCcC-Ccccc--cCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccc
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYG-APEFE--SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~-aPE~~--~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
++..+... .......-++. ..|++ ...+..+.|+||||.-+.|.++|...-.... .|..
T Consensus 413 ~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~----- 474 (524)
T KOG0601|consen 413 CWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT----- 474 (524)
T ss_pred ccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee-----
Confidence 98653221 11112222344 24433 3357789999999999999999875332211 1110
Q ss_pred hhhhhhhcCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 787 (801)
+..+.....+... .++..+...+...|+..||.+.++..+...
T Consensus 475 -------i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 475 -------IRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -------eecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0001011112222 567888999999999999999988776543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=128.42 Aligned_cols=167 Identities=19% Similarity=0.249 Sum_probs=126.0
Q ss_pred EeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCC
Q 003704 529 QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNL 608 (801)
Q Consensus 529 ~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l 608 (801)
+..++.+|.|...+.... .......+-++.++.++||||+++++.++..+..|||+|.+. .|..++...
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------
Confidence 556888999988865433 334556777889999999999999999999999999999885 677777642
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccccccccccccCcCCcccc
Q 003704 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688 (801)
Q Consensus 609 ~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 688 (801)
........+.||+.||.|||+.| +++|++|.-+.|++++.|+.||++|.++........ .......-..|..|+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence 24556677899999999999864 899999999999999999999999998754332211 01111112235666622
Q ss_pred cCCCCCcchHHHHHHHHHHHHhC
Q 003704 689 SGIYTCQSDVYSFGVVMLELLTG 711 (801)
Q Consensus 689 ~~~~~~k~DvwSlGvil~elltG 711 (801)
.. -+...|.|-|||+++|++.|
T Consensus 178 ~~-s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DP-SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cc-cccchhhhhHHHHHHHHhCc
Confidence 11 12457999999999999998
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-12 Score=142.03 Aligned_cols=147 Identities=24% Similarity=0.443 Sum_probs=119.3
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCccc-ccccEEEccCCcCCCCCCcccccCCccCeEEccC
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.|..+.|..|.|. .+|+.+++|..|++|||+.|+++ .+|..+. --|+.|.+++|+++ .+|..++.+..|..||.+.
T Consensus 99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 4566778888886 57888889999999999999998 5554444 78888999999988 7888888888888999999
Q ss_pred CcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCC-CCEEEccCCCCC
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232 (801)
Q Consensus 159 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-L~~L~ls~N~l~ 232 (801)
|.|. .+|..+++|.+|+.|.+..|++. .+|..+..| .|..||+|+|+++.++-.|..+. |++|-|.+|.|+
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence 9888 78888888888888888888888 777777755 58888888888888775555554 888888888887
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-12 Score=148.11 Aligned_cols=150 Identities=27% Similarity=0.341 Sum_probs=122.4
Q ss_pred CCeEEEEecCCCCccccCcccc-------------------------CCCCCCEEEccCCcCCCCCCCcc-c-ccccEEE
Q 003704 79 SDIIAIILNGANLGGELGENLG-------------------------AFSSIRVIDLSNNHIGGSIPSIL-P-VTMQNFF 131 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~-------------------------~l~~L~~L~Ls~N~l~~~~p~~~-~-~~L~~L~ 131 (801)
..++.|+|..|+|....+..|. .+..|+.|+|.+|+|+...-..+ . +.|+.|+
T Consensus 310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 3578899999888753322111 12347778999999986543333 3 8999999
Q ss_pred ccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccc
Q 003704 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211 (801)
Q Consensus 132 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 211 (801)
|++|+|.......+.+|..|++|+||+|+|+ .+|..+.++..|++|...+|+|. .+| .+..++.|+.+|||.|+|+.
T Consensus 390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 9999999666677899999999999999999 89999999999999999999999 888 79999999999999999986
Q ss_pred cc-cccCC-CCCCEEEccCCCC
Q 003704 212 TL-DVLQD-LPLRDLNIENNLF 231 (801)
Q Consensus 212 ~~-~~~~~-~~L~~L~ls~N~l 231 (801)
.. +.... .+|++|||++|.-
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhhCCCcccceeeccCCcc
Confidence 55 44333 5699999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.5e-10 Score=115.54 Aligned_cols=143 Identities=21% Similarity=0.308 Sum_probs=108.4
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCC--CccccceEEEec---CeEEEEEecc
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA--NIVELKGYCAEH---GQRLLIYEYC 589 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~Hp--nIv~l~~~~~~~---~~~~lV~E~~ 589 (801)
+.|+.|.++.||+++..+|..+++|........ .....+..|+++++.+.+. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877789999987543221 1345678888888888753 456677776553 3568999999
Q ss_pred CCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003704 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC-------------------------------------- 631 (801)
Q Consensus 590 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 631 (801)
+|.++.+.+.. ..++......++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99988775531 24667777788888888888888531
Q ss_pred ---------------CCCeEecCCCCCcEEECC--CCcEEEeeccCCCC
Q 003704 632 ---------------QPPIVHRNFKSANILLDD--DLAVSVSDCGLAPL 663 (801)
Q Consensus 632 ---------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 663 (801)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.7e-10 Score=104.58 Aligned_cols=133 Identities=23% Similarity=0.313 Sum_probs=98.9
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEE-eccccCchhh-----HHHHHHHHHHhhccCCCCccccceEEEecCeEEEEEec
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASSQQK-----DDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~-~~~~~~~~~~-----~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 588 (801)
..+++|+-+.+|.+.+.+. .+.+|. +.+.-..+.- ...-.+|..++.+++--.|.--.=|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977443 355553 3332222222 24456788888888766665555566777888899999
Q ss_pred cCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
++|..|.+.+... ...++..+-.-+.-||.. +|||+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988752 245666777788899986 999999999999998775 89999999863
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-10 Score=141.84 Aligned_cols=172 Identities=19% Similarity=0.243 Sum_probs=134.0
Q ss_pred CCeEEEEecCC------CCccccCccccCCC-CCCEEEccCCcCCCCCCCccc-ccccEEEccCCcCCCCCCcccccCCc
Q 003704 79 SDIIAIILNGA------NLGGELGENLGAFS-SIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTL 150 (801)
Q Consensus 79 ~~l~~L~L~~n------~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~ 150 (801)
.++..|.+..+ ++...+|+.|..++ +|+.|++.+|.+. .+|..|. .+|+.|+|++|+|. .++..+..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLE-KLWDGVHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCcccc-ccccccccCCC
Confidence 45666666544 33445677777764 5999999999887 6666665 89999999999988 57788889999
Q ss_pred cCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecc-cccccccccCCCCCCEEEccCC
Q 003704 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN-QLSGTLDVLQDLPLRDLNIENN 229 (801)
Q Consensus 151 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~L~~L~ls~N 229 (801)
|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+.++++|+.|+|++| ++...+..+...+|+.|+|++|
T Consensus 636 Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc 714 (1153)
T PLN03210 636 LRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGC 714 (1153)
T ss_pred CCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCC
Confidence 99999998875557774 888999999999998766689999999999999999986 4544444444445999999998
Q ss_pred CCCCCccccCCCCCCccccCCCCC
Q 003704 230 LFSGPIPEKMLQIPNFRKDGNPFN 253 (801)
Q Consensus 230 ~l~g~~p~~l~~l~~l~~~~N~~~ 253 (801)
...+.+|....++..|.+.+|.+.
T Consensus 715 ~~L~~~p~~~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 715 SRLKSFPDISTNISWLDLDETAIE 738 (1153)
T ss_pred CCccccccccCCcCeeecCCCccc
Confidence 877778877778888888888754
|
syringae 6; Provisional |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=112.19 Aligned_cols=112 Identities=26% Similarity=0.298 Sum_probs=37.5
Q ss_pred ccCCCCCCEEEccCCcCCCCCCCcc-cccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhh-hCCCCCC
Q 003704 99 LGAFSSIRVIDLSNNHIGGSIPSIL-PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF-QSLTGLI 176 (801)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~p~~~-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~ 176 (801)
+.+...+++|+|++|.|+.+-.-.. ..+|+.|+|++|+|+.. +.|..|++|+.|+|++|+|+ .+.+.+ ..+++|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccccccccchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 4444556777777777763321111 14667777777777743 24677888888888888888 454444 3678888
Q ss_pred eEEccCCCCCCCC-CCCccCCCCCcEEEeecccccccc
Q 003704 177 NLDLSSNNLSGEL-PPSLENLSQLTTLHLQNNQLSGTL 213 (801)
Q Consensus 177 ~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 213 (801)
.|+|++|+|...- -..+..+++|+.|+|.+|.++...
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~ 129 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKK 129 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGST
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchh
Confidence 8888888887321 135667888888888888887554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.5e-09 Score=100.10 Aligned_cols=144 Identities=19% Similarity=0.239 Sum_probs=103.8
Q ss_pred cCCeeeecCccEEEEEEeCCCcEEEEEE-eccccCc-----hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 513 QENLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASS-----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vavK~-~~~~~~~-----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
...+|-+|+-+.|+++.+ .|+...||. +.+.-.. +-...+..+|.+.+.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999988 677777764 3322111 122456678888888876555554445566666667999
Q ss_pred eccCC-CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---cEEEeeccCCC
Q 003704 587 EYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAP 662 (801)
Q Consensus 587 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~ 662 (801)
||++| .++.+++.... ............+..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 57888886532 12222333367888889999999986 899999999999997655 35899999974
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-10 Score=128.30 Aligned_cols=171 Identities=29% Similarity=0.458 Sum_probs=89.1
Q ss_pred CeEEEEecCCCCccccCccccCCC-CCCEEEccCCcCCCCC-CCcccccccEEEccCCcCCCCCCcccccCCccCeEEcc
Q 003704 80 DIIAIILNGANLGGELGENLGAFS-SIRVIDLSNNHIGGSI-PSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~-p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
.++.|++.+|+++. +++....+. +|+.|++++|++.... +....++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred ceeEEecCCccccc-CccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 35555555555553 333444443 5555555555555221 2222255555555555555 344444455555555555
Q ss_pred CCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCC-CCEEEccCCCCCCCcc
Q 003704 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP 236 (801)
Q Consensus 158 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-L~~L~ls~N~l~g~~p 236 (801)
+|+++ .+|.....+..|+.|.+++|.+. .++..+..+.+|..|.+++|++...+..+..+. ++.|++++|.++....
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~ 272 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS 272 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccccccc
Confidence 55555 45544444444555555555433 344455555555555555665555443333333 7777777777763322
Q ss_pred -ccCCCCCCccccCCCCCC
Q 003704 237 -EKMLQIPNFRKDGNPFNS 254 (801)
Q Consensus 237 -~~l~~l~~l~~~~N~~~~ 254 (801)
..+.++..|.+++|.+..
T Consensus 273 ~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 273 LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred ccccCccCEEeccCccccc
Confidence 223445556666666543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-10 Score=134.73 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=162.6
Q ss_pred cCCccCCeeeecCccEEEEEEe-CCCcEEEEEEeccccCc-hhhHHHHHHHHHHhhccCCCCccccceEEEecCeEEEEE
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~G~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (801)
+.|.+.+-+-+|.++.++-+.- ..|...++|........ ....+....+-.+.-..+||-++....-+......+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 3455556677888888887642 23444444443221111 111112222222222234566666555555667788999
Q ss_pred eccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCC
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 666 (801)
+|..+++|...++..+ ..+.+...-.+..+.+.++|||.. .+.|||++|.|+|...++..+++|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999998643 345455555667788999999985 589999999999999999999999984332210
Q ss_pred ---------------------CC----c----cccccccccccCcCCccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 003704 667 ---------------------GS----V----SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYD 716 (801)
Q Consensus 667 ---------------------~~----~----~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwSlGvil~elltG~~pf~ 716 (801)
.. . ........+|..|.+||. +.......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0 011233467889999994 55568889999999999999999999997
Q ss_pred ccccccccceeecccccccchhhhhhhcCCCC-CCCCCcccHHHHHHHHHHhcccCCCCCCCHH
Q 003704 717 RTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL-SGQYPAKSLSHFADIISRCVQSEPEFRPPMS 779 (801)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 779 (801)
...... ....+..... ....+.....+..+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 654321 0111111111 1223455667788999999999999998765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-10 Score=129.09 Aligned_cols=155 Identities=30% Similarity=0.484 Sum_probs=134.2
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCc--ccccccEEEccCCcCCCCCCcccccCCccCeEEcc
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
+++.|++++|.+.. +|..++.+++|+.|++++|+++ .+|.. ....|+.|++++|+++ .+|..+..+..|++|+++
T Consensus 141 nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 79999999999985 4567999999999999999999 45544 4489999999999999 777777778889999999
Q ss_pred CCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCCCCEEEccCCCCCCCccc
Q 003704 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE 237 (801)
Q Consensus 158 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p~ 237 (801)
+|.+. .++..+.++.+|..|.+++|++. .++..++.+++|++|++++|+++..........++.|++++|.++...|.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccccccccccCccCEEeccCccccccchh
Confidence 99755 57778999999999999999998 66888999999999999999999887744445699999999999977775
Q ss_pred cC
Q 003704 238 KM 239 (801)
Q Consensus 238 ~l 239 (801)
..
T Consensus 296 ~~ 297 (394)
T COG4886 296 IA 297 (394)
T ss_pred hh
Confidence 43
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.2e-10 Score=110.91 Aligned_cols=104 Identities=35% Similarity=0.471 Sum_probs=36.3
Q ss_pred ccccEEEccCCcCCCCCCcccc-cCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCc-cCCCCCcEE
Q 003704 125 VTMQNFFLSDNQFSGSIPSSLA-TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTL 202 (801)
Q Consensus 125 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L 202 (801)
.++++|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+. +. .+..|+.|+.|+|++|+|+ .+...+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 5678888888888843 3455 57788888888888883 43 4777888888888888888 454444 357888888
Q ss_pred Eeecccccccc--cccCCC-CCCEEEccCCCCCC
Q 003704 203 HLQNNQLSGTL--DVLQDL-PLRDLNIENNLFSG 233 (801)
Q Consensus 203 ~Ls~N~l~~~~--~~~~~~-~L~~L~ls~N~l~g 233 (801)
+|++|+|...- ..+..+ .|+.|+|.+|.++.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 88888887543 333333 38888888888873
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.2e-11 Score=119.34 Aligned_cols=127 Identities=23% Similarity=0.276 Sum_probs=90.9
Q ss_pred ccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEe
Q 003704 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204 (801)
Q Consensus 125 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 204 (801)
..|++||||+|.|+ .+.++..-++.++.|+||+|.|. .+- .+..|.+|+.||||+|.|+ .+-.+-..|.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 57888888888888 66777777888888888888887 333 3777888888888888888 66667777888888888
Q ss_pred ecccccccccccCCCCCCEEEccCCCCCCCcc-ccCC---CCCCccccCCCCCCC
Q 003704 205 QNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP-EKML---QIPNFRKDGNPFNST 255 (801)
Q Consensus 205 s~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p-~~l~---~l~~l~~~~N~~~~~ 255 (801)
+.|.|......-...+|..||+++|+|...-- ..++ .|..+.+.+||+...
T Consensus 360 a~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 88887654433334458888888888863111 1233 344566788887653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-11 Score=119.36 Aligned_cols=136 Identities=27% Similarity=0.396 Sum_probs=102.0
Q ss_pred cccCccccCCCCCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhh
Q 003704 93 GELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQ 170 (801)
Q Consensus 93 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 170 (801)
|..-..+..-+.|++||||+|.|+ .+..+.- ++++.|+||+|.|... ..++.|++|+.||||+|.|+ .+-.+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh
Confidence 333334444567888999999888 4433332 7888899999988833 33788899999999999998 5555556
Q ss_pred CCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc--cccCCCC-CCEEEccCCCCCCC
Q 003704 171 SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGP 234 (801)
Q Consensus 171 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~-L~~L~ls~N~l~g~ 234 (801)
.|-+.+.|.|+.|.|. .+ ..+..|-+|..||+++|+|...- ..++.++ |+.|.|.+|.|.+.
T Consensus 350 KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhcCEeeeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 7888999999999987 33 34677778899999999987544 5566777 89999999999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-08 Score=103.62 Aligned_cols=144 Identities=17% Similarity=0.077 Sum_probs=100.9
Q ss_pred CCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhh---------HHHHHHHHHHhhccCCCC--ccccceEEEe----
Q 003704 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK---------DDEFLELVNNIDRIRHAN--IVELKGYCAE---- 578 (801)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~~---- 578 (801)
++.+-+-....|+++.+ +|+.|.||+.......... ...+.+|...+.++..-+ ...++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555556777766 7788999987432211100 013668888887774333 3344555543
Q ss_pred -cCeEEEEEeccCCC-CHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-------
Q 003704 579 -HGQRLLIYEYCSNG-TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD------- 649 (801)
Q Consensus 579 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~------- 649 (801)
....+||||++++. +|.+++.... ....+......++.+++..+.-||+. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23568999999986 8999985321 23345667778999999999999996 9999999999999975
Q ss_pred CCcEEEeeccCCCC
Q 003704 650 DLAVSVSDCGLAPL 663 (801)
Q Consensus 650 ~~~~kl~DFGla~~ 663 (801)
++.+.++||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-10 Score=120.41 Aligned_cols=146 Identities=29% Similarity=0.398 Sum_probs=119.0
Q ss_pred cCCcCCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccC-CCCCCCC
Q 003704 111 SNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSS-NNLSGEL 189 (801)
Q Consensus 111 s~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~ 189 (801)
++-.|+ .+|..++...++|+|..|+|+.+.|..|+.+++|+.|||++|.|+-+-|.+|.+|.+|..|-+-+ |+|+...
T Consensus 54 r~~GL~-eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~ 132 (498)
T KOG4237|consen 54 RGKGLT-EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP 132 (498)
T ss_pred cCCCcc-cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence 333344 78888888899999999999988889999999999999999999999999999999988876655 9999444
Q ss_pred CCCccCCCCCcEEEeecccccccc-cccCCCC-CCEEEccCCCCCCCccc-c---CCCCCCccccCCCCCCCCCC
Q 003704 190 PPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPE-K---MLQIPNFRKDGNPFNSTVAP 258 (801)
Q Consensus 190 p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~-L~~L~ls~N~l~g~~p~-~---l~~l~~l~~~~N~~~~~~~~ 258 (801)
-..|++|.+|+.|.|.-|++.-+. +.+..+. +..|.|-.|.+. .++. . +..++.+.+.-|++-|.|.-
T Consensus 133 k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 133 KGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccccc
Confidence 478999999999999999998877 5555554 788889999887 4443 3 44566677889999998864
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.9e-10 Score=118.27 Aligned_cols=175 Identities=21% Similarity=0.192 Sum_probs=123.0
Q ss_pred eCCCeEEEEecCCCCcccc--CccccCCCCCCEEEccCCcCCCCCCCcc---cccccEEEccCCcCCCC-CCcccccCCc
Q 003704 77 NASDIIAIILNGANLGGEL--GENLGAFSSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGS-IPSSLATLTL 150 (801)
Q Consensus 77 ~~~~l~~L~L~~n~l~~~~--~~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L~L~~N~l~~~-~p~~~~~l~~ 150 (801)
...+++.|||++|-|..-. -.....|++|+.|+|+.|+|.-...... ...|+.|.|+.+.|+-. +-..+..+++
T Consensus 144 ~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs 223 (505)
T KOG3207|consen 144 ILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPS 223 (505)
T ss_pred hCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCc
Confidence 3468999999999887532 2445678999999999999884433322 27889999999998821 2233566889
Q ss_pred cCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCC--CCccCCCCCcEEEeecccccccc--cc------cCCCC
Q 003704 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGTL--DV------LQDLP 220 (801)
Q Consensus 151 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~~~~--~~------~~~~~ 220 (801)
|+.|+|..|...+..-....-+..|+.|||++|++- ..+ ...+.++.|+.|+++.+.+..+- +. -...+
T Consensus 224 l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 224 LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred HHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 999999999644344445566788999999999987 444 45688899999999999887643 22 12234
Q ss_pred CCEEEccCCCCCCCcc-----ccCCCCCCccccCCCCC
Q 003704 221 LRDLNIENNLFSGPIP-----EKMLQIPNFRKDGNPFN 253 (801)
Q Consensus 221 L~~L~ls~N~l~g~~p-----~~l~~l~~l~~~~N~~~ 253 (801)
|++|+++.|++.. .+ ..+.++..|.+..|+++
T Consensus 303 L~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 303 LEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ceeeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence 9999999999852 11 12344555566666654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.4e-08 Score=103.92 Aligned_cols=219 Identities=17% Similarity=0.287 Sum_probs=150.3
Q ss_pred CccEEEEEE-eCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCCccccceEEEe----cCeEEEEEeccCC-CCH
Q 003704 521 MLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLIYEYCSN-GTL 594 (801)
Q Consensus 521 ~~G~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL 594 (801)
...+.||+. ..||..|++|+++..... ........+++++++.|.|||++.+++.. ...+++||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 345789994 568999999999432211 11123356788999999999999998762 4567899999886 578
Q ss_pred HHHHhcCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCC
Q 003704 595 QDMLHSDDE-----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 595 ~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 663 (801)
.++...... .....++...+.++.|++.||.++|+. |+.-+=|.+.+||++.+..++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 776543211 123467889999999999999999997 888899999999999999999998888766
Q ss_pred cCCCCccccccccccccCcCCcccccCCCCCcchHHHHHHHHHHHHhCCCCccccccccccceeecccccccchhhhhhh
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~k~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
+.++.. +|- .--.+-|.=.||.+++.|.||..--..... .....+.++
T Consensus 443 l~~d~~--------------~~l----e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--------------~~~s~~~~I 490 (655)
T KOG3741|consen 443 LQEDPT--------------EPL----ESQQQNDLRDLGLLLLALATGTENSNRTDS--------------TQSSHLTRI 490 (655)
T ss_pred ecCCCC--------------cch----hHHhhhhHHHHHHHHHHHhhcccccccccc--------------hHHHHHHHh
Confidence 554421 010 012457889999999999998642110000 000001111
Q ss_pred cCCCCCCCCCcccHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 786 (801)
-...+.++.+++......++++ -++.+++.++-
T Consensus 491 ---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 491 ---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred ---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 1223456778888888888886 56777776554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.7e-09 Score=84.96 Aligned_cols=58 Identities=40% Similarity=0.564 Sum_probs=28.9
Q ss_pred ccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCC
Q 003704 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184 (801)
Q Consensus 127 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 184 (801)
|++|+|++|+|+...+..|.++++|++|+|++|.|+...|..|.++++|++|+|++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444444444445555555555555555554444445555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.1e-09 Score=84.58 Aligned_cols=61 Identities=43% Similarity=0.594 Sum_probs=55.5
Q ss_pred CccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccc
Q 003704 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209 (801)
Q Consensus 149 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 209 (801)
++|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999976667899999999999999999977778999999999999999986
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.6e-08 Score=96.34 Aligned_cols=127 Identities=25% Similarity=0.297 Sum_probs=81.2
Q ss_pred EEEEEEeCCCcEEEEEEeccccC------------------------chhhHHHHHHHHHHhhccCCCC--ccccceEEE
Q 003704 524 SVYRAQLPDGKLLAVKKLDKRAS------------------------SQQKDDEFLELVNNIDRIRHAN--IVELKGYCA 577 (801)
Q Consensus 524 ~Vy~~~~~~g~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~ 577 (801)
.||.|...+|..+|||..+.... .........+|++.|.++..-+ +-+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999989999999998753210 0111244568999999997664 44555432
Q ss_pred ecCeEEEEEeccC--CCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEECCCCcEE
Q 003704 578 EHGQRLLIYEYCS--NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHRNFKSANILLDDDLAVS 654 (801)
Q Consensus 578 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NILl~~~~~~k 654 (801)
..+|||||++ |..+..+.... ++......++.+++..+..+ |.. ||||+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3469999999 66665544321 11233456677777766665 554 99999999999999988 999
Q ss_pred EeeccCCCCc
Q 003704 655 VSDCGLAPLI 664 (801)
Q Consensus 655 l~DFGla~~~ 664 (801)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.6e-07 Score=95.80 Aligned_cols=263 Identities=14% Similarity=0.171 Sum_probs=156.8
Q ss_pred ccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhc-cCCCCccccceE------EEec-CeEE
Q 003704 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGY------CAEH-GQRL 583 (801)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~------~~~~-~~~~ 583 (801)
.....||+|+.+.+|..-.-.+ .+.|++...... ...+. +..|.+ -.||-+-.=+.| .-+. ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa--~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPA--AQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCch--HHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 3457799999999997522111 244666533221 11222 222222 245543321221 1122 2366
Q ss_pred EEEeccCCC-CHHHHHhc--CccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccC
Q 003704 584 LIYEYCSNG-TLQDMLHS--DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 584 lV~E~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 660 (801)
+.|..+++. ...+++.- .........|...+++++.++.+.+-||.. |.+-+|+.++|+|+.+++.+.++|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 888888764 22222221 112235578999999999999999999997 888999999999999999999998554
Q ss_pred CCCcCCCCccccccccccccCcCCccccc-C-----CCCCcchHHHHHHHHHHHHhC-CCCcccccccccc-ceee--cc
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEFES-G-----IYTCQSDVYSFGVVMLELLTG-RKSYDRTRNRGEQ-FLVR--WA 730 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-----~~~~k~DvwSlGvil~elltG-~~pf~~~~~~~~~-~~~~--~~ 730 (801)
-.....+.. .-...|...|.+||... + ..+...|.|.+||++++++.| ++||.+....... .-.+ ..
T Consensus 164 fqi~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQINANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeeccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 332222211 12235667899999544 2 246779999999999999996 9999764322110 0000 00
Q ss_pred cccccchhhhhhhcCCCCCC---CCC-cccHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHHHHh
Q 003704 731 IPQLHDIDALSRMVDPSLSG---QYP-AKSLSHFADIISRCVQSE--PEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~ 791 (801)
...+-+... ....+.. ..| ...+..+..+..+|+... +.-||+++.++..|.++.++
T Consensus 241 ~g~f~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000000000 0011110 111 244567888999999654 56899999999888777543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.2e-10 Score=124.90 Aligned_cols=170 Identities=24% Similarity=0.305 Sum_probs=122.9
Q ss_pred CCeEEEEecCCCCccccCccccCC-CCCCEEEccCCcCC----------CCCCCccc-ccccEEEccCCcCCCCCCcccc
Q 003704 79 SDIIAIILNGANLGGELGENLGAF-SSIRVIDLSNNHIG----------GSIPSILP-VTMQNFFLSDNQFSGSIPSSLA 146 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l-~~L~~L~Ls~N~l~----------~~~p~~~~-~~L~~L~L~~N~l~~~~p~~~~ 146 (801)
..+..|.|.++.|.. ...+..| .+|+.|..++ .+. |.+-..+. ..|.+.+.++|+|. ....++.
T Consensus 109 ~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD~SLq 184 (1096)
T KOG1859|consen 109 RSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMDESLQ 184 (1096)
T ss_pred cceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHHHHHH
Confidence 467778888877764 1112112 3455554432 222 12222222 57888899999998 7788888
Q ss_pred cCCccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCC-CccCCCCCcEEEeecccccccccccCCCCCCEEE
Q 003704 147 TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLN 225 (801)
Q Consensus 147 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ 225 (801)
-++.|+.|||++|+++... .+..|+.|++|||+.|.|+ .+|. ....+. |+.|.|++|.++.....-...+|..||
T Consensus 185 ll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL~gie~LksL~~LD 260 (1096)
T KOG1859|consen 185 LLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTLRGIENLKSLYGLD 260 (1096)
T ss_pred HHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhhhhHHhhhhhhccc
Confidence 9999999999999999554 7889999999999999999 6664 334454 999999999998766555555689999
Q ss_pred ccCCCCCCC---cc-ccCCCCCCccccCCCCCCCC
Q 003704 226 IENNLFSGP---IP-EKMLQIPNFRKDGNPFNSTV 256 (801)
Q Consensus 226 ls~N~l~g~---~p-~~l~~l~~l~~~~N~~~~~~ 256 (801)
|++|-|.+. .| -.+..|..|.+.|||+.|..
T Consensus 261 lsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 261 LSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999999864 22 33567888999999999853
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.9e-09 Score=118.52 Aligned_cols=171 Identities=24% Similarity=0.251 Sum_probs=108.5
Q ss_pred CCeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCCCcccccccEEEccCCcCCCCCCcccccCCccCeEEccC
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.++..|+|.+|+|..+.. .+..+.+|++|+|++|+|+...+-.....|+.|++++|.|+.. ..+..+.+|+.|+|++
T Consensus 95 ~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~ 171 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSY 171 (414)
T ss_pred cceeeeeccccchhhccc-chhhhhcchheeccccccccccchhhccchhhheeccCcchhc--cCCccchhhhcccCCc
Confidence 567777777777775432 2666777777777777777665555555677777777777743 3445577777777777
Q ss_pred CcccccCChh-hhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccccccCCCC--CCEEEccCCCCCCC-
Q 003704 159 NLLSGEIPDA-FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP--LRDLNIENNLFSGP- 234 (801)
Q Consensus 159 N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--L~~L~ls~N~l~g~- 234 (801)
|++...-+ . ...+.+|+.+++.+|.+. . ...+..+..+..+++..|.++-.-+...... |+.+++++|.+.-.
T Consensus 172 n~i~~ie~-~~~~~~~~l~~l~l~~n~i~-~-i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~~ 248 (414)
T KOG0531|consen 172 NRIVDIEN-DELSELISLEELDLGGNSIR-E-IEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRSP 248 (414)
T ss_pred chhhhhhh-hhhhhccchHHHhccCCchh-c-ccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCcccccc
Confidence 77773333 2 466677777777777776 2 2334455555566777777665443333222 77888888888742
Q ss_pred -ccccCCCCCCccccCCCCCCC
Q 003704 235 -IPEKMLQIPNFRKDGNPFNST 255 (801)
Q Consensus 235 -~p~~l~~l~~l~~~~N~~~~~ 255 (801)
....+..+..|.+.+|.+...
T Consensus 249 ~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 249 EGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred ccccccccccccchhhcccccc
Confidence 234456666777777766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.7e-07 Score=94.69 Aligned_cols=137 Identities=20% Similarity=0.165 Sum_probs=94.8
Q ss_pred CCccCCeeeecCccEEEEEEeCCCcEEEEEEecccc------------------Cc--hhhHHHHHHHHHHhhccCCC--
Q 003704 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRA------------------SS--QQKDDEFLELVNNIDRIRHA-- 567 (801)
Q Consensus 510 ~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~------------------~~--~~~~~~~~~e~~~l~~l~Hp-- 567 (801)
-..+++.||.|--+.||.|....|.++|||.=+... .+ ......-.+|++.|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 355678999999999999999999999999642111 01 11223456788888888544
Q ss_pred CccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 003704 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 568 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 647 (801)
.|-+.+++ +...+||||++|-.|...- ++......++..|++-+..+-.. ||||+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 55555554 4557999999997775432 11222333344444444433343 89999999999999
Q ss_pred CCCCcEEEeeccCCC
Q 003704 648 DDDLAVSVSDCGLAP 662 (801)
Q Consensus 648 ~~~~~~kl~DFGla~ 662 (801)
++||.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.6e-08 Score=110.64 Aligned_cols=149 Identities=18% Similarity=0.249 Sum_probs=103.1
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCCCccc-------cccccccccCcCCccccc-
Q 003704 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-------LSGHLLTAYGYGAPEFES- 689 (801)
Q Consensus 618 ~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~- 689 (801)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+++.......... ..........|.|||++.
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455899999986 689999999999999999999999999875544321100 011112334699999544
Q ss_pred CCCCCcchHHHHHHHHHHHH-hCCCCccccccccccceeecccccccchhhhhhhcCCCCCCCCCcccHHHHHHHHHHhc
Q 003704 690 GIYTCQSDVYSFGVVMLELL-TGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCV 768 (801)
Q Consensus 690 ~~~~~k~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 768 (801)
...+.++|+||+||++|.+. .|+.-+........ .......+..-...+....+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 45788999999999999999 45554443221110 1111112222222355677889999999999
Q ss_pred ccCCCCCCCHHHHH
Q 003704 769 QSEPEFRPPMSEVV 782 (801)
Q Consensus 769 ~~dP~~RPt~~evl 782 (801)
..+...||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999887765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3e-07 Score=103.92 Aligned_cols=144 Identities=21% Similarity=0.267 Sum_probs=91.5
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCch----------------------------hh----------HHHHHH
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ----------------------------QK----------DDEFLE 556 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------~~----------~~~~~~ 556 (801)
+.|+.++-|+||+|++++|+.||||+.+...... .. +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999986431100 00 012233
Q ss_pred HHHHhhccC-----CCCccccceEEEecCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 003704 557 LVNNIDRIR-----HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA-LEYLHEI 630 (801)
Q Consensus 557 e~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~ 630 (801)
|...+.+++ .++|.--.=|++-.+...|+|||++|-.+.+...-. ....+.. .++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k---~ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRK---ELAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHH---HHHHHHHHHHHHHHHh-
Confidence 444333331 222221111222345678999999999998874321 1334422 233333322 222222
Q ss_pred CCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcCCC
Q 003704 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 631 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 667 (801)
.|++|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 28999999999999999999999999999877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.6e-07 Score=90.86 Aligned_cols=126 Identities=22% Similarity=0.238 Sum_probs=89.9
Q ss_pred CCcEEEEEEeccccCc-----hhhHHHHHHHHHHhhccC--CCCccccceEEEec----CeEEEEEeccCCC-CHHHHHh
Q 003704 532 DGKLLAVKKLDKRASS-----QQKDDEFLELVNNIDRIR--HANIVELKGYCAEH----GQRLLIYEYCSNG-TLQDMLH 599 (801)
Q Consensus 532 ~g~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~--HpnIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~ 599 (801)
.++.+-+|........ ........+|...+.++. .-.+.+.+++.... ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4556666654321111 122345667777777764 33455566666542 2458999999984 8999987
Q ss_pred cCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---cEEEeeccCCCCc
Q 003704 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAPLI 664 (801)
Q Consensus 600 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 664 (801)
... ..+......++.++++.++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 522 255667788999999999999997 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.3e-09 Score=115.92 Aligned_cols=169 Identities=25% Similarity=0.289 Sum_probs=119.0
Q ss_pred CeEEEEecCCCCccccCccccCCCCCCEEEccCCcCCCCCC-CcccccccEEEccCCcCCCCCCcccccCCccCeEEccC
Q 003704 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.+..++|..|.|.. +-..+..+++|+.|+|.+|+|..... .....+|++|+|++|+|+.+. .+..|+.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 45556677777764 33457888889999999999886665 344488999999999988663 456777788999999
Q ss_pred CcccccCChhhhCCCCCCeEEccCCCCCCCCCCC-ccCCCCCcEEEeecccccccccccCCCCCCEEEccCCCCCCCccc
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE 237 (801)
Q Consensus 159 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~g~~p~ 237 (801)
|.|+ .+ ..+..+.+|+.++|++|++. .+... ...+.+|+.|++.+|.+......-....+..+++..|.++-.-+-
T Consensus 150 N~i~-~~-~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 150 NLIS-DI-SGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccch-hc-cCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 9888 33 24566888889999999988 44332 577888888899998887655333333355558888888744332
Q ss_pred c-CC--CCCCccccCCCCCC
Q 003704 238 K-ML--QIPNFRKDGNPFNS 254 (801)
Q Consensus 238 ~-l~--~l~~l~~~~N~~~~ 254 (801)
. +. .++.+++.+|++.-
T Consensus 227 ~~~~~~~L~~l~l~~n~i~~ 246 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRISR 246 (414)
T ss_pred ccchhHHHHHHhcccCcccc
Confidence 2 12 26778888887753
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.7e-09 Score=94.70 Aligned_cols=62 Identities=26% Similarity=0.395 Sum_probs=36.2
Q ss_pred CccCeEEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeeccccccc
Q 003704 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212 (801)
Q Consensus 149 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 212 (801)
+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..|+..+|.+..+
T Consensus 77 ~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ei 138 (177)
T KOG4579|consen 77 PTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEI 138 (177)
T ss_pred chhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccC
Confidence 35555556666655 55666666666666666666665 5555555566666666665555433
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-08 Score=106.92 Aligned_cols=175 Identities=23% Similarity=0.248 Sum_probs=126.0
Q ss_pred CCeEEEEecCCCCccccC-ccccCCCCCCEEEccCCcCCCCCCCc-cc---ccccEEEccCCcCCCCCCccc-ccCCccC
Q 003704 79 SDIIAIILNGANLGGELG-ENLGAFSSIRVIDLSNNHIGGSIPSI-LP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~---~~L~~L~L~~N~l~~~~p~~~-~~l~~L~ 152 (801)
.+|+.+.|.+..+...-- +....|++++.||||.|-|....|-. +. ++|+.|+|+.|++.-...+.. ..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 457777788777653221 46778999999999999988443321 11 799999999999984443322 3577899
Q ss_pred eEEccCCccccc-CChhhhCCCCCCeEEccCCCCCCCCCCCccCCCCCcEEEeecccccccc--cccCCCC-CCEEEccC
Q 003704 153 DMSLNNNLLSGE-IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIEN 228 (801)
Q Consensus 153 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~-L~~L~ls~ 228 (801)
.|.|+.+.|+.. +-..+..+++|+.|+|+.|..-+.--....-+..|+.|||++|+|-... .....++ |+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 999999999832 2223567899999999999644344455667889999999999987665 3334443 88888888
Q ss_pred CCCCCC-cc--------ccCCCCCCccccCCCCC
Q 003704 229 NLFSGP-IP--------EKMLQIPNFRKDGNPFN 253 (801)
Q Consensus 229 N~l~g~-~p--------~~l~~l~~l~~~~N~~~ 253 (801)
+.++.. .| ..|.+++.|.+..|++.
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 888642 33 33778888999999873
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=84.97 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=101.3
Q ss_pred eeecCccEEEEEEeCCCcEEEEEEecccc-Cc---hhhHHHHHHHHHHhhccCC--CCccccceEEEe-----cCeEEEE
Q 003704 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRA-SS---QQKDDEFLELVNNIDRIRH--ANIVELKGYCAE-----HGQRLLI 585 (801)
Q Consensus 517 iG~G~~G~Vy~~~~~~g~~vavK~~~~~~-~~---~~~~~~~~~e~~~l~~l~H--pnIv~l~~~~~~-----~~~~~lV 585 (801)
-|+||.+-||+... +|..+-+|+-.... .+ ......|.+|+..+.++.. -.+.++. ++.. .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999877 44578888764111 11 2245778899998888853 2344444 3321 1245799
Q ss_pred EeccCC-CCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCc--EEEeeccCCC
Q 003704 586 YEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA--VSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~ 662 (801)
+|-+.| .+|.+++.... ..+.+......++.++++.+.-||+. |+.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 58999886432 23456777789999999999999996 9999999999999986666 9999998764
Q ss_pred C
Q 003704 663 L 663 (801)
Q Consensus 663 ~ 663 (801)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.6e-06 Score=85.33 Aligned_cols=138 Identities=14% Similarity=0.177 Sum_probs=83.5
Q ss_pred CeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhHHHHHHHHHHhhccCCCC--ccccceEEEecCeEEEEEeccCCC
Q 003704 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN--IVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 24567788775322 2344678888888875433 456777777777788999999996
Q ss_pred C-HHHHH---------------------hcCccccCCCCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCeEe
Q 003704 593 T-LQDML---------------------HSDDELKNNLSWNTRIR-MAL----------GAA-RALEYLHEI-CQPPIVH 637 (801)
Q Consensus 593 s-L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia-~~L~yLH~~-~~~~ivH 637 (801)
+ +...+ |.-.. .......... +.. .+. ....+|... ....++|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 3 22111 11000 0011111000 000 000 112222211 1236789
Q ss_pred cCCCCCcEEECCCCcEEEeeccCCC
Q 003704 638 RNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 638 rDlkp~NILl~~~~~~kl~DFGla~ 662 (801)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.1e-06 Score=83.40 Aligned_cols=155 Identities=21% Similarity=0.252 Sum_probs=95.8
Q ss_pred chhhhHhhhccCCccCCeee---ecCccEEEEEEeCCCcEEEEEEeccccCchhh-----------------HHH-----
Q 003704 499 FTIASLQQYTNSFSQENLIG---AGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK-----------------DDE----- 553 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~iG---~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------~~~----- 553 (801)
.+...+....+...+.+..| .|--+.||+|...++..+|||++......-.. ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34555555556666655555 55556799998889999999998633211111 000
Q ss_pred HHHHHHHhhccC--CCCccccceEEEecCeEEEEEeccCCCCH-HHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 003704 554 FLELVNNIDRIR--HANIVELKGYCAEHGQRLLIYEYCSNGTL-QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630 (801)
Q Consensus 554 ~~~e~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 630 (801)
..+|+..|.++. +-.+-+-+++. ...|||||+....+ .-.|. .-.+.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 134555555553 22233333332 33699999865311 11111 11222335666777888888888763
Q ss_pred CCCCeEecCCCCCcEEECCCCcEEEeeccCCCCcC
Q 003704 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 631 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 665 (801)
.++||+||+.-|||++ ++.+.|+|||-|....
T Consensus 186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 3899999999999999 8899999999886543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1e-08 Score=114.19 Aligned_cols=122 Identities=28% Similarity=0.336 Sum_probs=92.1
Q ss_pred CCCEEEccCCcCCCCCCCccc--ccccEEEccCCcCCCCCCcccccCCccCeEEccCCcccccCChh-hhCCCCCCeEEc
Q 003704 104 SIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDA-FQSLTGLINLDL 180 (801)
Q Consensus 104 ~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L 180 (801)
.|.+.+.+.|.|. .....+. +.|+.|+|++|+++..- .+..|++|++|||+.|.|. .+|.. ..++. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4777888888887 4444443 77888999999988553 7888999999999999998 55542 33444 999999
Q ss_pred cCCCCCCCCCCCccCCCCCcEEEeeccccccccc--ccCC-CCCCEEEccCCCCC
Q 003704 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD--VLQD-LPLRDLNIENNLFS 232 (801)
Q Consensus 181 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~-~~L~~L~ls~N~l~ 232 (801)
++|.++ .+ ..+.+|.+|..|||++|-|++.-. .+.. ..|+.|+|.+|.+.
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999988 33 347888899999999999887653 2222 34889999999885
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.3e-08 Score=89.72 Aligned_cols=108 Identities=24% Similarity=0.298 Sum_probs=87.3
Q ss_pred CeEEEEecCCCCccccC---ccccCCCCCCEEEccCCcCCCCCCCccc---ccccEEEccCCcCCCCCCcccccCCccCe
Q 003704 80 DIIAIILNGANLGGELG---ENLGAFSSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLATLTLLTD 153 (801)
Q Consensus 80 ~l~~L~L~~n~l~~~~~---~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 153 (801)
.+-.++|+++.|- .++ ..+.....|+..+|++|.|. .+|..|. +.++.|+|++|+|+ .+|..++.++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4556777777664 233 34555677888899999998 5555554 47899999999999 78888999999999
Q ss_pred EEccCCcccccCChhhhCCCCCCeEEccCCCCCCCCCCC
Q 003704 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192 (801)
Q Consensus 154 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 192 (801)
|+++.|.|. ..|..|..|.+|-.|+..+|.+. .||-.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 999999999 88888888999999999999998 77754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6e-08 Score=100.17 Aligned_cols=175 Identities=18% Similarity=0.277 Sum_probs=129.5
Q ss_pred CCeEEEEecCCCCccccCcc----ccCCCCCCEEEccCCcCCCCCCCc---------------ccccccEEEccCCcCCC
Q 003704 79 SDIIAIILNGANLGGELGEN----LGAFSSIRVIDLSNNHIGGSIPSI---------------LPVTMQNFFLSDNQFSG 139 (801)
Q Consensus 79 ~~l~~L~L~~n~l~~~~~~~----l~~l~~L~~L~Ls~N~l~~~~p~~---------------~~~~L~~L~L~~N~l~~ 139 (801)
++++.|+||+|.|.-.-+.. +.++..|++|.|.||.+.-.--.. ...+|+.+...+|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 48999999999987554433 566789999999999987211111 11589999999999974
Q ss_pred CC----CcccccCCccCeEEccCCcccc----cCChhhhCCCCCCeEEccCCCCCC----CCCCCccCCCCCcEEEeecc
Q 003704 140 SI----PSSLATLTLLTDMSLNNNLLSG----EIPDAFQSLTGLINLDLSSNNLSG----ELPPSLENLSQLTTLHLQNN 207 (801)
Q Consensus 140 ~~----p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N 207 (801)
-- ...|...+.|+.+.+..|.|.. .+-..|..++.|+.|||.+|-|+. .+...+..+++|+.|+++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 32 3457778899999999999862 233467889999999999999974 24456788899999999999
Q ss_pred ccc--ccc---cccC--CCCCCEEEccCCCCCCC----cc---ccCCCCCCccccCCCCC
Q 003704 208 QLS--GTL---DVLQ--DLPLRDLNIENNLFSGP----IP---EKMLQIPNFRKDGNPFN 253 (801)
Q Consensus 208 ~l~--~~~---~~~~--~~~L~~L~ls~N~l~g~----~p---~~l~~l~~l~~~~N~~~ 253 (801)
.++ |.. ..+. ..+|+.|.|.+|.++-. +- .....|..|++++|.+.
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 997 333 2232 23599999999999731 11 22556778899999883
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.7e-06 Score=81.40 Aligned_cols=139 Identities=19% Similarity=0.271 Sum_probs=90.0
Q ss_pred hccCCccCCeeeecCccEEEEEEeCCCcEEEEEEeccccCchhhH-------HHHHHHHHHhhccCCCC---ccccceEE
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKD-------DEFLELVNNIDRIRHAN---IVELKGYC 576 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~G~Vy~~~~~~g~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~Hpn---Iv~l~~~~ 576 (801)
...+|...+++-......|.+... +|+.+.+|.........+.. ....+++..+.+++... ...++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346677777777777677777666 67889999876543222111 11234444444443333 33333322
Q ss_pred Ee-----cCeEEEEEeccCCCCHHHHHhcCccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 003704 577 AE-----HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (801)
Q Consensus 577 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 651 (801)
.. ....++||||++|..|.+... ++. .++..+.+++.-||+. |++|+|..|.|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 22 235568999999988876532 121 2445677789999987 99999999999999865
Q ss_pred cEEEeeccCCC
Q 003704 652 AVSVSDCGLAP 662 (801)
Q Consensus 652 ~~kl~DFGla~ 662 (801)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 801 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 344 bits (885), Expect = e-112
Identities = 109/297 (36%), Positives = 167/297 (56%), Gaps = 14/297 (4%)
Query: 496 ARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFL 555
+ F++ LQ +++FS +N++G G G VY+ +L DG L+AVK+L K +Q + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQ 75
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR 615
V I H N++ L+G+C +RLL+Y Y +NG++ L E + L W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
+ALG+AR L YLH+ C P I+HR+ K+ANILLD++ V D GLA L+ H
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-----DTH 190
Query: 676 LLTA----YGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF--LVR 728
+ TA G+ APE+ +G + ++DV+ +GV++LEL+TG++++D R + L+
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
W L L +VD L G Y + + + C QS P RP MSEVV+ L
Sbjct: 251 WVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-110
Identities = 101/293 (34%), Positives = 157/293 (53%), Gaps = 7/293 (2%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
+ + L++ TN+F + LIG G+ G VY+ L DG +A+K+ S Q +E
Sbjct: 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE 81
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F + + RH ++V L G+C E + +LIY+Y NG L+ L+ D ++SW R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ + +GAAR L YLH I+HR+ KS NILLD++ ++D G++ + + LS
Sbjct: 142 LEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 674 GHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732
+ GY PE F G T +SDVYSFGVV+ E+L R + ++ R L WA+
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 733 QLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
H+ L ++VDP+L+ + +SL F D +C+ E RP M +V+ L
Sbjct: 259 -SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-104
Identities = 91/300 (30%), Positives = 151/300 (50%), Gaps = 16/300 (5%)
Query: 494 TTARSFTIASLQQYTNSFSQE------NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRA-- 545
T SF+ L+ TN+F + N +G G G VY+ + + +AVKKL
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
++++ +F + + + + +H N+VEL G+ ++ L+Y Y NG+L D L D
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
LSW+ R ++A GAA + +LHE +HR+ KSANILLD+ +SD GLA
Sbjct: 129 P-LSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 666 SGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
+ + ++ ++ Y APE G T +SD+YSFGVV+LE++TG + D +R Q
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQL 242
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
L+ + + +D + + S+ + S+C+ + RP + +V Q L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-71
Identities = 75/320 (23%), Positives = 124/320 (38%), Gaps = 33/320 (10%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
++ +L + + G G V++AQ + +AVK Q K
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIF----PIQDKQSW 63
Query: 554 FLEL-VNNIDRIRHANIVELKGYCAE----HGQRLLIYEYCSNGTLQDMLHSDDELKNNL 608
E V ++ ++H NI++ G LI + G+L D L N +
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVV 118
Query: 609 SWNTRIRMALGAARALEYLHE-------ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
SWN +A AR L YLHE +P I HR+ KS N+LL ++L ++D GLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPE-FESGI-----YTCQSDVYSFGVVMLELLTGRKSY 715
+G + + + Y APE E I + D+Y+ G+V+ EL + +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 716 DRTRNRGEQ--FLVRWAIPQLHDIDAL--SRMVDPSLSGQYPAKS-LSHFADIISRCVQS 770
D + P L D+ + + P L + + ++ + I C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 771 EPEFRPPMSEVVQDLVDMIR 790
+ E R V + + M R
Sbjct: 299 DAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 87/280 (31%), Positives = 131/280 (46%), Gaps = 26/280 (9%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ IGAG G+V+RA+ G +AVK L ++ ++ +EFL V + R+RH NIV
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G + ++ EY S G+L +LH + L R+ MA A+ + YLH P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS--GHLLTAYGYGAPE-FESG 690
PIVHRN KS N+L+D V V D GL+ L +S +S S G + APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT----PEWMAPEVLRDE 214
Query: 691 IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSG 750
+SDVYSFGV++ EL T ++ + L+ ++ +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPW----------------GNLNPAQVVAAVGFKCKRL 258
Query: 751 QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ P A II C +EP RP + ++ L +I+
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-55
Identities = 65/317 (20%), Positives = 114/317 (35%), Gaps = 44/317 (13%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRH 566
++ LIG G G+VY+ L D + +AVK S + + E + + + H
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEH 66
Query: 567 ANIVELKGYCAE-----HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
NI + LL+ EY NG+L L + W + R+A
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVT 121
Query: 622 RALEYLHE------ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
R L YLH +P I HR+ S N+L+ +D +SD GL+ ++ + +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 676 LLTA------YGYGAPE-FESGI-------YTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
A Y APE E + Q D+Y+ G++ E+ +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 722 GE-QFLVRWAIPQLHDIDALSRMVD-----PSLSGQYPAKS--LSHFADIISRCVQSEPE 773
E Q + + + + +V P + S + + I C + E
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301
Query: 774 FRPPMSEVVQDLVDMIR 790
R + + +++
Sbjct: 302 ARLTAQXAEERMAELMM 318
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 9e-55
Identities = 75/288 (26%), Positives = 133/288 (46%), Gaps = 30/288 (10%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
E ++G G G V +A+ K +A+K+++ S+ + F+ + + R+ H NIV+L
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C L+ EY G+L ++LH + + + L ++ + YLH +
Sbjct: 68 GACLNP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 634 PIVHRNFKSANILLDDDLAVS-VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGI 691
++HR+ K N+LL V + D G A I + + G + APE FE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-GS----AAWMAPEVFEGSN 179
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
Y+ + DV+S+G+++ E++T RK +D F + WA+ R P L
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGG--PAFRIMWAVHNGT------R---PPLIKN 228
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNESL 799
P +++RC +P RP M E+V+ + ++R ++E L
Sbjct: 229 LPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-54
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 41/334 (12%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQ---ENLIGAGMLGSVYRAQLPDGKLL 536
G + S +A+ F S T LQ++ F Q LIG G G VY + G++
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEV- 58
Query: 537 AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQD 596
A++ +D ++ + F V + RH N+V G C +I C TL
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 597 MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656
++ K L N ++A + + YLH I+H++ KS N+ D+ V ++
Sbjct: 119 VVRDA---KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGK-VVIT 171
Query: 657 DCGLAPLISSGSVSQLSGHLLTAYG---YGAPE----------FESGIYTCQSDVYSFGV 703
D GL + + L G + APE + ++ SDV++ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 704 VMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADI 763
+ EL + P I + + P+LS +DI
Sbjct: 232 IWYELHAREWPFKT-------------QPAEAIIWQMGTGMKPNLS---QIGMGKEISDI 275
Query: 764 ISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797
+ C E E RP ++++ L + +R R +
Sbjct: 276 LLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 77/278 (27%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG+G G+VY+ + G + AVK L+ A + Q+ F V + + RH NI+ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
Q ++ ++C +L LH+ + I +A AR ++YLH I+
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE----FESGIY 692
HR+ KS NI L +D V + D GLA S S S L + + APE +S Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 693 TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752
+ QSDVY+FG+V+ EL+TG+ Y NR + + + + D S +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS------LSPDLS---KV 250
Query: 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ +++ C++ + + RP ++ ++ ++ R
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-53
Identities = 54/281 (19%), Positives = 104/281 (37%), Gaps = 33/281 (11%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ G +++ + G + VK L R S +K +F E + H N++ +
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 574 GYCAE--HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
G C LI + G+L ++LH + + ++ AL AR + +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF---- 687
+P I S ++++D+D+ +S + S + APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---MYA----PAWVAPEALQKK 183
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
+D++SF V++ EL+T + L +++ ++
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFA----------------DLSNMEIGMKVALEG 227
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
L P H + ++ C+ +P RP +V L M
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-53
Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 37/286 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIVE 571
E +IG G G VYRA G +AVK + + ++H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L+G C + L+ E+ G L +L + + + A+ AR + YLH+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 632 QPPIVHRNFKSANILLDDDLA--------VSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
PI+HR+ KS+NIL+ + + ++D GLA + +G Y +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA----YAWM 181
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
APE + +++ SDV+S+GV++ ELLTG + + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPF----------------RGIDGLAVAYG 225
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ L+ P+ FA ++ C +P RP + ++ L +
Sbjct: 226 VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-52
Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 47/293 (16%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKL-----DKRASSQQKDDEFLELVNNIDRIRHA 567
E IG G G V++ + + D ++A+K L + +K EF V + + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV+L G ++ E+ G L L + + W+ ++R+ L A +EY+
Sbjct: 84 NIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 628 HEICQPPIVHRNFKSANILLDD-----DLAVSVSDCGLAPLISSGSVSQLSGHLLTA--- 679
PPIVHR+ +S NI L + V+D GL SQ S H ++
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL---------SQQSVHSVSGLLG 188
Query: 680 -YGYGAPE---FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
+ + APE E YT ++D YSF +++ +LTG +D + I +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--GKIKFINMIREEG 246
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
R P++ P + ++I C +P+ RP S +V++L ++
Sbjct: 247 -----LR---PTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 37/300 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
+G G G V+R G+ +AVK SS+ + F E + N +RH NI+
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
Q LI Y G+L D L L + +R+ L A L +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA--YG 681
+P I HR+ KS NIL+ + ++D GLA + S + G+
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 682 YGAPE-------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
Y APE + + D+++FG+V+ E+ S + F +P
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF--YDVVPND 240
Query: 735 HDIDALSRMVD-----PSLSGQYPAKS-LSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ + ++V P++ ++ + L+ A ++ C P R + + L +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 65/302 (21%), Positives = 107/302 (35%), Gaps = 37/302 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
IG G G V+ + G+ +AVK + ++ F E + +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
Q LI +Y NG+L D L L + +++A + L +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA--YG 681
+P I HR+ KS NIL+ + ++D GLA S +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 682 YGAPE-------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
Y PE +D+YSFG+++ E+ S Q +P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV--EEYQLPYHDLVPSD 269
Query: 735 HDIDALSRMVD-----PSLSGQYPAKS-LSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ + +V PS ++ + L +++ C P R V + L M
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 789 IR 790
Sbjct: 330 SE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 37/304 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
+ IG G G V+R + G+ +AVK SS+++ F E + +RH NI+
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 573 KGYCAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ Q L+ +Y +G+L D L+ + ++ I++AL A L +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA--YG 681
+P I HR+ KS NIL+ + ++D GLA S + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 682 YGAPE-------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRN-RGEQFLVRWAIPQ 733
Y APE + ++D+Y+ G+V E+ + + + + + P
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 734 LHDIDAL-----SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
+ ++ + R P+ A L A I+ C + R + + L +
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEA--LRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 789 IRRE 792
++E
Sbjct: 335 SQQE 338
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 66/292 (22%), Positives = 113/292 (38%), Gaps = 37/292 (12%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
++G G G + G+++ +K+L + Q+ FL+ V + + H N+++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVLKF 72
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G + + I EY GTL+ ++ S D + W+ R+ A A + YLH +
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG--------- 683
I+HR+ S N L+ ++ V V+D GLA L+ L
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 684 ---APE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
APE Y + DV+SFG+V+ E++ + R F + ++
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRG 238
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
P P F I RC +PE RP ++ L +
Sbjct: 239 FLDRYCPP---NCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 35 VTNPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGG 93
+ NP D A+ + LG+P L W+ + D C +W GV C+
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTT-DCCNRTWLGVLCD---------------- 44
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGS--IPSILP--VTMQNFFLSD-NQFSGSIPSSLATL 148
+ +DLS ++ IPS L + ++ N G IP ++A L
Sbjct: 45 ----TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
T L + + + +SG IPD + L+ LD S N LSG LPPS+ +L L + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 209 LSGTL-DVLQDLP--LRDLNIENNLFSGPIPE 237
+SG + D + I N +G IP
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 5/163 (3%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ N+ G + + L ++ +D S N + G++P + + N+ SG+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 144 SLATLT-LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
S + + L T M+++ N L+G+IP F +L L +DLS N L G+ + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 203 HLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
HL N L+ L + L L++ NN G +P+ + Q+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 6/152 (3%)
Query: 90 NLGGELGENLGAFSS-IRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLAT 147
+ G + ++ G+FS + +S N + G IP + + + LS N G +
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ L N L+ ++ L LDL +N + G LP L L L +L++ N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 208 QLSG---TLDVLQDLPLRDLNIENNLFSGPIP 236
L G LQ + L P+P
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 27/288 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
IG G G V+ +L L AVK + K FL+ + + H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV L G C + ++ E G L ++ L T ++M AA +EYL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYL 229
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
+HR+ + N L+ + + +SD G++ + G + G + APE
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 687 FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
G Y+ +SDV+SFG+++ E + G Y N+ ++ R+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QT------REFVEKGGRLPC 336
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
P L P ++ +C EP RP S + Q+L + +R R
Sbjct: 337 PELC---PDA----VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 7/175 (4%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFS-SIRVIDLSNNHIGGSIPSIL----PVTMQNFF 131
+ + L+ GEL E+L S S+ +DLS+N+ G I L T+Q +
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
L +N F+G IP +L+ + L + L+ N LSG IP + SL+ L +L L N L GE+P
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 192 SLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L + L TL L N L+G + L + L +++ NN +G IP+ + ++ N
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-38
Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 4/174 (2%)
Query: 75 QCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFL 132
Q + + + L G++ L S + + LS N++ G+IPS L +++ L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
N G IP L + L + L+ N L+GEIP + T L + LS+N L+GE+P
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 193 LENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L L L L NN SG + L D L L++ NLF+G IP M +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-36
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
N S+++++ L+ L G + +LG+ S +R + L N + G IP L T++ L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N +G IPS L+ T L +SL+NN L+GEIP L L L LS+N+ SG +P L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 194 ENLSQLTTLHLQNNQLSGTL-DVLQDLPLRDLNIENNLFSGPIPEKM 239
+ L L L N +GT+ + I N +G +
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQS---GKIAANFIAGKRYVYI 578
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-36
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 40/227 (17%)
Query: 53 SPVLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGE--------------- 97
+LP W ++ +PC ++ GV C + +I L+ L
Sbjct: 27 KNLLPDWSSNK-NPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83
Query: 98 -----------NLGAFSSIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSGSIP 142
+S+ +DLS N + G + ++ + ++ +S N
Sbjct: 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
Query: 143 -SSLATLTLLTDMSLNNNLLSGEIPDAFQ---SLTGLINLDLSSNNLSGELPPSLENLSQ 198
S L L + L+ N +SG + L +L +S N +SG++ +
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 199 LTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L L + +N S + L D L+ L+I N SG +
Sbjct: 202 LEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTE 248
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-35
Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L+G + G + G+ S + + LS+N+ G +P + M+ LS N+FSG +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 143 SSLATLTL-LTDMSLNNNLLSGEIPDAF--QSLTGLINLDLSSNNLSGELPPSLENLSQL 199
SL L+ L + L++N SG I L L L +N +G++PP+L N S+L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420
Query: 200 TTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFR 246
+LHL N LSGT+ L L LRDL + N+ G IP++++ +
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-35
Identities = 56/157 (35%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLA 146
G + S++ + L+ N G IP L LS N F G++P
Sbjct: 258 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 147 TLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLS-QLTTLHL 204
+ +LL ++L++N SGE+P D + GL LDLS N SGELP SL NLS L TL L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 205 QNNQLSGTL--DVLQDLP--LRDLNIENNLFSGPIPE 237
+N SG + ++ Q+ L++L ++NN F+G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-35
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSI 141
+ ++ N + LG S+++ +D+S N + G + ++ +S NQF G I
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIPDA-FQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
P L L +SL N +GEIPD + L LDLS N+ G +PP + S L
Sbjct: 264 PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 201 TLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPE 237
+L L +N SG L D L + L+ L++ N FSG +PE
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-32
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 86 LNGANLGGELGENLGA-FSSIRVIDLSNNHIGGSIPSILPVT-----MQNFFLSDNQFSG 139
++ L + G +S+ V+DLS N I G+ ++ +++ +S N+ SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+ ++ L + +++N S IP + L +LD+S N LSG+ ++ ++L
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE 237
L++ +NQ G + L L+ L++ N F+G IP+
Sbjct: 250 KLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPD 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-31
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 2/160 (1%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLAT 147
L GE+ + L ++ + L N + G IPS L + LS+N+ +G IP +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L + L+NN SG IP LI LDL++N +G +P ++ S +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 208 QLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK 247
+ + F G E++ ++
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-31
Identities = 43/138 (31%), Positives = 62/138 (44%), Gaps = 2/138 (1%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
N G E L S+ ++++ GG +M +S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N SG IP + ++ L ++L +N +SG IPD L GL LDLSSN L G +P ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 194 ENLSQLTTLHLQNNQLSG 211
L+ LT + L NN LSG
Sbjct: 701 SALTMLTEIDLSNNNLSG 718
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-31
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 54/229 (23%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-------------- 121
++ + L+ + G + LG S+ +DL+ N G+IP+
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 122 --ILPVTMQNFFL--------SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
V ++N + + +F G L L+ ++ + + G F +
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-------------TLDV--- 215
++ LD+S N LSG +P + ++ L L+L +N +SG LD+
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 216 ---------LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKD---GNP 251
+ L L ++++ NN SGPIPE M Q F NP
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-MGQFETFPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-28
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 12/179 (6%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS---ILPVTMQNFFL 132
+ +IL+ +L GE+ L +++ I LSNN + G IP L + L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKL 521
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
S+N FSG+IP+ L L + LN NL +G IP A + +++N ++G+
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY 577
Query: 193 LENLSQLTTLHLQNN--QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
++N H N + G + L L NI + ++ G +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-14
Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
S N+ + + SLTGL +L LS+++++G + + + LT+L L N LSG +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVT 117
Query: 215 VLQDLP----LRDLNIENNLFSGPIP-EKMLQIPNFRK---DGNPFNSTVAPSRPPTSSV 266
L L L+ LN+ +N P L++ + N + +
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 267 T 267
Sbjct: 178 G 178
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G +VY+ +A +L R ++ + F E + ++H NIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 575 YC---AEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNL--SWNTRIRMALGAARALEYLH 628
+ + +++ E ++GTL+ L +K + SW +I + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 629 EICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
PPI+HR+ K NI + +V + D GLA L + + G T + APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG---TPE-FMAPEM 201
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y DVY+FG+ MLE+ T Y + + + R V
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPY----------------SECQNAAQIYRRVTSG 245
Query: 748 LSGQYPAKSLS-HFADIISRCVQSEPEFRPPMSE 780
+ K +II C++ + R + +
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 29/292 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY L AVK L + + EFL+ + I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 276
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 334
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
+ +HRN + N L+ ++ V V+D GL+ L++ + + +G + APE
Sbjct: 335 EKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPES 390
Query: 687 FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
++ +SDV++FGV++ E+ T G Y V + + + RM
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDY------RMER 440
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797
P P K +++ C Q P RP +E+ Q M + S+E
Sbjct: 441 PEGC---PEK----VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 485
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY L AVK L + + EFL+ + I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 69
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 127
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYG 683
+ +HR+ + N L+ ++ V V+D GL+ L++ + + +G T
Sbjct: 128 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 179
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
APE ++ +SDV++FGV++ E+ T G Y V ++
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QV------YELLEKDY 229
Query: 742 RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797
RM P Y +++ C Q P RP +E+ Q M + S+E
Sbjct: 230 RMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L S + FL+ + ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 241 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE 297
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
+ VHR+ ++ANIL+ ++L V+D GLA LI + G + APE
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 353
Query: 688 ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G +T +SDV+SFG+++ EL T GR Y NR V + + + RM P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGY------RMPCP 403
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
P D++ +C + EPE RP + L D
Sbjct: 404 PEC---PES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ + IG+G G V+ + +A+K + + A S++ +F+E + ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C E L+ E+ +G L D L + + T + M L + YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYGA 684
E C ++HR+ + N L+ ++ + VSD G+ + + +G +
Sbjct: 122 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-----S 173
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE F Y+ +SDV+SFGV+M E+ + G+ Y+ N V + DI R
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EV------VEDISTGFR 223
Query: 743 MVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ P L + Y I++ C + PE RP S +++ L ++
Sbjct: 224 LYKPRLASTHVY---------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 65/293 (22%), Positives = 118/293 (40%), Gaps = 41/293 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G+G G V + +AVK + + + S+ EF + + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPK 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+ G C++ ++ EY SNG L + L S + L + + M + +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLE 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYGA 684
+HR+ + N L+D DL V VSD G+ + G +A
Sbjct: 122 SHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----- 173
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE F Y+ +SDV++FG++M E+ + G+ YD N V + + R
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EV------VLKVSQGHR 223
Query: 743 MVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+ P L Y I+ C PE RP +++ + + +++
Sbjct: 224 LYRPHLASDTIY---------QIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/299 (20%), Positives = 114/299 (38%), Gaps = 44/299 (14%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G G V + G+ +AVK L + D + + + + H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHEN 84
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C E G LI E+ +G+L++ L + KN ++ +++ A+ + ++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDY 141
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG--- 683
L VHR+ + N+L++ + V + D GL I + T
Sbjct: 142 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK------EYYTVKDDRDSP 192
Query: 684 ----APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLV-RWAIPQLHD 736
APE + SDV+SFGV + ELLT + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 737 IDALS---RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
++ L R+ P Y ++ +C + +P R +++ +++
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 69/291 (23%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
F + ++G+G G+VY+ P+G+ + A+K+L + A+S + + E L+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ + ++ L G C LI + G L D + K+N+ + + A+
Sbjct: 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 129
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+ YL + +VHR+ + N+L+ V ++D GLA L+ + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
A E IYT QSDV+S+GV + EL+T G K YD I + ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSI--LEKGE 236
Query: 742 RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
R+ P + Y I+ +C + + RP E++ + M R
Sbjct: 237 RLPQPPICTIDVY---------MIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 41/300 (13%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G GSV + G L+AVK+L + S + +F + + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDF 85
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ +G G++ L+ EY +G L+D L + L + + + + +EY
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEY 142
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG--- 683
L VHR+ + NIL++ + V ++D GLA L+ G
Sbjct: 143 LGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY------VVREPGQSP 193
Query: 684 ----APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD- 736
APE I++ QSDV+SFGVV+ EL T KS + +P L
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 737 IDALS---RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
++ L R+ P+ P + +++ C P+ RP S + L + R
Sbjct: 254 LELLEEGQRL--PA-----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G G V + +A+K + + + S+ EF+E + + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 80
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C + +I EY +NG L + L + M A+EYL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE 137
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYGA 684
+HR+ + N L++D V VSD GL+ + + G +
Sbjct: 138 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS-----P 189
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE ++ +SD+++FGV+M E+ + G+ Y+R N I R
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ET------AEHIAQGLR 239
Query: 743 MVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
+ P L Y I+ C + + RP ++ +++D++ E
Sbjct: 240 LYRPHLASEKVY---------TIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 79/385 (20%), Positives = 138/385 (35%), Gaps = 61/385 (15%)
Query: 428 RRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTST 487
H +S+ ++ P P + +E + +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKA-------GSENLYFQGAN 62
Query: 488 KTAKPFTTARSFTIASLQQYTNSFSQENL-----IGAGMLGSVYRAQL--PDGKLL--AV 538
+ + ++Q S + IG G G VY L DGK + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 539 KKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-GQRLLIYEYCSNGTLQDM 597
K L++ + FL + H N++ L G C G L++ Y +G L++
Sbjct: 123 KSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 598 LHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657
+ ++ +N + I L A+ +++L VHR+ + N +LD+ V V+D
Sbjct: 182 IRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235
Query: 658 CGLAPLISSG---SVSQLSGHLL----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELL 709
GLA + SV +G L A E ++ +T +SDV+SFGV++ EL+
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMA-----LESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 710 T-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS---RMVDPSLSGQYPAKSLSHFADIIS 765
T G Y + L R+ P +++
Sbjct: 291 TRGAPPY-------------PDVNTFDITVYLLQGRRL-------LQPEYCPDPLYEVML 330
Query: 766 RCVQSEPEFRPPMSEVVQDLVDMIR 790
+C + E RP SE+V + +
Sbjct: 331 KCWHPKAEMRPSFSELVSRISAIFS 355
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 40/295 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ P+ L A+K S ++ FL+ + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 73
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L +L + I A + AL
Sbjct: 74 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 129
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAY 680
YL VHR+ + N+L+ + V + D GL+ + + + S L A
Sbjct: 130 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA- 185
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDID 738
PE +T SDV+ FGV M E+L G K + +N V + I+
Sbjct: 186 ----PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V------IGRIE 231
Query: 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
R+ P P ++++C +P RP +E+ L ++ E+
Sbjct: 232 NGERL--PM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 76/292 (26%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +GAG G V+ +AVK L + + S FL N + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V L + +I EY NG+L D L + L+ N + MA A + ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYGA 684
E +HR+ ++ANIL+ D L+ ++D GLA LI + G TA
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----- 178
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE G +T +SDV+SFG+++ E++T GR Y N V + +++ R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EV------IQNLERGYR 228
Query: 743 MVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
MV P Y ++ C + PE RP + L D
Sbjct: 229 MVRPDNCPEELY---------QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-32
Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 49/294 (16%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + K ++ Q FL + + ++RH+N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ---AFLAEASVMTQLRHSN 247
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 305
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG---- 683
VHR+ + N+L+ +D VSD GL + G
Sbjct: 306 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT------------KEASSTQDTGKLPV 350
Query: 684 ---APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDID 738
APE ++ +SDV+SFG+++ E+ + GR Y R + V + + +
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGY--- 403
Query: 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
+M + P D++ C + RP ++ + L + E
Sbjct: 404 ---KM--DA-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 49/294 (16%)
Query: 514 ENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+IG G G VY L DGK + AVK L++ + FL + H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 88
Query: 570 VELKGYCAE-HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G C G L++ Y +G L++ + ++ +N + I L A+ ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA 145
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG---SVSQLSGHLL----TAYG 681
VHR+ + N +LD+ V V+D GLA + SV +G L A
Sbjct: 146 SKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA-- 200
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
E ++ +T +SDV+SFGV++ EL+T G Y +
Sbjct: 201 ---LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------------PDVNTFDITVY 244
Query: 740 LS---RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
L R+ P +++ +C + E RP SE+V + +
Sbjct: 245 LLQGRRL-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-32
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 37/288 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +GAG G V+ A +AVK + + S + FL N + ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDK 244
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L + +I E+ + G+L D L SD+ + I + A + ++
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYGA 684
+ +HR+ ++ANIL+ L ++D GLA +I + G TA
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----- 353
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
PE G +T +SDV+SFG++++E++T GR Y N V A+ + + R
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALERGY------R 403
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
M P P +I+ RC ++ PE RP + L D
Sbjct: 404 MPRPENC---PE----ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G GSV + G+++AVKKL + S+++ +F + + ++H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDN 72
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C G+R LI EY G+L+D L K + ++ + +EY
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEY 129
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG--- 683
L +HR+ + NIL++++ V + D GL ++ G
Sbjct: 130 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL------PQDKEFFKVKEPGESP 180
Query: 684 ----APE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
APE ++ SDV+SFGVV+ EL T + + + Q+
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 739 ALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ R+ P P + I++ C + RP ++ + +
Sbjct: 241 LIELLKNNGRLPRPDGC---PDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 46/307 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +G G G V G+++AVK L A Q + + + ++ +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRT 89
Query: 564 IRHANIVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
+ H +I++ KG C + G L+ EY G+L+D L ++++ + A
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQIC 144
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ YLH +HR+ + N+LLD+D V + D GLA + G
Sbjct: 145 EGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVRE 195
Query: 682 YG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLV-RWAI 731
G APE + + SDV+SFGV + ELLT S E + + +
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 732 PQLHDIDALS---RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
L + L R+ P + Y ++ C ++E FRP ++ L
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVY---------HLMKNCWETEASFRPTFENLIPILK 306
Query: 787 DMIRRER 793
+ + +
Sbjct: 307 TVHEKYQ 313
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L S + FL+ + ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 323
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 324 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE 380
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
+ VHR+ ++ANIL+ ++L V+D GLA LI + G + APE
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 436
Query: 688 ESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G +T +SDV+SFG+++ EL T GR Y NR V + + + RM P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGY------RMPCP 486
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
P D++ +C + EPE RP + L D
Sbjct: 487 PEC---PES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G + + DGK+L K+LD + +K E VN + ++H NIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE-VNLLRELKHPNIVRYY 71
Query: 574 G-YCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L I EYC G L ++ + + L +R+ AL+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 632 QPP--IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FE 688
++HR+ K AN+ LD V + D GLA +++ + S + T Y Y +PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPY-YMSPEQMN 189
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
Y +SD++S G ++ EL + L+ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAF-----------------SQKELAGKI---R 229
Query: 749 SGQYPA--KSLSH-FADIISRCVQSEPEFRPPMSEVVQD 784
G++ S +II+R + + RP + E++++
Sbjct: 230 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 71/298 (23%), Positives = 118/298 (39%), Gaps = 46/298 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
++G G G VY G+ + AVK K+ + ++F+ + +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E +I E G L L + KN+L T + +L +A+
Sbjct: 71 DHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAM 126
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAY 680
YL I VHR+ NIL+ V + D GL+ I + S L +
Sbjct: 127 AYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS- 182
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ-LHDI 737
PE +T SDV+ F V M E+L+ G++ + N+ + +
Sbjct: 183 ----PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----------DVIGVL 227
Query: 738 DALSRMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+ R+ P L Y +++RC +P RP +E+V L D+ + E+
Sbjct: 228 EKGDRLPKPDLCPPVLY---------TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 46/301 (15%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G GSV + G+++AVKKL + S+++ +F + + ++H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDN 103
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C G+R LI EY G+L+D L K + ++ + +EY
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEY 160
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG--- 683
L +HR+ + NIL++++ V + D GL ++ G
Sbjct: 161 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL------PQDKEYYKVKEPGESP 211
Query: 684 ----APE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738
APE ++ SDV+SFGVV+ EL T + + + Q+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 739 ALS------RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ R+ P Y I++ C + RP ++ + +
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQIRD 322
Query: 791 R 791
+
Sbjct: 323 Q 323
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 68/348 (19%), Positives = 122/348 (35%), Gaps = 71/348 (20%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
PP P P P + +L
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYN---------------------------------TL 31
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVNNI 561
+ E IG G VYRA L DG +A+KK + ++ + D E ++ +
Sbjct: 32 ANFR----IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE-IDLL 86
Query: 562 DRIRHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
++ H N+++ L I E G L M+ + K + T + +
Sbjct: 87 KQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
ALE++H ++HR+ K AN+ + V + D GL SS + + T Y
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 201
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y +PE Y +SD++S G ++ E+ + + ++ +
Sbjct: 202 -YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG---------------DKMNLYS 245
Query: 740 LSRMVDPSLSGQY---PAKSLSH-FADIISRCVQSEPEFRPPMSEVVQ 783
L + + Y P+ S +++ C+ +PE RP ++ V
Sbjct: 246 LCKKI---EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 47/293 (16%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + A++Q FL + + ++RH+N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 75
Query: 569 IVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L I EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 133
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL----TAYGYG 683
VHR+ + N+L+ +D VSD GL SS L TA
Sbjct: 134 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA---- 182
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
PE ++ +SDV+SFG+++ E+ + GR Y R + V + ++
Sbjct: 183 -PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DV------VPRVEKGY 231
Query: 742 RMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
+M P Y +++ C + RP ++ + L + E
Sbjct: 232 KMDAPDGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 80/329 (24%), Positives = 135/329 (41%), Gaps = 54/329 (16%)
Query: 485 TSTKTAKPFTTARSFTIASLQQYTNSFSQE---------NLIGAGMLGSVYRAQL--PDG 533
K +P A T + SF++E +IG+G G V +L P
Sbjct: 16 FQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ 75
Query: 534 KLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
+ + A+K L + +Q+ D FL + + + H NI+ L+G +++ EY N
Sbjct: 76 RDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+L L + D + + M G + YL ++ VHR+ + N+L+D +L
Sbjct: 135 GSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNL 188
Query: 652 AVSVSDCGLAPLI--SSGSVSQLSGHLL----TAYGYGAPE-FESGIYTCQSDVYSFGVV 704
VSD GL+ ++ + +G + TA PE ++ SDV+SFGVV
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA-----PEAIAFRTFSSASDVWSFGVV 243
Query: 705 MLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL--SGQYPAKSLSHFA 761
M E+L G + Y NR V + ++ R+ P +
Sbjct: 244 MWEVLAYGERPYWNMTNR----DV------ISSVEEGYRLPAPMGCPHALH--------- 284
Query: 762 DIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
++ C + RP S++V L +IR
Sbjct: 285 QLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 32/292 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
+ ++G+G+ G+V++ P+G+ + +K + + S +Q + + I
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ HA+IV L G C L+ +Y G+L D + + L + + A+
Sbjct: 72 LDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+ YL E +VHRN + N+LL V V+D G+A L+ L T +
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
A E G YT QSDV+S+GV + EL+T G + Y R +P L ++
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDL--LEKGE 234
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
R+ P ++ +C + RP E+ + M R
Sbjct: 235 RL--AQ-----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +IG G G VY + D A+K L + QQ + FL + + H N+
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNV 84
Query: 570 VELKGYC-AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G G ++ Y +G L + S + N + I L AR +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLA 141
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG---SVSQLSGHLL----TAYG 681
E VHR+ + N +LD+ V V+D GLA I SV Q L TA
Sbjct: 142 EQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA-- 196
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
E ++ +T +SDV+SFGV++ ELLT G Y + H +
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----L------THFLAQ 243
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
R+ P ++ +C +++P RP +V ++ ++
Sbjct: 244 GRRL-------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 68/289 (23%), Positives = 124/289 (42%), Gaps = 32/289 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
F + ++G+G G+VY+ P+G+ + A+K+L + A+S + + E L+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ + ++ L G C LI + G L D + K+N+ + + A+
Sbjct: 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 129
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+ YL + +VHR+ + N+L+ V ++D GLA L+ + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
A E IYT QSDV+S+GV + EL+T G K YD I + ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSI--LEKGE 236
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
R+ P I+ +C + + RP E++ + M R
Sbjct: 237 RL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 53/296 (17%), Positives = 109/296 (36%), Gaps = 44/296 (14%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI- 564
YT F + IG+G GSV++ DG + A+K+ K + + L V +
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+H+++V +LI EYC+ G+L D + + + + + L R
Sbjct: 69 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-----------GSVSQL 672
L Y+H +VH + K +NI + + + + G V+++
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 673 SGHLL---TAYGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV 727
S + + + A E E+ + ++D+++ + ++
Sbjct: 185 SSPQVEEGDSR-FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR----------- 232
Query: 728 RWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
Q H+I + P + F +++ + +PE RP +V+
Sbjct: 233 --NGDQWHEI---RQGRLPRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 55/301 (18%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++G G GSV L AVK + SSQ++ +EFL + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 570 VELKGYCAEHGQR-----LLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIRMALGAAR 622
+ L G C E + ++I + G L L + ++ T ++ + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQLSGHLL---- 677
+EYL +HR+ + N +L DD+ V V+D GL+ I SG Q +
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 678 TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735
A E +YT +SDV++FGV M E+ T G Y P +
Sbjct: 216 IA-----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPY----------------PGVQ 254
Query: 736 DIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
+ + R+ + P L +I+ C +++P RP S + L ++
Sbjct: 255 NHEMYDYLLHGHRL-------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307
Query: 790 R 790
Sbjct: 308 E 308
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/290 (23%), Positives = 114/290 (39%), Gaps = 43/290 (14%)
Query: 513 QENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++ +G+G G+V + K++ AVK L A+ DE L N + ++ + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V + G C +L+ E G L L + + I + + ++YL E
Sbjct: 81 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHV----KDKNIIELVHQVSMGMKYLEE 135
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG------ 683
VHR+ + N+LL +SD GL+ + + + A +G
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------NYYKAQTHGKWPVKW 186
Query: 684 -APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE ++ +SDV+SFGV+M E + G+K Y + E V ++
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E---V------TAMLEKG 236
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
RM PA D+++ C + E RP + V L +
Sbjct: 237 ERM--GC-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ P+ + A+K S ++ FL+ + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 448
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L K +L + I A + AL
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTAL 504
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
YL VHR+ + N+L+ + V + D GL+ + + + S L A
Sbjct: 505 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-A 560
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQ-LHDIDALS 741
PE +T SDV+ FGV M E+L G K + +N + I+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------DVIGRIENGE 609
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
R+ P ++++C +P RP +E+ L ++ E+
Sbjct: 610 RL-------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 46/295 (15%)
Query: 517 IGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G GSV AQL DG + AVK L + +EFL + H ++ +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 573 KGYCAEHGQR------LLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIRMALGAARAL 624
G + ++I + +G L L E NL T +R + A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
EYL +HR+ + N +L +D+ V V+D GL+ I SG + + A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS- 741
E +YT SDV++FGV M E++T G+ Y + + + +
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY----------------AGIENAEIYNY 251
Query: 742 -----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
R+ + P + + D++ +C ++P+ RP + + +L +++
Sbjct: 252 LIGGNRL-------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 42/295 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +++ +IGAG G VY+ L GK A+K L + +Q+ D FL + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H NI+ L+G +++ ++I EY NG L L D S + M G A
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAG 159
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL--SGHLL---- 677
++YL + VHR+ + NIL++ +L VSD GL+ ++ + SG +
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 678 TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735
TA PE +T SDV+SFG+VM E++T G + Y N V +
Sbjct: 217 TA-----PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----V------MK 261
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
I+ R+ P+ P S ++ +C Q E RP +++V L +IR
Sbjct: 262 AINDGFRL--PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ S + ++GAG G V +L P K + A+K L + +Q+ D FL + + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + +++ EY NG+L L D + + M G A +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 160
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS--VSQLSGHLL----T 678
+YL ++ VHR+ + NIL++ +L VSD GL ++ G + T
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 AYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHD 736
+ PE +T SDV+S+G+V+ E+++ G + Y N+ V +
Sbjct: 218 S-----PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----V------IKA 262
Query: 737 IDALSRMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+D R+ P + Y ++ C Q + RP ++V L +IR
Sbjct: 263 VDEGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 43/289 (14%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+ +G G GSV + K + A+K L K+ + + +E + + ++ + IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L G C +L+ E G L L E + + + + ++YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK 129
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG------- 683
VHR+ + N+LL + +SD GL+ + + TA G
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD------SYYTARSAGKWPLKWY 180
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
APE ++ +SDV+S+GV M E L+ G+K Y + + V + I+
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----V------MAFIEQGK 230
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
RM P + ++S C + E RP V Q +
Sbjct: 231 RM--EC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 36/289 (12%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G V + L DG A+K++ QQ +E + H NI
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNI 88
Query: 570 VELKGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+ L YC L+ + GTL + + + N L+ + + + LG R LE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA----PLISSGSVSQLSGHLLTAYG 681
+H HR+ K NILL D+ + D G + +
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 682 ---YGAPE----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
Y APE + ++DV+S G V+ ++ G YD +G+ +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL------- 258
Query: 735 HDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
A+ + S ++ S +++ + +P RP + ++
Sbjct: 259 ----AVQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 60/300 (20%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
+ F + LIG+G G V++A+ DGK +K++ + E V + ++
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-----NNEKAERE-VKALAKLD 62
Query: 566 HANIVELKGY---------------CAEHGQRLLIY-EYCSNGTLQDML--HSDDELKNN 607
H NIV G + L I E+C GTL+ + ++L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISS 666
L+ ++ ++Y+H +++R+ K +NI L D V + D GL L +
Sbjct: 123 LALELFEQITK----GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 667 GSVSQLSGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
G ++ G T Y +PE S Y + D+Y+ G+++ ELL + T
Sbjct: 176 GKRTRSKG---TLR-YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----- 226
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+ + D +S + ++ + + +PE RP SE+++ L
Sbjct: 227 -------------FFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 47/303 (15%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY Q+ +AVK L + S Q + D FL I + H NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYL 627
G + R ++ E + G L+ L ++L+ + +A A +YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 628 HEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
E +HR+ + N LL + D G+A I S + G + +
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS- 741
PE F GI+T ++D +SFGV++ E+ + G Y P + + L
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSKSNQEVLEF 257
Query: 742 -----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSN 796
RM P I+++C Q +PE RP + +++ + + N
Sbjct: 258 VTSGGRM-------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310
Query: 797 ESL 799
+L
Sbjct: 311 TAL 313
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 55/298 (18%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY +A+K +++ AS +++ + FL + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML------HSDDELKNNLSWNTRIRMALGAARAL 624
L G ++ L+I E + G L+ L +++ + S + I+MA A +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG- 683
YL+ VHR+ + N ++ +D V + D G+ I + G G
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-------GL 201
Query: 684 ------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLH 735
+PE + G++T SDV+SFGVV+ E+ T + Y L
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----------------QGLS 245
Query: 736 DIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ L R V G P +++ C Q P+ RP E++ + + +
Sbjct: 246 NEQVL-RFVM---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 33/289 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKD-DEFLELVNNIDR 563
+G G G V R + P GK + AVK L SQ + D+F+ VN +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ H N++ L G ++ E G+L D L + + T R A+ A
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQLSGHLLTAYGY 682
+ YL +HR+ + N+LL V + D GL + + H + +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE ++ ++ SD + FGV + E+ T G++ + + LH ID
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QI------LHKIDKE 240
Query: 741 -SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
R+ P P +++ +C +PE RP + L++
Sbjct: 241 GERL--PR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 30/168 (17%), Positives = 59/168 (35%), Gaps = 10/168 (5%)
Query: 95 LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLL 151
+ N + +D ++++ + ++++N +S + L+ L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 152 TDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
+ + N PD F L L LDLS L P + +LS L L++ +N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 211 GTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK----DGNPF 252
+ L L+ L+ N +++ P+ N F
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 36/168 (21%), Positives = 63/168 (37%), Gaps = 7/168 (4%)
Query: 76 CNASDIIAIILNGANLGGEL-GENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFL 132
+ + +NL + ++ +D+S+ H + I +++ +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 133 SDNQFSGSI-PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
+ N F + P L LT + L+ L P AF SL+ L L++S NN
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 192 SLENLSQLTTLHLQNNQLSGT-LDVLQDLP--LRDLNIENNLFSGPIP 236
+ L+ L L N + + LQ P L LN+ N F+
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 43/220 (19%), Positives = 75/220 (34%), Gaps = 26/220 (11%)
Query: 65 DPCGESWQG--VQCNASDIIAII-----------LNGANLGGELGENLGAFSSIRVIDLS 111
+PC E QC + I L+ L + +F ++V+DLS
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 112 NNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF 169
I + L+ N + + L+ L + L+
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 170 QSLTGLINLDLSSNNL-SGELPPSLENLSQLTTLHLQNNQLSG----TLDVLQDLPLRD- 223
L L L+++ N + S +LP NL+ L L L +N++ L VL +PL +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 224 -LNIENNLFSGPIPEKMLQIPNFRK---DGNPFNSTVAPS 259
L++ N + I + K N + V +
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-28
Identities = 31/163 (19%), Positives = 59/163 (36%), Gaps = 5/163 (3%)
Query: 87 NGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSS- 144
NG + G ++ +S++ +DLS N + + L + +++ + S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLH 203
+L L + +++ F L+ L L ++ N+ P L LT L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 204 LQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L QL L L+ LN+ +N F + +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 32/151 (21%), Positives = 64/151 (42%), Gaps = 8/151 (5%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ S + + L+ N I ++Q + + + L L ++++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 157 -NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQLSG 211
+N + S ++P+ F +LT L +LDLSSN + L L Q+ +L L N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 212 T-LDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+++ L L + NN S + + +Q
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 33/160 (20%), Positives = 53/160 (33%), Gaps = 9/160 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIG--GSIPSIL--PVTMQNFFLSDNQFSGSI 141
L + G + S+ +DLS N + G +++ LS N +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
S+ L L + ++ L F SL LI LD+S + LS L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 201 TLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPE 237
L + N D+ +L L L++ P
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-20
Identities = 27/155 (17%), Positives = 46/155 (29%), Gaps = 8/155 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
++ + +++ L + I Q+ L + +F L +L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSLENLSQLTTLHLQNN 207
L G + L L LDLS N LS G S + L L L N
Sbjct: 329 -----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 208 QLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+ L L L+ +++ +
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-18
Identities = 31/203 (15%), Positives = 64/203 (31%), Gaps = 41/203 (20%)
Query: 92 GGELGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSL 145
+L E +++ +DLS+N I + +P+ + LS N + P +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 146 ATLTLLTDMSLNNNLLSGEIPDA----------------------------FQSLTGLIN 177
+ L ++L NN S + +L GL N
Sbjct: 198 KEIRLHK-LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 178 LDLSSNNLS------GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLF 231
L + L+ ++ L+ +++ L + + D + + L + N F
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 232 SGPIPEKMLQIPNFRKDGNPFNS 254
K+ + N +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 19/143 (13%), Positives = 42/143 (29%), Gaps = 30/143 (20%)
Query: 91 LGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATL 148
L + ++ +DLS + P+ ++Q +S N F L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSL-TGLINLDLSSNNLSG-------------------- 187
L + + N + Q + L L+L+ N+ +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 188 ------ELPPSLENLSQLTTLHL 204
P + + + +L++
Sbjct: 578 VERMECATPSDKQGMP-VLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 24/197 (12%), Positives = 53/197 (26%), Gaps = 40/197 (20%)
Query: 84 IILNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGS--IPSILPVTMQN---FFLSDNQF 137
+ L + + + + + V L + ++ + + +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 138 S------GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
+ I LT ++ SL + + ++ G +L+L + + P
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG-QFPT 321
Query: 192 --------------------SLENLSQLTTLHLQNNQLSG---TLDVLQDLP-LRDLNIE 227
S +L L L L N LS L+ L++
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 228 NNLFSGPIPEKMLQIPN 244
N + L +
Sbjct: 382 FNGVIT-MSSNFLGLEQ 397
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 17/103 (16%), Positives = 40/103 (38%), Gaps = 6/103 (5%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI---LPVTMQNFFLSDNQFSGS 140
+ ++ N +S++V+D S NHI S P ++ L+ N F+ +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 141 IPSS--LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLS 181
L + + + + P Q + +++L+++
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 35/281 (12%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI- 564
+ SF + + +G G G V++ + DG+L AVK+ + L V + +++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+H V L+ E G L + E C +LQ +L A
Sbjct: 115 QHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-LSGHLLTAYGY 682
L +LH +VH + K ANI L + D GL + + + G Y
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG---DPR-Y 222
Query: 683 GAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
APE G Y +DV+S G+ +LE+ + H + +
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTILEVACNMELP-------------------HGGEGWQQ 263
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
+ L ++ A S ++ ++ +P+ R ++
Sbjct: 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 37/288 (12%)
Query: 516 LIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLEL----VNNIDRIRHAN 568
+G G + +VY A+ D L +A+K + ++ +E L+ V+N ++ H N
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV + E L+ EY TL + + S LS +T I +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH 128
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
++ IVHR+ K NIL+D + + + D G+A +S S++Q + L T Y +PE
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ-YFSPEQA 184
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH-DIDALSRMVDP 746
+ +D+YS G+V+ E+L G ++ GE V AI + + ++ V
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFN-----GET-AVSIAIKHIQDSVPNVTTDVRK 238
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSEVVQDLVDMIRRER 793
+ +++I R + + R + E+ DL ++ R
Sbjct: 239 DIPQS--------LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 58/302 (19%), Positives = 101/302 (33%), Gaps = 41/302 (13%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD 542
+T T ++ + + + +G G G V+R + G AVKK+
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92
Query: 543 KRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSD 601
+ E + + IV L G G + I+ E G+L ++
Sbjct: 93 LEVFRVE------E-LVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQM 144
Query: 602 DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGL 660
L + + + AL LEYLH I+H + K+ N+LL D ++ D G
Sbjct: 145 GCLPEDRALYY-LGQAL---EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 661 APLISSGSVSQLSGHLLTAYG---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSY 715
A + + + G + APE + D++S +ML +L G +
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPW 256
Query: 716 DRTRNRGEQFLVRWAIPQLHDIDALSRMV-DPSLSGQYPAKSLSHFADIISRCVQSEPEF 774
Q ++ +P + P A I ++ EP
Sbjct: 257 ----------------TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVH 300
Query: 775 RP 776
R
Sbjct: 301 RA 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/308 (18%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
Y F +G G G V+ A+ D A+K++ ++ E V + ++
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 61
Query: 566 HANIVELKGYCAE---------HGQRLLIY---EYCSNGTLQDMLH---SDDELKNNLSW 610
H IV E ++ +Y + C L+D ++ + +E + ++
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
+ +++A A+E+LH ++HR+ K +NI D V V D GL +
Sbjct: 122 HIFLQIAE----AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 671 QLSGHLLTAYG----------YGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTR 719
Q + AY Y +PE G Y+ + D++S G+++ ELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------- 224
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP---AKSLSHFADIISRCVQSEPEFRP 776
+ + V + ++P + ++ + P RP
Sbjct: 225 ---------YPFSTQMERVRTLTDV---RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP 272
Query: 777 PMSEVVQD 784
++++
Sbjct: 273 EAINIIEN 280
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 70/307 (22%), Positives = 122/307 (39%), Gaps = 55/307 (17%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
Y + F + ++G G G V +A+ D + A+KK+ +++K L V + +
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLN 60
Query: 566 HANIVELKGYCAEHGQRLL----------IY---EYCSNGTLQDMLHSDDELKN-NLSWN 611
H +V E + ++ EYC NGTL D++HS++ + + W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 612 TRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA---------P 662
R L AL Y+H I+HR+ K NI +D+ V + D GLA
Sbjct: 121 L-FRQIL---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 663 LISSGSVSQLSGHLLTAYG---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDR 717
+ S ++ S +L +A G Y A E +G Y + D+YS G++ E++ S
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF-STGM 232
Query: 718 TRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777
R +++ + R V + + II + +P RP
Sbjct: 233 ERVN----ILK-------KL----RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277
Query: 778 MSEVVQD 784
++
Sbjct: 278 ARTLLNS 284
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 74/398 (18%), Positives = 130/398 (32%), Gaps = 47/398 (11%)
Query: 409 IPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVE 468
+ + + + S+ P P P P
Sbjct: 232 LWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDG 291
Query: 469 KVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY----TNSFSQENLIGAGMLGS 524
+ + T+ + ++ N + +G G GS
Sbjct: 292 YTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGS 351
Query: 525 VYRAQLPDGK---LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581
V + K +A+K L K+ + + +E + + ++ + IV L G C
Sbjct: 352 VRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A 409
Query: 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641
+L+ E G L L E + + + + ++YL E VHRN
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLA 463
Query: 642 SANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG-------APE-FESGIYT 693
+ N+LL + +SD GL+ + + TA G APE ++
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGADD------SYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 694 CQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752
+SDV+S+GV M E L+ G+K Y + + E V + I+ RM
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGP-E---V------MAFIEQGKRM--EC----- 560
Query: 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
P + ++S C + E RP V Q +
Sbjct: 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/316 (16%), Positives = 110/316 (34%), Gaps = 66/316 (20%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFLELVNN 560
+G G +++ + +K LDK + + F E +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASM 65
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ ++ H ++V G C + +L+ E+ G+L L + KN ++ ++ +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQL 122
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLD--------DDLAVSVSDCGLAPLISSGSVSQL 672
A A+ +L E ++H N + NILL + + +SD G++ +
Sbjct: 123 AAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 673 SGHLLTAYGYG-------APE--FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRG 722
PE +D +SFG + E+ + G K ++
Sbjct: 176 ---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ- 225
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
L + ++ P + ++I+ C+ EP+ RP ++
Sbjct: 226 R---K------LQFYEDRHQLPAPKAAELA---------NLINNCMDYEPDHRPSFRAII 267
Query: 783 QDLVDMIRRERCSNES 798
+DL + + S
Sbjct: 268 RDLNSLFTPDLVPRGS 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 47/303 (15%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY Q+ +AVK L + S Q + D FL I + H NIV
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYL 627
G + R ++ E + G L+ L ++L+ + +A A +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 628 HEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
E +HR+ + N LL + D G+A I + G + +
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS- 741
PE F GI+T ++D +SFGV++ E+ + G Y P + + L
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSKSNQEVLEF 298
Query: 742 -----RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSN 796
RM P I+++C Q +PE RP + +++ + + N
Sbjct: 299 VTSGGRM-------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
Query: 797 ESL 799
+L
Sbjct: 352 TAL 354
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 43/191 (22%), Positives = 71/191 (37%), Gaps = 11/191 (5%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI---LPVTMQNFFLSDN 135
++I + L L N +S + +D+ N I P + LP ++ L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLP-MLKVLNLQHN 83
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLEN 195
+ S + A T LT++ L +N + + F LI LDLS N LS +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 196 LSQLTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---D 248
L L L L NN++ LD+ + L+ L + +N P I +
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 249 GNPFNSTVAPS 259
++
Sbjct: 204 NVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-27
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 3/143 (2%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
S V D S+ + +P LP + L+ NQ ++ + LT + + N +S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-L 221
P+ Q L L L+L N LS + + LT LHL +N + + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 222 RDLNIENNLFSGPIPEKMLQIPN 244
L++ +N S +Q+ N
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 15/167 (8%)
Query: 86 LNGANLGGEL-GENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSG--S 140
L +G EL G+ +I I LS N + ++Q L S
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 141 IPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--------GELPPS 192
PS L LT + L+NN ++ D + L L LDL NNL+ G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 193 LENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L+ LS L L+L++N ++V +DL L+ +++ N +
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 29/174 (16%), Positives = 62/174 (35%), Gaps = 15/174 (8%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF--------LSDN 135
+ + ++ G +++ + LSN+ S+ ++ T + L+ N
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT--SLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLE 194
+ S + + L L + L N + E+ ++ L + + LS N S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 195 NLSQLTTLHLQNNQLSG---TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L L L+ L + Q L L L++ NN + + + +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 46/167 (27%), Positives = 69/167 (41%), Gaps = 15/167 (8%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L + + + V+DL N IG + ++N +LS N++
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 143 SSLATLTLLTDMSLNNNLLSG--EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
+S A + L + L L P FQ L L LDLS+NN++ LE L +L
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 201 TLHLQNNQLS---------GTLDVLQDLP-LRDLNIENNLFSGPIPE 237
L LQ+N L+ G + L+ L L LN+E+N F E
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 17/169 (10%)
Query: 84 IILNGANLGGELGENLGAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFS 138
++L L + + F ++ ++DLSNN+I +L ++ L N +
Sbjct: 459 LMLRRVALKN-VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 139 --------GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
G L L+ L ++L +N + F+ L L +DL NNL+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 191 PSLENLSQLTTLHLQNNQLSGT-LDVLQDLP--LRDLNIENNLFSGPIP 236
N L +L+LQ N ++ V L +L++ N F
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 11/163 (6%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L ++ ++ +DLS+N + + +Q LS+N+
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 144 SLATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL---ENLSQ 198
L L + L++N + P F ++ L L L++ L L L +
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 199 LTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPIPE 237
+ L L N+QLS T L+ L L++ N + +
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV-----TMQNFFLSDNQFSGS 140
L+ + A + + L+N +G S+ L + +++N LS++Q S +
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 141 IPSSLATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
++ L LT + L+ N L+ D+F L L L NN+ SL L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 199 LTTLHLQNNQLSGTL----------DVLQDLP-LRDLNIENNLFSGPIPE 237
+ L+L+ + ++ Q L L LN+E+N G
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 35/172 (20%), Positives = 60/172 (34%), Gaps = 18/172 (10%)
Query: 99 LGAFSSIRVIDLSNNHIGG--SIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
S++ + L + S PS + LS+N + L L L +
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
Query: 155 SLNNNLLS--------GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
L +N L+ G + L+ L L+L SN ++L +L + L
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 207 NQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKML----QIPNFRKDGNPF 252
N L+ V + L+ LN++ NL + + + NPF
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-23
Identities = 34/153 (22%), Positives = 57/153 (37%), Gaps = 17/153 (11%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
++++ ++DLS N++ ++ FFL N SL L + ++L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 160 L---------LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
L +FQ L L +L++ N++ G L L L L N+ S
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 211 ------GTLDVLQDLPLRDLNIENNLFSGPIPE 237
T L PL LN+ N S +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 29/157 (18%), Positives = 60/157 (38%), Gaps = 9/157 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
++ A+L + + +++ +N I G ++ + ++ LS++ S +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 144 SLA----TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQ 198
+ + L ++L N +S DAF L L LDL N + EL L
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 199 LTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSG 233
+ ++L N+ + +P L+ L +
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-21
Identities = 32/183 (17%), Positives = 61/183 (33%), Gaps = 17/183 (9%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-----------ILP 124
+++ + L+ NL ++ + L N+I L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184
+ +S S L L +++ +N + G + F L L L LS++
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 185 LSGELPPS--LENL--SQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEK 238
S + +L S L L+L N++S D L L L++ N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 239 MLQ 241
+
Sbjct: 425 EWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-19
Identities = 25/158 (15%), Positives = 46/158 (29%), Gaps = 8/158 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L G L S + +++L +N + ++ L N + S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQ-SLTGLINLDLSSNNLSGELPPSLE-----NLS 197
L ++L NL++ F + L LD+ N N +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
Query: 198 QLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPI 235
L ++ L T P+R + + S
Sbjct: 639 HTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAHH 676
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 58/302 (19%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V+ A+ + L+AVK L K + + D F + ++H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD-FQREAELLTNLQHEHIV 80
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTRIRMAL 618
+ G C + ++++EY +G L L + K L + + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL- 677
A + YL VHR+ + N L+ +L V + D G++ + S ++ GH +
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 678 ----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAI 731
PE +T +SDV+SFGV++ E+ T G++ +
Sbjct: 198 PIRWM-----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---------------- 236
Query: 732 PQLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
QL + + + + G+ P D++ C Q EP+ R + E+ + L +
Sbjct: 237 FQLSNTEVI-ECIT---QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
Query: 789 IR 790
+
Sbjct: 293 GK 294
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
SF ++++G G G++ + D + +AVK++ D E ++L+ D H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-CFSFADRE-VQLLRESD--EHPNV 80
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ + + + E C+ TLQ+ + D L T ++ L +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT---SGLAHLHS 136
Query: 630 ICQPPIVHRNFKSANILL-----DDDLAVSVSDCGLAPLISSG--SVSQLSGHLLTAYGY 682
+ IVHR+ K NIL+ + +SD GL ++ G S S+ SG T G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE-GW 192
Query: 683 GAPE----FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDI 737
APE T D++S G V +++ G + ++ R L+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--------- 243
Query: 738 DALSRMVDPSLSGQYPAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQ 783
SL +P K A ++I + + +P+ RP V++
Sbjct: 244 -------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 76/316 (24%), Positives = 129/316 (40%), Gaps = 71/316 (22%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V +A K +AVK L + AS + D L N + ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPHVI 89
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML--------------------HSDDELKNNLSW 610
+L G C++ G LLI EY G+L+ L D + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV- 669
I A ++ ++YL E+ +VHR+ + NIL+ + + +SD GL+ +
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 670 SQLSGHLL----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGE 723
+ S + A E IYT QSDV+SFGV++ E++T G Y
Sbjct: 207 VKRSQGRIPVKWM-----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-------- 253
Query: 724 QFLVRWAIPQLHDIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777
P + + RM + P ++ +C + EP+ RP
Sbjct: 254 --------PGIPPERLFNLLKTGHRM-------ERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 778 MSEVVQDLVDMIRRER 793
+++ +DL M+ + R
Sbjct: 299 FADISKDLEKMMVKRR 314
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 58/354 (16%), Positives = 122/354 (34%), Gaps = 56/354 (15%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P + + P + + +S+ R ++I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI------ 60
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH- 566
IG+G V++ ++ A+K ++ + Q D + + +++++
Sbjct: 61 ------LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 567 -ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
I+ L Y Q + + C N L L K ++ R A+
Sbjct: 115 SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 169
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---Y 682
+H+ IVH + K AN L+ D + + + D G+A + + S + G Y
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV---VKDSQVGAVNY 222
Query: 683 GAPE------------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730
PE + +SDV+S G ++ + G+ + + N
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------- 272
Query: 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
I L ++DP+ ++P D++ C++ +P+ R + E++
Sbjct: 273 -----QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 66/303 (21%), Positives = 116/303 (38%), Gaps = 57/303 (18%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+G G VY+ L +A+K L +A +++ F R++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHP 72
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTRIR 615
N+V L G + +I+ YCS+G L + L D +K+ L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
+ A +EYL +VH++ + N+L+ D L V +SD GL + + +L G+
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 676 LL-----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVR 728
L APE G ++ SD++S+GVV+ E+ + G + Y
Sbjct: 190 SLLPIRWM-----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY------------- 231
Query: 729 WAIPQLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+ D + M+ + Q P + ++ C P RP ++ L
Sbjct: 232 ---CGYSNQDVV-EMIR---NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 786 VDM 788
Sbjct: 285 RAW 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 61/289 (21%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
S+++Y + IG G G + DG+ +K+++ S ++ +E V +
Sbjct: 22 SMEKYV----RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
++H NIV+ + E+G ++ +YC G L +++ + + +
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQIC 135
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
AL+++H+ I+HR+ KS NI L D V + D G+A +++S G
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-----LARACIG 187
Query: 682 ---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
Y +PE E+ Y +SD+++ G V+ EL T + +++ +
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----------------SM 230
Query: 738 DALSRMVDPSLSGQYPA--KSLSH-FADIISRCVQSEPEFRPPMSEVVQ 783
L + +SG +P S+ ++S+ + P RP ++ +++
Sbjct: 231 KNLVLKI---ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 57/311 (18%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V+ A+ + L+AVK L K AS + D F + ++H +IV
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD-FQREAELLTMLQHQHIV 106
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML-----------HSDDELKNNLSWNTRIRMALG 619
G C E L+++EY +G L L +D L + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-- 677
A + YL + VHR+ + N L+ L V + D G++ I S ++ G +
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 678 ---TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIP 732
PE +T +SDV+SFGVV+ E+ T G++ +
Sbjct: 224 IRWM-----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----------------Y 262
Query: 733 QLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
QL + +A+ + G+ P I+ C Q EP+ R + +V L +
Sbjct: 263 QLSNTEAI-DCIT---QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 790 RRERCSNESLG 800
+ + LG
Sbjct: 319 QAPPVYLDVLG 329
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 517 IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+G G G V A + +AVK L + A+ + + +++ +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGH--HL 91
Query: 568 NIVELKGYCAEHGQ-RLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTRI 614
N+V L G C + G ++I E+C G L L +D K+ L+ I
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQLS 673
+ A+ +E+L +HR+ + NILL + V + D GLA I +
Sbjct: 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 674 GHLL----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLV 727
L A PE +YT QSDV+SFGV++ E+ + G Y
Sbjct: 209 DARLPLKWMA-----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------------ 251
Query: 728 RWAIPQLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
P + + R + G P + + C EP RP SE+V+
Sbjct: 252 ----PGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 785 LVDMI 789
L +++
Sbjct: 305 LGNLL 309
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 70/313 (22%), Positives = 121/313 (38%), Gaps = 57/313 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFL---ELVN 559
N+ +GAG G V A +AVK L A + +K+ + ++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMS 104
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML----------HSDDELKNNLS 609
++ + H NIV L G C G L+I EYC G L + L + + S
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 610 WNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
+ + A+ + +L +HR+ + N+LL + + D GLA I + S
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 670 SQLSGHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRN 720
+ G+ APE +YT QSDV+S+G+++ E+ + G Y
Sbjct: 220 YIVKGN-------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 721 RGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSE 780
+F + +M PA + + I+ C EP RP +
Sbjct: 273 -NSKF--------YKLVKDGYQM-------AQPAFAPKNIYSIMQACWALEPTHRPTFQQ 316
Query: 781 VVQDLVDMIRRER 793
+ L + + +R
Sbjct: 317 ICSFLQEQAQEDR 329
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 67/307 (21%), Positives = 122/307 (39%), Gaps = 60/307 (19%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+++IG G G V +A++ L A+K++ + AS D F E++ + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH--HP 86
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTRIR 615
NI+ L G C G L EY +G L D L + + LS +
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
A AR ++YL + +HR+ + NIL+ ++ ++D GL+ + +
Sbjct: 147 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201
Query: 676 LL----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRW 729
L A E +YT SDV+S+GV++ E+++ G Y
Sbjct: 202 RLPVRWM-----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-------------C 243
Query: 730 AIPQLHDIDALS---RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
+ + L R+ + P D++ +C + +P RP ++++ L
Sbjct: 244 GMTCAELYEKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 787 DMIRRER 793
M+ +
Sbjct: 297 RMLEERK 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 72/311 (23%), Positives = 122/311 (39%), Gaps = 74/311 (23%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK-- 99
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + +++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA I++ + +
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 674 GHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724
+ G APE +YT QSDV+SFGV+M E+ T G Y
Sbjct: 217 TN-------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--------- 260
Query: 725 FLVRWAIPQLHDIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
P + + RM PA + ++ C + P RP
Sbjct: 261 -------PGIPVEELFKLLKEGHRM-------DKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 779 SEVVQDLVDMI 789
++V+DL ++
Sbjct: 307 KQLVEDLDRIL 317
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 43/342 (12%), Positives = 88/342 (25%), Gaps = 51/342 (14%)
Query: 477 PAEGTAVKTSTKTAKPFTTARSFTIAS-LQQYTNSFSQENLIGAGMLGSVYRA-QLPDGK 534
+ A TA + T+ S L Q + G V+ + +
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 535 LLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVELKGYC----------------- 576
A+K A + + + + E R+ + E +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 577 ---------AEHGQRLLIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
LL+ L L + + + R
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
L +VH +F N+ + D + + D G+ S Y
Sbjct: 209 NLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--WKVGTRGPASS---VPVTYAPR 260
Query: 686 EF---ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742
EF + +T + + G+ + + + G + + ++ D+L+
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL-VTPGIKGSWKRPSLRVPGTDSLAF 319
Query: 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
L K +I R + + R E ++
Sbjct: 320 GSCTPLPD--FVK------TLIGRFLNFDRRRRLLPLEAMET 353
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFL---ELVN 559
N S +GAG G V A +AVK L A +++ + ++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLS 81
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML--------------HSDDELK 605
+ H NIV L G C G L+I EYC G L + L ++ +
Sbjct: 82 YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
L + + A+ + +L +HR+ + NILL + D GLA I
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 666 SGSV-SQLSGHLL----TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRT 718
+ S L APE + +YT +SDV+S+G+ + EL + G Y
Sbjct: 197 NDSNYVVKGNARLPVKWM-----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PG 250
Query: 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
+F I RM P + + DI+ C ++P RP
Sbjct: 251 MPVDSKF--------YKMIKEGFRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 779 SEVVQDLVDMI 789
++VQ + I
Sbjct: 296 KQIVQLIEKQI 306
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 53/287 (18%), Positives = 109/287 (37%), Gaps = 44/287 (15%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--ANIVEL 572
IG+G V++ ++ A+K ++ + Q D + + +++++ I+ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
Y ++ E C N L L K ++ R A+ +H+
Sbjct: 94 YDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YGAPE--- 686
IVH + K AN L+ D + + + D G+A + + S + G Y PE
Sbjct: 148 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSV---VKDSQVGTVNYMPPEAIK 201
Query: 687 ---------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ +SDV+S G ++ + G+ + + N I
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QI 246
Query: 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
L ++DP+ ++P D++ C++ +P+ R + E++
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 72/311 (23%), Positives = 122/311 (39%), Gaps = 74/311 (23%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK-- 145
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + +++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA I++ + +
Sbjct: 206 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 674 GHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724
+ G APE +YT QSDV+SFGV+M E+ T G Y
Sbjct: 263 TN-------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--------- 306
Query: 725 FLVRWAIPQLHDIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
P + + RM PA + ++ C + P RP
Sbjct: 307 -------PGIPVEELFKLLKEGHRM-------DKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 779 SEVVQDLVDMI 789
++V+DL ++
Sbjct: 353 KQLVEDLDRIL 363
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/289 (18%), Positives = 113/289 (39%), Gaps = 40/289 (13%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--AN 568
+S IG+G V++ ++ A+K ++ + Q D + + +++++
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ L Y ++ E C N L L K ++ R A+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-TAYGYGAPE- 686
+ IVH + K AN L+ D + + + D G+A + + S + + T Y PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN-YMPPEA 180
Query: 687 -----------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
+ +SDV+S G ++ + G+ + + N+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------------- 226
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
I L ++DP+ ++P D++ C++ +P+ R + E++
Sbjct: 227 -ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 77/315 (24%), Positives = 124/315 (39%), Gaps = 64/315 (20%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK-- 133
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + LS
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ A AR +EYL +HR+ + N+L+ +D + ++D GLA I + +
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 674 GHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724
+ G APE IYT QSDV+SFGV++ E+ T G Y E+
Sbjct: 251 TN-------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 301
Query: 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ RM P+ + ++ C + P RP ++V+D
Sbjct: 302 L--------FKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 785 LVDMIRRERCSNESL 799
L ++ SN+ +
Sbjct: 347 LDRIV--ALTSNQEM 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 67/359 (18%), Positives = 121/359 (33%), Gaps = 90/359 (25%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P P P P P +P V ++ + + R
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPE----VLVDPRSRRRYVRGR---------- 47
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---R 563
+G G + ++ A K + K + E ++ I
Sbjct: 48 --------FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRS 97
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR- 622
+ H ++V G+ ++ ++ E C +L ++ R + AR
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR------------RKALTEPEARY 145
Query: 623 -------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
+YLH ++HR+ K N+ L++DL V + D GLA + G
Sbjct: 146 YLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------GE 196
Query: 676 LL-TAYG---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQF 725
G Y APE ++ + DV+S G +M LL G+ T R ++
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK- 255
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
++IP ++ A SL I + +Q++P RP ++E++ D
Sbjct: 256 -NEYSIP-------------KHINP--VAASL------IQKMLQTDPTARPTINELLND 292
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 71/314 (22%), Positives = 118/314 (37%), Gaps = 69/314 (21%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
IG G G V++A+ P ++AVK L + AS+ + D F + + NIV
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIV 113
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS--------------------DDELKNNLSW 610
+L G CA L++EY + G L + L S LS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
++ +A A + YL E VHR+ + N L+ +++ V ++D GL+ I S
Sbjct: 174 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 671 QLSGHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNR 721
+ G+ PE YT +SDV+++GVV+ E+ + G + Y
Sbjct: 231 KADGN-------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY------ 277
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPM 778
+ + + + D G P +++ C P RP
Sbjct: 278 ----------YGMAHEEVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSF 323
Query: 779 SEVVQDLVDMIRRE 792
+ + L M R
Sbjct: 324 CSIHRILQRMCERA 337
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 72/313 (23%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+G+G G V A +AVK L ++A S +++ + +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGS--HE 109
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDML-------------------HSDDELKNNL 608
NIV L G C G LI+EYC G L + L ++E N L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++ + A A+ +E+L VHR+ + N+L+ V + D GLA I S S
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 669 VSQLSGHLLTAYGYG-------APE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTR 719
+ G+ APE GIYT +SDV+S+G+++ E+ + G Y
Sbjct: 227 NYVVRGN-------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY---- 275
Query: 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRP 776
P + +++ +G P + I+ C + RP
Sbjct: 276 ------------PGIPVDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320
Query: 777 PMSEVVQDLVDMI 789
+ L +
Sbjct: 321 SFPNLTSFLGCQL 333
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 50/377 (13%), Positives = 109/377 (28%), Gaps = 60/377 (15%)
Query: 447 PPPPPPPPPPPPPPPPPPPVVEKVIVK-------PIVPAEGTAVKTSTKTAKPFTTARSF 499
P P P +K+I K P+ T F
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNT--FEWQCKLPAIKPKTEF 60
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKDDE 553
+ S +L+G G VY A + + +K ++ +
Sbjct: 61 QLGS-----KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYI 113
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN-LSWNT 612
+L+ + ++ +L+ E S GTL + ++ +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 613 RIRMALGAARALEYLHEICQPPIVHRNFKSANILL-----------DDDLAVSVSDCGLA 661
I A+ +E +H+ I+H + K N +L D +++ D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRN 720
+ + G+ E S + Q D + + +L G Y + +N
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT--YMKVKN 288
Query: 721 RGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSE 780
G + +L +D + + + P +
Sbjct: 289 EGGECKPEGLFRRLPHLDMWN--------------------EFFHVMLNIPDCHHLPSLD 328
Query: 781 VVQDLVDMIRRERCSNE 797
+++ + + ++ +N+
Sbjct: 329 LLRQKLKKVFQQHYTNK 345
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 44/277 (15%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVK--KLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++G G G VY L + +A+K SQ +E + ++H NI
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE----IALHKHLKHKNI 81
Query: 570 VELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDD---ELKNNLSWNTRIRMALGAARALE 625
V+ G + I+ E G+L +L S + ++ G L+
Sbjct: 82 VQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LK 136
Query: 626 YLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQLS--GHLLTAYGY 682
YLH+ IVHR+ K N+L++ + +SD G + ++ + + G T Y
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQ-Y 189
Query: 683 GAPE---FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
APE Y +D++S G ++E+ TG+ + GE + +
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVH-- 244
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P + P + I +C + +P+ R
Sbjct: 245 ------PEI----PESMSAEAKAFILKCFEPDPDKRA 271
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 22/182 (12%), Positives = 63/182 (34%), Gaps = 19/182 (10%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
+ SD+I +N + ++ I +N+I + + ++ F++
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMG 214
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
++ F + + +L L ++++ + +LP L
Sbjct: 215 NSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQDLP----------LRDLNI-ENNLFSGPIPEKMLQI 242
+ L ++ +++ N+ + D ++ + I NNL + P+ + ++
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 243 PN 244
Sbjct: 330 KK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 31/175 (17%), Positives = 67/175 (38%), Gaps = 26/175 (14%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSG-------SIP 142
+ + ++N + IP+I M S N+ +
Sbjct: 371 NFCGFT---EQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-------ELPPSLEN 195
+ ++ ++L+NN +S + F + + L +++L N L+ + + +N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 196 LSQLTTLHLQNNQLSGTLDVLQD--LP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
LT++ L+ N+L+ D + LP L +++ N FS P + L +
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 29/173 (16%), Positives = 66/173 (38%), Gaps = 17/173 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHI--------GGSIPSILPVT--MQNFFLSDN 135
+ +L L A +++I+++ N + PV +Q ++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 136 QF-SGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL- 193
+ + +SL + L + N L G++P AF S L +L+L+ N ++ +P +
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFC 373
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQ--DLP-LRDLNIENNLFSGPIPEKMLQIP 243
Q+ L +N+L ++ + + ++ N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 37/172 (21%), Positives = 61/172 (35%), Gaps = 22/172 (12%)
Query: 89 ANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSG------- 139
L ++ I+LSNN I + + + L N +
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQ--SLTGLINLDLSSNNLSGELPPSLENLS 197
+ LLT + L N L+ + D F+ +L L+ +DLS N+ S P N S
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
Query: 198 QLTTLHLQN------NQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L ++N N+ + + P L L I +N + EK+
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 23/161 (14%), Positives = 62/161 (38%), Gaps = 22/161 (13%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQFSGSIPSSLA--TLTLLT 152
G+ + ++L+ N I + ++N + N+ IP+ ++++++
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405
Query: 153 DMSLNNNLLSGEIPDAFQS-------LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
+ + N + F + +++LS+N +S S L++++L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 206 NNQLSG-TLDVLQDLP--------LRDLNIENNLFSGPIPE 237
N L+ + L+D L +++ N + + +
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 31/177 (17%), Positives = 54/177 (30%), Gaps = 32/177 (18%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF---------FLSD 134
I L+ + E S + I+L N + + L +NF L
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 135 NQFSGSIPSSLA--TLTLLTDMSLNNNLLSGEIPDAFQSLTGLI------NLDLSSNNLS 186
N+ + + TL L + L+ N S P + + L D N
Sbjct: 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP------LRDLNIENNLFSGPIPE 237
E P + LT L + +N + + + L+I++N
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-------VNEKITPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-21
Identities = 30/200 (15%), Positives = 58/200 (29%), Gaps = 19/200 (9%)
Query: 59 WVASAGDPCGESWQGVQ----CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNH 114
W A G S QG N + + + GA G L N + + L
Sbjct: 39 WDALNGKNW--SQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN----GRVTGLSLEGFG 92
Query: 115 IGGSIPSILP--VTMQNFFLSDNQFSG----SIPSSLATLTLLTDMSLNNNLLSGEIPDA 168
G +P + ++ L + P ++ D
Sbjct: 93 ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY 152
Query: 169 --FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLN 225
+ + LI ++S+ + S + T + +N ++ + L LR
Sbjct: 153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFY 212
Query: 226 IENNLFSGPIPEKMLQIPNF 245
+ N+ F + + N
Sbjct: 213 MGNSPFVAENICEAWENENS 232
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 15/121 (12%), Positives = 32/121 (26%), Gaps = 14/121 (11%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPS---------ILPVTMQNFFLSDNQFSGSIPSSLATLT 149
+ IDLS N P+ + N+ P +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR-NQRDAQGNRTLREWPEGITLCP 566
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
LT + + +N + + + + LD+ N + + L ++
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 210 S 210
Sbjct: 624 Q 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 13/101 (12%), Positives = 30/101 (29%), Gaps = 11/101 (10%)
Query: 171 SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD------VLQDLPLRDL 224
S + L L SG +P ++ L++L L L ++ + ++
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 225 NIENNLFSGPIP-----EKMLQIPNFRKDGNPFNSTVAPSR 260
+ E + + +P ++ S
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 16/97 (16%), Positives = 27/97 (27%), Gaps = 9/97 (9%)
Query: 85 ILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS 144
G E E + S+ + + +N I I P + + DN S
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP-NISVLDIKDNPNISIDLSY 606
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLS 181
+ L + Q + G LD+
Sbjct: 607 VCPYIEAGMYMLFYDKT--------QDIRGCDALDIK 635
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 50/295 (16%), Positives = 103/295 (34%), Gaps = 37/295 (12%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF--------LELVNNIDR----- 563
+ G + + D K A+KK +K +++D ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 564 --IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
I++ + +G + + +IYEY N ++ L N + I++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 622 R----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
+ + Y+H + I HR+ K +NIL+D + V +SD G S + +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGE-------SEYMVDKKIK 208
Query: 678 TAYG---YGAPEF---ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL-VRWA 730
+ G + PEF ES + D++S G+ + + + + E F +R
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ + LS+ D + ++ P R + ++
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 3/144 (2%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI 165
+ + N + IP LP + + S N ++ + L LT + L +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 166 PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRD 223
D FQS L L L++N L +L L L +S L + L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 224 LNIENNLFSGPIPEKMLQIPNFRK 247
L + +N S K +
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKV 157
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 30/190 (15%), Positives = 55/190 (28%), Gaps = 10/190 (5%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQ 136
+ + + L ++ +DL+ I + L+ N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
++L+ L + +S + L +L L SN++S P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 197 SQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---DG 249
+L L QNN + + LQ LN+ N +G I F+ G
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGG 211
Query: 250 NPFNSTVAPS 259
+
Sbjct: 212 TQNLLVIFKG 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 13/169 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
AF + ++DL+ + + LS + S L L
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 154 MSLNNNLLSGEI---PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
++L N ++ Q+L L L LS +LS + +L + + L +N+L+
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 211 G-TLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNST 255
+++ L L LN+ +N S +P + + R NP + T
Sbjct: 514 SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-21
Identities = 39/164 (23%), Positives = 58/164 (35%), Gaps = 13/164 (7%)
Query: 86 LNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSI-----LPVTMQNFFLSDNQFSG 139
+ G ELG L ++R +DLS++ I S L +Q+ LS N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLS 390
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ L + L L + FQ+L L L+LS + L + L
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 199 LTTLHLQNNQLSG----TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L L+LQ N + LQ L L L + S
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 8/169 (4%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
+ +I L FS ++ +DL+ H+ +PS L T++ LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLS 309
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNL--SGELP 190
N+F S + LT +S+ N E+ ++L L LDLS +++ S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 191 PSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L NLS L +L+L N+ + ++ P L L++ +
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 8/142 (5%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSI---PSSLATLTLLTD 153
++V++LS++ + S + +Q+ L N F +SL TL L
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT- 212
+ L+ LS AF SL + ++DLS N L+ +L +L + L+L +N +S
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 213 LDVLQDLP-LRDLNIENNLFSG 233
+L L R +N+ N
Sbjct: 540 PSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 30/155 (19%), Positives = 61/155 (39%), Gaps = 10/155 (6%)
Query: 84 IILNGANLGGELGENLG--AFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQF 137
+ G + + L S+ + + P++ +++++ L + F
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266
Query: 138 SGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS 197
++ + L ++ L LS E+P L+ L L LS+N S N
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 198 QLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
LT L ++ N L L++L LR+L++ ++
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-20
Identities = 31/160 (19%), Positives = 54/160 (33%), Gaps = 9/160 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIPSSL 145
N + + + ++ I L ++ D P+
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 146 ATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L + ++L + + F +GL LDL++ +LS ELP L LS L L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L N+ + P L L+I+ N + L+
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 12/143 (8%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPV-----TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
+++ ++L NH ++ LS S + +L ++ + L+
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT----- 212
+N L+ +A L G+ L+L+SN++S LP L LSQ T++L+ N L T
Sbjct: 509 HNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567
Query: 213 -LDVLQDLPLRDLNIENNLFSGP 234
L+ ++ + + E+ L P
Sbjct: 568 FLEWYKENMQKLEDTEDTLCENP 590
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 24/159 (15%), Positives = 52/159 (32%), Gaps = 13/159 (8%)
Query: 98 NLGAFS---SIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSGSIPSSLATLTL 150
L ++V+D NN I + T + L+ N +G P + +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 151 LT-DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS--QLTTLHLQNN 207
+ + NLL ++ L + P E L + +++LQ +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 208 QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L++L++ S +P ++ +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLST 302
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-25
Identities = 26/175 (14%), Positives = 51/175 (29%), Gaps = 9/175 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLA 146
N + N ++ +D ++ + ++++ +S
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 147 TLTLLTDMSL-NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
LT L + + N+ + + F + T L LDLS L + L +L L++
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 206 NNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNST 255
+N L L L L+ N + N
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-25
Identities = 30/157 (19%), Positives = 54/157 (34%), Gaps = 7/157 (4%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+ + +P +P + +N LS N S + + L + L+ +
Sbjct: 12 PNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-L 221
A+ L L NL L+ N + P S L+ L L +L+ + L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 222 RDLNIENNLFSG-PIPEKMLQIPNFRK---DGNPFNS 254
+ LN+ +N +P + N N +
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 13/193 (6%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQ 136
S I L+ L + FS ++ +DLS I + N L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLEN 195
P S + LT L ++ L+ L L L+++ N + +LP N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 196 LSQLTTLHLQNNQLSG----TLDVLQDLP--LRDLNIENNLFSGPIPEKMLQIPNFRK-- 247
L+ L + L N + L L++ P L++ N I ++ Q +
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELT 210
Query: 248 -DGNPFNSTVAPS 259
GN +S + +
Sbjct: 211 LRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-21
Identities = 30/153 (19%), Positives = 62/153 (40%), Gaps = 11/153 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
A+ + + L+ N I P +++N + + + + L L +
Sbjct: 74 KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133
Query: 155 SLNNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQL 209
++ +N + ++P F +LT L+++DLS N + L+ L + +L + N +
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193
Query: 210 SG-TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
Q + L +L + N S I + LQ
Sbjct: 194 DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 31/153 (20%), Positives = 54/153 (35%), Gaps = 10/153 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIPSSLATLTLLT 152
A S+ +DLS N + S ++++ LS N + ++ L L
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402
Query: 153 DMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+ ++ L AF SL L+ LD+S N + L+ L TL + N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 212 TL--DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+V + L L++ I +
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 27/158 (17%), Positives = 53/158 (33%), Gaps = 9/158 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
++ N + +S+ + ++ N + S + N LS Q
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
TL L +++++N L + L L LD S N + L
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 203 HLQNNQLSGT------LDVLQDLPLRDLNIENNLFSGP 234
+L NN ++ L +++ +N+E + P
Sbjct: 551 NLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATP 588
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-16
Identities = 31/159 (19%), Positives = 48/159 (30%), Gaps = 8/159 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
L N + +++ + L+ I Q+ + Q L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL--SQLTTLH 203
L L +L N S I +L L LDLS N LS S +L + L L
Sbjct: 328 PFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 204 LQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L N L L+ L+ +++
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 21/141 (14%), Positives = 41/141 (29%), Gaps = 10/141 (7%)
Query: 103 SSIRVIDLSNNHIGGSIPSIL-PVTMQNFFLSDNQFSGSIP-------SSLATLTLLTDM 154
+D+S N I + + L N S +I + L L+
Sbjct: 181 QVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 155 SLNNNLLSGEIPDAFQSLTGL--INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
+ L P + L + L+ N + L+ ++ + L +
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL 300
Query: 213 LDVLQDLPLRDLNIENNLFSG 233
DV + + L+I
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-13
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 18/156 (11%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSLAT 147
+L +++ +DLS N+I + P + +S N +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 148 LTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGEL------PPSLENLSQLT 200
+ L ++L N S I Q+L GL L E P +E L +T
Sbjct: 204 IKLHE-LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 201 TLHL---QNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
N S + L + +++
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 63/299 (21%), Positives = 114/299 (38%), Gaps = 36/299 (12%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDD 552
T F + + + + +G+G G V A+K + K + S +
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS 81
Query: 553 EFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
+ LE V + + H NI++L + + L+ E G L D + + +
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFN--- 134
Query: 613 RIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLIS 665
A + + YLH+ IVHR+ K N+LL + D + + D GL+ +
Sbjct: 135 -EVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190
Query: 666 SGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
+ + L TAY Y APE Y + DV+S GV++ LL G + ++
Sbjct: 191 NQKK--MKERLGTAY-YIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
V + ++S AK D+I + +Q + + R + ++
Sbjct: 248 KVEKGKYTFDSPEW------KNVSEG--AK------DLIKQMLQFDSQRRISAQQALEH 292
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-25
Identities = 67/316 (21%), Positives = 120/316 (37%), Gaps = 68/316 (21%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-IDR 563
Q N E ++G G G+V G+ +AVK++ +F ++ I
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---------DFCDIALMEIKL 61
Query: 564 IR----HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ H N++ + E C N LQD++ E KN N +++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV----ESKNVSDENLKLQKEYN 116
Query: 620 AAR-------ALEYLHEICQPPIVHRNFKSANILLD-------------DDLAVSVSDCG 659
+ +LH + I+HR+ K NIL+ ++L + +SD G
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 660 LAPLISSGSVSQLSGHLLTAYG---YGAPEFESGI--------YTCQSDVYSFGVVMLEL 708
L + SG S + +L G + APE T D++S G V +
Sbjct: 174 LCKKLDSGQSSFRT-NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 709 LT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRC 767
L+ G+ + +R + + +D + + D SL + A D+IS+
Sbjct: 233 LSKGKHPFGDKYSRESNIIR-----GIFSLDEMKCLHDRSLIAE--AT------DLISQM 279
Query: 768 VQSEPEFRPPMSEVVQ 783
+ +P RP +V++
Sbjct: 280 IDHDPLKRPTAMKVLR 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 64/289 (22%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVE 571
+G G + ++ A K + K + E ++ I + H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRSLAHQHVVG 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------A 623
G+ ++ ++ E C +L ++ R + AR
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKR------------RKALTEPEARYYLRQIVLG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-TAYG- 681
+YLH ++HR+ K N+ L++DL V + D GLA + G G
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------GERKKVLCGT 178
Query: 682 --YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP-QLHDI 737
Y APE ++ + DV+S G +M LL G+ P + +
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------------------PPFETSCL 220
Query: 738 DALSRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ +Y K ++ A +I + +Q++P RP ++E++ D
Sbjct: 221 KETYLRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 54/299 (18%)
Query: 516 LIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIR------- 565
++G G + V+ A+ D + +AVK L + +D F R R
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLR---ADLARDPSFYL------RFRREAQNAA 67
Query: 566 ---HANIVELKGYCAEHGQRLLIY----EYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
H IV + + EY TL+D++H+ + ++ I +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIA 123
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-LSGHLL 677
A +AL + H+ I+HR+ K ANI++ AV V D G+A I+ S + ++
Sbjct: 124 DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 678 -TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
TA Y +PE +SDVYS G V+ E+LTG + G+ V A +
Sbjct: 181 GTAQ-YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDS-PVSVAYQHVR 233
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSEVVQDLVDMIRRER 793
+ LS ++ + + PE R +E+ DLV + E
Sbjct: 234 EDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/281 (22%), Positives = 105/281 (37%), Gaps = 37/281 (13%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLEL----VNNIDRIRH 566
L+G G +G VY A+ D +A+K + + SS D F R++
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSS---DPVFRTRMQREARTAGRLQE 93
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
++V + + GQ + + L ML L+ + + AL+
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDA 149
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
H HR+ K NIL+ D + D G+A + ++Q G+ + Y APE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPE 205
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
F T ++D+Y+ V+ E LTG Y G+Q V ++ V
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ-----GDQLSV--MGAHINQAIPRPSTVR 258
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSEVVQDL 785
P + A F +I+R + PE R ++
Sbjct: 259 PGIP---VA-----FDAVIARGMAKNPEDRYVTCGDLSAAA 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 68/299 (22%), Positives = 112/299 (37%), Gaps = 83/299 (27%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
L+G G VYRA+ + G +A+K +DK+A + +V + ++H
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG------MVQRVQNEVKIHCQLKHP 71
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDELKNNLSWNTRIRMALGAA 621
+I+EL Y + L+ E C NG + L S++E A
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE----------------AR 115
Query: 622 R-------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
+ YLH I+HR+ +N+LL ++ + ++D GLA +
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----HE 167
Query: 675 HLLTAYG---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQF 725
T G Y +PE + +SDV+S G + LL GR + T N+
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL- 226
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ +P LS AK L I + ++ P R +S V+
Sbjct: 227 -ADYEMP-------------SFLSI--EAKDL------IHQLLRRNPADRLSLSSVLDH 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 41/301 (13%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDE 553
T F S +++ + + ++G G G V G+ AVK + KR Q+ D E
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 554 FLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW 610
L + ++ H NI++L + + G L+ E + G L D + S + S
Sbjct: 72 SLL--REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFS- 124
Query: 611 NTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPL 663
A R + Y+H+ IVHR+ K N+LL D + + D GL+
Sbjct: 125 ---EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 664 ISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGE 723
+ + + TAY Y APE G Y + DV+S GV++ LL+G ++
Sbjct: 179 FEASKK--MKDKIGTAY-YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235
Query: 724 QFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQ 783
V +S AK D+I + + P R + +
Sbjct: 236 LKKVEKGKYTFELPQW------KKVSES--AK------DLIRKMLTYVPSMRISARDALD 281
Query: 784 D 784
Sbjct: 282 H 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 30/231 (12%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ S + + +++G G +V+R + G L A+K + + + D + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FE 59
Query: 560 NIDRIRHANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+ ++ H NIV+L E R LI E+C G+L +L + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVL 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSVSQLS 673
+ +L E IVHRN K NI+ D ++D G A +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---- 171
Query: 674 GHLLTAYG---YGAPEFESGI---------YTCQSDVYSFGVVMLELLTGR 712
++ YG Y P+ Y D++S GV TG
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 63/327 (19%), Positives = 111/327 (33%), Gaps = 60/327 (18%)
Query: 501 IASLQQYTNSFSQENLIGAGM--LGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL 557
++S + +IG G L +V A+ P G+ + V++++ ++ L
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFL 73
Query: 558 VNNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDML--HSDDELKNNLSWN 611
+ H NIV + L ++ + + G+ +D++ H D +
Sbjct: 74 QGELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA--- 129
Query: 612 TRIRMAL-GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
I L G +AL+Y+H + VHR+ K+++IL+ D V +S + S
Sbjct: 130 --IAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 671 QLSGHLLTAYGYG-----APE----FESGIYTCQSDVYSFGVVMLELLTGR--------- 712
Q H Y +PE G Y +SD+YS G+ EL G
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 713 -------------------KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP 753
+ + + + S S Y
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 754 AKSLSHFADIISRCVQSEPEFRPPMSE 780
HF + +C+Q P+ RP S
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARPSAST 330
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 62/288 (21%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRH 566
+G G G+VY A+ +LA+K L K + + + + R +RH
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG------VEHQLRREVEIQSHLRH 68
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NI+ L GY + + LI EY GT+ L + + A AL Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----TYITELANALSY 124
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YG 683
H ++HR+ K N+LL + ++D G SV S G Y
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTLDYL 174
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQFLVRWAIPQLHDI 737
PE E ++ + D++S GV+ E L G+ +Y T R I
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---------I------ 219
Query: 738 DALSRMVDPSLSGQYPAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
V+ +P ++ A D+ISR ++ P RP + EV++
Sbjct: 220 ----SRVEF----TFP-DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 49/291 (16%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
S++ + +G G G V + + +P G+++AVK++ +SQ++ ++L ++
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI------R 615
+ V G G + E D K + I +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTS-------LDKFYKQVIDKGQTIPEDILGK 113
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL-APLISSGSVSQLSG 674
+A+ +ALE+LH ++HR+ K +N+L++ V + D G+ L+ + +G
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG 171
Query: 675 HLLTAYGYGAPE-----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW 729
Y APE Y+ +SD++S G+ M+EL R YD
Sbjct: 172 ---CKP-YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD------------- 214
Query: 730 AIPQLHDIDALSRMVD---PSL-SGQYPAKSLSHFADIISRCVQSEPEFRP 776
L ++V+ P L + ++ A F D S+C++ + RP
Sbjct: 215 --SWGTPFQQLKQVVEEPSPQLPADKFSA----EFVDFTSQCLKKNSKERP 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 74/339 (21%), Positives = 123/339 (36%), Gaps = 89/339 (26%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+++L+ F L+G G G VY+ + + G+L A+K +D DE E+
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD------VTGDEEEEIKQ 69
Query: 560 NI----DRIRHANIVE-----LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLS 609
I H NI +K +L L+ E+C G++ D++ +
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 610 WNTRI-RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
W I R L R L +LH+ ++HR+ K N+LL ++ V + D G++
Sbjct: 130 WIAYICREIL---RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS------- 176
Query: 669 VSQLSGHLL-------TAYGYGAPE------FESGIYTCQSDVYSFGVVMLELLTGRKSY 715
+QL + T Y + APE Y +SD++S G+ +E+ G
Sbjct: 177 -AQLDRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA--- 231
Query: 716 DRTRNRGEQFLVRWAIPQLHDIDALSRMVD------PSLSGQYPAKSLSHFADIISRCVQ 769
P L D+ + + P L + +K F I C+
Sbjct: 232 ----------------PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSF---IESCLV 272
Query: 770 SEPEFRPPMSE---------------VVQDLVDMIRRER 793
RP + V L D I R +
Sbjct: 273 KNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTK 311
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL--- 572
+G G G V R G+ +A+K+ + S + ++ LE + + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE-IQIMKKLNHPNVVSAREV 80
Query: 573 ---KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
A + LL EYC G L+ L+ E L + + AL YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 630 ICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---YG 683
I+HR+ K NI+L L + D G A + G + G Y
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL------CTEFVGTLQYL 190
Query: 684 APE-FESGIYTCQSDVYSFGVVMLELLTGR 712
APE E YT D +SFG + E +TG
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 70/312 (22%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F++ IG G G V++ K++A+K +D ++ +DE ++ I +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 79
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARA 623
+ + G +L +I EY G+ D+L DE + T +R L +
Sbjct: 80 PYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA----TILREIL---KG 131
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL------ 677
L+YLH +HR+ K+AN+LL + V ++D G+A QL+ +
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--------GQLTDTQIKRNTFV 180
Query: 678 -TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
T + + APE + Y ++D++S G+ +EL G P
Sbjct: 181 GTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGE-------------------PPHS 220
Query: 736 DIDAL------SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
++ + + P+L G Y + + C+ EP FRP E+++ I
Sbjct: 221 ELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELLKH--KFI 274
Query: 790 RRERCSNESLGD 801
R L +
Sbjct: 275 LRNAKKTSYLTE 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 42/348 (12%), Positives = 99/348 (28%), Gaps = 77/348 (22%)
Query: 482 AVKTSTKTAKPFTTARSFTIAS-LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVK 539
+ S + + T + F + S L + + + ++G + A G+ V
Sbjct: 45 SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 104
Query: 540 KLDKRASSQQKDDE--------------------------FLELVNNIDRIRHANIVELK 573
+ F+ + + + ++ ++
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 574 GYCAEHG--QRLLIYE--YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ R +Y + T ++L S +L + R+++ L R L LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-- 687
+VH + +I+LD V ++ + G+ S G+ PE
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGARVVSSVSR----GFEPPELEA 275
Query: 688 ----------ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ T D ++ G+V+ + +P
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------------------LP--ITK 315
Query: 738 DALSRMVDPSLSGQYPAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
DA + ++ ++ ++ E R + ++
Sbjct: 316 DAALGGSEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 60/316 (18%), Positives = 119/316 (37%), Gaps = 63/316 (19%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR----HAN 568
++ G VY AQ + G+ A+K+L + + ++ + ++ H N
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-----AIIQEVCFMKKLSGHPN 87
Query: 569 IVELKGYCAEHGQR-------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
IV+ + + L+ G L + L E + LS +T +++
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTC 146
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-------PLISSGSVSQLSG 674
RA++++H +PPI+HR+ K N+LL + + + D G A S L
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 675 HLLTAYG---YGAPE----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV 727
+T Y PE + + + D+++ G ++ L + ++ L
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-----DGAKL- 259
Query: 728 RWAIPQLHDIDALSRMVDPSLSGQY-----PAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
I ++G+Y + + F +I +Q PE R ++EVV
Sbjct: 260 --RI----------------VNGKYSIPPHDTQY-TVFHSLIRAMLQVNPEERLSIAEVV 300
Query: 783 QDLVDMIRRERCSNES 798
L ++ + +S
Sbjct: 301 HQLQEIAAARNVNPKS 316
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 68/373 (18%), Positives = 125/373 (33%), Gaps = 70/373 (18%)
Query: 441 MMMMPPPPPPPPPPPPPPPPPPPP-----PVVEKVIVKPIVPAEGTAVKTSTKTAKPFTT 495
++ +P P P P P + + + +G + P++
Sbjct: 9 LVEIPRAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSF 68
Query: 496 ARSFTIASL--QQYTNSFSQENLIGAGMLGSVYRA--QLPDGKLLAVKKLDKRASSQQKD 551
+ QY + I G LG +Y A + +G+ + +K L S D
Sbjct: 69 LPQLNPGDIVAGQYE----VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSG---D 119
Query: 552 DEFLELVN----NIDRIRHANIVEL--KGYCAEHGQRLLIY---EYCSNGTLQDMLHSDD 602
E + + + H +IV++ + + Y EY +L+
Sbjct: 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---- 175
Query: 603 ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662
L I L AL YLH I +V+ + K NI+L ++ + + D G
Sbjct: 176 --GQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
Query: 663 LISSGSVSQLSGHLL-TAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
I+S G+L T G+ APE T +D+Y+ G + L + +
Sbjct: 230 RINS------FGYLYGTP-GFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN----- 277
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSE 780
G + L + D + Y + + ++ R + +P R E
Sbjct: 278 GR------YVDGLPE--------DDPVLKTYDS-----YGRLLRRAIDPDPRQRFTTAEE 318
Query: 781 VVQDLVDMIRRER 793
+ L ++R
Sbjct: 319 MSAQLTGVLREVV 331
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 26/139 (18%), Positives = 62/139 (44%), Gaps = 5/139 (3%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ +I+ + ++N H + I ++ ++ + + +L+ LT LT +
Sbjct: 60 TGIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
++++ I +L + ++DLS N ++ P L+ L +L +L++Q + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRG 176
Query: 216 LQDLP-LRDLNIENNLFSG 233
++D P L L + G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 23/130 (17%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+S+ I L+N ++ + I +++ +++ + + ++ L+ L + +
Sbjct: 43 MNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKD 99
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP 220
++ + LT L LD+S + + + L ++ ++ L N + L+ LP
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 221 -LRDLNIENN 229
L+ LNI+ +
Sbjct: 160 ELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-11
Identities = 20/126 (15%), Positives = 51/126 (40%), Gaps = 25/126 (19%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+ G ++ + NL +S+ ++D+S++ SI + +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAH----------------------DDSILTKI 132
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL + + L+ N +I ++L L +L++ + + + +E+ +L L+
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAF 189
Query: 206 NNQLSG 211
+ + G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 14/67 (20%), Positives = 30/67 (44%), Gaps = 7/67 (10%)
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LR 222
IPD+ + +N L ++ + + ++ LT + L N ++ L ++ ++
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTGIEYAHNIK 69
Query: 223 DLNIENN 229
DL I N
Sbjct: 70 DLTINNI 76
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 59/323 (18%), Positives = 114/323 (35%), Gaps = 41/323 (12%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ S + + +++G G +V+R + G L A+K + + + D + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FE 59
Query: 560 NIDRIRHANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+ ++ H NIV+L E R LI E+C G+L +L + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVL 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSVSQLS 673
+ +L E IVHRN K NI+ D ++D G A +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----- 170
Query: 674 GHLLTAYG---YGAPEFESGI---------YTCQSDVYSFGVVMLELLTGR---KSYDRT 718
++ YG Y P+ Y D++S GV TG + ++
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 719 RNRGE--------QFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQS 770
R E + + Q + + D +S +++ +++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 771 EPEFRPPMSEVVQDLVDMIRRER 793
+ E + + D++ R
Sbjct: 290 DQEKCWGFDQFFAETSDILHRMV 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 11/162 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + + + L+ N I P ++ F NQ + P +A +T L + +
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN ++ P +L+ L L++ +N +S ++++L++L L++ +NQ+S + VL
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVL 283
Query: 217 QDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNS 254
+L L L + NN E + + N N
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 9/142 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
SI + ++ + SI I +T ++ L+ NQ + P L+ L LT++
Sbjct: 38 VTQEELESITKLVVAGEKV-ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ N ++ A Q+LT L L L+ +N+S L NL+++ +L+L N L
Sbjct: 95 IGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP 150
Query: 216 LQDLP-LRDLNIENNLFSGPIP 236
L ++ L L + + P
Sbjct: 151 LSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 29/141 (20%), Positives = 64/141 (45%), Gaps = 7/141 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + +++ ++L+ N I P V + N ++ N+ + S+L LT L ++ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYL 117
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N + +S +LT + +L+L +N+ L N++ L L + +++ + +
Sbjct: 118 NEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD-VTPI 173
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
+L L L++ N P
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 9/142 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L +++R + L+ ++I P + L M + L N S S L+ +T L ++
Sbjct: 104 SALQNLTNLRELYLNEDNISDISPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ + + P +LT L +L L+ N + L +L+ L NQ++ +
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD-ITP 216
Query: 216 LQDLP-LRDLNIENNLFSGPIP 236
+ ++ L L I NN + P
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 28/135 (20%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ + + + + NN I + + ++ + + NQ S +++ LT L ++
Sbjct: 215 TPVANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ +N +S +L+ L +L L++N L E + L+ LTTL L N ++ +
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP 328
Query: 216 LQDLP-LRDLNIENN 229
L L + + N
Sbjct: 329 LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L S + +++ N I I ++ +T ++ + NQ S S L L+ L +
Sbjct: 237 SPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
LNNN L E + LT L L LS N+++ + P L +LS++ + N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 27/142 (19%), Positives = 57/142 (40%), Gaps = 8/142 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ L + + ++ ++ + + SI + LT L ++L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N ++ P +L L NL + +N ++ +L+NL+ L L+L + +S + L
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD-ISPL 128
Query: 217 QDLP-LRDLNIENNLFSGPIPE 237
+L + LN+ N +
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
++ ++ PDA L I L +++ + E L +T L + +++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 211 GTLDVLQDLP-LRDLNIENNLFSGPIP 236
++ ++ L L LN+ N + P
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 8/57 (14%), Positives = 22/57 (38%), Gaps = 4/57 (7%)
Query: 174 GLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN 229
G L ++ ++ P +L++ LQ ++ + ++L + L +
Sbjct: 1 GAATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGE 54
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 25/169 (14%), Positives = 54/169 (31%), Gaps = 17/169 (10%)
Query: 82 IAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFS 138
L ++ I++ + N++ S M N+
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP--SLEN 195
+ T LTD+ L+ N + EIP D + L S N L +P + ++
Sbjct: 587 --HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
Query: 196 LSQLTTLHLQNNQLSG-------TLDVLQDLPLRDLNIENNLFSGPIPE 237
+ + ++ N++ ++D + + + + N E
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-21
Identities = 34/175 (19%), Positives = 57/175 (32%), Gaps = 22/175 (12%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFS----- 138
+ + + + LS N I + + LS+N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 139 --GSIPSSLATLTLLTDMSLNNNLLSGEIPD--AFQSLTGLINLDLSSNNLSGELPPSLE 194
+ LLT + L N L+ + D +L L N+D+S N S P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL 773
Query: 195 NLSQLTTLHLQ------NNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
N SQL ++ N++ + P L L I +N + EK+
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 24/177 (13%), Positives = 58/177 (32%), Gaps = 19/177 (10%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSD 134
N SD++ +N + ++ I N I I + +Q + ++
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFAN 457
Query: 135 NQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLE 194
+ F+ + D + + ++ +L L +++L + +LP L
Sbjct: 458 SPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512
Query: 195 NLSQLTTLHLQNNQLSGTLDVLQDLP-----------LRDLNIENNLFSGPIPEKML 240
+L +L +L++ N+ + D ++ + N L
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 7e-21
Identities = 36/192 (18%), Positives = 58/192 (30%), Gaps = 33/192 (17%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF----------LSDN 135
L+ + E S I I LSNN + SIP + L N
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 136 QFSGSIPSSLA--TLTLLTDMSLNNNLLSGEIPDAFQSLTGLI------NLDLSSNNLSG 187
+ + S+ TL L++M ++ N S P + + L D N +
Sbjct: 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 188 ELPPSLENLSQLTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPI----PEKM 239
+ P + L L + +N + L L + D N S + P
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIAD----NPNISIDVTSVCPYIE 852
Query: 240 LQIPNFRKDGNP 251
+ D
Sbjct: 853 AGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 26/177 (14%), Positives = 61/177 (34%), Gaps = 19/177 (10%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-----------MQNFFLSD 134
L +L + L ++ ++++ N + T +Q F++
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 135 NQFSGSIPS-SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N S SL + L + +N + +AF + L +L L N + E+P
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDF 614
Query: 194 -ENLSQLTTLHLQNNQLSGTLDV--LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFR 246
Q+ L +N+L ++ + + + ++ N + +++
Sbjct: 615 CAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-20
Identities = 27/224 (12%), Positives = 66/224 (29%), Gaps = 33/224 (14%)
Query: 52 GSPVLPGWVASAGDPCGESWQGVQC-NASDIIAIILNGANLGGELGENLGAFSSIRVIDL 110
+ W + GV N + + L G G + + +G + ++V+
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 111 SNNHIGGSIPSILPVTM---------QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ S + + + L LL D N +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG---------- 211
D+ SL + +N ++ + +++ L++L ++ N+ +
Sbjct: 415 KPIKKDSRISLKDT-QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 212 ---TLDVLQDLP--------LRDLNIENNLFSGPIPEKMLQIPN 244
++ L D+ + N +P+ + +P
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-20
Identities = 30/192 (15%), Positives = 61/192 (31%), Gaps = 45/192 (23%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVT--MQNFFLSDNQFSGSIPS--SLATLTLLTDM 154
G + + L N I T ++ S N+ IP+ + ++ ++ +
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649
Query: 155 SLNNNLLSGEIPDAFQSLTG-----LINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
+ N + E + S+ + LS N + S ++T+ L NN +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
Query: 210 SG--------------------TLDV----LQDLP----------LRDLNIENNLFSGPI 235
+ T+D+ L L L ++++ N FS
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-F 768
Query: 236 PEKMLQIPNFRK 247
P + L +
Sbjct: 769 PTQPLNSSQLKA 780
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 9/113 (7%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
+ ++ ++ + + ++ + + + L L+ G +P +
Sbjct: 284 KNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 193 LENLSQLTTLHLQNNQLSGTLDV--LQDLPLRDLNIENNLFSGPIPEKMLQIP 243
+ L++L L + + + + ++L + + L
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 22/140 (15%), Positives = 40/140 (28%), Gaps = 9/140 (6%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQ-NFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE 164
+D N + ++ NF + + L +T +SL G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--------GTLDVL 216
+PDA LT L L +++ + + + +++ L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 217 QDLPLRDLNIENNLFSGPIP 236
L I N PI
Sbjct: 399 NLSDLLQDAINRNPEMKPIK 418
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 10/77 (12%), Positives = 25/77 (32%), Gaps = 2/77 (2%)
Query: 85 ILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQF-SGSIPS 143
G + + + S+ + + +N I + L + ++DN S + S
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNISIDVTS 846
Query: 144 SLATLTLLTDMSLNNNL 160
+ + L +
Sbjct: 847 VCPYIEAGMYVLLYDKT 863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 33/271 (12%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G GSV + P G+++AVK++ +++ ++L + IV+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G + E S + + L + + ++ L +AL +L E + I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 636 VHRNFKSANILLDDDLAVSVSDCGL-APLISSGSVSQLSGHLLTAYGYGAPE-----FES 689
+HR+ K +NILLD + + D G+ L+ S + ++ +G Y APE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG---CRP-YMAPERIDPSASR 203
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH-DIDALSRMVD--- 745
Y +SDV+S G+ + EL TGR Y P+ + D L+++V
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPY----------------PKWNSVFDQLTQVVKGDP 247
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
P LS + F + ++ C+ + RP
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 71/306 (23%), Positives = 125/306 (40%), Gaps = 61/306 (19%)
Query: 502 ASLQQYTNS---FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL 557
+S ++ + + + +IG+G V A P + +A+K+++ ++ EL
Sbjct: 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDEL 60
Query: 558 VNNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWN-- 611
+ I + H NIV L L+ + S G++ D++ + S
Sbjct: 61 LKEIQAMSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 612 -----TRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
T +R L LEYLH+ Q +HR+ K+ NILL +D +V ++D G++ +++
Sbjct: 120 ESTIATILREVL---EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 667 GSVSQLSGHLLTAYG---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
G + T G + APE + Y ++D++SFG+ +EL TG
Sbjct: 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA--------- 224
Query: 722 GEQFLVRWAIPQLHDIDAL------SRMVDPSLSGQYPAKSLSH-----FADIISRCVQS 770
H + + PSL K + F +IS C+Q
Sbjct: 225 ----------APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274
Query: 771 EPEFRP 776
+PE RP
Sbjct: 275 DPEKRP 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 59/313 (18%), Positives = 117/313 (37%), Gaps = 59/313 (18%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V++ + G ++AVK++ + + ++ ++L + IV+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELK-NNLSWNTRIRMALGAARALEYLHEICQPP 634
+ + E + + L +M + +AL YL E +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE--KHG 145
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGL-APLISSGSVSQLSGHLLTAYGYGAPE------F 687
++HR+ K +NILLD+ + + D G+ L+ + + +G A Y APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG---CAA-YMAPERIDPPDP 201
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD-- 745
Y ++DV+S G+ ++EL TG+ Y + D + L++++
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKT---------------DFEVLTKVLQEE 246
Query: 746 -PSLSGQYPAKSLSHFADIISRCVQSEPEFRP-------------------PMSEVVQDL 785
P L G F + C+ + RP ++ +D+
Sbjct: 247 PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDV 304
Query: 786 VDMIRRERCSNES 798
+ R S
Sbjct: 305 MAKTESPRSGPSS 317
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 38/300 (12%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDD 552
++ + + ++ ++G G G V + + AVK ++K ++ +
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 553 EFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
L V + ++ H NI++L + ++ E + G L D + + S
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFS--- 119
Query: 613 RIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLIS 665
A + + Y+H+ IVHR+ K NILL + D + + D GL+
Sbjct: 120 -EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 666 SGSV-SQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQ 724
+ G TAY Y APE G Y + DV+S GV++ LL+G +
Sbjct: 176 QNTKMKDRIG---TAY-YIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
V ++S AK D+I + + P R ++ ++
Sbjct: 232 KRVETGKYAFDLPQW------RTISDD--AK------DLIRKMLTFHPSLRITATQCLEH 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 69/313 (22%), Positives = 111/313 (35%), Gaps = 67/313 (21%)
Query: 489 TAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASS 547
TA R FTI + F +G G G+VY A+ + ++A+K L K
Sbjct: 1 TALAEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE 53
Query: 548 QQKDDEFLELVNNIDR-------IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS 600
++ + + + R +RH NI+ + Y + + L+ E+ G L L
Sbjct: 54 KEG------VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK 107
Query: 601 DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
S A AL Y HE ++HR+ K N+L+ + ++D G
Sbjct: 108 HGRFDEQRSA----TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160
Query: 661 APLISSGSVSQLSGHLLTAYG---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGR---- 712
SV S T G Y PE E + + D++ GV+ E L G
Sbjct: 161 -------SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
Query: 713 -KSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSE 771
S+ T R V P + D+IS+ ++
Sbjct: 214 SPSHTETHRRIVN--VDLKFPPFLSDGS---------------------KDLISKLLRYH 250
Query: 772 PEFRPPMSEVVQD 784
P R P+ V++
Sbjct: 251 PPQRLPLKGVMEH 263
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 61/318 (19%), Positives = 127/318 (39%), Gaps = 77/318 (24%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
+ +G G G VY+A+ G L A K ++ + ++E + + I+ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALE 625
IV+L G G+ ++ E+C G + ++ EL L+ +I++ AL
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLT-EPQIQVVCRQMLEALN 131
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-------T 678
+LH I+HR+ K+ N+L+ + + ++D G++ ++ L T
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQKRDSFIGT 180
Query: 679 AYGYGAPE------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP 732
Y + APE + Y ++D++S G+ ++E+ P
Sbjct: 181 PY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE-------------------P 220
Query: 733 QLHDIDALS------RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD-- 784
H+++ + + P+L P+K F D + + PE RP +++++
Sbjct: 221 PHHELNPMRVLLKIAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278
Query: 785 ---------LVDMIRRER 793
L +++ +
Sbjct: 279 VSSITSNKALRELVAEAK 296
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V+ + G +K ++K S + E + + + H NI+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE-IEVLKSLDHPNIIKIFEV 88
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEIC 631
++ ++ E C G L + + S LS + AL Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELMKQMMNALAYFHSQ- 143
Query: 632 QPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPEF 687
+VH++ K NIL + + D GLA L S + +G TA Y APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG---TAL-YMAPEV 197
Query: 688 ESGIYTCQSDVYSFGVVMLELLTG 711
T + D++S GVVM LLTG
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 35/154 (22%), Positives = 57/154 (37%), Gaps = 7/154 (4%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
+ IP LP + +N LS N S + L + L+ +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDL 224
A+QSL+ L L L+ N + + LS L L L+ + + L L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 225 NIENN-LFSGPIPEKMLQIPNFRK---DGNPFNS 254
N+ +N + S +PE + N N S
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 34/153 (22%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
GA+ + + L+ N I ++Q + + + L L ++
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 155 SLNNNLL-SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQL 209
++ +NL+ S ++P+ F +LT L +LDLSSN + L L Q+ +L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 210 SG-TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ +++ L L + NN S + + +Q
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 28/146 (19%), Positives = 53/146 (36%), Gaps = 8/146 (5%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGSIPSSLATLTL 150
+ N + +D ++++ + + +S + L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 151 LTDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQ 208
L + + N PD F L L LDLS L +L P+ +LS L L++ +NQ
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQ 505
Query: 209 LSG-TLDVLQDLP-LRDLNIENNLFS 232
L + L L+ + + N +
Sbjct: 506 LKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 27/122 (22%), Positives = 50/122 (40%), Gaps = 8/122 (6%)
Query: 98 NLGAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F ++ +D+S+ H + I +++ ++ N F + L L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS 210
T + L+ L P AF SL+ L L+++SN L +P + L+ L + L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 211 GT 212
+
Sbjct: 532 CS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 7/145 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIP-SSLATLTLLTDMS 155
++ + ++L N G P++ +++ + N+ + L +L L D+S
Sbjct: 298 KDFSYNFGWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL-DLS 355
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD- 214
N G + T L LDLS N + + + L QL L Q++ L +
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 215 -VLQDLP-LRDLNIENNLFSGPIPE 237
V L L L+I +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNG 439
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 14/161 (8%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQF-SGSIPSSLATLTLLTD 153
GAF SS++ + ++ + T++ ++ N S +P + LT L
Sbjct: 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 154 MSLNNNLLSGEIPDAFQSLTGL----INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
+ L++N + + L + ++LDLS N ++ + P +L L L+NN
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFD 212
Query: 210 SGTL--DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
S + +Q L L + F +
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 33/180 (18%), Positives = 54/180 (30%), Gaps = 22/180 (12%)
Query: 95 LGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSLATL 148
L E +++ +DLS+N I + +P+ + LS N + I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 149 TLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDL------SSNNLSGELPPSLENLSQLTT 201
L ++L NN S + Q L GL L + NL +LE L LT
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 202 LHLQNNQL-------SGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+ L + L ++ L + + F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV-SVTIERVKDFSYNFGWQHLELVNCKFGQ 318
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 28/192 (14%), Positives = 45/192 (23%), Gaps = 59/192 (30%)
Query: 100 GAFS--SIRVIDLSNNHIGGSIPSILPVTMQN---------FFLSDNQFSGSIPSSLATL 148
GAF + + L NN ++ + F ++ S+L L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 149 TLLTDMSLN---NNLLSGEIPDAFQ-------------------------SLTGLINLDL 180
LT + +I D F L ++
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
Query: 181 SSNNLSGELPPSLE----------------NLSQLTTLHLQNNQLSG---TLDVLQDLP- 220
SL+ +L L L L N LS
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 221 LRDLNIENNLFS 232
L+ L++ N
Sbjct: 375 LKYLDLSFNGVI 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 73/322 (22%), Positives = 136/322 (42%), Gaps = 70/322 (21%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ Q+ + ++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII 65
Query: 559 NNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNT 612
N I ++ NIV G L ++ EY + G+L D++ DE
Sbjct: 66 NEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIA 119
Query: 613 RI-RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
+ R L +ALE+LH ++HR+ KS NILL D +V ++D G +Q
Sbjct: 120 AVCRECL---QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--------AQ 165
Query: 672 LSGHLL-------TAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSY-DRTRNRG 722
++ T Y + APE + Y + D++S G++ +E++ G Y + R
Sbjct: 166 ITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
+ P+L + + LS + F D ++RC++ + E R E++
Sbjct: 225 LYLIATNGTPELQNPEKLSAI----------------FRDFLNRCLEMDVEKRGSAKELL 268
Query: 783 Q-----------DLVDMIRRER 793
Q L +I +
Sbjct: 269 QHQFLKIAKPLSSLTPLIAAAK 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 3e-21
Identities = 38/340 (11%), Positives = 91/340 (26%), Gaps = 76/340 (22%)
Query: 489 TAKPFTTARSFTIASL-QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRAS 546
+ + T + F + S + + + ++G + A G+ V
Sbjct: 57 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER 116
Query: 547 SQQKDDEFLE-----------------------LVNNIDRIRHANIVELKGYCAEHGQRL 583
+ ++ + D ++ ++ + +
Sbjct: 117 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM-IRVRLDERDM 175
Query: 584 LIYEY--------CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ + T ++L S +L + R+++ L R L LH +
Sbjct: 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF-------- 687
VH + +I+LD V ++ + +VS G+ PE
Sbjct: 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP------IGRGFAPPETTAERMLPF 286
Query: 688 ---ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
+ T D ++ G+ + + G W +I
Sbjct: 287 GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG---GSEWIFRSCKNI------- 336
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
P ++ ++ E R + ++
Sbjct: 337 --------PQ----PVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 67/313 (21%), Positives = 127/313 (40%), Gaps = 74/313 (23%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F +G G GSVY+A G+++A+K++ + + E++ I +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDS 83
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
++V+ G ++ ++ EYC G++ D++ ++ T ++ L + LEY
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEY 140
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-------TA 679
LH + +HR+ K+ NILL+ + ++D G+A QL+ + T
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--------GQLTDTMAKRNTVIGTP 189
Query: 680 YGYGAPEF--ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ + APE E G Y C +D++S G+ +E+ G+ P DI
Sbjct: 190 F-WMAPEVIQEIG-YNCVADIWSLGITAIEMAEGK-------------------PPYADI 228
Query: 738 DAL------SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD------- 784
+ P+ P +F D + +C+ PE R ++++Q
Sbjct: 229 HPMRAIFMIPTNPPPTFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286
Query: 785 ----LVDMIRRER 793
L D+I
Sbjct: 287 GVSILRDLINEAM 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 78/382 (20%), Positives = 143/382 (37%), Gaps = 98/382 (25%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P P + A +
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGR--------------------AGSLKDPDVAELFFK 49
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID- 562
FS IG G G+VY A+ + + +++A+KK+ S +Q ++++ +++ +
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRF 107
Query: 563 --RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
++RH N ++ +G C L+ EYC G+ D+L + + AL
Sbjct: 108 LQKLRHPNTIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL- 164
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS------ 673
+ L YLH ++HR+ K+ NILL + V + D G A S ++
Sbjct: 165 --QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFV 211
Query: 674 GHLLTAYGYGAPE----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW 729
G T Y + APE + G Y + DV+S G+ +EL +
Sbjct: 212 G---TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK----------------- 250
Query: 730 AIPQLHDIDALSRMVD------PSLSGQYPAKSLS-HFADIISRCVQSEPEFRPPMSEVV 782
P L +++A+S + P+L S +F + + C+Q P+ RP ++
Sbjct: 251 --PPLFNMNAMSALYHIAQNESPALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304
Query: 783 QD-----------LVDMIRRER 793
+ ++D+I+R +
Sbjct: 305 KHRFVLRERPPTVIMDLIQRTK 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 10/165 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L + + + L N I +I + +T + N L++NQ P ++ L LT ++
Sbjct: 259 APLSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L N +S P SLT L L +N +S SL NL+ + L +NQ+S L
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTP 370
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPS 259
L +L + L + + ++ + N + +AP+
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPA 415
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-20
Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 9/141 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L +++ + L NN I P + LS N S S+L+ LT L +S
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N + +LT L LD+SSN +S L L+ L +L NNQ+S + L
Sbjct: 164 GNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPL 217
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
L L +L++ N
Sbjct: 218 GILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 42/141 (29%), Positives = 61/141 (43%), Gaps = 8/141 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L +++ + +NN I P + + L+ NQ +LA+LT LTD+ L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 250
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN +S P LT L L L +N +S L L+ LT L L NQL + +
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED-ISPI 305
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
+L L L + N S P
Sbjct: 306 SNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-19
Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT----MQNFFLSDNQFSGSIPSSLATLTLLT 152
L +S++ + N + + P+ ++ +S N+ S S LA LT L
Sbjct: 150 SALSGLTSLQQLSFGNQ-----VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE 202
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
+ NN +S P LT L L L+ N L +L +L+ LT L L NNQ+S
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN- 257
Query: 213 LDVLQDLP-LRDLNIENNLFSGPIP 236
L L L L +L + N S P
Sbjct: 258 LAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 30/141 (21%), Positives = 59/141 (41%), Gaps = 8/141 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
A + L ++ ++ + + L LT ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+NN L+ P ++LT L+++ +++N ++ L NL+ LT L L NNQ++ +D L
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD-IDPL 130
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
++L L L + +N S
Sbjct: 131 KNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 6/162 (3%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ ++ + L N+I P +Q F +N+ S SSLA LT + +S
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+N +S P +LT + L L+ + N+S T+ L +
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
Query: 217 QDLPLRDLNIENNL--FSGPIPEKMLQIPNFRKDGNPFNSTV 256
+ +I NL ++ + Q K F+ TV
Sbjct: 419 DGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
D + L L ++ + L + L +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP 236
+E L+ LT ++ NNQL+ + L++L L D+ + NN + P
Sbjct: 63 GVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP 107
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 64/350 (18%), Positives = 113/350 (32%), Gaps = 71/350 (20%)
Query: 455 PPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQE 514
+ + + P + + S+ +
Sbjct: 4 HHHHSSGRENLYFQGIAINP----------------------GMYVRKKEGKIGESYFKV 41
Query: 515 NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFL--------ELVNNID--- 562
+G+G G V + A+K + K + + + E+ N I
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
+ H NI++L + L+ E+ G L + + + ++ A +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFD----ECDAANIMK 153
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV-SQLSG 674
+ YLH+ IVHR+ K NILL + L + + D GL+ S G
Sbjct: 154 QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 675 HLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
TAY Y APE Y + DV+S GV+M LL G + ++ V
Sbjct: 211 ---TAY-YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 735 HDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
D ++S + AK ++I + + R E +
Sbjct: 267 DFNDW------KNISDE--AK------ELIKLMLTYDYNKRCTAEEALNS 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 68/332 (20%), Positives = 105/332 (31%), Gaps = 51/332 (15%)
Query: 399 HRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPP 458
H G E+ R ++ + +P + + P
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQ----------RRAFIRSLRDDPSQS 51
Query: 459 PPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIG 518
+ A+ F Q+Y IG
Sbjct: 52 ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY----QKYD--PKDV--IG 103
Query: 519 AGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR--------IRHANI 569
G+ V R G AVK ++ A ++ E+ R H +I
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERL-SPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS-WNTR--IRMALGAARALEY 626
+ L L+++ G L D L K LS TR +R L A+ +
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLE---AVSF 215
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH IVHR+ K NILLDD++ + +SD G + + G L T Y APE
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPG-YLAPE 269
Query: 687 -------FESGIYTCQSDVYSFGVVMLELLTG 711
Y + D+++ GV++ LL G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 78/350 (22%), Positives = 129/350 (36%), Gaps = 80/350 (22%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNS------FSQENLIGAGMLGSVYRAQ-LPD 532
G + T + A+L+ + IG G G V A+
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 533 GKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRL-LIYEY 588
G+ +AVK +D R K L N + +H N+VE+ G+ L ++ E+
Sbjct: 70 GRQVAVKMMDLR-----KQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEF 123
Query: 589 CSNGTLQDMLHSD--DELKNNLSWNTRI-RMALGAARALEYLHEICQPPIVHRNFKSANI 645
G L D++ +E + L +AL YLH ++HR+ KS +I
Sbjct: 124 LQGGALTDIVSQVRLNE-----EQIATVCEAVL---QALAYLH---AQGVIHRDIKSDSI 172
Query: 646 LLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL-------TAYGYGAPEFESGI-YTCQSD 697
LL D V +SD G +Q+S + T Y + APE S Y + D
Sbjct: 173 LLTLDGRVKLSDFGFC--------AQISKDVPKRKSLVGTPY-WMAPEVISRSLYATEVD 223
Query: 698 VYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD---PSLSGQYPA 754
++S G++++E++ G Y + A+ R+ D P L
Sbjct: 224 IWSLGIMVIEMVDGEPPY----------------FSDSPVQAMKRLRDSPPPKLKN--SH 265
Query: 755 KSLSHFADIISRCVQSEPEFRPPMSEVVQD-----------LVDMIRRER 793
K D + R + +P+ R E++ LV +I+ R
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYR 315
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 40/212 (18%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V + + AVK ++K ++ + L V + ++ H NI++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
+ ++ E + G L D I A +
Sbjct: 90 LEDSSSFYIVGELYTGGELFD----------------EIIKRKRFSEHDAARIIKQVFSG 133
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTA 679
+ Y+H+ IVHR+ K NILL + D + + D GL+ + G TA
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG---TA 187
Query: 680 YGYGAPEFESGIYTCQSDVYSFGVVMLELLTG 711
Y Y APE G Y + DV+S GV++ LL+G
Sbjct: 188 Y-YIAPEVLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 24/169 (14%)
Query: 100 GAFS--SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSL 156
GAF + + +S + IP LP T+ L N+ +I L + L + L
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS------ 210
+N + + L L L L +N LS +P L +L L ++L N ++
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 211 --GTLDVLQDLPLRDLNIENN-LFSGPIPEKM---------LQIPNFRK 247
++ +++ NN + + +Q N++K
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYKK 332
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 34/162 (20%), Positives = 55/162 (33%), Gaps = 26/162 (16%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + ++P + L +N S L L + L NN +S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 164 EIPDAFQSLTGLINLDLSSNN---LSGELPPSLE------------------NLSQLTTL 202
AF L L L +S N+ + LP SL L + +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 203 HLQNNQLSGTL---DVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ N L + L L L I +G IP+ + +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 33/139 (23%), Positives = 56/139 (40%), Gaps = 14/139 (10%)
Query: 100 GAFS---SIRVIDLSNNHIG-GSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
G FS ++ I++ N + + + +S+ + + IP L L +
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNE 197
Query: 154 MSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+ L++N + I + L L L N + + SL L L LHL NN+LS
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR 255
Query: 212 TLDVLQDLP-LRDLNIENN 229
L DL L+ + + N
Sbjct: 256 VPAGLPDLKLLQVVYLHTN 274
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 56/303 (18%), Positives = 112/303 (36%), Gaps = 49/303 (16%)
Query: 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F + + +GAG G V++ P G ++A K + + K +++ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHECNS 90
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARAL 624
IV G G+ + E+ G+L D LK +I ++++ + L
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
YL E + I+HR+ K +NIL++ + + D G +S + ++ + Y +
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMS 198
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQFLVRWAIPQLHDID 738
PE + Y+ QSD++S G+ ++E+ GR + A
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 739 ALSRMVDPSLSGQYPAKSL---------------------SHFADIISRCVQSEPEFRPP 777
R ++ P ++ F D +++C+ P R
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
Query: 778 MSE 780
+ +
Sbjct: 319 LKQ 321
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 9/143 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
IP+ LP T+ L N P + + L + L+NN +S PDAFQ L L +
Sbjct: 25 EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFS 232
L L N ++ ELP SL E L L L L N+++ L +L L L +N L +
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY-DNKLQT 142
Query: 233 GP--IPEKMLQIPNFRKDGNPFN 253
+ I NPF
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 69/290 (23%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL----VNNIDRIRHANIVE 571
IG G V A+ + G+ +A+K +DK Q + L+ V + + H NIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDK----TQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 572 LKGY-CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------- 622
L + E + L LI EY S G + D L + RM AR
Sbjct: 79 L--FEVIETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIV 124
Query: 623 -ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
A++Y H+ IVHR+ K+ N+LLD D+ + ++D G + + G G L G
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG------GKLDAFCG 175
Query: 682 ---YGAPEFESG-IYT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736
Y APE G Y + DV+S GV++ L++G +D +
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----------------QN 218
Query: 737 IDALSRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ L V L G+Y +S +++ R + P R + ++++D
Sbjct: 219 LKELRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 6/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ V D + SIPS L M++ LS N+ + L L + L ++ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS--GTLDVLQDL 219
DAF SL L +LDLS N+LS L S LS L L+L N G + +L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L I N I
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 30/180 (16%)
Query: 102 FSSIRVIDLSNNHI-----GGSIPSILPVTMQNFFLSDNQFS--GSIPSSLATLTLLTDM 154
S+ +DLS N + S ++Q LS N L TL LT +
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS---GELPPSLE--------------NLS 197
++ N +PD+ Q + L+LSS + +P +LE L
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLP 451
Query: 198 QLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFN 253
+L L++ N+L TL P L + I N ++ + +K NP++
Sbjct: 452 RLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 25/155 (16%), Positives = 58/155 (37%), Gaps = 14/155 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF---LSDNQFSGSI- 141
+ L +L ++ I + N+ + +P +++ LS+N
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 142 --PSSLATLTLLTDMSLNNNLLS--GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS 197
+ L + L+ N L + + +L L +LD+S N +P S +
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 198 QLTTLHLQNNQLS----GTLDVLQDLPLRDLNIEN 228
++ L+L + + L+ L + + N+++
Sbjct: 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-14
Identities = 30/150 (20%), Positives = 56/150 (37%), Gaps = 8/150 (5%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + + S + + + + VT++ + + + + L + +++ N+ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPS---LENLSQLTTLHLQNNQLS---GTLDV 215
Q L L LDLS N + E + L TL L N L T ++
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L L L L+I N F P+P+
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 30/170 (17%), Positives = 63/170 (37%), Gaps = 14/170 (8%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L A ++++V+ L ++ I ++++ LSDN S S L+ L ++L
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 157 NNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS---- 210
N + F +LT L L + + E+ L+ L L ++ L
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 211 GTLDVLQDLPLRDLN------IENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+L ++D+ L+ + + L++ + F+
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 26/169 (15%), Positives = 60/169 (35%), Gaps = 18/169 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIP-SSLATLTLLTDMSLN 157
SS++ ++L N ++ +Q + + + I A LT L ++ +
Sbjct: 98 SSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG------ 211
L + +S+ + +L L + + L + LS + L L++ L+
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 212 ----TLDVLQDLPLRDLNIENNLFSG--PIPEKMLQIPNFRKDGNPFNS 254
++ L R + + F+ + +L++ D N
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
++ V+D+SNN++ S LP +Q ++S N+ ++P + + +L M ++ N
Sbjct: 428 CIPQTLEVLDVSNNNLD-SFSLFLP-RLQELYISRNKLK-TLPDA-SLFPVLLVMKISRN 483
Query: 160 LLSGEIPDAFQSLTGLINLDLSSNNL 185
L F LT L + L +N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 30/171 (17%), Positives = 59/171 (34%), Gaps = 22/171 (12%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS 143
+ L+ + L SS+R ++L + ++ S LPV + + F GS+ +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 144 SLATLTL--------------LTDMSLNN-NLLSGEIPDAFQSLTG-----LINLDLSSN 183
+ L D +LN + D L + L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFS 232
L +L L ++ + ++N+++ Q L L L++ NL
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 18/179 (10%), Positives = 51/179 (28%), Gaps = 24/179 (13%)
Query: 86 LNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNFFLSDNQFSGSIP 142
+ E+ +S+ +++ + L + + L ++ + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-------GELPPSLEN 195
L+ + + L + L+ + + S EL L
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 196 LSQLTTLHLQNNQLSGTLDV-------------LQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ +L+ + + L+G D ++ + +R L+I +
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYS 307
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 33/142 (23%), Positives = 52/142 (36%), Gaps = 9/142 (6%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI 165
R+ ++ +P +L T + LS N SS L L + L + I
Sbjct: 7 RIAFYRFCNLT-QVPQVLN-TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 166 -PDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL---DVLQDLP 220
+AF++L L LDL S+ + L P + L L L L LS + ++L
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 221 -LRDLNIENNLFSGPIPEKMLQ 241
L L++ N
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFG 145
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 31/156 (19%), Positives = 59/156 (37%), Gaps = 10/156 (6%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
+++++L + + +I + N L ++ P + L L ++
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103
Query: 156 LNNNLLSGEI--PDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLS-- 210
L LS + F++L L LDLS N + L PS L+ L ++ +NQ+
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 211 --GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPN 244
L+ LQ L ++ N + + N
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-16
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 11/162 (6%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSG-SIPSSLATLTLLTDMSLNNN 159
+ +I LS N + + + + L+ N+FS S + + L + L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 160 LLSGEI-----PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
+L D F+ L+ L L L+ N L+ P +L+ L L L +N+L+ L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 215 VLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNST 255
L L+I N P P+ + + N F
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 29/142 (20%), Positives = 56/142 (39%), Gaps = 8/142 (5%)
Query: 98 NLGAFSSIRVIDLSNNHIG----GSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
+L I ++I + + ++++ LS TL L
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG- 211
++L N ++ +AF L L L+LS N L EL + L ++ + LQ N ++
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 212 TLDVLQDLP-LRDLNIENNLFS 232
+ L L+ L++ +N +
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 32/156 (20%), Positives = 60/156 (38%), Gaps = 20/156 (12%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSI--PSSLATLTLL 151
AF ++R++DL ++ I + + + L S ++ L L
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 152 TDMSL-NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ--LTTLHLQNNQ 208
T + L N + S + +F L L ++D SSN + LE L L+ L N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 209 LS--------GTLDVLQDLPLRDLNIENNLFSGPIP 236
L ++ +++ L L++ N ++ I
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 11/135 (8%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
++V++L+ N I I + N LS N S+ L + + L
Sbjct: 289 LKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQD 218
N ++ F+ L L LDL N L+ ++ + + + L N+L TL + +
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKI-N 400
Query: 219 LPLRDLNIENNLFSG 233
L +++ N
Sbjct: 401 LTANLIHLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 20/138 (14%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S+ + L N + + + L L+ L + LN+N L+
Sbjct: 451 PSLEQLFLGENMLQLAWETELC-----------------WDVFEGLSHLQVLYLNHNYLN 493
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
P F LT L L L+SN L+ L + + L L + NQL + + L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLS 550
Query: 223 DLNIENNLFSGPIPEKML 240
L+I +N F
Sbjct: 551 VLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 25/166 (15%), Positives = 47/166 (28%), Gaps = 28/166 (16%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNF---FLSDNQFSGSIPSSLATLTL--LTDMSLN 157
++ +DLS N I + + S NQ L L L+ SL
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 158 NNLLSGEIPDAFQSLTGLI-NLDLSSNNLSG-----------------ELPPSLENLSQL 199
N L + + N+ L ++SG SL +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 200 TTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ + T L +R L++ + + ++ +
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFE 287
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 27/149 (18%), Positives = 55/149 (36%), Gaps = 11/149 (7%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L A + S ++V+ L++N++ P + ++ L+ N+ + +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH 521
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP----PSLENLSQL 199
+ L + ++ N L PD F SL+ LD++ N E + N + +
Sbjct: 522 N-DLPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELSTFINWLNHTNV 577
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIEN 228
T + D + L L+ E
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLSTEG 606
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 70/294 (23%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
+G G G V A + +AVK +D ++ NI + + H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHE 65
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
N+V+ G+ E + L EYCS G L D + I M A+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP------------DIGMPEPDAQRFFHQ 113
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
+ YLH I I HR+ K N+LLD+ + +SD GLA + + +L L
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKM 167
Query: 680 YG---YGAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
G Y APE + DV+S G+V+ +L G +D+ + + +
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---------SCQEY 218
Query: 735 HDIDALSRMVDPSLSGQY---PAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
D + P K + ++ + + P R + ++ +D
Sbjct: 219 SDW----------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 30/168 (17%), Positives = 64/168 (38%), Gaps = 9/168 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ L SI + +NN+I + +N +L++N+ + + + + L
Sbjct: 93 QELLVGPSIETLHAANNNI-SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 157 NNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
N + + S L +L+L N + ++ + ++L TL L +N+L+
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPE 209
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNSTVAPS 259
Q + +++ NN I + + N GN F+
Sbjct: 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-18
Identities = 30/146 (20%), Positives = 53/146 (36%), Gaps = 7/146 (4%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSG-SIPSSLATLTLLTDMS 155
+ I L+NN I +Q L N+ + A+ L ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L N + ++ L LDLSSN L+ + P ++ + +T + L+NN+L
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKML 240
L+ L ++ N F
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
++D+ ++ S + + ++ L+ N LS T L L+LSSN L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
LE+LS L TL L NN + L P + L+ NN S + Q
Sbjct: 75 DLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 23/135 (17%), Positives = 54/135 (40%), Gaps = 13/135 (9%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
L F+ + +++LS+N + + ++ ++ L++N L + +
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG--TLDV 215
NN +S Q N+ L++N ++ S++ L L+ N++ ++
Sbjct: 108 NNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 216 LQDLP-LRDLNIENN 229
L LN++ N
Sbjct: 165 AASSDTLEHLNLQYN 179
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+I + ++ L + QS + LDLS N LS L ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 TTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
L+L +N L L+ L LR L++ NN
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 26/150 (17%), Positives = 51/150 (34%), Gaps = 6/150 (4%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLT 152
E + ++ ++L N I + + ++ LS N+ + + + +T
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-GELPPSLENLSQLTTLHLQNNQLSG 211
+SL NN L I A + L + DL N G L ++ T+ Q +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KL 275
Query: 212 TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
T ++ + L +P
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 29/148 (19%), Positives = 61/148 (41%), Gaps = 14/148 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ ++L L + +++ +DLS N + + L ++ LS N
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L +L+ L + LNNN + E+ + L ++NN+S + S ++
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCS--RGQGKKNIY 126
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENN 229
L NN+++ D ++ L+++ N
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 16/178 (8%), Positives = 36/178 (20%), Gaps = 7/178 (3%)
Query: 94 ELGENLGAFSSIRVIDLSNNHI-GGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLT 152
+ + L ++ DL N G++ + ++ + T+ T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG----ELPPSLENLSQLTTLHLQNNQ 208
L L + + + G L EN ++ + Q
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 209 LSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTS 264
V L + + +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 11/157 (7%), Positives = 35/157 (22%), Gaps = 11/157 (7%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQF-------S 138
+ + G+N + + +P+ + ++ +
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ ++ I I L+ L ++ ++
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 199 LTTL---HLQNNQLSGTLDVLQDLPLRDLNIENNLFS 232
L + +L + L L ++
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM 422
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 40/211 (18%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V A Q A KK+ K F + + + + H NI+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYET 74
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
++ L+ E C+ G L + R+ A + A
Sbjct: 75 FEDNTDIYLVMELCTGGELFE----------------RVVHKRVFRESDAARIMKDVLSA 118
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
+ Y H++ + HR+ K N L D + + D GLA G + + + T Y
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPY 173
Query: 681 GYGAPEFESGIYTCQSDVYSFGVVMLELLTG 711
Y +P+ G+Y + D +S GV+M LL G
Sbjct: 174 -YVSPQVLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 29/147 (19%), Positives = 53/147 (36%), Gaps = 9/147 (6%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSG-SIPSSLATLTLLTDM 154
+ I L+NN I + + L N+ + A+ L +
Sbjct: 116 CSRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
+L N + ++ L LDLSSN L+ + P ++ + +T + L+NN+L
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEK 231
Query: 215 VLQDLP-LRDLNIENNLFSGPIPEKML 240
L+ L ++ N F
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
++D+ ++ S + + ++ L+ N LS T L L+LSSN L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
LE+LS L TL L NN + L V + L+ NN S + Q
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLVGPS--IETLHAANNNISR-VSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 26/150 (17%), Positives = 51/150 (34%), Gaps = 6/150 (4%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLT 152
E + ++ ++L N I + + ++ LS N+ + + + +T
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-GELPPSLENLSQLTTLHLQNNQLSG 211
+SL NN L I A + L + DL N G L ++ T+ Q +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL- 275
Query: 212 TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
T ++ + L +P
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 24/138 (17%), Positives = 56/138 (40%), Gaps = 15/138 (10%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+L F+ + +++LS+N + + ++ ++ L++N L + +
Sbjct: 52 ADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG--T 212
NN +S Q N+ L++N ++ L S++ L L+ N++
Sbjct: 106 AANNNISRVSCSRGQGKK---NIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 213 LDVLQDLP-LRDLNIENN 229
++ L LN++ N
Sbjct: 162 AELAASSDTLEHLNLQYN 179
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+I + ++ L + QS + LDLS N LS L ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 TTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
L+L +N L L+ L LR L++ NN
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 28/148 (18%), Positives = 60/148 (40%), Gaps = 14/148 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ ++L L + +++ +DLS N + + L ++ LS N
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L +L+ L + LNNN + E+ + L ++NN+S + ++
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSC--SRGQGKKNIY 126
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENN 229
L NN+++ D ++ L+++ N
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 7/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ ++P +P Q FL N+ S +S LT + L++N+L+
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDL 219
AF L L LDLS N + P+ L +L TLHL L L + + L
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L +++N +P+ +
Sbjct: 129 AALQYLYLQDNALQA-LPDDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 15/141 (10%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTM---QNFFLSDNQFSGSIPS-SLATLTLLT 152
F + + L + + L + Q +L DN ++P + L LT
Sbjct: 99 ATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLT 156
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+ L+ N +S AF+ L L L L N ++ + P + +L +L TL+L N LS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS- 214
Query: 212 TL--DVLQDLP-LRDLNIENN 229
L + L L L+ L + +N
Sbjct: 215 ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 11/118 (9%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPS-SLATLTLLT 152
G F +++ + L +N + ++P + N FL N+ S S+P + L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLD 180
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ L+ N ++ P AF+ L L+ L L +NNLS LP L L L L L +N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 12/164 (7%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS- 162
S I ++ + S+P+ +P + L N+ LT LT +SL++N LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 163 -GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDL 219
G + T L LDLS N + + + L QL L Q++ L V L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ-IPNFRK---DGNPFNSTVAP 258
L L+I + + + + GN F P
Sbjct: 126 RNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 32/160 (20%), Positives = 54/160 (33%), Gaps = 27/160 (16%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNFF---------LSDNQFSGSIPSSLAT 147
G F + + LS+N + S Q+ F LS N ++ S+
Sbjct: 46 GVFDKLTQLTKLSLSSNGL-----SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 99
Query: 148 LTLLTDMSLNNNLLSGEIPD--AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHL 204
L L + ++ L ++ + F SL LI LD+S + LS L L +
Sbjct: 100 LEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKM 157
Query: 205 QNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
N D+ +L L L++ +
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 17/146 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F ++ +D+S+ H + L +++ ++ N F + L L
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 152 TDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
T + L+ L ++ AF SL+ L L++S NN L + L+ L L N +
Sbjct: 178 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 210 SG-TLDVLQDLP--LRDLNIENNLFS 232
LQ P L LN+ N F+
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 17/141 (12%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPSS--LATLTLLTDM 154
+S++ +DLS N + + + + +L L +
Sbjct: 78 TSLKYLDLSFNGV-----ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 131
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-T 212
+++ F L+ L L ++ N+ P L LT L L QL +
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191
Query: 213 LDVLQDLP-LRDLNIENNLFS 232
L L+ LN+ +N F
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFF 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 46/217 (21%)
Query: 514 ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIV 570
++G+G V+ Q GKL A+K + K + + +E + + +I+H NIV
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVLKKIKHENIV 69
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR 622
L+ L+ + S G L D RI + A +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFD----------------RILERGVYTEKDASLVIQ 113
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGH 675
A++YLHE IVHR+ K N+L +++ + ++D GL+ + +G +S G
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG- 169
Query: 676 LLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
T Y APE Y+ D +S GV+ LL G
Sbjct: 170 --TPG-YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 37/142 (26%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + +P LP L +N+ + L L + L NN +S
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP- 220
P AF L L L LS N L ELP + L L + N+++ + V L
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 221 LRDLNIENN-LFSGPIPEKMLQ 241
+ + + N L S I Q
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 17/144 (11%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSL 156
G S+ + L N I + + + N LS N S SLA L ++ L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-------LENLSQLTTLHLQNNQL 209
NNN L ++P + + L +NN+S + + + + + L +N +
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
Query: 210 SGTL---DVLQDLP-LRDLNIENN 229
+ + + + N
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 19/145 (13%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPSSLATLTL 150
F+ + V++L N + I Q ++D + +IP L
Sbjct: 139 SVFNGLNQMIVVELGTNPL--KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
Query: 151 LTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQ 208
LT++ L+ N ++ ++ + + L L L LS N++S + SL N L LHL NN+
Sbjct: 194 LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNK 251
Query: 209 LSGTLDVLQDLP-LRDLNIENNLFS 232
L L D ++ + + NN S
Sbjct: 252 LVKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 27/137 (19%), Positives = 49/137 (35%), Gaps = 29/137 (21%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
+++ + + N I + + F+G L + + L N
Sbjct: 118 KMPKTLQELRVHENEI--------------TKVRKSVFNG--------LNQMIVVELGTN 155
Query: 160 LLSGEI--PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVL 216
L AFQ + L + ++ N++ +P L LT LHL N+++ L
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASL 212
Query: 217 QDLP-LRDLNIENNLFS 232
+ L L L + N S
Sbjct: 213 KGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 28/149 (18%), Positives = 57/149 (38%), Gaps = 19/149 (12%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
G F ++ + L NN I I + +LS NQ +P + L +
Sbjct: 70 GDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE 125
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL-SGELPP-SLENLSQLTTLHLQNNQLS- 210
+ ++ N ++ F L +I ++L +N L S + + + + +L+ + + + ++
Sbjct: 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185
Query: 211 ---GTLDVLQDLPLRDLNIEN---NLFSG 233
G L +L L I G
Sbjct: 186 IPQGLPPSLTELHLDGNKITKVDAASLKG 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 38/283 (13%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIA 502
M+ PP P P P PPP P + P P + K + I
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI- 59
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
+ Y ++G G+ G V + + A+K L ++++ +
Sbjct: 60 -IDDY---KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-- 113
Query: 562 DRIRHANIVELKGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---- 613
+IV + L++ E G L + + + ++ R
Sbjct: 114 ----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASE 165
Query: 614 -IRMALGAARALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
++ A++YLH I I HR+ K N+L + + ++D G A +S +
Sbjct: 166 IMKSIGE---AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 670 SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
L+ T Y Y APE Y D++S GV+M LL G
Sbjct: 220 --LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 8e-19
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV------TMQNFFLSDNQF-- 137
+ A+ E + F ++ +DLS+N G I + T+Q L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 138 -SGSIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLEN 195
SG + A L + L++N L + + L +L+LS L ++P L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 196 LSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGP 234
++L+ L L N+L +LP + +L+++ N F
Sbjct: 273 PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 23/147 (15%), Positives = 41/147 (27%), Gaps = 16/147 (10%)
Query: 102 FSSIRVIDLSNNHIGG------SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ +++L N + L ++ ++ + L+ +
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 156 LNNNLLSGEI-------PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
L++N GE P F +L L + SG QL L L +N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 209 LSGTLDVLQDLP---LRDLNIENNLFS 232
L L LN+
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 31/164 (18%), Positives = 53/164 (32%), Gaps = 19/164 (11%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQN---FFLSDNQFSGSIPSSLATL----- 148
+ S ++ + L N + G+ P +L T + L + ++ + LA L
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS----LENLSQLTTLHL 204
L +S+ + + L LDLS N GE L L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 205 QNNQLSGTLDVLQDL-----PLRDLNIENNLFSGPIPEKMLQIP 243
+N + V L L+ L++ +N P
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 34/196 (17%), Positives = 66/196 (33%), Gaps = 28/196 (14%)
Query: 65 DPCGESWQGVQCNASDIIAIILNGANL-----GGELGENLGAFS------SIRVIDLSNN 113
DP + C + + + G +L + +LG F+ S++ + +
Sbjct: 19 DPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAA 78
Query: 114 HIGGSIPSILPVTM-----QNFFLSDNQFSGSIPSSLATLTL--LTDMSLNNNLLSG--- 163
I I + Q L + + +G+ P L T L ++L N +
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 164 EIPDAFQ-SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
+ + Q GL L ++ + + L+TL L +N G ++ L
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 221 ----LRDLNIENNLFS 232
L+ L + N
Sbjct: 199 KFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 22/128 (17%), Positives = 42/128 (32%), Gaps = 11/128 (8%)
Query: 130 FFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD---AFQSLTGLINLDLSSNNLS 186
D + + + L +++ + I ++GL L L + ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 187 GELPPSLENL--SQLTTLHLQNNQLSGTLDVLQDLP------LRDLNIENNLFSGPIPEK 238
G PP L L L+L+N + L +L L+ L+I E+
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 239 MLQIPNFR 246
+ P
Sbjct: 169 VRVFPALS 176
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 63/214 (29%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR---I-----RHA 567
+G G+ V R P K AVK +D +E EL + I H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS-WNTR--IRMALGAARAL 624
NI++LK + L+++ G L D L K LS TR +R L +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLE---VI 137
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
LH++ IVHR+ K NILLDDD+ + ++D G + + G L T Y A
Sbjct: 138 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS-YLA 191
Query: 685 PE-------FESGIYTCQSDVYSFGVVMLELLTG 711
PE Y + D++S GV+M LL G
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 70/294 (23%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
+G G G V A + +AVK +D ++ NI + + H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHE 65
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
N+V+ G+ E + L EYCS G L D + I M A+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP------------DIGMPEPDAQRFFHQ 113
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
+ YLH I I HR+ K N+LLD+ + +SD GLA + + +L L
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKM 167
Query: 680 YG---YGAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734
G Y APE + DV+S G+V+ +L G +D+ + + +
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---------SCQEY 218
Query: 735 HDIDALSRMVDPSLSGQY---PAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
D + P K + ++ + + P R + ++ +D
Sbjct: 219 SDW----------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 48/324 (14%), Positives = 99/324 (30%), Gaps = 53/324 (16%)
Query: 482 AVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKL 541
A+K + + A + + Q ++ +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 542 DKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI-YEYCSNGTLQDML-- 598
S + + + + L I + C L+D +
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 599 ---HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655
D E L +I A A+E+LH ++HR+ K +NI D V V
Sbjct: 155 RCSLEDREHGVCLHIFIQI------AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 205
Query: 656 SDCGLA-PLISSGSVSQLSGHLL----------TAYGYGAPEFESGI-YTCQSDVYSFGV 703
D GL + + + T Y +PE G Y+ + D++S G+
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL-YMSPEQIHGNNYSHKVDIFSLGL 264
Query: 704 VMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYP---AKSLSHF 760
++ ELL + E+ + + D+ + ++P +
Sbjct: 265 ILFELLYSFSTQM------ERVRI------ITDVR----------NLKFPLLFTQKYPQE 302
Query: 761 ADIISRCVQSEPEFRPPMSEVVQD 784
++ + P RP ++++++
Sbjct: 303 HMMVQDMLSPSPTERPEATDIIEN 326
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 8/118 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLI 176
+P + P + LS N + +S + L L + + I + F+ L+ LI
Sbjct: 24 QVPEL-PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 177 NLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL---DVLQDLP-LRDLNIENN 229
L L N +L L+ L L L L G + + + L L L + +N
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSLNN 158
S ++ DLS + I ++ + ++ L+ N+ + I + LT L ++L+
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS----GTL 213
N L F++L L LDLS N++ L S L L L L NQL G
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIF 391
Query: 214 DVLQDLPLRDLNIENN 229
D L L+ + + N
Sbjct: 392 DRLT--SLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 31/169 (18%), Positives = 59/169 (34%), Gaps = 21/169 (12%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPSS-LATLTLL 151
+FS + + + + G I + L ++ L NQF + + L L
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS-SLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 152 TDMSLNNNLL-SGEIP-DAFQSLTGLINLDLSSNNLSGELPPS--LENLSQLTTLHLQNN 207
++L L + + F+ LT L L L NN+ ++ P+ N+ + L L N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFN 164
Query: 208 QLS----GTLDVLQDLPLRDLNIENN--LFSGPIPEKMLQIPNFRKDGN 250
++ L Q L + + + N K+ +
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 35/206 (16%), Positives = 58/206 (28%), Gaps = 36/206 (17%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP-------VTMQNFFLSDNQF-SGSIPS-SLAT 147
F SS+ ++ L N L ++ L+ +
Sbjct: 73 NTFRGLSSLIILKLDYNQF-----LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 148 LTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENL--SQLTTLHL 204
LT L + L +N + P F ++ LDL+ N + L N T L L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 205 QNNQLS------------GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK--DGN 250
+ L G + L++ N F + ++ K
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTS--ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 251 PFNSTVAPSRPPTSSVTPPPAPPFFG 276
NS S ++ P F G
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 13/95 (13%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
AF + + ++LS N +G SI S L ++ LS N ++ S L L
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD-KLEVLDLSYNHIR-ALGDQSFLGLPNL 373
Query: 152 TDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNL 185
+++L+ N L +PD F LT L + L +N
Sbjct: 374 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 56/276 (20%), Positives = 96/276 (34%), Gaps = 27/276 (9%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P P P P + + G +S F + + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 508 TNSFSQ----ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G V+R + G A K + + D E + I
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVR--KEIQ 206
Query: 563 ---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+RH +V L + + ++IYE+ S G L + + + + +R
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 620 AARALEYLHEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSG-SVSQLSGHL 676
L ++HE VH + K NI+ + + D GL + SV +G
Sbjct: 267 ---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG-- 318
Query: 677 LTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
TA + APE E +D++S GV+ LL+G
Sbjct: 319 -TAE-FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 61/285 (21%), Positives = 91/285 (31%), Gaps = 62/285 (21%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P + V F
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAA------PGTASLVPDYWIDGSNRDALSDF----- 54
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ E +G G VYR Q K A+K L K + E + + R
Sbjct: 55 --FE--VESE--LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLR 104
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------R 615
+ H NI++LK + L+ E + G L D RI R
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFD----------------RIVEKGYYSER 148
Query: 616 MALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGS 668
A A + A+ YLHE IVHR+ K N+L D + ++D GL+ ++
Sbjct: 149 DAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 669 V-SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
+ + G T Y APE Y + D++S G++ LL G
Sbjct: 206 LMKTVCG---TPG-YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 14/144 (9%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + ++ +P + + L +NQ +S L L + L+ N +
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS-------GTL 213
AF L L L+L N L+ +P + LS+L L L+NN + +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 214 DVLQDLPLRDLN----IENNLFSG 233
L+ L L +L I F G
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 40/165 (24%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN-------------------F------- 130
GAF ++ + L NN I SIPS + + F
Sbjct: 130 GAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 131 --FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE 188
L+ IP+ L L L ++ L+ N LS P +FQ L L L + + +
Sbjct: 189 YLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-V 245
Query: 189 LPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
+ + +NL L ++L +N L+ L D+ L L +++ +N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
GAF S++R ++L+ ++ IP++ P+ + LS N S P S L L +
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ + + +AF +L L+ ++L+ NNL+ LP L L +HL +N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 32/161 (19%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
L S+ ++S N + ++ P+ ++ S N + + + LT + L +
Sbjct: 182 LSLIPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 235
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDVLQ 217
N L+ + + GL+ +DLS N L ++ + +L L++ NN+L Q
Sbjct: 236 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQ 292
Query: 218 DLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNS 254
+P L+ L++ +N + Q D N +
Sbjct: 293 PIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 332
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 7/166 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
N+ L L ++ +D S+N I + + V + L N + L
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYP 248
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L ++ L+ N L + F + L L +S+N L L + + L L L +N L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 210 SGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRKDGNPFN 253
L +L +++N + + N N ++
Sbjct: 308 LHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 33/140 (23%), Positives = 58/140 (41%), Gaps = 11/140 (7%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
L +F + +++L++ I I + ++ N P + LLT +
Sbjct: 65 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 156 LNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSG-T 212
L N LS +P F + L L +S+NNL + + + L L L +N+L+
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVD 181
Query: 213 LDVLQDLPLRDLNIENNLFS 232
L ++ L N+ NL S
Sbjct: 182 LSLIPS--LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 20/151 (13%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSL-ATLTLLT 152
AF +I+ + + N I +P + + L N S S+P + LT
Sbjct: 87 YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+S++NN L I D FQ+ T L NL LSSN L+ + S + L ++ N LS
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNLLS- 199
Query: 212 TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L + +L+ +N + + +
Sbjct: 200 ---TLAIPIAVEELDASHNSINV-VRGPVNV 226
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 31/139 (22%), Positives = 55/139 (39%), Gaps = 9/139 (6%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP- 166
ID+ + I + ++ + L + + ++LN+ + EI
Sbjct: 28 IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDT 86
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDLP-LR 222
AF + L + N + LPP +N+ LT L L+ N LS +L + + P L
Sbjct: 87 YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 223 DLNIENNLFSGPIPEKMLQ 241
L++ NN I + Q
Sbjct: 145 TLSMSNNNLER-IEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 9/130 (6%)
Query: 118 SIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGL 175
I S L + + TL ++ N+ + S +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 176 INLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLF 231
L+L+ + E+ + + L++ N + L V Q++P L L +E N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 232 SGPIPEKMLQ 241
S +P +
Sbjct: 130 SS-LPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 16/111 (14%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS- 192
I S+L + D+ ++ +L + ++ + +LP +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 193 LENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L++ Q+ L+L + Q+ ++ L + N +P + Q
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 17/116 (14%), Positives = 38/116 (32%), Gaps = 12/116 (10%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
F + + +SNN + ++ T++ LS N + + L ++
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
L++N + + + L NL LS N+ + + +
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQH 374
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 11/119 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPS--SLATLTLLTDMSLNNNLLSGEIP-DAFQSLTG 174
++P LP LS N S + + + LT L + L++N L+ I +AF +
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 175 LINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
L LDLSSN+L L +L L L L NN + + + +D+ L+ L + N
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 36/174 (20%), Positives = 64/174 (36%), Gaps = 27/174 (15%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTM-------QNFFLSDNQFSGSIPS-SLATLTLL 151
S ++DLS+N++ + + LS N + I S + + L
Sbjct: 36 SLPSYTALLDLSHNNL----SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS 210
+ L++N L F L L L L +N++ + + E+++QL L+L NQ+S
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 211 ----GTLDVLQDLP-LRDLNIENNLFSGPIPEKM------LQIPNFRKDGNPFN 253
+ LP L L++ +N +P NP
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 48/244 (19%), Positives = 80/244 (32%), Gaps = 52/244 (21%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
IG G G V A + + A+K ++K Q + + + ++ H NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG------------- 619
+ L+ E C G L D L+ + ++ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 620 ----------------AAR-------ALEYLHEICQPPIVHRNFKSANILL--DDDLAVS 654
+ AL YLH I HR+ K N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 655 VSDCGLAPLISSGSVSQLSGHLLTAYG---YGAPE---FESGIYTCQSDVYSFGVVMLEL 708
+ D GL+ + + + T G + APE + Y + D +S GV++ L
Sbjct: 211 LVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 709 LTGR 712
L G
Sbjct: 270 LMGA 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 27/217 (12%)
Query: 508 TNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ FS +G G V R G A K ++ + S + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
+++H NIV L E L+++ + G L + + + + S A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSE----ADASHCIQ 112
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGH 675
++ Y H IVHRN K N+LL AV ++D GLA ++ G
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 167
Query: 676 LLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
T Y +PE + Y+ D+++ GV++ LL G
Sbjct: 168 AGTPG-YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 50/243 (20%), Positives = 90/243 (37%), Gaps = 39/243 (16%)
Query: 486 STKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR 544
S + F + + ++++++ + +G G V R G A K ++ +
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 545 ASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
S + + +++H NIV L E L+++ + G L +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE-------- 117
Query: 605 KNNLSWNTRI--------RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DD 649
I A + ++ Y H IVHRN K N+LL
Sbjct: 118 --------DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166
Query: 650 DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLEL 708
AV ++D GLA ++ G T Y +PE + Y+ D+++ GV++ L
Sbjct: 167 GAAVKLADFGLAIEVNDSEA--WHGFAGTPG-YLSPEVLKKDPYSKPVDIWACGVILYIL 223
Query: 709 LTG 711
L G
Sbjct: 224 LVG 226
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 34/124 (27%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 109 DLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDA 168
+ ++ ++P LP LS+N ++L T LT ++L+ L+ ++
Sbjct: 16 NCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-V 72
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLN 225
+L L LDLS N L LP + L LT L + N+L+ +L L+ L L++L
Sbjct: 73 DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 226 IENN 229
++ N
Sbjct: 131 LKGN 134
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 37/140 (26%), Positives = 54/140 (38%), Gaps = 11/140 (7%)
Query: 98 NLGAFS---SIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSL-ATLTLL 151
L + +DLS+N + S+P + + +S N+ + S+P L L
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS 210
++ L N L P L L L++NNL+ ELP L L L TL LQ N L
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
Query: 211 GTLDVLQDLP-LRDLNIENN 229
L + N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 58/286 (20%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V + G +AVK L+++ ++ + N+ RH +I++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+ ++ EY S G L D + R+ AR A++
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQILSAVD 125
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---Y 682
Y H +VHR+ K N+LLD + ++D GL+ ++S G L T+ G Y
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNY 176
Query: 683 GAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE SG Y + D++S GV++ LL G +D + L
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----------------EHVPTL 219
Query: 741 SRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ + G + + L+ ++ +Q +P R + ++ +
Sbjct: 220 FKKI---RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 70/296 (23%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
L+G G G V AVK L K+ + + E N+ + +RH
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGE-----ANVKKEIQLLRRLRHK 66
Query: 568 NIVELKG-YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
N+++L E Q++ ++ EYC G +Q+ML D + R + A
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEML---DSVPEK-------RFPVCQAHGYF 115
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
LEYLH IVH++ K N+LL + +S G+A + + +
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA----ADDTC 168
Query: 678 -TAYG---YGAPEFESGI--YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730
T+ G + PE +G+ ++ + D++S GV + + TG ++
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG------------- 215
Query: 731 IPQLHDIDALSRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+I L + G Y D++ ++ EP R + ++ Q
Sbjct: 216 ----DNIYKLFENI---GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 32/161 (19%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
L S+ ++S N + ++ P+ ++ S N + + + LT + L +
Sbjct: 188 LSLIPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDVLQ 217
N L+ + + GL+ +DLS N L ++ + +L L++ NN+L Q
Sbjct: 242 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQ 298
Query: 218 DLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNS 254
+P L+ L++ +N + Q D N +
Sbjct: 299 PIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 338
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 9e-17
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 7/166 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
N+ L L ++ +D S+N I + + V + L N + L
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYP 254
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L ++ L+ N L + F + L L +S+N L L + + L L L +N L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 210 SGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRKDGNPFN 253
L +L +++N + + N N ++
Sbjct: 314 LHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 11/140 (7%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
L +F + +++L++ I I + ++ N P + LLT +
Sbjct: 71 LDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 156 LNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL 213
L N LS +P F + L L +S+NNL + + + L L L +N+L+ +
Sbjct: 130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HV 186
Query: 214 DVLQDLP-LRDLNIENNLFS 232
D L +P L N+ NL S
Sbjct: 187 D-LSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-15
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 20/151 (13%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSL-ATLTLLT 152
AF +I+ + + N I +P + + L N S S+P + LT
Sbjct: 93 YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 150
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+S++NN L I D FQ+ T L NL LSSN L+ + SL + L ++ N LS
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS- 205
Query: 212 TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L + +L+ +N + + +
Sbjct: 206 ---TLAIPIAVEELDASHNSINV-VRGPVNV 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 32/140 (22%), Positives = 59/140 (42%), Gaps = 11/140 (7%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS-LATLTLLTDMSLNNNLLSGEIP 166
ID+ + I + ++ +P++ L + + ++LN+ + EI
Sbjct: 34 IDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EID 91
Query: 167 -DAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLSGTLD--VLQDLP-L 221
AF + L + N + LPP + +N+ LT L L+ N LS +L + + P L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 222 RDLNIENNLFSGPIPEKMLQ 241
L++ NN I + Q
Sbjct: 150 TTLSMSNNNLER-IEDDTFQ 168
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 23/131 (17%), Positives = 50/131 (38%), Gaps = 11/131 (8%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTL--LTDMSLNNNLLSGEIP-DAFQSLTG 174
I S L + + + + + +TL ++ N+ + ++P S
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 175 LINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNL 230
+ L+L+ + E+ + + L++ N + L V Q++P L L +E N
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 231 FSGPIPEKMLQ 241
S +P +
Sbjct: 135 LSS-LPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 17/118 (14%), Positives = 43/118 (36%), Gaps = 8/118 (6%)
Query: 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG 187
N ++ I S+L + D+ ++ +L + ++ +
Sbjct: 7 YNVKPRQPEYK-CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64
Query: 188 ELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+LP + L++ Q+ L+L + Q+ + ++ L + N +P + Q
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ 120
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 19/114 (16%), Positives = 41/114 (35%), Gaps = 11/114 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
F + + +SNN + ++ T++ LS N + + L ++
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNN 207
L++N + + + L NL LS N+ L N+++ +
Sbjct: 330 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 64/312 (20%), Positives = 119/312 (38%), Gaps = 54/312 (17%)
Query: 497 RSFTIASLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR---ASSQ 548
T+ Y + E +G+G G V A + K +A++ + KR S
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 549 QKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
++ D L + I+ ++ H I+++K + + ++ E G L D +
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG----N 233
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAP 662
L T A++YLHE I+HR+ K N+LL ++D + ++D G +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 663 LISSGSVSQLSGHLLTAYGYGAPE----FESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718
++ S+ + T Y APE + Y D +S GV++ L+G
Sbjct: 291 ILGETSL--MRTLCGTPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------ 341
Query: 719 RNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY-----PAKSLSHFA-DIISRCVQSEP 772
P + + D SG+Y +S A D++ + + +P
Sbjct: 342 -------------PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 773 EFRPPMSEVVQD 784
+ R E ++
Sbjct: 389 KARFTTEEALRH 400
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 29/171 (16%)
Query: 94 ELGENLGAFSSIRVIDLSNN--------HIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L ++ + + +R + + + + S + N L S+P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
+S+A L L + + N+ LS + A L L LDL PP + L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 203 HLQN-NQLSGTLDVLQDLP--------LRDLNIENNLFSGPIPEKMLQIPN 244
L++ + L LP L L++ + +P + Q+P
Sbjct: 259 ILKDCSNLL-------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 25/158 (15%), Positives = 55/158 (34%), Gaps = 14/158 (8%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTM------QNFFLSDNQFSGSIPSSLAT 147
+ +++ + L I LP ++ ++ + ++ S ++ ++
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGI-----RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L ++ L P F L L L + LP + L+QL L L+
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 208 QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIP 243
L ++ LP + + +L + + + P
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 28/157 (17%), Positives = 53/157 (33%), Gaps = 31/157 (19%)
Query: 94 ELGENLGAFSSI--RVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLT 149
+ L + ++L + + P +Q+ + +P ++
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL---------ENLSQLT 200
L ++L N L +P + SL L L + + ELP L + L L
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 201 TLHLQNNQLSGTLDVLQDLP--------LRDLNIENN 229
+L L+ ++ LP L+ L I N+
Sbjct: 187 SLRLEWTG-------IRSLPASIANLQNLKSLKIRNS 216
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 12/94 (12%), Positives = 24/94 (25%), Gaps = 7/94 (7%)
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
GS + ++ + D N D + + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 199 LTTLHLQNNQLSGTLDVLQDLP---LRDLNIENN 229
L T D+L+D L + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSV 91
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 18/168 (10%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
A S + V+ L + +I +I + +S + ++ + LT
Sbjct: 170 EALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 154 MSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+S+ + L+ +P A + L L L+LS N +S + L L +L + L QL+
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV 286
Query: 212 -TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRK---DGNPFN 253
+ L LR LN+ N + + E + + N D NP
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 34/140 (24%), Positives = 57/140 (40%), Gaps = 10/140 (7%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSL 156
G + R++DL N I ++ + + L++N S P + L L + L
Sbjct: 29 GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87
Query: 157 NNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-- 213
+N L IP F L+ L LD+S N + L ++L L +L + +N L +
Sbjct: 88 RSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH 145
Query: 214 DVLQDLP-LRDLNIENNLFS 232
L L L +E +
Sbjct: 146 RAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 32/152 (21%), Positives = 64/152 (42%), Gaps = 14/152 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F +++ +++ +N + I L +++ L + SIP+ +L+ L L
Sbjct: 122 YMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN-SLEQLTLEKCNLT-SIPTEALSHLHGL 178
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+ L + ++ +F+ L L L++S + P+ LT+L + + L+
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 212 -TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
++ L LR LN+ N S I ML
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPIST-IEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 29/129 (22%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
++ + N ++ + +++ ++ ++P + + LS N S
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTT 201
S L L L ++ L L+ P AF+ L L L++S N L+ L S+ ++ L T
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 202 LHLQNNQLS 210
L L +N L+
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 31/143 (21%), Positives = 51/143 (35%), Gaps = 30/143 (20%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ R + ++P +P + L N+ ++
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIK-TLN------------------- 48
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TLDVLQDL 219
D F S L L+L+ N +S + P + NL L TL L++N+L L V L
Sbjct: 49 ----QDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L L+I N + + M Q
Sbjct: 104 SNLTKLDISENKIVI-LLDYMFQ 125
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 65/219 (29%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-------LELVNN 560
N FS +IG G G VY + D GK+ A+K LDK+ ++ + L LV+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 561 IDRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
D IV + Y +L I + + G L L M
Sbjct: 249 GD---CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DMRFY 297
Query: 620 AAR---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL 676
AA LE++H +V+R+ K ANILLD+ V +SD GLA S G
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-- 352
Query: 677 LTAYGYGAPE---FESGIYTCQSDVYSFGVVMLELLTGR 712
T GY APE Y +D +S G ++ +LL G
Sbjct: 353 -TH-GYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGH 388
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 51/238 (21%), Positives = 86/238 (36%), Gaps = 25/238 (10%)
Query: 490 AKPFTTARSFTIASLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR 544
P + I + F +IG G V R G+ AVK +D
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 545 ASSQQKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD 601
+ +L ++H +IVEL + G +++E+ L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 602 DELKNNLSWNTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVS 654
+ S +A R AL Y H+ I+HR+ K +LL ++ V
Sbjct: 121 ADAGFVYSE----AVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173
Query: 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
+ G+A + G + T + + APE + Y DV+ GV++ LL+G
Sbjct: 174 LGGFGVAIQLGESG-LVAGGRVGTPH-FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 6/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ S+ + SIPS L +++ LS+N+ + S L L + L +N ++
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN 89
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS--GTLDVLQDL 219
D+F SL L +LDLS N LS L S + LS LT L+L N G + L
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L + N I K
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFA 171
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 28/149 (18%), Positives = 55/149 (36%), Gaps = 21/149 (14%)
Query: 100 GAF---SSIRVIDLSNNHI----GGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F SS+ ++L N S+ S L + + F+ I A LT L
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFL 176
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQL- 209
++ ++ + L P + +S+ + +L L L ++ S + L L++ L
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235
Query: 210 --------SGTLDVLQDLP-LRDLNIENN 229
+G + L R++ I +
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDE 264
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 21/148 (14%), Positives = 52/148 (35%), Gaps = 22/148 (14%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPS-SLATLTLLT 152
F+ + +++ + + S ++QN L Q + + + +
Sbjct: 168 KDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVE 225
Query: 153 DMSLNNNLLSG----EIP----DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
+ L + L E+ ++ N+ ++ +L ++ L +S L L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 205 QNNQLSGTL--DVLQDLP-LRDLNIENN 229
NQL ++ + L L+ + + N
Sbjct: 285 SRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP----------VTMQNFFLSDNQFSGSIPSSLA 146
SS+ ++L + + S L T +N ++D + L
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLN 274
Query: 147 TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
++ L ++ + N L F LT L + L +N
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 5/124 (4%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
IP LP + +N LS N S + L + L+ + A+QSL+ L
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENN-LFSG 233
L L+ N + L LS L L L+ + L L++LN+ +N + S
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 234 PIPE 237
+PE
Sbjct: 140 KLPE 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 32/144 (22%), Positives = 67/144 (46%), Gaps = 17/144 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLAT-LTLLT 152
GA+ + + L+ N I S+ ++Q + + S+ + L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLK 127
Query: 153 DMSLNNN-LLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLT----TLHLQN 206
++++ +N + S ++P+ F +LT L +LDLSSN + + L L Q+ +L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 207 NQLSG-TLDVLQDLPLRDLNIENN 229
N ++ +++ L++L ++ N
Sbjct: 187 NPMNFIQPGAFKEIRLKELALDTN 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 32/146 (21%), Positives = 59/146 (40%), Gaps = 21/146 (14%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGSIPSS--LATLTLL 151
GAF SS++ + ++ S+ + T++ ++ N S + LT L
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNL 151
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGL----INLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ L++N + + L + ++LDLS N ++ + P +L L L N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 208 QLS----GTLDVLQDLPLRDLNIENN 229
QL G D L L+ + + N
Sbjct: 211 QLKSVPDGIFDRLTS--LQKIWLHTN 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 38/212 (17%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G V R ++ G+ A ++ + S + + ++H NIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
+E G LI++ + G L + I A + A
Sbjct: 79 ISEEGHHYLIFDLVTGGELFE----------------DIVAREYYSEADASHCIQQILEA 122
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
+ + H++ +VHRN K N+LL AV ++D GLA + G T
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPG 178
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
Y +PE Y D+++ GV++ LL G
Sbjct: 179 -YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 62/304 (20%), Positives = 109/304 (35%), Gaps = 64/304 (21%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
Q Y + L G G + + AVK + KR + + E + +
Sbjct: 8 QHYDLDLKDKPL-GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKE-ITALKL 61
Query: 564 IR-HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI-------- 614
H NIV+L + L+ E + G L + RI
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------------RIKKKKHFSE 105
Query: 615 RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSG 667
A R A+ ++H++ +VHR+ K N+L +D+L + + D G A L
Sbjct: 106 TEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL 726
+ L T + Y APE Y D++S GV++ +L+G+ F
Sbjct: 163 N-QPLKTPCFTLH-YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ----------VPF- 209
Query: 727 VRWAIPQLHDIDALSRMVDPSLSGQY-----PAKSLSHFA-DIISRCVQSEPEFRPPMSE 780
+ + + ++ G + K++S A D+I + +P R MS
Sbjct: 210 --QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 781 VVQD 784
+ +
Sbjct: 268 LRYN 271
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 56/280 (20%), Positives = 99/280 (35%), Gaps = 46/280 (16%)
Query: 492 PFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQK 550
P A +Y+ +S + +G+G G V+ A K + VK + K +
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 551 DDEFLEL------VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
E +L + + R+ HANI+++ G L+ E +G +L
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---------DL 117
Query: 605 KNNLSWNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656
+ + R + A A+ YL I+HR+ K NI++ +D + +
Sbjct: 118 FAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172
Query: 657 DCGLAPLISSGSVSQLSGHLLTAYG---YGAPEFESG-IYTC-QSDVYSFGVVMLELLTG 711
D G A + G T G Y APE G Y + +++S GV + L+
Sbjct: 173 DFGSAAYLERG------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
Query: 712 RKSYD--RTRNRGEQFLVRWAIPQLHDIDALSRM--VDPS 747
+ +L + +S + P
Sbjct: 227 ENPFCELEETVEAAIHPPYLVSKELMSL--VSGLLQPVPE 264
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 45/346 (13%), Positives = 83/346 (23%), Gaps = 90/346 (26%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
+ P PP V I + +
Sbjct: 1 IAFDALREPDRESSAPPDDVQLVPGARIA-----------------------NGRYRL-- 35
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQLPDGKL---LAVKKLDKR-ASSQQKDDEFLELVN 559
G ++A D L +A+ +D + E L
Sbjct: 36 ----------LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ RI + + L++ E+ G+LQ++ + + S IR
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQS 137
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
A A + H + + + + D G V +L
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSID----------------GDV------VLAY 172
Query: 680 YGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Q D+ G + LL R R + A
Sbjct: 173 PATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGVRS---GLAPAERDTAGQPI 223
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
+D + Q + + +R VQ + R S ++ +
Sbjct: 224 EPADIDRDIPFQ--------ISAVAARSVQGDGGIRSA-STLLNLM 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 51/206 (24%), Positives = 78/206 (37%), Gaps = 22/206 (10%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + + G A K + KR S + E + + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L +LI E S G L D L K +LS + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 632 QPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPE 686
I H + K NI+L + + D GLA I G + G T + APE
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG---TPE-FVAPE 188
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTG 711
++D++S GV+ LL+G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S ++ + +S+N + S+P+ LP + + +N+ + S+P+ + L L ++ N L
Sbjct: 180 PSGLQELSVSDNQLA-SLPT-LPSELYKLWAYNNRLT-SLPALPSGLKELI---VSGNRL 233
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+ +P + L L +S N L+ LP L +L + NQL+ + L L
Sbjct: 234 T-SLPV---LPSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLTRLPESLIHLSS 285
Query: 221 LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+N+E N S + + +I + P
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 5e-16
Identities = 35/184 (19%), Positives = 65/184 (35%), Gaps = 40/184 (21%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ V+++ + + ++P LP + + DN + S+P+ L L ++ N L+
Sbjct: 40 NGNAVLNVGESGL-TTLPDCLPAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT 94
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL--------------SQLTTLHLQNNQ 208
+P L L +L LP L L L L + +NQ
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQ 152
Query: 209 LSG---------TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGN 250
L+ L L LP L++L++ +N + +P ++ N
Sbjct: 153 LASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNN 211
Query: 251 PFNS 254
S
Sbjct: 212 RLTS 215
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 50/190 (26%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S + + + N + S+P + P +Q +SDNQ + S+P+ + L L NN L+
Sbjct: 121 SGLCKLWIFGNQLT-SLPVLPP-GLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT 174
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL-----------------SQLTTLHLQ 205
+P +GL L +S N L+ LP L S L L +
Sbjct: 175 -SLPM---LPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVS 229
Query: 206 NNQLSG---------TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRK 247
N+L+ L V L LP L L++ N + +PE ++ + +
Sbjct: 230 GNRLTSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETT 288
Query: 248 ---DGNPFNS 254
+GNP +
Sbjct: 289 VNLEGNPLSE 298
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 7e-14
Identities = 33/165 (20%), Positives = 57/165 (34%), Gaps = 38/165 (23%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
L + + H+ LP + ++ NQ + S+P L L+
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHL-----PALPSGLCKLWIFGNQLT-SLPVLPPGLQELS- 147
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL----------------- 196
+++N L+ +P L L +N L+ LP L
Sbjct: 148 --VSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQELSVSDNQLASLPTLP 200
Query: 197 SQLTTLHLQNNQLSGTLDVLQDLP--LRDLNIENNLFSGPIPEKM 239
S+L L NN+L+ L LP L++L + N + +P
Sbjct: 201 SELYKLWAYNNRLT----SLPALPSGLKELIVSGNRLTS-LPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 5e-12
Identities = 30/137 (21%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S ++ + +S N + S+P LP ++ +S N+ + S+P + L L S+ N L+
Sbjct: 221 SGLKELIVSGNRLT-SLPV-LPSELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT 274
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
+P++ L+ ++L N LS E + L ++T+ + + P
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLS-ERTL--QALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 221 LRDLNIENNLFSGPIPE 237
R L++ + P E
Sbjct: 331 TRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 10/150 (6%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S ++ + +S N + S+P + + + + NQ + +P SL L+ T ++L N LS
Sbjct: 241 SELKELMVSGNRLT-SLPMLPS-GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
A + +T + S + + LHL + P
Sbjct: 298 ERTLQALREIT---SAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 223 DL----NIENNLFSGPIPEKMLQIPNFRKD 248
+N +++ + NF KD
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSETENFIKD 384
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 20/103 (19%), Positives = 36/103 (34%), Gaps = 18/103 (17%)
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+ ++ G L++ + L+ LP L + +TTL + +N L+
Sbjct: 26 GRAAVVQKMRACL--NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT------ 74
Query: 217 QDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
LP LR L + N + +P + NP
Sbjct: 75 -SLPALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTH 115
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIV 570
QE+++G G V L + AVK ++K+ + F E V + + + H N++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFRE-VEMLYQCQGHRNVL 74
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEY 626
EL + E + L++E G++ +H + + + A + AL++
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNE----LEASVVVQDVASALDF 126
Query: 627 LHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV-SQLSGHLL----- 677
LH I HR+ K NIL + V + D L I S +S L
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 678 TAYGYGAPE------FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731
+A Y APE E+ IY + D++S GV++ LL+G + G
Sbjct: 184 SAE-YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-----GRCGSDCGWD 237
Query: 732 PQLHDIDALSRMVDPSLSGQY-----PAKSLSHFA-DIISRCVQSEPEFRPPMSEVVQ 783
+ + + G+Y +S A D+IS+ + + + R ++V+Q
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 52/206 (25%), Positives = 78/206 (37%), Gaps = 22/206 (10%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + + G A K + KR S + E + + ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L +LI E S G L D L K +LS + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 632 QPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPE 686
I H + K NI+L + + D GLA I G + G T + APE
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG---TPE-FVAPE 188
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTG 711
++D++S GV+ LL+G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/309 (21%), Positives = 108/309 (34%), Gaps = 77/309 (24%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
Y S++ L G G+ G V G+ A+K L ++Q+ D +
Sbjct: 28 DDYQ--LSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---- 80
Query: 564 IRHANIVELKGYC--AEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----- 614
+IV + HG+R L+I E G L RI
Sbjct: 81 --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------------RIQERGD 122
Query: 615 -----RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAP 662
R A R A+++LH I HR+ K N+L + D + ++D G A
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 663 LISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
+ ++ T Y Y APE Y D++S GV+M LL G
Sbjct: 180 ETTQNALQTPCY---TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF--------- 226
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQY-----PAKSLSHFA-DIISRCVQSEPEFR 775
F ++ + R + GQY +S A +I ++++P R
Sbjct: 227 -PPF---YSNTGQAISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 776 PPMSEVVQD 784
+++ +
Sbjct: 280 LTITQFMNH 288
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 27/158 (17%), Positives = 51/158 (32%), Gaps = 7/158 (4%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
++D S N + +P L +S N S S + +L+ L + +++N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRD 223
F+ L LDLS N L ++ L L L N ++ L+
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 224 LNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRP 261
L + + + + + P
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 10/135 (7%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIP---SSLATLTLLTDMSL 156
S +D SNN + ++ ++ L NQ + + L + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDI 381
Query: 157 -NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
N++ E L++L++SSN L+ + L ++ L L +N++
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQ 439
Query: 216 LQDLP-LRDLNIENN 229
+ L L++LN+ +N
Sbjct: 440 VVKLEALQELNVASN 454
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 23/146 (15%), Positives = 54/146 (36%), Gaps = 11/146 (7%)
Query: 103 SSIRVIDLSNNHIGG----SIPSILPVTMQNFFLSD---NQFSGSIPSSLATLTLLTDMS 155
+++ +SN + G +++ + + F + + +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS---GT 212
+ ++ ++LD S+N L+ + + +L++L TL LQ NQL
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 213 LDVLQDLP-LRDLNIENNLFSGPIPE 237
++ + L+ L+I N S +
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 21/164 (12%), Positives = 47/164 (28%), Gaps = 19/164 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
F ++ + LS H+ S + + L + L SL
Sbjct: 109 KEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGEL-----------PPSLENLSQLTTLHLQ 205
+ + + ++ +L +N+ L L+ +L+ L L
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 206 NNQLSGT-----LDVLQDLPLRDLNIENNLFSGPIPEKMLQIPN 244
N + + L ++ + +I N G + +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + Q GK A K + KR S + E + ++ IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYL 627
L +LI E S G L D L + L A + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 628 HEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGY 682
H I H + K NI+L + + + D G+A I +G+ + G T +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG---TPE-F 177
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
APE ++D++S GV+ LL+G
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 54/288 (18%), Positives = 106/288 (36%), Gaps = 21/288 (7%)
Query: 432 HEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
+D+ + ++ + + V ++ T+ A
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 492 PFTTARSFTIASLQQYTN--SFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQ 548
P A + + S+ ++G G G V++ + G LA K + R
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---G 126
Query: 549 QKDDEFLEL-VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN 607
KD E ++ ++ ++++ HAN+++L +L+ EY G L D + +
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLIS 665
L ++ + ++H++ I+H + K NIL D + + D GLA
Sbjct: 187 LDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 666 SGSV-SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
G T + APE + +D++S GV+ LL+G
Sbjct: 241 PREKLKVNFG---TPE-FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
N+F Q ++G G G V Q+ GK+ A KKL+K+ ++K + I +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
+V L Y E L L+ + G L H + R AA
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEA---RAVFYAAEICC 297
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYG 681
LE LH IV+R+ K NILLDD + +SD GLA + G ++ G T G
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG---TV-G 350
Query: 682 YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y APE YT D ++ G ++ E++ G+
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+P +P + +L NQF+ +P L+ LT + L+NN +S +F ++T L+
Sbjct: 24 VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDL 219
L LS N L +PP + L L L L N +S G + L L
Sbjct: 83 LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSAL 128
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 10/135 (7%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
I + + +I + + + L DNQ + + + L LT +T++
Sbjct: 35 VTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT-DL-APLKNLTKITELE 91
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N L + A L + LDL+S ++ ++ P L LS L L+L NQ++ +
Sbjct: 92 LSGNPLK-NV-SAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISP 146
Query: 216 LQDLP-LRDLNIENN 229
L L L+ L+I N
Sbjct: 147 LAGLTNLQYLSIGNA 161
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 24/139 (17%), Positives = 54/139 (38%), Gaps = 6/139 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L ++++ + + N + + + ++ + DN+ S I S LA+L L ++
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVH 201
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L NN +S P + + L + L++ ++ + NL + + +
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATI 259
Query: 216 LQDLPLRDLNIENNLFSGP 234
+ N+ NL S
Sbjct: 260 SDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 15/75 (20%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
++ PD +L I + +N++ + +L +TTL ++ T++
Sbjct: 4 TQPTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG 58
Query: 216 LQDLP-LRDLNIENN 229
+Q L L L +++N
Sbjct: 59 VQYLNNLIGLELKDN 73
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 31/145 (21%), Positives = 50/145 (34%), Gaps = 27/145 (18%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L S + + +N I I + + + L +NQ S + S LA + L ++
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DV-SPLANTSNLFIVT 223
Query: 156 LNNNLLSGEIPDAFQSLTGLI-----------------NLDLSSNNLSGELPPSLENLS- 197
L N ++ + +L N +S NL+ L + N+S
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSY 283
Query: 198 ---QLTTLHLQNNQLSGTLDVLQDL 219
Q T SGT V Q L
Sbjct: 284 TFNQSVTFKNTTVPFSGT--VTQPL 306
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 61/305 (20%)
Query: 503 SLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL 557
L + + F+ IG G R AVK +DK ++ E L
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR 71
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+H NI+ LK + ++ E G L D + + S R A
Sbjct: 72 Y-----GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSE----REA 118
Query: 618 LGAAR----ALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV 669
+EYLH +VHR+ K +NIL + ++ + D G A + +
Sbjct: 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-- 173
Query: 670 SQLSGHLLTAYG---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF 725
+G L+T + APE E Y D++S GV++ +LTG + + +
Sbjct: 174 ---NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 726 LVRWAIPQLHDIDALSRMVDPSLSGQY-----PAKSLSHFA-DIISRCVQSEPEFRPPMS 779
++ I SG++ S+S A D++S+ + +P R +
Sbjct: 231 ILA-RI----------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 780 EVVQD 784
V++
Sbjct: 274 LVLRH 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 72/355 (20%), Positives = 113/355 (31%), Gaps = 95/355 (26%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVN 559
F ++ L +G G G V A + +AVK L + A+ + EL
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 560 NIDRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNL---------- 608
I H N+V L G C + G L +I E+C G L L S
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 609 -------------------SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL-- 647
S + ++L + E P ++++F + L+
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 648 ----------------------------DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
+ V + D GLA I G
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 680 YGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ APE +YT QSDV+SFGV++ E+ + G Y P +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----------------PGVKID 302
Query: 738 DALSRMVDPSLSGQY---PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
+ R + G P + + C EP RP SE+V+ L +++
Sbjct: 303 EEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 46/241 (19%), Positives = 84/241 (34%), Gaps = 67/241 (27%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-----------------ASSQQKDDEFLEL 557
IG G G V A D A+K L K+ + +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 558 VNNIDR-------IRHANIVELKGYCA-EHGQRLLIY---EYCSNGTLQDMLHSDDELKN 606
+ + + + H N+V+L + +Y E + G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129
Query: 607 NLSWNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658
T ++ AR +EYLH I+HR+ K +N+L+ +D + ++D
Sbjct: 130 -----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 659 GLAPLISSGSVSQLSGHLLTAYG---YGAPEFESG---IYT-CQSDVYSFGVVMLELLTG 711
G++ L G + APE S I++ DV++ GV + + G
Sbjct: 182 GVSNEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 712 R 712
+
Sbjct: 237 Q 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 47/205 (22%), Positives = 78/205 (38%), Gaps = 22/205 (10%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA-NIVELKG 574
+G G V + G+ A K L KR Q E L + ++ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEI 630
+ +LI EY + G + + EL +S + + + YLH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSE----NDVIRLIKQILEGVYYLHQN 150
Query: 631 CQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
IVH + K NILL + + D G++ I L + T Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPE-YLAPEI 204
Query: 687 FESGIYTCQSDVYSFGVVMLELLTG 711
T +D+++ G++ LLT
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-16
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F ++G G G V+ Q+ GKL A KKL+K+ ++K + + I ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR 622
IV L Y E L L+ + G + H + N N R A+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYH----IYNVDEDNPGFQEPRAIFYTAQ 297
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
LE+LH+ I++R+ K N+LLDDD V +SD GLA + +G
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG------QTKTKG 348
Query: 680 Y----GYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR---KSYDRTRNRGEQF 725
Y G+ APE G Y D ++ GV + E++ R ++ E
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 31/131 (23%), Positives = 52/131 (39%), Gaps = 9/131 (6%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
L + I NN + +P LP+++++ +N L L LT + +
Sbjct: 190 ELQNLPFLTAIYADNNSLK-KLPD-LPLSLESIVAGNNILE--ELPELQNLPFLTTIYAD 245
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
NNLL +PD L L++ N L+ +LP ++L+ L + LS L
Sbjct: 246 NNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLY 300
Query: 218 DLPLRDLNIEN 228
L I +
Sbjct: 301 YLNASSNEIRS 311
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 41/181 (22%), Positives = 71/181 (39%), Gaps = 34/181 (18%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
EL E + S+ V + + + S LP ++ +S+NQ +P L + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKAL-----SDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-- 211
+ ++NN L ++PD L + +N L E P L+NL LT ++ NN L
Sbjct: 158 IDVDNNSLK-KLPD---LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLKKLP 211
Query: 212 -------TLDV----LQDLP-------LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
++ L++LP L + +NNL +P+ + N
Sbjct: 212 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLT 270
Query: 254 S 254
Sbjct: 271 D 271
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 21/148 (14%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S+ +++SNN + +P++ P ++ S N + +P L L + N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPP-RLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR 370
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
E PD +S+ DL N+ E+P +N L LH++ N L D+P
Sbjct: 371 -EFPDIPESVE-----DLRMNSHLAEVPELPQN---LKQLHVETNPLR----EFPDIPES 417
Query: 221 LRDLNIENNLFSGPIPEKMLQIPNFRKD 248
+ DL + + P D
Sbjct: 418 VEDLRMNSERVVDPYEFAHETTDKLEDD 445
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 24/133 (18%), Positives = 51/133 (38%), Gaps = 17/133 (12%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + S NH+ +P LP ++ + N P ++ L +N++L
Sbjct: 336 PPRLERLIASFNHL-AEVPE-LPQNLKQLHVEYNPLR-EFPDIPESVEDLR---MNSHLA 389
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+P+ Q+L L + +N L E P E+ + L + + ++ + +
Sbjct: 390 E--VPELPQNLK---QLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTD 440
Query: 221 -LRDLNIENNLFS 232
L D E++
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 26/135 (19%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
E+ S + + + P P + ++ ++ + L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAP---PGNGEQREMAVSRLRDCLDRQAHEL----- 76
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
LNN LS +P+ L +L S N+L+ ELP ++L L + LS
Sbjct: 77 -ELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 214 DVLQDLPLRDLNIEN 228
+L+ L + + +E
Sbjct: 131 PLLEYLGVSNNQLEK 145
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 14/124 (11%)
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTT 201
P +++ L + ++NL E+P +++ + + PP ++
Sbjct: 5 PRNVSNTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 202 LHLQNNQLSG--TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGN 250
L++ L++ L LP L L N + +PE + + D N
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 251 PFNS 254
+
Sbjct: 122 NLKA 125
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 9/77 (11%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
L + E+ E +++ + + N + P I ++++ ++ + +
Sbjct: 382 LRMNSHLAEVPELPQ---NLKQLHVETNPL-REFPDIPE-SVEDLRMNSERVVDPYEFAH 436
Query: 146 ATLTLLTDMSLNNNLLS 162
T L D ++
Sbjct: 437 ETTDKLEDDVFEHHHHH 453
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 58/286 (20%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V + G +AVK L+++ + + N+ RH +I++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+ ++ EY S G L D + + R+ +R ++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQILSGVD 130
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---Y 682
Y H +VHR+ K N+LLD + ++D GL+ ++S G L T+ G Y
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNY 181
Query: 683 GAPEFESG-IYT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE SG +Y + D++S GV++ LL G +D + L
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-----------------DHVPTL 224
Query: 741 SRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ + G + + L+ ++ +Q +P R + ++ +
Sbjct: 225 FKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 30/227 (13%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
T+ + + + +G+G V + + G A K + KR + + E +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 559 NN-ID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ I+H N++ L +LI E + G L D L + L
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-------- 113
Query: 615 RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS 666
A + + YLH + I H + K NI+L + + D GLA I
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 667 GSV-SQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
G+ + G T + APE ++D++S GV+ LL+G
Sbjct: 171 GNEFKNIFG---TPE-FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ S ++ + N++I S+ + T ++ LS NQ S + S L LT L ++S
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELS 91
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+N N L + + S L L L +N L SL +L L L ++NN+L ++ +
Sbjct: 92 VNRNRLK-NL-NGIPSAC-LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM 145
Query: 216 LQDLP-LRDLNIENN 229
L L L L++ N
Sbjct: 146 LGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 33/136 (24%), Positives = 59/136 (43%), Gaps = 13/136 (9%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
++ +L + + S L +QNF ++ S+ + + T L ++
Sbjct: 13 FPDPGLANAVKQNLGKQSV-TDLVSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
L++N +S ++ + LT L L ++ N L L + + L+ L L NN+L D
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELR-DTD 122
Query: 215 VLQDLP-LRDLNIENN 229
L L L L+I NN
Sbjct: 123 SLIHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 19/155 (12%), Positives = 43/155 (27%), Gaps = 25/155 (16%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIP-------------- 142
L + + + ++ N + ++ I + FL +N+
Sbjct: 79 SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELR-DTDSLIHLKNLEILSIR 136
Query: 143 -------SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLEN 195
L L+ L + L+ N ++ L + +DL+ E
Sbjct: 137 NNKLKSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPE 194
Query: 196 LSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNL 230
L T+ + + + D + L
Sbjct: 195 LYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 13/75 (17%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
++ PD L + +L +++ +L + LS + + N+ + +L
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG 58
Query: 216 LQDLP-LRDLNIENN 229
+Q L++L++ +N
Sbjct: 59 MQFFTNLKELHLSHN 73
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 59/286 (20%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V A + +A+K + ++ + +E ++ + +RH +I++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+++ EY G L D + RM R A+E
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------------RMTEDEGRRFFQQIICAIE 122
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG---Y 682
Y H IVHR+ K N+LLDD+L V ++D GL+ +++ G L T+ G Y
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG------NFLKTSCGSPNY 173
Query: 683 GAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
APE +G Y + DV+S G+V+ +L GR +D I L
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-----------------EFIPNL 216
Query: 741 SRMVDPSLSGQYPA-KSLSHFA-DIISRCVQSEPEFRPPMSEVVQD 784
+ V S Y LS A +I R + ++P R + E+ +D
Sbjct: 217 FKKV---NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 34/117 (29%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+IPS +P + L N+ S + LT L + LN+N L F+ L L
Sbjct: 30 AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENN 229
L ++ N L LP + + L L L L NQL D L L L++ N
Sbjct: 90 LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK--LTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 16/147 (10%)
Query: 100 GAFSSIR---VIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
AF + ++ L++N + ++P+ + ++ +++DN+ ++P + L L
Sbjct: 55 KAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLA 112
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS- 210
++ L+ N L P F SLT L L L N L LP + + L+ L L L NNQL
Sbjct: 113 ELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR 171
Query: 211 ---GTLDVLQDLPLRDLNIENNLFSGP 234
G D L +L L+ N L P
Sbjct: 172 VPEGAFDKLTELKTLKLD-NNQLKRVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F ++ + L N + S+P + + L N+ S+P + LT L
Sbjct: 103 GVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
++ L NN L AF LT L L L +N L + ++L +L L LQ N
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V+R + G++ K ++ K E ++ ++++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNE-ISIMNQLHHPKLINLHDA 116
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ + +LI E+ S G L D + ++D + +R A L+++HE I
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SI 170
Query: 636 VHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPE-FESGI 691
VH + K NI+ +V + D GLA ++ + + TA + APE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAE-FAAPEIVDREP 226
Query: 692 YTCQSDVYSFGVVMLELLTG 711
+D+++ GV+ LL+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSS--LATLTLLTDMSLNNNLLSGEIPDAFQSLTGL 175
IP +P+ L+DN+ I S L L + L N L+G P+AF+ + +
Sbjct: 22 EIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 176 INLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENN 229
L L N + E+ + L QL TL+L +NQ+S G+ + L L LN+ +N
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS--LTSLNLASN 136
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 55/293 (18%), Positives = 100/293 (34%), Gaps = 72/293 (24%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELV----NNIDRIRHA--N 568
L+G+G GSVY + D +A+K ++K S + V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 569 IVELKGYCAEHGQRLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
++ L + +LI E L D + L+ L AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSFFWQ 157
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
A+ + H ++HR+ K NIL+D + + + D G L+
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-------DTVYTD 207
Query: 679 AYG---YGAPEFESG-IYT-CQSDVYSFGVVMLELLTGRKSYDRTRN--RGEQFLVRWAI 731
G Y PE+ Y + V+S G+++ +++ G ++ RG+ F +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR-- 265
Query: 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+S + + L I C+ P RP E+
Sbjct: 266 ----------------VSSE--CQHL------IRWCLALRPSDRPTFEEIQNH 294
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 3e-15
Identities = 31/134 (23%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
AF+ +L + ++ ++ +++ S+ + L +T + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N L+ +I +L L L L N + +L L++L +L +L L++N +S ++ L
Sbjct: 73 NGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 127
Query: 217 QDLP-LRDLNIENN 229
LP L L + NN
Sbjct: 128 VHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 42/232 (18%), Positives = 70/232 (30%), Gaps = 8/232 (3%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L + + L NN I I + +T + L DNQ S I LA LT L ++
Sbjct: 125 NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 181
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N +S ++ A L L L+L S + NL T+ + L +
Sbjct: 182 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 216 LQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFF 275
D N++ +L + ++P T
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGT 299
Query: 276 GPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSNSGKKKSSTTKKIVWISI 327
+ + P G G + N G + + T +
Sbjct: 300 VIKTKVEAGTRITAPKPPTKQGYVFKGWYT--EKNGGHEWNFNTDYMSGNDF 349
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 16/144 (11%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSLNNNLLS 162
S RV + + IPS LP + I + + L + ++ N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 163 GEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS-------GTL 213
I D F +L L + + N + P +NL L L + N +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 214 DVLQDLPLRDLN----IENNLFSG 233
L ++D IE N F G
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 32/135 (23%), Positives = 52/135 (38%), Gaps = 14/135 (10%)
Query: 103 SSIRVIDLS-NNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++D+ N +I +I L +L+ N S+ L +
Sbjct: 128 LQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 158 NNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDV 215
NN L E+P D F +G + LD+S + LP LENL +L N + L
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241
Query: 216 LQDLP-LRDLNIENN 229
L+ L L + ++
Sbjct: 242 LEKLVALMEASLTYP 256
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 27/160 (16%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPS-SLATLTLLT 152
G S+ R ++L N+I I T ++ L N I + L L
Sbjct: 72 GIPSNTRYLNLMENNI----QMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLN 126
Query: 153 DMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQ-NNQL 209
+ L +N L+ IP AF+ L+ L L L +N + +P + + L L L +L
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184
Query: 210 SG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
+ + L L+ LN+ +PN
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK--------DMPNLTP 216
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 32/142 (22%), Positives = 62/142 (43%), Gaps = 18/142 (12%)
Query: 100 GAFS---SIRVIDLSN-NHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPSSLATLTLL 151
AF+ S+ +DL + I L ++ L +P+ L L L
Sbjct: 165 YAFNRVPSLMRLDLGELKKLE-YISEGAFEGLF-NLKYLNLGMCNIK-DMPN-LTPLVGL 220
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS 210
++ ++ N P +F L+ L L + ++ +S + + + L+ L L+L +N LS
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
Query: 211 GTL--DVLQDLP-LRDLNIENN 229
+L D+ L L +L++ +N
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 7/115 (6%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
GAF +++ ++L +I +P++ P+ ++ +S N F P S L+ L +
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ N+ +S +AF L L+ L+L+ NNLS LP L L LHL +N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 9/106 (8%)
Query: 131 FLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGEL 189
+ S +P + + L +L N + D F+ L L L L N++ ++
Sbjct: 60 VCTRRGLS-EVPQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QI 114
Query: 190 PP-SLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFS 232
+ L+ L TL L +N L+ + L LR+L + NN
Sbjct: 115 EVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 32/145 (22%), Positives = 54/145 (37%), Gaps = 35/145 (24%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSS--------LATLTL------------------L 151
IP +P L++N+F+ + ++ L + +
Sbjct: 25 KIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS 210
++ L +N L F+ L L L L SN ++ + S LS + L L +NQ++
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 211 ----GTLDVLQDLPLRDLNIENNLF 231
G D L L LN+ N F
Sbjct: 143 TVAPGAFDTLHS--LSTLNLLANPF 165
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 51/222 (22%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL------VNNIDRIRHANI 569
+G+G G V A + K +A+K + KR + E + + ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----RMALGAAR--- 622
+++K + + ++ E G L D ++ R+ +
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFD----------------KVVGNKRLKEATCKLYF 120
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV-SQLS 673
A++YLHE I+HR+ K N+LL ++D + ++D G + ++ S+ L
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 674 GHLLTAYGYGAPE----FESGIYTCQSDVYSFGVVMLELLTG 711
G T Y APE + Y D +S GV++ L+G
Sbjct: 178 G---TPT-YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 21/241 (8%)
Query: 477 PAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKL 535
AE S + A+P R F ++G G +V A+ +
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATSRE 57
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKGYCAEHGQRL-LIYEYCSNGT 593
A+K L+KR ++ ++ ++ R+ H V+L + + ++L Y NG
Sbjct: 58 YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE 116
Query: 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653
L + TR A ALEYLH I+HR+ K NILL++D+ +
Sbjct: 117 LLKYIRKIGSFDETC---TRFYTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHI 169
Query: 654 SVSDCGLAPLISSGSVSQLSGHLL-TAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG 711
++D G A ++S S + + TA Y +PE SD+++ G ++ +L+ G
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
Query: 712 R 712
Sbjct: 229 L 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 26/135 (19%), Positives = 55/135 (40%), Gaps = 10/135 (7%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++ + + ++ N + S P + + N + I ++ T LT++ +
Sbjct: 101 DVTPLTKLTYLNCDTNKLTKLDVSQNP-LLTYLNCARNTLT-EID--VSHNTQLTELDCH 156
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
N ++ T L LD S N ++ EL + L L+ N ++ LD+ Q
Sbjct: 157 LNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQ 210
Query: 218 DLPLRDLNIENNLFS 232
++ L L+ +N +
Sbjct: 211 NIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 29/140 (20%), Positives = 59/140 (42%), Gaps = 12/140 (8%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ +++ +D N+ I + I + + N + ++ L+ T LT ++
Sbjct: 37 SEEQLATLTSLDCHNSSI-TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
++N L+ + LT L L+ +N L+ +L S LT L+ N L+ +DV
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EIDVS 145
Query: 217 QDLPLRDLNIENNLFSGPIP 236
+ L +L+ N +
Sbjct: 146 HNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 33/140 (23%), Positives = 52/140 (37%), Gaps = 20/140 (14%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVT----MQNFFLSDNQFSGSIPSSLATLTLLTD 153
+L + +D S+N + + + VT + F S N + + S TL+ LT
Sbjct: 207 DLNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTT 258
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L EI T LI EL + + +QL L Q ++ L
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-EL 312
Query: 214 DVLQDLP-LRDLNIENNLFS 232
D L P L L + N +
Sbjct: 313 D-LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 25/136 (18%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + + + ++N+I ++ + N+ + ++ + LT LT ++
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+ N L+ ++ L L+ + N L+ E+ + + +QLT L N+ LDV
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT 167
Query: 217 QDLPLRDLNIENNLFS 232
L L+ N +
Sbjct: 168 PQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 17/162 (10%), Positives = 49/162 (30%), Gaps = 10/162 (6%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++ + + ++D I + + +L++ + + + ++ T L +S
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT-TLHLQNNQLSGTLDVL 216
N + + + + L N + +P + LT + G +
Sbjct: 348 NAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNI 404
Query: 217 QDLPLRDLNIENNLFS-GPIPEKMLQIP-NFRKDGNPFNSTV 256
+ + N + + + F + TV
Sbjct: 405 EPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 17/85 (20%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ + + L L +LD +++++ ++ +E L+ LT L +N
Sbjct: 20 FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN 74
Query: 208 QLSGTLDVLQDLPLRDLNIENNLFS 232
++ TLD+ Q+ L L ++N +
Sbjct: 75 NIT-TLDLSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 7/66 (10%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
PD + + S E L+ LT+L N+ ++ + ++ L L
Sbjct: 15 FPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTK 68
Query: 224 LNIENN 229
L +N
Sbjct: 69 LICTSN 74
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 35/152 (23%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
I V++++ N + S+P LP +++ DN+ S ++P A+L L ++NN L
Sbjct: 79 PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS-TLPELPASLKHL---DVDNNQL 132
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPL 221
+ +P+ L ++ +N L+ LP + L L ++NNQL+ ++ + L
Sbjct: 133 T-MLPELPALLE---YINADNNQLT-MLPELPTS---LEVLSVRNNQLTFLPELPES--L 182
Query: 222 RDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
L++ NL +P ++ + + F
Sbjct: 183 EALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 8/146 (5%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDM----SLNN 158
+S+ V+ + NN + +P LP +++ +S N S+P+ +
Sbjct: 160 TSLEVLSVRNNQLT-FLPE-LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQD 218
N ++ IP+ SL + L N LS + SL + H S +
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
Query: 219 LPLRDLNIENNLFSGPIPEKMLQIPN 244
L + F + QI +
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 34/139 (24%), Positives = 51/139 (36%), Gaps = 31/139 (22%)
Query: 119 IPSILPVTMQNFFLSDNQFSGSIP-------SSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
+ +LP+ NF LS N F +I S+ N N + +
Sbjct: 1 MSIMLPIN-NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL-- 57
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG---------TLDV----LQD 218
+ L L+ NLS LP +L Q+T L + N L LD L
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALISLPELPASLEYLDACDNRLST 114
Query: 219 LP-----LRDLNIENNLFS 232
LP L+ L+++NN +
Sbjct: 115 LPELPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 23/129 (17%), Positives = 31/129 (24%), Gaps = 5/129 (3%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLL 151
N + + N I IP + L DN S I SL+ T
Sbjct: 198 VPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
D S Q+ D + + + N S
Sbjct: 257 PDYHGPRIYFSMSDG--QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA 314
Query: 212 TLDVLQDLP 220
LD L D
Sbjct: 315 FLDRLSDTV 323
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 32/247 (12%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
+ + +Q +++ +IG G G V++A+L + +A+K
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK 70
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL------LIYEYCSNGT 593
K+ Q K + EL + ++H N+V+LK + +G + L+ EY T
Sbjct: 71 KV-----LQDKRFKNREL-QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-T 123
Query: 594 LQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652
+ +LK + I++ + R+L Y+H I I HR+ K N+LLD
Sbjct: 124 VYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSG 179
Query: 653 V-SVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE--FESGIYTCQSDVYSFGVVM 705
V + D G A ++ +G + +Y Y APE F + YT D++S G VM
Sbjct: 180 VLKLIDFGSAKILIAGEPN-------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 706 LELLTGR 712
EL+ G+
Sbjct: 233 AELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 33/256 (12%)
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL- 530
V+ V +K T + + S++ +IG G G VY+A+L
Sbjct: 17 VQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC 76
Query: 531 PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL------L 584
G+L+A+KK+ Q K + EL + ++ H NIV L+ + G++ L
Sbjct: 77 DSGELVAIKKV-----LQDKRFKNREL-QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPIVHRNFKSA 643
+ +Y T+ + K L +++ + R+L Y+H I HR+ K
Sbjct: 131 VLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ 185
Query: 644 NILLDDDLAV-SVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE--FESGIYTCQS 696
N+LLD D AV + D G A + G +Y Y APE F + YT
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRG-------EPNVSYICSRYYRAPELIFGATDYTSSI 238
Query: 697 DVYSFGVVMLELLTGR 712
DV+S G V+ ELL G+
Sbjct: 239 DVWSAGCVLAELLLGQ 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 40/203 (19%), Positives = 78/203 (38%), Gaps = 24/203 (11%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
+G G G V+R + K K + + D ++ I RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVK--KEISILNIARHRNILHL 66
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
+ ++I+E+ S + + +++ N + + AL++LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQFLHSH-- 121
Query: 633 PPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSV-SQLSGHLLTAYGYGAPE-FE 688
I H + + NI+ + + + G A + G L Y APE +
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APE-YYAPEVHQ 176
Query: 689 SGIYTCQSDVYSFGVVMLELLTG 711
+ + +D++S G ++ LL+G
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 63/291 (21%), Positives = 101/291 (34%), Gaps = 64/291 (21%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
IG+G G + +L+AVK +++ DE ++ + N +RH NIV K
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER----GAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+I EY S G L + + + R + AR +
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICN------------AGRFSEDEARFFFQQLLSGVS 130
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLA--VSVSDCGLAPLISSGSVSQLSGHLL-TAYG- 681
Y H + I HR+ K N LLD A + + D G S S + + G
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY-------SKSSVLHSQPKSTVGT 180
Query: 682 --YGAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
Y APE Y +DV+S GV + +L G ++ +
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----------------EEP 224
Query: 738 DALSRMVDPSLSGQYPAKSLSHF----ADIISRCVQSEPEFRPPMSEVVQD 784
+ + LS +Y +ISR ++P R + E+
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 65/371 (17%), Positives = 110/371 (29%), Gaps = 116/371 (31%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
M+ P PP PP P PPP K +
Sbjct: 2 MLTKPLQGPPAPPGTPTPPP--------------------GGKDREAFEAEYRLGP---- 37
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLE---- 556
L+G G G+V+ L D +A+K + +
Sbjct: 38 --------------LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 557 ------LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT-LQDMLHSDDELKNNLS 609
V H ++ L + +L+ E L D +
Sbjct: 84 EVALLWKVGAGGG--HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--------- 132
Query: 610 WNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGL 660
+ + G +R A+++ H +VHR+ K NIL+D + D G
Sbjct: 133 ---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186
Query: 661 APLISSGSVSQLSGHLLTAYG---YGAPEFESGI-YT-CQSDVYSFGVVMLELLTGRKSY 715
L+ G Y PE+ S Y + V+S G+++ +++ G +
Sbjct: 187 GALLH-------DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239
Query: 716 DRTR--NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPE 773
+R + E P +S +L I RC+ +P
Sbjct: 240 ERDQEILEAE-----LHFP-------------AHVSPD--CCAL------IRRCLAPKPS 273
Query: 774 FRPPMSEVVQD 784
RP + E++ D
Sbjct: 274 SRPSLEEILLD 284
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 8/117 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+PS +P + L + ++ LT LT ++L+ N L F LT L
Sbjct: 28 SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT 87
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDLPLRDLNIENN 229
L L++N L+ LP + ++L+QL L+L NQL SG D L L++L + N
Sbjct: 88 LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK--LKELRLNTN 141
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F + + + L+NN + S+P + + +L NQ S+PS + LT L
Sbjct: 77 GVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK 134
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
++ LN N L IP AF LT L L LS+N L + + L +L T+ L NQ
Sbjct: 135 ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKK--LDKRASSQQKDDEFLELVNNI 561
++ + F E + G G G+V + G +A+KK D R ++ E L+++ ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRE-LQIMQDL 73
Query: 562 DRIRHANIVELKGYCAEHGQR-------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ H NIV+L+ Y G+R ++ EY + TL + + I
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL-I 131
Query: 615 RMAL-GAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQL 672
++ L R++ LH + HR+ K N+L++ D + + D G A +S +
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-- 188
Query: 673 SGHLLTAY----GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
AY Y APE F + YT D++S G + E++ G
Sbjct: 189 -----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 31/134 (23%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ AF+ +L + ++ ++ +++ S+ + L +T + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N L+ +I +L L L L N + +L L++L +L +L L++N +S ++ L
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 130
Query: 217 QDLP-LRDLNIENN 229
LP L L + NN
Sbjct: 131 VHLPQLESLYLGNN 144
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 8/136 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L + + L NN I I + +T + L DNQ S I LA LT L ++
Sbjct: 128 NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 184
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N +S ++ A L L L+L S + NL T+ + L T ++
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEI 241
Query: 216 LQDLP-LRDLNIENNL 230
+ D N++ +L
Sbjct: 242 ISDDGDYEKPNVKWHL 257
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 42/222 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI------ 561
+ L+G G G V + + G+++A+KK + + ++V I
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--------LESDDDKMVKKIAMREIK 76
Query: 562 --DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT---RIRM 616
++RH N+V L C + + L++E+ +L + N L + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL 676
+ + + H I+HR+ K NIL+ V + D G A +++ G +
Sbjct: 133 II---NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------GEV 180
Query: 677 LTAYG----YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y DV++ G ++ E+ G
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 40/122 (32%), Positives = 49/122 (40%), Gaps = 7/122 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P L N LT LT + L N L F LT L
Sbjct: 21 SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDLPLRDLNIENNLFS 232
L+LS+N L LP + + L+QL L L NQL G D L L L N L S
Sbjct: 81 LNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ-NQLKS 138
Query: 233 GP 234
P
Sbjct: 139 VP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLS 181
++ LS NQ S+P+ + LT L +++LN N L +PD F LT L +L L
Sbjct: 75 LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132
Query: 182 SNNLSGELPPSLENLSQLTTLHLQNNQ 208
N L + L+ L + L +N
Sbjct: 133 QNQLKSVPDGVFDRLTSLQYIWLHDNP 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 6/115 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+P LP + LS N S ++ L+ L + L++N + F L
Sbjct: 45 HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRDLNIENN 229
LD+S N L + ++ L L L N +L L L +
Sbjct: 105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 28/147 (19%), Positives = 61/147 (41%), Gaps = 21/147 (14%)
Query: 99 LGAFSS---IRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQF----SGSIPSSLATLT 149
S+ ++ + L N + + + + M + D S + + A
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTG-LINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
+ ++L++N+L+ F+ L + LDL +N + +P + +L L L++ +NQ
Sbjct: 429 SILVLNLSSNMLT---GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 209 LS----GTLDVLQDLPLRDLNIENNLF 231
L G D L L+ + + +N +
Sbjct: 485 LKSVPDGVFDRLTS--LQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 11/136 (8%)
Query: 102 FSSIRVIDLSNNHIGG--SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
F+ + + LS + + P + + N F+ S+ +TL L + L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 160 LLSGEIPDAFQSLTGLINLDLSSNNL----SGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L + +L+ +L S + + L+L +N L T V
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML--TGSV 444
Query: 216 LQDLP--LRDLNIENN 229
+ LP ++ L++ NN
Sbjct: 445 FRCLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 22/140 (15%), Positives = 47/140 (33%), Gaps = 14/140 (10%)
Query: 108 IDLSNNHIGGSI----PSILPVTMQNFFLSD---NQFSGSIPSSLATLTLLTDMSLNNNL 160
+++ N I I + +++ + F S + + + L+ +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL------SGTLD 214
S + L+ + N + + L +L TL LQ N L +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 215 VLQDLPLRDLNIENNLFSGP 234
+ L D+++ N+L S
Sbjct: 401 NMSSLETLDVSL-NSLNSHA 419
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 34/171 (19%), Positives = 61/171 (35%), Gaps = 26/171 (15%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSILP-------VTMQNFFLSDNQFSGSIPSSLATLT 149
S + RV+ LS+N I L ++ +S N+ +I +
Sbjct: 70 PDISFLSELRVLRLSHNRI-----RSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMA 121
Query: 150 LLTDMSLNNNLLSGEIPDA--FQSLTGLINLDLSSNNLSGELPPSLENLSQLT-TLHLQN 206
L + L+ N +P F +LT L L LS+ + +L L L +
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180
Query: 207 NQLS-GTLDVLQDLPLRDLNIE---NNLFSGPIPEKMLQIPNFRKDGNPFN 253
+ G + LQ L++ N+LFS + + + + + N
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 39/124 (31%), Positives = 56/124 (45%), Gaps = 12/124 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P Q +L DNQ + P +L L ++ L +N L F SLT L
Sbjct: 33 SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS------GTLDVLQDLPLRDLNIENNL 230
LDL +N L+ LP ++ + L L L + N+L+ L L L L N L
Sbjct: 93 LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQ----NQL 147
Query: 231 FSGP 234
S P
Sbjct: 148 KSIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 125 VTMQNFFLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183
+ L NQ + +PS++ L L ++ + N L+ E+P + LT L +L L N
Sbjct: 88 TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQ 208
L + + LS LT +L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 42/222 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID----- 562
+ + IG G G V++ + G+++A+KK + E ++ I
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF--------LESEDDPVIKKIALREIR 54
Query: 563 ---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT---RIRM 616
+++H N+V L + L++EYC +LH D + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL 676
L +A+ + H+ +HR+ K NIL+ + + D G A L++
Sbjct: 111 TL---QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG------PSDY 158
Query: 677 LTAYG----YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y +PE Y DV++ G V ELL+G
Sbjct: 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 1e-12
Identities = 26/116 (22%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
++ +RV+ L++ + + + + + + LS N+ ++P +LA L L +
Sbjct: 435 VLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLS 210
++N L + +L L L L +N L L + +L L+LQ N L
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183
P+ ++F + + L + L+ + + L + +LDLS N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHN 473
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSG-PIPEKMLQ 241
L LPP+L L L L +N L +D + +LP L++L + NN + ++
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 242 IPNFRK---DGNPF 252
P GN
Sbjct: 532 CPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 31/115 (26%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
L L A + V+ S+N + ++ +A L L +
Sbjct: 477 ALPPALAALRCLEVLQASDNAL-ENVD-----------------------GVANLPRLQE 512
Query: 154 MSLNNNLLSG-EIPDAFQSLTGLINLDLSSNNLS------GELPPSLENLSQLTT 201
+ L NN L S L+ L+L N+L L L ++S + T
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 10/107 (9%)
Query: 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLS 186
++F ++ IPS + L L L IP AF +L + + +S +
Sbjct: 14 EDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68
Query: 187 GELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
+L S NLS++T + ++N + + D L++LP L+ L I N
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 25/159 (15%), Positives = 59/159 (37%), Gaps = 23/159 (14%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN------FFLSDNQFSGSIP--SSLATL 148
+F + I++ N ++ I P ++ + + P + + +
Sbjct: 74 HSFYNLSKVTHIEIRNTR---NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 149 TLLTDMSLNNNLLSGEIP-DAFQSLTG-LINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
+ + + +N IP +AFQ L + L L +N + + N ++L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 207 NQLSGTL--DVLQDLP--LRDLNIENNLFSGPIPEKMLQ 241
N+ + D + L++ + +P K L+
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 15/142 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSL- 156
S + + L H+ +IPS LP + ++S + + S S L+ +T + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP--SLENLSQLTTLHLQNNQLSGTL- 213
N L+ PDA + L L L + + L P + + L + +N ++
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 214 -DVLQDLP--LRDLNIENNLFS 232
+ Q L L + NN F+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT 169
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 34/107 (31%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P + L N+ LT LT +SL+ N + F LT L
Sbjct: 21 SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDL 219
L L N L LP + + L+QL L L NQL G D L L
Sbjct: 81 LYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 43/227 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F +IG G V ++ G++ A+K ++K ++ + ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
I +L + + L L+ EY G +L LS R+ AR
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGG----------DLLTLLS-KFGERIPAEMARFYL 168
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHL 676
A++ +H + VHR+ K NILLD + ++D G L + G+V
Sbjct: 169 AEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS----- 220
Query: 677 LTAYG---YGAPE--------FESGIYTCQSDVYSFGVVMLELLTGR 712
L A G Y +PE +G Y + D ++ GV E+ G+
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 511 FSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F +IG G G V +L + K+ A+K L+K ++ + ++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
I L Y + L L+ +Y G +L LS R+ AR
Sbjct: 136 ITTLH-YAFQDDNNLYLVMDYYVGG----------DLLTLLS-KFEDRLPEEMARFYLAE 183
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHLLT 678
A++ +H++ VHR+ K NIL+D + + ++D G L+ G+V
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSV 235
Query: 679 AYG---YGAPE------FESGIYTCQSDVYSFGVVMLELLTGR 712
A G Y +PE G Y + D +S GV M E+L G
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI------ 561
+ F IG G G V Q D K+ A+K ++K+ ++ + V N+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE------VRNVFKELQI 68
Query: 562 -DRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ H +V L Y + + + ++ + G +L+ +L N +
Sbjct: 69 MQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGG----------DLRYHLQQNVHFKEE-- 115
Query: 620 AAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
+ AL+YL I+HR+ K NILLD+ V ++D +A ++ +
Sbjct: 116 TVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 672 -LSGHLLTAYGYGAPE----FESGIYTCQSDVYSFGVVMLELLTGR 712
++G T Y APE + Y+ D +S GV ELL GR
Sbjct: 173 TMAG---TK-PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 3e-12
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLS 197
L LT++ + N + + L L NL + + L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 198 QLTTLHLQNNQLSGTL--DVLQDLPLRDLNIENN 229
+L+ L+L N L +L +Q L L++L + N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 19/103 (18%), Positives = 29/103 (28%), Gaps = 7/103 (6%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TL 213
+ L L L + + L L L +L L + + L
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 214 DVLQDLP-LRDLNIENNLFSG--PIPEKMLQIPNFRKDGNPFN 253
D P L LN+ N + L + GNP +
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 517 IGAGMLGSVYRAQ---LPDGKLLAVKKLDK--RASSQQKDDEFL-ELVNNIDRIRHANIV 570
+G G G VY+A+ D K A+K+++ + S ++ L EL +H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-------KHPNVI 81
Query: 571 ELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA------- 621
L+ H R L+++Y D+ H + + + +++ G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 622 -RALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSDCGLAPLISS--GSVSQLSG 674
+ YLH ++HR+ K ANIL+ + V ++D G A L +S ++ L
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 675 HLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++T + Y APE + YT D+++ G + ELLT
Sbjct: 195 VVVTFW-YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 31/150 (20%), Positives = 55/150 (36%), Gaps = 34/150 (22%)
Query: 101 AFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
S ++ + L N+ G + L +S N
Sbjct: 15 TPSDVKELVLDNSRSN---------------------EGKLEGLTDEFEELEFLSTINVG 53
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQD 218
L+ I + L L L+LS N +SG L E LT L+L N++ T++ L+
Sbjct: 54 LT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK 111
Query: 219 LP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
L L+ L++ N + + ++R+
Sbjct: 112 LENLKSLDLFNC----EV----TNLNDYRE 133
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 28/134 (20%), Positives = 51/134 (38%), Gaps = 28/134 (20%)
Query: 77 NASDIIAIILNGANLG-GELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDN 135
SD+ ++L+ + G+L F + + N + SI
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSI------------- 57
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSL 193
++L L L + L++N +SG + + L +L+LS N + + P L
Sbjct: 58 -------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-L 109
Query: 194 ENLSQLTTLHLQNN 207
+ L L +L L N
Sbjct: 110 KKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-12
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 124 PVTMQNFFLSDNQFS-GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSS 182
P ++ L + + + G I A L +SL N L + + L L L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 183 NNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRDLNIENN 229
N + G L E L LT L+L N+L TL+ L+ L L+ L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 77 NASDIIAIILNGANLGGELGENLGA-FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDN 135
+ + ++L+ E L A F ++ + L N + S+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISV------------- 64
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSL 193
S+L L L + L+ N + G + + L L +L+LS N L L P L
Sbjct: 65 -------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-L 116
Query: 194 ENLSQLTTLHLQNNQLSGTLD----VLQDLP-LRDL 224
+ L L +L L N +++ D V + LP L L
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 59/211 (27%), Positives = 85/211 (40%), Gaps = 33/211 (15%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
L+G G G V + G+ A+K L K + + N + RH + LK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR---ALEY 626
Y + RL + EY + G L H LS R A AL+Y
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFSEDRARFYGAEIVSALDY 263
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG---Y 682
LH + +V+R+ K N++LD D + ++D GL I G+ + T G Y
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK------TFCGTPEY 315
Query: 683 GAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
APE Y D + GVVM E++ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 41/221 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE------------FLE 556
+ + +G G G VY+A+ G+++A+K++ +DE E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKE 75
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR--- 613
L H NIV L L++E+ +D+ DE K L +
Sbjct: 76 L-------HHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIY 124
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ L R + + H+ I+HR+ K N+L++ D A+ ++D GLA V +
Sbjct: 125 LYQLL---RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYT 177
Query: 674 GHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++T + Y AP+ S Y+ D++S G + E++TG+
Sbjct: 178 HEVVTLW-YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 1e-11
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE------------FLELV 558
+ IG G G VY+AQ G+ A+KK+ +K+DE EL
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKEL- 57
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---IR 615
+H+NIV+L + +L++E+ QD+ D + L T +
Sbjct: 58 ------KHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLL 107
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH 675
L + Y H+ ++HR+ K N+L++ + + ++D GLA V + +
Sbjct: 108 QLL---NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHE 160
Query: 676 LLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++T + Y AP+ S Y+ D++S G + E++ G
Sbjct: 161 IVTLW-YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 34/144 (23%), Positives = 55/144 (38%), Gaps = 14/144 (9%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
++ L+ I + V + L + I + ATL + ++N + ++
Sbjct: 1 MVKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD 58
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRD 223
F L L L +++N + + L LT L L NN L G LD L L L
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 224 LNIENNLFSGPIPEKMLQIPNFRK 247
L I N P+ K ++R
Sbjct: 118 LCILRN----PVTNK----KHYRL 133
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 64/372 (17%), Positives = 115/372 (30%), Gaps = 32/372 (8%)
Query: 351 RGEVDRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIP 410
G D K + + ++++ + + P +K + R +
Sbjct: 190 NGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWD 249
Query: 411 HAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKV 470
+ L P PP E+
Sbjct: 250 LTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA 309
Query: 471 IVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL 530
+ A + + F+ ++G G G V ++
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKL-------TDFNFLMVLGKGSFGKVMLSER 362
Query: 531 PD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVELKGYCAEHGQRL-LIY 586
+L AVK L K Q D E + + + + +L C + RL +
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 421
Query: 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEICQPPIVHRNFKSANI 645
EY + G L M H + A A L +L I++R+ K N+
Sbjct: 422 EYVNGGDL--MYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNV 473
Query: 646 LLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG---YGAPEFESGI-YTCQSDVYS 700
+LD + + ++D G+ I G ++ T G Y APE + Y D ++
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGVTTK------TFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 701 FGVVMLELLTGR 712
FGV++ E+L G+
Sbjct: 528 FGVLLYEMLAGQ 539
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 50/294 (17%), Positives = 92/294 (31%), Gaps = 92/294 (31%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P +
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSI---------------------------------- 33
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE---------- 553
+ + + +G G G VY+A + +A+K++ + ++E
Sbjct: 34 ----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREV 84
Query: 554 --FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN 611
EL +H NI+ELK + + LI+EY +++LK + N
Sbjct: 85 SLLKEL-------QHRNIIELKSVIHHNHRLHLIFEYA-----------ENDLKKYMDKN 126
Query: 612 TRIRMALGAA------RALEYLHEICQPPIVHRNFKSANILLDDDLAVS-----VSDCGL 660
+ M + + + + H +HR+ K N+LL A + D GL
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
Query: 661 APLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
A + Q + ++T + Y PE S Y+ D++S + E+L
Sbjct: 184 ARAFGI-PIRQFTHEIITLW-YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 42/224 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ +IG G G V + K+ A+K L K ++ D F +I
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
+V+L Y + + L ++ EY G L ++ + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYT 174
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHL 676
AL+ +H + +HR+ K N+LLD + ++D G + G V
Sbjct: 175 AEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC----- 226
Query: 677 LTAYG---YGAPEF-----ESGIYTCQSDVYSFGVVMLELLTGR 712
TA G Y +PE G Y + D +S GV + E+L G
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 16/159 (10%)
Query: 97 ENLGAFSSIRVIDLSNNH-----IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLL 151
+ ++L + ++ ++ ++ LS N I SSL+ + L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTL--KACKHLALSTNNIE-KI-SSLSGMENL 72
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS- 210
+SL NL+ +I + L L +S N ++ L +E L L L++ NN+++
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN 129
Query: 211 -GTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
G +D L L L DL + N E +R
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENN-ATSEYRI 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 9e-11
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 42/221 (19%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE------------FLEL 557
+ + IG G G+V++A+ +++A+K++ DDE EL
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKEL 58
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---I 614
+H NIV L + L++E+C QD+ D +L +
Sbjct: 59 -------KHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
L + L + H ++HR+ K N+L++ + + +++ GLA V S
Sbjct: 108 FQLL---KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSA 160
Query: 675 HLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGRK 713
++T + Y P+ F + +Y+ D++S G + EL +
Sbjct: 161 EVVTLW-YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 60/211 (28%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
L+G G G V + G+ A+K L K + + + + RH + LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR---ALEY 626
Y + RL + EY + G L H LS R A ALEY
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSALEY 120
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG---Y 682
LH +V+R+ K N++LD D + ++D GL IS G+ + T G Y
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK------TFCGTPEY 171
Query: 683 GAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
APE Y D + GVVM E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-----------LE 556
++ + + +G G +VY+ + L+A+K++ + ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR--- 613
L +HANIV L L++EY +D+ D+ N ++ +
Sbjct: 57 L-------KHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLF 105
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ L R L Y H ++HR+ K N+L+++ + ++D GLA S
Sbjct: 106 LFQLL---RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYD 158
Query: 674 GHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++T + Y P+ S Y+ Q D++ G + E+ TGR
Sbjct: 159 NEVVTLW-YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 30/189 (15%), Positives = 61/189 (32%), Gaps = 31/189 (16%)
Query: 72 QGVQCNASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGS----IPSIL 123
+G+ + + L +L L L A + + +SNN I + + L
Sbjct: 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL 194
Query: 124 PV---TMQNFFLSDNQFS----GSIPSSLATLTLLTDMSLNNNLLSGE-----IPDAFQS 171
++ L + + +A+ L +++L +N L P
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 172 LTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQD--LP 220
+ L L + ++ + L L L L L N+L + L +
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 221 LRDLNIENN 229
L L +++
Sbjct: 315 LESLWVKSC 323
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 34/153 (22%), Positives = 55/153 (35%), Gaps = 23/153 (15%)
Query: 103 SSIRVIDLSNNHIG-GSIPSILPV--TMQNFFLSDNQFS----GSIPSSLATLTLLTDMS 155
I+ +D+ + +LP+ Q L D + I S+L L +++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 156 LNNNLLSGE----IPDAFQSL-TGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQN 206
L +N L + Q+ + L L + L+G L +L L L LHL +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 207 NQLSGT-----LDVLQD--LPLRDLNIENNLFS 232
N L + L D L L +E S
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 30/178 (16%), Positives = 62/178 (34%), Gaps = 31/178 (17%)
Query: 86 LNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGS-IPSILPV------TMQNFFLSD 134
+ + + L L A S++ + L+ N +G + +++ ++
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 135 NQFSG----SIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQS-LTGLINLDLSSNNL 185
F+ S LA L ++ ++NN L + + L L L+ ++
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 186 SGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQD--LPLRDLNIENNLFS 232
S L +L L L L NN L ++ ++ L L + + +S
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 26/152 (17%)
Query: 104 SIRVIDLSNNHIG----GSIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTL-----LT 152
I+ + L N + G + S L T+Q LSDN + L L L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 153 DMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLE-NLSQLTTLH 203
+ L LS + ++ L +S+N+++ L L+ + QL L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 204 LQNNQLSGT-----LDVLQDLP-LRDLNIENN 229
L++ ++ ++ LR+L + +N
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSN 237
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 26/160 (16%)
Query: 99 LGAFSSIRVIDLSNNHIG----GSIPSILPV--TMQNFFLSDNQFSGSIPSSLATL---- 148
L +V+ L + + I S L V + L N+ +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 149 -TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE-----LPPSLENLSQ 198
+ +SL N L+G + ++L L L LS N L L+ +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 199 LTTLHLQNNQLSGT-----LDVLQDLP-LRDLNIENNLFS 232
L L L+ LS VL+ P ++L + NN +
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 50/235 (21%), Positives = 95/235 (40%), Gaps = 65/235 (27%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-- 565
+ + + +G G +VY+A+ +++A+KK+ K + D N +R
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGI-----NRTALREI 63
Query: 566 -------HANIVELKGYCAEHGQRLLIYEYCSN---GTLQDMLH--SDDELKNNLSWNTR 613
H NI+ L L++++ ++D + +K ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK---AY--- 117
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ M L + LEYLH+ I+HR+ K N+LLD++ + ++D GLA
Sbjct: 118 MLMTL---QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA------------ 159
Query: 674 GHLLTAYG--------------YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++G Y APE F + +Y D+++ G ++ ELL
Sbjct: 160 ----KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 49/226 (21%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF-----------LE 556
+ F Q +G G +VY+ G +A+K++ ++ E
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREISLMKE 59
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDM-----LHSDDELKNNLSWN 611
L +H NIV L + L++E+ D+ + L N
Sbjct: 60 L-------KHENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELN 108
Query: 612 TR---IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
L + L + HE I+HR+ K N+L++ + + D GLA
Sbjct: 109 LVKYFQWQLL---QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-P 161
Query: 669 VSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
V+ S ++T + Y AP+ S Y+ D++S G ++ E++TG+
Sbjct: 162 VNTFSSEVVTLW-YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 39/208 (18%), Positives = 71/208 (34%), Gaps = 52/208 (25%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG- 574
+G G+ G V + + A+K L ++++ + +IV +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------CPHIVRIVDV 79
Query: 575 YCAEHGQRLLIY---EYCSNGTLQDMLHSDDELKNNLSWNTR-----IRMALGAARALEY 626
Y + R + E G L + + + ++ R ++ A++Y
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGE---AIQY 132
Query: 627 LHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
LH I I HR+ K N+L + + ++D G
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------- 166
Query: 684 APEFESGIYTCQSDVYSFGVVMLELLTG 711
A E Y D++S GV+M LL G
Sbjct: 167 AKETTGEKYDKSCDMWSLGVIMYILLCG 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 42/220 (19%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID--RI---------- 564
I +G G+V +G +A+K++ S + + ++ R+
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS---DSFLCKRVLREIRLLNHF 86
Query: 565 RHANIVELKG-YCAEHGQRL----LIYEYCSNGT-LQDMLHSDDELKNNLSWNTRIRM-- 616
H NI+ L+ + + L+ E T L ++H + +S I+
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQ---RIVIS-PQHIQYFM 140
Query: 617 --ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSG 674
L L LHE +VHR+ NILL D+ +++ D LA ++ + +
Sbjct: 141 YHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTH 192
Query: 675 HLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
++ + Y APE + +T D++S G VM E+ +
Sbjct: 193 YVTHRW-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEF----LELVNNI 561
+ + + IG G G V++A+ G+ +A+KK ++ + + F L + +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN------EKEGFPITALREIKIL 70
Query: 562 DRIRHANIVELKGYCAEHGQRL--------LIYEYCSN---GTLQDMLH--SDDELKNNL 608
++H N+V L C L++++C + G L ++L + E+K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--- 127
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++M L L Y+H I+HR+ K+AN+L+ D + ++D GLA S
Sbjct: 128 ---RVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 669 VSQLSG--HLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
SQ + + + Y PE Y D++ G +M E+ T
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 26/153 (16%)
Query: 84 IILNGANLGGE----LGENLGAFSSIRVIDLSNNHIG-----GSIPSILPV--TMQNFFL 132
II L + + + + + N I + L ++ L
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 133 SDNQFSG----SIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSL--TGLINLDLSS 182
DN F+ ++ +L + L ++ LN+ LLS + DAF L GL L L
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 183 NNLSGE----LPPSL-ENLSQLTTLHLQNNQLS 210
N + + L + E + L L L N+ S
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 33/200 (16%), Positives = 60/200 (30%), Gaps = 34/200 (17%)
Query: 81 IIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGG----SIPSILPV--TMQNFFLSD 134
IA L + + +R I N + + +
Sbjct: 141 KIARALQELAVNKKAKNA----PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 196
Query: 135 NQF-----SGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNL 185
N + LA L + L +N + + A +S L L L+ L
Sbjct: 197 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
Query: 186 SGE----LPPSLENLS--QLTTLHLQNNQLS--GTLDVLQDLP-----LRDLNIENNLFS 232
S + + L L TL LQ N++ + + L L + N FS
Sbjct: 257 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
Query: 233 --GPIPEKMLQIPNFRKDGN 250
+ +++ ++ + R G
Sbjct: 317 EEDDVVDEIREVFSTRGRGE 336
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 29/180 (16%), Positives = 55/180 (30%), Gaps = 39/180 (21%)
Query: 77 NASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFL 132
+ I+L+G +G E L EN+ + + + + S+ G I
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR----- 84
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE 188
+ +L L + L++N + D T L +L L +N L +
Sbjct: 85 -------LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137
Query: 189 -------------LPPSLENLSQLTTLHLQNNQLS--GTL---DVLQDLP-LRDLNIENN 229
+ +N L ++ N+L Q L + + N
Sbjct: 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 197
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 24/131 (18%)
Query: 104 SIRVIDLSNNHIGG----SIPSILPV--TMQNFFLSDNQFSG----SIPSSLATLTLLTD 153
SI L + I S+ ++L +++ LS N + ++A+ L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 154 MSLNNN---LLSGEIPDAFQSL-------TGLINLDLSSNNLSGE----LPPSLENLSQL 199
++ + EIP+A + L L + LS N L L + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 200 TTLHLQNNQLS 210
L+L NN L
Sbjct: 125 EHLYLHNNGLG 135
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 56/278 (20%)
Query: 457 PPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENL 516
P E + + + + K + T + + S + F +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL-------QDFDLLRV 59
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHAN 568
IG G V +L ++ A++ + K + +D + E +N H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 114
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
+V L C + RL + EY + G L M H + ++ AR
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQ----------RKLPEEHARFYSAE 161
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLT 678
AL YLHE I++R+ K N+LLD + + ++D G+ + G + T
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------T 212
Query: 679 AYG---YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
G Y APE G Y D ++ GV+M E++ GR
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 49/219 (22%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
+IG G V +L ++ A+K + K + +D + E +N H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 70
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+V L C + RL + EY + G L M H + ++ AR
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQR----------KLPEEHARFYSA 117
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLL 677
AL YLHE I++R+ K N+LLD + + ++D G+ + G +
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------ 168
Query: 678 TAYG---YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
T G Y APE G Y D ++ GV+M E++ GR
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 40/128 (31%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 94 ELGEN----LGAF---SSIRVIDLSNNHIGGSIPS---ILPVTMQNFFLSDNQFSGSIPS 143
LG N + A +++ + L+ N + S+P+ ++ L +NQ S+P
Sbjct: 69 ALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126
Query: 144 SL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTT 201
+ LT LT ++L +N L F LT L LDLS N L LP + + L+QL
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKD 185
Query: 202 LHLQNNQL 209
L L NQL
Sbjct: 186 LRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 46/138 (33%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 103 SSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+SI I +N+ I S+ I ++ L N+ I + L LT LT + L N L
Sbjct: 41 NSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQL 97
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVL 216
F LT L L L N L LP + + L+ LT L+L +NQL G D L
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL 156
Query: 217 QDLPLRDLNIENNLFSGP 234
+L DL+ N L S P
Sbjct: 157 TNLTELDLS-YNQLQSLP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 11/117 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPS---ILPVTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F ++++ + L N + S+P + L+ NQ S+P + LT LT
Sbjct: 103 GVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLT 160
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
++ L+ N L +P+ F LT L +L L N L + L+ L + L +N
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 52/232 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVN------ 559
+ + IG G G+VY+A+ G +A+K + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-------GGGGGGGLPISTVRE 61
Query: 560 -----NIDRIRHANIVELK----GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLS 609
++ H N+V L + ++ L++E+ D +L+ L
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----------DQDLRTYLD 110
Query: 610 WNTRIRMALGAA--------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ R L++LH C IVHR+ K NIL+ V ++D GLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 662 PLISSGSVSQLSGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
+ L+ ++T + Y APE Y D++S G + E+ +
Sbjct: 168 RIY--SYQMALTPVVVTLW-YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 51/252 (20%), Positives = 85/252 (33%), Gaps = 65/252 (25%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVNNIDRI 564
+ +S +G G G V + GK A+KK D R K+ E + +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIM----KVL 57
Query: 565 RHANIVELK--------------GYCAEHGQRLLIYEYCSNGTLQDMLHSDDE------- 603
H NI++L +H + +N +++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 604 ------LKNNLSWNTRIRMALGAA----------RALEYLHEICQPPIVHRNFKSANILL 647
L L R ++ RA+ ++H + I HR+ K N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174
Query: 648 D-DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----GYGAPE--FESGIYTCQSDVYS 700
+ D + + D G A + AY Y APE + YT D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPS-------EPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 701 FGVVMLELLTGR 712
G V EL+ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 69/285 (24%), Positives = 104/285 (36%), Gaps = 73/285 (25%)
Query: 449 PPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYT 508
P P P PPP +++ + P +S AKP
Sbjct: 4 QPQEPELMNANPAPPPAPSQQINLGP----------SSNPHAKP---------------- 37
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIR 565
+ F +IG G G V A+ AVK L K+A ++K+++ + N+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 566 HANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR-- 622
H +V L + + +L + +Y + G L H E AR
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR----------ARFY 144
Query: 623 ------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGH 675
AL YLH + IV+R+ K NILLD + ++D GL I S
Sbjct: 145 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS------- 194
Query: 676 LLTAY---G---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
T G Y APE + Y D + G V+ E+L G
Sbjct: 195 --TTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGL 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 516 LIGAGMLGSVY----RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIV 570
++G G G V+ + +L A+K L K A+ + +D ++ +I + H IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA---LGAARALEY 626
+L Y + +L LI ++ G L E+ + +A L AL++
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEED-VKFYLAELAL----ALDH 141
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAY---G- 681
LH + I++R+ K NILLD++ + ++D GL+ I AY G
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---------KAYSFCGT 189
Query: 682 --YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y APE + +T +D +SFGV+M E+LTG
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 37/218 (16%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F + +G G G V + G A+K LDK+ + K E I +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+V+L+ ++ ++ EY + G + L AR
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------------HARFYAA 148
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
EYLH + +++R+ K N+L+D + V+D G A ++ G T
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA--------KRVKGRTWT 197
Query: 679 AYG---YGAPE-FESGIYTCQSDVYSFGVVMLELLTGR 712
G APE S Y D ++ GV++ E+ G
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 49/219 (22%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
++G G G V ++ +L AVK L K Q D E L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PP 81
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+ +L C + RL + EY + G L M H R A
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQV----------GRFKEPHAVFYAA 128
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLL 677
L +L I++R+ K N++LD + + ++D G+ I G ++
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK------ 179
Query: 678 TAYG---YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
T G Y APE + Y D ++FGV++ E+L G+
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
++G G G V A++ + G L AVK L K Q D E L L N H
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HP 84
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---A 623
+ +L C + RL + E+ + G L M H + + + R AA A
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA-----RARFYAAEIISA 136
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG- 681
L +LH+ I++R+ K N+LLD + ++D G+ I +G + T G
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA------TFCGT 187
Query: 682 --YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE E Y D ++ GV++ E+L G
Sbjct: 188 PDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGH 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 63/246 (25%), Positives = 96/246 (39%), Gaps = 67/246 (27%)
Query: 516 LIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEF---------LELVNNID 562
++G G G V+ + G L A+K L K A+ QK LE +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLEHIRQ-- 117
Query: 563 RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGA 620
+V L Y + +L LI +Y + G L H LS +
Sbjct: 118 ---SPFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--------LS---QRERFTEHE 160
Query: 621 AR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL 672
+ ALE+LH++ I++R+ K NILLD + V ++D GL+ +
Sbjct: 161 VQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-------FV 210
Query: 673 SGHLLTAY---G---YGAPE----FESGIYTCQSDVYSFGVVMLELLTGR---KSYDRTR 719
+ AY G Y AP+ +SG + D +S GV+M ELLTG
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
Query: 720 NRGEQF 725
++ E
Sbjct: 270 SQAEIS 275
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 35/178 (19%), Positives = 69/178 (38%), Gaps = 32/178 (17%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL-------PVTMQNFFLSDNQ 136
+ G+N + E + +DLS N++ L P ++ + LS N
Sbjct: 6 TLHPGSNP---VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 137 FSGSIPSSLATL-----TLLTDMSLNNNLLSGE----IPDAFQSL-TGLINLDLSSNNLS 186
L + +T ++L+ N LS + + ++ + LDL N+ S
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 187 GE----LPPSLENL-SQLTTLHLQNNQLSGT-----LDVLQDLP--LRDLNIENNLFS 232
+ + NL + +T+L+L+ N L + +L +P + LN+ N +
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 24/148 (16%), Positives = 51/148 (34%), Gaps = 23/148 (15%)
Query: 103 SSIRVIDLSNNHIGGS----IPSIL---PVTMQNFFLSDNQFSGS----IPSSLATLTLL 151
+S+ +DLS N +G + I P + + L N G + +L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 152 TDMSLNNNLLSGEIPD-------AFQSLTGLINLDLSSNNLSGELPPSLENLSQ-----L 199
+ L+ +++ + AF ++ +I +D + + + NL +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIE 227
L N L ++ ++ E
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDE 343
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 37/195 (18%), Positives = 76/195 (38%), Gaps = 34/195 (17%)
Query: 72 QGVQCNASDIIAIILNGANLGGELGENLGAF-----SSIRVIDLSNNHIGG----SIPSI 122
Q + + ++ L+G +LG + + L +++ ++LS N + +
Sbjct: 44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103
Query: 123 L---PVTMQNFFLSDNQFSGS----IPSSLATLTL-LTDMSLNNNLLSGE----IPDAFQ 170
L P T+ L N FS + + L +T ++L N L + +
Sbjct: 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163
Query: 171 SL-TGLINLDLSSNNLSGE----LPPSLENL-SQLTTLHLQNNQLSGT-----LDVLQDL 219
++ + +L+L NNL+ + L L ++ + +T+L L N L + +
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 220 P--LRDLNIENNLFS 232
P + LN+ N
Sbjct: 224 PNHVVSLNLCLNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 16/90 (17%)
Query: 156 LNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSL-ENLSQLTTLHLQN 206
+N L + + G+ +LDLS NNL L + + +T+L+L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 207 NQLSGT-----LDVLQDLP--LRDLNIENN 229
N L + +L +P + LN+ N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGN 90
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 46/230 (20%), Positives = 88/230 (38%), Gaps = 50/230 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ--LPDGKLLAVKK--LDKRASSQQKDDEFL--------E 556
+ IG G G V++A+ G+ +A+K+ + +E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIREVA 63
Query: 557 LVNNIDRIRHANIVELK----GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWN 611
++ +++ H N+V L + +L L++E+ D +L L
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----------DQDLTTYLDKV 112
Query: 612 TRIRMALGAA--------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
+ R L++LH +VHR+ K NIL+ + ++D GLA +
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 664 ISSGSVSQLSGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
L+ ++T + Y APE Y D++S G + E+ +
Sbjct: 170 Y--SFQMALTSVVVTLW-YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 516 LIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDD-EFLELVNNI-DRIRHANI 569
++G G G V++ + GK+ A+K L K + D + NI + ++H I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------ 622
V+L Y + G +L LI EY S G L + L A
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL--FMQ--------LE--REGIFMEDTACFYLAEI 130
Query: 623 --ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHLLTA 679
AL +LH+ I++R+ K NI+L+ V ++D GL I G+V+ T
Sbjct: 131 SMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH------TF 181
Query: 680 YG---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
G Y APE SG + D +S G +M ++LTG
Sbjct: 182 CGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGA 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
R L+Y+H I+HR+ K +N+ +++D + + D GLA + +++G++ T +
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTGYVATRW- 194
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ L+Y+H +VHR+ K N+ +++D + + D GLA ++++G+++T +
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRW- 188
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M E+LTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 38/243 (15%), Positives = 71/243 (29%), Gaps = 66/243 (27%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKL------DKRASSQQKDDEFLE---------LVNNI 561
IG G+ G V++ D +A+K + S Q+ +E L L++
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 562 DRIRHANIVELKG------------------YCAEHG------------QRLLIYEYCSN 591
R + L Y + G Q ++ E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--- 648
G + + S T + +L + HR+ N+LL
Sbjct: 147 GIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTS 199
Query: 649 --------DDLAVSVSDCGLAPLIS--SGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDV 698
+ + ++ CGL I + S + G ++ + +G Q D+
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDI 259
Query: 699 YSF 701
Y
Sbjct: 260 YRL 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+++LH I+HR+ K +NI++ D + + D GLA + + ++ +++T Y
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY- 191
Query: 682 YGAPEFE-SGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+ L Y+H I+HR+ K N+ +++D + + D GLA S+++G+++T +
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRW- 190
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y APE YT D++S G +M E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 33/90 (36%), Positives = 45/90 (50%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P T Q +L DNQ + P LT LT + L+NN L+ F LT L
Sbjct: 23 SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L+ N L + +NL LT + L NN
Sbjct: 83 LSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 39/214 (18%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
++G G G V+ A+ + A+K L K D E + + H + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------A 623
+ + L + EY + G L M H + L A
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDL--MYHIQSC----------HKFDLSRATFYAAEIILG 130
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-ISSGSVSQLSGHLLTAYG- 681
L++LH IV+R+ K NILLD D + ++D G+ + + + T G
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------TFCGT 181
Query: 682 --YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y APE G Y D +SFGV++ E+L G+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKL-DKRASSQQKDDE--FLELVNNIDR 563
+ + ++LIG G G V +A + + +A+K + +K+A Q E LEL+N D
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD--DELKNN----LSWNTRIRMA 617
IV LK + L++E ML + D L+N +S N + A
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE---------MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
AL +L + I+H + K NILL + ++ ++ GS QL +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK------IVDFGSSCQLGQRIY 216
Query: 678 TAY----GYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y Y +PE G+ Y D++S G +++E+ TG
Sbjct: 217 Q-YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 41/209 (19%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKL----DKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G V+ A + + + + VK L K+ + K LE + NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK---ILENLRG-----GPNIIT 95
Query: 572 LKG--YCAEHGQRLLIYEYCSNGTLQDMLH--SDDELKNNLSWNTRIRMALGAARALEYL 627
L L++E+ +N + + +D +++ + L +AL+Y
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF------YMYEIL---KALDYC 146
Query: 628 HEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
H I+HR+ K N+++D + + + D GLA G + + + + Y + PE
Sbjct: 147 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRY-FKGPE 200
Query: 687 --FESGIYTCQSDVYSFGVVMLELLTGRK 713
+ +Y D++S G ++ ++ ++
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA----PLISSGSVSQLSGHLL 677
RA++ LH ++HR+ K +N+L++ + + V D GLA + S +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 678 TAY----GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+ Y APE S Y+ DV+S G ++ EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 5e-08
Identities = 22/171 (12%), Positives = 55/171 (32%), Gaps = 31/171 (18%)
Query: 67 CGESWQGVQCNASDIIAIILNGANL-------GGELGENLGAFSSIRVIDLSNNHIGGS- 118
SW D+ ++ L L +++ +++ + + S
Sbjct: 154 QEISW----IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSV 209
Query: 119 IPSILPVTMQN------FFLSDNQFSGSIPSSLA------TLTLLTDMSLNNNLLSGEIP 166
+ IL + N + ++ + L + + + +
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 167 DAF---QSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLS 210
+ F L L +D+S+ L+ E L ++ + L ++++ N LS
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 7e-05
Identities = 18/144 (12%), Positives = 49/144 (34%), Gaps = 21/144 (14%)
Query: 85 ILNGANLGGELGENLGA--FSSIRVIDL---SNNHIGGSIPSILPV--------TMQNFF 131
+ L + E++ ++ + L ++ ++ ++
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 132 LSDNQFSGSIPSSLAT---LTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNN 184
+ D + + L L M ++ +L+ E + D + L +++ N
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318
Query: 185 LSGELPPSLENLSQLTTLHLQNNQ 208
LS E+ L+ S + + ++Q
Sbjct: 319 LSDEMKKELQK-SLPMKIDVSDSQ 341
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-08
Identities = 29/90 (32%), Positives = 45/90 (50%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P Q +L++NQ + P L L + N+N L+ F LT L
Sbjct: 26 SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
LDL+ N+L + +NL LT ++L NN
Sbjct: 86 LDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQ 198
S+P+ + T + LNNN ++ P F L L L +SN L+ +P + + L+Q
Sbjct: 26 SVPAGIPTDK--QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 199 LTTLHLQNNQL 209
LT L L +N L
Sbjct: 83 LTQLDLNDNHL 93
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS--GSVSQLSGHLLTA 679
R L+Y+H ++HR+ K +N+LL+ + + D GLA + L+ ++ T
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 680 YGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+ Y APE S YT D++S G ++ E+L+ R
Sbjct: 196 W-YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 22/151 (14%)
Query: 104 SIRVIDLSNNHIGG-SIPSILPV--TMQNFFLSDNQFSGSIPSSLATL-----TLLTDMS 155
++ ++L++ + + ++LPV + L N L L +T +
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLR 161
Query: 156 LNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNN 207
L+NN L+ + + T + +L L L E L L+ QL L++ N
Sbjct: 162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYN 221
Query: 208 QLSGT-----LDVLQDLP-LRDLNIENNLFS 232
T ++ P L L++ N S
Sbjct: 222 GAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 24/135 (17%), Positives = 47/135 (34%), Gaps = 17/135 (12%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATL- 148
LG + L + + + + +++ L+ + + + +A +
Sbjct: 37 KLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVL 96
Query: 149 ----TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSL-EN 195
L +++L + L + F L L N+L E L L +
Sbjct: 97 GSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR---KLGLQLNSLGPEACKDLRDLLLHD 153
Query: 196 LSQLTTLHLQNNQLS 210
Q+TTL L NN L+
Sbjct: 154 QCQITTLRLSNNPLT 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 34/212 (16%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKL-DKRASSQQKDDE--FLELVNNIDRIRHANIVE 571
+IG G G V +A + +A+K + +++ +Q +E LE + D+ N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSD--DELKNN----LSWNTRIRMALGAARALE 625
+ + +E +L + + +K N S + A + L+
Sbjct: 164 MLENFTFRNHICMTFE---------LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY----G 681
LH+ I+H + K NILL G+ +I GS + T Y
Sbjct: 215 ALHKNR---IIHCDLKPENILL-----KQQGRSGIK-VIDFGSSCYEHQRVYT-YIQSRF 264
Query: 682 YGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y APE G Y D++S G ++ ELLTG
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 25/92 (27%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+++LH I+HR+ K +NI++ D + + D GLA + + ++ +++T Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY- 228
Query: 682 YGAPEFE-SGIYTCQSDVYSFGVVMLELLTGR 712
Y APE Y D++S G +M E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISS--GSVSQLSGHLLT 678
R L+Y+H ++HR+ K AN+ ++ +DL + + D GLA ++ LS L+T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 679 AYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
+ Y +P YT D+++ G + E+LTG+
Sbjct: 188 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 42/346 (12%), Positives = 90/346 (26%), Gaps = 128/346 (36%)
Query: 466 VVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFT---------IASLQQYTNSFSQENL 516
++ + + P+ T + + + + + F L+Q
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRD-RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 517 IGA-GMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK- 573
+ G+LGS GK +A+ + ++ I L
Sbjct: 153 VLIDGVLGS--------GKTWVALDVC--------LSYKVQCKMDF-------KIFWLNL 189
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
C L + LQ +L+ D + ++ I++ + + + L +
Sbjct: 190 KNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRL-- 237
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIY 692
+ + +++ ++L + V + A+
Sbjct: 238 --LKSKPYENCLLVLLN-----VQN----------------AKAWNAFNLS--------- 265
Query: 693 TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS------RMVDP 746
C+ LLT TR + D LS +D
Sbjct: 266 -CKI-----------LLT-------TRFKQ-------------VTDFLSAATTTHISLDH 293
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD---LVDMI 789
P + S + Q P EV+ + +I
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPR------EVLTTNPRRLSII 333
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 40/275 (14%), Positives = 75/275 (27%), Gaps = 78/275 (28%)
Query: 35 VTNPNDVAAI-NSLYAALGSPVLPGWVASAGDP-CGESWQGVQ-CNASDIIAIILNGA-- 89
V+ + +L P V G G++W + C + + +
Sbjct: 131 VSRLQPYLKLRQALLEL--RPA--KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 90 -NLG-----GELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQF 137
NL + E L ID N S + + + + L +
Sbjct: 187 LNLKNCNSPETVLEMLQKLL--YQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 138 SGSIPSSLATL-----------------TLLT--DMSLNNNLLSGE-----IPDAFQSLT 173
+ L L LLT + + L + + +LT
Sbjct: 244 ----ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 174 GLINLDLSSNNLS---GELPPSLENLSQL-----------------TTLHLQNNQLSGT- 212
L L +LP + + H+ ++L+
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 213 ---LDVLQDLPLRDLNIENNLF--SGPIPEKMLQI 242
L+VL+ R + ++F S IP +L +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 88/626 (14%), Positives = 175/626 (27%), Gaps = 158/626 (25%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD 167
+D IL V F + + + ++L+ +++ ++S D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAF-VDNFDCK-DVQDMP--KSILSKEEIDHIIMS---KD 59
Query: 168 AFQSLTGLINLDLSSNN------LSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPL 221
A L LS + L + + L ++ + + Q S + +
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQ-- 115
Query: 222 RD-LNIENNLFSG---PIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGP 277
RD L +N +F+ + L++ R + P G
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKL-----------------RQALLELRPAKNVLIDG- 157
Query: 278 RPVSGSSPVSRTPPSQHTPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGV----LLF 333
V GS GK AL+ S K + KI W+++ +
Sbjct: 158 --VLGS-------------GKTW---VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 334 VILALVFLLFMPRCIKR--------------RGEVDRIFKRHQ----------VGAFRGN 369
+L + P R + E+ R+ K V
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV-----Q 254
Query: 370 NRE--EARDNG--TLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNK---QR 422
N + A + L + D H S + + + K R
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 423 MSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTA 482
+PR E+ ++ P +I + I T
Sbjct: 315 PQDLPR----EVLTTN--------------------------PRRLSIIAESIRDGLATW 344
Query: 483 VKTSTKTAKPFTTARSFTIASL-----QQYTNSFS--QENL-IGAGMLGSVYRAQLPDGK 534
TT ++ L ++ + S + I +L ++ +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 535 LLAVKKLDKRASSQQKDDEF--------LELVNNIDRIR--HANIVE----LKGYCAEHG 580
++ V KL K + +++ E LEL ++ H +IV+ K + ++
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 581 QRLLI--YEYCSNG---TLQDMLHSDDELKN---NLSW-NTRIRMALGAARALEYLHEIC 631
+ Y Y G + + + + +IR A A +
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSD 657
Q ++ + N + L ++ D
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILD 550
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 47/223 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
F +G G G V+ + +G+ A+K L K + K E + + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
I+ + + Q++ +I +Y G EL + L + R + A+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGG----------ELFSLLRKSQRFPNPV--AKFYA 112
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLL 677
ALEYLH I++R+ K NILLD + + ++D G A +
Sbjct: 113 AEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----------- 158
Query: 678 TAY---G---YGAPE--FESGIYTCQSDVYSFGVVMLELLTGR 712
Y G Y APE Y D +SFG+++ E+L G
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGY 200
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 13/60 (21%), Positives = 18/60 (30%)
Query: 433 EIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
+ M + + P PPP P P P P P ++ K K K
Sbjct: 36 SVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKK 95
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 16/48 (33%), Positives = 18/48 (37%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
PPP P P P P P P PP VI KP + +P
Sbjct: 53 PPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQP 100
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 14/48 (29%), Positives = 16/48 (33%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P P P P PP P V+EK KP +
Sbjct: 57 PVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDV 104
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 12/59 (20%), Positives = 17/59 (28%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P PP P P K KP+ + + + T +
Sbjct: 63 PEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPA 121
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 13/54 (24%), Positives = 17/54 (31%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTA 496
+ P P P P P PP P K KP + + KP +
Sbjct: 57 PVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESR 110
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 15/59 (25%), Positives = 22/59 (37%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P P P P V++ + + P E TA T+ + T A+
Sbjct: 74 EAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAAT 132
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 13/52 (25%), Positives = 16/52 (30%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTA 496
P P P P P P PP PVV + P K + +
Sbjct: 56 EPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPV 107
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 12/59 (20%), Positives = 17/59 (28%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P P P P + K V + + + P S A+
Sbjct: 73 KEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAA 131
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 15/49 (30%), Positives = 17/49 (34%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P P P P P PP V KP + VK + K
Sbjct: 54 PPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKR 102
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 14/59 (23%), Positives = 18/59 (30%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P PP P P P P P + V P S + TA + +S
Sbjct: 68 IPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSS 126
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 13/57 (22%), Positives = 14/57 (24%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFT 500
P P P P P PP P K KP + A F
Sbjct: 60 EPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFE 116
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 13/62 (20%), Positives = 20/62 (32%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P P P P P P + V+ + + T+ T A S + S+
Sbjct: 80 EKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSV 139
Query: 505 QQ 506
Sbjct: 140 AS 141
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 434 IDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
I ++ + + PP PPP P P P P + + + V E K K
Sbjct: 35 ISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPV 93
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 10/50 (20%), Positives = 13/50 (26%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P PP P P P K V + ++
Sbjct: 63 PEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPA 112
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 9e-04
Identities = 8/53 (15%), Positives = 13/53 (24%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTA 496
+ P P P P P P ++ + T+ T
Sbjct: 77 VVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 44/218 (20%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKL-DKRASSQQKDDE--FLELVNNIDRIRHA---- 567
+G G +V+ A+ + + +A+K + + ++ +DE L+ VN+ D +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 568 -NIVEL------KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR-MALG 619
+I++L KG H ++++E L ++ + L ++ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRGIPLI---YVKQISKQ 139
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
L+Y+H C I+H + K N+L++ S + + G+ H T
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVD--SPENLIQIKIADLGNACWYDEHY-TN 194
Query: 680 Y----GYGAPEFESGI-YTCQSDVYSFGVVMLELLTGR 712
Y +PE G + C +D++S ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 22/118 (18%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG--ELPP 191
S + +L S L I + L +L+LS+N L ++
Sbjct: 135 KGLRSDPDLVAQNIDVVLNRRSCMAATLRI-IEENIPELL---SLNLSNNRLYRLDDMSS 190
Query: 192 SLENLSQLTTLHLQNNQLS--GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK 247
++ L L+L N+L LD ++ L L +L ++ N + + +
Sbjct: 191 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN----SLCDTFRDQSTYIS 244
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 41/210 (19%), Positives = 72/210 (34%), Gaps = 55/210 (26%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA---------------PLISS 666
+ ++YLH ++HR+ K +NILL+ + V V+D GL+ + +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 667 GSVSQLSGHLLTAY----GYGAPE--FESGIYTCQSDVYSFGVVMLELLTGR-----KSY 715
+LT Y Y APE S YT D++S G ++ E+L G+ S
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 716 ------------------------DRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
+ E + I + + L
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR-QSNKRDIFTKWKNLLLKI 295
Query: 752 YPAKSLSHFA-DIISRCVQSEPEFRPPMSE 780
P + A D++ + +Q P R ++
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 34/123 (27%), Positives = 50/123 (40%), Gaps = 27/123 (21%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-------------------- 661
++HE I+HR+ K AN LL+ D +V V D GLA
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 662 -PLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRT 718
+ QL+ H++T + Y APE YT D++S G + ELL +S+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRW-YRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 719 RNR 721
Sbjct: 256 PTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 54/262 (20%), Positives = 87/262 (33%), Gaps = 87/262 (33%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID------------R 563
IG G G V A + +++A+KK+ + ID R
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI------------LRVFEDLIDCKRILREIAILNR 108
Query: 564 IRHANIVEL----KGYCAEHGQRL-LIYEYCSNGT-LQDMLHSDDELKNN---------L 608
+ H ++V++ E L ++ E + + + + L L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA------- 661
++Y+H I+HR+ K AN L++ D +V V D GLA
Sbjct: 167 -------------VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 662 -------------------PLISSGSVSQLSGHLLTAYGYGAPE--FESGIYTCQSDVYS 700
+ QL+GH++T + Y APE YT DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW-YRAPELILLQENYTEAIDVWS 269
Query: 701 FGVVMLELLTGRKSYDRTRNRG 722
G + ELL K
Sbjct: 270 IGCIFAELLNMIKENVAYHADR 291
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 22/137 (16%), Positives = 43/137 (31%), Gaps = 23/137 (16%)
Query: 74 VQCNASDIIAIILNGANLGGE-----LGENLGAFSSIRVIDLSNNHIGG----SIPSILP 124
+Q N D+ + LN E L + ++ + ++ +L
Sbjct: 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK 90
Query: 125 V--TMQNFFLSDNQFSGSIPSSLA-------TLTLLTDMSLNNNLLSG----EIPDAFQS 171
V T+++ + N SGS +L +L L + + L EI + +
Sbjct: 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIEL-RIDNQSQPLGNNVEMEIANMLEK 149
Query: 172 LTGLINLDLSSNNLSGE 188
T L+
Sbjct: 150 NTTLLKFGYHFTQQGPR 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 41/223 (18%), Positives = 73/223 (32%), Gaps = 40/223 (17%)
Query: 516 LIGAGMLGSVYRA--QLPDGKLLAVKKL-DKRASSQQKDDE--FLELVNNIDRIRHANIV 570
+G G G V +A+K + + + E L+ + D+ V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD--DELKNN----LSWNTRIR-MALGAARA 623
+ + HG + +E +L + + LK N +R MA A
Sbjct: 86 LMSDWFNFHGHMCIAFE---------LLGKNTFEFLKENNFQPYP-LPHVRHMAYQLCHA 135
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL----------S 673
L +LHE + H + K NIL + ++ + + S + +
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 674 GHLLTAY----GYGAPEFESGI-YTCQSDVYSFGVVMLELLTG 711
T Y PE + + DV+S G ++ E G
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 32/151 (21%), Positives = 59/151 (39%), Gaps = 18/151 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE--FLELVNNIDRIRHANIVELK 573
IG+G G +Y + G+ +A+K + Q E +++ I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV-----GIPTIR 71
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
AE +++ E +L+D+ + S T + +A +EY+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 634 PIVHRNFKSANILL---DDDLAVSVSDCGLA 661
+HR+ K N L+ V + D GLA
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 14/61 (22%), Positives = 17/61 (27%), Gaps = 1/61 (1%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTT-ARSFTIAS 503
P P P P P P V P+ + + K K T S I
Sbjct: 115 AAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTATDVIRALVAQKLKKELTEIPPSKAIKD 174
Query: 504 L 504
L
Sbjct: 175 L 175
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 41.8 bits (96), Expect = 8e-04
Identities = 11/48 (22%), Positives = 12/48 (25%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P PP P P P E P K T +
Sbjct: 443 VPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRL 490
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 801 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 1e-04 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 2e-04 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 5e-04 | |
| d2gqba1 | 130 | a.282.1.1 (A:1-130) Hypothetical protein RPA2825 { | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 9e-66
Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 25/286 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ IG+G G+VY+ + +AVK L+ A + Q+ F V + + RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ GY Q ++ ++C +L LH ++ I +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF- 687
I+HR+ KS NI L +DL V + D GLA + S S S L + + APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 688 ---ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
+ Y+ QSDVY+FG+V+ EL+TG+ Y NR + + D+ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
++ +++ C++ + + RP +++ + + R
Sbjct: 239 PKAM------------KRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-59
Identities = 67/282 (23%), Positives = 124/282 (43%), Gaps = 27/282 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ + IG+G G V+ + +A+K + + +++F+E + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPK 61
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C E L++E+ +G L D L + L + T + M L + YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
E ++HR+ + N L+ ++ + VSD G+ + + +G + +PE F
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VKWASPEVF 174
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y+ +SDV+SFGV+M E+ + K R+ E DI R+ P
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------EDISTGFRLYKPR 225
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
L+ H I++ C + PE RP S +++ L ++
Sbjct: 226 LAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 61/302 (20%), Positives = 122/302 (40%), Gaps = 33/302 (10%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ IG G G V+R + G+ +AVK R +++ + +RH NI+
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI 63
Query: 574 GYCAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ Q L+ +Y +G+L D L+ + ++ I++AL A L +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 118
Query: 630 IC-----QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG--SVSQLSGHLLTAYGY 682
+P I HR+ KS NIL+ + ++D GLA S ++ H + Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 683 GAPEF-------ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF----LVRWAI 731
APE + ++D+Y+ G+V E+ + + ++
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 732 PQLHDIDALSRMVDPSLSGQY-PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
++ + + + P++ ++ ++L A I+ C + R + + L + +
Sbjct: 239 EEMRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 791 RE 792
+E
Sbjct: 298 QE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 67/280 (23%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +GAG G V+ +AVK L + D FL N + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQR 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V L +I EY NG+L D L + L+ N + MA A + ++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688
E +HR+ ++ANIL+ D L+ ++D GLA LI + G
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
G +T +SDV+SFG+++ E++T + E + +++ RMV P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD- 233
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
++ C + PE RP + L D
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-56
Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 27/281 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G G V + +A+K + + +DEF+E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 60
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C + +I EY +NG L + L ++ + M A+EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF- 687
+HR+ + N L++D V VSD GL+ + + G + PE
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVL 173
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
++ +SD+++FGV+M E+ + K E I R+ P
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQGLRLYRPH 224
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
L+ + I+ C + + RP ++ +++D+
Sbjct: 225 LASE-------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 2e-55
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 40/309 (12%)
Query: 499 FTIASLQQYTNSFSQE---------NLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRA 545
FT + F++E +IGAG G V L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
+ +Q+ +FL + + + H N++ L+G + ++I E+ NG+L L +D
Sbjct: 67 TEKQRR-DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--- 122
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+ + M G A ++YL VHR+ + NIL++ +L VSD GL+ +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 666 SGSVSQLSGHLLTAYG---YGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNR 721
+ L + APE + +T SDV+S+G+VM E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 722 GEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
+ ++ P S ++ C Q + RP ++
Sbjct: 240 QDVI----------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 782 VQDLVDMIR 790
V L MIR
Sbjct: 284 VNTLDKMIR 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (477), Expect = 1e-54
Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 27/291 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY +AVK L + + +EFL+ + I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 131
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP-E 686
+ +HR+ + N L+ ++ V V+D GL+ L++ + + +G + AP
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPES 187
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
++ +SDV++FGV++ E+ T S + + + +++
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEK 231
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797
+ P +++ C Q P RP +E+ Q M + S+E
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-54
Identities = 59/280 (21%), Positives = 111/280 (39%), Gaps = 25/280 (8%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ IG G G + + DGK+L K+LD + ++ + + VN + ++H NI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 570 VELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
V + L + EYC G L ++ + + L +R+ AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 628 HE--ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
H ++HR+ K AN+ LD V + D GLA +++ + + + Y +P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSP 183
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
E Y +SD++S G ++ EL + A Q +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAGKIREGK 230
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ +Y +II+R + + RP + E++++
Sbjct: 231 FRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 25/281 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L + FL+ + ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L ++ EY S G+L D L + + MA A + Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVE 130
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688
+ VHR+ ++ANIL+ ++L V+D GLA LI + G
Sbjct: 131 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 689 SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748
G +T +SDV+SFG+++ EL T + E V+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----------------DQVERGY 231
Query: 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
P + D++ +C + EPE RP + L D
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-53
Identities = 52/308 (16%), Positives = 116/308 (37%), Gaps = 39/308 (12%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
++ + F + + +GAG G V++ P G ++A K + ++ + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLH 59
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
IV G G+ + E+ G+L +L + ++++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
L YL E I+HR+ K +NIL++ + + D G++ + + G Y
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT----RSY 169
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI---------- 731
+PE + Y+ QSD++S G+ ++E+ GR + + + +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 732 ----------------PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFR 775
P + + L +V+ F D +++C+ P R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 776 PPMSEVVQ 783
+ +++
Sbjct: 290 ADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 41/303 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
N S +GAG G V A +AVK L A +++ + + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLS 81
Query: 563 RI-RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS--------------DDELKNN 607
+ H NIV L G C G L+I EYC G L + L ++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
L + + A+ + +L +HR+ + NILL + D GLA I +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 668 SVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL 726
S + G+ + APE + +YT +SDV+S+G+ + EL + S +F
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 727 VRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786
+M+ P + + DI+ C ++P RP ++VQ +
Sbjct: 259 ---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 787 DMI 789
I
Sbjct: 304 KQI 306
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-53
Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 32/290 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDG-----KLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +++ +IGAG G VY+ L +A+K L + +Q+ +FL + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQ 65
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H NI+ L+G +++ ++I EY NG L L D S + M G A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAG 122
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG--SVSQLSGHLLTAYG 681
++YL VHR+ + NIL++ +L VSD GL+ ++ + SG +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP-IR 178
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
+ APE +T SDV+SFG+VM E++T + + E
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------------- 223
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
+ ++ P S ++ +C Q E RP +++V L +IR
Sbjct: 224 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 71/303 (23%), Positives = 115/303 (37%), Gaps = 44/303 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ ++G+G G V A +AVK L ++A S +++ EL
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-------------------DDE 603
H NIV L G C G LI+EYC G L + L S ++E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
N L++ + A A+ +E+L VHR+ + N+L+ V + D GLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 664 ISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRG 722
I S S + G+ + APE GIYT +SDV+S+G+++ E+ + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 723 EQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVV 782
F +++ P + I+ C + RP +
Sbjct: 274 ANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 783 QDL 785
L
Sbjct: 319 SFL 321
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-53
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 33/286 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + A++Q FL + + ++RH+N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 61
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 119
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
VHR+ + N+L+ +D VSD GL SS + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEA 171
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
++ +SDV+SFG+++ E+ + + + V+
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----------------PRVEK 215
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792
P +++ C + RP ++ + L + E
Sbjct: 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 29/278 (10%)
Query: 513 QENLIGAGMLGSVYRAQLPD---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++ +G+G G+V + K +AVK L A+ DE L N + ++ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V + G C E +L+ E G L L ++ I + + ++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE- 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE-F 687
+ VHR+ + N+LL +SD GL+ + + + + H + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
++ +SDV+SFGV+M E + + R E M++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----------------AMLEKG 226
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
PA D+++ C + E RP + V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 58/277 (20%), Positives = 106/277 (38%), Gaps = 30/277 (10%)
Query: 514 ENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+ IG G +VY+ + +A +L R ++ + F E + ++H NIV
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 573 KGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ +L+ E ++GTL+ L + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 629 EICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
PPI+HR+ K NI + +V + D GLA L + + G + APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG----TPEFMAPEM 184
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y DVY+FG+ MLE+ T Y +N + + R+
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---------------RRVTSGV 229
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ ++ +II C++ + R + +++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 2e-51
Identities = 68/312 (21%), Positives = 121/312 (38%), Gaps = 47/312 (15%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEF 554
+ SL+ N+ IG G G V++A+ P ++AVK L + AS+ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DF 63
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-------------- 600
+ + NIV+L G CA L++EY + G L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 601 ------DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654
LS ++ +A A + YL E VHR+ + N L+ +++ V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 655 VSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRK 713
++D GL+ I S + G+ + PE YT +SDV+++GVV+ E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 714 SYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPE 773
+ + + + D ++ P +++ C P
Sbjct: 241 QPY---------------YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPA 284
Query: 774 FRPPMSEVVQDL 785
RP + + L
Sbjct: 285 DRPSFCSIHRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-50
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+IG G G VY L D AVK L R + + +FL + H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 570 VELKGYCAEH-GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G C G L++ Y +G L++ + ++ +N + I L A+ +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM---K 144
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQL--SGHLLTAYGYGAPE 686
+ VHR+ + N +LD+ V V+D GLA + + + A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
++ +T +SDV+SFGV++ EL+T N + + R++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------ITVYLLQGRRLLQ 255
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791
P +++ +C + E RP SE+V + +
Sbjct: 256 PEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 29/274 (10%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G GSV + +A+K L K+ + + +E + + ++ + IV L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C + +L+ E G L L + + + + + ++YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE---EK 128
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE-FESGI 691
VHR+ + N+LL + +SD GL+ + + S + APE
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
++ +SDV+S+GV M E L+ + + E ++ +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----------------AFIEQGKRME 232
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785
P + ++S C + E RP V Q +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 36/300 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
N +++IG G G V +A++ L A+K++ + AS D EL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------------SDDELKNNLSWNTR 613
H NI+ L G C G L EY +G L D L + + LS
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLS 673
+ A AR ++YL Q +HR+ + NIL+ ++ ++D GL+ +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 674 GHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQ 733
L +YT SDV+S+GV++ E+++ + E +
Sbjct: 187 R--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------- 236
Query: 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+ + P D++ +C + +P RP ++++ L M+ +
Sbjct: 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 6e-49
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 28/278 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G G V A + +AVK +D + + + + + + H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 65
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+ G+ E + L EYCS G L D + + R + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--F 687
I I HR+ K N+LLD+ + +SD GLA + + +L + Y APE
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL-VRWAIPQLHDIDALSRMVDP 746
+ DV+S G+V+ +L G +D+ + +++ + L+ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----- 233
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
S ++ + + P R + ++ +D
Sbjct: 234 -----------SAPLALLHKILVENPSARITIPDIKKD 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 6e-49
Identities = 65/306 (21%), Positives = 130/306 (42%), Gaps = 46/306 (15%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-ASSQQKDDEFLELVNNIDRIRHAN 568
FS IG G G+VY A+ + + +++A+KK+ S +K + ++ V + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
++ +G L+ EYC + K L + GA + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-- 686
++HR+ K+ NILL + V + D G A +++ + + + APE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVI 183
Query: 687 --FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
+ G Y + DV+S G+ +EL + + + + + +++
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------FNMNAMSALYHIAQNE 230
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD-----------LVDMIRRER 793
P+L + ++ F + + C+Q P+ RP +++ ++D+I+R +
Sbjct: 231 SPALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287
Query: 794 CSNESL 799
+ L
Sbjct: 288 DAVREL 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 9e-49
Identities = 65/277 (23%), Positives = 107/277 (38%), Gaps = 32/277 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHAN 568
F +G G G+VY A+ +LA+K L K + + + V +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ L GY + + LI EY GT+ L + A AL Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH 123
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
++HR+ K N+LL + ++D G + S + L G Y PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT----LDYLPPEMI 176
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
E ++ + D++S GV+ E L G+ ++ + R+
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKRISRVE 220
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ +P D+ISR ++ P RP + EV++
Sbjct: 221 FT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 60/289 (20%), Positives = 106/289 (36%), Gaps = 28/289 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ +A+K K +S ++FL+ + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 65
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L +L + I A + AL
Sbjct: 66 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 121
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
YL VHR+ + N+L+ + V + D GL+ + + + S L
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 685 PEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
+T SDV+ FGV M E+L + + I +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIENGE 226
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793
+ P ++++C +P RP +E+ L ++ E+
Sbjct: 227 RLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 73/302 (24%), Positives = 116/302 (38%), Gaps = 38/302 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRA------QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G V A + + +AVK L + A+ + EL I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 563 RIRHANIVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHS------------DDELKNNLS 609
H N+V L G C + G L++ E+C G L L S +D K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 610 WNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
I + A+ +E+L +HR+ + NILL + V + D GLA I
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 670 SQLSGHLLTAYGYGA-PEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR 728
G + A +YT QSDV+SFGV++ E+ + S E+F
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247
Query: 729 WAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788
R + + P + + C EP RP SE+V+ L ++
Sbjct: 248 -------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 789 IR 790
++
Sbjct: 295 LQ 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-48
Identities = 62/285 (21%), Positives = 117/285 (41%), Gaps = 28/285 (9%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVK---KLDKRASSQQKDDEFLELVNNIDRIRH 566
F + ++G+G G+VY+ +P+G+ + + K + A+S + + E L+ + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
++ L G C LI + G L D + K+N+ + + A+ + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNY 126
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
L +VHR+ + N+L+ V ++D GLA L+ + + + A E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
IYT QSDV+S+GV + EL+T E +S +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE 227
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790
P I+ +C + + RP E++ + M R
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 62/288 (21%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ + Q K + + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEI 68
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ ++ NIV + ++ EY + G+L D++ + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLT 678
+ALE+LH ++HR+ KS NILL D +V ++D G I+ ++
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVG 178
Query: 679 AYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-RWAIPQLHD 736
+ APE Y + D++S G++ +E++ G Y +L+ P+L +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ LS + F D ++RC+ + E R E++Q
Sbjct: 239 PEKLS----------------AIFRDFLNRCLDMDVEKRGSAKELLQH 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 58/277 (20%), Positives = 125/277 (45%), Gaps = 32/277 (11%)
Query: 515 NLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G VY+AQ + L A K +D + S+++ ++++ ++ + H NIV+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
++ E+C+ G + ++ EL+ L+ + + AL YLH+
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---N 129
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE------F 687
I+HR+ K+ NIL D + ++D G++ + Q + + APE
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETS 187
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
+ Y ++DV+S G+ ++E+ + + + + +++ P+
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHH-------------ELNPMRVLLKIAKSEPPT 234
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
L+ P++ S+F D + +C++ + R S+++Q
Sbjct: 235 LA--QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-47
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 33/294 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G VY +A+K +++ AS +++ EFL + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMK 78
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDELKNNLSWNTRIRM 616
++V L G ++ L+I E + G L+ L +++ + S + I+M
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHL 676
A A + YL VHR+ + N ++ +D V + D G+ I + G
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 677 LTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLH 735
L + +PE + G++T SDV+SFGVV+ E+ T L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGLS 240
Query: 736 DIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789
+ L +++ L P +++ C Q P+ RP E++ + + +
Sbjct: 241 NEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-47
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 40/302 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNN 560
+ +G G G V A+ +AVK L A+ + D E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------------SDDELKNNL 608
+H NI+ L G C + G +I EY S G L++ L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
S + A AR +EYL +HR+ + N+L+ +D + ++D GLA I
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV 727
+ + + + APE IYT QSDV+SFGV++ E+ T S
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 242
Query: 728 RWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
++ L +++ P+ + ++ C + P RP ++V+DL
Sbjct: 243 ---------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 788 MI 789
++
Sbjct: 294 IV 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 59/278 (21%), Positives = 104/278 (37%), Gaps = 29/278 (10%)
Query: 517 IGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVE 571
+G G G V R + +AVK L SQ + D+F+ VN + + H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G ++ E G+L D L + + T R A+ A + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQLSGHLLTAYGYGAPE-FES 689
+HR+ + N+LL V + D GL + + H + + APE ++
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 690 GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLS 749
++ SD + FGV + E+ T + L+ L ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYG---------------QEPWIGLNGSQILHKIDKEGER 233
Query: 750 GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787
P +++ +C +PE RP + L++
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 28/274 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F ++G G +V A+ L + A+K L+KR ++ ++ ++ R+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
V+L + + Y NG L + + ALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH 125
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
I+HR+ K NILL++D+ + ++D G A ++S S + + Y +PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
SD+++ G ++ +L+ G + R N F I +L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIF---QKIIKLE------------ 226
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEV 781
+P K D++ + + + R E+
Sbjct: 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 9e-44
Identities = 48/281 (17%), Positives = 105/281 (37%), Gaps = 18/281 (6%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G VY+AQ G+ A+KK+ + + ++ + ++H+NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ +L++E+ + + + L T L + Y H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTC 694
++HR+ K N+L++ + + ++D GLA + Y S Y+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 695 QSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA-----------IPQLHDIDALSRM 743
D++S G + E++ G + + + + +L D +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+P + D++S+ ++ +P R + ++
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (393), Expect = 4e-42
Identities = 65/275 (23%), Positives = 102/275 (37%), Gaps = 33/275 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIR- 565
N FS +IG G G VY + D GK+ A+K LDK R +Q + L + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 --HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
IV + + I + + G L L S A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
LE++H +V+R+ K ANILLD+ V +SD GLA S G GY
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----GYM 172
Query: 684 APEFESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
APE Y +D +S G ++ +LL G + + + + + + R + ++
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---- 228
Query: 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
S S ++ +Q + R
Sbjct: 229 ---PDSFS--------PELRSLLEGLLQRDVNRRL 252
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 7e-42
Identities = 49/280 (17%), Positives = 103/280 (36%), Gaps = 29/280 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ + +G G G V+R G A K + + + + + + +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V L + + ++IYE+ S G L + + + N +S + + + L ++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 628 HEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP 685
HE VH + K NI+ + + D GL + +++ + AP
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194
Query: 686 E-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744
E E +D++S GV+ LL+G + + L ++ + +
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------DETLRNVKSCDWNM 244
Query: 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
D S D I + + ++P R + + ++
Sbjct: 245 DDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 9e-42
Identities = 50/273 (18%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G+G G V+R G++ K ++ + ++ ++++ H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHD 93
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ + +LI E+ S G L D + ++ +S I A L+++HE
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 635 IVHRNFKSANILLD--DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGI 691
IVH + K NI+ + +V + D GLA ++ + + + APE +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREP 204
Query: 692 YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQ 751
+D+++ GV+ LL+G + + + L ++ + D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------LETLQNV----KRCDWEFDED 250
Query: 752 YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ D I +Q EP R + + ++
Sbjct: 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 2e-41
Identities = 62/287 (21%), Positives = 105/287 (36%), Gaps = 34/287 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR------ 563
+ + ++G G+ V R P K AVK +D +E EL +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 564 --IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
H NI++LK + L+++ G L D L K LS ++
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALL 120
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS----VSQLSGHLL 677
+ LH++ IVHR+ K NILLDDD+ + ++D G + + G V +L
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 678 TAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
+ Y + D++S GV+M LL G + + ++ Q
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+ S D++SR + +P+ R E +
Sbjct: 238 E------WDDYS--------DTVKDLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 46/272 (16%), Positives = 97/272 (35%), Gaps = 28/272 (10%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G G G V+R K K + + + Q + ++ ++ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHE 68
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ ++I+E+ S + + +++ L+ + AL++LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 635 IVHRNFKSANILLD--DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIY 692
I H + + NI+ + + + G A + G +L Y + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVV 180
Query: 693 TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQY 752
+ +D++S G ++ LL+G + N+ + +I D +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQ----------IIENIMNAEYTFDEEAFKEI 230
Query: 753 PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
D + R + E + R SE +Q
Sbjct: 231 S----IEAMDFVDRLLVKERKSRMTASEALQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 1e-40
Identities = 59/279 (21%), Positives = 103/279 (36%), Gaps = 24/279 (8%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
+ + +++G G V A+ KL+A+K + K+ + + K+ + + +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-ALEGKEGSMENEIAVLHKIKH 66
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NIV L G LI + S G L D + K + R+ A++Y
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKY 122
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAP- 685
LH++ + LD+D + +SD GL+ + GSV GY AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPE 179
Query: 686 EFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
Y+ D +S GV+ LL G + + + A +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------SPYW 233
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+S D I ++ +PE R + +Q
Sbjct: 234 DDIS--------DSAKDFIRHLMEKDPEKRFTCEQALQH 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (372), Expect = 3e-40
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 30/288 (10%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIR 565
++ + ++G G + V+ A+ L + +AVK L + F N +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 566 HANIVELKGYCAEHGQRL----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
H IV + ++ EY TL+D++H++ ++ I + A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 121
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGSVSQLSGHLLTAY 680
+AL + H+ I+HR+ K ANI++ AV V D G+A + SG+ + ++
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y +PE +SDVYS G V+ E+LTG + + P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------ 232
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-MSEVVQDLV 786
LS + ++ + + PE R +E+ DLV
Sbjct: 233 PPSARHEGLS--------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 4e-40
Identities = 52/304 (17%), Positives = 97/304 (31%), Gaps = 32/304 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N + IG+G G +Y + G+ +A+K + K + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGG 62
Query: 568 NIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ +C G ++ E S T + +A +EY
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEY 118
Query: 627 LHEICQPPIVHRNFKSANIL---LDDDLAVSVSDCGLAPLISSGSVSQ-----LSGHLLT 678
+H +HR+ K N L V + D GLA Q + +L
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 679 AYGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDI 737
Y + GI + + D+ S G V++ G + + ++ +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 738 DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797
L YP S FA ++ C + +P S + Q ++ R+ S +
Sbjct: 236 P------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
Query: 798 SLGD 801
+ D
Sbjct: 286 YVFD 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 52/288 (18%), Positives = 109/288 (37%), Gaps = 22/288 (7%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F + IG G G VY+A+ G+++A+KK+ ++ + ++ + + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L + L++E+ + M S + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE--F 687
++HR+ K N+L++ + A+ ++D GLA + H + Y APE
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILL 175
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y+ D++S G + E++T R + + F + + ++ P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 748 LSGQYPAKSLSHFA-----------DIISRCVQSEPEFRPPMSEVVQD 784
+P + F+ ++S+ + +P R +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 43/293 (14%)
Query: 511 FSQENL---------IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNN 560
F QEN+ +G+G V + + G A K + KR + + E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 561 ----IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM 616
+ I+H N++ L +LI E + G L D L K +L+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEF 118
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDD----LAVSVSDCGLAPLISSGSVSQL 672
+ YLH I H + K NI+L D + + D GLA I G+
Sbjct: 119 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---E 172
Query: 673 SGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731
++ + APE ++D++S GV+ LL+G + +
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---------- 222
Query: 732 PQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
L ++ V+ +Y + + + D I R + +P+ R + + +Q
Sbjct: 223 ETLANV----SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (364), Expect = 4e-39
Identities = 42/301 (13%), Positives = 88/301 (29%), Gaps = 34/301 (11%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-IVE 571
IG G G ++ L + + +A+K +R+ + Q DE+ + I
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY----KLLAGCTGIPN 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
+ + E +L+ + + D S T A ++ +HE
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 632 QPPIVHRNFKSANILLDDDLA-----VSVSDCGLAPLISSGSVSQL-----SGHLLTAYG 681
+V+R+ K N L+ + + V D G+ Q +L
Sbjct: 122 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 682 YGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
Y + + + D+ + G V + L G + A + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ----------GLKAATNKQKYERI 228
Query: 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNESLG 800
+ + A F + + P + ++ R + +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
Query: 801 D 801
D
Sbjct: 289 D 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 25/286 (8%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDD---EFLELVNNIDRIRHANIV 570
+ +G G +VY+A+ +++A+KK+ S+ KD L + + + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L L++++ + + L+ + L + LEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESG 690
I+HR+ K N+LLD++ + ++D GLA S + + H + Y APE G
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFG 174
Query: 691 I--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--PQLHDIDALSRMVDP 746
Y D+++ G ++ ELL + + + + P + + D
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 747 SLSGQYPAKSLSH--------FADIISRCVQSEPEFRPPMSEVVQD 784
+P L H D+I P R ++ ++
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 56/298 (18%), Positives = 109/298 (36%), Gaps = 30/298 (10%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
++ + IG G G V A + +A+KK+ Q L + + R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRH 65
Query: 567 ANIVELKGYCA----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
NI+ + E + + + + L +L +LS + R
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILR 120
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ-LSGHLLTAYG 681
L+Y+H ++HR+ K +N+LL+ + + D GLA + +
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 682 YGAPE--FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--PQLHDI 737
Y APE S YT D++S G ++ E+L+ R + + + + P D+
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 738 DALSRMVDPSLSGQYPAKSL-----------SHFADIISRCVQSEPEFRPPMSEVVQD 784
+ + + + P K+ S D++ + + P R + + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 30/294 (10%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S++ +IG G G VY+A+L D G+L+A+KK+ + + ++ + + ++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR------KLDHCN 74
Query: 569 IVELKGYCAEHGQR------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
IV L+ + G++ L+ +Y + H K L R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAPLISSGSVSQLSGHLLTAYG 681
+L Y+H I HR+ K N+LLD D + + D G A + G +S Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYR 189
Query: 682 YGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--PQLHDIDA 739
F + YT DV+S G V+ ELL G+ + + + + P I
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 740 LSRMVDPSLSGQYPAKSLS---------HFADIISRCVQSEPEFRPPMSEVVQD 784
++ Q A + + SR ++ P R E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 59/270 (21%), Positives = 92/270 (34%), Gaps = 31/270 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE--FLELVNNIDRIRHA 567
F ++G G G V+ A+ + A+K L K D E +E H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+ + + EY + G L + S + + A L++L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL 119
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
H IV+R+ K NILLD D + ++D G+ G + Y APE
Sbjct: 120 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEI 174
Query: 688 ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
G Y D +SFGV++ E+L G+ + +R P
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-------------- 220
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
YP D++ + EPE R
Sbjct: 221 ----FYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-36
Identities = 56/290 (19%), Positives = 109/290 (37%), Gaps = 29/290 (10%)
Query: 515 NLIGAGMLGSVYRAQ--LPDGKLLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHANI 569
IG G G V++A+ G+ +A+K++ + + + ++ +++ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 570 VELKGYCA-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
V L C + L++E+ + + + T M R L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGL 129
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGA 684
++LH +VHR+ K NIL+ + ++D GLA + S ++ Y A
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRA 183
Query: 685 PE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID----- 738
PE Y D++S G + E+ + + + + + + I + D
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 739 ALSRMVDPSLSGQYPAKSLSH----FADIISRCVQSEPEFRPPMSEVVQD 784
AL R S S Q K ++ D++ +C+ P R +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 47/277 (16%), Positives = 88/277 (31%), Gaps = 27/277 (9%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
++G G+ G V + + A+K L +++ E+ + + +IV +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 70
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
A L++ E G L + D + + A++YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-F 687
I I HR+ K N+L ++ + Y APE
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 688 ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747
Y D++S GV+M LL G + + + RM
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----------LAISPGMKTRIRMGQYE 235
Query: 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
++ +I +++EP R ++E +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (339), Expect = 2e-35
Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 37/278 (13%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNN 560
SLQ + +G G G V+ + +G+ A+K L K + K + +
Sbjct: 2 SLQDFQ----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 57
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ + H I+ + G + Q +I +Y G L +L A
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYA 110
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAY 680
A L + I++R+ K NILLD + + ++D G A + L G
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGT----P 165
Query: 681 GYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739
Y APE + Y D +SFG+++ E+L G + + +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF----------------YDSNTMKT 209
Query: 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777
++++ L ++P D++SR + + R
Sbjct: 210 YEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 49/295 (16%), Positives = 113/295 (38%), Gaps = 26/295 (8%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+Q+Y + IG G G+V++A+ +++A+K++ + L + +
Sbjct: 1 MQKYE----KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
++H NIV L + L++E+C + + + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQ 109
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGY 682
L+ L ++HR+ K N+L++ + + +++ GLA S ++T +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYR 168
Query: 683 GAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI---PQLHDID 738
F + +Y+ D++S G + EL + + +Q + + P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 739 ALSRMVDPSLSGQYPAKSL---------SHFADIISRCVQSEPEFRPPMSEVVQD 784
+++++ D YPA + + D++ ++ P R E +Q
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 7e-34
Identities = 47/279 (16%), Positives = 92/279 (32%), Gaps = 44/279 (15%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI------RHAN 568
L+G+G GSVY + D +A+K ++K S + V + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
++ L + +LI E ++ + L A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 629 EICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEF 687
++HR+ K NIL+D + + + D G L+ + G Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT----RVYSPPEW 180
Query: 688 ESG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
+ + V+S G+++ +++ G ++ +I
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------------EEIIRGQVFFR 224
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784
+S S +I C+ P RP E+
Sbjct: 225 QRVS--------SECQHLIRWCLALRPSDRPTFEEIQNH 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 44/291 (15%), Positives = 97/291 (33%), Gaps = 22/291 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ +G+G G+V A G +A+KKL + S+ + + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N++ L ++ L + + + L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE- 686
H HR+ K N+ +++D + + D GLA S+++G+++T +
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVI 190
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQFLVRWAIPQLHDIDALS 741
YT D++S G +M E++TG+ + + + + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 742 RMVDPSLSGQYPAKSLSH--------FADIISRCVQSEPEFRPPMSEVVQD 784
+ K + +++ + + + E R E +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 56/297 (18%), Positives = 105/297 (35%), Gaps = 34/297 (11%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V++A+ G+ +A+KK+ + L + + ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 574 GYCAEH--------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
C G L++++C + + + + + R+ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVM---QMLLN 128
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGH--LLTAYGYG 683
L+ I + I+HR+ K+AN+L+ D + ++D GLA S SQ + + + Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 684 APEFESGI--YTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQFLVRWAIPQLHD 736
PE G Y D++ G +M E+ T + Q +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 737 IDALSRMVDPSLSGQYPAKSLSHFA---------DIISRCVQSEPEFRPPMSEVVQD 784
+D L K D+I + + +P R + +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-31
Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 35/304 (11%)
Query: 491 KPFTTARSFTIASLQQYTNSFSQEN-----LIGAGMLGSVYRAQL----PDGKLLAVKKL 541
+ T A+L + EN ++G G G V+ + GKL A+K L
Sbjct: 1 QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60
Query: 542 DKRASSQQKD--DEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIYEYCSNGTLQDML 598
K Q+ + ++ IR + +V L + LI +Y + G L L
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 599 HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658
+ + + L + + I++R+ K NILLD + V ++D
Sbjct: 121 SQRERFTEHEVQIY-------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173
Query: 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFESGI--YTCQSDVYSFGVVMLELLTGRKSYD 716
GL+ + + T G + D +S GV+M ELLTG +
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
Query: 717 RTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP 776
+ Q + I + YP + + D+I R + +P+ R
Sbjct: 234 VDGEKNSQAEISRRILKSEP--------------PYPQEMSALAKDLIQRLLMKDPKKRL 279
Query: 777 PMSE 780
Sbjct: 280 GCGP 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 9e-31
Identities = 52/272 (19%), Positives = 92/272 (33%), Gaps = 28/272 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRH 566
N F L+G G G V + G+ A+K L K + + + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ LK H + + EY + G L L + T R A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-------TEERARFYGAEIVSA 117
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
L + +V+R+ K N++LD D + ++D GL S + + T
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEV 176
Query: 687 FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746
E Y D + GVVM E++ GR + + L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------- 222
Query: 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPM 778
++P +++ ++ +P+ R
Sbjct: 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 4e-29
Identities = 52/272 (19%), Positives = 96/272 (35%), Gaps = 33/272 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRH 566
+ F + +G G G V + G A+K LDK+ + K + L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V+L+ ++ ++ EY + G + L S A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEY 156
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
LH + +++R+ K N+L+D + V+D G A G L G APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWTLCGT----PEALAPE 208
Query: 687 -FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745
S Y D ++ GV++ E+ G + + + +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGK------------- 254
Query: 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP 777
++P+ S D++ +Q + R
Sbjct: 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (285), Expect = 3e-28
Identities = 50/303 (16%), Positives = 113/303 (37%), Gaps = 45/303 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-H 566
+ + +G G V+ A + + + + VK L K + + ++ +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 89
Query: 567 ANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
NI+ L + R L++E+ +N + + + L+ +AL
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKAL 142
Query: 625 EYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYG 683
+Y H + I+HR+ K N+++D + + + D GLA G Q + + +
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFK 196
Query: 684 APEFESGI--YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI---PQLHD-I 737
PE Y D++S G ++ ++ ++ + + +Q + + L+D I
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 738 DALSRMVDPSLSGQYPAKSLSHFA----------------DIISRCVQSEPEFRPPMSEV 781
D + +DP + S + D + + ++ + + R E
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
Query: 782 VQD 784
++
Sbjct: 317 MEH 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 51/292 (17%), Positives = 104/292 (35%), Gaps = 22/292 (7%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
+ + +G+G GSV A G +AVKKL + S + + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
N++ L + L ++ L+ + + R L+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
+H HR+ K +N+ +++D + + D GLA +++G++ T +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 687 F-ESGIYTCQSDVYSFGVVMLELLTGR-----KSYDRTRNRGEQFLVRWAIPQLHDIDAL 740
Y D++S G +M ELLTGR + + + L I +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 741 SRMVDPSLSGQYPAKSLSH--------FADIISRCVQSEPEFRPPMSEVVQD 784
S Q P + ++ D++ + + + + R ++ +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 2e-25
Identities = 45/316 (14%), Positives = 106/316 (33%), Gaps = 50/316 (15%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G +V+ A+ + + +A+K + + + + + + R+ A+ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 573 KGYCAEHGQRLLIY--EYCSNGTLQDM----------LHSDDELKNNLSWNTRIRMALGA 620
A H +LL + NG M + +++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQLSGHLLTA 679
L+Y+H + I+H + K N+L++ D ++ +A L ++ + + +
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 680 YGYGAPEFESGI-YTCQSDVYSFGVVMLELLTGRKSYD---------------------- 716
Y +PE G + C +D++S ++ EL+TG ++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 717 --------RTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCV 768
+ F R + + + + ++ +D +S +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 769 QSEPEFRPPMSEVVQD 784
Q +P R +V
Sbjct: 313 QLDPRKRADAGGLVNH 328
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-24
Identities = 49/300 (16%), Positives = 103/300 (34%), Gaps = 43/300 (14%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG+G G V A + +A+KKL + +Q + + + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 575 YCA------EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E L+ E Q + D + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFE 688
+HR+ K +NI++ D + + D GLA + ++ +++T Y
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 191
Query: 689 SGIYTCQSDVYSFGVVMLELLTGR-------------KSYDRTRNRGEQFLVRWAIPQLH 735
Y D++S G +M E++ + K ++ +F+ + +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 736 DIDALSRMVDPSLSGQYPAKSL-----------SHFADIISRCVQSEPEFRPPMSEVVQD 784
++ + + +P S D++S+ + +P R + + +Q
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 29/201 (14%), Positives = 63/201 (31%), Gaps = 23/201 (11%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK--------DDEFLELVNNIDRIRH 566
L+G G +V+ VK +S +K D F L R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ +L+G +Y + N L +++ + + + + + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE 686
+ IVH + N+L+ ++ + D + + +L
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSEEGIW-IIDFPQSVEVGEEG----WREILERDVRNIIT 170
Query: 687 FESGIYTCQSDVYSFGVVMLE 707
+ S Y + D+ S +L+
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.8 bits (198), Expect = 1e-16
Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 26/154 (16%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLAT--------- 147
L + +++ +DL+NN I P + L NQ S P + T
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 148 -----------LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
L LT ++L N +S P SLT L L ++N +S SL NL
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 197 SQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN 229
+ + L +NQ+S L L +L + L + +
Sbjct: 351 TNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 1e-14
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 28/157 (17%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+++ + L+ N + I ++ +T + + L++NQ S P L+ LT LT++ L N
Sbjct: 218 LTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 161 LSGEIP--------------------DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
+S P +L L L L NN+S P + +L++L
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 201 TLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP 236
L NN++S + L +L + L+ +N S P
Sbjct: 333 RLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 2e-11
Identities = 41/148 (27%), Positives = 57/148 (38%), Gaps = 26/148 (17%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD 167
+ +NN I P + + L+ NQ +LA+LT LTD+ L NN +S P
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 168 AFQSLTGLINLDLSSNNLSGELP--------------------PSLENLSQLTTLHLQNN 207
LT L L L +N +S P + NL LT L L N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 208 QLSGTLDVLQDLP-LRDLNIENNLFSGP 234
+S + + L L+ L NN S
Sbjct: 318 NISD-ISPVSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 5e-08
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 11/98 (11%)
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
L + T+ D +N D +L + L N++ + S +L Q+TTL
Sbjct: 1 LGSATITQDTPINQI-----FTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQA 51
Query: 205 QNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+ ++D ++ L L +N NN + P K L
Sbjct: 52 DRLGIK-SIDGVEYLNNLTQINFSNNQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 26/89 (29%), Positives = 35/89 (39%), Gaps = 4/89 (4%)
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN +S P T L L L+ N L +L +L+ LT L L NNQ+S +
Sbjct: 205 TNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 260
Query: 217 QDLPLRDLNIENNLFSGPIPEKMLQIPNF 245
L +L + N S P L
Sbjct: 261 GLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 6e-05
Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 4/74 (5%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L ++ + L + L + +E L+ LT ++ NNQL+ +
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPL 84
Query: 216 LQDLPLRDLNIENN 229
L D+ + NN
Sbjct: 85 KNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 24/73 (32%), Positives = 32/73 (43%), Gaps = 4/73 (5%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIE 227
LT L +L ++N +S P L+ L L L NQL + L L L DL++
Sbjct: 193 LAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249
Query: 228 NNLFSGPIPEKML 240
NN S P L
Sbjct: 250 NNQISNLAPLSGL 262
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 9e-14
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 27/183 (14%)
Query: 37 NPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGEL 95
NP D A+ + LG+P L W+ + D C +W GV C+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTD---------------- 46
Query: 96 GENLGAFSSIRVIDLSNNHIGGSIP-----SILPVTMQNFFLSDNQFSGSIPSSLATLTL 150
+ +DLS ++ P + LP + N G IP ++A LT
Sbjct: 47 ----TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
L + + + +SG IPD + L+ LD S N LSG LPPS+ +L L + N++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 211 GTL 213
G +
Sbjct: 163 GAI 165
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 19/56 (33%), Positives = 28/56 (50%), Gaps = 1/56 (1%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
+ L NN + G +P L L +L++S NNL GE+ P NL + NN+
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.7 bits (148), Expect = 8e-11
Identities = 19/61 (31%), Positives = 27/61 (44%), Gaps = 3/61 (4%)
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN--LFSGPI 235
DL +N + G LP L L L +L++ N L G + +L NN L P+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 236 P 236
P
Sbjct: 310 P 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 3/68 (4%)
Query: 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
+ L +N+ G++P L L L ++++ N L GEIP +L ++N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
Query: 186 --SGELPP 191
LP
Sbjct: 304 LCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 12/77 (15%), Positives = 28/77 (36%), Gaps = 1/77 (1%)
Query: 67 CGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT 126
G + ++ + L + G L + L + +++S N++ G IP +
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 127 -MQNFFLSDNQFSGSIP 142
++N+ P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.9 bits (167), Expect = 3e-13
Identities = 30/152 (19%), Positives = 51/152 (33%), Gaps = 2/152 (1%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + +P LP L +N+ + L L + L NN +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL-SGTLDVLQDLPLR 222
P AF L L L LS N L + L +L + ++ + L + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 223 DLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+L SG + +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 32/165 (19%), Positives = 62/165 (37%), Gaps = 14/165 (8%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
G + I +++ +I +IP LP ++ L N+ + +SL L
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L + L+ N +S + + L L L++N L P L + + ++L NN +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNI 254
Query: 210 S--------GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFR 246
S + +++ +N P+ +Q FR
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSN----PVQYWEIQPSTFR 295
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.1 bits (132), Expect = 7e-10
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 6/111 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+L + +DLS+N + P++ + + + ++ L +
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE------LPPSLENLSQLTT 201
NN L S L+ L+L N+L E L L ++S + T
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.1 bits (132), Expect = 8e-10
Identities = 27/116 (23%), Positives = 48/116 (41%), Gaps = 6/116 (5%)
Query: 106 RVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE 164
RV+ L++ + + + + + + LS N+ P+ LA L L + + + E
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALE 56
Query: 165 IPDAFQSLTGLINLDLSSNNL-SGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL 219
D +L L L L +N L L + +L L+LQ N L + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 14/104 (13%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ N S I S L +++++NN L E+P L L S N+L+
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA 317
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP--LRDLNIEN 228
E+P +NL LH++ N L D+P + DL + +
Sbjct: 318 -EVPELPQNL---KQLHVEYNPLRE----FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 3e-07
Identities = 19/81 (23%), Positives = 37/81 (45%), Gaps = 10/81 (12%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S+ +++SNN + +P++ P ++ S N + +P L L + N L
Sbjct: 283 PPSLEELNVSNNKL-IELPALPP-RLERLIASFNHLA-EVPELPQNLKQL---HVEYNPL 336
Query: 162 SGEIPDAFQSLTGLINLDLSS 182
E PD +S+ +L ++S
Sbjct: 337 R-EFPDIPESVE---DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 5/59 (8%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
++ LNN LS +P+ L +L S N+L+ ELP ++L L + L
Sbjct: 40 AHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 5/73 (6%)
Query: 173 TGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFS 232
L+L++ LS LP +L +L N L+ ++ Q L ++ NNL +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLTELPELPQSLKSLLVDN-NNLKA 92
Query: 233 GPIPEKMLQIPNF 245
+L+
Sbjct: 93 LSDLPPLLEYLGV 105
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (132), Expect = 7e-09
Identities = 29/139 (20%), Positives = 54/139 (38%), Gaps = 3/139 (2%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQ--NFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+++ + L +N + + FL N+ S + L L + L+ N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+ P AF+ L L+ L L +NNLS +L L L L L +N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249
Query: 221 LRDLNIENNLFSGPIPEKM 239
L+ ++ +P+++
Sbjct: 250 LQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 33/174 (18%), Positives = 47/174 (27%), Gaps = 28/174 (16%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLT-------------- 152
+ ++P +P Q FL N+ S +S LT
Sbjct: 15 TTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 153 -----------DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTT 201
+N L P F L L L L L P L+ L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 202 LHLQNNQLSGTLD--VLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
L+LQ+N L D L L + N S + + + N
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 7e-06
Identities = 26/141 (18%), Positives = 43/141 (30%), Gaps = 6/141 (4%)
Query: 73 GVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNF 130
+ ++ + L+G + S+ + L N + P +
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 131 FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
+L N S +LA L L + LN+N + L SS+ + LP
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLP 265
Query: 191 PSLENLSQLTTLHLQNNQLSG 211
L L N L G
Sbjct: 266 QRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 8e-04
Identities = 20/85 (23%), Positives = 30/85 (35%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ L P L L + L +N L D F+ L L +L L N +S
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 187 GELPPSLENLSQLTTLHLQNNQLSG 211
+ L L L L N+++
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAH 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 127 MQNFFLSDNQFSGS-IPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLS 181
+Q+ + + S + L L + L++ L+ I A + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 182 SNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
SN L + Q + +Q L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 6e-08
Identities = 22/106 (20%), Positives = 34/106 (32%), Gaps = 10/106 (9%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLD 179
+ + N L D ++L + L + +S + + L LD
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403
Query: 180 LSSNNLSGELPPSL-----ENLSQLTTLHLQNNQLSG-TLDVLQDL 219
LS+N L L + L L L + S D LQ L
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 9e-08
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 23/102 (22%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S +RV+ L++ + S S S+ ++L L ++ L+NN L
Sbjct: 368 GSVLRVLWLADCDVSDSSCS------------------SLAATLLANHSLRELDLSNNCL 409
Query: 162 SGEIPDAF-----QSLTGLINLDLSSNNLSGELPPSLENLSQ 198
Q L L L S E+ L+ L +
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 11/85 (12%)
Query: 169 FQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQDL 219
Q + L L L+ ++S L +L L L L NN L ++ ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 220 P--LRDLNIENNLFSGPIPEKMLQI 242
L L + + +S + +++ +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 21/118 (17%)
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNH 114
E QG+ S + + L ++ L L A S+R +DLSNN
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 115 IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSL 172
+G + L +++ LL + L + S E+ D Q+L
Sbjct: 409 LGDAGILQLVESVRQP-----------------GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 13/103 (12%), Positives = 27/103 (26%), Gaps = 19/103 (18%)
Query: 86 LNGANLGGE-LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS 144
+ L E L +V+ L + + + I S+
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK------------------DISSA 50
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG 187
L L +++L +N L + + +L
Sbjct: 51 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 5e-07
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 12/89 (13%)
Query: 154 MSLNNNLLSGEIPDA------FQSLTGLINLDLSSNNLSGELPPSL-----ENLSQLTTL 202
+ LN+ LLS A GL L L N + + +L E + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 203 HLQNNQLSGTLDVLQDLP-LRDLNIENNL 230
L N+ S DV+ ++ + L
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 8/67 (11%)
Query: 151 LTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTL 202
+ SL + ++ E + + + LS N + E L ++ + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 203 HLQNNQL 209
+
Sbjct: 65 EFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 15/104 (14%), Positives = 37/104 (35%), Gaps = 17/104 (16%)
Query: 127 MQNFFLSDNQFSGSIPSSLA------TLTLLTDMSLNNNLLSGEIPDA-----FQSLTGL 175
++ L+D S +++ L + L N + + + + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 176 INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL 219
+ L+L+ N E ++ + ++ + + LD L D+
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREVFSTRGRGE-----LDELDDM 342
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 11/84 (13%), Positives = 23/84 (27%), Gaps = 10/84 (11%)
Query: 171 SLTGL-INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-----DVLQDLP-LRD 223
S+ G + LD + + L + + L N + + + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 224 LNIENN---LFSGPIPEKMLQIPN 244
+ IPE + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQ 87
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 27/97 (27%), Positives = 40/97 (41%), Gaps = 4/97 (4%)
Query: 110 LSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF 169
L + + S L +LS S + LA L+ LT + ++N +S P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 170 QSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
SL LI + L +N +S L N S L + L N
Sbjct: 192 ASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 18/78 (23%), Positives = 36/78 (46%), Gaps = 6/78 (7%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
PD +L I + +N++ + + +L +TTL ++ T++ +Q L L
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIG 67
Query: 224 LNIENNLFSGPIPEKMLQ 241
L +++N + P K L
Sbjct: 68 LELKDNQITDLAPLKNLT 85
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 4/61 (6%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIE 227
+L+ L L N +S L +L L +HL+NNQ+S + L + L + +
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225
Query: 228 N 228
N
Sbjct: 226 N 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 19/119 (15%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE-LP 190
L+ + L + ++ + + + + F S + ++DLS++ + L
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLH 64
Query: 191 PSLENLSQLTTLHLQNNQLSGT-LDVLQDLP-LRDLNIE--NNLFSGPIPEKMLQIPNF 245
L S+L L L+ +LS ++ L L LN+ + + +
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 3e-06
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 5/111 (4%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
S + +DL S P ++ + + + ++ + L ++L+NN L
Sbjct: 23 SQQALDLKGLR---SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYR 79
Query: 164 --EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
++ Q L L+LS N L E +L L L N LS T
Sbjct: 80 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 22/90 (24%), Positives = 31/90 (34%), Gaps = 1/90 (1%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+Q +L N+ P L L +SL NN L+ L L L L N+L
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+P L L N ++L
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 6e-05
Identities = 12/58 (20%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
+S ++ ++ ++P LP LS+N ++L T LT ++L+
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ +++ + L+ +P L LS N L +L ++LT L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 208 Q 208
+
Sbjct: 66 E 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 7e-04
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNI 226
+ + ++ NL+ LPP L T LHL N L +L L L LN+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 227 ENNLFSGPIPEKMLQ 241
+ + + L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 1e-05
Identities = 12/44 (27%), Positives = 18/44 (40%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
D F +G + LD+S + LENL +L N +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 10/56 (17%), Positives = 18/56 (32%), Gaps = 1/56 (1%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
S RV + + IPS LP + + + L + ++ N
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 7/65 (10%), Positives = 17/65 (26%), Gaps = 3/65 (4%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ +N + + ++ + ++L L NL
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
Query: 187 GELPP 191
+LP
Sbjct: 237 -KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L L+ E + + LDL + + L Q + +N++ L
Sbjct: 1 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 56
Query: 214 DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNF 245
D L L+ L + NN +P+
Sbjct: 57 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 6/70 (8%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
D +L + L N++ S +L Q+TTL + ++D ++ L L
Sbjct: 12 FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQ 66
Query: 224 LNIENNLFSG 233
+N NN +
Sbjct: 67 INFSNNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 13/37 (35%), Positives = 18/37 (48%), Gaps = 2/37 (5%)
Query: 166 PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
+LT L LD+SSN +S L L+ L +L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 6e-05
Identities = 31/162 (19%), Positives = 53/162 (32%), Gaps = 27/162 (16%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIP----SSLATLTLLTD------ 153
+D + + IP +P+ L+DN+ L L L
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 154 ---------------MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ L N + F L L L+L N +S +P S E+L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 199 LTTLHLQNNQLSGTLDVLQDLPL-RDLNIENNLFSGPIPEKM 239
LT+L+L +N + + R ++ P K+
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 8/64 (12%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+L ++ + L + + +++++ ++ L +T L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 208 QLSG 211
+L+
Sbjct: 79 KLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 14/39 (35%), Positives = 18/39 (46%), Gaps = 2/39 (5%)
Query: 168 AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
LT L NL LS N++S +L L L L L +
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 11/72 (15%)
Query: 165 IPDA---FQSLTGLINLDLSSNNLSGELPP------SLENLSQLTTLHLQNNQLSGTLDV 215
I DA F+ ++ + L G +PP +L L L L N + +
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS 65
Query: 216 LQDLP-LRDLNI 226
L + LR L++
Sbjct: 66 LSGMENLRILSL 77
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 801 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.87 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.85 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.81 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.69 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.69 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.59 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.55 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.54 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.36 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.18 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.16 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.0 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.93 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.68 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.02 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.97 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.29 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.43 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=213.3
Q ss_pred CCCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEE
Q ss_conf 16886678153039608999993999599999934545763559999999998650499972321207872594899995
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (801)
.++|.+.+.||+|+||.||+|+.. ..||||++..........+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 14799988998018321378999999999999999999998569999383588999589779994999614688786789
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~ 667 (801)
|+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 58998889998523---57899999999999999998887509---9951614789979818997887500221333556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHH
Q ss_conf 8432246643346767954356----898972047889999999990998856446555410000114544315566320
Q 003704 668 SVSQLSGHLLTAYGYGAPEFES----GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..........||..|+|||++. +.|+.++|||||||++|||+||+.||.......... ..+...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------------~~~~~~ 225 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------------FMVGRG 225 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------------HHHHHT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------------HHHHCC
T ss_conf 77631256655743179999950568999953151635999999997889989989699999------------999658
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 39987899981018999999998100199999998999999999987
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 744 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 790 (801)
.........+..++.++.+|+.+||+.||++|||+.|++++|+.+.+
T Consensus 226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 88986000365554999999999758897689299999999999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.16 Aligned_cols=260 Identities=26% Similarity=0.478 Sum_probs=213.2
Q ss_pred CCCCCCCEEEECCCCEEEEEEEC-CC---CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEE
Q ss_conf 68866781530396089999939-99---599999934545763559999999998650499972321207872594899
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~l 584 (801)
++|++.+.||+|+||+||+|+.. ++ ..||||.+.... .....+.|.+|++++++++|||||+++|++.+.+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 04278569802788299999995799788999999978445-98999999999999985799888618999962887799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99514799988998018321378999999999999999999998569999383588999589779994999614688786
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~ 664 (801)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCEEEECCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 99722798530021045---67999999999999999988988527---9835761504489889991998884431575
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHH
Q ss_conf 78984322---46643346767954-356898972047889999999990-99885644655541000011454431556
Q 003704 665 SSGSVSQL---SGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDA 739 (801)
Q Consensus 665 ~~~~~~~~---~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 739 (801)
........ .....++..|+||| +..+.|+.++|||||||++|||+| |+.||...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----------------~ 241 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----------------D 241 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------H
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-----------------H
T ss_conf 67777653650256668830038788836997861214453578999986799999999999-----------------9
Q ss_pred HHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 63203998789998101899999999810019999999899999999998764
Q 003704 740 LSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 740 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
+...+........+..++.++.+|+.+||+.||++|||+.|+++.|+.+++..
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf 99999737889997422699999999975879768929999999999984186
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.25 Aligned_cols=269 Identities=19% Similarity=0.356 Sum_probs=210.3
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 316886678153039608999993-9995999999345457635599999999986504999723212078725948999
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
..++|++.+.||+|+||+||+|+. .+|+.||+|++.... .......+.+|+.++++++|||||++++++.+.+..++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 7568889789712778099999998999699999987540-978999999999999867999999499999989999999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 95147999889980183213789999999999999999999985699993835889995897799949996146887867
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~ 665 (801)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 976799868998742----49999999999999999999999985--999714457799468789989995487762567
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC-C-------------
Q ss_conf 898432246643346767954-3568989720478899999999909988564465554100001-1-------------
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW-A------------- 730 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~------------- 730 (801)
... .....||..|+||| +....|+.++||||+||++|||++|+.||........+..... .
T Consensus 157 ~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CCC----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 886----2111377141194687589989488899899999999988899899887899999988751775457742123
Q ss_pred ------------CCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf ------------45443155663203998789998101899999999810019999999899999999
Q 003704 731 ------------IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 731 ------------~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 786 (801)
.+.....+....+.............+.++.+|+.+||+.||++|||+.|+++|-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHH
T ss_conf 33221111222354134778876650268766764448999999999986899467908999960986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.15 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=214.1
Q ss_pred CCCCCCCCEEEECCCCEEEEEEECC-C-----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEEECC
Q ss_conf 1688667815303960899999399-9-----5999999345457635599999999986504-9997232120787259
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD-G-----KLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~ 580 (801)
.++|++.+.||+|+||+||+|+... + ..||+|.+.... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 89939701983078819999998578855420499999966335-87899999999999997158996868778886299
Q ss_pred EEEEEEECCCCCCHHHHHHCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 48999951479998899801832-------------------13789999999999999999999985699993835889
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDE-------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLk 641 (801)
..++||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 995897799949996146887867898432246643346767954-356898972047889999999990-998856446
Q 003704 642 SANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTR 719 (801)
Q Consensus 642 p~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~ 719 (801)
|+|||++.++.+||+|||+|+...............+|..|+||| +..+.|+.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCCCEEECCCCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 55541000011454431556632039987899981018999999998100199999998999999999
Q 003704 720 NRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 787 (801)
.. ..+.+++........|..++.++.+|+.+||+.||++|||++||+++|..
T Consensus 272 ~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH----------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 89----------------99999985699899887678999999999758896689399999999748
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.30 Aligned_cols=256 Identities=24% Similarity=0.477 Sum_probs=211.4
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEEC
Q ss_conf 68866781530396089999939995999999345457635599999999986504999723212078725948999951
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|+..++..||||++.... ...+.|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf 9958888982088829999998899999999987886---7689999999999966899756535243159933799983
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 6999189975201---34788999999999999987765316---43104431532666688776865532100236887
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCC
Q ss_conf 432246643346767954-3568989720478899999999909-98856446555410000114544315566320399
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG-RKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....++..|+||| +..+.|+.++|||||||++|||+|+ ++||..... ..+...+..
T Consensus 156 ~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----------------~~~~~~i~~ 217 (263)
T d1sm2a_ 156 YTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDIST 217 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----------------HHHHHHHHH
T ss_pred CEE-ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHH
T ss_conf 335-04300176667857860799984033210599999998789888778999-----------------999999980
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 878999810189999999981001999999989999999999876
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 747 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 791 (801)
......|..++.++.+|+.+||+.||++|||++|++++|+++.+.
T Consensus 218 ~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 218 GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 688899543679999999997657976891999999999999857
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.23 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=209.1
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 316886678153039608999993-9995999999345457635599999999986504999723212078725948999
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
+.++|++.+.||+|+||.||+|+. .+|+.||||++..... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 87460899897217480999999999997999999845664-12799999999999857998884696540467436798
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 95147999889980183213789999999999999999999985699993835889995897799949996146887867
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~ 665 (801)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 82 mEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 82 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEEC
T ss_conf 864589808999753----79999999999999999999999975---98357546899788789987983231422404
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHH
Q ss_conf 89843224664334676795435-6898-972047889999999990998856446555410000114544315566320
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFE-SGIY-TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~-~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
............||..|+|||+. ...+ +.++||||+||++|||++|+.||......... ....
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~~~~ 219 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDW 219 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------HHHH
T ss_pred CCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH---------------HHHH
T ss_conf 6886531113255747428728618999997101617379999998299788889859999---------------9998
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 39987899981018999999998100199999998999999
Q 003704 744 VDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.............+.++.+|+.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 63888788644699999999999767996689099999619
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=380.02 Aligned_cols=260 Identities=24% Similarity=0.415 Sum_probs=216.4
Q ss_pred CCCCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 168866781530396089999939-9959999993454576355999999999865049997232120787259489999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ...++|.+|++++++++|||||++++++.+.+..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 799398659820888089999999999699999977761---03999999999998679998826775274578547876
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 3146760677753035--54157999999999999978889878---930576045768998999289832445465378
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 98432246643346767954-35689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
..... .....++..|+||| +..+.|+.++|||||||++|||++|..|+..... ...+.+.+.
T Consensus 168 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~~~~i~ 230 (287)
T d1opja_ 168 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYELLE 230 (287)
T ss_dssp SSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHHHHHHH
T ss_pred CCCEE-ECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHH
T ss_conf 87221-0355665466692787279998104302178999999867998877425----------------999999985
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 98789998101899999999810019999999899999999998764
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
.......+..++.++.+|+.+||+.||++|||+.|+++.|+.+.++.
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 58888887433099999999975779768939999999999998757
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.04 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=211.3
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE--CCEEEEE
Q ss_conf 6886678153039608999993-999599999934545763559999999998650499972321207872--5948999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~--~~~~~lV 585 (801)
++|++.+.||+|+||.||+|+. .+|+.||||.+......+...+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9514799988998018321378999999999999999999998569--99938358899958977999499961468878
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
|||+++|+|.+++.........+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHH
Q ss_conf 678984322466433467679543-5689897204788999999999099885644655541000011454431556632
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
+..... ......||+.|+|||+ ....|+.++|||||||++|||++|+.||....... ....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----------------~~~~ 225 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----------------LAGK 225 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHHH
T ss_pred CCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH----------------HHHH
T ss_conf 245777--5566778823279999839999938988752789999801889989989999----------------9999
Q ss_pred HCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 039987899981018999999998100199999998999999
Q 003704 743 MVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
+.... ....|...+.++.+|+.+||+.||++|||+.|++++
T Consensus 226 i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 226 IREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 97189-988974359999999999767995579189999729
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.98 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=208.1
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 16886678153039608999993-99959999993454576355999999999865049997232120787259489999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 1053887898128582999999989998999999843017--27999999999998679998805857798899989999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 Ey~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 70379808988641-----5999999999999999999999987---972267768886887899686425156413213
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 98432246643346767954-35689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......||..|+||| +..+.|+.++||||+||++|||++|+.||......... ..+.. .
T Consensus 169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------------~~~~~--~ 231 (293)
T d1yhwa1 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-------------YLIAT--N 231 (293)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHH--H
T ss_pred CCC--CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHH-------------HHHHH--C
T ss_conf 666--444444477736826644799880120313729999980488998997999999-------------99985--7
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 9878999810189999999981001999999989999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
.......+...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 9998888553799999999998669966890999996499
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.17 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=210.5
Q ss_pred CCCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEE
Q ss_conf 16886678153039608999993999599999934545763559999999998650499972321207872594899995
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (801)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 89938867981079828999999999999999986476---888999999999986799988578731045-97699999
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 14799988998018321378999999999999999999998569999383588999589779994999614688786789
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~ 667 (801)
|+++|+|.+++.... ...+++..++.|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ECCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 578982888875147--89887889999999999999999748---9546756422515620244042341014773588
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCC
Q ss_conf 8432246643346767954-356898972047889999999990998856446555410000114544315566320399
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
.. .......++..|+||| +..+.++.++|||||||++|||+||..|+...... ..+...+..
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------~~~~~~i~~ 225 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVIQNLER 225 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHT
T ss_pred CC-CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHH
T ss_conf 64-4203567744445828983799982456452579999999689888888899----------------999999970
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 878999810189999999981001999999989999999999876
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 747 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 791 (801)
......|..++.++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 688889655719999999997588976893999999986113213
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.87 Aligned_cols=269 Identities=26% Similarity=0.434 Sum_probs=217.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCC-----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEE
Q ss_conf 6886678153039608999993999-----59999993454576355999999999865049997232120787259489
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDG-----KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (801)
+.|++.++||+|+||.||+|.+..+ ..||||++.... .......|.+|++++.+++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 996861598117790999999968998787999999988445-9689999999999998568987832367783388038
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99951479998899801832137899999999999999999999856999938358899958977999499961468878
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
+||||+.++++.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 999721357402221023---45420899999999999854121212---342576564427888998499845510300
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 6789843-2246643346767954-3568989720478899999999909988564465554100001145443155663
Q 003704 664 ISSGSVS-QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+...... .......|+..|+||| +..+.++.++|||||||++|||+++..|+...... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHH
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH----------------HHHH
T ss_conf 357876526742677773434888870499997355634489899999679886556899----------------9999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 203998789998101899999999810019999999899999999998764104577899
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNESLGD 801 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~~~~~~ 801 (801)
+.+........+..++.++.+|+.+||+.||++|||+.|+++.|+.+++... +-++++|
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~-~l~~l~d 282 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD-SLKTLAD 282 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG-GGGSBCC
T ss_pred HHHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC-CCCCCCC
T ss_conf 9986357899850457999999999776797689399999999999866956-4633248
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.29 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=203.5
Q ss_pred CCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE----CCEEEEE
Q ss_conf 86678153039608999993-999599999934545763559999999998650499972321207872----5948999
Q 003704 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLI 585 (801)
Q Consensus 511 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~----~~~~~lV 585 (801)
|+..+.||+|+||+||+|.. .++..||+|++............+.+|++++++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCC
Q ss_conf 951479998899801832137899999999999999999999856999938358899958977-9994999614688786
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLI 664 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~-~~~~~ki~DfGla~~~ 664 (801)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. .++|+||||||+|||++ .++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 957898948999751----35546999999999999999999978-9979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHC
Q ss_conf 78984322466433467679543568989720478899999999909988564465554100001145443155663203
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
.... .....||+.|+|||+..+.|+.++|||||||++|||++|+.||........ ....+.
T Consensus 166 ~~~~----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~---------------~~~~i~ 226 (270)
T d1t4ha_ 166 RASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVT 226 (270)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---------------HHHHHT
T ss_pred CCCC----CCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH---------------HHHHHH
T ss_conf 6876----677553813008988478999867110079999999878899987655999---------------999997
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 9987899981018999999998100199999998999999
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.......++...++++.+|+.+||+.||++|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3899865675578999999999763797589299999677
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.76 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=208.3
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-6355999999999865049997232120787259489999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+. .+++.||+|++.+... .......+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 50479858988750----48999999999999999999999988---946522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 984322466433467679543-5689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. .....||..|+|||+ ....|+.++|||||||++|||++|+.||...... ..+..+..
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~~~~i~~ 218 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------------ETYKRISR 218 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHT
T ss_pred CC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHHC
T ss_conf 85----23557887634999975899893144046759999983299998889999----------------99999971
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 9878999810189999999981001999999989999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
.. ..+|...+.++.+|+.+||+.||++|||+.|++++-
T Consensus 219 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 219 VE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 89--999866899999999997647976890999997190
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.99 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=210.7
Q ss_pred CCCCCCCE-EEECCCCEEEEEEEC---CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEE
Q ss_conf 68866781-530396089999939---99599999934545763559999999998650499972321207872594899
Q 003704 509 NSFSQENL-IGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~-iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~l 584 (801)
++|.+.+. ||+|+||.||+|... ++..||||++... ......+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 4718878487306080999999960897689999998820-397899999999999986799888068656036-80799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99514799988998018321378999999999999999999998569999383588999589779994999614688786
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~ 664 (801)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 99807899689975212---56999999999999999987899868---8105767646604546885420331342115
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 789843-2246643346767954-356898972047889999999990-9988564465554100001145443155663
Q 003704 665 SSGSVS-QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 665 ~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
...... .......++..|+||| +..+.++.++|||||||++|||+| |+.||...... .+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-----------------~~~ 222 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----------------EVM 222 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------HHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-----------------HHH
T ss_conf 543432113562113743358688727999954123220178999993899999997999-----------------999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 203998789998101899999999810019999999899999999998764
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
..+........|..++.++.+|+.+||+.||++|||+.++++.|+.....-
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 999818999999767899999999975779768909999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=371.52 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=204.4
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 16886678153039608999993-99959999993454576-35599999999986504999723212078725948999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
.+.|+..+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999989988999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 95147999889980183213789999999999999999999985699993835889995897799949996146887867
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~ 665 (801)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCC
T ss_conf 980699945789973----79999999999999999999999868---97666788421798799978984436533467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 898432246643346767954356----8989720478899999999909988564465554100001145443155663
Q 003704 666 SGSVSQLSGHLLTAYGYGAPEFES----GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
.. ....||..|+|||+.. +.|+.++|||||||++|||++|+.||...... ..+.
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----------------~~~~ 224 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALY 224 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHH
T ss_pred CC------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHH
T ss_conf 78------7313476636889983467888672145455899999998788999997999----------------9999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 2039987899981018999999998100199999998999999
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.+.........+...+.++.+|+.+||+.||++|||+.|+++|
T Consensus 225 ~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 9982899988878889999999999773796579189999719
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.88 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=208.7
Q ss_pred CEEEECCCCEEEEEEEC---CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEECCCC
Q ss_conf 81530396089999939---995999999345457635599999999986504999723212078725948999951479
Q 003704 515 NLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (801)
Q Consensus 515 ~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~~~~ 591 (801)
+.||+|+||.||+|.+. .++.||||++..........+.|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf 9988998018321378999999999999999999998569999383588999589779994999614688786789843-
Q 003704 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS- 670 (801)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~~~- 670 (801)
|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 968999752----25789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCCCC
Q ss_conf 2246643346767954-356898972047889999999990-99885644655541000011454431556632039987
Q 003704 671 QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSL 748 (801)
Q Consensus 671 ~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (801)
.......++..|+||| +..+.++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTC
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHCCC
T ss_conf 22445677842039166537999843443034031328965899999998999-----------------9999998289
Q ss_pred CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 89998101899999999810019999999899999999998764
Q 003704 749 SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 749 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
....|..++.++.+|+.+||+.||++|||+.++++.|.....+-
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 99998656799999999975889768909899999852887504
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=366.71 Aligned_cols=250 Identities=19% Similarity=0.315 Sum_probs=206.4
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 16886678153039608999993-99959999993454576355999999999865049997232120787259489999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 657589889840768199999988999899999984524--316999999999998679979992999999899999999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCC
Q ss_conf 514799988998018321378999999999999999999998569999383588999589779--994999614688786
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD--DLAVSVSDCGLAPLI 664 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~--~~~~ki~DfGla~~~ 664 (801)
||++||+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+
T Consensus 103 E~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred ECCCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEEC
T ss_conf 857998899999762---37899999999999999999999756---976000154673641688986999545210442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHH
Q ss_conf 7898432246643346767954-356898972047889999999990998856446555410000114544315566320
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..... .....||..|+||| +....|+.++||||+||++|||++|+.||....... .+..+
T Consensus 177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~i 237 (350)
T d1koaa2 177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------------TLRNV 237 (350)
T ss_dssp CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHH
T ss_pred CCCCC---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHH
T ss_conf 56543---200068624218899758998726765546599999985989989979999----------------99999
Q ss_pred CC--CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 39--987899981018999999998100199999998999999
Q 003704 744 VD--PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~--~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.. ...........+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8478898942235899999999999756896679089998629
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=369.59 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=208.3
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 316886678153039608999993-9995999999345457635599999999986504999723212078725948999
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
+.+.|++.+.||+|+||.||+|+. .+|+.||||++.+.... .....+.+|++++++++|||||++++++.+.+..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 766669988994065839999999999989999998157731-2899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCC
Q ss_conf 951479998899801832137899999999999999999999856999938358899958977---99949996146887
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~---~~~~~ki~DfGla~ 662 (801)
|||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+. .++.+||+|||+++
T Consensus 86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf 852689848886530----36788789999999999998752413---05568704630011046888249983154358
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 867898432246643346767954-3568989720478899999999909988564465554100001145443155663
Q 003704 663 LISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
....... .....||..|+||| +..+.|+.++||||+||++|||++|+.||....... ...
T Consensus 159 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----------------~~~ 219 (307)
T d1a06a_ 159 MEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----------------LFE 219 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------------HHH
T ss_pred ECCCCCE---EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHH
T ss_conf 7258970---440032842259188737999807873451599999985979999989999----------------999
Q ss_pred HHCCC--CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 20399--87899981018999999998100199999998999999
Q 003704 742 RMVDP--SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 742 ~~~~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.+... ......+...++++.+|+.+||+.||++|||+.|++++
T Consensus 220 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 986168777876666789999999999760897579189998629
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.05 Aligned_cols=252 Identities=23% Similarity=0.426 Sum_probs=212.7
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEEC
Q ss_conf 68866781530396089999939995999999345457635599999999986504999723212078725948999951
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|+.++++.||||++.+... ....|.+|++++++++||||++++|++.+.+..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf 99799689820788399999988998999999874757---789999999999966898601588998507816999970
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+++|+|.+++... ...+++..+++++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf 4899388864102---46776899999999999999987546---84346654135887699847988614420235787
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCC
Q ss_conf 432246643346767954-356898972047889999999990-998856446555410000114544315566320399
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDP 746 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (801)
... .....++..|+||| +..+.++.++||||||+++|||+| |+.||...... .+...+..
T Consensus 155 ~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------~~~~~i~~ 216 (258)
T d1k2pa_ 155 YTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------ETAEHIAQ 216 (258)
T ss_dssp CCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------HHHHHHHT
T ss_pred CEE-ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHH
T ss_conf 225-246578877578078637998852103364324673975599998899999-----------------99999980
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 87899981018999999998100199999998999999999
Q 003704 747 SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVD 787 (801)
Q Consensus 747 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 787 (801)
......|...+.++.+|+.+||+.||++|||++|++++|.+
T Consensus 217 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 79789965465999999999766897689399999987418
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.02 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=211.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-6355999999999865049997232120787259489999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++.+... .......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 70489877776531----59999999999999999999762165---088476774123668885388603210242256
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 984322466433467679543-5689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
...........||..|+|||+ ....|+.++||||+||++|||++|+.||...... .....+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----------------LIFQKIIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHT
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHC
T ss_conf 77643335556775525844002689896662304569999980388998995999----------------99999971
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 98789998101899999999810019999999899999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLV 786 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 786 (801)
.. ..+|...+.++.+|+.+||+.||++|||++|++.+..
T Consensus 225 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 225 LE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp TC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf 89--9998547999999999985579768919789737789
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=365.97 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=207.2
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 16886678153039608999993-99959999993454576355999999999865049997232120787259489999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
.+.|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 403599899931778299999998999799999988726--467999999999998679979891999999899999999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977--9994999614688786
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLAVSVSDCGLAPLI 664 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~--~~~~~ki~DfGla~~~ 664 (801)
||++||+|.+++... ...+++..++.|+.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 106 E~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 106 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred ECCCCCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 828998088889863---89989999999999999999999977---926513144553113467884899525630343
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHH
Q ss_conf 7898432246643346767954-356898972047889999999990998856446555410000114544315566320
Q 003704 665 SSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRM 743 (801)
Q Consensus 665 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (801)
..... .....++..|+||| +....|+.++||||+||++|||++|+.||....... .+..+
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------------~~~~i 240 (352)
T d1koba_ 180 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------------TLQNV 240 (352)
T ss_dssp CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------HHHHH
T ss_pred CCCCC---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHH
T ss_conf 78872---010047645348999747998976333898999999996889989979999----------------99999
Q ss_pred C--CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3--9987899981018999999998100199999998999999
Q 003704 744 V--DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~--~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
. +.......+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8478898930024799999999999756996689189999609
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.26 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=205.9
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 16886678153039608999993-99959999993454576355999999999865049997232120787259489999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
.+.|++.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 037598479930778199999999999399999987289--999999999999998679999884988980099589999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 Ey~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred ECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCC
T ss_conf 627998188999862---89999999999999999999999988---988714070031487899989971612303577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHH
Q ss_conf 9843224664334676795435------6898972047889999999990998856446555410000114544315566
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE------SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~------~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
.. .......|+..|+|||+. ...|+.++|||||||++|||++|+.||....... .+
T Consensus 163 ~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----------------~~ 224 (288)
T d2jfla1 163 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----------------VL 224 (288)
T ss_dssp HH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----------------HH
T ss_pred CC--CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------------HH
T ss_conf 86--4100102562647999983202578888806657878999999820889999989999----------------99
Q ss_pred HHHCCC-CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 320399-87899981018999999998100199999998999999
Q 003704 741 SRMVDP-SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 741 ~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
..+... ......+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 225 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999707998777656699999999999766996689199999629
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.43 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=212.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEEC-CCC----EEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEE
Q ss_conf 68866781530396089999939-995----9999993454576355999999999865049997232120787259489
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (801)
++|++.+.||+|+||+||+|... +|+ .||+|++... ......+.|.+|++++++++|||||+++|++.+. ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 99978319820899299999995899889899999996513-4979999999999999867998881589999619-836
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99951479998899801832137899999999999999999999856999938358899958977999499961468878
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
+++||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEECCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf 999842687401011133---45799999999999999999999876---950476212031167998758602552223
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 67898432246643346767954-356898972047889999999990-9988564465554100001145443155663
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
..............++..|+||| +..+.|+.++|||||||++|||+| |+.||...... .+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~~~ 223 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EIS 223 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------GHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHH
T ss_conf 354445322365105864467088746999835654407999999997799999999989-----------------999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 20399878999810189999999981001999999989999999999876
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 791 (801)
..+........|..++.++.+|+.+||+.||++|||+.|++++|..+.+.
T Consensus 224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99975998999855689999999984789934691999999999998758
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.82 Aligned_cols=265 Identities=26% Similarity=0.441 Sum_probs=211.8
Q ss_pred CCCCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEEEC-
Q ss_conf 168866781530396089999939------995999999345457635599999999986504-999723212078725-
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH- 579 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~- 579 (801)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|...+.++ +|+||+.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 79979844984167839999998677755578399999986001-71789999999999886149984997411540479
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 948999951479998899801832------------13789999999999999999999985699993835889995897
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl 647 (801)
...++||||+++|+|.++++.... ....+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEE
T ss_conf 757999984589929999985366666532220233214689999999999999999988737---97178677310657
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCC
Q ss_conf 799949996146887867898432246643346767954-35689897204788999999999099-8856446555410
Q 003704 648 DDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGR-KSYDRTRNRGEQF 725 (801)
Q Consensus 648 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~-~Pf~~~~~~~~~~ 725 (801)
+.++.+||+|||+|+...............||..|+||| +..+.++.++|||||||++|||++|. .||......
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---- 243 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---- 243 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS----
T ss_pred CCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH----
T ss_conf 7998289845752001135665222475166721020368646889966322136789999986889999899989----
Q ss_pred EEECCCCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 0001145443155663203998789998101899999999810019999999899999999998764
Q 003704 726 LVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
..+...+........|...+.++.+++.+||+.||++|||+.|++++|+++++..
T Consensus 244 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 ------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp ------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ------------9999999638988888657899999999976779667919999999997998677
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=365.91 Aligned_cols=267 Identities=26% Similarity=0.393 Sum_probs=217.2
Q ss_pred HHHHHHCCCCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEE
Q ss_conf 657543168866781530396089999939------99599999934545763559999999998650499972321207
Q 003704 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575 (801)
Q Consensus 502 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~ 575 (801)
.+++...++|++.+.||+|+||.||+|+.. +++.||||++.... .......|.+|++++++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 31138988938867982078839999998887657788299999988210-85799999999999996689976552466
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 872594899995147999889980183--------------------213789999999999999999999985699993
Q 003704 576 CAEHGQRLLIYEYCSNGTLQDMLHSDD--------------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635 (801)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 635 (801)
+.+.+..++||||+++|+|.+++.... .....+++..++.|+.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CE
T ss_conf 605980389998158992999998527554210000111001210346788989999999999999985541357---86
Q ss_pred EECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCC-C
Q ss_conf 835889995897799949996146887867898432246643346767954-35689897204788999999999099-8
Q 003704 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGR-K 713 (801)
Q Consensus 636 vHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~-~ 713 (801)
+||||||+|||++.++.+||+|||+++.+.............++..|+||| +....|+.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 8564465554100001145443155663203998789998101899999999810019999999899999999998
Q 003704 714 SYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMI 789 (801)
Q Consensus 714 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~ 789 (801)
||...... +.+..+.+ ......|..++.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~~----------------e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE----------------EVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH----------------HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH----------------HHHHHHHC-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 99998999----------------99999973-9978887325299999999974889657939999999999842
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.08 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=208.4
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-6355999999999865049997232120787259489999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++.+... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 03579860555532----56775999999999996521134315---962246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 984322466433467679543-5689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
... ......||..|+|||+ ....|+.++||||+||++|||++|++||....... ....+..
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----------------~~~~i~~ 219 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILM 219 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHHH
T ss_pred CCC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHC
T ss_conf 786--2055100889966665048988833310223067889987899999969999----------------9999852
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 98789998101899999999810019999999-----8999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 784 (801)
. ...+|...+.++.+|+.+||+.||.+|++ ++|+++|
T Consensus 220 ~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 8--99898668999999998666389344225652349999729
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.41 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=207.1
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCH----HHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCE
Q ss_conf 316886678153039608999993-999599999934545763----559999999998650499972321207872594
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ----QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~ 581 (801)
+.++|++.+.||+|+||.||+|+. .+|+.||||++.+..... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEE
Q ss_conf 8999951479998899801832137899999999999999999999856999938358899958977999----499961
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSD 657 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~----~~ki~D 657 (801)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 9999986778643100103----56421557899999999998766625---4221133301279825898666469643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 468878678984322466433467679543-5689897204788999999999099885644655541000011454431
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 658 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
||++........ .....++..|+|||+ ....++.++||||+||++|||++|+.||.......
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------------- 223 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------------- 223 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred HHHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH--------------
T ss_conf 344210577763---122477774309999818999976652214099999970889988999999--------------
Q ss_pred HHHHHHHCCCC--CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 55663203998--7899981018999999998100199999998999999
Q 003704 737 IDALSRMVDPS--LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.+..+.... .....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 224 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 224 --TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --999998168888701047889999999999863896689199999619
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=361.44 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=201.6
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCH-HHHHHH---HHHHHHHHCCCCCCCCCCCEEEEECCEEE
Q ss_conf 6886678153039608999993-999599999934545763-559999---99999865049997232120787259489
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEF---LELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~~~---~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++.+..... .....+ .+++++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99951479998899801832137899999999999999999999856999938358899958977999499961468878
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 99991489838999873----25532789999999999999999977---962204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 678984322466433467679543-568-989720478899999999909988564465554100001145443155663
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEF-ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~-~~~-~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
+.... .....||..|+|||+ ..+ .|+.++|||||||++|||+||+.||......... .+.
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------------~~~ 218 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EID 218 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--------------HHH
T ss_pred CCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH--------------HHH
T ss_conf 37886----433113455421687603899984410467789999998599988889989999--------------999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 203998789998101899999999810019999999-----8999999
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPP-----MSEVVQD 784 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 784 (801)
... ......++...+.++.+|+.+||+.||++||| ++|+++|
T Consensus 219 ~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 219 RMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHC-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 860-46888788778999999999985669888088743579999749
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.37 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=212.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEEC
Q ss_conf 68866781530396089999939995999999345457635599999999986504999723212078725948999951
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||.||+|+..++..||||++..... ..+.|.+|+.++++++|+|||+++|++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf 99798469930798099999999999999999880448---88999999999986666788689999823-975999994
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+++|+|..++.... ...++|..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 47994354200003--55305999999999999999987541---14335312307999899929984425554256887
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCCCC
Q ss_conf 432246643346767954-3568989720478899999999909988564465554100001145443155663203998
Q 003704 669 VSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVDPS 747 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (801)
.. ......++..|+||| +..+.++.++||||||+++|||++|..|+...... ..+...+...
T Consensus 168 ~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------~~~~~~i~~~ 230 (285)
T d1fmka3 168 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQVERG 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTT
T ss_pred CE-EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHHC
T ss_conf 33-524545566545808983799891774132358999998689999988889----------------9999999826
Q ss_pred CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 7899981018999999998100199999998999999999987641
Q 003704 748 LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 748 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~ 793 (801)
.....+..++.++.+++.+||+.||++||++++|++.|........
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 8999983237999999999756697589199999998766623899
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.00 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=213.8
Q ss_pred CCCCCCCCEEEECCCCEEEEEEECC----CCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEE
Q ss_conf 1688667815303960899999399----959999993454576355999999999865049997232120787259489
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (801)
.++|++.+.||+|+||.||+|+... +..||||.+... ........+.+|++++++++|||||++++++.+ +..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf 89969877993078829999999369964499999993656-687999999999999986899998569889953-7479
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99951479998899801832137899999999999999999999856999938358899958977999499961468878
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 999840698077654224---78999999999999998775230226---744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHH
Q ss_conf 67898432246643346767954-356898972047889999999990-9988564465554100001145443155663
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALS 741 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (801)
....... ......++..|+||| +..+.|+.++|||||||++|||++ |.+||....... .+.
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------------~~~ 220 (273)
T d1mp8a_ 158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------VIG 220 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHH
T ss_pred CCCCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH----------------HHH
T ss_conf 3677623-30540058310326675169988745244424789999826999988899999----------------999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 20399878999810189999999981001999999989999999999876410
Q 003704 742 RMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERC 794 (801)
Q Consensus 742 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~ 794 (801)
.+.. ......|..++.++.+|+.+||+.||++|||+.|++++|..+++++++
T Consensus 221 ~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 221 RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHC-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHC
T ss_conf 9981-899989877799999999997687976892999999999999778617
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.44 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=211.9
Q ss_pred CCCCCCCEEEECCCCEEEEEEEC-CCC--EEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEEECCEEEE
Q ss_conf 68866781530396089999939-995--999999345457635599999999986504-99972321207872594899
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP-DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~~~~l 584 (801)
++|++.+.||+|+||.||+|... +|. .||||++.... .....+.|.+|++++.++ +|||||++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 9968877982078828999999899969999999978233-857999999999999862289988367888841873699
Q ss_pred EEECCCCCCHHHHHHCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 995147999889980183------------21378999999999999999999998569999383588999589779994
Q 003704 585 IYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~ 652 (801)
||||+++|+|.++++... .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCC
T ss_conf 9980289869999864035555512310123457899999999999999998766308---9545550520489868876
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCEEECC
Q ss_conf 9996146887867898432246643346767954-356898972047889999999990998-85644655541000011
Q 003704 653 VSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRK-SYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 653 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~-Pf~~~~~~~~~~~~~~~ 730 (801)
+||+|||+++....... .....++..|+||| +..+.|+.++||||||+++|||++|.. ||.....
T Consensus 166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---------- 232 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232 (309)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------
T ss_pred EEECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCH----------
T ss_conf 38743443224442234---55301377555538752699996221531388999998368999999999----------
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 454431556632039987899981018999999998100199999998999999999987641
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~ 793 (801)
..+...+........+..++.++.+|+.+||+.||++|||+.|++++|..++++..
T Consensus 233 -------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 233 -------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------HHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf -------99999998268888876678999999999767896689499999999999986186
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=358.36 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=206.7
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-6355999999999865049997232120787259489999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||++||+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 50378632234322----22111007999999998765541247---677055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 9843224664334676795435-689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .....||..|+|||+. ...|+.++||||+||++|||++|+.||...... ..+..+..
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~i~~ 215 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEKILN 215 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHH
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH----------------HHHHHHHC
T ss_conf 5-----64345763435999983899980430465333689997598999996999----------------99999970
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 9878999810189999999981001999999-----98999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 784 (801)
.. ..+|...+.++.+++.+||+.||.+|+ |++|+++|
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 216 AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 89--8899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=358.33 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=206.3
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-6355999999999865049997232120787259489999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++.+... .......+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 51479998899801832137899999999999999999999856999938358899958977999499961468878678
Q 003704 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (801)
Q Consensus 587 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~ 666 (801)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. +||||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 23346622666751----58989999999999999989999859---986176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 98432246643346767954-35689897204788999999999099885644655541000011454431556632039
Q 003704 667 GSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 667 ~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
. .....|+..|+||| +....|+.++|||||||++|||+||+.||...... ..+..+..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~i~~ 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QIYEKIVS 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHH
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHC
T ss_conf 6-----64336763567889971799885331145007899997588998995999----------------99999861
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 9878999810189999999981001999999-----98999999
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 784 (801)
.. ...|...+.++.+|+.+||+.||.+|+ |++|+++|
T Consensus 253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 79--8897668999999999983409986065534549999719
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.23 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=218.6
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE------CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEEECC
Q ss_conf 16886678153039608999993------9995999999345457635599999999986504-9997232120787259
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~ 580 (801)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .......|.+|+.++.++ +|||||++++++.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 89969854982068829999998066447788699999987424-87799999999999876269998878998983199
Q ss_pred EEEEEEECCCCCCHHHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 48999951479998899801832--------------1378999999999999999999998569999383588999589
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDE--------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NIL 646 (801)
..++||||+++|+|.++++.... ....+++..+..++.||+.||+|||+. +++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCC
Q ss_conf 7799949996146887867898432246643346767954-3568989720478899999999909-9885644655541
Q 003704 647 LDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTG-RKSYDRTRNRGEQ 724 (801)
Q Consensus 647 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG-~~Pf~~~~~~~~~ 724 (801)
++.++.+|++|||.++...............++..|+||| +..+.++.++||||||+++|||+|+ ++||......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH---
T ss_conf 00257521023401023367886158620135968767788617999974001025899999985899887789989---
Q ss_pred CEEECCCCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 00001145443155663203998789998101899999999810019999999899999999998764
Q 003704 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
..+.+++........+...+.++.+|+.+||+.||++|||+.|+++.|++++.+.
T Consensus 255 -------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf -------------9999998668988985436599999999975779657929999999998765349
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.20 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=208.9
Q ss_pred CCEEEECCCCEEEEEEECCC----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE-CCEEEEEEEC
Q ss_conf 78153039608999993999----599999934545763559999999998650499972321207872-5948999951
Q 003704 514 ENLIGAGMLGSVYRAQLPDG----KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYEY 588 (801)
Q Consensus 514 ~~~iG~G~~g~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E~ 588 (801)
.++||+|+||+||+|+..++ ..||||++.+. ........|.+|++++++++|||||+++|++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66981368809999999779987999999998843-69789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+++|+|.+++... ...+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 4067414421013---45404899999999988765200336---76257766875767799988991065232255665
Q ss_pred CC--CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 43--2246643346767954-35689897204788999999999099885644655541000011454431556632039
Q 003704 669 VS--QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 669 ~~--~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.. .......++..|+||| +..+.++.++||||||+++|||++|+.||........ ....+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------------~~~~i~- 248 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVYLL- 248 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHHHH-
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------------HHHHHH-
T ss_conf 5531002565556455676887437999745746619999999978999988899999---------------999998-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 98789998101899999999810019999999899999999998764104
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCS 795 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~ 795 (801)
.......|..++.++.+|+.+||+.||++||++.||+++|+++.++....
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHH
T ss_conf 08988996447599999999976889768939999999999999752012
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.39 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=216.4
Q ss_pred CCCCCCCCEEEECCCCEEEEEEEC--------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEEE
Q ss_conf 168866781530396089999939--------995999999345457635599999999986504-99972321207872
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~ 578 (801)
.++|.+.+.||+|+||.||+|+.. ++..||||++.+.. .......+.+|...+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 8996970098516782899999857875556675499999988112-868899999999999981399969734652201
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 5948999951479998899801832------------1378999999999999999999998569999383588999589
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NIL 646 (801)
.+..++||||+++|+|.+++..... ....+++..+++++.|++.||.|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCC
Q ss_conf 7799949996146887867898432246643346767954-356898972047889999999990-99885644655541
Q 003704 647 LDDDLAVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQ 724 (801)
Q Consensus 647 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~ 724 (801)
++.++.+||+|||+++...............++..|+||| +..+.|+.++||||||+++|||++ |.+||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH----
T ss_conf 5478976762211101135555543146678884663266751798882555477588888740179898999999----
Q ss_pred CEEECCCCCCCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 000011454431556632039987899981018999999998100199999998999999999987
Q 003704 725 FLVRWAIPQLHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIR 790 (801)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~ 790 (801)
..+.+.+........|...+.++.+|+.+||+.||++|||+.|+++.|++++.
T Consensus 244 -------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -------------99999997288889874352999999999766797679399999999988860
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.05 Aligned_cols=252 Identities=26% Similarity=0.455 Sum_probs=209.5
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE-CCEEEEEEE
Q ss_conf 6886678153039608999993999599999934545763559999999998650499972321207872-594899995
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E 587 (801)
++|++.+.||+|+||.||+|+. .|+.||||++++. ...+.+.+|++++++++||||++++|++.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 9948857982079808999999-9909999998857----7799999999999867898985498788723892899996
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 14799988998018321378999999999999999999998569999383588999589779994999614688786789
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~ 667 (801)
|+++|+|.+++.... ...+++..+++++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC
T ss_conf 369998999987457--88889999999999998523211337---6553666567601468997763245600344787
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHCC
Q ss_conf 8432246643346767954-356898972047889999999990-99885644655541000011454431556632039
Q 003704 668 SVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMVD 745 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (801)
.....++..|+||| +..+.++.++||||||+++|||+| |++||...... .+...+.
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------~~~~~i~ 214 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVE 214 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHT
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHH
T ss_conf -----765566646778178727988858877757999999997899999999999-----------------9999998
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 98789998101899999999810019999999899999999998764
Q 003704 746 PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRE 792 (801)
Q Consensus 746 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~ 792 (801)
.......+...+.++.+|+.+||+.||++|||+.|++++|+++...+
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 08999997657999999999975669768939999999999998677
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.74 Aligned_cols=275 Identities=23% Similarity=0.310 Sum_probs=205.5
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECC----EEEE
Q ss_conf 688667815303960899999399959999993454576355999999999865049997232120787259----4899
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----QRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----~~~l 584 (801)
++|...+.||+|+||.||+|+. +|+.||||++... ......+..|+..+.+++|||||++++++.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 9951479998899801832137899999999999999999999856-----99993835889995897799949996146
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI-----CQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDLkp~NILl~~~~~~ki~DfG 659 (801)
||||+++|+|.++++. ..++|..+++++.+++.||.|+|+. +.++|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 9964669898999865-----89998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC
Q ss_conf 88786789843--224664334676795435689-------897204788999999999099885644655541000011
Q 003704 660 LAPLISSGSVS--QLSGHLLTAYGYGAPEFESGI-------YTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA 730 (801)
Q Consensus 660 la~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-------~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~ 730 (801)
+++........ .......|+.+|+|||+..+. ++.++|||||||++|||+||..||............ ..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TS
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH-CC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012-25
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCC-----CCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 45443155663203998789998-----1018999999998100199999998999999999987641
Q 003704 731 IPQLHDIDALSRMVDPSLSGQYP-----AKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRER 793 (801)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~ 793 (801)
..............+..+.+..+ ...+.++.+|+.+||+.||++|||+.|++++|.++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 56430999999875024688877655776899999999999760698589599999999998888659
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.91 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=214.3
Q ss_pred CCCCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCE
Q ss_conf 168866781530396089999939------99599999934545763559999999998650499972321207872594
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~ 581 (801)
.++|.+.+.||+|+||.||+|... ++..||||++... ........|.+|++++++++|||||++++++...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 8991883598207881899999878644778968999998701-286899999999999997699988412547842881
Q ss_pred EEEEEECCCCCCHHHHHHCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 8999951479998899801832------1378999999999999999999998569999383588999589779994999
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDE------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki 655 (801)
.++||||+++|+|.+++..... ....+++..+.+++.|+++||.|||+. +|+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEE
T ss_conf 0677760489988999875033211344468879999999999999999987647---9654328677540359964999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCEEECCCCC
Q ss_conf 6146887867898432246643346767954-35689897204788999999999099-885644655541000011454
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGR-KSYDRTRNRGEQFLVRWAIPQ 733 (801)
Q Consensus 656 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~~ 733 (801)
+|||+++.+.............++..|+||| +..+.++.++||||||+++|||+||. .||......
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------------ 242 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------------ 242 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------------
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH------------
T ss_conf 42454202357763031340231632378888736998833344437899999996899999998999------------
Q ss_pred CCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 4315566320399878999810189999999981001999999989999999999876
Q 003704 734 LHDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRR 791 (801)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~ 791 (801)
+.+..+.+.. ....|..++..+.+++.+||+.||++|||+.+++++|++.++.
T Consensus 243 ----~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 243 ----QVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----HHHHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf ----9999998088-8888633539999999997577965893999999997876177
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.34 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=204.4
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 316886678153039608999993-9995999999345457635599999999986504999723212078725948999
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
..++|++.+.||+|+||+||+|.. .+++.||||.+.... .....+.+|+++++.++|||||++++++.+.+..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 7010588789831778399999998999699999975786---6599999999999857997989098999889988999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCCC
Q ss_conf 95147999889980183213789999999999999999999985699993835889995897799--9499961468878
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD--LAVSVSDCGLAPL 663 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~--~~~ki~DfGla~~ 663 (801)
|||++||+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ ..+||+|||+++.
T Consensus 80 mE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHC
T ss_conf 9538998088998753---89999999999999999999999876---99751355444344378851899764411100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHH
Q ss_conf 67898432246643346767954-35689897204788999999999099885644655541000011454431556632
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSR 742 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (801)
...... .....++..|+||| .....|+.++||||+||++|+|++|+.||....... .+..
T Consensus 154 ~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------------~~~~ 214 (321)
T d1tkia_ 154 LKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------IIEN 214 (321)
T ss_dssp CCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH----------------HHHH
T ss_conf 346775---321223322234021048777840113027999999982899999989999----------------9999
Q ss_pred HCCCCCC--CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 0399878--999810189999999981001999999989999999
Q 003704 743 MVDPSLS--GQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 743 ~~~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
+...... ...+...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 215 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 983899988022367899999999998669966890999996399
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=348.45 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=207.2
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCH-------HHHHHHHHHHHHHHCCC-CCCCCCCCEEEEE
Q ss_conf 16886678153039608999993-999599999934545763-------55999999999865049-9972321207872
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-------QKDDEFLELVNNIDRIR-HANIVELKGYCAE 578 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~ 578 (801)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+..... .....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 59489999514799988998018321378999999999999999999998569999383588999589779994999614
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~Df 658 (801)
.+..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986----59999999999999999999999875---9943234625489868998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC
Q ss_conf 6887867898432246643346767954356-------898972047889999999990998856446555410000114
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFES-------GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI 731 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 731 (801)
|+++.+..... .....|+..|+|||... ..++.++||||+||++|||++|+.||.......
T Consensus 155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------- 222 (277)
T d1phka_ 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------- 222 (277)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred HHEEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH---------
T ss_conf 03167268872---134524678889888605344567889923318565602310322888988999999---------
Q ss_pred CCCCCHHHHHHHCCC--CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 544315566320399--87899981018999999998100199999998999999
Q 003704 732 PQLHDIDALSRMVDP--SLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 732 ~~~~~~~~~~~~~~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
....+... ..........++++.+|+.+||+.||++||++.|++++
T Consensus 223 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 -------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -------HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------999998189888985434689999999999765896689199999739
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=349.20 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=210.6
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECC----
Q ss_conf 316886678153039608999993-99959999993454576-355999999999865049997232120787259----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHG---- 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~---- 580 (801)
..++|++.+.||+|+||.||+|+. .+|+.||||.+.+.... ......+.+|+++++.++|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 06206986899608992999999999998999999855664698999999999999985699988731143543268876
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 48999951479998899801832137899999999999999999999856999938358899958977999499961468
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGl 660 (801)
..|+||||++|++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++..+++|||.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHH
T ss_conf 69999977889871011203----58999999999999999999999857---952763467556657543201003444
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHH
Q ss_conf 878678984-322466433467679543-568989720478899999999909988564465554100001145443155
Q 003704 661 APLISSGSV-SQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 661 a~~~~~~~~-~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
+........ ........|+..|+|||+ ....|+.++||||+||++|||+||++||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------------- 222 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------------- 222 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------------
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH---------------
T ss_conf 32212354433334642576243699998399999663202652899999769799899699999---------------
Q ss_pred HHHHHCCC--CCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 66320399--878999810189999999981001999999-9899999999998
Q 003704 739 ALSRMVDP--SLSGQYPAKSLSHFADIISRCVQSEPEFRP-PMSEVVQDLVDMI 789 (801)
Q Consensus 739 ~~~~~~~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~~~ 789 (801)
+...+.. ..........+.++.+++.+||+.||++|| +++++++.|.++.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 -AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -99998469999710034789999999999866797677739999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.59 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=209.8
Q ss_pred CCCCCCCEEEECCCCEEEEEEEC--CC--CEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEE
Q ss_conf 68866781530396089999939--99--5999999345457-6355999999999865049997232120787259489
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLP--DG--KLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (801)
++|++.+.||+|+||.||+|+.. ++ ..||||++.+... .....+.|.+|++++++++|||||+++|++.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99951479998899801832137899999999999999999999856999938358899958977999499961468878
Q 003704 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 584 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
+||||+++|++.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 146542386125444212---68999999999999999999875217---875205668881565565433256115553
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCCCCHHHH
Q ss_conf 6789843-2246643346767954-356898972047889999999990-998856446555410000114544315566
Q 003704 664 ISSGSVS-QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLT-GRKSYDRTRNRGEQFLVRWAIPQLHDIDAL 740 (801)
Q Consensus 664 ~~~~~~~-~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (801)
....... .......++..|+||| +....++.++||||||+++|||+| |+.||...... +.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~~~ 224 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------QIL 224 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHH
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHH
T ss_conf 0358875265476325731079999837999942156614899999996899999996999----------------999
Q ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 320399878999810189999999981001999999989999999999
Q 003704 741 SRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDM 788 (801)
Q Consensus 741 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~ 788 (801)
..+.........+...+.++.+|+.+||+.||++|||+.|+++.|.++
T Consensus 225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 999847999998544539999999997688966792999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.22 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=196.0
Q ss_pred CCCCCCC-CEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCEEEEE----CC
Q ss_conf 1688667-8153039608999993-999599999934545763559999999998650-499972321207872----59
Q 003704 508 TNSFSQE-NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYCAE----HG 580 (801)
Q Consensus 508 ~~~~~~~-~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~-l~Hpniv~l~~~~~~----~~ 580 (801)
.++|.+. +.||+|+||.||+|+. .+++.||||++.+. ..+.+|++++.+ .+|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCC
T ss_conf 148798107965454869999998899989999998974-------7799999999986699997829899950346897
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEE
Q ss_conf 489999514799988998018321378999999999999999999998569999383588999589779---99499961
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSD 657 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~---~~~~ki~D 657 (801)
..|+|||||+||+|.+++...+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999997789984999998627--87757999999999999999999976---986444100220113555566311354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 4688786789843224664334676795435-689897204788999999999099885644655541000011454431
Q 003704 658 CGLAPLISSGSVSQLSGHLLTAYGYGAPEFE-SGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 658 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
||+++....... .....|+..|+|||+. ...|+.++||||+||++|+|+||+.||............
T Consensus 158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--------- 225 (335)
T d2ozaa1 158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 225 (335)
T ss_dssp CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred CCEEEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHH---------
T ss_conf 551233368886---43226775637927774898888888876451677886588998898877889999---------
Q ss_pred HHHHHHHCCCCC--CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 556632039987--8999810189999999981001999999989999999
Q 003704 737 IDALSRMVDPSL--SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 737 ~~~~~~~~~~~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
...+..... ........+.++.+|+.+||+.||++|||+.|++++-
T Consensus 226 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 226 ---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred ---HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf ---999853888889854346999999999997569965790999997098
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.59 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEECCEEEEE
Q ss_conf 6886678153039608999993-9995999999345457-635599999999986-504999723212078725948999
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNI-DRIRHANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l-~~l~Hpniv~l~~~~~~~~~~~lV 585 (801)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... .......+..|..++ ..++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 95147999889980183213789999999999999999999985699993835889995897799949996146887867
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~ 665 (801)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 750379808998640----47899999999999999999999868---93403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHC
Q ss_conf 898432246643346767954-3568989720478899999999909988564465554100001145443155663203
Q 003704 666 SGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDIDALSRMV 744 (801)
Q Consensus 666 ~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (801)
... .......||..|+||| +..+.|+.++||||+||++|||++|+.||....... .+..+.
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----------------~~~~i~ 216 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----------------LFHSIR 216 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------HHHHHH
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHH
T ss_conf 665--33454578777689999827998832320112278989873889999989999----------------999997
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HHHHH
Q ss_conf 99878999810189999999981001999999989-99999
Q 003704 745 DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMS-EVVQD 784 (801)
Q Consensus 745 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-eil~~ 784 (801)
.. ...+|...+.++.+|+.+||+.||++||++. |+++|
T Consensus 217 ~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 217 MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf 18--9989756799999999996544898783889999809
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.90 Aligned_cols=268 Identities=19% Similarity=0.322 Sum_probs=202.0
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEE
Q ss_conf 6886678153039608999993-999599999934545763559999999998650499972321207872594899995
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||+|+||.||+|+. .+|+.||||++......+.....+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 14799988998018321378999999999999999999998569999383588999589779994999614688786789
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~ 667 (801)
|+.++.+ +++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~-~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHH-HHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCCCHH-HHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 2377445-5544202--56888899999999999999986528---8992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEE--ECCCCCCCCHHHHHHH
Q ss_conf 84322466433467679543-568-9897204788999999999099885644655541000--0114544315566320
Q 003704 668 SVSQLSGHLLTAYGYGAPEF-ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWAIPQLHDIDALSRM 743 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~-~~~-~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 743 (801)
.. ......++..|+|||. ... .++.++||||+||++|+|++|+.||...........+ ....+...........
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CC--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCC
T ss_conf 64--1001036521541122136657774221033331342796687998988999999999983289833314442224
Q ss_pred CCC--CC----CCC---CCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 399--87----899---981018999999998100199999998999999
Q 003704 744 VDP--SL----SGQ---YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 744 ~~~--~~----~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.+. .. ... .....+.++.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.69 Aligned_cols=263 Identities=20% Similarity=0.283 Sum_probs=197.7
Q ss_pred CCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHH---HHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEEC
Q ss_conf 678153039608999993-9995999999345457635---599999999986504999723212078725948999951
Q 003704 513 QENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ---KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 513 ~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~---~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 588 (801)
..++||+|+||+||+|+. .+|+.||||++........ ....+.+|++++++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+.++++..+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412----66778999999999999999886316---35503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE--CCCCCCCCHHHHHHHC
Q ss_conf 4322466433467679543-56-898972047889999999990998856446555410000--1145443155663203
Q 003704 669 VSQLSGHLLTAYGYGAPEF-ES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR--WAIPQLHDIDALSRMV 744 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~-~~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 744 (801)
. ......++..|+|||. .. ..|+.++||||+||++|||++|+.||......+....+. ...+............
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred C--CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCC
T ss_conf 5--43302047333639997267788805643630428999985969999999999999999851899725452100021
Q ss_pred CCCCCCCC--------CCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 99878999--------81018999999998100199999998999999
Q 003704 745 DPSLSGQY--------PAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ~~~~~~~~--------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
........ ....+.++.+|+.+||+.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 344303478988678565689999999999763894569089999679
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=344.84 Aligned_cols=267 Identities=18% Similarity=0.309 Sum_probs=207.2
Q ss_pred CCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEEC
Q ss_conf 68866781530396089999939995999999345457635599999999986504999723212078725948999951
Q 003704 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E~ 588 (801)
++|++.+.||+|+||+||+|+..+|+.||||++............+.+|+.++++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 47999889980183213789999999999999999999985699993835889995897799949996146887867898
Q 003704 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (801)
Q Consensus 589 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~~ 668 (801)
+.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 004567899860----47751445689999999999986057---48826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE--CCCCCCCCHHHHHHHC
Q ss_conf 43224664334676795435-6-898972047889999999990998856446555410000--1145443155663203
Q 003704 669 VSQLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVR--WAIPQLHDIDALSRMV 744 (801)
Q Consensus 669 ~~~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 744 (801)
. ......++..|+|||.. . ..++.++||||+||++|||++|+.||......+....+. ...+............
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred C--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5--41010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred ---------CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---------9987899981018999999998100199999998999999
Q 003704 745 ---------DPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 745 ---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
............+.++.+|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2143333356764666512589999999999866896689099998569
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.13 Aligned_cols=270 Identities=19% Similarity=0.288 Sum_probs=198.9
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CC-CCEEEEEEECCCCCCHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEE---
Q ss_conf 316886678153039608999993-99-9599999934545763559999999998650---499972321207872---
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDR---IRHANIVELKGYCAE--- 578 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~---l~Hpniv~l~~~~~~--- 578 (801)
..++|++.+.||+|+||+||+|+. .+ ++.||||++............+.+|+.+++. .+||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf --594899995147999889980183213789999999999999999999985699993835889995897799949996
Q 003704 579 --HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656 (801)
Q Consensus 579 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~ 656 (801)
....+++|||++++.+....... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf 6674699999740587144444303---78999899999999999999999758---89835798627898589975421
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC--CCC
Q ss_conf 146887867898432246643346767954-35689897204788999999999099885644655541000011--454
Q 003704 657 DCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA--IPQ 733 (801)
Q Consensus 657 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~ 733 (801)
|||+++...... ......||..|+||| +....|+.++||||+||++|||++|+.||...........+... .+.
T Consensus 159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CHHHHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 000101100234---57776548511483100179888111000328999999878799899898999999998407996
Q ss_pred CCCH-------HHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 4315-------566320399878999810189999999981001999999989999999
Q 003704 734 LHDI-------DALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 734 ~~~~-------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
...+ ..............++...+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 11053211110333022345645440445899999999998748966791899996696
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.48 Aligned_cols=264 Identities=19% Similarity=0.289 Sum_probs=204.5
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECC-----
Q ss_conf 316886678153039608999993-99959999993454576355999999999865049997232120787259-----
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----- 580 (801)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.+........+.+.+|+++++.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf -4899995147999889980183213789999999999999999999985699993835889995897799949996146
Q 003704 581 -QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 581 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfG 659 (801)
..++||||+ +.+|..++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-521899987-----40226999999999999999998737---87645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC--C---
Q ss_conf 88786789843224664334676795435-6-898972047889999999990998856446555410000114--5---
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAI--P--- 732 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~--- 732 (801)
+++..... .....++..|+|||.. . ..++.++||||+||++|||++|+.||................ +
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf 02206876-----3102455333588998178789965010300389999997869988897689999998503788488
Q ss_pred -----CCCCHHHHHHHCCCCC---CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----4431556632039987---899981018999999998100199999998999999
Q 003704 733 -----QLHDIDALSRMVDPSL---SGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 -----~~~~~~~~~~~~~~~~---~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
................ ........+.++.+|+.+||+.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 886530003443311578666556677556899999999999772995579299999639
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.17 Aligned_cols=242 Identities=19% Similarity=0.323 Sum_probs=197.5
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHH----HHHHHHHHHHHHHCCC--CCCCCCCCEEEEECC
Q ss_conf 16886678153039608999993-9995999999345457635----5999999999865049--997232120787259
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ----KDDEFLELVNNIDRIR--HANIVELKGYCAEHG 580 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~----~~~~~~~e~~~l~~l~--Hpniv~l~~~~~~~~ 580 (801)
.++|++.+.||+|+||.||+|+. .+|+.||||++.+...... ....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEC
Q ss_conf 48999951479-9988998018321378999999999999999999998569999383588999589779-994999614
Q 003704 581 QRLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDC 658 (801)
Q Consensus 581 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~-~~~~ki~Df 658 (801)
..++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 689999833686228999861----58999999999999999999999877---97556676111477447884897754
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 688786789843224664334676795435-6898-97204788999999999099885644655541000011454431
Q 003704 659 GLAPLISSGSVSQLSGHLLTAYGYGAPEFE-SGIY-TCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~-~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
|+++...... .....||..|+|||+. ...+ +.++||||+||++|||++|+.||.....
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------- 215 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------- 215 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------
T ss_pred CCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH----------------
T ss_conf 6535324445----56656587747999984899788653325540345367568899887367----------------
Q ss_pred HHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 556632039987899981018999999998100199999998999999
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
.... ...++...+.++.+|+.+||+.||++|||+.|++++
T Consensus 216 --i~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 --IIRG------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --HHHC------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHC------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --7615------447787799999999999760897589399998539
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.35 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=192.2
Q ss_pred CCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEEC------CEE
Q ss_conf 886678153039608999993-9995999999345457635599999999986504999723212078725------948
Q 003704 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQR 582 (801)
Q Consensus 510 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~------~~~ 582 (801)
+|+..++||+|+||+||+|+. .+|+.||||++...... +.+|++++++++|+||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 767516982176839999999999979999998816068------99999999866898987387899744765773189
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCC
Q ss_conf 999951479998899801832137899999999999999999999856999938358899958977999-4999614688
Q 003704 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLA 661 (801)
Q Consensus 583 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~-~~ki~DfGla 661 (801)
++||||++++.+..+.+ .......+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 99984168860788886-310368999999999999999999999866---87645788603787358971167336605
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCCCCH
Q ss_conf 7867898432246643346767954-356-8989720478899999999909988564465554100001--14544315
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPE-FES-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW--AIPQLHDI 737 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~ 737 (801)
+.+..... .....++..|+||| +.. ..|+.++||||+||++|||++|+.||......+....+.. ..+.....
T Consensus 171 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred HHCCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf 44047765---320025555568277640468882100024652778550287998987999999999997489817765
Q ss_pred HHHHH-HCCCC--------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 56632-03998--------7899981018999999998100199999998999999
Q 003704 738 DALSR-MVDPS--------LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 738 ~~~~~-~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
..... ..+.. .........+.++.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43062101103554456744443156899999999999765895579299999669
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.58 Aligned_cols=269 Identities=19% Similarity=0.288 Sum_probs=200.7
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECC----E
Q ss_conf 316886678153039608999993-99959999993454576355999999999865049997232120787259----4
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----Q 581 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----~ 581 (801)
+.++|++.+.||+|+||+||+|+. .+|+.||||++.+.. .....+.+.+|+++++.++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 3898599789940648099999999999499999980310-958999999999999976898988588899505645541
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 89999514799988998018321378999999999999999999998569999383588999589779994999614688
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla 661 (801)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 4999996259865664405-----8999999999999999999999978---9867778764378879997787545705
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCCC-
Q ss_conf 786789843-224664334676795435-6-8989720478899999999909988564465554100001--145443-
Q 003704 662 PLISSGSVS-QLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRW--AIPQLH- 735 (801)
Q Consensus 662 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~- 735 (801)
+........ .......++..|+|||.+ . ..++.++||||+||++|||++|+.||......+....... ..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 65047776410101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred -----CHHHHHHHCCCCCCCC-----CCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----1556632039987899-----981018999999998100199999998999999
Q 003704 736 -----DIDALSRMVDPSLSGQ-----YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 736 -----~~~~~~~~~~~~~~~~-----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
................ .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 42343322220244677557787778378999999999999764895679089998619
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.32 Aligned_cols=270 Identities=19% Similarity=0.287 Sum_probs=201.4
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE--------
Q ss_conf 16886678153039608999993-999599999934545763559999999998650499972321207872--------
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-------- 578 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-------- 578 (801)
.++|++.+.||+|+||+||+|+. .+|+.||||++......+.....+.+|++++++++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 59489999514799988998018321378999999999999999999998569999383588999589779994999614
Q 003704 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (801)
Q Consensus 579 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~Df 658 (801)
.+..++||||+.++.+...... ...+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHHC----CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf 7638999853578741012220----34433089999999999999885229---9885676722203668996876313
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC--
Q ss_conf 688786789843--224664334676795435-6-8989720478899999999909988564465554100001145--
Q 003704 659 GLAPLISSGSVS--QLSGHLLTAYGYGAPEFE-S-GIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIP-- 732 (801)
Q Consensus 659 Gla~~~~~~~~~--~~~~~~~~~~~y~aPE~~-~-~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-- 732 (801)
|+++.+...... .......+|..|+|||.. . ..|+.++||||+||++|||++|+.||...........+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred ------CCCCHHHHHHHCCCCCCCCC-------CCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf ------44315566320399878999-------810189999999981001999999989999999
Q 003704 733 ------QLHDIDALSRMVDPSLSGQY-------PAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 733 ------~~~~~~~~~~~~~~~~~~~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
........ ........... ......++.+|+.+||+.||++|||++|+++|=
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 242 TPEVWPNVDNYELY-EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp CTTTSTTCCCC--------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CHHHCCCCCHHHHH-HHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 82553443203444-332013344555033404445998999999998738965890999997495
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.59 Aligned_cols=267 Identities=17% Similarity=0.293 Sum_probs=207.5
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCEEEEEEE
Q ss_conf 6886678153039608999993-999599999934545763559999999998650499972321207872594899995
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (801)
++|++.+.||+|+||+||+|+. .+++.||||++............+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 14799988998018321378999999999999999999998569999383588999589779994999614688786789
Q 003704 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (801)
Q Consensus 588 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~~~~~ 667 (801)
++.+++|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 0233222112123----56540367899999999998774339---9860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCE---EECCCCCCCCHHHHHH
Q ss_conf 843224664334676795435-68-989720478899999999909988564465554100---0011454431556632
Q 003704 668 SVSQLSGHLLTAYGYGAPEFE-SG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFL---VRWAIPQLHDIDALSR 742 (801)
Q Consensus 668 ~~~~~~~~~~~~~~y~aPE~~-~~-~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 742 (801)
.. ......++..|+|||.. .. .++.++||||+||++|||++|+.||....+..+... ..+..+..........
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CC--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 75--1001034431014667506988880444026541889985189999889999999999986118997355134432
Q ss_pred HCC---------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 039---------987899981018999999998100199999998999999
Q 003704 743 MVD---------PSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 743 ~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
..+ ...........+.++.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 221133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.90 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred CCCCCCCEEEECCCCEEEEEEE----CCCCEEEEEEECCCCCC--HHHHHHHHHHHHHHHCCCC-CCCCCCCEEEEECCE
Q ss_conf 6886678153039608999993----99959999993454576--3559999999998650499-972321207872594
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASS--QQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQ 581 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H-pniv~l~~~~~~~~~ 581 (801)
++|++.+.||+|+||+||+|+. .+|+.||||.+.+.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 89999514799988998018321378999999999999999999998569999383588999589779994999614688
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla 661 (801)
.+++|||+.+|+|.+++.. ...+.+.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 0012312341179999873----04543788888899999999885149---9896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCCHH
Q ss_conf 786789843224664334676795435-68--989720478899999999909988564465554100001145443155
Q 003704 662 PLISSGSVSQLSGHLLTAYGYGAPEFE-SG--IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHDID 738 (801)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~--~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 738 (801)
+.+...... ......++..|++||.. .. .++.++||||+||++|||++|+.||...........
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~------------ 243 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE------------ 243 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH------------
T ss_pred HHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------------
T ss_conf 220344443-2212223333310687605776887132517777999999768999888877779999------------
Q ss_pred HHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 66320399878999810189999999981001999999-----98999999
Q 003704 739 ALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRP-----PMSEVVQD 784 (801)
Q Consensus 739 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 784 (801)
....... ....+|...+.++.+|+.+||+.||++|| |++|+++|
T Consensus 244 i~~~~~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 244 ISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHCCC--CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf 9983356--899886547999999999974458988199974509999749
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=322.85 Aligned_cols=268 Identities=17% Similarity=0.197 Sum_probs=202.0
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-CEEEEECCEEEEE
Q ss_conf 16886678153039608999993-999599999934545763559999999998650499972321-2078725948999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL-KGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l-~~~~~~~~~~~lV 585 (801)
.++|++.+.||+|+||.||+|+. .+|+.||||.+..... ...+..|+++++.++|++++.. +++..+.+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 8889996898507880999999988998999999721005----888999999999703899601799999519877899
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCC
Q ss_conf 9514799988998018321378999999999999999999998569999383588999589779---9949996146887
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSDCGLAP 662 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~---~~~~ki~DfGla~ 662 (801)
|||+. ++|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. +..+|++|||+|+
T Consensus 82 me~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EECCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEECC-CCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCE
T ss_conf 98738-7133324430---68876899999999999999999979---94426678766064335777615650467513
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 86789843-----2246643346767954-35689897204788999999999099885644655541000011454431
Q 003704 663 LISSGSVS-----QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQLHD 736 (801)
Q Consensus 663 ~~~~~~~~-----~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 736 (801)
.+...... .......||..|+||| +....++.++|||||||++|||++|+.||...............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~------ 228 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------ 228 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH------
T ss_pred ECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHH------
T ss_conf 42554455410001357767873532999991899898321886177899998498766553057799999985------
Q ss_pred HHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 556632039987899981018999999998100199999998999999999987641045
Q 003704 737 IDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSN 796 (801)
Q Consensus 737 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~ 796 (801)
........ .......++.++.+++.+||+.||++||++.++.+.|+++..+.....
T Consensus 229 ---~~~~~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 229 ---SEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp ---HHHHHHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred ---HCCCCCCC-HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCC
T ss_conf ---23567898-357534788999999999843995579199999999999999769997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.06 Aligned_cols=266 Identities=19% Similarity=0.246 Sum_probs=201.6
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE------C
Q ss_conf 316886678153039608999993-999599999934545763559999999998650499972321207872------5
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE------H 579 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~------~ 579 (801)
+.++|++.+.||+|+||+||+|+. .+|+.||||++.+..........+.+|+.++++++|||||++++++.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 33775998896217585999999999998999999882336979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 94899995147999889980183213789999999999999999999985699993835889995897799949996146
Q 003704 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (801)
Q Consensus 580 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfG 659 (801)
...|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CEEEEEEECCCHHHH-HHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 626999841446778-7650------3899999999999999999886522---11245677632113654431320102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEE-E-CCCC----
Q ss_conf 8878678984322466433467679543-5689897204788999999999099885644655541000-0-1145----
Q 003704 660 LAPLISSGSVSQLSGHLLTAYGYGAPEF-ESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV-R-WAIP---- 732 (801)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~-~-~~~~---- 732 (801)
+++....... .....+|..|+|||. ....++.++||||+||++|||++|+.||...........+ . ...+
T Consensus 165 ~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 165 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HHHCCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 3211466655---3322146555581331477778774333566257898659899888977889999997205898799
Q ss_pred ---CCCCHHHHH------------HHCCCCCCC---CCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf ---443155663------------203998789---99810189999999981001999999989999999
Q 003704 733 ---QLHDIDALS------------RMVDPSLSG---QYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDL 785 (801)
Q Consensus 733 ---~~~~~~~~~------------~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 785 (801)
......... ......... ..+...+.++.+|+.+||..||++|||++|+++|=
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 98765667777641754356664212643335432101333799999999998769945790899996694
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.83 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=202.6
Q ss_pred HCCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE-----CC
Q ss_conf 316886678153039608999993-999599999934545763559999999998650499972321207872-----59
Q 003704 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-----HG 580 (801)
Q Consensus 507 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-----~~ 580 (801)
+.++|++.+.||+|+||+||+|+. .+|+.||||++.+..........+.+|+++++.++|||+|++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 48999951479998899801832137899999999999999999999856999938358899958977999499961468
Q 003704 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (801)
Q Consensus 581 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki~DfGl 660 (801)
..+++|+|+.+|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 64999996258862320022-----4530999999999999999999738---876516677633455432200132100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC--C-----
Q ss_conf 878678984322466433467679543-568-9897204788999999999099885644655541000011--4-----
Q 003704 661 APLISSGSVSQLSGHLLTAYGYGAPEF-ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWA--I----- 731 (801)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~-~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~----- 731 (801)
+...... .....++..|+|||. ... .++.++||||+||++|+|++|+.||...........+... .
T Consensus 168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 0125754-----44434543555835533775678551243205899999768899788988999999997307997577
Q ss_pred -CCCCC--HHHHHHHCCCCCCCC---CCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -54431--556632039987899---981018999999998100199999998999999
Q 003704 732 -PQLHD--IDALSRMVDPSLSGQ---YPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 732 -~~~~~--~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
..... ............... .....+.++.+|+.+||+.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 32001024454443035578755566267899999999999775883459389998559
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=319.51 Aligned_cols=269 Identities=14% Similarity=0.173 Sum_probs=207.9
Q ss_pred CCCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCCCEEEEECCEEEEE
Q ss_conf 16886678153039608999993-999599999934545763559999999998650499-9723212078725948999
Q 003704 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQRLLI 585 (801)
Q Consensus 508 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-pniv~l~~~~~~~~~~~lV 585 (801)
.++|++.+.||+|+||+||+|+. .+|+.||||.+...... ..+.+|++.+..++| +|++.+++++.+....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 98069979984178829999999889979999997502582----99999999999964899987799996018811799
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCC
Q ss_conf 9514799988998018321378999999999999999999998569999383588999589779-----99499961468
Q 003704 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-----DLAVSVSDCGL 660 (801)
Q Consensus 586 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~-----~~~~ki~DfGl 660 (801)
|||+ +++|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEC-CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf 9964-88879999752---03110689999999999999999977---96626677131523475434479568723660
Q ss_pred CCCCCCCCCC-----CCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 8786789843-----2246643346767954-356898972047889999999990998856446555410000114544
Q 003704 661 APLISSGSVS-----QLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLVRWAIPQL 734 (801)
Q Consensus 661 a~~~~~~~~~-----~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 734 (801)
++.+...... .......||..|+||| +....++.++||||||+++|||++|+.||............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~------- 225 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------- 225 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-------
T ss_pred EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------
T ss_conf 5771467665411102467627751026798964888886999898319999998698767885302199999-------
Q ss_pred CCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf 315566320399878999810189999999981001999999989999999999876410457
Q 003704 735 HDIDALSRMVDPSLSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQDLVDMIRRERCSNE 797 (801)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~~~~~~~~~~~ 797 (801)
..+...............+++++.+++..|+..+|++||+++.+.+.|.+++++......
T Consensus 226 ---~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 226 ---ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp ---HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred ---HHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
T ss_conf ---999705679995896579989999999998439930085999999999999997599999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=323.94 Aligned_cols=258 Identities=16% Similarity=0.294 Sum_probs=195.2
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCEEEEE--CCEEEE
Q ss_conf 6886678153039608999993-99959999993454576355999999999865049-9972321207872--594899
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAE--HGQRLL 584 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~--~~~~~l 584 (801)
++|++.+.||+|+||+||+|+. .+|+.||||++... ..+.+.+|++++.+++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEE
T ss_conf 6718978983174819999998899979999998889-----99999999999985157998767999998168771268
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf 9951479998899801832137899999999999999999999856999938358899958977999-499961468878
Q 003704 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (801)
Q Consensus 585 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~-~~ki~DfGla~~ 663 (801)
||||+++++|..+. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 88631798589974-------6899999999999999999887643---3443456441237748998366415654266
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEE--ECC-CC------
Q ss_conf 678984322466433467679543-568-9897204788999999999099885644655541000--011-45------
Q 003704 664 ISSGSVSQLSGHLLTAYGYGAPEF-ESG-IYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQFLV--RWA-IP------ 732 (801)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~y~aPE~-~~~-~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~-~~------ 732 (801)
...... .....++..|+|||. ... .++.++||||+||++|||++|+.||........+... ... .+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 468874---44322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred ---CCCCHHHHHHHCCCC--------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---443155663203998--------7899981018999999998100199999998999999
Q 003704 733 ---QLHDIDALSRMVDPS--------LSGQYPAKSLSHFADIISRCVQSEPEFRPPMSEVVQD 784 (801)
Q Consensus 733 ---~~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 784 (801)
............... .........+.++.+|+.+||+.||++|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 422544474300000333433112115521124489999999999866995689089999649
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=288.45 Aligned_cols=265 Identities=15% Similarity=0.218 Sum_probs=187.4
Q ss_pred CCCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-----------CCCCCCCCEEE
Q ss_conf 6886678153039608999993-99959999993454576355999999999865049-----------99723212078
Q 003704 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----------HANIVELKGYC 576 (801)
Q Consensus 509 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----------Hpniv~l~~~~ 576 (801)
.+|++.+.||+|+||+||+|+. .+|+.||||++.+.. .....+.+|+++++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEE
T ss_conf 85799899750778189999999999799999983431---336899999999998401455555422767647899876
Q ss_pred EE--CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC---
Q ss_conf 72--5948999951479998899801832137899999999999999999999856999938358899958977999---
Q 003704 577 AE--HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL--- 651 (801)
Q Consensus 577 ~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~--- 651 (801)
.. ....+++|+++..+......... .....+.+..+..++.|++.||.|||+. .||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred EECCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCC
T ss_conf 312565202343200035420000012-2346786899999999999998887640--5864656770570563057656
Q ss_pred ---CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCC--
Q ss_conf ---49996146887867898432246643346767954-356898972047889999999990998856446555410--
Q 003704 652 ---AVSVSDCGLAPLISSGSVSQLSGHLLTAYGYGAPE-FESGIYTCQSDVYSFGVVMLELLTGRKSYDRTRNRGEQF-- 725 (801)
Q Consensus 652 ---~~ki~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~k~DvwslGvil~elltG~~Pf~~~~~~~~~~-- 725 (801)
.++++|||.+...... .....++..|+||| .....|+.++||||+||+++||++|+.||..........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 4430567531442123445-----42236652105713214667776432012378999998788998987554321026
Q ss_pred --EEE--CCCCCCC-C-H---HHHHHHCCC-----C--------------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --000--1145443-1-5---566320399-----8--------------789998101899999999810019999999
Q 003704 726 --LVR--WAIPQLH-D-I---DALSRMVDP-----S--------------LSGQYPAKSLSHFADIISRCVQSEPEFRPP 777 (801)
Q Consensus 726 --~~~--~~~~~~~-~-~---~~~~~~~~~-----~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt 777 (801)
+.. +...... . . .......+. . .....+...+.++.+|+.+||+.||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHHH
Q ss_conf 8999999
Q 003704 778 MSEVVQD 784 (801)
Q Consensus 778 ~~eil~~ 784 (801)
++|+++|
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHHCC
T ss_conf 9999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=258.82 Aligned_cols=217 Identities=25% Similarity=0.538 Sum_probs=184.4
Q ss_pred CCCHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCCCCCCCEEEECC----CEEEEEECCCCCCC--CCCCCCCCCCCCCE
Q ss_conf 79976899999999960999-9999889999999999952692099----95799906998765--35746569999979
Q 003704 35 VTNPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNAS----DIIAIILNGANLGG--ELGENLGAFSSIRV 107 (801)
Q Consensus 35 ~~~~~d~~aL~~~~~~~~~~-~~~~w~~~~~~~C~~~w~gv~C~~~----~v~~l~L~~~~l~g--~~p~~l~~l~~L~~ 107 (801)
-|+++|++||++||+++.++ .+.+|+.+ +|||.++|.||+|+.. +|+.|+|+++++.| .+|..+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 98989999999999977999867788999-99988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC
Q ss_conf 98448-867998898633--456679824886888898112367766868754775555688333279999919921798
Q 003704 108 IDLSN-NHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184 (801)
Q Consensus 108 L~Ls~-N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 184 (801)
|+|++ |+++|.+|..+. .+|++|+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+.+++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCCCCCCCC-CEEEEECCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCC---CCCCCCC
Q ss_conf 988789875678988-399902564565453-2489888879825897989866237899774---2448777
Q 003704 185 LSGELPPSLENLSQL-TTLHLQNNQLSGTLD-VLQDLPLRDLNIENNLFSGPIPEKMLQIPNF---RKDGNPF 252 (801)
Q Consensus 185 l~g~~p~~~~~l~~L-~~L~ls~N~l~g~~~-~~~~~~L~~L~ls~N~l~g~~p~~l~~l~~l---~~~~N~~ 252 (801)
+.|.+|..+..+..+ +.+++++|++++..+ .+..+....+++++|.+.|.+|..+..++.+ ...+|.+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3562031214431123231022464353324332222222333333433222222222222211122222222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.96 E-value=1.7e-30 Score=176.74 Aligned_cols=172 Identities=12% Similarity=0.090 Sum_probs=120.8
Q ss_pred CCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCC----------------HHHHHHHHHHHHHHHCCCCCCCCCCCEE
Q ss_conf 667815303960899999399959999993454576----------------3559999999998650499972321207
Q 003704 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS----------------QQKDDEFLELVNNIDRIRHANIVELKGY 575 (801)
Q Consensus 512 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------~~~~~~~~~e~~~l~~l~Hpniv~l~~~ 575 (801)
.+++.||+|+||+||+|...+|+.||||.++..... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 87259489999514799988998018321378999999999999999999998569999383588999589779994999
Q 003704 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (801)
Q Consensus 576 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDLkp~NILl~~~~~~ki 655 (801)
.. .+++|||+++..+.+ ++......++.|++.++.|||+. +|+||||||+|||++++ .+++
T Consensus 83 ~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred CC----CEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf 28----889999504565420-----------01578999999999999998268---88983689036114289-8999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 614688786789843224664334676795435689897204788999999
Q 003704 656 SDCGLAPLISSGSVSQLSGHLLTAYGYGAPEFESGIYTCQSDVYSFGVVML 706 (801)
Q Consensus 656 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~k~DvwslGvil~ 706 (801)
+|||+|................. .-.++..+.|+.++|+||..--++
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~----~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVR----NIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHH----HHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHHHHHHHH----HHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 87788430899870999987799----999997578998446899999874
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-28 Score=166.69 Aligned_cols=176 Identities=24% Similarity=0.231 Sum_probs=151.7
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99579990699876535746569999979984488679988986334566798248868888981123677668687547
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.+++.|+|++|.+++..+..|.++++|++|+|++|+|+...+.....+|++|+|++|+++ .++..+..+++|+.|++++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
T ss_conf 688989884992898597786345655221356654444311111223211111222221-1111212222222222222
Q ss_pred CCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCC-CCCC-CCCEEECCCCCCCCCCC
Q ss_conf 755556883332799999199217989887898756789883999025645654532-4898-88879825897989866
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV-LQDL-PLRDLNIENNLFSGPIP 236 (801)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~-~~~~-~L~~L~ls~N~l~g~~p 236 (801)
|.+....+..+..+.+++.|++++|.+....+..+..+++|+.|++++|+|++.++. +..+ .|++|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCC
T ss_conf 3110110011222211112212434210221233322111000000015652237200134212423430139785-568
Q ss_pred CCCCCC---CCCCCCCCCCCCCC
Q ss_conf 237899---77424487778888
Q 003704 237 EKMLQI---PNFRKDGNPFNSTV 256 (801)
Q Consensus 237 ~~l~~l---~~l~~~~N~~~~~~ 256 (801)
..+..+ ..+.+.+|||.|.|
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSG
T ss_pred HHHCCCCCCCEEEECCCCCCCCC
T ss_conf 66777888999983699987886
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.3e-26 Score=151.51 Aligned_cols=186 Identities=20% Similarity=0.259 Sum_probs=101.9
Q ss_pred CCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--------------
Q ss_conf 995269209-----------9957999069987653574656999997998448867998898633--------------
Q 003704 70 SWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-------------- 124 (801)
Q Consensus 70 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~-------------- 124 (801)
.|.-|.|+. ..++.|+|++|+++...+..|..++.|++|++++|.+....+..+.
T Consensus 12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CCEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99699847999894497889998889774881798797786414213000013445433211121222222222222102
Q ss_pred -------------CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCC
Q ss_conf -------------4566798248868888981123677668687547755556883332799999199217989887898
Q 003704 125 -------------VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191 (801)
Q Consensus 125 -------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 191 (801)
.+|++|++++|.+....+..+..+.+|+.+++++|.|++..+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHH
T ss_conf 23544620101010277875688544320135332000121102001431445805740434050223141765662566
Q ss_pred CCCCCCCCCEEEEECCCCCCCCC-CCCCC-CCCEEECCCCCCCCCCCCCCCC---CCCCCCCCCCCCCC
Q ss_conf 75678988399902564565453-24898-8887982589798986623789---97742448777888
Q 003704 192 SLENLSQLTTLHLQNNQLSGTLD-VLQDL-PLRDLNIENNLFSGPIPEKMLQ---IPNFRKDGNPFNST 255 (801)
Q Consensus 192 ~~~~l~~L~~L~ls~N~l~g~~~-~~~~~-~L~~L~ls~N~l~g~~p~~l~~---l~~l~~~~N~~~~~ 255 (801)
.|..+++|+.+++++|++++..+ .+..+ .|++|++++|.+.+..+..+.. +..+.+.+|+|.|.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred HHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
T ss_conf 654656341314211434662816766532000233333522100000235546568898119988787
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=2e-27 Score=160.39 Aligned_cols=179 Identities=25% Similarity=0.466 Sum_probs=144.9
Q ss_pred CCEEEEEECC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 9957999069-987653574656999997998448867998898633--4566798248868888981123677668687
Q 003704 79 SDIIAIILNG-ANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (801)
Q Consensus 79 ~~v~~l~L~~-~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (801)
.+++.|+|++ |++.|.+|..+++|++|++|+|++|++.+..+..+. ..|+.+++++|.+.+.+|..+.+++.|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 53352020265433300243114542001102035643443322222011100111122455556851220674000000
Q ss_pred CCCCCCCCCCCHHHHCCCCC-CEEECCCCCCCCCCCC-----------------------CCCCCCCCCEEEEECCCCCC
Q ss_conf 54775555688333279999-9199217989887898-----------------------75678988399902564565
Q 003704 156 LNNNLLSGEIPDAFQSLTGL-INLDLSSNNLSGELPP-----------------------SLENLSQLTTLHLQNNQLSG 211 (801)
Q Consensus 156 L~~N~l~g~~p~~~~~l~~L-~~L~Ls~N~l~g~~p~-----------------------~~~~l~~L~~L~ls~N~l~g 211 (801)
+++|.+.|.+|..+..+..+ +.++++.|+++|..|. .+..+++|+.+++++|.+++
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 23553356203121443112323102246435332433222222233333343322222222222221112222222222
Q ss_pred CCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCC
Q ss_conf 45324898-8887982589798986623789977---4244877788889
Q 003704 212 TLDVLQDL-PLRDLNIENNLFSGPIPEKMLQIPN---FRKDGNPFNSTVA 257 (801)
Q Consensus 212 ~~~~~~~~-~L~~L~ls~N~l~g~~p~~l~~l~~---l~~~~N~~~~~~~ 257 (801)
.++.+... .++.|+|++|+|+|.+|..+.+++. |.+.+|.+.+.+|
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC
T ss_conf 22222245544444476570666087688479999989795883516689
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.93 E-value=3.3e-26 Score=153.91 Aligned_cols=180 Identities=20% Similarity=0.267 Sum_probs=144.2
Q ss_pred CCCCCCCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CC--CCCCEEECCCCCCCCCC
Q ss_conf 9999999526920999579990699876535746569999979984488679988986-33--45667982488688889
Q 003704 65 DPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI-LP--VTMQNFFLSDNQFSGSI 141 (801)
Q Consensus 65 ~~C~~~w~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~Ls~N~l~~~~ 141 (801)
..|.|+|..|.|+. ++|+ .+|..+. +.+++|+|++|.|+..++.. |. .+|+.|+|++|.+....
T Consensus 4 ~~C~C~~~~v~Cs~----------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~ 70 (192)
T d1w8aa_ 4 AMCHCEGTTVDCTG----------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70 (192)
T ss_dssp TTSEEETTEEECTT----------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC
T ss_pred CCCEECCCEEEEEC----------CCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 99897699999708----------9967-0298989--787889848987755302002578762721301363221212
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCC-C
Q ss_conf 811236776686875477555568833327999991992179898878987567898839990256456545324898-8
Q 003704 142 PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL-P 220 (801)
Q Consensus 142 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~-~ 220 (801)
+..|..+++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|.+....+..... .
T Consensus 71 ~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~ 150 (192)
T d1w8aa_ 71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEW 150 (192)
T ss_dssp TTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHH
T ss_pred CCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHH
T ss_conf 12221122221010035534434979980797465524577453535977856875334200036443435302777642
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8879825897989866237899774244877788889
Q 003704 221 LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVA 257 (801)
Q Consensus 221 L~~L~ls~N~l~g~~p~~l~~l~~l~~~~N~~~~~~~ 257 (801)
+..+.+..|.++...|..+..++-+.+..|.+.|..+
T Consensus 151 l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 151 LRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp HHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCCC
T ss_pred HHHHCCCCCCEEECCCHHHCCCEEEECCHHHCCCCCC
T ss_conf 3540356898276898433698861448755758998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.9e-24 Score=144.53 Aligned_cols=174 Identities=17% Similarity=0.314 Sum_probs=101.3
Q ss_pred CCCCCCCCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEE
Q ss_conf 999999995269209-----------9957999069987653574656999997998448867998898633--456679
Q 003704 64 GDPCGESWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNF 130 (801)
Q Consensus 64 ~~~C~~~w~gv~C~~-----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 130 (801)
.-.|.|.|.+|.|+. .+++.|+|++|+++...+..|.++++|++|++++|.+....|..|. ..|+.|
T Consensus 5 p~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84 (305)
T ss_dssp CTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCEECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEE
T ss_conf 99889559999855999885198889997989784991898696576046565231123443445235665279855783
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEEEECCC
Q ss_conf 82488688889811236776686875477555568833327999991992179898--8789875678988399902564
Q 003704 131 FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSLENLSQLTTLHLQNNQ 208 (801)
Q Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~ls~N~ 208 (801)
++++|+++. +|..+ ...+..|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.
T Consensus 85 ~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~ 161 (305)
T d1xkua_ 85 YLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161 (305)
T ss_dssp ECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 156875676-76400--111323210246102344445401331100001233333467776422345656712034677
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 565453248988887982589798986623789
Q 003704 209 LSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241 (801)
Q Consensus 209 l~g~~~~~~~~~L~~L~ls~N~l~g~~p~~l~~ 241 (801)
++..... ...+++.|++++|.+++..+..+..
T Consensus 162 l~~l~~~-~~~~L~~L~l~~n~~~~~~~~~~~~ 193 (305)
T d1xkua_ 162 ITTIPQG-LPPSLTELHLDGNKITKVDAASLKG 193 (305)
T ss_dssp CCSCCSS-CCTTCSEEECTTSCCCEECTGGGTT
T ss_pred CCCCCCC-CCCCCCEEECCCCCCCCCCHHHHHC
T ss_conf 4516710-1776678989788677888267641
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=9.1e-22 Score=130.23 Aligned_cols=169 Identities=22% Similarity=0.245 Sum_probs=138.8
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 9957999069987653574656999997998448867998898633--45667982488688889811236776686875
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (801)
.+...++.++++|+. +|+.+. ++|++|+|++|.|++..+..|. .+|++|+|++|+++ .++ .++.+++|+.|+|
T Consensus 10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred CCCEEEECCCCCCCE-ECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf 898699806999886-196757--68898988499289859778634565522135665444-431-1111223211111
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCC-CCCC-CCCEEECCCCCCCCC
Q ss_conf 47755556883332799999199217989887898756789883999025645654532-4898-888798258979898
Q 003704 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV-LQDL-PLRDLNIENNLFSGP 234 (801)
Q Consensus 157 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~-~~~~-~L~~L~ls~N~l~g~ 234 (801)
++|.++ .++..+.++++|+.|++++|.+....+..+..+.+|..|++++|.++...+. +..+ .+..+++++|+|++.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCC
T ss_conf 222221-1111212222222222222311011001122221111221243421022123332211100000001565223
Q ss_pred CCCCCCC---CCCCCCCCCCCC
Q ss_conf 6623789---977424487778
Q 003704 235 IPEKMLQ---IPNFRKDGNPFN 253 (801)
Q Consensus 235 ~p~~l~~---l~~l~~~~N~~~ 253 (801)
.+..+.. +..|.+.+|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCEEECCCCCCC
T ss_conf 7200134212423430139785
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=8.1e-23 Score=135.84 Aligned_cols=179 Identities=21% Similarity=0.237 Sum_probs=116.8
Q ss_pred CCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 52692099957999069987653574656999997998448867998898633--4566798248868888981123677
Q 003704 72 QGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLT 149 (801)
Q Consensus 72 ~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~ 149 (801)
.+-.|....-..++.++.+++ .+|..+. +.+++|+|++|+|+...+..|. .+|++|++++|.+....+..+..+.
T Consensus 4 ~~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~ 80 (284)
T d1ozna_ 4 GACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (284)
T ss_dssp TTCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCCEECCCCCEEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 988986999969984799989-4497889--9988897748817987977864142130000134454332111212222
Q ss_pred CCCEEECC-CCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC-CCCCC-CCCEEEC
Q ss_conf 66868754-775555688333279999919921798988789875678988399902564565453-24898-8887982
Q 003704 150 LLTDMSLN-NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDL-PLRDLNI 226 (801)
Q Consensus 150 ~L~~L~L~-~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~-~~~~~-~L~~L~l 226 (801)
.+..++.. .|.++...+..|.++++|+.|++++|.+....+..+..+.+|+.+++++|+|++.++ .+... .|+.|++
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCC
T ss_conf 22222222102235446201010102778756885443201353320001211020014314458057404340502231
Q ss_pred CCCCCCCCCCCCCCCCCCC---CCCCCCCC
Q ss_conf 5897989866237899774---24487778
Q 003704 227 ENNLFSGPIPEKMLQIPNF---RKDGNPFN 253 (801)
Q Consensus 227 s~N~l~g~~p~~l~~l~~l---~~~~N~~~ 253 (801)
++|+|++..+..+..++.| .+.+|.+.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCHHHHCCCCCCCHHHHHHCCCC
T ss_conf 417656625666546563413142114346
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.87 E-value=4.7e-22 Score=131.75 Aligned_cols=151 Identities=23% Similarity=0.337 Sum_probs=123.3
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC
Q ss_conf 799844886799889863345667982488688889-8112367766868754775555688333279999919921798
Q 003704 106 RVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSI-PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184 (801)
Q Consensus 106 ~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 184 (801)
+.++.++|+|+ .+|..++.++++|+|++|++++.+ +..|.++++|+.|+|++|.+.+..+..|..+++|+.|+|++|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEEECCCCC-CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 99997089967-02989897878898489877553020025787627213013632212121222112222101003553
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCCCC-CCCCC-CCEEECCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
Q ss_conf 9887898756789883999025645654532-48988-8879825897989866237--899774244877788889
Q 003704 185 LSGELPPSLENLSQLTTLHLQNNQLSGTLDV-LQDLP-LRDLNIENNLFSGPIPEKM--LQIPNFRKDGNPFNSTVA 257 (801)
Q Consensus 185 l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~-~~~~~-L~~L~ls~N~l~g~~p~~l--~~l~~l~~~~N~~~~~~~ 257 (801)
|+...+..|.++++|++|+|++|+|++..+. +..+. |++++|++|.+.......+ ..+..+.+..|...|..|
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCEEECCC
T ss_conf 44349799807974655245774535359778568753342000364434353027776423540356898276898
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.85 E-value=5.5e-20 Score=120.75 Aligned_cols=59 Identities=17% Similarity=0.358 Sum_probs=32.4
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 995799906998765357465699999799844886799889863345667982488688
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFS 138 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~ 138 (801)
.+++.|+++++.+....+..|.+++.|+.|++++|++. .+|..+...+..|.+..|.+.
T Consensus 55 ~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~ 113 (305)
T d1xkua_ 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEIT 113 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCHHHHHHHHHCCCCCHH
T ss_conf 56523112344344523566527985578315687567-676400111323210246102
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=9.4e-20 Score=119.50 Aligned_cols=82 Identities=20% Similarity=0.319 Sum_probs=61.6
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 99957999069987653574656999997998448867998898633456679824886888898112367766868754
Q 003704 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 78 ~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
-.+++.|+++++++... +.+..|++|++|+|++|++++..+-.-..+|++|++++|.+.+.. .++.+++|+.|+++
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 57878998999898776--242458999989681881798863347711010301343332222--11123343334433
Q ss_pred CCCCCC
Q ss_conf 775555
Q 003704 158 NNLLSG 163 (801)
Q Consensus 158 ~N~l~g 163 (801)
+|.+++
T Consensus 119 ~~~~~~ 124 (384)
T d2omza2 119 NNQITD 124 (384)
T ss_dssp SSCCCC
T ss_pred CCCCCC
T ss_conf 222222
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=3.6e-19 Score=116.41 Aligned_cols=159 Identities=24% Similarity=0.345 Sum_probs=128.7
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99579990699876535746569999979984488679988986334566798248868888981123677668687547
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
..++.|+++++.+.... .+..+++|++|+|++|.+++..+.....+|++|++++|++++ ++ .+..+++|+.|++++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 48458978279888744--476489989876989602586011358621201433333212-22-121222111223456
Q ss_pred CCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 75555688333279999919921798988789875678988399902564565453248988887982589798986623
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238 (801)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~N~l~g~~p~~ 238 (801)
|.+. .+ ..+..++.|+.++++.|.++. +..+..+++|+.+++++|++++..+......|+.|++++|+++. ++ .
T Consensus 122 ~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~-~ 195 (210)
T d1h6ta2 122 NGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-A 195 (210)
T ss_dssp SCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-G
T ss_pred CCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CH-H
T ss_conf 5322-11-220111112221122233345--43100013321001346430256453678989999897998998-72-1
Q ss_pred CCCCCCCCC
Q ss_conf 789977424
Q 003704 239 MLQIPNFRK 247 (801)
Q Consensus 239 l~~l~~l~~ 247 (801)
+..+++|+.
T Consensus 196 l~~l~~L~~ 204 (210)
T d1h6ta2 196 LAGLKNLDV 204 (210)
T ss_dssp GTTCTTCSE
T ss_pred HCCCCCCCE
T ss_conf 169999899
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=5.8e-19 Score=115.30 Aligned_cols=158 Identities=25% Similarity=0.405 Sum_probs=126.2
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99579990699876535746569999979984488679988986334566798248868888981123677668687547
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.+++.|+++++++... +.+..+++|++|+|++|++++..|-.-..+|++|++++|.+.. ++ .+.+++.|+.|++++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFN 115 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 6878998999999775--2021378867575456556676401677522311112222222-21-111122322211122
Q ss_pred CCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 75555688333279999919921798988789875678988399902564565453248988887982589798986623
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238 (801)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~N~l~g~~p~~ 238 (801)
|.+... ..+..+++|+.|++++|.+. .++ .+..+++|+.|++++|.+++..+......|+.|++++|+++. ++ .
T Consensus 116 ~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~ 189 (199)
T d2omxa2 116 NQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-V 189 (199)
T ss_dssp SCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-G
T ss_pred CCCCCC--CCCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CC-C
T ss_conf 222232--10001223677643111100-234-333211111122345555677011679989999787997998-81-0
Q ss_pred CCCCCCCC
Q ss_conf 78997742
Q 003704 239 MLQIPNFR 246 (801)
Q Consensus 239 l~~l~~l~ 246 (801)
+.++++|+
T Consensus 190 l~~L~~L~ 197 (199)
T d2omxa2 190 LAKLTNLE 197 (199)
T ss_dssp GGGCTTCS
T ss_pred CCCCCCCC
T ss_conf 12789989
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=3e-19 Score=116.81 Aligned_cols=188 Identities=15% Similarity=0.120 Sum_probs=116.4
Q ss_pred CCCCCCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CC--CCCCEEE
Q ss_conf 9999995269209-----------99579990699876535746569999979984488679988986-33--4566798
Q 003704 66 PCGESWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI-LP--VTMQNFF 131 (801)
Q Consensus 66 ~C~~~w~gv~C~~-----------~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~ 131 (801)
.|.|++..|.|.. .+++.|+|++|.+....+..|.++++|++|+|++|.+...++.. |. ..++++.
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf 28873999998189988768888998899987699189649668614643232110221124201001122222222211
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEEEECCC
Q ss_conf 24-8868888981123677668687547755556883-332799999199217989887898756789-88399902564
Q 003704 132 LS-DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLS-QLTTLHLQNNQ 208 (801)
Q Consensus 132 Ls-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~ls~N~ 208 (801)
+. .|.+....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+....+..|..++ .++.|++++|.
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 11123432222221222222222234211112554333222111122222221211122222222223310012200123
Q ss_pred CCCCCCC-CCCCCCCEE-ECCCCCCCCCCCCCCC---CCCCCCCCCCCCC
Q ss_conf 5654532-489888879-8258979898662378---9977424487778
Q 003704 209 LSGTLDV-LQDLPLRDL-NIENNLFSGPIPEKML---QIPNFRKDGNPFN 253 (801)
Q Consensus 209 l~g~~~~-~~~~~L~~L-~ls~N~l~g~~p~~l~---~l~~l~~~~N~~~ 253 (801)
++..... +....+..+ ++++|+++...+..|. ++..|.+.+|.+.
T Consensus 165 l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp CCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
T ss_conf 33322222220111012123543246424788668999998989799289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=8.3e-19 Score=114.47 Aligned_cols=67 Identities=19% Similarity=0.244 Sum_probs=46.1
Q ss_pred CCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 9526920999579990699876535746569999979984488679988986334566798248868888
Q 003704 71 WQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGS 140 (801)
Q Consensus 71 w~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~ 140 (801)
-+|+. ...+++.|+|++|.+++.. .++++++|++|+|++|.+.+..+-....+|+.|++++|.+++.
T Consensus 59 l~gl~-~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~l~~l~~L~~L~~~~~~~~~~ 125 (384)
T d2omza2 59 IDGVE-YLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 125 (384)
T ss_dssp CTTGG-GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCC-CCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 62424-5899998968188179886--3347711010301343332222111233433344332222222
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8e-18 Score=109.22 Aligned_cols=167 Identities=19% Similarity=0.265 Sum_probs=99.5
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99579990699876535746569999979984488679988986334566798248868888981123677668687547
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (801)
.+++.|++.++++.. + +.+.++++|++|+|++|.+.+..|-....+++++++++|.++. ++ .+..+++|+.+++++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred CCCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 886899777999976-6-4574488883763578532025431123343201211122222-22-222222221221222
Q ss_pred CCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-C
Q ss_conf 755556883332799999199217989887898756789883999025645654532489888879825897989866-2
Q 003704 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP-E 237 (801)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~N~l~g~~p-~ 237 (801)
+...+.. .+.....+..+.++.+.+.... .+..+++|+.|++++|.++...+......|+.|++++|++++..+ .
T Consensus 117 ~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~l~~l~ 192 (227)
T d1h6ua2 117 TQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192 (227)
T ss_dssp SCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred CCCCCCC--HHCCCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCCHHHCCCCCCEECCCCCCCCCCCHHHC
T ss_conf 4433110--0000230122200000000000--00102111002333333331001056463356445888417785344
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 3789977424487778
Q 003704 238 KMLQIPNFRKDGNPFN 253 (801)
Q Consensus 238 ~l~~l~~l~~~~N~~~ 253 (801)
.+.++..|.+.+|.+.
T Consensus 193 ~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 193 SLPNLIEVHLKNNQIS 208 (227)
T ss_dssp GCTTCCEEECTTSCCC
T ss_pred CCCCCCEEECCCCCCC
T ss_conf 7999998979599689
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.2e-17 Score=108.36 Aligned_cols=162 Identities=22% Similarity=0.330 Sum_probs=116.2
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 99069987653574656999997998448867998898633456679824886888898112367766868754775555
Q 003704 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163 (801)
Q Consensus 84 l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 163 (801)
+.+..+.+.+.+. ...+..|+.|++++|.+...-.-...++|++|+|++|++++..| +.++++|+.|++++|.+.
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~- 97 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 97 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred HHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-
T ss_conf 9967787788559--87946878998999999775202137886757545655667640--167752231111222222-
Q ss_pred CCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCC
Q ss_conf 6883332799999199217989887898756789883999025645654532489888879825897989866-237899
Q 003704 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP-EKMLQI 242 (801)
Q Consensus 164 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~N~l~g~~p-~~l~~l 242 (801)
.++ .+.+++.|+.|++++|.+.. + ..+..+++|+.|++++|.+...........++.|++.+|++++..+ ..+.++
T Consensus 98 ~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L 174 (199)
T d2omxa2 98 DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 174 (199)
T ss_dssp CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGGGTTCTTC
T ss_pred CCC-CCCCCCCCCCCCCCCCCCCC-C-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 221-11112232221112222223-2-10001223677643111100234333211111122345555677011679989
Q ss_pred CCCCCCCCCCC
Q ss_conf 77424487778
Q 003704 243 PNFRKDGNPFN 253 (801)
Q Consensus 243 ~~l~~~~N~~~ 253 (801)
..|.+.+|.+.
T Consensus 175 ~~L~ls~N~i~ 185 (199)
T d2omxa2 175 ERLDISSNKVS 185 (199)
T ss_dssp CEEECCSSCCC
T ss_pred CEEECCCCCCC
T ss_conf 99978799799
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.5e-17 Score=107.81 Aligned_cols=139 Identities=26% Similarity=0.367 Sum_probs=68.0
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC-CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 995799906998765357465699999799844886799889863-3456679824886888898112367766868754
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL-PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (801)
.+++.|+|++|.+++.. .++.+++|++|++++|++++ +|... ..+|+.|++++|.+.. + ..+..++.|+.++++
T Consensus 68 ~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred CCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCC
T ss_conf 99898769896025860--11358621201433333212-2212122211122345653221-1-220111112221122
Q ss_pred CCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCC-CCCEEECC
Q ss_conf 77555568833327999991992179898878987567898839990256456545324898-88879825
Q 003704 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL-PLRDLNIE 227 (801)
Q Consensus 158 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~-~L~~L~ls 227 (801)
+|.+++ +..+..+++|+.+++++|.+++ ++ .+.++++|+.|++++|.|+... .+..+ .|++|+|+
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEE
T ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCCH-HHCCCCCCCEEECC
T ss_conf 233345--4310001332100134643025-64-5367898999989799899872-11699998999711
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.71 E-value=5.5e-16 Score=99.42 Aligned_cols=141 Identities=21% Similarity=0.298 Sum_probs=97.2
Q ss_pred ECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 09995799906998765357465699999799844886799889863345667982488688889811236776686875
Q 003704 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (801)
Q Consensus 77 ~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (801)
...++..|+|++++++. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 36 ~~~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 36 LDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred HHCCCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCCH-HHHHHHHHHHCCCC-HHHHH---CCCCCCCCC
T ss_conf 87699899937999887-8898---789888989999796-336203-32033266551432-03210---221111133
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 47755556883332799999199217989887898756789883999025645654532489888879825897989
Q 003704 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSG 233 (801)
Q Consensus 157 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~N~l~g 233 (801)
++|.+. .+|. ++.++.|+.|++++|.+. ..+.. ...+..+.+..+.............++.+++++|.+..
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS
T ss_pred CCCCCC-CCCC-HHHHCCCEEECCCCCCCC-CCCCC---CCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCC
T ss_conf 455432-2210-011013123113565100-13223---33321000012222233320001222001112334432
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.69 E-value=1.4e-15 Score=97.21 Aligned_cols=98 Identities=29% Similarity=0.416 Sum_probs=43.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf 99799844886799889863345667982488688889811236776686875477555568833327999991992179
Q 003704 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (801)
Q Consensus 104 ~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 183 (801)
+|++|||++|+++ .+|. +..+|++|+|++|+++ .+|..+ .+|+.|++++|.++ .++.. .+.|++|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~-~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE-LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCS-CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSS
T ss_pred CCCEEEECCCCCC-CCCC-CCCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHH---CCCCCCCCCCCC
T ss_conf 9989993799988-7889-8789888989999796-336203---32033266551432-03210---221111133455
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 898878987567898839990256456545
Q 003704 184 NLSGELPPSLENLSQLTTLHLQNNQLSGTL 213 (801)
Q Consensus 184 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 213 (801)
.+. .+|. +..+++|+.|++++|.+....
T Consensus 109 ~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~ 136 (353)
T d1jl5a_ 109 QLE-KLPE-LQNSSFLKIIDVDNNSLKKLP 136 (353)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSCCC
T ss_pred CCC-CCCC-HHHHCCCEEECCCCCCCCCCC
T ss_conf 432-2210-011013123113565100132
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=6.6e-17 Score=104.35 Aligned_cols=113 Identities=25% Similarity=0.257 Sum_probs=76.0
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCC
Q ss_conf 4656999997998448867998898633--45667982488688889811236776686875477555568833327999
Q 003704 97 ENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTG 174 (801)
Q Consensus 97 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~ 174 (801)
+.+.+...|++|||++|+++ .++..+. .+|+.|+|++|.++. + +.|..+++|+.|++++|.++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-C-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 75168574848978899788-657620041459989897997876-4-77445761306431021345777632233453
Q ss_pred CCEEECCCCCCCCCCC--CCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 9919921798988789--87567898839990256456545
Q 003704 175 LINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGTL 213 (801)
Q Consensus 175 L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~ 213 (801)
|+.|++++|+++ .++ ..+..+++|++|++++|.++...
T Consensus 89 L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 89 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred CCCCEECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf 443420300016-6542110013653206640799634561
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4.6e-16 Score=99.85 Aligned_cols=165 Identities=24% Similarity=0.326 Sum_probs=129.4
Q ss_pred CCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC-CCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 995269209995799906998765357465699999799844886799889863-3456679824886888898112367
Q 003704 70 SWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL-PVTMQNFFLSDNQFSGSIPSSLATL 148 (801)
Q Consensus 70 ~w~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l 148 (801)
+..|+ ....++..|++++|.+.+..+ +..++.|+.+++++|.++ .++... ..+|+.+.++++...+. ..+...
T Consensus 55 ~l~~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~ 128 (227)
T d1h6ua2 55 TIEGV-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDV--TPLAGL 128 (227)
T ss_dssp CCTTG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCC--GGGTTC
T ss_pred CCHHH-HCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CHHCCC
T ss_conf 66457-448888376357853202543--112334320121112222-222222222221221222443311--000002
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 76686875477555568833327999991992179898878987567898839990256456545324898888798258
Q 003704 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIEN 228 (801)
Q Consensus 149 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~~~~~~~~L~~L~ls~ 228 (801)
+.+..+.++++.+.... .+.++++|+.|++++|.+... + .+..+++|+.|++++|.+++..+......|++|++++
T Consensus 129 ~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~ 204 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN 204 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTT
T ss_pred CCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCC-H-HHCCCCCCEECCCCCCCCCCCHHHCCCCCCCEEECCC
T ss_conf 30122200000000000--001021110023333333310-0-1056463356445888417785344799999897959
Q ss_pred CCCCCCCCCCCCCCCCCC
Q ss_conf 979898662378997742
Q 003704 229 NLFSGPIPEKMLQIPNFR 246 (801)
Q Consensus 229 N~l~g~~p~~l~~l~~l~ 246 (801)
|++++..| +.++++|.
T Consensus 205 N~lt~i~~--l~~l~~L~ 220 (227)
T d1h6ua2 205 NQISDVSP--LANTSNLF 220 (227)
T ss_dssp SCCCBCGG--GTTCTTCC
T ss_pred CCCCCCCC--CCCCCCCC
T ss_conf 96899802--03699989
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=7.4e-16 Score=98.73 Aligned_cols=101 Identities=27% Similarity=0.388 Sum_probs=47.1
Q ss_pred CEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf 7998448867998898633--45667982488688889811236776686875477555568833327999991992179
Q 003704 106 RVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (801)
Q Consensus 106 ~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 183 (801)
++|||++|+++ .++. +. .+|++|++++|.++ .+|..++.+++|+.|++++|.++ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf 98986899898-8710-105898898979787168-65215655431354532432112-357-4123355576888898
Q ss_pred CCCCCC-CCCCCCCCCCCEEEEECCCCCC
Q ss_conf 898878-9875678988399902564565
Q 003704 184 NLSGEL-PPSLENLSQLTTLHLQNNQLSG 211 (801)
Q Consensus 184 ~l~g~~-p~~~~~l~~L~~L~ls~N~l~g 211 (801)
+++... ...+..+++|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf 65888882565379999999897996886
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.1e-16 Score=101.63 Aligned_cols=104 Identities=25% Similarity=0.227 Sum_probs=44.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 56679824886888898112367766868754775555688333279999919921798988789875678988399902
Q 003704 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205 (801)
Q Consensus 126 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 205 (801)
++++|+|++|+++ .++..+..+++|+.|+|++|.|+ .++ .|..+++|+.|++++|.++...+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEC
T ss_conf 4848978899788-65762004145998989799787-647-74457613064310213457776322334534434203
Q ss_pred CCCCCCCC--CCCCCC-CCCEEECCCCCCC
Q ss_conf 56456545--324898-8887982589798
Q 003704 206 NNQLSGTL--DVLQDL-PLRDLNIENNLFS 232 (801)
Q Consensus 206 ~N~l~g~~--~~~~~~-~L~~L~ls~N~l~ 232 (801)
+|.|+... ..+..+ .|+.+++++|.++
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 000166542110013653206640799634
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=8.8e-16 Score=98.35 Aligned_cols=101 Identities=29% Similarity=0.390 Sum_probs=68.3
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf 67982488688889811236776686875477555568833327999991992179898878987567898839990256
Q 003704 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207 (801)
Q Consensus 128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 207 (801)
+.|+|++|+++ .++ .+..+++|++|++++|.|+ .+|..|..+++|+.|++++|.|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf 98986899898-871-0105898898979787168-65215655431354532432112-357-4123355576888898
Q ss_pred CCCCCC--CCCCCC-CCCEEECCCCCCCC
Q ss_conf 456545--324898-88879825897989
Q 003704 208 QLSGTL--DVLQDL-PLRDLNIENNLFSG 233 (801)
Q Consensus 208 ~l~g~~--~~~~~~-~L~~L~ls~N~l~g 233 (801)
.|+... ..+..+ .|+.+++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf 65888882565379999999897996886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=4.1e-15 Score=94.77 Aligned_cols=110 Identities=23% Similarity=0.265 Sum_probs=66.5
Q ss_pred CCCCCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 999995269209995799906998765357465699999799844886-7998898633456679824886888898112
Q 003704 67 CGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNH-IGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145 (801)
Q Consensus 67 C~~~w~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~~L~~L~Ls~N~l~~~~p~~~ 145 (801)
|++.+.+|+|...+++ ..|..+..+++|+.|++++|+ ++ ...+..|
T Consensus 6 ~c~~~~~l~c~~~~~~-----------~~p~~l~~l~~l~~L~l~~n~~l~----------------------~i~~~~f 52 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-----------DSLHHLPGAENLTELYIENQQHLQ----------------------HLELRDL 52 (156)
T ss_dssp CCSSSSCEECCSSCCC-----------TTTTTSCSCSCCSEEECCSCSSCC----------------------EECGGGS
T ss_pred CCCCCCEEEECCCCCC-----------CCCCCCCCCCCCCEEECCCCCCCC----------------------CCCCHHH
T ss_conf 8699996985289976-----------586002576565743168986644----------------------3692122
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 36776686875477555568833327999991992179898878987567898839990256456
Q 003704 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (801)
Q Consensus 146 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 210 (801)
.++++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 53 ~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 56666672162021247742011124554333322678785-15745633532124335798633
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.1e-14 Score=91.03 Aligned_cols=105 Identities=20% Similarity=0.190 Sum_probs=85.4
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 667982488688889811236776686875477-5555688333279999919921798988789875678988399902
Q 003704 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN-LLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205 (801)
Q Consensus 127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls 205 (801)
...++.+++.+. .+|..+..+++|+.|++++| .|+..-+..|.++++|+.|+|++|+|+...+..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECC
T ss_conf 996985289976-5860025765657431689866443692122566666721620212477420111245543333226
Q ss_pred CCCCCCCCC-CCCCCCCCEEECCCCCCC
Q ss_conf 564565453-248988887982589798
Q 003704 206 NNQLSGTLD-VLQDLPLRDLNIENNLFS 232 (801)
Q Consensus 206 ~N~l~g~~~-~~~~~~L~~L~ls~N~l~ 232 (801)
+|+|+...+ .+...+|..|+|++|.|.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 7878515745633532124335798633
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.9e-14 Score=89.06 Aligned_cols=168 Identities=14% Similarity=0.136 Sum_probs=115.9
Q ss_pred CCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCC-CCCCC
Q ss_conf 9952692099957999069987653574656999997998448867998898633--45667982488688889-81123
Q 003704 70 SWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSI-PSSLA 146 (801)
Q Consensus 70 ~w~gv~C~~~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~-p~~~~ 146 (801)
.-.--.|+. ..++.++.+++ .+|..+. +++++|+|++|++....+..|. .+|++|+|++|.+...+ +..|.
T Consensus 2 ~~~~C~C~~---~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~ 75 (242)
T d1xwdc1 2 HHRICHCSN---RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75 (242)
T ss_dssp CCSSEEECS---SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEE
T ss_pred CCCCCCCCC---CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCC
T ss_conf 498288739---99998189988-7688889--98899987699189649668614643232110221124201001122
Q ss_pred CCCCCCEEECCC-CCCCCCCCHHHHCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCCCCC-CCCCC--CC
Q ss_conf 677668687547-75555688333279999919921798988789-875678988399902564565453-24898--88
Q 003704 147 TLTLLTDMSLNN-NLLSGEIPDAFQSLTGLINLDLSSNNLSGELP-PSLENLSQLTTLHLQNNQLSGTLD-VLQDL--PL 221 (801)
Q Consensus 147 ~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~~-~~~~~--~L 221 (801)
.+++++.+.+.. |.+....+..|.++++|+.|++++|.+....+ ..+..+..+..+..+++.+..... .+... .+
T Consensus 76 ~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l 155 (242)
T d1xwdc1 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 155 (242)
T ss_dssp SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 22222221111123432222221222222222234211112554333222111122222221211122222222223310
Q ss_pred CEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 87982589798986623789977
Q 003704 222 RDLNIENNLFSGPIPEKMLQIPN 244 (801)
Q Consensus 222 ~~L~ls~N~l~g~~p~~l~~l~~ 244 (801)
..+++++|+++. ++....+...
T Consensus 156 ~~L~l~~n~l~~-i~~~~~~~~~ 177 (242)
T d1xwdc1 156 VILWLNKNGIQE-IHNCAFNGTQ 177 (242)
T ss_dssp EEEECCSSCCCE-ECTTTTTTCC
T ss_pred EEEECCCCCCCC-CCCCCCCCHH
T ss_conf 012200123333-2222222011
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.49 E-value=1.4e-16 Score=102.67 Aligned_cols=112 Identities=23% Similarity=0.327 Sum_probs=71.5
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCC
Q ss_conf 574656999997998448867998898633--456679824886888898112367766868754775555688333279
Q 003704 95 LGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSL 172 (801)
Q Consensus 95 ~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 172 (801)
++..+..|++|+.|+|++|+++ .++. +. .+|+.|+|++|.++ .+|..+..+++|+.|++++|.++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCCC-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred HHHHHHCCCCCCEEECCCCCCC-CCCC-CCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCC
T ss_conf 2467762604615199446899-8644-247825357341353432-100003322123333333322222-2-222222
Q ss_pred CCCCEEECCCCCCCCCCC--CCCCCCCCCCEEEEECCCCCCC
Q ss_conf 999919921798988789--8756789883999025645654
Q 003704 173 TGLINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGT 212 (801)
Q Consensus 173 ~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~ 212 (801)
++|+.|++++|+++. ++ ..+..+++|+.|++++|.+...
T Consensus 115 ~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 115 VNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred CCCCCCCCCCCHHCC-CCCCCCCCCCCCCCEEECCCCCCCCC
T ss_conf 234111234102125-54221236777630234279843467
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.45 E-value=3.9e-16 Score=100.20 Aligned_cols=104 Identities=29% Similarity=0.347 Sum_probs=62.5
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 45667982488688889811236776686875477555568833327999991992179898878987567898839990
Q 003704 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204 (801)
Q Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l 204 (801)
.+|++|+|++|+++. ++ .+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|.++ .++ .+..+++|+.|++
T Consensus 48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf 046151994468998-64-4247825357341353432-10000332212333333332222-222-2222223411123
Q ss_pred ECCCCCCCC--CCCCCC-CCCEEECCCCCCCC
Q ss_conf 256456545--324898-88879825897989
Q 003704 205 QNNQLSGTL--DVLQDL-PLRDLNIENNLFSG 233 (801)
Q Consensus 205 s~N~l~g~~--~~~~~~-~L~~L~ls~N~l~g 233 (801)
++|.|+... ..+..+ .|+.|++++|.+..
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCHHCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 41021255422123677763023427984346
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=4.4e-15 Score=94.61 Aligned_cols=36 Identities=25% Similarity=0.527 Sum_probs=14.6
Q ss_pred CEEEEEECCCCCCCC----CCCCCCCCCCCCEEECCCCCC
Q ss_conf 957999069987653----574656999997998448867
Q 003704 80 DIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHI 115 (801)
Q Consensus 80 ~v~~l~L~~~~l~g~----~p~~l~~l~~L~~L~Ls~N~l 115 (801)
.++.|+|++|.+... +...+...+.|+.|+++++.+
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~ 71 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 9788978498377899999999998589988888877754
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=9.5e-14 Score=87.50 Aligned_cols=167 Identities=18% Similarity=0.216 Sum_probs=87.8
Q ss_pred CCEEEEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCEEECCCC-CCCCC-CCCCCCCCCCCCE
Q ss_conf 9957999069987653-574656999997998448867998898633--45667982488-68888-9811236776686
Q 003704 79 SDIIAIILNGANLGGE-LGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDN-QFSGS-IPSSLATLTLLTD 153 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~ 153 (801)
.++..|+|+++.+... +...+..+++|++|+|+++.+++..+..+. .+|++|+|+++ .++.. +...+..+++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf 87887889898457779999997487765145234679867899985189975715100134123554036578874356
Q ss_pred EECCCC-CCCCC-CCHHHHC-CCCCCEEECCCC--CCCC-CCCCCCCCCCCCCEEEEECC-CCCCCC-CCCCCC-CCCEE
Q ss_conf 875477-55556-8833327-999991992179--8988-78987567898839990256-456545-324898-88879
Q 003704 154 MSLNNN-LLSGE-IPDAFQS-LTGLINLDLSSN--NLSG-ELPPSLENLSQLTTLHLQNN-QLSGTL-DVLQDL-PLRDL 224 (801)
Q Consensus 154 L~L~~N-~l~g~-~p~~~~~-l~~L~~L~Ls~N--~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~~-~~~~~~-~L~~L 224 (801)
|+++++ .++.. +...+.. .+.|+.|++++. .++. .+......+++|+.|++++| .+++.. ..+... .|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEE
T ss_conf 52245332333220001000111110122135542444443434232322212355322347783033332135768779
Q ss_pred ECCC-CCCCCCCCCCCCCCCCC
Q ss_conf 8258-97989866237899774
Q 003704 225 NIEN-NLFSGPIPEKMLQIPNF 245 (801)
Q Consensus 225 ~ls~-N~l~g~~p~~l~~l~~l 245 (801)
++++ +.+++.....+.+++.|
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTC
T ss_pred ECCCCCCCCHHHHHHHHCCCCC
T ss_conf 8999997873789997269998
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.22 E-value=1.2e-12 Score=81.63 Aligned_cols=154 Identities=19% Similarity=0.293 Sum_probs=73.2
Q ss_pred CCEEEEEECCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCC---------------CCCCCEEECCCCCCCC
Q ss_conf 9957999069987653----57465699999799844886799889863---------------3456679824886888
Q 003704 79 SDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGSIPSIL---------------PVTMQNFFLSDNQFSG 139 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~---------------~~~L~~L~Ls~N~l~~ 139 (801)
.+++.|+|++|.+... +...+...+.|+.|+|++|.+...-...+ ...|+.+.+++|.+..
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 77563300001345543331011100234321000002466665431111212222110001467642111013650135
Q ss_pred CC----CCCCCCCCCCCEEECCCCCCCCC-----CCHHHHCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEEC
Q ss_conf 89----81123677668687547755556-----883332799999199217989887----898756789883999025
Q 003704 140 SI----PSSLATLTLLTDMSLNNNLLSGE-----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQN 206 (801)
Q Consensus 140 ~~----p~~~~~l~~L~~L~L~~N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~ls~ 206 (801)
.. ...+..+..|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred CCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHC
T ss_conf 54332211112333213354333222222232002433211012112223333222222223444332322111103004
Q ss_pred CCCCCCC-----CC---CCCCCCCEEECCCCCCC
Q ss_conf 6456545-----32---48988887982589798
Q 003704 207 NQLSGTL-----DV---LQDLPLRDLNIENNLFS 232 (801)
Q Consensus 207 N~l~g~~-----~~---~~~~~L~~L~ls~N~l~ 232 (801)
|.|++.- .. .....|++|++++|+++
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 7567156678887763156888898989898698
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.18 E-value=2.6e-10 Score=69.18 Aligned_cols=148 Identities=12% Similarity=0.117 Sum_probs=94.1
Q ss_pred HHHHHCCCCCCCCEEEECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCEEEEECCE
Q ss_conf 575431688667815303960899999399959999993454576355999999999865049-9972321207872594
Q 003704 503 SLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ 581 (801)
Q Consensus 503 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~~~~ 581 (801)
++....+.|+..+..+.++...||+... ++..+.+|+....... ....+.+|...+..+. +--+-+++.+..+.+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCC--CHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 9997513527997678998771899990-8986999984887653--255699999999987606998728999750896
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------
Q ss_conf 89999514799988998018321378999999999999999999998569------------------------------
Q 003704 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC------------------------------ 631 (801)
Q Consensus 582 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------ 631 (801)
.++||++++|.++.+..... . ....++.++++.+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEEECCCCCCCCCCCCC------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 49999860433435433440------2---69999998999999985568421435764465655577899877655554
Q ss_pred --------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf --------------------------9993835889995897799949996146887
Q 003704 632 --------------------------QPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 632 --------------------------~~~ivHrDLkp~NILl~~~~~~ki~DfGla~ 662 (801)
...++|+|+.+.|||++++..+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 303323200579999999984498678178986004764236499659996023144
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=2.6e-12 Score=79.83 Aligned_cols=172 Identities=18% Similarity=0.235 Sum_probs=85.3
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCC--CCCCCEEECCCC-CCCCC-CCCCCCC-CCCC
Q ss_conf 99579990699876535746569999979984488-67998-89863--345667982488-68888-9811236-7766
Q 003704 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNN-HIGGS-IPSIL--PVTMQNFFLSDN-QFSGS-IPSSLAT-LTLL 151 (801)
Q Consensus 79 ~~v~~l~L~~~~l~g~~p~~l~~l~~L~~L~Ls~N-~l~g~-~p~~~--~~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L 151 (801)
.+++.|+|+++.+.......++.+++|+.|+|+++ .++.. +.... .++|++|+++++ .++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 77651452346798678999851899757151001341235540365788743565224533233322000100011111
Q ss_pred CEEECCCC--CCCCC-CCHHHHCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEEEECC-CCCCCC-CCCCC-CCCCEE
Q ss_conf 86875477--55556-8833327999991992179-898878987567898839990256-456545-32489-888879
Q 003704 152 TDMSLNNN--LLSGE-IPDAFQSLTGLINLDLSSN-NLSGELPPSLENLSQLTTLHLQNN-QLSGTL-DVLQD-LPLRDL 224 (801)
Q Consensus 152 ~~L~L~~N--~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~ls~N-~l~g~~-~~~~~-~~L~~L 224 (801)
+.|++++. .++.. +...+..+++|+.|++++| .+++.....+.++++|++|+++++ .+++.. ..+.. ..|+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEE
T ss_conf 01221355424444434342323222123553223477830333321357687798999997873789997269998989
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 82589798986623789977424487
Q 003704 225 NIENNLFSGPIPEKMLQIPNFRKDGN 250 (801)
Q Consensus 225 ~ls~N~l~g~~p~~l~~l~~l~~~~N 250 (801)
+++++.-.+.+..-...++.+.+..+
T Consensus 231 ~l~~~~~d~~l~~l~~~lp~L~i~~~ 256 (284)
T d2astb2 231 QVFGIVPDGTLQLLKEALPHLQINCS 256 (284)
T ss_dssp ECTTSSCTTCHHHHHHHSTTSEESCC
T ss_pred EEECCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 64488898999999976843661686
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=1.1e-12 Score=81.88 Aligned_cols=85 Identities=28% Similarity=0.359 Sum_probs=36.7
Q ss_pred CCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CHHHH-CCCCCCEEECCCCCCCCC----CCCC
Q ss_conf 56679824886888----89811236776686875477555568----83332-799999199217989887----8987
Q 003704 126 TMQNFFLSDNQFSG----SIPSSLATLTLLTDMSLNNNLLSGEI----PDAFQ-SLTGLINLDLSSNNLSGE----LPPS 192 (801)
Q Consensus 126 ~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~----p~~~~-~l~~L~~L~Ls~N~l~g~----~p~~ 192 (801)
++++|+|++|.++. .+...+..+++|+.|+|++|.|+..- ...+. ...+|+.|+|++|.++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf 99999828999988999999999853999888979598597289999999984378877887788877543221012110
Q ss_pred CCCCCCCCEEEEECCCCC
Q ss_conf 567898839990256456
Q 003704 193 LENLSQLTTLHLQNNQLS 210 (801)
Q Consensus 193 ~~~l~~L~~L~ls~N~l~ 210 (801)
+..+++|++|++++|.++
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred HHCCCCCCCCCCCCCCCH
T ss_conf 000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=7.6e-12 Score=77.38 Aligned_cols=108 Identities=24% Similarity=0.336 Sum_probs=61.4
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCHHHHCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf 5667982488688889-8112367766868754775555----6883332799999199217989887----898756-7
Q 003704 126 TMQNFFLSDNQFSGSI-PSSLATLTLLTDMSLNNNLLSG----EIPDAFQSLTGLINLDLSSNNLSGE----LPPSLE-N 195 (801)
Q Consensus 126 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~-~ 195 (801)
+|+.|++++|++++.. ...+..+++++.|+|++|.++. .+...+..+++|+.|||++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEEEECCCCCCCC-----CCCCC-CCCCEEECCCCCCCC
Q ss_conf 898839990256456545-----32489-888879825897989
Q 003704 196 LSQLTTLHLQNNQLSGTL-----DVLQD-LPLRDLNIENNLFSG 233 (801)
Q Consensus 196 l~~L~~L~ls~N~l~g~~-----~~~~~-~~L~~L~ls~N~l~g 233 (801)
..+|+.|+|++|.++... ..+.. ..|++|++++|.+..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf 88778877888775432210121100003432002444332023
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.93 E-value=3.7e-09 Score=63.05 Aligned_cols=130 Identities=18% Similarity=0.160 Sum_probs=79.4
Q ss_pred EEEECCC-CEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC--CCCCCCCCEEEEECCEEEEEEECCCCC
Q ss_conf 1530396-0899999399959999993454576355999999999865049--997232120787259489999514799
Q 003704 516 LIGAGML-GSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR--HANIVELKGYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 516 ~iG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--Hpniv~l~~~~~~~~~~~lV~E~~~~g 592 (801)
.+..|.. ..||+....++..+.+|....... ..+..|...++.+. .-.+.+++.+..+.+..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf 76786547758999938987899995896677-----6899999999999865999886132224566159998744135
Q ss_pred CHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q ss_conf 988998018321378999999999999999999998--------------------------------------------
Q 003704 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH-------------------------------------------- 628 (801)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-------------------------------------------- 628 (801)
++.+.. ... ..++.++...|..||
T Consensus 92 ~~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCCCCC---------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf 543221---------268---99999999999987368854488755412468899999987541101134011213799
Q ss_pred -------HCC----CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -------569----9993835889995897799949996146887
Q 003704 629 -------EIC----QPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 629 -------~~~----~~~ivHrDLkp~NILl~~~~~~ki~DfGla~ 662 (801)
... ...++|+|+.+.|||++.+..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 999999871876579567867888763577379658999853326
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.3e-10 Score=70.73 Aligned_cols=90 Identities=18% Similarity=0.293 Sum_probs=47.3
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEEEEECCCCCCCCC--CCCCCCC
Q ss_conf 3677668687547755556883332799999199217989887--89875678988399902564565453--2489888
Q 003704 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE--LPPSLENLSQLTTLHLQNNQLSGTLD--VLQDLPL 221 (801)
Q Consensus 146 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~ls~N~l~g~~~--~~~~~~L 221 (801)
..+..+..+++.+|... .++..+..++.|+.|+|++|+++.. ++..+..+++|+.|+|++|.++...+ .+....|
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L 117 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred HHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCC
T ss_conf 54664011225556766-60788974878788637776666773158898658856100043572134234422203310
Q ss_pred CEEECCCCCCCCCCC
Q ss_conf 879825897989866
Q 003704 222 RDLNIENNLFSGPIP 236 (801)
Q Consensus 222 ~~L~ls~N~l~g~~p 236 (801)
+.+++++|.++....
T Consensus 118 ~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 118 EELWLDGNSLSDTFR 132 (162)
T ss_dssp SSCCCTTSTTSSSSS
T ss_pred CEEECCCCCCCCCCC
T ss_conf 426648997676766
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.68 E-value=1.2e-07 Score=54.94 Aligned_cols=78 Identities=18% Similarity=0.075 Sum_probs=45.1
Q ss_pred CCEEEECCCCEEEEEEECC-CCEEEEEEECCCC-----CCHHHHHHHHHHHHHHHCCC-C-C-CCCCCCEEEEECCEEEE
Q ss_conf 7815303960899999399-9599999934545-----76355999999999865049-9-9-72321207872594899
Q 003704 514 ENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRA-----SSQQKDDEFLELVNNIDRIR-H-A-NIVELKGYCAEHGQRLL 584 (801)
Q Consensus 514 ~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~~~e~~~l~~l~-H-p-niv~l~~~~~~~~~~~l 584 (801)
.+.||.|....||++...+ ++.+.||.-.... .......+...|.+.+..+. + | .+.+++. .+.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCCEE
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899--85988779
Q ss_pred EEECCCCCC
Q ss_conf 995147999
Q 003704 585 IYEYCSNGT 593 (801)
Q Consensus 585 V~E~~~~gs 593 (801)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEECCCCCC
T ss_conf 871357765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=8.2e-09 Score=61.21 Aligned_cols=44 Identities=25% Similarity=0.093 Sum_probs=19.1
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf 12367766868754775555688333279999919921798988
Q 003704 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG 187 (801)
Q Consensus 144 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 187 (801)
.+..+++|+.|+|++|.++..-+-.+.....|+.|++++|.+..
T Consensus 86 ~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCC
T ss_conf 98658856100043572134234422203310426648997676
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.36 E-value=1e-05 Score=44.74 Aligned_cols=139 Identities=15% Similarity=0.123 Sum_probs=74.6
Q ss_pred CCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-----CCCCCCCC--EEEEECCEEEEEEECCCCC
Q ss_conf 3960899999399959999993454576355999999999865049-----99723212--0787259489999514799
Q 003704 520 GMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----HANIVELK--GYCAEHGQRLLIYEYCSNG 592 (801)
Q Consensus 520 G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----Hpniv~l~--~~~~~~~~~~lV~E~~~~g 592 (801)
+..-.||+++..+|..+++|....... ...++..|...+..+. .+..+..- ......+..+.++++++|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCC
T ss_conf 612026999838999799998478778---89999999999999985599878752068980566534799998652776
Q ss_pred CHH-----H---------HHHC----CC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHH----C
Q ss_conf 988-----9---------9801----83-2137899999-------------------99999999999999985----6
Q 003704 593 TLQ-----D---------MLHS----DD-ELKNNLSWNT-------------------RIRMALGAARALEYLHE----I 630 (801)
Q Consensus 593 sL~-----~---------~l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~----~ 630 (801)
.+. . .+|. .. ......++.. ...+...+...+..+.. .
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 88999999999989999998863035786556778978876656899987476998898999999999999999845456
Q ss_pred CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 999938358899958977999499961468878
Q 003704 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (801)
Q Consensus 631 ~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~~ 663 (801)
...+++|+|+.+.|||++.+ ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 87120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.30 E-value=1.7e-05 Score=43.52 Aligned_cols=159 Identities=13% Similarity=0.117 Sum_probs=81.2
Q ss_pred CHHHHHHHHCCCCCCCCEE-----EECCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-----CCCC
Q ss_conf 2166575431688667815-----30396089999939995999999345457635599999999986504-----9997
Q 003704 499 FTIASLQQYTNSFSQENLI-----GAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-----RHAN 568 (801)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~i-----G~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-----~Hpn 568 (801)
.+.++++.+..+|.+++.. ..|.--+.|+....+|+ +++|++...... . .+..+++.+..+ ..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-~---~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-N---DLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-C---HHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCCH-H---HHHHHHHHHHHHHHCCCCCCC
T ss_conf 89999999998679998568523788852673899978972-899980789998-8---999999998754302555455
Q ss_pred CCCCC-E--EEEECCEEEEEEECCCCCCHH--------------HHHHCC---C--CCCCCC------------------
Q ss_conf 23212-0--787259489999514799988--------------998018---3--213789------------------
Q 003704 569 IVELK-G--YCAEHGQRLLIYEYCSNGTLQ--------------DMLHSD---D--ELKNNL------------------ 608 (801)
Q Consensus 569 iv~l~-~--~~~~~~~~~lV~E~~~~gsL~--------------~~l~~~---~--~~~~~l------------------ 608 (801)
.+... | +....+....++.+..+.... ..++.. . ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred CCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHH
T ss_conf 64104897621341255024531146553332046788888998764544432024531011101200245677776531
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 999999999999999999985-699993835889995897799949996146887
Q 003704 609 SWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (801)
Q Consensus 609 ~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDLkp~NILl~~~~~~ki~DfGla~ 662 (801)
........+..+...+...+. ....++||+|+.++||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 1412799999998764204855454503337863656402045412674222123
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.11 E-value=2.9e-07 Score=52.97 Aligned_cols=10 Identities=10% Similarity=0.614 Sum_probs=4.5
Q ss_pred CCCCEEECCC
Q ss_conf 9997998448
Q 003704 103 SSIRVIDLSN 112 (801)
Q Consensus 103 ~~L~~L~Ls~ 112 (801)
+.|+.|+|++
T Consensus 15 ~~L~~L~L~~ 24 (167)
T d1pgva_ 15 TDLKEVNINN 24 (167)
T ss_dssp SSCCEEECTT
T ss_pred CCCCEEEECC
T ss_conf 9981978279
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.02 E-value=6.6e-06 Score=45.74 Aligned_cols=73 Identities=12% Similarity=0.163 Sum_probs=44.6
Q ss_pred CCEEEECCCCEEEEEEECCC--------CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCCEEEEECCEEEE
Q ss_conf 78153039608999993999--------5999999345457635599999999986504999723-21207872594899
Q 003704 514 ENLIGAGMLGSVYRAQLPDG--------KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV-ELKGYCAEHGQRLL 584 (801)
Q Consensus 514 ~~~iG~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpniv-~l~~~~~~~~~~~l 584 (801)
.+.|+.|-.-.+|++...++ ..|.++.... ... .....+|..+++.+.-.++. ++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CCH---HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CE
T ss_conf 99917853343489996887754457898179996599-611---65899999999999757999808998189----56
Q ss_pred EEECCCCCCH
Q ss_conf 9951479998
Q 003704 585 IYEYCSNGTL 594 (801)
Q Consensus 585 V~E~~~~gsL 594 (801)
|+||++|.++
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEECCCCC
T ss_conf 9997345548
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.97 E-value=1.3e-06 Score=49.53 Aligned_cols=64 Identities=17% Similarity=0.206 Sum_probs=25.2
Q ss_pred HHCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEECCCCCCCC-----CCC-CCCCCCEEECCCCCCC
Q ss_conf 32799999199217989887----8987567898839990256456545-----324-8988887982589798
Q 003704 169 FQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGTL-----DVL-QDLPLRDLNIENNLFS 232 (801)
Q Consensus 169 ~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~-----~~~-~~~~L~~L~ls~N~l~ 232 (801)
+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.|+..- ..+ ....|++|++++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 76377645401201562156798875310002343300330102145999999999984893898778877688
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.29 E-value=2.1e-05 Score=43.08 Aligned_cols=40 Identities=20% Similarity=0.244 Sum_probs=15.5
Q ss_pred CCCCCCEEECCCCCCCCCCC----HHHHCCCCCCEEECCCCCCC
Q ss_conf 67766868754775555688----33327999991992179898
Q 003704 147 TLTLLTDMSLNNNLLSGEIP----DAFQSLTGLINLDLSSNNLS 186 (801)
Q Consensus 147 ~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~ 186 (801)
..+.|+.|+|++|.++...- ..+.....++.+++++|.+.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCC
T ss_conf 19825743015896117789999987752122101210254322
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.26 E-value=3.5e-06 Score=47.16 Aligned_cols=63 Identities=29% Similarity=0.406 Sum_probs=24.3
Q ss_pred CCCCCCCEEECCCCCCCCC----CCHHHHCCCCCCEEEC--CCCCCCC----CCCCCCCCCCCCCEEEEECCC
Q ss_conf 3677668687547755556----8833327999991992--1798988----789875678988399902564
Q 003704 146 ATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDL--SSNNLSG----ELPPSLENLSQLTTLHLQNNQ 208 (801)
Q Consensus 146 ~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~L--s~N~l~g----~~p~~~~~l~~L~~L~ls~N~ 208 (801)
.....++.+++++|.+... +-..+...++|+.++| +.|.+.. .+...+...++|+.|+++.|.
T Consensus 71 ~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 71 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 5212210121025432201478899999848652477321677867679999999999849984788581898
|